<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:hsic="http://henryschein.com/20221231" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" version="-//XBRL International//DTD XHTML Inline XBRL 1.1//EN" xml:lang="en-US"><head><title>hsic-20221231</title>
<meta http-equiv="Content-Type" content="text/html;">
</head>
<body style="background-color:RGB(230, 230, 230);font-family:Times New Roman;font-style:normal;font-size:13.28px;font-weight:normal;font-stretch:normal;color:#000000;">
<div style="display:none;">
<ix:header>
<ix:hidden>
<ix:nonnumeric id="ID_93" name="dei:AmendmentFlag" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">false</ix:nonnumeric>
<ix:nonfraction id="ID_111" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction>
<ix:nonfraction id="ID_134" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction>
<ix:nonnumeric id="ID_206" name="dei:DocumentFiscalYearFocus" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">2022</ix:nonnumeric>
<ix:nonfraction id="ID_578" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction>
<ix:nonfraction id="ID_580" name="us-gaap:PreferredStockSharesAuthorized" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">1000000</ix:nonfraction>
<ix:nonfraction id="ID_582" name="us-gaap:PreferredStockSharesOutstanding" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="shares" decimals="INF" format="ixt-sec:numwordsen">none</ix:nonfraction>
<ix:nonfraction id="ID_601" name="us-gaap:InterestExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction>
<ix:nonfraction id="ID_686" name="us-gaap:InterestExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction>
<ix:nonfraction id="ID_687" name="us-gaap:InterestExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction>
<ix:nonfraction id="ID_707" name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction>
<ix:nonfraction id="ID_709" name="us-gaap:CommonStockSharesAuthorized" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">480000000</ix:nonfraction>
<ix:nonnumeric id="ID_772" name="dei:DocumentFiscalPeriodFocus" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">FY</ix:nonnumeric>
<ix:nonnumeric id="ID_777" name="dei:EntityCentralIndexKey" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">0001000228</ix:nonnumeric>
<ix:nonnumeric id="ID_796" name="dei:CurrentFiscalYearEndDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">--12-31</ix:nonnumeric>
<ix:nonfraction id="ID_1128" name="us-gaap:TemporaryEquityNetIncome" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentDiscontinuedOperationsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction>
<ix:nonfraction id="ID_1129" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction>
<ix:nonfraction id="ID_1748" name="hsic:CurrentCompensationPaidUnderLifetimeConsultingAgreement" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_LifetimeConsultingAgreementMember" unitref="USD" decimals="0">400000</ix:nonfraction>
<ix:nonfraction id="ID_1749" name="hsic:AmountOfIncreaseEffectiveEveryFifthYearOnLifetimeConsultingAgreement" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_LifetimeConsultingAgreementMember" unitref="USD" decimals="0">25000</ix:nonfraction>
<ix:nonfraction id="ID_1756" name="us-gaap:GainLossRelatedToLitigationSettlement" contextref="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_CasesInUtahMember" unitref="USD" decimals="0">60000</ix:nonfraction>
<ix:nonfraction id="ID_1759" name="hsic:MaximumSalesOfOpioidsInNorthAmericaPercentage" contextref="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_ActionsConsolidatedInTheMultiDistrictLitigationMember_srt_RangeAxis_srt_MaximumMember" unitref="pure" decimals="4">0.002</ix:nonfraction>
<ix:nonfraction id="ID_1803" name="hsic:StockBasedCompensationPercentageOfOptionsVestPerYear" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">33.33</ix:nonfraction>
<ix:nonnumeric id="ID_794" name="dei:DocumentAnnualReport" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleantrue">☒</ix:nonnumeric>
<ix:nonnumeric id="ID_795" name="dei:DocumentTransitionReport" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleanfalse">☐</ix:nonnumeric>
<ix:nonnumeric id="ID_782" name="dei:EntityRegistrantName" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">HENRY SCHEIN INC</ix:nonnumeric>
<ix:nonnumeric id="ID_780" name="dei:SecurityExchangeName" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">NASDAQ</ix:nonnumeric>
<ix:nonnumeric id="ID_775" name="dei:EntityWellKnownSeasonedIssuer" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">Yes</ix:nonnumeric>
<ix:nonnumeric id="ID_893" name="dei:EntityVoluntaryFilers" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">No</ix:nonnumeric>
<ix:nonnumeric id="ID_791" name="dei:EntityCurrentReportingStatus" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">Yes</ix:nonnumeric>
<ix:nonnumeric id="ID_792" name="dei:EntityInteractiveDataCurrent" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">Yes</ix:nonnumeric>
<ix:nonnumeric id="ID_172" name="dei:EntitySmallBusiness" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleanfalse">☐</ix:nonnumeric>
<ix:nonnumeric id="ID_781" name="dei:EntityEmergingGrowthCompany" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleanfalse">☐</ix:nonnumeric>
<ix:nonnumeric id="ID_883" name="dei:IcfrAuditorAttestationFlag" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleantrue">☒</ix:nonnumeric>
<ix:nonnumeric id="ID_790" name="dei:EntityShellCompany" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:booleanfalse">☒</ix:nonnumeric>
<ix:nonfraction id="ID_1420" name="us-gaap:CommitmentsAndContingencies" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" xsi:nil="true"></ix:nonfraction>
<ix:nonfraction id="ID_1421" name="us-gaap:CommitmentsAndContingencies" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" xsi:nil="true"></ix:nonfraction>
<ix:nonnumeric id="ID_1810" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextref="AS_OF_Dec25_2021_Entity_0001000228">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonnumeric>
<ix:nonnumeric id="ID_1809" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextref="AS_OF_Dec31_2022_Entity_0001000228">http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent</ix:nonnumeric>
<ix:nonnumeric id="ID_259" name="hsic:NoteReceivableMaturityDateRangeEnd" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember" format="ixt:datemonthdayyear">5/11/2028</ix:nonnumeric>
<ix:nonnumeric id="ID_1380" name="us-gaap:DebtInstrumentTerm" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">P5Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1680" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">1/20/2012</ix:nonnumeric>
<ix:nonnumeric id="ID_1688" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">1/20/2024</ix:nonnumeric>
<ix:nonnumeric id="ID_1681" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">12/24/2012</ix:nonnumeric>
<ix:nonnumeric id="ID_1689" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">12/24/2024</ix:nonnumeric>
<ix:nonnumeric id="ID_1682" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/16/2017</ix:nonnumeric>
<ix:nonnumeric id="ID_1690" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/16/2027</ix:nonnumeric>
<ix:nonnumeric id="ID_1683" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">9/15/2017</ix:nonnumeric>
<ix:nonnumeric id="ID_1691" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">9/15/2029</ix:nonnumeric>
<ix:nonnumeric id="ID_1684" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">1/2/2018</ix:nonnumeric>
<ix:nonnumeric id="ID_1692" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">1/2/2028</ix:nonnumeric>
<ix:nonnumeric id="ID_1685" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">9/2/2020</ix:nonnumeric>
<ix:nonnumeric id="ID_1693" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">9/2/2030</ix:nonnumeric>
<ix:nonnumeric id="ID_1686" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/2/2021</ix:nonnumeric>
<ix:nonnumeric id="ID_1694" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/2/2031</ix:nonnumeric>
<ix:nonnumeric id="ID_1687" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/2/2021</ix:nonnumeric>
<ix:nonnumeric id="ID_1695" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyear">6/2/2033</ix:nonnumeric>
<ix:nonnumeric id="ID_1721" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember">P4Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1722" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember">P3Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1723" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_NonEmployeeDirectorStockIncentivePlanMember">P12M</ix:nonnumeric>
<ix:nonnumeric id="ID_1726" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_LongTermIncentiveProgram2018Member">P3Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_SpecialPandemicRecognitionAwardMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember">P2Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1155A" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">P6Y</ix:nonnumeric>
<ix:nonnumeric id="ID_1732" name="hsic:TransitionServicesAgreementPeriodServicesProvided" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember">P24M</ix:nonnumeric>
<ix:nonnumeric id="ID_1732A" name="hsic:TransitionServicesAgreementPeriodServicesProvided" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember">P24M</ix:nonnumeric>
<ix:nonnumeric id="ID_1733" name="hsic:RoyaltyAgreementTerm" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementScenarioAxis_us-gaap_ScenarioPlanMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">P10Y</ix:nonnumeric>
</ix:hidden>
<ix:references xml:lang="en-US"><link:schemaref xlink:href="hsic-20221231.xsd" xlink:type="simple"></link:schemaref></ix:references>
<ix:resources>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:FinanceReceivablesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hsic:ComputerEquipmentAndSoftwareMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:TimeBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:OtherCommitmentsAxis">hsic:EmploymentConsultingAndNoncompeteAgreementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hsic:ComputerEquipmentAndSoftwareMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:TimeBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:StockIncentivePlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:FinanceReceivablesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:TimeBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hsic:ComputerEquipmentAndSoftwareMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:FinanceReceivablesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CounterpartyNameAxis_hsic_SingleLargestSupplierMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_PurchasesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hsic:PurchasesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">hsic:SingleLargestSupplierMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hsic:ComputerEquipmentAndSoftwareMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_NonEmployeeDirectorStockIncentivePlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:NonEmployeeDirectorStockIncentivePlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CounterpartyNameAxis_hsic_TopTenHealthCareDistributionSuppliersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_PurchasesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hsic:PurchasesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CounterpartyNameAxis">hsic:TopTenHealthCareDistributionSuppliersMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Feb07_2019_TO_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_VetsFirstCorpMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DisposalGroupClassificationAxis">hsic:AnimalHealthMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="dei:LegalEntityAxis">hsic:VetsFirstCorpMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:OwnershipAxis">hsic:CovetrusIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-02-07</xbrli:startdate>

      <xbrli:enddate>2019-02-07</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DisposalGroupClassificationAxis">hsic:AnimalHealthMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_VetsFirstCorpMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DisposalGroupClassificationAxis">hsic:AnimalHealthMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="dei:LegalEntityAxis">hsic:VetsFirstCorpMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:OwnershipAxis">hsic:CovetrusIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-02-07</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_HenryScheinStockholdersAndTheShareSaleInvestorsMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DisposalGroupClassificationAxis">hsic:AnimalHealthMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="dei:LegalEntityAxis">hsic:HenryScheinStockholdersAndTheShareSaleInvestorsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:OwnershipAxis">hsic:CovetrusIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-02-07</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Feb07_2023_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2023-02-07</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Jun25_2022_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-06-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:CorporateTsaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:CorporateTsaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:CorporateTsaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_country_US">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:LocationsOtherThanUnitedStatesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:CovetrusIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:TrademarkAndTradenameMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentContinuingOperationsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentDiscontinuedOperationsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForwardContractsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForwardContractsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Mar20_2020_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SerpAndDcpMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-03-20</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SerpAndDcpMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementScenarioAxis_us-gaap_ScenarioPlanMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementScenarioAxis">us-gaap:ScenarioPlanMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:VariableRateAxis">hsic:AssetBackedCommercialPaperRateMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:VariableRateAxis">hsic:AssetBackedCommercialPaperRateMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:VariableRateAxis">hsic:AssetBackedCommercialPaperRateMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:VariableRateAxis">hsic:AssetBackedCommercialPaperRateMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">hsic:VariousBankCreditLinesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">hsic:VariousBankCreditLinesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_CommittedLoanAssociatedWithAnimalHealthSpinOffMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">hsic:CommittedLoanAssociatedWithAnimalHealthSpinOffMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_CommittedLoanAssociatedWithAnimalHealthSpinOffMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">hsic:CommittedLoanAssociatedWithAnimalHealthSpinOffMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_RevolvingCreditFacilityApril2022Member">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">hsic:RevolvingCreditFacilityApril2022Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_UnfundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_UnfundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:UnfundedPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:DentalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:MedicalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthCareDistributionAndTechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:CorporateTsaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:CorporateTsaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">hsic:InternationalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SupplementalExecutiveRetirementPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SupplementalExecutiveRetirementPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SupplementalExecutiveRetirementPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">hsic:DeferredCompensationBonusAndCommissionPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">hsic:DeferredCompensationBonusAndCommissionPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">srt:ManagementMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">hsic:DeferredCompensationBonusAndCommissionPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:Qualified401kPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:Qualified401kPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:Qualified401kPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_PledgedStatusAxis_us-gaap_AssetPledgedAsCollateralMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_PledgedStatusAxis_us-gaap_AssetPledgedAsCollateralMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PledgedStatusAxis">us-gaap:AssetPledgedAsCollateralMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_RecourseStatusAxis_us-gaap_RecourseMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RecourseStatusAxis">us-gaap:RecourseMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_RecourseStatusAxis_us-gaap_RecourseMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RecourseStatusAxis">us-gaap:RecourseMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2019-12-28</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:TrademarkAndTradenameMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:TrademarkAndTradenameMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:TrademarkAndTradenameMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:TrademarkAndTradenameMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hsic:ProductDevelopmentMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2020-12-26</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Jun27_2021_TO_Sep25_2021_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hsic:HuFriedyMfgCoLlcMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-06-27</xbrli:startdate>

      <xbrli:enddate>2021-09-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep27_2020_TO_Dec26_2020_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hsic:HuFriedyMfgCoLlcMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-09-27</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">hsic:PropertyOwnedByEmployeesAndShareholdersMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">hsic:PropertyOwnedByEmployeesAndShareholdersMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">hsic:PropertyOwnedByEmployeesAndShareholdersMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_MajorCustomersAxis_hsic_AnySingleCustomerMember_srt_RangeAxis_srt_MaximumMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:MajorCustomersAxis">hsic:AnySingleCustomerMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:FairValueDisclosureItemAmountsDomain</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_OtherComprehensiveIncomeLocationAxis_us-gaap_OtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_OtherComprehensiveIncomeLocationAxis_us-gaap_OtherComprehensiveIncomeMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SerpAndDcpMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember_us-gaap_VariableRateAxis_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SerpAndDcpMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-09-25</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Jun26_2022_TO_Sep24_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-06-26</xbrli:startdate>

      <xbrli:enddate>2022-09-24</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:USTradeAccountsReceivableSecuritizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_hsic_AccruedTaxesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">hsic:AccruedTaxesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_hsic_AccruedTaxesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">hsic:AccruedTaxesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_BuildingVacatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:BuildingVacatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-09-25</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_BuildingVacatedMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:BuildingVacatedMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-09-25</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-09-25</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_hsic_MidwayDentalSupplyMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">hsic:MidwayDentalSupplyMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-09-25</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ExitAndOtherRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_IntegrationEmployeeRelatedAndOtherCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:IntegrationEmployeeRelatedAndOtherCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_AcceleratedDepreciationAndAmortizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:AcceleratedDepreciationAndAmortizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ExitAndOtherRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_AcceleratedDepreciationAndAmortizationMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:AcceleratedDepreciationAndAmortizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ExitAndOtherRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ImpairmentAndAcceleratedDepreciationAndAmortizationMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ImpairmentAndAcceleratedDepreciationAndAmortizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ImpairmentAndAcceleratedDepreciationAndAmortizationMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ImpairmentAndAcceleratedDepreciationAndAmortizationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:ExitAndOtherRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_IntegrationEmployeeRelatedAndOtherCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:IntegrationEmployeeRelatedAndOtherCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">hsic:SeveranceAndEmployeeRelatedCostsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:TechnologyAndValueAddedServicesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_ActionsConsolidatedInTheMultiDistrictLitigationMember_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentContinuingOperationsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentContinuingOperationsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">hsic:ActionsConsolidatedInTheMultiDistrictLitigationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2024Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesDecember2024Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesJune2027Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesSeptember2029Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesJanuary2028Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:Privateplacementfacilities2030memberMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2031Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2033Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2024Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesDecember2024Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesJune2027Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesSeptember2029Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilitiesJanuary2028Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:Privateplacementfacilities2030memberMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2031Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">hsic:PrivatePlacementFacilitiesMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">hsic:PrivatePlacementFacilities2033Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:EmployeeAndDirectorsStockOptionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:EmployeeAndDirectorsStockOptionsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_NonEmployeeDirectorStockIncentivePlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:TimeBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:NonEmployeeDirectorStockIncentivePlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_LongTermIncentiveProgram2018Member">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:LongTermIncentiveProgram2018Member</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_SpecialPandemicRecognitionAwardMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:StockIncentivePlanMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:SpecialPandemicRecognitionAwardMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">hsic:StockIncentivePlanMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:CovetrusIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hsic:InternetBrandsIncMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:TotalReturnSwapMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:SerpAndDcpMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_LifetimeConsultingAgreementMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:OtherCommitmentsAxis">hsic:LifetimeConsultingAgreementMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_DchHealthCareAuthorityEtAlMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">hsic:DchHealthCareAuthorityEtAlMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_OtherHospitalsLocatedThroughoutFloridaMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">hsic:OtherHospitalsLocatedThroughoutFloridaMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_CasesInUtahMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">hsic:CasesInUtahMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-12-01</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_ActionsConsolidatedInTheMultiDistrictLitigationMember_srt_RangeAxis_srt_MaximumMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="srt:LitigationCaseAxis">hsic:ActionsConsolidatedInTheMultiDistrictLitigationMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2022-12-01</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_CurrentOperatingLeaseLiabilitiesMember_us-gaap_ConcentrationRiskByTypeAxis_hsic_RelatedPartyConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">hsic:PropertyOwnedByEmployeesAndShareholdersMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">hsic:RelatedPartyConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hsic:CurrentOperatingLeaseLiabilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_NonCurrentOperatingLeaseLiabilitiesMember_us-gaap_ConcentrationRiskByTypeAxis_hsic_RelatedPartyConcentrationRiskMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">hsic:PropertyOwnedByEmployeesAndShareholdersMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByTypeAxis">hsic:RelatedPartyConcentrationRiskMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">hsic:NonCurrentOperatingLeaseLiabilitiesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2020-12-27</xbrli:startdate>

      <xbrli:enddate>2021-12-25</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">hsic:RestrictedStockAndRestrictedStockUnitAwardsMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2019-12-29</xbrli:startdate>

      <xbrli:enddate>2020-12-26</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:Qualified401kPlanMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">hsic:Qualified401kPlanMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_BusinessesWithinMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:BusinessesWithinMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_BusinessesWithinMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">hsic:HealthcareDistributionMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">hsic:BusinessesWithinMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:startdate>2021-12-26</xbrli:startdate>

      <xbrli:enddate>2022-12-31</xbrli:enddate>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_FundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:FundedPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2022-12-31</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:context id="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_FundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember">

    <xbrli:entity>

      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier>

      <xbrli:segment>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember>

        <xbrldi:explicitmember dimension="us-gaap:RetirementPlanFundingStatusAxis">us-gaap:FundedPlanMember</xbrldi:explicitmember>

      </xbrli:segment>

    </xbrli:entity>

    <xbrli:period>

      <xbrli:instant>2021-12-25</xbrli:instant>

    </xbrli:period>

  </xbrli:context>

  <xbrli:unit id="EUR" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>iso4217:EUR</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="USD" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>iso4217:USD</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="pure" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>xbrli:pure</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="shares" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>xbrli:shares</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="myUSDperShare" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:divide>

      <xbrli:unitnumerator>

        <xbrli:measure>iso4217:USD</xbrli:measure>

      </xbrli:unitnumerator>

      <xbrli:unitdenominator>

        <xbrli:measure>xbrli:shares</xbrli:measure>

      </xbrli:unitdenominator>

    </xbrli:divide>

  </xbrli:unit>

  <xbrli:unit id="myNumber" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>hsic:number</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="myCountries" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>hsic:countries</xbrli:measure>

  </xbrli:unit>

  <xbrli:unit id="myClaims" xmlns:xbrli="http://www.xbrl.org/2003/instance">

    <xbrli:measure>hsic:claims</xbrli:measure>

  </xbrli:unit>
</ix:resources>
</ix:header>
</div>
<div id="fixed-layout-inline-document" style="display:none;"></div><div id="Doc1" style="background-color:RGB(230, 230, 230);line-height:normal;font-family:Times New Roman;font-size:13.28px;font-weight:400;">
<div style="padding: 7px">
<div id="Page1" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:77.3px; height:1px; left:142px; top:444.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:370.9px; top:444.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:189px; height:1px; left:543.9px; top:444.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:145.2px; height:1px; left:565.8px; top:456.8px; background-color:#000000; ">&nbsp;</div>
<div id="a1" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:344px;top:46px;">UNITED STATES </div><div id="a3" style="position:absolute;font-family:'Times New Roman';font-size:21.28px;font-weight:bold;left:178px;top:64px;">SECURITIES AND EXCHANGE COMMISSION </div><div id="a5" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:337px;top:89px;">Washington,<div style="display:inline-block;width:4px">&nbsp;</div>D.C.<div style="display:inline-block;width:7px">&nbsp;</div>20549<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a9" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:358px;top:104px;">FORM </div><div id="a9_5_4" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:419px;top:104px;"><ix:nonnumeric id="ID_771" name="dei:DocumentType" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">10-K</ix:nonnumeric></div><div id="a13" style="position:absolute;font-family:'Times New Roman';left:29px;top:126px;">(Mark One) </div><div id="a15" style="position:absolute;font-family:'Segoe UI Symbol';left:29px;top:141px;-sec-ix-hidden:ID_794;">☒</div><div id="a16" style="position:absolute;font-family:'Times New Roman';left:40px;top:143px;"><div style="display:inline-block;width:10px">&nbsp;</div>ANNUAL REPORT PURSUANT TO<div style="display:inline-block;width:5px">&nbsp;</div>SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </div><div id="a20" style="position:absolute;font-family:'Times New Roman';left:53px;top:159px;">For the fiscal year ended </div><div id="a20_26_17" style="position:absolute;font-family:'Times New Roman';left:188px;top:159px;"><ix:nonnumeric id="ID_793" name="dei:DocumentPeriodEndDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt:datemonthdayyearen">December 31, 2022</ix:nonnumeric></div><div id="a24" style="position:absolute;font-family:'Segoe UI Symbol';left:29px;top:177px;-sec-ix-hidden:ID_795;">☐</div><div id="a25" style="position:absolute;font-family:'Times New Roman';left:40px;top:179px;"><div style="display:inline-block;width:10px">&nbsp;</div>TRANSITION REPORT PURSUANT TO<div style="display:inline-block;width:5px">&nbsp;</div>SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF<div style="display:inline-block;width:5px">&nbsp;</div>1934 </div><div id="a32" style="position:absolute;font-family:'Times New Roman';left:53px;top:195px;">For the transition period from ____________ to ____________ </div><div id="a34" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:314px;top:218px;">Commission file number </div><div id="a34_23_7" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:458px;top:218px;"><ix:nonnumeric id="ID_784" name="dei:EntityFileNumber" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">0-27078</ix:nonnumeric></div><div id="a38" style="position:absolute;font-family:'Times New Roman';font-size:20px;font-weight:bold;left:305px;top:233px;-sec-ix-hidden:ID_782;">HENRY SCHEIN, INC.</div><div id="a40" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:290px;top:256px;">(Exact name of registrant as specified in its charter) </div><div id="a43" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:169px;top:272px;"><ix:nonnumeric id="ID_783" name="dei:EntityIncorporationStateCountryCode" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:stateprovnameen">Delaware</ix:nonnumeric></div><div id="a45" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:511px;top:272px;"><ix:nonnumeric id="ID_785" name="dei:EntityTaxIdentificationNumber" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">11-3136595</ix:nonnumeric></div><div id="a49" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:129px;top:287px;">(State or other jurisdiction of</div><div id="a51" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:462px;top:287px;">(I.R.S. Employer Identification No.) </div><div id="a53" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:126px;top:299px;">incorporation or organization)</div><div id="a57" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:358px;top:314px;"><ix:nonnumeric id="ID_786" name="dei:EntityAddressAddressLine1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">135 Duryea Road</ix:nonnumeric></div><div id="a59" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:353px;top:330px;"><ix:nonnumeric id="ID_773" name="dei:EntityAddressCityOrTown" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">Melville</ix:nonnumeric></div><div id="a59_8_2" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:398px;top:330px;">, </div><div id="a59_10_8" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:405px;top:330px;"><ix:nonnumeric id="ID_778" name="dei:EntityAddressStateOrProvince" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:stateprovnameen">New York</ix:nonnumeric></div><div id="a61" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:320px;top:345px;">(Address of principal executive offices) </div><div id="a64" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:391px;top:358px;"><ix:nonnumeric id="ID_779" name="dei:EntityAddressPostalZipCode" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">11747</ix:nonnumeric></div><div id="a66" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:383px;top:373px;">(Zip Code) </div><div id="a69" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:365px;top:388px;"><div style="display:inline-block;width:3px">&nbsp;</div>(</div><div id="a69_2_3" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:373px;top:388px;"><ix:nonnumeric id="ID_787" name="dei:CityAreaCode" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">631</ix:nonnumeric></div><div id="a69_5_2" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:393px;top:388px;">) </div><div id="a69_7_8" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:400px;top:388px;"><ix:nonnumeric id="ID_774" name="dei:LocalPhoneNumber" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">843-5500</ix:nonnumeric></div><div id="a74" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:287px;top:403px;">(Registrant’s telephone number, including area code)</div><div id="a77" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:245px;top:419px;">Securities registered pursuant to Section 12(b)<div style="display:inline-block;width:5px">&nbsp;</div>of the Act: </div><div id="a79" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:142px;top:434px;">Title of each class </div><div id="a81" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:371px;top:434px;">Trading Symbol(s)</div><div id="a83" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:544px;top:434px;">Name of each exchange on which registered</div><div id="a85" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:94px;top:446px;"><ix:nonnumeric id="ID_882" name="dei:Security12bTitle" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">Common Stock, par value $.01 per share</ix:nonnumeric></div><div id="a99" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:400px;top:446px;"><ix:nonnumeric id="ID_788" name="dei:TradingSymbol" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">HSIC</ix:nonnumeric></div><div id="a101" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:566px;top:446px;-sec-ix-hidden:ID_780;">The Nasdaq Global Select Market</div><div id="a104" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:229px;top:462px;">Securities registered pursuant to Section<div style="display:inline-block;width:5px">&nbsp;</div>12(g) of the Act: None </div><div id="a111" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:480px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a117" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:496px;-sec-ix-hidden:ID_775;">YES</div><div id="a117_3_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:52px;top:496px;">:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a118" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:61px;top:494px;">☒</div><div id="a119" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:71px;top:496px;"><div style="display:inline-block;width:15px">&nbsp;</div>NO: </div><div id="a121" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:110px;top:494px;">☐</div><div id="a124" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:511px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. </div><div id="a127" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:527px;">YES:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a128" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:61px;top:525px;">☐</div><div id="a129" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:71px;top:527px;"><div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a129_5_2" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:86px;top:527px;-sec-ix-hidden:ID_893;">NO</div><div id="a129_7_2" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:104px;top:527px;">: </div><div id="a131" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:110px;top:525px;">☒</div><div id="a134" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:543px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 </div><div id="a137" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:557px;">during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing </div><div id="a139" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:570px;">requirements for the past 90 days. </div><div id="a141" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:586px;-sec-ix-hidden:ID_791;">YES</div><div id="a141_3_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:52px;top:586px;">:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a142" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:61px;top:584px;">☒</div><div id="a143" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:71px;top:586px;"><div style="display:inline-block;width:15px">&nbsp;</div>NO: </div><div id="a145" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:110px;top:584px;">☐</div><div id="a148" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:602px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of </div><div id="a151" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:615px;">Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </div><div id="a156" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:631px;-sec-ix-hidden:ID_792;">YES</div><div id="a156_3_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:52px;top:631px;">:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a157" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:61px;top:629px;">☒</div><div id="a158" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:71px;top:631px;"><div style="display:inline-block;width:15px">&nbsp;</div>NO: </div><div id="a160" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:110px;top:629px;">☐</div><div id="a162" style="position:absolute;font-family:'Times New Roman';font-size:1.28px;left:29px;top:645px;"><div style="display:inline-block;width:1px">&nbsp;</div></div><div id="a164" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:637px;"><div style="display:inline-block;width:21px">&nbsp;</div></div><div id="a166" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:648px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark whether the registrant is a<div style="display:inline-block;width:4px">&nbsp;</div>large accelerated filer, an<div style="display:inline-block;width:4px">&nbsp;</div>accelerated filer, a non-accelerated filer,<div style="display:inline-block;width:5px">&nbsp;</div>a smaller reporting company,<div style="display:inline-block;width:4px">&nbsp;</div>or an </div><div id="a170" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:662px;">emerging<div style="display:inline-block;width:6px">&nbsp;</div>growth<div style="display:inline-block;width:6px">&nbsp;</div>company.<div style="display:inline-block;width:12px">&nbsp;</div>See<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>definitions<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>“large<div style="display:inline-block;width:6px">&nbsp;</div>accelerated<div style="display:inline-block;width:5px">&nbsp;</div>filer,”<div style="display:inline-block;width:6px">&nbsp;</div>“accelerated<div style="display:inline-block;width:6px">&nbsp;</div>filer,”<div style="display:inline-block;width:6px">&nbsp;</div>“smaller<div style="display:inline-block;width:5px">&nbsp;</div>reporting<div style="display:inline-block;width:6px">&nbsp;</div>company,”<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>“emerging<div style="display:inline-block;width:6px">&nbsp;</div>growth </div><div id="a173" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:676px;">company” in Rule 12b-2 of the Exchange Act.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a177" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:691px;"><ix:nonnumeric id="ID_789" name="dei:EntityFilerCategory" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:entityfilercategoryen">Large accelerated filer</ix:nonnumeric></div><div id="a177_23_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:137px;top:691px;">:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a178" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:146px;top:689px;">☒</div><div id="a179" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:157px;top:691px;"><div style="display:inline-block;width:64px">&nbsp;</div>Accelerated filer: </div><div id="a182" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:308px;top:689px;">☐</div><div id="a183" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:318px;top:691px;"><div style="display:inline-block;width:48px">&nbsp;</div>Non-accelerated filer: </div><div id="a188" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:474px;top:689px;">☐</div><div id="a189" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:484px;top:691px;"><div style="display:inline-block;width:73px">&nbsp;</div>Smaller reporting company: </div><div id="a192" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:695px;top:689px;-sec-ix-hidden:ID_172;">☐</div><div id="a193" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:705px;top:691px;"><div style="display:inline-block;width:3px">&nbsp;</div>Emerging </div><div id="a195" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:707px;">growth company: </div><div id="a196" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:116px;top:705px;-sec-ix-hidden:ID_781;">☐</div><div id="a199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:29px;top:721px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a200" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:58px;top:723px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any </div><div id="a203" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:739px;">new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </div><div id="a206" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:526px;top:737px;">☐</div><div id="a209" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:755px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal </div><div id="a213" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:768px;">control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared </div><div id="a216" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:784px;">or issued its audit report. YES:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a219" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:183px;top:782px;-sec-ix-hidden:ID_883;">☒</div><div id="a220" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:193px;top:784px;"><div style="display:inline-block;width:15px">&nbsp;</div>NO: </div><div id="a222" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:232px;top:782px;">☐</div><div id="a224" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:798px;"><div style="display:inline-block;width:24px">&nbsp;</div>If securities are registered pursuant to<div style="display:inline-block;width:4px">&nbsp;</div>Section 12(b) of the Act, indicate by<div style="display:inline-block;width:5px">&nbsp;</div>check mark whether the financial statements of<div style="display:inline-block;width:5px">&nbsp;</div>the registrant included in the </div><div id="a228" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:814px;">filing reflect the correction of an error to previously issued financial statements.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a229" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:418px;top:812px;">☐</div><div id="a231" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:53px;top:828px;">Indicate<div style="display:inline-block;width:5px">&nbsp;</div>by<div style="display:inline-block;width:5px">&nbsp;</div>check<div style="display:inline-block;width:5px">&nbsp;</div>mark<div style="display:inline-block;width:5px">&nbsp;</div>whether<div style="display:inline-block;width:5px">&nbsp;</div>any<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>those<div style="display:inline-block;width:5px">&nbsp;</div>error<div style="display:inline-block;width:5px">&nbsp;</div>corrections<div style="display:inline-block;width:5px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>restatements<div style="display:inline-block;width:5px">&nbsp;</div>that<div style="display:inline-block;width:5px">&nbsp;</div>required<div style="display:inline-block;width:5px">&nbsp;</div>a<div style="display:inline-block;width:5px">&nbsp;</div>recovery<div style="display:inline-block;width:5px">&nbsp;</div>analysis<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>incentive-based<div style="display:inline-block;width:5px">&nbsp;</div>compensation </div><div id="a235" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:843px;">received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a239" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:594px;top:841px;">☐</div><div id="a242" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:859px;"><div style="display:inline-block;width:24px">&nbsp;</div>Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </div><div id="a247" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:875px;">YES:<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a248" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:61px;top:873px;">☐</div><div id="a249" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:71px;top:875px;"><div style="display:inline-block;width:15px">&nbsp;</div>NO: </div><div id="a251" style="position:absolute;font-family:'Segoe UI Symbol';font-size:12px;left:110px;top:873px;-sec-ix-hidden:ID_790;">☒</div><div id="a254" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:890px;"><div style="display:inline-block;width:24px">&nbsp;</div>The aggregate market value of the registrant’s voting stock held by non-affiliates of the registrant, computed by reference to the closing sales price as </div><div id="a258" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:904px;">quoted on the Nasdaq Global Select Market on June 25, 2022, was approximately $</div><div id="a258_79_14" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:430px;top:904px;"><ix:nonfraction id="ID_799" name="dei:EntityPublicFloat" contextref="AS_OF_Jun25_2022_Entity_0001000228" unitref="USD" decimals="0" format="ixt:numdotdecimal">10,463,590,000</ix:nonfraction></div><div id="a258_93_2" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:505px;top:904px;">. </div><div id="a261" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:29px;top:920px;"><div style="display:inline-block;width:24px">&nbsp;</div>As of February 7, 2023, there were </div><div id="a261_43_11" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:224px;top:920px;"><ix:nonfraction id="ID_797" name="dei:EntityCommonStockSharesOutstanding" contextref="AS_OF_Feb07_2023_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">131,283,515</ix:nonfraction></div><div id="a261_54_77" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:284px;top:920px;"><div style="display:inline-block;width:3px">&nbsp;</div>shares of registrant’s Common Stock, par value $.01 per share, outstanding. </div><div id="a265" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:307px;top:947px;">Documents Incorporated by Reference:</div><div id="div_523_XBRL_TS_f7b3cf37b76e4925ad6ad50bb3778556" style="position:absolute;left:25px;top:961px;float:left;"><ix:nonnumeric id="ID_798" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer524" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:719px;height:28px;"><div id="a267" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">Portions of the Registrant’s definitive proxy statement to be filed pursuant to Regulation 14A not later than 120 days after the end of the fiscal year </div><div id="a269" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:14px;">(December 31, 2022) are incorporated by reference in Part III hereof.</div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page2" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:158.1px; height:1px; left:328.3px; top:60.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:687.9px; top:109.4px; background-color:#000000; ">&nbsp;</div>
<div id="a272" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">2 </div><div id="a280" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:329px;top:46px;">TABLE OF CONTENTS </div><div id="a293" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:705px;top:79px;">Page </div><div id="a300" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:695px;top:95px;">Number </div><div id="a308" style="position:absolute;font-family:'Times New Roman';font-weight:bold;color:#0000FF;left:67px;top:127px;"><a href="#a622" style="color:#0000FF;text-decoration:underline;">PART<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>I.</a></div><div id="a312" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:143px;"><a href="#a625" style="color:#0000FF;text-decoration:underline;">ITEM 1.</a></div><div id="a315" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:143px;"><a href="#a625" style="color:#0000FF;text-decoration:underline;">Business</a></div><div id="a319" style="position:absolute;font-family:'Times New Roman';left:715px;top:143px;">3 </div><div id="a322" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:159px;"><a href="#a16164" style="color:#0000FF;text-decoration:underline;">ITEM 1A.</a></div><div id="a325" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:159px;"><a href="#a16164" style="color:#0000FF;text-decoration:underline;">Risk Factors</a></div><div id="a329" style="position:absolute;font-family:'Times New Roman';left:712px;top:159px;">25 </div><div id="a332" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:175px;"><a href="#a21002" style="color:#0000FF;text-decoration:underline;">ITEM 1B.</a></div><div id="a335" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:175px;"><a href="#a21002" style="color:#0000FF;text-decoration:underline;">Unresolved Staff Comments</a></div><div id="a339" style="position:absolute;font-family:'Times New Roman';left:712px;top:175px;">40 </div><div id="a342" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:191px;"><a href="#a21017" style="color:#0000FF;text-decoration:underline;">ITEM 2.</a></div><div id="a345" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:191px;"><a href="#a21017" style="color:#0000FF;text-decoration:underline;">Properties</a></div><div id="a349" style="position:absolute;font-family:'Times New Roman';left:712px;top:191px;">40 </div><div id="a352" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:207px;"><a href="#a21067" style="color:#0000FF;text-decoration:underline;">ITEM 3.</a></div><div id="a355" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:207px;"><a href="#a21067" style="color:#0000FF;text-decoration:underline;">Legal Proceedings</a></div><div id="a359" style="position:absolute;font-family:'Times New Roman';left:712px;top:207px;">40 </div><div id="a362" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:223px;"><a href="#a21080" style="color:#0000FF;text-decoration:underline;">ITEM 4.</a></div><div id="a365" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:223px;"><a href="#a21080" style="color:#0000FF;text-decoration:underline;">Mine Safety Disclosures</a></div><div id="a369" style="position:absolute;font-family:'Times New Roman';left:712px;top:223px;">40 </div><div id="a377" style="position:absolute;font-family:'Times New Roman';font-weight:bold;color:#0000FF;left:67px;top:255px;"><a href="#a21090" style="color:#0000FF;text-decoration:underline;">PART<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>II</a></div><div id="a381" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:271px;"><a href="#a21093" style="color:#0000FF;text-decoration:underline;">ITEM 5.</a></div><div id="a384" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:271px;"><a href="#a21093" style="color:#0000FF;text-decoration:underline;">Market for Registrant's Common Equity,<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Related Stockholder Matters</a></div><div id="a391" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:181px;top:287px;"><a href="#a21093" style="color:#0000FF;text-decoration:underline;">and Issuer Purchases of Equity Securities</a></div><div id="a395" style="position:absolute;font-family:'Times New Roman';left:712px;top:287px;">41 </div><div id="a398" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:303px;"><a href="#a21592" style="color:#0000FF;text-decoration:underline;">ITEM 6.</a></div><div id="a401" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:303px;"><a href="#a21592" style="color:#0000FF;text-decoration:underline;">[Reserved]</a></div><div id="a405" style="position:absolute;font-family:'Times New Roman';left:712px;top:303px;">42 </div><div id="a408" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:319px;"><a href="#a21623" style="color:#0000FF;text-decoration:underline;">ITEM 7.</a></div><div id="a411" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:319px;"><a href="#a21623" style="color:#0000FF;text-decoration:underline;">Management's Discussion and Analysis of Financial Condition</a></div><div id="a418" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:181px;top:335px;"><a href="#a21623" style="color:#0000FF;text-decoration:underline;">and Results of Operations</a></div><div id="a422" style="position:absolute;font-family:'Times New Roman';left:712px;top:335px;">43 </div><div id="a425" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:351px;"><a href="#a28206" style="color:#0000FF;text-decoration:underline;">ITEM 7A.</a></div><div id="a428" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:351px;"><a href="#a28206" style="color:#0000FF;text-decoration:underline;">Quantitative and Qualitative Disclosures About Market Risk</a></div><div id="a432" style="position:absolute;font-family:'Times New Roman';left:712px;top:351px;">58 </div><div id="a435" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:367px;"><a href="#a28576" style="color:#0000FF;text-decoration:underline;">ITEM 8.</a></div><div id="a440" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:367px;"><a href="#a28576" style="color:#0000FF;text-decoration:underline;">Financial Statements and Supplementary Data</a></div><div id="a443" style="position:absolute;font-family:'Times New Roman';left:712px;top:367px;">60 </div><div id="a446" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:383px;"><a href="#a51960" style="color:#0000FF;text-decoration:underline;">ITEM 9.</a></div><div id="a449" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:383px;"><a href="#a51960" style="color:#0000FF;text-decoration:underline;">Changes in and Disagreements with Accountants on Accounting</a></div><div id="a458" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:181px;top:399px;"><a href="#a51960" style="color:#0000FF;text-decoration:underline;">and Financial Disclosure</a></div><div id="a462" style="position:absolute;font-family:'Times New Roman';left:708px;top:399px;">116 </div><div id="a465" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:415px;"><a href="#a51969" style="color:#0000FF;text-decoration:underline;">ITEM 9A.</a></div><div id="a468" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:415px;"><a href="#a51969" style="color:#0000FF;text-decoration:underline;">Controls and Procedures</a></div><div id="a472" style="position:absolute;font-family:'Times New Roman';left:708px;top:415px;">116 </div><div id="a475" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:431px;"><a href="#a52268" style="color:#0000FF;text-decoration:underline;">ITEM 9B.</a></div><div id="a478" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:431px;"><a href="#a52268" style="color:#0000FF;text-decoration:underline;">Other Information</a></div><div id="a482" style="position:absolute;font-family:'Times New Roman';left:708px;top:431px;">118 </div><div id="a485" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:447px;"><a href="#a52273" style="color:#0000FF;text-decoration:underline;">ITEM 9C.</a></div><div id="a490" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:447px;"><a href="#a52273" style="color:#0000FF;text-decoration:underline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspection</a></div><div id="a491" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:525px;top:446px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a493" style="position:absolute;font-family:'Times New Roman';left:708px;top:447px;">118 </div><div id="a501" style="position:absolute;font-family:'Times New Roman';font-weight:bold;color:#0000FF;left:67px;top:479px;"><a href="#a52285" style="color:#0000FF;text-decoration:underline;">PART<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>III</a></div><div id="a505" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:495px;"><a href="#a52288" style="color:#0000FF;text-decoration:underline;">ITEM 10.</a></div><div id="a508" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:495px;"><a href="#a52288" style="color:#0000FF;text-decoration:underline;">Directors, Executive Officers and Corporate Governance</a></div><div id="a512" style="position:absolute;font-family:'Times New Roman';left:708px;top:495px;">118 </div><div id="a515" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:511px;"><a href="#a52333" style="color:#0000FF;text-decoration:underline;">ITEM 11.</a></div><div id="a518" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:511px;"><a href="#a52333" style="color:#0000FF;text-decoration:underline;">Executive Compensation</a></div><div id="a522" style="position:absolute;font-family:'Times New Roman';left:708px;top:511px;">118 </div><div id="a525" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:527px;"><a href="#a52359" style="color:#0000FF;text-decoration:underline;">ITEM 12.</a></div><div id="a528" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:527px;"><a href="#a52359" style="color:#0000FF;text-decoration:underline;">Security Ownership of Certain Beneficial Owners and Management</a></div><div id="a535" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:181px;top:543px;"><a href="#a52359" style="color:#0000FF;text-decoration:underline;">and Related Stockholder Matters</a></div><div id="a539" style="position:absolute;font-family:'Times New Roman';left:708px;top:543px;">119 </div><div id="a542" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:559px;"><a href="#a52476" style="color:#0000FF;text-decoration:underline;">ITEM 13.</a></div><div id="a545" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:559px;"><a href="#a52476" style="color:#0000FF;text-decoration:underline;">Certain Relationships and Related Transactions,<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>and Director Independence</a></div><div id="a549" style="position:absolute;font-family:'Times New Roman';left:708px;top:559px;">119 </div><div id="a552" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:575px;"><a href="#a52498" style="color:#0000FF;text-decoration:underline;">ITEM 14.</a></div><div id="a555" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:575px;"><a href="#a52498" style="color:#0000FF;text-decoration:underline;">Principal Accounting Fees and Services</a></div><div id="a561" style="position:absolute;font-family:'Times New Roman';left:708px;top:575px;">119 </div><div id="a569" style="position:absolute;font-family:'Times New Roman';font-weight:bold;color:#0000FF;left:67px;top:607px;"><a href="#a52516" style="color:#0000FF;text-decoration:underline;">PART<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>IV.</a></div><div id="a573" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:623px;"><a href="#a52519" style="color:#0000FF;text-decoration:underline;">ITEM 15.</a></div><div id="a578" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:623px;"><a href="#a52519" style="color:#0000FF;text-decoration:underline;">Exhibits and Financial Statement Schedules</a></div><div id="a585" style="position:absolute;font-family:'Times New Roman';left:708px;top:623px;">119 </div><div id="a588" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:82px;top:639px;"><a href="#a54708" style="color:#0000FF;text-decoration:underline;">ITEM 16.</a></div><div id="a593" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:639px;"><a href="#a54708" style="color:#0000FF;text-decoration:underline;">Form</a></div><div id="a595" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:200px;top:639px;"><a href="#a54708" style="color:#0000FF;text-decoration:underline;">10-K Summary</a></div><div id="a601" style="position:absolute;font-family:'Times New Roman';left:708px;top:639px;">127 </div><div id="a606" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:167px;top:655px;"><a href="#a54715" style="color:#0000FF;text-decoration:underline;">Signatures</a></div><div id="a610" style="position:absolute;font-family:'Times New Roman';left:708px;top:655px;">128 </div></div>
</div>
<div style="padding: 7px">
<div id="Page3" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a617" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a620" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">3 </div><div id="a622" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:383px;top:60px;">PART<div style="display:inline-block;width:5px">&nbsp;</div>I </div><div id="a625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:93px;">ITEM 1.<div style="display:inline-block;width:7px">&nbsp;</div>Business </div><div id="a628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:127px;">General </div><div id="a631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">Henry Schein, Inc. is a solutions company for health care professionals powered<div style="display:inline-block;width:2px">&nbsp;</div>by a network of people and </div><div id="a632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">technology.<div style="display:inline-block;width:8px">&nbsp;</div>We believe we are the world’s largest<div style="display:inline-block;width:5px">&nbsp;</div>provider of health care products and services primarily to<div style="display:inline-block;width:2px">&nbsp;</div>office-</div><div id="a636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">based dental and medical practitioners, as well as alternate sites of care.<div style="display:inline-block;width:6px">&nbsp;</div>Our philosophy is grounded in our </div><div id="a639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">commitment to help customers operate a more efficient and successful business so<div style="display:inline-block;width:2px">&nbsp;</div>the practitioner can provide </div><div id="a642" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">better clinical care. </div><div id="a645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">With more than 90 years of experience distributing health care products, we have built a vast set of small,<div style="display:inline-block;width:2px">&nbsp;</div>mid-sized </div><div id="a649" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">and large customers in the dental and medical markets, serving more than one million<div style="display:inline-block;width:2px">&nbsp;</div>customers worldwide across </div><div id="a652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">dental practices, laboratories,<div style="display:inline-block;width:3px">&nbsp;</div>physician practices, and ambulatory surgery centers, as well as government, </div><div id="a664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">institutional health care clinics and other alternate care clinics.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a670" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">We are headquartered in Melville, New York<div style="display:inline-block;width:6px">&nbsp;</div>and employ more than 22,000 people.<div style="display:inline-block;width:7px">&nbsp;</div>Approximately 50% of our </div><div id="a679" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">workforce is based in the United States and approximately 50% is based<div style="display:inline-block;width:2px">&nbsp;</div>outside of the United States.<div style="display:inline-block;width:7px">&nbsp;</div>We have </div><div id="a682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">operations or affiliates in 32 countries and territories.<div style="display:inline-block;width:7px">&nbsp;</div>Our broad global footprint has evolved over time through our </div><div id="a690" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">organic success as well as through contribution from strategic acquisitions. </div><div id="a694" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">We offer<div style="display:inline-block;width:5px">&nbsp;</div>a comprehensive selection of more than 300,000 branded products<div style="display:inline-block;width:2px">&nbsp;</div>and Henry Schein corporate brand </div><div id="a698" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">products through our distribution centers.<div style="display:inline-block;width:7px">&nbsp;</div>Our infrastructure, including over 3.8 million square<div style="display:inline-block;width:2px">&nbsp;</div>feet of space in 29 </div><div id="a702" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">strategically located distribution and 19 manufacturing facilities around<div style="display:inline-block;width:2px">&nbsp;</div>the world, enables us to historically provide </div><div id="a711" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">rapid and accurate order fulfillment, better serve our customers and increase<div style="display:inline-block;width:2px">&nbsp;</div>our operating efficiency.<div style="display:inline-block;width:8px">&nbsp;</div>This </div><div id="a712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">infrastructure, together with broad product and service offerings at competitive prices,<div style="display:inline-block;width:2px">&nbsp;</div>and a strong commitment to </div><div id="a714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">customer service, enables us to be a single source of supply for our customers’<div style="display:inline-block;width:2px">&nbsp;</div>needs. </div><div id="a717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and </div><div id="a720" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">value-added services.<div style="display:inline-block;width:7px">&nbsp;</div>These segments offer different products and services to the same customer base.<div style="display:inline-block;width:6px">&nbsp;</div>Our dental </div><div id="a724" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">businesses serve office-based dental practitioners, dental laboratories, schools, government<div style="display:inline-block;width:2px">&nbsp;</div>and other </div><div id="a728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">institutions.<div style="display:inline-block;width:7px">&nbsp;</div>Our medical businesses serve physician offices, urgent care centers, ambulatory care sites,<div style="display:inline-block;width:2px">&nbsp;</div>emergency </div><div id="a731" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">medical technicians, dialysis centers, home health, federal and state governments<div style="display:inline-block;width:2px">&nbsp;</div>and large enterprises, such as </div><div id="a732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">group practices<div style="display:inline-block;width:3px">&nbsp;</div>and integrated delivery networks, among other providers across a<div style="display:inline-block;width:2px">&nbsp;</div>wide range of specialties.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">The health care distribution reportable segment, combining our global dental<div style="display:inline-block;width:2px">&nbsp;</div>and medical businesses, distributes </div><div id="a739" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">consumable products, small equipment, laboratory products, large equipment, equipment<div style="display:inline-block;width:2px">&nbsp;</div>repair services, branded </div><div id="a743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">and generic pharmaceuticals, vaccines, surgical products, dental specialty products<div style="display:inline-block;width:2px">&nbsp;</div>(including implant, orthodontic </div><div id="a746" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">and endodontic products), diagnostic tests, infection-control products, personal<div style="display:inline-block;width:2px">&nbsp;</div>protective equipment products </div><div id="a752" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">(“PPE”) and vitamins.<div style="display:inline-block;width:7px">&nbsp;</div>While our primary go-to-market strategy is in our capacity<div style="display:inline-block;width:2px">&nbsp;</div>as a distributor, we also market </div><div id="a760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">and sell under our own corporate brand portfolio of cost-effective, high-quality consumable<div style="display:inline-block;width:2px">&nbsp;</div>merchandise products, </div><div id="a770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">and manufacture certain dental specialty products in the areas of oral<div style="display:inline-block;width:2px">&nbsp;</div>surgery, implants, orthodontics and </div><div id="a773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">endodontics.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">The technology and value-added services reportable segment provides<div style="display:inline-block;width:2px">&nbsp;</div>software, technology and other value-added </div><div id="a782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">services to health care practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Henry Schein One, the largest contributor of sales to this category, offers </div><div id="a787" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">dental practice management solutions for dental and medical practitioners.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, we offer dentists and </div><div id="a793" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">physicians a broad suite of electronic health records, patient communication<div style="display:inline-block;width:2px">&nbsp;</div>services including electronic marketing </div><div id="a797" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">and web-site design, analytics and patient demand generation.<div style="display:inline-block;width:6px">&nbsp;</div>Finally, our value-added practice solutions include </div><div id="a808" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">practice consultancy, education, integrated revenue cycle management and the facilitation of financial service </div><div id="a811" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">offerings (on a non-recourse basis) to help dentists and physicians operate and<div style="display:inline-block;width:2px">&nbsp;</div>expand their business operations.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a820" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">We believe our hands-on consultative approach to provide solutions to support practice decision-making is a key </div><div id="a826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">differentiator for our business. </div><div id="a828" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;"><div style="display:inline-block;width:4px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page4" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a830" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">4 </div><div id="a835" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Recent Developments </div><div id="a838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Recent </div><div id="a842" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">Developments” herein for a discussion related to the COVID-19<div style="display:inline-block;width:2px">&nbsp;</div>pandemic and recent corporate transactions. </div><div id="a848" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:144px;">Industry </div><div id="a851" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">The global health care distribution industry, as it relates to office-based health care practitioners, is fragmented and </div><div id="a854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">diverse.<div style="display:inline-block;width:7px">&nbsp;</div>The industry ranges from sole practitioners working out of<div style="display:inline-block;width:2px">&nbsp;</div>relatively small offices to mid-sized and large </div><div id="a858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">group practices ranging in size from a few practitioners to several<div style="display:inline-block;width:2px">&nbsp;</div>hundred practices owned or operated by dental </div><div id="a859" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">support organizations (DSOs), medical group purchasing organizations (GPOs), hospital systems<div style="display:inline-block;width:2px">&nbsp;</div>or integrated </div><div id="a860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">delivery networks (IDNs). </div><div id="a864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">Due in part to the limited capacity of office-based health care practitioners<div style="display:inline-block;width:2px">&nbsp;</div>to store and manage large quantities of </div><div id="a867" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">supplies in their offices, the distribution of health care supplies and small equipment<div style="display:inline-block;width:2px">&nbsp;</div>to office-based health care </div><div id="a871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">practitioners has been characterized by frequent, small quantity orders,<div style="display:inline-block;width:2px">&nbsp;</div>and a need for rapid, reliable and </div><div id="a872" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">substantially complete order fulfillment.<div style="display:inline-block;width:7px">&nbsp;</div>The purchasing decisions within an office-based health care practice<div style="display:inline-block;width:2px">&nbsp;</div>are </div><div id="a877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">typically made by the practitioner, hygienist or office manager.<div style="display:inline-block;width:8px">&nbsp;</div>Supplies and small equipment are generally </div><div id="a881" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">purchased from more than one distributor, with one generally serving as the primary supplier. </div><div id="a884" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">The health care distribution industry continues to experience growth due<div style="display:inline-block;width:2px">&nbsp;</div>to demand driven by the aging population, </div><div id="a886" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">increased health care awareness and the importance of preventative care,<div style="display:inline-block;width:2px">&nbsp;</div>an increasing understanding of the </div><div id="a887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">connection between good oral health and overall health, improved access<div style="display:inline-block;width:2px">&nbsp;</div>to care globally, the proliferation of </div><div id="a889" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">medical technology and testing, new pharmacology treatments and<div style="display:inline-block;width:2px">&nbsp;</div>expanded third-party insurance coverage, </div><div id="a892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">partially offset by the effects of unemployment on insurance coverage and technological<div style="display:inline-block;width:2px">&nbsp;</div>improvements, including </div><div id="a893" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">the advancement of software and services, prosthetic solutions and<div style="display:inline-block;width:2px">&nbsp;</div>telemedicine.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, the non-acute market </div><div id="a899" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">continues to benefit from the shift of procedures and diagnostic<div style="display:inline-block;width:2px">&nbsp;</div>testing from acute care settings to alternate-care </div><div id="a902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">sites, particularly physicians’ offices and ambulatory surgery centers. </div><div id="a906" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">We believe that consolidation within the industry will continue to result in a number of distributors, particularly </div><div id="a907" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">those with limited financial, operating and marketing resources, seeking<div style="display:inline-block;width:2px">&nbsp;</div>to combine with larger companies that can </div><div id="a908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">provide growth<div style="display:inline-block;width:3px">&nbsp;</div>opportunities.<div style="display:inline-block;width:7px">&nbsp;</div>This consolidation also may continue to result in distributors seeking<div style="display:inline-block;width:2px">&nbsp;</div>to acquire </div><div id="a912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">companies that can enhance their current product and service offerings or provide<div style="display:inline-block;width:2px">&nbsp;</div>opportunities to serve a broader </div><div id="a913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">customer base.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">In addition, customer consolidation will likely lead to multiple locations<div style="display:inline-block;width:2px">&nbsp;</div>under common management and the </div><div id="a918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">movement of more procedures from the hospital setting to the physician<div style="display:inline-block;width:2px">&nbsp;</div>or alternate care setting as the health care </div><div id="a919" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">industry is increasingly focused on efficiency and cost containment.<div style="display:inline-block;width:6px">&nbsp;</div>This trend has benefited distributors capable </div><div id="a923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">of providing a broad array of products and services at low prices.<div style="display:inline-block;width:6px">&nbsp;</div>It also has accelerated the growth of health </div><div id="a926" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">maintenance organizations (“HMOs”), group practices, other managed care accounts<div style="display:inline-block;width:2px">&nbsp;</div>and collective buying groups, </div><div id="a929" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">which, in addition to their emphasis on obtaining products at competitive<div style="display:inline-block;width:2px">&nbsp;</div>prices, tend to favor distributors capable </div><div id="a930" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">of providing specialized management information support.<div style="display:inline-block;width:6px">&nbsp;</div>We believe that the trend towards cost containment has </div><div id="a934" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">the potential to favorably affect demand for technology solutions, including software,<div style="display:inline-block;width:2px">&nbsp;</div>which can enhance the </div><div id="a935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">efficiency and facilitation of practice management. </div><div id="a938" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:819px;">Competition<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a941" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">The distribution and manufacture of health care supplies and equipment is<div style="display:inline-block;width:2px">&nbsp;</div>highly competitive.<div style="display:inline-block;width:7px">&nbsp;</div>Many of the health </div><div id="a943" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">care products we sell are available to our customers from a number of suppliers.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, our competitors could </div><div id="a944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">obtain exclusive rights from manufacturers to market particular products.<div style="display:inline-block;width:6px">&nbsp;</div>Manufacturers also could seek to sell </div><div id="a946" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">directly to end-users, and thereby eliminate or reduce our role and<div style="display:inline-block;width:2px">&nbsp;</div>that of other distributors.<div style="display:inline-block;width:7px">&nbsp;</div>In certain parts of the </div><div id="a949" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">dental end market, such as those related to dental specialty products, and<div style="display:inline-block;width:2px">&nbsp;</div>medical end market manufacturers already </div><div id="a950" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">sell directly to end customers. </div><div id="a954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">In North America, we compete with other distributors, as well as several<div style="display:inline-block;width:2px">&nbsp;</div>manufacturers, of dental and medical </div><div id="a955" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">products, primarily on the basis of price, breadth of product line, e-commerce<div style="display:inline-block;width:2px">&nbsp;</div>capabilities, customer service and </div></div>
</div>
<div style="padding: 7px">
<div id="Page5" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a958" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">5 </div><div id="a963" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">value-added products and services.<div style="display:inline-block;width:7px">&nbsp;</div>In the dental market, our primary competitors in the U.S. are the Patterson </div><div id="a967" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Dental division of Patterson Companies, Inc. and Benco Dental Supply<div style="display:inline-block;width:2px">&nbsp;</div>Company.<div style="display:inline-block;width:8px">&nbsp;</div>In addition, we compete against </div><div id="a968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">a number of other distributors that operate on a national, regional and<div style="display:inline-block;width:2px">&nbsp;</div>local level.<div style="display:inline-block;width:7px">&nbsp;</div>Our primary competitors in the </div><div id="a970" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">U.S. medical market, which accounts for the large majority of our global medical<div style="display:inline-block;width:2px">&nbsp;</div>sales, are McKesson Corporation </div><div id="a971" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">and Medline Industries, Inc., which are national distributors.<div style="display:inline-block;width:6px">&nbsp;</div>We also compete with a number of regional and local </div><div id="a974" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">medical distributors, as well as a number of manufacturers that<div style="display:inline-block;width:2px">&nbsp;</div>sell directly to physicians.<div style="display:inline-block;width:7px">&nbsp;</div>With regard to our dental </div><div id="a975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">software, we compete against numerous companies, including the<div style="display:inline-block;width:2px">&nbsp;</div>Patterson Dental division of Patterson </div><div id="a977" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">Companies, Inc., Carestream Health, Inc., Carestream Dental LLC, Centaur<div style="display:inline-block;width:2px">&nbsp;</div>Software Development Co Pty Ltd. </div><div id="a978" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">(d.b.a. dental4windows, dental4web), Open Dental Software, Inc., PlanetDDS<div style="display:inline-block;width:2px">&nbsp;</div>LLC, Good Methods Global Inc. </div><div id="a980" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">(d.b.a. CareStack) and Curve Dental, LLC.<div style="display:inline-block;width:7px">&nbsp;</div>In other software end markets, including revenue cycle<div style="display:inline-block;width:2px">&nbsp;</div>management, </div><div id="a982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">patient relationship management and patient demand generation, we<div style="display:inline-block;width:2px">&nbsp;</div>compete with companies such as Vyne </div><div id="a983" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">Therapeutics Inc., EDI-Health Group, Inc. (d.b.a. Dental X Change, Inc.),<div style="display:inline-block;width:2px">&nbsp;</div>Weave Communications, Inc., and </div><div id="a988" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Solutionreach, Inc.<div style="display:inline-block;width:7px">&nbsp;</div>The medical practice management and electronic medical<div style="display:inline-block;width:2px">&nbsp;</div>records market is fragmented and we </div><div id="a989" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">compete with numerous companies such as the NextGen division of<div style="display:inline-block;width:2px">&nbsp;</div>Quality Systems, Inc., eClinicalWorks, </div><div id="a991" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">Allscripts Healthcare Solutions, Inc. and Epic Systems Corporation. </div><div id="a995" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">Outside of the U.S., we believe we are the only global distributor of supplies<div style="display:inline-block;width:2px">&nbsp;</div>and equipment to dental practices and </div><div id="a996" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">our competitors are primarily local and regional companies.<div style="display:inline-block;width:6px">&nbsp;</div>We also face significant competition internationally, </div><div id="a998" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">where we compete on the basis of price and customer service against<div style="display:inline-block;width:2px">&nbsp;</div>several large competitors, including the </div><div id="a999" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">GACD Group, Proclinic SA, Lifco AB, Planmeca Oy and Billericay Dental<div style="display:inline-block;width:2px">&nbsp;</div>Supply Co. Ltd., as well as a large </div><div id="a1000" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">number of other dental and medical product distributors and manufacturers<div style="display:inline-block;width:2px">&nbsp;</div>in international countries and territories </div><div id="a1002" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">we serve. </div><div id="a1005" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:448px;">Competitive Strengths </div><div id="a1008" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">We have more than 90 years of experience in distributing products to health care practitioners resulting in strong </div><div id="a1011" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">awareness of the Henry Schein</div><div id="a1012" style="position:absolute;font-family:'Times New Roman';font-size:9.28px;left:249px;top:498px;">®</div><div id="a1013" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:256px;top:498px;"><div style="display:inline-block;width:4px">&nbsp;</div>brand.<div style="display:inline-block;width:7px">&nbsp;</div>Our competitive strengths include: </div><div id="a1017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:532px;">A focus on meeting our customers’ unique needs</div><div id="a1018" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:352px;top:532px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We are committed to providing customized solutions to our </div><div id="a1021" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">customers that are driven by our understanding of the end markets we<div style="display:inline-block;width:2px">&nbsp;</div>serve and reflect the technology-driven </div><div id="a1024" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">products and services best suited for their practice needs.<div style="display:inline-block;width:6px">&nbsp;</div>We are committed to continuing to enhance these </div><div id="a1028" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">offerings through organic investment in our products and our teams, as well as through the acquisition<div style="display:inline-block;width:2px">&nbsp;</div>of new </div><div id="a1033" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">products and services that may help us better serve our customers. </div><div id="a1036" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:633px;">Direct sales and marketing expertise.</div><div id="a1037" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:287px;top:633px;"><div style="display:inline-block;width:7px">&nbsp;</div>Our sales and marketing efforts are designed to establish and solidify </div><div id="a1040" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">customer relationships through personal or virtual visits by field sales representatives,<div style="display:inline-block;width:2px">&nbsp;</div>frequent direct marketing and </div><div id="a1043" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">telesales contact, emphasizing our broad product lines, including exclusive<div style="display:inline-block;width:2px">&nbsp;</div>distribution agreements, competitive </div><div id="a1044" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">prices and ease of order placement,<div style="display:inline-block;width:3px">&nbsp;</div>particularly through our e-commerce platforms.<div style="display:inline-block;width:6px">&nbsp;</div>The key elements of our direct </div><div id="a1050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">sales and marketing efforts are: </div><div id="a1053" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:734px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1054" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:734px;">Field sales consultants.</div><div id="a1055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:253px;top:734px;"><div style="display:inline-block;width:7px">&nbsp;</div>Our field sales consultants, including equipment sales specialists, covering<div style="display:inline-block;width:2px">&nbsp;</div>major </div><div id="a1059" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:751px;">North American, European and other international markets.<div style="display:inline-block;width:6px">&nbsp;</div>These consultants complement our direct </div><div id="a1060" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:768px;">marketing and telesales efforts and enable us to better market, service and support<div style="display:inline-block;width:2px">&nbsp;</div>the sale of more </div><div id="a1061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:785px;">sophisticated products and equipment. </div><div id="a1064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:819px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1066" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:819px;">Marketing.</div><div id="a1068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:180px;top:819px;"><div style="display:inline-block;width:7px">&nbsp;</div>We market to existing and prospective office-based health care providers through a </div><div id="a1072" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:836px;">combination of owned, earned and paid digital channels, tradeshows, as well<div style="display:inline-block;width:2px">&nbsp;</div>as through catalogs, flyers, </div><div id="a1073" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:852px;">direct mail and other promotional materials.<div style="display:inline-block;width:6px">&nbsp;</div>Our strategies include an emphasis on educational content </div><div id="a1078" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:869px;">through webinars and content marketing initiatives.<div style="display:inline-block;width:6px">&nbsp;</div>We continue to enhance our marketing technology to </div><div id="a1082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:886px;">improve our targeting capability and the relevance of messaging and offers. </div><div id="a1087" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:920px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1088" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:920px;">Telesales.</div><div id="a1089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:173px;top:920px;"><div style="display:inline-block;width:7px">&nbsp;</div>We support our direct marketing effort with inbound and outbound telesales representatives, </div><div id="a1092" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:937px;">who facilitate order processing, generate new sales through direct and frequent<div style="display:inline-block;width:2px">&nbsp;</div>contact with customers and </div><div id="a1093" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:954px;">stay abreast of market developments and the hundreds of new products,<div style="display:inline-block;width:2px">&nbsp;</div>services and technologies </div><div id="a1095" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:971px;">introduced each year to educate practice personnel. </div></div>
</div>
<div style="padding: 7px">
<div id="Page6" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a1098" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a1101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">6 </div><div id="a1103" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:60px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1104" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:60px;">Electronic commerce solutions.</div><div id="a1105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:300px;top:60px;"><div style="display:inline-block;width:7px">&nbsp;</div>We provide our customers and sales teams with innovative and </div><div id="a1107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:76px;">competitive e-commerce solutions.<div style="display:inline-block;width:7px">&nbsp;</div>We continue to invest in our e-commerce platform to offer enhanced </div><div id="a1115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:93px;">content management so customers can more easily find the products<div style="display:inline-block;width:2px">&nbsp;</div>they need and to enable an engaging </div><div id="a1116" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:110px;">purchase experience, supported by excellent customer service.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a1119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:144px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:144px;">Social media.</div><div id="a1121" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:195px;top:144px;"><div style="display:inline-block;width:7px">&nbsp;</div>Our operating entities and employees engage our customers and<div style="display:inline-block;width:2px">&nbsp;</div>supplier partners through </div><div id="a1125" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:161px;">various social media platforms, which are an important element of our<div style="display:inline-block;width:2px">&nbsp;</div>communications and marketing </div><div id="a1126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:178px;">efforts.<div style="display:inline-block;width:8px">&nbsp;</div>We continue to expand our social media presence to raise awareness about issues, engage </div><div id="a1127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:195px;">customers beyond a sale and deliver services and solutions to specialized<div style="display:inline-block;width:2px">&nbsp;</div>audiences. </div><div id="a1131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:228px;">Broad product and service offerings at competitive prices.</div><div id="a1132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:410px;top:228px;"><div style="display:inline-block;width:7px">&nbsp;</div>We offer<div style="display:inline-block;width:5px">&nbsp;</div>a broad range of products and services to our </div><div id="a1134" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">customers, at competitive prices, in the following categories: </div><div id="a1137" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:85px;top:279px;"><div style="display:inline-block;width:4px">&nbsp;</div>•<div style="display:inline-block;width:11px">&nbsp;</div></div><div id="a1140" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:109px;top:279px;">Consumable supplies and equipment</div><div id="a1141" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:324px;top:279px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We distribute consumable products, small equipment, laboratory </div><div id="a1144" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:109px;top:296px;">products, large equipment, equipment repair services, branded and generic pharmaceuticals,<div style="display:inline-block;width:2px">&nbsp;</div>vaccines, dental </div><div id="a1145" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:109px;top:313px;">specialty products, diagnostic tests, infection-control products and vitamins.<div style="display:inline-block;width:6px">&nbsp;</div>We offer over 300,000 branded </div><div id="a1151" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:109px;top:330px;">products, through our distribution centers, to our customers.<div style="display:inline-block;width:6px">&nbsp;</div>We also market and sell our own corporate </div><div id="a1157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:109px;top:346px;">brand portfolio of cost-effective, high-quality consumable merchandise products<div style="display:inline-block;width:2px">&nbsp;</div>and manufacture certain </div><div id="a1162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:109px;top:363px;">dental specialty products in the areas of implants, orthodontics and endodontics.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a1167" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:397px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1168" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:397px;">Technology and other value-added products and services.</div><div id="a1171" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:455px;top:397px;"><div style="display:inline-block;width:7px">&nbsp;</div>We sell practice management, business </div><div id="a1173" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:414px;">analytics, patient engagement and patient demand creation software solutions<div style="display:inline-block;width:2px">&nbsp;</div>to our dental customers.<div style="display:inline-block;width:7px">&nbsp;</div>Our </div><div id="a1178" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:431px;">practice management solutions provide practitioners with electronic<div style="display:inline-block;width:2px">&nbsp;</div>medical records, patient treatment </div><div id="a1179" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:448px;">history, analytics, billing, accounts receivable analyses and management, appointment calendars, electronic </div><div id="a1182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:464px;">claims processing and word processing programs, network and hardware<div style="display:inline-block;width:2px">&nbsp;</div>services, e-commerce and </div><div id="a1186" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:481px;">electronic marketing services, sourcing third party patient payment plans,<div style="display:inline-block;width:2px">&nbsp;</div>transition services and training </div><div id="a1187" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:498px;">and education programs for practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>We also sell medical software for practice management, certified </div><div id="a1192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:515px;">electronic health records (“EHR”) and e-Prescribe medications and prescription<div style="display:inline-block;width:2px">&nbsp;</div>solutions through </div><div id="a1195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:532px;">MicroMD®.<div style="display:inline-block;width:7px">&nbsp;</div>We have technical representatives supporting customers using our practice management </div><div id="a1199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:549px;">solutions and services.<div style="display:inline-block;width:7px">&nbsp;</div>As of December 31, 2022, we had an active user base of approximately<div style="display:inline-block;width:2px">&nbsp;</div>110,000 </div><div id="a1203" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:566px;">practices and 380,000 consumers, including users of AxiUm, Dentally®, Dentrix<div style="display:inline-block;width:2px">&nbsp;</div>Ascend®, Dental </div><div id="a1204" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:583px;">Vision®, Dentrix® Dental Systems, Dentrix® Enterprise, Easy Dental®, EndoVision®, Evolution® and </div><div id="a1205" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:599px;">EXACT®, Gesden®, Jarvis Analytics™, Julie® Software, Oasis, OMSVision®, Orisline®, PBS Endo®, </div><div id="a1214" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:616px;">PerioVision®, Power Practice® Px, PowerDent,<div style="display:inline-block;width:4px">&nbsp;</div>and Viive® and subscriptions for Demandforce®, Sesame, </div><div id="a1218" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:633px;">and Lighthouse360® for dental practices and DentalPlans.com®<div style="display:inline-block;width:2px">&nbsp;</div>for dental patients; and MicroMD® for </div><div id="a1220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:650px;">physician practices. </div><div id="a1224" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:684px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1225" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:684px;">Repair services.</div><div id="a1226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:209px;top:684px;"><div style="display:inline-block;width:7px">&nbsp;</div>We have over 130 equipment sales and service centers worldwide that provide a variety of </div><div id="a1230" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:701px;">repair, installation and technical services for our health care customers.<div style="display:inline-block;width:7px">&nbsp;</div>Our technicians provide </div><div id="a1233" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:718px;">installation and repair services for: dental handpieces,<div style="display:inline-block;width:2px">&nbsp;</div>dental and medical small equipment,<div style="display:inline-block;width:3px">&nbsp;</div>table-top </div><div id="a1243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:734px;">sterilizers and large dental equipment. </div><div id="a1246" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:768px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1247" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:768px;">Financial services.</div><div id="a1248" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:226px;top:768px;"><div style="display:inline-block;width:7px">&nbsp;</div>We offer our customers solutions in operating their practices more efficiently by </div><div id="a1250" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:785px;">providing access to a number of financial services and products<div style="display:inline-block;width:2px">&nbsp;</div>provided by third party suppliers (including </div><div id="a1252" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:802px;">non-recourse financing for equipment, technology and software<div style="display:inline-block;width:2px">&nbsp;</div>products, non-recourse practice financing </div><div id="a1257" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:819px;">for leasehold improvements, business debt consolidation and commercial<div style="display:inline-block;width:2px">&nbsp;</div>real estate, non-recourse patient </div><div id="a1260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:836px;">financing and credit card processing) at rates that we believe are<div style="display:inline-block;width:2px">&nbsp;</div>generally lower than what our customers </div><div id="a1263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:852px;">would be able to secure independently.<div style="display:inline-block;width:8px">&nbsp;</div>We also provide staffing services, dental practice valuation and </div><div id="a1267" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:869px;">brokerage services. </div><div id="a1270" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:903px;">Commitment to superior customer service</div><div id="a1271" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:314px;top:903px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We maintain a strong commitment to providing superior customer </div><div id="a1273" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">service.<div style="display:inline-block;width:7px">&nbsp;</div>We frequently monitor our customer service through customer surveys, focus groups and statistical </div><div id="a1274" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">reports.<div style="display:inline-block;width:7px">&nbsp;</div>Our customer service policy primarily focuses on: </div></div>
</div>
<div style="padding: 7px">
<div id="Page7" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:676.1px; height:15px; left:67.2px; top:651.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:13.9px; left:384.2px; top:652.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:322.1px; height:1px; left:66.8px; top:649.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:388.9px; top:649.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:32px; height:16px; left:479.3px; top:650.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32px; height:1px; left:478.9px; top:649.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:510.9px; top:649.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:32px; height:1px; left:601px; top:649.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633px; top:649.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:16px; left:723.3px; top:650.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:317px; height:15.4px; left:67.2px; top:682.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16px; left:67.2px; top:682.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:13.9px; left:384.2px; top:684.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:388.9px; top:697.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:510.9px; top:697.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633px; top:697.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16px; left:67.2px; top:714.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:13.9px; left:384.2px; top:716.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:317px; height:15.4px; left:67.2px; top:746.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16px; left:67.2px; top:746.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:13.9px; left:384.2px; top:748.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:388.9px; top:761.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:510.9px; top:761.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633px; top:761.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:317px; height:15.4px; left:67.2px; top:778.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16px; left:67.2px; top:778.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:13.9px; left:384.2px; top:780.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:388.9px; top:793.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:510.9px; top:793.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633px; top:793.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:389.3px; top:810.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:389.3px; top:812.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:511.3px; top:810.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:511.3px; top:812.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633.4px; top:810.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:633.4px; top:812.1px; background-color:#000000; ">&nbsp;</div>
<div id="a1277" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a1280" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">7 </div><div id="a1282" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:60px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1283" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:60px;">Exceptional order fulfillment</div><div id="a1285" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:285px;top:60px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We ship an average of approximately 157,000 cartons daily.<div style="display:inline-block;width:8px">&nbsp;</div>Historically, </div><div id="a1287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:76px;">approximately 99% of items have been shipped without back-ordering and were<div style="display:inline-block;width:2px">&nbsp;</div>shipped on the same </div><div id="a1290" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:93px;">business day the order is received.<div style="display:inline-block;width:7px">&nbsp;</div>Due to supply chain disruptions during the year ended December<div style="display:inline-block;width:2px">&nbsp;</div>31, </div><div id="a1300" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:110px;">2022, approximately 96% of items ordered were shipped without back-ordering.<div style="display:inline-block;width:6px">&nbsp;</div>As supply chains continue </div><div id="a1309" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:127px;">to stabilize, we expect our percentage of items shipped without back-ordering and<div style="display:inline-block;width:2px">&nbsp;</div>shipped on the same day </div><div id="a1312" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:144px;">to return to historical levels. </div><div id="a1316" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:178px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1317" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:178px;">Comprehensive ordering process</div><div id="a1320" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:310px;top:178px;">.<div style="display:inline-block;width:7px">&nbsp;</div>Customers may place orders 24 hours a day, 7 days a week via e-</div><div id="a1327" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:195px;">commerce solutions, telephone, fax, e-mail and mail. </div><div id="a1334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:228px;">Integrated management information systems</div><div id="a1335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:329px;top:228px;">.<div style="display:inline-block;width:7px">&nbsp;</div>Certain of our information systems generally allow for centralized </div><div id="a1339" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">management of key functions, including accounts receivable, inventory, accounts payable, payroll, purchasing, </div><div id="a1340" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">sales, order fulfillment and financial and operational reporting.<div style="display:inline-block;width:6px">&nbsp;</div>These systems allow us to manage our growth, </div><div id="a1351" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">deliver superior customer service, properly target customers, manage financial<div style="display:inline-block;width:2px">&nbsp;</div>performance and monitor daily </div><div id="a1352" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">operational statistics. </div><div id="a1355" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:330px;">Cost-effective purchasing</div><div id="a1358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:218px;top:330px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We believe that cost-effective purchasing is a key element to maintaining and enhancing </div><div id="a1362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">our position as a competitively priced provider of health care products.<div style="display:inline-block;width:6px">&nbsp;</div>We continuously evaluate our purchase </div><div id="a1366" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">requirements and suppliers’ offerings and prices in order to obtain products at the<div style="display:inline-block;width:2px">&nbsp;</div>lowest possible cost.<div style="display:inline-block;width:7px">&nbsp;</div>In 2022, </div><div id="a1367" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">our top 10 health care distribution suppliers and our single largest supplier accounted for approximately<div style="display:inline-block;width:2px">&nbsp;</div>28% and </div><div id="a1369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">4%, respectively, of our aggregate purchases. </div><div id="a1372" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:431px;">Efficient distribution</div><div id="a1373" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:189px;top:431px;">.<div style="display:inline-block;width:7px">&nbsp;</div>We distribute our products from our 29 strategically located distribution centers.<div style="display:inline-block;width:7px">&nbsp;</div>We strive </div><div id="a1376" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">to maintain optimal inventory levels in order to satisfy customer demand<div style="display:inline-block;width:2px">&nbsp;</div>for prompt delivery and complete order </div><div id="a1379" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">fulfillment.<div style="display:inline-block;width:7px">&nbsp;</div>These inventory levels are managed on a daily basis with<div style="display:inline-block;width:2px">&nbsp;</div>the aid of our management information </div><div id="a1380" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">systems.<div style="display:inline-block;width:7px">&nbsp;</div>Once an order is entered, it is electronically transmitted to the distribution<div style="display:inline-block;width:2px">&nbsp;</div>center nearest the customer’s </div><div id="a1382" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">location for order fulfillment. </div><div id="a1385" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:532px;">Products and Services </div><div id="a1388" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">The following table sets forth the percentage of consolidated net sales<div style="display:inline-block;width:2px">&nbsp;</div>by principal categories of products and </div><div id="a1389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">services offered through our health care distribution and technology and value-added services<div style="display:inline-block;width:2px">&nbsp;</div>reportable segments: </div><div id="a1399" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:399px;top:620px;">December 31, </div><div id="a1403" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:521px;top:620px;">December 25, </div><div id="a1407" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:643px;top:620px;">December 26, </div><div id="a1414" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:422px;top:637px;">2022 </div><div id="a1418" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:544px;top:637px;">2021 </div><div id="a1422" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:666px;top:637px;">2020 </div><div id="a1425" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:651px;">Health care distribution: </div><div id="a1440" style="position:absolute;font-family:'Times New Roman';left:87px;top:667px;">Dental products </div><div id="a1441" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:175px;top:668px;">(1)</div><div id="a1445" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:458px;top:669px;">59.1 </div><div id="a1447" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:479px;top:669px;">% </div><div id="a1451" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:580px;top:669px;">60.8 </div><div id="a1453" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:601px;top:669px;">% </div><div id="a1457" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:702px;top:669px;">58.4 </div><div id="a1459" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:723px;top:669px;">% </div><div id="a1462" style="position:absolute;font-family:'Times New Roman';left:87px;top:683px;">Medical products </div><div id="a1463" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:184px;top:684px;">(2)</div><div id="a1467" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:458px;top:685px;">35.2 </div><div id="a1472" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:580px;top:685px;">34.0 </div><div id="a1477" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:702px;top:685px;">35.8 </div><div id="a1482" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:102px;top:699px;">Total<div style="display:inline-block;width:5px">&nbsp;</div>health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a1486" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:458px;top:701px;">94.3 </div><div id="a1491" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:580px;top:701px;">94.8 </div><div id="a1496" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:702px;top:701px;">94.2 </div><div id="a1499" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:715px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services: </div><div id="a1516" style="position:absolute;font-family:'Times New Roman';left:87px;top:731px;">Software and related products and </div><div id="a1532" style="position:absolute;font-family:'Times New Roman';left:102px;top:747px;"><div style="display:inline-block;width:3px">&nbsp;</div>other value-added products </div><div id="a1536" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:254px;top:748px;">(3)</div><div id="a1540" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:464px;top:749px;">5.7 </div><div id="a1545" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:586px;top:749px;">5.2 </div><div id="a1550" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:708px;top:749px;">5.1 </div><div id="a1553" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:763px;">Total<div style="display:inline-block;width:5px">&nbsp;</div>excluding Corporate TSA net sales </div><div id="a1557" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:765px;">100.0 </div><div id="a1562" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:574px;top:765px;">100.0 </div><div id="a1567" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:702px;top:765px;">99.3 </div><div id="a1571" style="position:absolute;font-family:'Times New Roman';left:87px;top:779px;">Corporate TSA net sales </div><div id="a1572" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:221px;top:780px;">(4)</div><div id="a1576" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:475px;top:781px;">- </div><div id="a1581" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:597px;top:781px;">- </div><div id="a1586" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:708px;top:781px;">0.7 </div><div id="a1589" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:795px;">Total </div><div id="a1593" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:797px;">100.0 </div><div id="a1598" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:574px;top:797px;">100.0 </div><div id="a1603" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:696px;top:797px;">100.0 </div><div id="a1636" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:79px;top:821px;">(1)</div><div id="a1638" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:821px;">Includes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, </div><div id="a1642" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:835px;">gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, PPE products, </div><div id="a1648" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:849px;">equipment repair and high-tech and digital restoration equipment. </div><div id="a1652" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:79px;top:863px;">(2)</div><div id="a1654" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:863px;">Includes branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray </div><div id="a1659" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:877px;">products, equipment, PPE products and vitamins. </div><div id="a1665" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:79px;top:890px;">(3)</div><div id="a1667" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:890px;">Consists of practice management software and other value-added products, which are distributed primarily to health care providers, </div><div id="a1671" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:904px;">and financial services on a non-recourse basis, e-services, continuing education services for practitioners, consulting and other </div><div id="a1676" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:918px;">services. </div><div id="a1678" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:80px;top:932px;">(4)</div><div id="a1680" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:932px;">Corporate TSA net sales represents sales of certain products to Covetrus under the transition services agreement entered into in </div><div id="a1682" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:946px;">connection with the Animal Health Spin-off, which ended in December 2020.<div style="display:inline-block;width:6px">&nbsp;</div>See </div><div id="a1686" style="position:absolute;font-family:'Times New Roman';font-size:12px;color:#0000FF;left:509px;top:946px;"><a href="#a51119" style="color:#0000FF;text-decoration:underline;">Note-23 Related Party Transactions</a></div><div id="a1689" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:681px;top:946px;"><div style="display:inline-block;width:3px">&nbsp;</div>for further </div><div id="a1691" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:959px;">information. </div></div>
</div>
<div style="padding: 7px">
<div id="Page8" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a1694" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a1697" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">8 </div><div id="a1699" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Business Strategy </div><div id="a1703" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Our mission is to provide innovative, integrated health care products and<div style="display:inline-block;width:2px">&nbsp;</div>services; and to be trusted advisors and </div><div id="a1704" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">consultants to our customers - enabling them to deliver the best quality patient<div style="display:inline-block;width:2px">&nbsp;</div>care and enhance their practice </div><div id="a1708" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">management efficiency and profitability.<div style="display:inline-block;width:8px">&nbsp;</div>Our BOLD+1 Strategic Plan consists of the following: </div><div id="a1712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:161px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:161px;">Build (“B”) </div><div id="a1714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:191px;top:161px;">Complementary software, specialty, and services businesses for high growth </div><div id="a1716" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:178px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:178px;">Operationalize (“O”)</div><div id="a1718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:247px;top:178px;"><div style="display:inline-block;width:4px">&nbsp;</div>One Distribution to deliver exceptional customer experience, increased<div style="display:inline-block;width:2px">&nbsp;</div>efficiency, </div><div id="a1720" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:195px;">and growth </div><div id="a1722" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:211px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1723" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:211px;">Leverage (“L”)</div><div id="a1724" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:211px;top:211px;"><div style="display:inline-block;width:4px">&nbsp;</div>One Schein to broaden and deepen relationships with our customers </div><div id="a1727" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:228px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:228px;">Drive (“D”)</div><div id="a1729" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:189px;top:228px;"><div style="display:inline-block;width:4px">&nbsp;</div>Drive digital transformation for our customers and for Henry Schein </div><div id="a1733" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:245px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1734" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:245px;">+1 </div><div id="a1735" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:134px;top:245px;">Create Value<div style="display:inline-block;width:5px">&nbsp;</div>for our stakeholders </div><div id="a1738" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">To accomplish this, we apply our competitive strengths in executing the following strategies: </div><div id="a1741" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:313px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:313px;">Increase penetration of our existing customer base.</div><div id="a1743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:417px;top:313px;"><div style="display:inline-block;width:7px">&nbsp;</div>We have over 1 million customers worldwide and we </div><div id="a1747" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:330px;">intend to increase sales to our existing customer base and enhance our position<div style="display:inline-block;width:2px">&nbsp;</div>as their primary supplier.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a1748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:346px;">We believe our offering of a broad range of products, services and support, including software solutions </div><div id="a1749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:363px;">that can help drive improved workflow efficiency and patient communications for<div style="display:inline-block;width:2px">&nbsp;</div>practices, coupled with </div><div id="a1751" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:380px;">our full-service value proposition, helps us to retain and grow our customer<div style="display:inline-block;width:2px">&nbsp;</div>base. </div><div id="a1756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:414px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1757" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:414px;">Increase the number of customers we serve.</div><div id="a1758" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:372px;top:414px;"><div style="display:inline-block;width:7px">&nbsp;</div>This strategy includes increasing the productivity of our field </div><div id="a1762" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:431px;">sales consultants and telesales team, as well as using our customer<div style="display:inline-block;width:2px">&nbsp;</div>database to focus our marketing efforts </div><div id="a1765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:448px;">in all of our operating segments.<div style="display:inline-block;width:7px">&nbsp;</div>In the dental business, we provide products and services to<div style="display:inline-block;width:2px">&nbsp;</div>independent </div><div id="a1766" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:464px;">practices, mid-market groups, and large DSOs as well as community health centers and government<div style="display:inline-block;width:2px">&nbsp;</div>sites of </div><div id="a1770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:481px;">care.<div style="display:inline-block;width:7px">&nbsp;</div>Leveraging our broad array of assets and capabilities, we offer solutions to address these<div style="display:inline-block;width:2px">&nbsp;</div>new </div><div id="a1774" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:498px;">markets.<div style="display:inline-block;width:7px">&nbsp;</div>In the medical business, we have expanded to serve customers<div style="display:inline-block;width:2px">&nbsp;</div>located in settings outside of the </div><div id="a1776" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:515px;">traditional office, such as urgent care clinics, retail, occupational health and home health settings.<div style="display:inline-block;width:6px">&nbsp;</div>As </div><div id="a1777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:532px;">settings of health care shift, we remain committed to serving these practitioners<div style="display:inline-block;width:2px">&nbsp;</div>and providing them with </div><div id="a1778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:549px;">the products and services they need. </div><div id="a1782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:583px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:583px;">Leverage our value-added products and services.</div><div id="a1786" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:405px;top:583px;"><div style="display:inline-block;width:7px">&nbsp;</div>We continue to increase cross-selling efforts for key </div><div id="a1790" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:599px;">product lines utilizing a consultative selling process.<div style="display:inline-block;width:6px">&nbsp;</div>In the dental business, we have significant cross-</div><div id="a1792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:616px;">selling opportunities between our dental software users and our dental customers.<div style="display:inline-block;width:6px">&nbsp;</div>In the medical business, </div><div id="a1794" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:633px;">we have opportunities to expand our vaccine, injectables and other pharmaceuticals<div style="display:inline-block;width:2px">&nbsp;</div>sales to health care </div><div id="a1795" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:650px;">practitioners, as well as cross-selling EHR systems and software<div style="display:inline-block;width:2px">&nbsp;</div>when we sell our core products.<div style="display:inline-block;width:7px">&nbsp;</div>Our </div><div id="a1802" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:667px;">strategy extends to providing health systems, integrated delivery networks<div style="display:inline-block;width:2px">&nbsp;</div>and other large group and multi-</div><div id="a1804" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:684px;">site health care organizations, including physician clinics, these same value added<div style="display:inline-block;width:2px">&nbsp;</div>products and services.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a1807" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:701px;">As physicians and health systems closely align, we have increased<div style="display:inline-block;width:2px">&nbsp;</div>access to opportunities for cross-</div><div id="a1810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:718px;">marketing and selling our product and service portfolios. </div><div id="a1813" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:751px;">•<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a1814" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:751px;">Pursue strategic acquisitions and joint ventures.</div><div id="a1815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:399px;top:751px;"><div style="display:inline-block;width:7px">&nbsp;</div>Our acquisition strategy is focused on investments in </div><div id="a1818" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:768px;">companies that add new customers and sales teams, increase our geographic<div style="display:inline-block;width:2px">&nbsp;</div>footprint (whether entering a </div><div id="a1826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:785px;">new country, such as emerging markets, or building scale where we have already invested in businesses), </div><div id="a1827" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:802px;">and finally, those that enable us to access new products and technologies. </div><div id="a1833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:836px;">Markets Served<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a1836" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">Demographic trends indicate that our markets are growing, as an<div style="display:inline-block;width:2px">&nbsp;</div>aging U.S. population is increasingly using health </div><div id="a1838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">care services.<div style="display:inline-block;width:7px">&nbsp;</div>According to the U.S. Census Bureau’s International Database, between 2022 and 2032, the 45 and </div><div id="a1844" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">older population is expected to grow by approximately 11%.<div style="display:inline-block;width:7px">&nbsp;</div>Between 2022 and 2042, this age group is expected to </div><div id="a1849" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">grow by approximately 21%.<div style="display:inline-block;width:7px">&nbsp;</div>This compares with expected total U.S. population growth<div style="display:inline-block;width:2px">&nbsp;</div>rates of approximately 6% </div><div id="a1855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">between 2022 and 2032 and approximately 12% between 2022 and 2042.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a1865" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">In the dental industry, there is predicted to be a rise in oral health care expenditures as the 45-and-older segment of </div><div id="a1870" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">the population increases.<div style="display:inline-block;width:7px">&nbsp;</div>There is increasing demand for new technologies that allow<div style="display:inline-block;width:2px">&nbsp;</div>dentists to increase </div></div>
</div>
<div style="padding: 7px">
<div id="Page9" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a1874" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a1877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:404px;top:1011px;">9 </div><div id="a1879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">productivity, and this is being driven in the U.S. by lower insurance reimbursement rates.<div style="display:inline-block;width:7px">&nbsp;</div>At the same time, there is </div><div id="a1888" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">an expected increase in dental insurance coverage. </div><div id="a1892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">In the medical market, there continues to be a migration of procedures from<div style="display:inline-block;width:2px">&nbsp;</div>acute-care settings to physicians’ </div><div id="a1896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">offices and home health settings,<div style="display:inline-block;width:3px">&nbsp;</div>a trend that we believe provides additional opportunities for us.<div style="display:inline-block;width:6px">&nbsp;</div>There also is the </div><div id="a1902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">continuing use of vaccines, injectables and other pharmaceuticals in alternate-care<div style="display:inline-block;width:2px">&nbsp;</div>settings.<div style="display:inline-block;width:7px">&nbsp;</div>We believe we have </div><div id="a1905" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">established a leading position as a vaccine supplier to the office-based physician<div style="display:inline-block;width:2px">&nbsp;</div>practitioner. </div><div id="a1910" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">We support our dental and medical professionals through the many SKUs that we offer, as well as through </div><div id="a1914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">important value-added services, including practice management software,<div style="display:inline-block;width:2px">&nbsp;</div>electronic claims processing, financial </div><div id="a1917" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">services and continuing education, all designed to help maximize a practitioner’s efficiency.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a1923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Additionally, we seek to expand our dental full-service model and medical offerings in countries where </div><div id="a1926" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">opportunities exist.<div style="display:inline-block;width:7px">&nbsp;</div>We do this through both direct sales and by partnering with local distribution and </div><div id="a1931" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">manufacturing companies. </div><div id="a1936" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">For information on revenues and long-lived assets by geographic area, see </div><div id="a1939" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:507px;top:330px;"><a href="#a36932" style="color:#0000FF;text-decoration:underline;">Note 3 – Segment and Geographic Data</a></div><div id="a1944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">of “Notes to Consolidated Financial Statements.”<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a1949" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:380px;">Seasonality and Other Factors Affecting Our Business and Quarterly Results </div><div id="a1953" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">We experience fluctuations in quarterly earnings.<div style="display:inline-block;width:8px">&nbsp;</div>As a result, we may fail to meet or exceed the expectations of </div><div id="a1954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">securities analysts and investors, which could cause our stock price<div style="display:inline-block;width:2px">&nbsp;</div>to decline. </div><div id="a1957" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">Our business is subject to seasonal and other quarterly fluctuations.<div style="display:inline-block;width:6px">&nbsp;</div>Sales and profitability generally have been </div><div id="a1959" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">higher in the third and fourth quarters due to the timing of sales of seasonal<div style="display:inline-block;width:2px">&nbsp;</div>products (including influenza vaccine) </div><div id="a1960" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">purchasing patterns of office-based health care practitioners for certain products (including<div style="display:inline-block;width:2px">&nbsp;</div>equipment and </div><div id="a1964" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">software) and year-end promotions.<div style="display:inline-block;width:7px">&nbsp;</div>Sales and profitability may also be impacted by the timing of<div style="display:inline-block;width:2px">&nbsp;</div>certain annual </div><div id="a1967" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">and biennial dental tradeshows where equipment promotions are offered.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, some dental practices delay </div><div id="a1969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">equipment purchases in the U.S. until year-end due to tax incentives.<div style="display:inline-block;width:6px">&nbsp;</div>We expect our historical seasonality of sales </div><div id="a1972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">to continue in the foreseeable future. </div><div id="a1975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:599px;">Governmental Regulations </div><div id="a1979" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">&nbsp;</div><div id="a1980" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">We </div><div id="a1982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:633px;">strive to be compliant in all material respects with the applicable<div style="display:inline-block;width:2px">&nbsp;</div>laws, regulations and guidance described </div><div id="a2014" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">below, and believe we have effective compliance programs and other controls in place to ensure substantial </div><div id="a2046" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">compliance.<div style="display:inline-block;width:7px">&nbsp;</div>However, compliance is not guaranteed either now or in the future, as certain laws, regulations and </div><div id="a2081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">guidance may be subject to varying and evolving interpretations that could<div style="display:inline-block;width:2px">&nbsp;</div>affect our ability to comply, as well as </div><div id="a2119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">future changes, additions and enforcement approaches, including political changes.<div style="display:inline-block;width:6px">&nbsp;</div>When we discover situations of </div><div id="a2148" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">non-compliance we seek to remedy them and bring the affected area back into compliance.<div style="display:inline-block;width:6px">&nbsp;</div>President Biden’s </div><div id="a2182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">administration (the “Biden Administration”) has indicated that it will be<div style="display:inline-block;width:2px">&nbsp;</div>more aggressive in its pursuit of alleged </div><div id="a2217" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">violations of law, and has revoked certain guidance that would have limited governmental use of informal agency </div><div id="a2251" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">guidance to pursue potential violations, and has stated that it is more prepared<div style="display:inline-block;width:2px">&nbsp;</div>to pursue individuals for corporate </div><div id="a2287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">law violations, including an aggressive approach to anti-corruption activities.<div style="display:inline-block;width:6px">&nbsp;</div>Changes to applicable laws, </div><div id="a2315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">regulations and guidance described below, as well as related administrative or judicial interpretations, may require </div><div id="a2345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">us to update or revise our operations, services, marketing practices and<div style="display:inline-block;width:2px">&nbsp;</div>compliance programs and controls, and may </div><div id="a2380" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">impose additional and unforeseen costs on us, pose new or previously immaterial<div style="display:inline-block;width:2px">&nbsp;</div>risks to us, or may otherwise have </div><div id="a2418" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">a material adverse effect on our business. </div><div id="a2433" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:886px;">Government </div><div id="a2436" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">Certain of our businesses involve the distribution, manufacturing, importation,<div style="display:inline-block;width:2px">&nbsp;</div>exportation, marketing and sale of, </div><div id="a2464" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">and/or third party payment for, pharmaceuticals and/or medical devices, and in this regard, we are subject<div style="display:inline-block;width:2px">&nbsp;</div>to </div><div id="a2498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">extensive local, state, federal and foreign governmental laws and regulations,<div style="display:inline-block;width:2px">&nbsp;</div>including as applicable to our </div><div id="a2529" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">wholesale distribution of pharmaceuticals and medical devices, manufacturing<div style="display:inline-block;width:2px">&nbsp;</div>activities, and as part of our </div><div id="a2557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">specialty home medical supply business that distributes and sells medical equipment<div style="display:inline-block;width:2px">&nbsp;</div>and supplies directly to </div></div>
</div>
<div style="padding: 7px">
<div id="Page10" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a2587" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a2590" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">10 </div><div id="a2592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">patients.<div style="display:inline-block;width:7px">&nbsp;</div>Federal, state and certain foreign governments have also increased enforcement<div style="display:inline-block;width:2px">&nbsp;</div>activity in the health care </div><div id="a2624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">sector, particularly in areas of fraud and abuse, anti-bribery and corruption, controlled substances handling,<div style="display:inline-block;width:2px">&nbsp;</div>medical </div><div id="a2657" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">device regulations and data privacy and security standards. </div><div id="a2674" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Government and private insurance programs fund a large portion of the total cost of medical care,<div style="display:inline-block;width:2px">&nbsp;</div>and there have </div><div id="a2712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">been efforts to limit such private and government insurance programs, including efforts, thus far<div style="display:inline-block;width:2px">&nbsp;</div>unsuccessful, to </div><div id="a2745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">seek repeal of the entire United States Patient Protection and Affordable Care Act,<div style="display:inline-block;width:2px">&nbsp;</div>as amended by the Health Care </div><div id="a2783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">and Education Reconciliation Act, each enacted in March 2010 (as amended,<div style="display:inline-block;width:2px">&nbsp;</div>the “ACA”).<div style="display:inline-block;width:7px">&nbsp;</div>In addition, activities to </div><div id="a2816" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">control medical costs, including laws and regulations lowering reimbursement<div style="display:inline-block;width:2px">&nbsp;</div>rates for pharmaceuticals, medical </div><div id="a2842" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">devices and/or medical treatments or services, are ongoing.<div style="display:inline-block;width:6px">&nbsp;</div>Many of these laws and regulations are subject to </div><div id="a2876" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">change and their evolving implementation may impact our operations and our<div style="display:inline-block;width:2px">&nbsp;</div>financial performance. </div><div id="a2904" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Our businesses are generally subject to numerous laws and regulations that could<div style="display:inline-block;width:2px">&nbsp;</div>impact our financial performance, </div><div id="a2936" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">and failure to comply with such laws or regulations could have a material adverse<div style="display:inline-block;width:2px">&nbsp;</div>effect on our business. </div><div id="a2973" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:313px;">Operating, Security and Licensure Standards</div><div id="a2984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">Certain of our businesses are subject to local, state and federal governmental<div style="display:inline-block;width:2px">&nbsp;</div>laws and regulations relating to the </div><div id="a3020" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">distribution of pharmaceuticals and medical devices and supplies.<div style="display:inline-block;width:6px">&nbsp;</div>Among the United States federal laws applicable </div><div id="a3050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">to us are the Controlled Substances Act, the Federal Food, Drug,<div style="display:inline-block;width:2px">&nbsp;</div>and Cosmetic Act, as amended (“FDC Act”), </div><div id="a3086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">Section 361 of the Public Health Service Act and Section 401 of the Consolidated<div style="display:inline-block;width:2px">&nbsp;</div>Appropriations Act of the Social </div><div id="a3125" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">Security Act, as well as laws regulating the billing of and reimbursement<div style="display:inline-block;width:2px">&nbsp;</div>from government programs, such as </div><div id="a3159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">Medicare and Medicaid, and from commercial payers.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a3173" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:393px;top:431px;">We </div><div id="a3175" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:417px;top:431px;">are also subject to comparable foreign regulations. </div><div id="a3190" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">The FDC Act, the Controlled Substances Act, their implementing regulations,<div style="display:inline-block;width:2px">&nbsp;</div>and similar foreign laws generally </div><div id="a3221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">regulate the introduction, manufacture, advertising, marketing and promotion,<div style="display:inline-block;width:2px">&nbsp;</div>sampling, pricing and </div><div id="a3243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">reimbursement, labeling, packaging, storage, handling, returning or recalling,<div style="display:inline-block;width:2px">&nbsp;</div>reporting, and distribution of, and </div><div id="a3270" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">record keeping for, pharmaceuticals and medical devices shipped in interstate commerce, and states<div style="display:inline-block;width:2px">&nbsp;</div>may similarly </div><div id="a3300" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">regulate such activities within the state.<div style="display:inline-block;width:7px">&nbsp;</div>Furthermore, Section 361 of the Public Health Service Act, which provides </div><div id="a3335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">authority to prevent the introduction, transmission or spread of communicable<div style="display:inline-block;width:2px">&nbsp;</div>diseases, serves as the legal basis for </div><div id="a3369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">the United States Food and Drug Administration’s (“FDA”) regulation of human cells, tissues and cellular and </div><div id="a3401" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">tissue-based products, also known as “HCT/P products.” </div><div id="a3418" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">The Federal Drug Quality and Security Act of 2013 brought about significant<div style="display:inline-block;width:2px">&nbsp;</div>changes with respect to </div><div id="a3450" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">pharmaceutical supply chain requirements.<div style="display:inline-block;width:7px">&nbsp;</div>Title II of this measure, known as the Drug Supply Chain Security Act </div><div id="a3485" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">(“DSCSA”), was first implemented in November 2014 and will be phased<div style="display:inline-block;width:2px">&nbsp;</div>in over a period of ten years. DSCSA is </div><div id="a3525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">intended to build a national electronic, interoperable system by November<div style="display:inline-block;width:2px">&nbsp;</div>27, 2023, that will identify and trace </div><div id="a3559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">certain prescription drugs as they are distributed in the United States.<div style="display:inline-block;width:6px">&nbsp;</div>The law’s track and trace requirements </div><div id="a3594" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">applicable to manufacturers, wholesalers, third-party logistics providers (e.g.,<div style="display:inline-block;width:2px">&nbsp;</div>trading partners), repackagers and </div><div id="a3620" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">dispensers (e.g., pharmacies) of prescription drugs took effect in January 2015, and<div style="display:inline-block;width:2px">&nbsp;</div>continues to be implemented.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a3653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">The DSCSA product tracing requirements replace the former FDA drug pedigree<div style="display:inline-block;width:2px">&nbsp;</div>requirements and pre-empt certain </div><div id="a3685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">state requirements that are inconsistent with, more stringent than, or<div style="display:inline-block;width:2px">&nbsp;</div>in addition to, the DSCSA requirements. </div><div id="a3718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">The DSCSA also establishes certain requirements for the licensing and operation<div style="display:inline-block;width:2px">&nbsp;</div>of prescription drug wholesalers </div><div id="a3748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">and third-party logistics providers (“3PLs”), and includes the eventual<div style="display:inline-block;width:2px">&nbsp;</div>creation of national wholesaler and 3PL </div><div id="a3781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">licenses in cases where states do not license such entities.<div style="display:inline-block;width:6px">&nbsp;</div>The DSCSA requires that wholesalers and 3PLs </div><div id="a3815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">distribute drugs in accordance with certain standards regarding the recordkeeping,<div style="display:inline-block;width:2px">&nbsp;</div>storage and handling of </div><div id="a3843" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">prescription drugs.<div style="display:inline-block;width:7px">&nbsp;</div>The DSCSA requires wholesalers and 3PLs to submit annual reports<div style="display:inline-block;width:2px">&nbsp;</div>to the FDA, which include </div><div id="a3878" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">information regarding each state where the wholesaler or 3PL is licensed, the name<div style="display:inline-block;width:2px">&nbsp;</div>and address of each facility and </div><div id="a3916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">contact information.<div style="display:inline-block;width:7px">&nbsp;</div>According to FDA guidance, states are pre-empted from imposing<div style="display:inline-block;width:2px">&nbsp;</div>any licensing requirements </div><div id="a3946" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">that are inconsistent with, less stringent than, directly related to, or covered<div style="display:inline-block;width:2px">&nbsp;</div>by the standards established by federal </div><div id="a3982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">law in this area.<div style="display:inline-block;width:7px">&nbsp;</div>Current state licensing requirements concerning wholesalers will<div style="display:inline-block;width:2px">&nbsp;</div>remain in effect until the FDA </div><div id="a4017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">issues new regulations as directed by the DSCSA.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, with respect to our specialty home medical supply </div><div id="a4053" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">business, we are subject to certain state licensure laws (including state pharmacy<div style="display:inline-block;width:2px">&nbsp;</div>laws), and also certain </div><div id="a4085" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">accreditation standards, including to qualify for reimbursement from<div style="display:inline-block;width:2px">&nbsp;</div>Medicare and other third-party payers. </div></div>
</div>
<div style="padding: 7px">
<div id="Page11" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a4115" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a4118" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">11 </div><div id="a4120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">The Food and Drug Administration Amendments Act of 2007 and<div style="display:inline-block;width:2px">&nbsp;</div>the Food and Drug Administration Safety and </div><div id="a4154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Innovation Act of 2012 amended the FDC Act to require the FDA to promulgate<div style="display:inline-block;width:2px">&nbsp;</div>regulations to implement a unique </div><div id="a4193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">device identification (“UDI”) system.<div style="display:inline-block;width:7px">&nbsp;</div>The UDI rule phased in the implementation of the UDI<div style="display:inline-block;width:2px">&nbsp;</div>regulations, </div><div id="a4223" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">generally beginning with the highest-risk devices (i.e., Class III medical devices)<div style="display:inline-block;width:2px">&nbsp;</div>and ending with the lowest-risk </div><div id="a4260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">devices.<div style="display:inline-block;width:7px">&nbsp;</div>Most compliance dates were reached as of September 24, 2018, with<div style="display:inline-block;width:2px">&nbsp;</div>a final set of requirements for low </div><div id="a4298" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">risk devices being reached on September 24, 2022, which completed the<div style="display:inline-block;width:2px">&nbsp;</div>phase in.<div style="display:inline-block;width:7px">&nbsp;</div>However, in May 2021, the </div><div id="a4325" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">FDA issued an enforcement policy stating that it does not intend to<div style="display:inline-block;width:2px">&nbsp;</div>object to the use of legacy identification </div><div id="a4327" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">numbers on device labels and packages for finished devices manufactured<div style="display:inline-block;width:2px">&nbsp;</div>and labeled prior to September 24, 2023.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a4328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">The UDI regulations require “labelers” to include unique device identifiers<div style="display:inline-block;width:2px">&nbsp;</div>(“UDIs”), with a content and format </div><div id="a4360" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">prescribed by the FDA and issued under a system operated by an FDA-accredited<div style="display:inline-block;width:2px">&nbsp;</div>issuing agency, on the labels and </div><div id="a4400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">packages of medical devices (including, but not limited to, certain software<div style="display:inline-block;width:2px">&nbsp;</div>that qualifies as a medical device under </div><div id="a4437" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">FDA rules), and to directly mark certain devices with UDIs.<div style="display:inline-block;width:6px">&nbsp;</div>The UDI regulations also require labelers to submit </div><div id="a4473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">certain information concerning UDI-labeled devices to the FDA, much of which<div style="display:inline-block;width:2px">&nbsp;</div>information is publicly available </div><div id="a4505" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">on an FDA database, the Global Unique Device Identification Database.<div style="display:inline-block;width:6px">&nbsp;</div>On July 22, 2022, the FDA posted the </div><div id="a4541" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">final guidance regarding the Global Unique Device Identification Database<div style="display:inline-block;width:2px">&nbsp;</div>called Unique Device Identification </div><div id="a4567" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">Policy Regarding Compliance Dates for Class I and Unclassified Devices, Direct<div style="display:inline-block;width:2px">&nbsp;</div>Marketing, and Global Unique </div><div id="a4597" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">Device Identification Database Requirements for Certain Devices.<div style="display:inline-block;width:6px">&nbsp;</div>The UDI regulations and subsequent FDA </div><div id="a4623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">guidance regarding the UDI requirements provide for certain exceptions, alternatives<div style="display:inline-block;width:2px">&nbsp;</div>and time extensions.<div style="display:inline-block;width:7px">&nbsp;</div>For </div><div id="a4651" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">example, the UDI regulations include a general exception for Class I devices<div style="display:inline-block;width:2px">&nbsp;</div>exempt from the Quality System </div><div id="a4685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">Regulation (other than record-keeping requirements and complaint files).<div style="display:inline-block;width:6px">&nbsp;</div>Regulated labelers include entities such </div><div id="a4713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">as device manufacturers, repackagers, reprocessors and relabelers that cause a<div style="display:inline-block;width:2px">&nbsp;</div>device’s label to be applied or </div><div id="a4745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">modified, with the intent that the device will be commercially distributed without<div style="display:inline-block;width:2px">&nbsp;</div>any subsequent replacement or </div><div id="a4778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">modification of the label and include certain of our businesses. </div><div id="a4799" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">Under the Controlled Substances Act, as a distributor of controlled substances,<div style="display:inline-block;width:2px">&nbsp;</div>we are required to obtain and renew </div><div id="a4835" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">annually registrations for our facilities from the United States Drug<div style="display:inline-block;width:2px">&nbsp;</div>Enforcement Administration (“DEA”) </div><div id="a4862" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">permitting us to handle controlled substances.<div style="display:inline-block;width:7px">&nbsp;</div>We are also subject to other statutory and regulatory requirements </div><div id="a4894" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">relating to the storage, sale, marketing, handling, reporting, record-keeping<div style="display:inline-block;width:2px">&nbsp;</div>and distribution of such drugs, in </div><div id="a4927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">accordance with the Controlled Substances Act and its implementing regulations,<div style="display:inline-block;width:2px">&nbsp;</div>and these requirements have been </div><div id="a4957" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">subject to heightened enforcement activity in recent times.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a4973" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:418px;top:549px;">We </div><div id="a4975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:442px;top:549px;">are subject to inspection by the DEA.<div style="display:inline-block;width:7px">&nbsp;</div>Certain of </div><div id="a4993" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">our businesses are also required to register for permits and/or licenses<div style="display:inline-block;width:2px">&nbsp;</div>with, and comply with operating and security </div><div id="a5030" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">standards of, the DEA, the FDA, the United States Department of Health<div style="display:inline-block;width:2px">&nbsp;</div>and Human Services (“HHS”), and </div><div id="a5064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">various state boards of pharmacy, state health departments and/or comparable state agencies as well as comparable </div><div id="a5097" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">foreign agencies, and certain accrediting bodies, depending on the type of<div style="display:inline-block;width:2px">&nbsp;</div>operations and location of product </div><div id="a5129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">distribution, manufacturing or sale.<div style="display:inline-block;width:7px">&nbsp;</div>These businesses include those that distribute, manufacture, relabel, and/or </div><div id="a5155" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">repackage prescription pharmaceuticals and/or medical devices and/or HCT/P<div style="display:inline-block;width:2px">&nbsp;</div>products, or own pharmacy </div><div id="a5179" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">operations, or install, maintain or repair equipment.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a5195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">In addition, Section 301 of the National Organ Transplant Act, and a number of comparable state laws, impose civil </div><div id="a5233" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">and/or criminal penalties for the transfer of certain human tissue (for example,<div style="display:inline-block;width:2px">&nbsp;</div>human bone products) for valuable </div><div id="a5267" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">consideration, while generally permitting payments for the reasonable costs<div style="display:inline-block;width:2px">&nbsp;</div>incurred in procuring, processing, </div><div id="a5293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">storing and distributing that tissue.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a5303" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:278px;top:751px;">We </div><div id="a5305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:302px;top:751px;">are also subject to foreign government regulation of such products.<div style="display:inline-block;width:6px">&nbsp;</div>The </div><div id="a5327" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">DEA, the FDA and state regulatory authorities have broad inspection and enforcement<div style="display:inline-block;width:2px">&nbsp;</div>powers, including the ability </div><div id="a5359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">to suspend or limit the distribution of products by our distribution centers,<div style="display:inline-block;width:2px">&nbsp;</div>seize or order the recall of products and </div><div id="a5399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">impose significant criminal, civil and administrative sanctions for violations of<div style="display:inline-block;width:2px">&nbsp;</div>these laws and regulations.<div style="display:inline-block;width:7px">&nbsp;</div>Foreign </div><div id="a5429" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">regulations subject us to similar foreign enforcement powers. </div><div id="a5447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:852px;">EU Regulation of Medicinal and Dental Products<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a5463" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">European Union (“EU”) member states regulate their own healthcare systems,<div style="display:inline-block;width:2px">&nbsp;</div>as does EU law.<div style="display:inline-block;width:8px">&nbsp;</div>The latter regulates </div><div id="a5497" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">certain matters, most notably medicinal products and medical devices.<div style="display:inline-block;width:6px">&nbsp;</div>Medicinal products are defined, broadly, as </div><div id="a5527" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">substances or combinations of substances having certain functionalities and<div style="display:inline-block;width:2px">&nbsp;</div>may not include medical devices.<div style="display:inline-block;width:7px">&nbsp;</div>EU </div><div id="a5557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">“regulations” apply in all member states, whereas “directives” are implemented<div style="display:inline-block;width:2px">&nbsp;</div>by the individual laws of member </div><div id="a5590" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">states.<div style="display:inline-block;width:4px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page12" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a5594" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a5597" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">12 </div><div id="a5599" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">On medicines for humans, we are regulated under Directive No. 2001/83/EC<div style="display:inline-block;width:2px">&nbsp;</div>of 6 November 2001, as amended by </div><div id="a5635" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Directive 2003/63/EC of 25 June 2003, and EU Regulation (EC) No. 726/2004<div style="display:inline-block;width:2px">&nbsp;</div>of 31 March 2004.<div style="display:inline-block;width:7px">&nbsp;</div>These rules </div><div id="a5672" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">provide for the authorization of products, and regulate their manufacture,<div style="display:inline-block;width:2px">&nbsp;</div>importation, marketing and distribution.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a5700" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">It implements requirements which may be implemented without warning, as<div style="display:inline-block;width:2px">&nbsp;</div>well as a national pharmacovigilance </div><div id="a5730" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">system under which marketing authorizations may be withdrawn, and includes<div style="display:inline-block;width:2px">&nbsp;</div>potential sanctions for breaches of </div><div id="a5761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">the rules, and on other bases such as harmfulness or lack of efficacy.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a5789" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">EU Regulation No. 1223/2009 of 30 November 2009 </div><div id="a5805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:383px;top:178px;">on cosmetic products</div><div id="a5810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:508px;top:178px;"><div style="display:inline-block;width:4px">&nbsp;</div>requires that cosmetic products (which </div><div id="a5821" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">includes dental products) be safe for human health when used under normal<div style="display:inline-block;width:2px">&nbsp;</div>or reasonably foreseeable conditions of </div><div id="a5855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">use and comply with certain obligations which apply to manufacturer, importer and distributor.<div style="display:inline-block;width:7px">&nbsp;</div>It includes market </div><div id="a5887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">surveillance, and non-compliance may result in the recall or withdrawal of<div style="display:inline-block;width:2px">&nbsp;</div>products, along with other sanctions.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a5924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">In the EU, the EU Medical Device Regulation No. 2017/745 of 5 April 2017<div style="display:inline-block;width:2px">&nbsp;</div>(“EU MDR”) covers a wide scope of </div><div id="a5966" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">our activities, from dental material to X-ray machines, and certain software.<div style="display:inline-block;width:6px">&nbsp;</div>It was meant to become applicable </div><div id="a6003" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">three years after publication (i.e., May 26, 2020).<div style="display:inline-block;width:7px">&nbsp;</div>However, on April 23, 2020, to allow European Economic Area </div><div id="a6039" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">(“EEA”) national authorities, notified bodies, manufacturers and other actors<div style="display:inline-block;width:2px">&nbsp;</div>to focus fully on urgent priorities </div><div id="a6070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">related to the COVID-19 pandemic, the European Council and Parliament<div style="display:inline-block;width:2px">&nbsp;</div>adopted Regulation 2020/561, </div><div id="a6098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">postponing the date of application of the EU MDR by one year (to<div style="display:inline-block;width:2px">&nbsp;</div>May 26, 2021). </div><div id="a6131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">The EU MDR significantly modifies and intensifies the regulatory compliance<div style="display:inline-block;width:2px">&nbsp;</div>requirements for the medical device </div><div id="a6162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">industry as a whole.<div style="display:inline-block;width:7px">&nbsp;</div>Among other things, the EU MDR: </div><div id="a6183" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:431px;">•<div style="display:inline-block;width:19px">&nbsp;</div>strengthens the rules on placing devices on the market and reinforces surveillance<div style="display:inline-block;width:2px">&nbsp;</div>once they are available; </div><div id="a6219" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:448px;">•<div style="display:inline-block;width:19px">&nbsp;</div>establishes explicit provisions on manufacturers’ responsibilities<div style="display:inline-block;width:2px">&nbsp;</div>for the follow-up of the quality, </div><div id="a6250" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:464px;">performance and safety of devices placed on the market; </div><div id="a6268" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:481px;">•<div style="display:inline-block;width:19px">&nbsp;</div>improves the traceability of medical devices throughout the supply chain to the<div style="display:inline-block;width:2px">&nbsp;</div>end-user or patient through </div><div id="a6307" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:498px;">a unique identification number; </div><div id="a6315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:515px;">•<div style="display:inline-block;width:19px">&nbsp;</div>sets up a central database to provide patients, healthcare professionals and<div style="display:inline-block;width:2px">&nbsp;</div>the public with comprehensive </div><div id="a6349" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:532px;">information on products available in the EU;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a6364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:549px;">•<div style="display:inline-block;width:19px">&nbsp;</div>strengthens rules for the assessment of certain high-risk devices, such<div style="display:inline-block;width:2px">&nbsp;</div>as implants, which may have to </div><div id="a6402" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:566px;">undergo an additional check by experts before they are placed on the market; and </div><div id="a6430" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:583px;">•<div style="display:inline-block;width:19px">&nbsp;</div>identifies importers and distributors and medical device products through<div style="display:inline-block;width:2px">&nbsp;</div>registration in a database </div><div id="a6435" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:599px;">(EUDAMED, which is not fully functional for the time being and might<div style="display:inline-block;width:2px">&nbsp;</div>not be so before the end of 2024 at </div><div id="a6437" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:616px;">the earliest; therefore, the use of this database is only possible through<div style="display:inline-block;width:2px">&nbsp;</div>a voluntary basis and, by a way of </div><div id="a6438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:633px;">consequence, is currently not mandatory). </div><div id="a6444" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">In particular, the EU MDR imposes strict requirements for the confirmation that a product meets<div style="display:inline-block;width:2px">&nbsp;</div>the regulatory </div><div id="a6478" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">requirements, including regarding a product’s clinical evaluation and a company’s quality systems, and for the </div><div id="a6508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">distribution, marketing and sale of medical devices, including post-market<div style="display:inline-block;width:2px">&nbsp;</div>surveillance. Medical devices that have </div><div id="a6539" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">been assessed and/or certified under the Directive No. 93/42/EEC of<div style="display:inline-block;width:2px">&nbsp;</div>14 June 1993 </div><div id="a6565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:554px;top:718px;">concerning medical devices </div><div id="a6571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">(“EU Medical Device Directive”) may for the moment continue to be placed<div style="display:inline-block;width:2px">&nbsp;</div>on the market until 2024 (or until the </div><div id="a6612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">expiry of their certificates, if applicable and earlier).<div style="display:inline-block;width:3px">&nbsp;</div>However, on January 6, 2023, the EU Commission submitted a </div><div id="a6642" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">proposed amendment to extend the MDR transitional periods until December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2027 for higher risk devices and </div><div id="a6644" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">December 31, 2028, for other medical devices to ensure continued access<div style="display:inline-block;width:2px">&nbsp;</div>to medical devices for patients and to </div><div id="a6645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">allow medical devices already placed on the market in accordance with<div style="display:inline-block;width:2px">&nbsp;</div>the current legal framework to remain on </div><div id="a6647" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">the market. We continue to monitor developments and whether the proposed amendment and new deadlines will be </div><div id="a6648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">approved by the European Parliament and Council. Nevertheless, EU MDR<div style="display:inline-block;width:2px">&nbsp;</div>requirements regarding the distribution, </div><div id="a6663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">marketing and sale including quality systems and post-market surveillance<div style="display:inline-block;width:2px">&nbsp;</div>have to be observed by manufacturers, </div><div id="a6696" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">importers and distributors as of the application date (i.e., since May 26, 2021). </div><div id="a6723" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">Other EU regulations that may apply under appropriate circumstances<div style="display:inline-block;width:2px">&nbsp;</div>include EU Regulation No. 1907/2006 of 18 </div><div id="a6756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">December 2006 </div><div id="a6760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:164px;top:920px;">concerning the Registration, Evaluation, Authorisation and<div style="display:inline-block;width:2px">&nbsp;</div>Restriction of Chemicals</div><div id="a6777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:662px;top:920px;">, which </div><div id="a6781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">requires importers to register substances or mixtures that they import<div style="display:inline-block;width:2px">&nbsp;</div>in the EU beyond certain quantities, and the </div><div id="a6817" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">EU Regulation No. 1272/2008 of 16 December 2008 on classification, labelling<div style="display:inline-block;width:2px">&nbsp;</div>and packaging of substances and </div><div id="a6850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">mixtures, which sets various obligations with respect to the labelling and<div style="display:inline-block;width:2px">&nbsp;</div>packaging of concerned substances and </div><div id="a6882" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">mixtures. </div></div>
</div>
<div style="padding: 7px">
<div id="Page13" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a6884" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a6887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">13 </div><div id="a6890" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Furthermore, compliance with legal requirements has required and may in the future<div style="display:inline-block;width:2px">&nbsp;</div>require us to delay product </div><div id="a6924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">release, sale or distribution, or institute voluntary recalls of, or other corrective<div style="display:inline-block;width:2px">&nbsp;</div>action with respect to products we </div><div id="a6960" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">sell, each of which could result in regulatory and enforcement actions, financial<div style="display:inline-block;width:2px">&nbsp;</div>losses and potential reputational </div><div id="a6993" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">harm.<div style="display:inline-block;width:7px">&nbsp;</div>Our customers are also subject to significant federal, state, local<div style="display:inline-block;width:2px">&nbsp;</div>and foreign governmental regulation, which </div><div id="a7025" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">may affect our interactions with customers, including the design and functionality<div style="display:inline-block;width:2px">&nbsp;</div>of our products. </div><div id="a7055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">Certain of our businesses are subject to various additional federal, state,<div style="display:inline-block;width:2px">&nbsp;</div>local and foreign laws and regulations, </div><div id="a7089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">including with respect to the sale, transportation, storage, handling and<div style="display:inline-block;width:2px">&nbsp;</div>disposal of hazardous or potentially </div><div id="a7119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">hazardous substances, and safe working conditions.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, certain of our businesses must operate in </div><div id="a7149" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">compliance with a variety of burdensome and complex billing and record-keeping<div style="display:inline-block;width:2px">&nbsp;</div>requirements in order to </div><div id="a7181" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">substantiate claims for payment under federal, state and commercial healthcare<div style="display:inline-block;width:2px">&nbsp;</div>reimbursement programs.<div style="display:inline-block;width:7px">&nbsp;</div>One of </div><div id="a7209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">these businesses was suspended in October 2021 by CMS from receiving<div style="display:inline-block;width:2px">&nbsp;</div>payments from Medicare, although it was </div><div id="a7243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">permitted to continue to perform and bill for Medicare services.<div style="display:inline-block;width:6px">&nbsp;</div>On September 30, 2022, CMS terminated the </div><div id="a7278" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">suspension of Medicare payments.<div style="display:inline-block;width:7px">&nbsp;</div>As a result of the termination of the suspension, we recognized<div style="display:inline-block;width:2px">&nbsp;</div>$4 million of </div><div id="a7314" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">previously deferred revenue during the year ended December 31, 2022. </div><div id="a7335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">Certain of our businesses also maintain contracts with governmental agencies<div style="display:inline-block;width:2px">&nbsp;</div>and are subject to certain regulatory </div><div id="a7368" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">requirements specific to government contractors. </div><div id="a7379" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:397px;">Antitrust and Consumer Protection </div><div id="a7388" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">The federal government of the United States, most U.S. states and many<div style="display:inline-block;width:2px">&nbsp;</div>foreign countries have antitrust laws that </div><div id="a7424" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">prohibit certain types of conduct deemed to be anti-competitive, as well as consumer<div style="display:inline-block;width:2px">&nbsp;</div>protection laws that seek to </div><div id="a7462" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">protect consumers from improper business practices.<div style="display:inline-block;width:6px">&nbsp;</div>At the U.S. federal level, the Federal Trade Commission </div><div id="a7493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">oversees enforcement of these types of laws, and states have similar government<div style="display:inline-block;width:2px">&nbsp;</div>agencies.<div style="display:inline-block;width:7px">&nbsp;</div>Violations of antitrust </div><div id="a7525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">or consumer protection laws may result in various sanctions, including criminal<div style="display:inline-block;width:2px">&nbsp;</div>and civil penalties.<div style="display:inline-block;width:7px">&nbsp;</div>Private </div><div id="a7555" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">plaintiffs may also bring civil lawsuits against us in the United States for alleged antitrust<div style="display:inline-block;width:2px">&nbsp;</div>law violations, including </div><div id="a7592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">claims for treble damages.<div style="display:inline-block;width:7px">&nbsp;</div>EU law also regulates competition and provides for detailed rules protecting<div style="display:inline-block;width:2px">&nbsp;</div>consumers.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a7624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">The Biden Administration has indicated increased antitrust enforcement and<div style="display:inline-block;width:2px">&nbsp;</div>has been more aggressive in </div><div id="a7626" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">enforcement activities, including investigation and challenging non-compete<div style="display:inline-block;width:2px">&nbsp;</div>restrictions and other restrictive </div><div id="a7629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">contractual terms that it believes harm workers and competition. </div><div id="a7632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:616px;">Health Care Fraud </div><div id="a7639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">Certain of our businesses are subject to federal and state (and similar<div style="display:inline-block;width:2px">&nbsp;</div>foreign) health care fraud and abuse, referral </div><div id="a7678" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">and reimbursement laws and regulations with respect to their operations.<div style="display:inline-block;width:6px">&nbsp;</div>Some of these laws, referred to as “false </div><div id="a7714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">claims laws,” prohibit the submission or causing the submission of false or fraudulent<div style="display:inline-block;width:2px">&nbsp;</div>claims for reimbursement to </div><div id="a7749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">federal, state and other health care payers and programs.<div style="display:inline-block;width:6px">&nbsp;</div>Other laws, referred to as “anti-kickback laws,” prohibit </div><div id="a7785" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">soliciting, offering, receiving or paying remuneration in order to induce the referral<div style="display:inline-block;width:2px">&nbsp;</div>of a patient or ordering, </div><div id="a7820" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">purchasing, leasing or arranging for, or recommending, ordering, purchasing or leasing of, items or services<div style="display:inline-block;width:2px">&nbsp;</div>that are </div><div id="a7854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">paid for by federal, state and other health care payers and programs.<div style="display:inline-block;width:6px">&nbsp;</div>Certain additional state and federal laws, such </div><div id="a7893" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">as the federal Physician Self-Referral Law, commonly known as the “Stark Law,” prohibit physicians and other </div><div id="a7927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">health professionals from referring a patient to an entity with which the<div style="display:inline-block;width:2px">&nbsp;</div>physician (or family member) has a </div><div id="a7964" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">financial relationship, for the furnishing of certain designated health services<div style="display:inline-block;width:2px">&nbsp;</div>(for example, durable medical </div><div id="a7992" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">equipment and medical supplies), unless an exception applies.<div style="display:inline-block;width:6px">&nbsp;</div>Violations of Anti-Kickback Statutes or the Stark </div><div id="a8011" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">Law may be enforced as violations of the federal False Claims Act. </div><div id="a8015" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">The fraud and abuse laws and regulations have been subject to heightened<div style="display:inline-block;width:2px">&nbsp;</div>enforcement activity over the past few </div><div id="a8051" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">years, and significant enforcement activity has been the result of “relators” who<div style="display:inline-block;width:2px">&nbsp;</div>serve as whistleblowers by filing </div><div id="a8086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">complaints in the name of the United States (and if applicable, particular states)<div style="display:inline-block;width:2px">&nbsp;</div>under applicable false claims laws, </div><div id="a8122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">and who may receive up to 30% of total government recoveries.<div style="display:inline-block;width:6px">&nbsp;</div>Penalties under fraud and abuse laws may be </div><div id="a8160" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">severe, including treble damages and substantial civil penalties under<div style="display:inline-block;width:2px">&nbsp;</div>the federal False Claims Act, as well as </div><div id="a8195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">potential loss of licenses and the ability to participate in federal and state<div style="display:inline-block;width:2px">&nbsp;</div>health care programs, criminal penalties, </div><div id="a8231" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">or imposition of a corporate integrity agreement or corporate compliance<div style="display:inline-block;width:2px">&nbsp;</div>monitor which could have a material </div><div id="a8264" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">adverse effect on our business.<div style="display:inline-block;width:7px">&nbsp;</div>Also, these measures may be interpreted or applied by a prosecutorial,<div style="display:inline-block;width:2px">&nbsp;</div>regulatory or </div></div>
</div>
<div style="padding: 7px">
<div id="Page14" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a8300" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a8303" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">14 </div><div id="a8305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">judicial authority in a manner that could require us to make changes<div style="display:inline-block;width:2px">&nbsp;</div>in our operations or incur substantial defense </div><div id="a8344" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">and settlement expenses.<div style="display:inline-block;width:7px">&nbsp;</div>Even unsuccessful challenges by regulatory authorities or private<div style="display:inline-block;width:2px">&nbsp;</div>relators could result in </div><div id="a8374" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">reputational harm and the incurring of substantial costs.<div style="display:inline-block;width:6px">&nbsp;</div>Most states have adopted similar state false claims laws, </div><div id="a8409" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">and these state laws have their own penalties, which may be in addition<div style="display:inline-block;width:2px">&nbsp;</div>to federal False Claims Act penalties, as </div><div id="a8449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">well as other fraud and abuse laws.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a8465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">With respect to measures of this type, the United States government (among others) has expressed concerns<div style="display:inline-block;width:2px">&nbsp;</div>about </div><div id="a8499" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">financial relationships between suppliers on the one hand and physicians,<div style="display:inline-block;width:2px">&nbsp;</div>dentists and other healthcare </div><div id="a8527" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">professionals on the other.<div style="display:inline-block;width:8px">&nbsp;</div>As a result, we regularly review and revise our marketing practices as necessary<div style="display:inline-block;width:2px">&nbsp;</div>to </div><div id="a8563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">facilitate compliance. </div><div id="a8569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">We </div><div id="a8571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:245px;">also are subject to certain United States and foreign laws and regulations<div style="display:inline-block;width:2px">&nbsp;</div>concerning the conduct of our foreign </div><div id="a8607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery<div style="display:inline-block;width:2px">&nbsp;</div>Act, German anti-corruption laws </div><div id="a8639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">and other anti-bribery laws and laws pertaining to the accuracy of our internal<div style="display:inline-block;width:2px">&nbsp;</div>books and records, which have been </div><div id="a8680" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">the focus of increasing enforcement activity globally in recent years. </div><div id="a8701" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">While we believe that we are substantially compliant with applicable fraud and<div style="display:inline-block;width:2px">&nbsp;</div>abuse laws and regulations, and </div><div id="a8735" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">have adequate compliance programs and controls in place to ensure substantial<div style="display:inline-block;width:2px">&nbsp;</div>compliance, we cannot predict </div><div id="a8765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">whether changes in applicable law, or interpretation of laws, or changes in our services or marketing practices in </div><div id="a8801" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">response to changes in applicable law or interpretation of laws, or failure<div style="display:inline-block;width:2px">&nbsp;</div>to comply with applicable law, could have </div><div id="a8839" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">a material adverse effect on our business. </div><div id="a8854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:431px;">Affordable Care Act and Other Insurance Reform </div><div id="a8869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">The ACA increased federal oversight of private health insurance plans and<div style="display:inline-block;width:2px">&nbsp;</div>included a number of provisions </div><div id="a8901" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">designed to reduce Medicare expenditures and the cost of health care generally, to reduce fraud and abuse, and to </div><div id="a8939" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">provide access to increased health coverage.<div style="display:inline-block;width:7px">&nbsp;</div>The ACA also materially expanded the number of individuals<div style="display:inline-block;width:2px">&nbsp;</div>in the </div><div id="a8974" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">United States with health insurance.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a8986" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">The ACA has faced frequent legal challenges, including litigation seeking<div style="display:inline-block;width:2px">&nbsp;</div>to invalidate and Congressional action </div><div id="a9016" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">seeking to repeal some of or all of the law or the manner in which it has been<div style="display:inline-block;width:2px">&nbsp;</div>implemented.<div style="display:inline-block;width:7px">&nbsp;</div>In 2012, the United </div><div id="a9061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">States Supreme Court, in upholding the constitutionality of the<div style="display:inline-block;width:2px">&nbsp;</div>ACA and its individual mandate provision requiring </div><div id="a9064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">that people buy health insurance or else face a penalty, simultaneously limited ACA provisions requiring Medicaid </div><div id="a9084" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">expansion, making such expansion a state-by-state decision.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, one of the major political parties in the </div><div id="a9091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">United States remains committed to seeking the ACA’s legislative repeal, but legislative efforts to do so have </div><div id="a9094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">previously failed to pass both chambers of Congress.<div style="display:inline-block;width:6px">&nbsp;</div>Under President Trump’s administration, a number of </div><div id="a9124" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">administrative actions were taken to materially weaken the ACA, including,<div style="display:inline-block;width:2px">&nbsp;</div>without limitation, by permitting the </div><div id="a9154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">use of less robust plans with lower coverage and eliminating “premium support”<div style="display:inline-block;width:2px">&nbsp;</div>for insurers providing policies </div><div id="a9186" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">under the ACA.<div style="display:inline-block;width:7px">&nbsp;</div>The Tax Cuts and Jobs Act enacted in 2017, which contains a broad range of tax reform provisions </div><div id="a9228" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">that impact the individual and corporate<div style="display:inline-block;width:3px">&nbsp;</div>tax rates, international tax provisions, income tax add-back provisions<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a9263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">deductions, also effectively repealed the ACA’s<div style="display:inline-block;width:6px">&nbsp;</div>individual mandate by zeroing out the penalty for non-compliance.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a9295" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">In the most recent ACA litigation, the federal Fifth Circuit Court of Appeals<div style="display:inline-block;width:2px">&nbsp;</div>found the individual mandate to be </div><div id="a9334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">unconstitutional, and returned the case to the District Court for the Northern<div style="display:inline-block;width:2px">&nbsp;</div>District of Texas for consideration of </div><div id="a9370" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">whether the remainder of the ACA could survive the excision of the individual<div style="display:inline-block;width:2px">&nbsp;</div>mandate.<div style="display:inline-block;width:7px">&nbsp;</div>The Fifth Circuit’s </div><div id="a9405" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">decision was appealed to the United States Supreme Court.<div style="display:inline-block;width:6px">&nbsp;</div>The Supreme Court issued a decision on June 17, 2021.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a9444" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">Without reaching the merits of the case, the Supreme Court held that the plaintiffs in the case did not have standing </div><div id="a9486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">to challenge the ACA.<div style="display:inline-block;width:7px">&nbsp;</div>Any outcomes of future cases that change the ACA, in addition<div style="display:inline-block;width:2px">&nbsp;</div>to future legislation, </div><div id="a9523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">regulation, guidance and/or Executive Orders that do the same, could have a<div style="display:inline-block;width:2px">&nbsp;</div>significant impact on the U.S. </div><div id="a9557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">healthcare industry.<div style="display:inline-block;width:8px">&nbsp;</div>For instance, the American Rescue Plan Act of 2021 enhanced<div style="display:inline-block;width:2px">&nbsp;</div>premium tax credits, which has </div><div id="a9563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">resulted in an expansion of the number of people covered under the ACA.<div style="display:inline-block;width:6px">&nbsp;</div>These changes are time-limited, with </div><div id="a9566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">some enhancements in place for 2021 only and others available through<div style="display:inline-block;width:2px">&nbsp;</div>the end of 2022. </div><div id="a9570" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">An ACA provision, generally referred to as the Physician Payment Sunshine<div style="display:inline-block;width:2px">&nbsp;</div>Act or Open Payments Program (the </div><div id="a9604" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">“Sunshine Act”), imposes annual reporting and disclosure requirements<div style="display:inline-block;width:2px">&nbsp;</div>for drug and device manufacturers and </div><div id="a9632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">distributors with regard to payments or other transfers of value made to certain<div style="display:inline-block;width:2px">&nbsp;</div>covered recipients (including </div><div id="a9665" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">physicians, dentists, teaching hospitals, physician assistants, nurse practitioners,<div style="display:inline-block;width:2px">&nbsp;</div>clinical nurse specialists, certified </div></div>
</div>
<div style="padding: 7px">
<div id="Page15" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a9678" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a9681" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">15 </div><div id="a9683" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">registered nurse anesthetists, and certified nurse midwives), and for such manufacturers<div style="display:inline-block;width:2px">&nbsp;</div>and distributors and for </div><div id="a9703" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">group purchasing organizations, with regard to certain ownership interests held by covered<div style="display:inline-block;width:2px">&nbsp;</div>recipients in the </div><div id="a9733" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">reporting entity.<div style="display:inline-block;width:8px">&nbsp;</div>The Centers for Medicare and Medicaid Services (“CMS”) publishes information<div style="display:inline-block;width:2px">&nbsp;</div>from these </div><div id="a9762" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">reports on a publicly available website, including amounts transferred and physician,<div style="display:inline-block;width:2px">&nbsp;</div>dentist, teaching hospital, and </div><div id="a9792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">non-physician practitioner identities.<div style="display:inline-block;width:7px">&nbsp;</div>The Sunshine Act pre-empts similar state reporting laws, although we<div style="display:inline-block;width:2px">&nbsp;</div>or our </div><div id="a9826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">subsidiaries may be required to report under certain state transparency laws that<div style="display:inline-block;width:2px">&nbsp;</div>address circumstances not covered </div><div id="a9858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">by the Sunshine Act, and some of these state laws, as well as the federal<div style="display:inline-block;width:2px">&nbsp;</div>law, can be unclear.<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a9896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:618px;top:161px;">We </div><div id="a9898" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:642px;top:161px;">are also subject to </div><div id="a9906" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">foreign regulations requiring transparency of certain interactions between<div style="display:inline-block;width:2px">&nbsp;</div>suppliers and their customers.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a9933" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">In the United States, government actions to seek to increase health-related<div style="display:inline-block;width:2px">&nbsp;</div>price transparency may also affect our </div><div id="a9969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">business.<div style="display:inline-block;width:7px">&nbsp;</div>For example, hospitals are currently required to publish online a<div style="display:inline-block;width:2px">&nbsp;</div>list of their standard charges for all items </div><div id="a10008" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">and services, including discounted cash prices and payer-specific and de-identified negotiated<div style="display:inline-block;width:2px">&nbsp;</div>charges, in a publicly </div><div id="a10042" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">accessible online file. Hospitals are also required to publish a consumer-friendly<div style="display:inline-block;width:2px">&nbsp;</div>list of standard charges for certain </div><div id="a10079" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">“shoppable” services (i.e., services that can be scheduled by a patient in<div style="display:inline-block;width:2px">&nbsp;</div>advance) and associated ancillary services </div><div id="a10113" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">or, alternatively, maintain an online price estimator tool. CMS may impose civil monetary penalties for </div><div id="a10144" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">noncompliance with these price transparency requirements. Additionally, the No Surprises Act (“NSA”), generally </div><div id="a10170" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">effective January 1, 2022, imposes additional price transparency requirements.<div style="display:inline-block;width:6px">&nbsp;</div>The NSA is intended to reduce the </div><div id="a10202" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">number of “out-of-network” patients.<div style="display:inline-block;width:7px">&nbsp;</div>This will result in fewer out-of-network payments to physicians and<div style="display:inline-block;width:2px">&nbsp;</div>other </div><div id="a10240" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">providers, which may cause financial stress to those providers who<div style="display:inline-block;width:2px">&nbsp;</div>are dependent on higher out-of-network fees. </div><div id="a10277" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">Another notable Medicare health care reform initiative, the Medicare Access<div style="display:inline-block;width:2px">&nbsp;</div>and CHIP Reauthorization Act of </div><div id="a10307" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">2015 (“MACRA”), enacted on April 16, 2015, established a new payment framework,<div style="display:inline-block;width:2px">&nbsp;</div>which modified certain </div><div id="a10337" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">Medicare payments to “eligible clinicians,” including physicians, dentists and<div style="display:inline-block;width:2px">&nbsp;</div>other practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Under MACRA, </div><div id="a10364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">certain eligible clinicians are required to participate in Medicare through the Merit-Based<div style="display:inline-block;width:2px">&nbsp;</div>Incentive Payment </div><div id="a10394" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">System (“MIPS”) or Advanced Alternative Payment Models, through which<div style="display:inline-block;width:2px">&nbsp;</div>Medicare reimbursement to eligible </div><div id="a10420" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">clinicians includes both positive and negative payment adjustments that take<div style="display:inline-block;width:2px">&nbsp;</div>into account quality, promoting </div><div id="a10449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">interoperability, cost and improvement activities.<div style="display:inline-block;width:7px">&nbsp;</div>Data collected in the first MIPS performance year (2017) </div><div id="a10477" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">determined payment adjustments that began January 1, 2019.<div style="display:inline-block;width:6px">&nbsp;</div>MACRA standards and payment levels continue to </div><div id="a10508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">evolve, and reflect a fundamental change in physician reimbursement<div style="display:inline-block;width:2px">&nbsp;</div>that is expected to provide substantial </div><div id="a10538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">financial incentives for physicians to participate in risk contracts, and to increase<div style="display:inline-block;width:2px">&nbsp;</div>physician information technology </div><div id="a10569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">and reporting obligations.<div style="display:inline-block;width:7px">&nbsp;</div>The implications of the implementation of MACRA are uncertain and will<div style="display:inline-block;width:2px">&nbsp;</div>depend on </div><div id="a10601" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">future regulatory activity and physician activity in the marketplace.<div style="display:inline-block;width:6px">&nbsp;</div>New state-level payment and delivery system </div><div id="a10633" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">reform programs, including those modeled after such federal programs, are<div style="display:inline-block;width:2px">&nbsp;</div>also increasingly being rolled out </div><div id="a10664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">through Medicaid administrators, as well as through the private sector, which may further<div style="display:inline-block;width:2px">&nbsp;</div>alter the marketplace and </div><div id="a10698" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">impact our business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a10706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">Recently, in addition to other government efforts to control health care costs, there has been increased scrutiny on </div><div id="a10742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">drug pricing and concurrent efforts to control or reduce drug costs by Congress, the<div style="display:inline-block;width:2px">&nbsp;</div>President, executive branch </div><div id="a10773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">agencies and various states.<div style="display:inline-block;width:7px">&nbsp;</div>At the state level, several states have adopted laws that require drug manufacturers<div style="display:inline-block;width:2px">&nbsp;</div>to </div><div id="a10805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">provide advance notice of certain price increases and to report information<div style="display:inline-block;width:2px">&nbsp;</div>relating to those price increases, while </div><div id="a10839" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">others have taken legislative or administrative action to establish prescription<div style="display:inline-block;width:2px">&nbsp;</div>drug affordability boards or multi-</div><div id="a10870" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">payer purchasing pools to reduce the cost of prescription drugs.<div style="display:inline-block;width:6px">&nbsp;</div>At the federal level, several related bills have been </div><div id="a10891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">introduced and regulations proposed which, if enacted or finalized,<div style="display:inline-block;width:2px">&nbsp;</div>respectively, would impact drug pricing and </div><div id="a10893" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">related costs. </div><div id="a10896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">As a result of political, economic and regulatory influences, the health care distribution<div style="display:inline-block;width:2px">&nbsp;</div>industry in the United </div><div id="a10930" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">States is under intense scrutiny and subject to fundamental changes.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a10950" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:473px;top:836px;">We </div><div id="a10952" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:497px;top:836px;">cannot predict what further reform </div><div id="a10963" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">proposals, if any, will be adopted, when they may be adopted, or what impact they may have on us. </div><div id="a11002" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:886px;">EU Directive on the pricing and reimbursement of medicinal products<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a11024" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">EU law provides for the regulation of the pricing of medicinal products which are<div style="display:inline-block;width:2px">&nbsp;</div>implemented by EU member </div><div id="a11061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">states (Directive No. 89/105/EC of 21 December 1988 </div><div id="a11077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:390px;top:937px;">relating to the transparency of measures regulating the </div><div id="a11093" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:954px;">pricing of medicinal products for human use and their inclusion in the scope of national health insurance<div style="display:inline-block;width:2px">&nbsp;</div>systems</div><div id="a11129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:735px;top:954px;">).<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a11131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">Member states may, subject notably to transparency conditions and to the statement of reasons based upon </div><div id="a11163" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">objective and verifiable criteria, regulate the price charged (or its increases) for authorized<div style="display:inline-block;width:2px">&nbsp;</div>medicines and their level </div></div>
</div>
<div style="padding: 7px">
<div id="Page16" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a11197" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a11200" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">16 </div><div id="a11202" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">of reimbursement, or they may freeze prices, place controls on the profitability<div style="display:inline-block;width:2px">&nbsp;</div>of persons responsible for placing </div><div id="a11237" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">medicinal products on the market, and include or exclude the medicine on<div style="display:inline-block;width:2px">&nbsp;</div>the list of products covered by national </div><div id="a11275" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">health insurance systems.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a11283" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">EU law does not expressly include provisions like those of the Sunshine Act<div style="display:inline-block;width:2px">&nbsp;</div>in the United States, but a growing </div><div id="a11324" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">number of EU member states (such as France in 2011 and Italy in 2022) have enacted laws to increase<div style="display:inline-block;width:2px">&nbsp;</div>the </div><div id="a11364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">transparency of relationships in the healthcare sector.<div style="display:inline-block;width:7px">&nbsp;</div>The scope of these laws varies from one member state to </div><div id="a11400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">another and may, for example, include the relations between healthcare industry players and physicians or their </div><div id="a11432" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">associations, students preparing for medical professions or their associations,<div style="display:inline-block;width:2px">&nbsp;</div>teachers, health establishments or </div><div id="a11459" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">publishers of prescription and dispensing assistance software. </div><div id="a11474" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:245px;">Regulated Software; Electronic Health Records </div><div id="a11485" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">The FDA has become increasingly active in addressing the regulation of<div style="display:inline-block;width:2px">&nbsp;</div>computer software and digital health </div><div id="a11517" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">products intended for use in health care settings.<div style="display:inline-block;width:6px">&nbsp;</div>The 21st Century Cures Act (the “Cures Act”), signed into law on </div><div id="a11558" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">December 13, 2016, among other things, amended the medical device definition<div style="display:inline-block;width:2px">&nbsp;</div>to exclude certain software from </div><div id="a11590" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">FDA regulation, including clinical decision<div style="display:inline-block;width:3px">&nbsp;</div>support software that meets certain criteria.<div style="display:inline-block;width:7px">&nbsp;</div>On September 27, 2019, </div><div id="a11621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">the FDA issued a suite of guidance documents on digital health products, which<div style="display:inline-block;width:2px">&nbsp;</div>incorporated applicable Cures Act </div><div id="a11655" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">standards, including regarding the types of clinical decision support tools and other<div style="display:inline-block;width:2px">&nbsp;</div>software that are exempt from </div><div id="a11690" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">regulation by the FDA as medical devices, and continues to issue new guidance<div style="display:inline-block;width:2px">&nbsp;</div>in this area.<div style="display:inline-block;width:7px">&nbsp;</div>Certain of our </div><div id="a11728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">businesses involve the development and sale of software and related products<div style="display:inline-block;width:2px">&nbsp;</div>to support physician and dental </div><div id="a11761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">practice management, and it is possible that the FDA or foreign government<div style="display:inline-block;width:2px">&nbsp;</div>authorities could determine that one or </div><div id="a11797" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">more of our products is a medical device, which could subject us or one<div style="display:inline-block;width:2px">&nbsp;</div>or more of our businesses to substantial </div><div id="a11839" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">additional requirements<div style="display:inline-block;width:3px">&nbsp;</div>with respect to these products. </div><div id="a11855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">In addition, our businesses that involve physician and dental practice management<div style="display:inline-block;width:2px">&nbsp;</div>products, and our specialty home </div><div id="a11887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">medical supply business, include electronic information technology systems<div style="display:inline-block;width:2px">&nbsp;</div>that store and process personal health, </div><div id="a11915" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">clinical, financial and other sensitive information of individuals.<div style="display:inline-block;width:6px">&nbsp;</div>These information technology systems may be </div><div id="a11943" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">vulnerable to breakdown, wrongful intrusions, data breaches and malicious<div style="display:inline-block;width:2px">&nbsp;</div>attack, which could require us to </div><div id="a11973" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">expend significant resources to eliminate these problems and address related<div style="display:inline-block;width:2px">&nbsp;</div>security concerns and could involve </div><div id="a12003" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">claims against us by private parties and/or governmental agencies.<div style="display:inline-block;width:6px">&nbsp;</div>For example, we are directly or indirectly </div><div id="a12035" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">subject to numerous and evolving federal, state, local and foreign laws and<div style="display:inline-block;width:2px">&nbsp;</div>regulations that protect the privacy and </div><div id="a12072" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">security of personal information, such as the federal Health Insurance Portability<div style="display:inline-block;width:2px">&nbsp;</div>and Accountability Act of 1996, </div><div id="a12104" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">as amended, and implementing regulations (“HIPAA”), the Controlling the Assault of Non-Solicited Pornography </div><div id="a12133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">and Marketing Act, the Telephone Consumer Protection Act of 1991, Section 5 of the Federal Trade Commission </div><div id="a12167" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">Act, the California Privacy Act (“CCPA”), and the California Privacy Rights Act (“CPRA”) that became effective </div><div id="a12199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">on January 1, 2023.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, Virginia,<div style="display:inline-block;width:5px">&nbsp;</div>Colorado, Connecticut and Utah recently passed comprehensive </div><div id="a12225" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">privacy legislation, and several privacy bills have been proposed both at<div style="display:inline-block;width:2px">&nbsp;</div>the federal and state level that may result </div><div id="a12263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">in additional legal requirements that impact our business.<div style="display:inline-block;width:6px">&nbsp;</div>Laws and regulations relating to privacy and data </div><div id="a12296" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">protection are continually evolving and subject to potentially differing interpretations.<div style="display:inline-block;width:6px">&nbsp;</div>These requirements may not </div><div id="a12324" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">be harmonized, may be interpreted and applied in a manner that is inconsistent<div style="display:inline-block;width:2px">&nbsp;</div>from one jurisdiction to another or </div><div id="a12362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">may conflict with other rules or our practices.<div style="display:inline-block;width:6px">&nbsp;</div>Our businesses’ failure to comply with these laws and regulations </div><div id="a12398" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">could expose us to breach of contract claims, substantial fines, penalties and<div style="display:inline-block;width:2px">&nbsp;</div>other liabilities and expenses, costs for </div><div id="a12435" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">remediation and harm to our reputation.<div style="display:inline-block;width:7px">&nbsp;</div>Also, evolving laws and regulations in this area could restrict the<div style="display:inline-block;width:2px">&nbsp;</div>ability of </div><div id="a12473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">our customers to obtain, use or disseminate patient information, or could<div style="display:inline-block;width:2px">&nbsp;</div>require us to incur significant additional </div><div id="a12508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">costs to re-design our products to reflect these legal requirements, which<div style="display:inline-block;width:2px">&nbsp;</div>could have a material adverse effect on </div><div id="a12546" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">our operations.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a12552" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">Also, the European Parliament and the Council of the EU adopted the pan-European<div style="display:inline-block;width:2px">&nbsp;</div>General Data Protection </div><div id="a12557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">Regulation (“GDPR”), effective from May 25, 2018, which increased privacy<div style="display:inline-block;width:2px">&nbsp;</div>rights for individuals (“Data </div><div id="a12559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">Subjects”), including individuals who are our customers, suppliers and<div style="display:inline-block;width:2px">&nbsp;</div>employees.<div style="display:inline-block;width:7px">&nbsp;</div>The GDPR extended the scope </div><div id="a12560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">of responsibilities for data controllers and data processors, and generally<div style="display:inline-block;width:2px">&nbsp;</div>imposes increased requirements and </div><div id="a12562" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">potential penalties on companies, such as us, that are either established<div style="display:inline-block;width:2px">&nbsp;</div>in the EU and process personal data of Data </div><div id="a12563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">Subjects (regardless the Data Subject location), or that are not established<div style="display:inline-block;width:2px">&nbsp;</div>in the EU but that offer goods or services </div><div id="a12565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">to Data Subjects in the EU or monitor their behavior in the EU. Noncompliance<div style="display:inline-block;width:2px">&nbsp;</div>can result in penalties of up to the </div><div id="a12566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">greater of EUR 20 million, or 4% of global company revenues (sanction<div style="display:inline-block;width:2px">&nbsp;</div>that may be public), and Data Subjects </div></div>
</div>
<div style="padding: 7px">
<div id="Page17" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a12568" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a12571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">17 </div><div id="a12573" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">may seek damages.<div style="display:inline-block;width:7px">&nbsp;</div>Member states may individually impose additional requirements<div style="display:inline-block;width:2px">&nbsp;</div>and penalties regarding </div><div id="a12574" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">certain limited matters (for which the GDPR let some room of flexibility),<div style="display:inline-block;width:2px">&nbsp;</div>such as employee personal data.<div style="display:inline-block;width:7px">&nbsp;</div>With </div><div id="a12575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">respect to the personal data it protects, the GDPR requires, among other things,<div style="display:inline-block;width:2px">&nbsp;</div>controller accountability, consents </div><div id="a12577" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">from Data Subjects or another acceptable legal basis to process the<div style="display:inline-block;width:2px">&nbsp;</div>personal data, notification within 72 hours of a </div><div id="a12578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">personal data breach where required, data integrity and security, and fairness and transparency regarding the </div><div id="a12580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">storage, use or other processing of the personal data.<div style="display:inline-block;width:7px">&nbsp;</div>The GDPR also provides rights to Data Subjects relating </div><div id="a12581" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">notably to information, access, rectification, erasure of the personal<div style="display:inline-block;width:2px">&nbsp;</div>data and<div style="display:inline-block;width:4px">&nbsp;</div>the right to object to the processing.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a12585" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">On August 20, 2021, China promulgated the PRC Personal Information<div style="display:inline-block;width:2px">&nbsp;</div>Protection Law (“PIPL”), which took effect </div><div id="a12586" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">on November 1, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>The PIPL imposes specific rules for processing personal information<div style="display:inline-block;width:2px">&nbsp;</div>and it also specifies </div><div id="a12587" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">that the law shall also apply to personal information activities carried out<div style="display:inline-block;width:2px">&nbsp;</div>outside China but for the purpose of </div><div id="a12589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">providing products or services to PRC citizens.<div style="display:inline-block;width:7px">&nbsp;</div>Any non-compliance with these laws and regulations may<div style="display:inline-block;width:2px">&nbsp;</div>subject </div><div id="a12592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">us to fines, orders to rectify or terminate any actions that are deemed<div style="display:inline-block;width:2px">&nbsp;</div>illegal by regulatory authorities, other </div><div id="a12595" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">penalties, as well as reputational damage or legal proceedings against us,<div style="display:inline-block;width:2px">&nbsp;</div>which may affect our business, financial </div><div id="a12596" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">condition or results of operations.<div style="display:inline-block;width:7px">&nbsp;</div>The PIPL carries maximum penalties of CNY50 million or 5% of the<div style="display:inline-block;width:2px">&nbsp;</div>annual </div><div id="a12599" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">revenue of entities that process personal data. </div><div id="a12602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">In the United States, the CCPA, which increases the privacy protections afforded California residents, became </div><div id="a12603" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">effective January 1, 2020.<div style="display:inline-block;width:7px">&nbsp;</div>The CCPA generally requires companies, such as us, to institute additional protections </div><div id="a12605" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">regarding the collection, use and disclosure of certain personal information<div style="display:inline-block;width:2px">&nbsp;</div>of California residents.<div style="display:inline-block;width:7px">&nbsp;</div>Compliance </div><div id="a12606" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">with the obligations imposed by the CCPA depends in part on how particular regulators interpret and apply them.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a12608" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">Regulations were released in August of 2020, but there remains some<div style="display:inline-block;width:2px">&nbsp;</div>uncertainty about how the CCPA will be </div><div id="a12609" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">interpreted by the courts and enforced by the regulators.<div style="display:inline-block;width:6px">&nbsp;</div>If we fail to comply with the CCPA or if regulators assert </div><div id="a12610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">that we have failed to comply with the CCPA, we may be subject to certain fines or other penalties and litigation, </div><div id="a12612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">any of which may negatively impact our reputation, require us to expend<div style="display:inline-block;width:2px">&nbsp;</div>significant resources, and harm our </div><div id="a12613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">business.<div style="display:inline-block;width:7px">&nbsp;</div>Furthermore, California voters approved the CPRA on November 3,<div style="display:inline-block;width:2px">&nbsp;</div>2020, which amends and expands </div><div id="a12618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">the CCPA, including by providing consumers with additional rights with respect to their personal information, and </div><div id="a12619" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">creating a new state agency, the California Privacy Protection Agency, to enforce the CCPA<div style="display:inline-block;width:5px">&nbsp;</div>and the CPRA.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a12621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">CPRA came into effect on January 1, 2023, applying to information collected by<div style="display:inline-block;width:2px">&nbsp;</div>businesses on or after January 1, </div><div id="a12622" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">2022.<div style="display:inline-block;width:15px">&nbsp;</div></div><div id="a12626" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">Other states, as well as the federal government, have increasingly<div style="display:inline-block;width:2px">&nbsp;</div>considered the adoption of similarly expansive </div><div id="a12658" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">personal privacy laws, backed by significant civil penalties for non-compliance.<div style="display:inline-block;width:6px">&nbsp;</div>Virginia and Colorado were both </div><div id="a12682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">successful in passing privacy legislation in 2021, becoming effective on January<div style="display:inline-block;width:2px">&nbsp;</div>1, 2023 and July 1, 2023, </div><div id="a12683" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">respectively.<div style="display:inline-block;width:8px">&nbsp;</div>In 2022, privacy legislation passed in Connecticut, effective July 1, 2023, and<div style="display:inline-block;width:2px">&nbsp;</div>Utah, effective </div><div id="a12685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">December 31, 2023.<div style="display:inline-block;width:7px">&nbsp;</div>While we believe we have substantially compliant programs<div style="display:inline-block;width:2px">&nbsp;</div>and controls in place to comply </div><div id="a12714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">with the GDPR, CCPA, PIPL, CPRA and state law requirements, our compliance with data privacy and </div><div id="a12747" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">cybersecurity laws is likely to impose additional costs on us, and we cannot<div style="display:inline-block;width:2px">&nbsp;</div>predict whether the interpretations of </div><div id="a12783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">the requirements, or changes in our practices in response to new requirements<div style="display:inline-block;width:2px">&nbsp;</div>or interpretations of the </div><div id="a12815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">requirements, could have a material adverse effect on our business. </div><div id="a12837" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">We </div><div id="a12839" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:751px;">also sell products and services that health care providers, such as physicians<div style="display:inline-block;width:2px">&nbsp;</div>and dentists, use to store and </div><div id="a12875" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">manage patient medical or dental records.<div style="display:inline-block;width:7px">&nbsp;</div>These customers, and we, are subject to laws, regulations and industry </div><div id="a12910" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">standards, such as HIPAA and the Payment Card Industry Data Security Standards, which require the protection of </div><div id="a12944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">the privacy and security of those records, and our products may also be<div style="display:inline-block;width:2px">&nbsp;</div>used as part of these customers’ </div><div id="a12982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">comprehensive data security programs, including in connection with their efforts to comply with<div style="display:inline-block;width:2px">&nbsp;</div>applicable privacy </div><div id="a13013" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">and security laws.<div style="display:inline-block;width:7px">&nbsp;</div>Perceived or actual security vulnerabilities in our products or services,<div style="display:inline-block;width:2px">&nbsp;</div>or the perceived or actual </div><div id="a13049" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">failure by us or our customers<div style="display:inline-block;width:3px">&nbsp;</div>who use our products or services to comply with applicable legal or<div style="display:inline-block;width:2px">&nbsp;</div>contractual data </div><div id="a13090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">privacy and security requirements, may not only cause us significant reputational<div style="display:inline-block;width:2px">&nbsp;</div>harm, but may also lead to claims </div><div id="a13126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">against us by our customers and/or governmental agencies and involve substantial<div style="display:inline-block;width:2px">&nbsp;</div>fines, penalties and other </div><div id="a13157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">liabilities and expenses and costs for remediation. </div><div id="a13172" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">Various<div style="display:inline-block;width:5px">&nbsp;</div>federal initiatives involve the adoption and use by health care<div style="display:inline-block;width:2px">&nbsp;</div>providers of certain electronic health care </div><div id="a13206" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">records systems and processes.<div style="display:inline-block;width:7px">&nbsp;</div>The initiatives include, among others, programs that incentivize<div style="display:inline-block;width:2px">&nbsp;</div>physicians and </div><div id="a13234" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">dentists, through MIPS, to use EHR technology in accordance with certain<div style="display:inline-block;width:2px">&nbsp;</div>evolving requirements, including </div><div id="a13262" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">regarding quality, promoting interoperability, cost and improvement activities.<div style="display:inline-block;width:8px">&nbsp;</div>Qualification for the MIPS </div></div>
</div>
<div style="padding: 7px">
<div id="Page18" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a13287" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a13290" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">18 </div><div id="a13292" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">incentive payments requires the use of EHRs that are certified as having certain<div style="display:inline-block;width:2px">&nbsp;</div>capabilities designated in evolving </div><div id="a13326" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">standards adopted by CMS and the Office of the National Coordinator for Health<div style="display:inline-block;width:2px">&nbsp;</div>Information Technology of HHS </div><div id="a13360" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">(“ONC”).<div style="display:inline-block;width:7px">&nbsp;</div>Certain of our businesses involve the manufacture and sale of such<div style="display:inline-block;width:2px">&nbsp;</div>certified EHR systems and other </div><div id="a13394" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">products linked to government supported incentive programs.<div style="display:inline-block;width:6px">&nbsp;</div>In order to maintain certification of our EHR </div><div id="a13424" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">products, we must satisfy these changing governmental standards.<div style="display:inline-block;width:6px">&nbsp;</div>If any of our EHR systems do not meet these </div><div id="a13460" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">standards, yet have been relied upon by health care providers to receive<div style="display:inline-block;width:2px">&nbsp;</div>federal incentive payments, we may be </div><div id="a13496" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">exposed to risk, such as under federal health care fraud and abuse laws,<div style="display:inline-block;width:2px">&nbsp;</div>including the False Claims Act.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a13534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">Moreover, in order to satisfy our customers, and comply with evolving legal requirements, our products<div style="display:inline-block;width:2px">&nbsp;</div>may need </div><div id="a13535" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">to incorporate increasingly complex functionality, such as with respect to reporting and information blocking.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a13537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Although we believe we are positioned to accomplish this, the effort may involve<div style="display:inline-block;width:2px">&nbsp;</div>increased costs, and our failure to </div><div id="a13538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">implement product modifications, or otherwise satisfy applicable standards,<div style="display:inline-block;width:2px">&nbsp;</div>could have a material adverse effect on </div><div id="a13539" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">our business. </div><div id="a13542" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">Other health information standards, such as regulations under HIPAA, establish standards regarding electronic </div><div id="a13568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">health data transmissions and transaction code set rules for specific electronic<div style="display:inline-block;width:2px">&nbsp;</div>transactions, such as transactions </div><div id="a13598" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">involving claims submissions to third party payers.<div style="display:inline-block;width:6px">&nbsp;</div>Failure to abide by these and other electronic health data </div><div id="a13632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">transmission standards could expose us to breach of contract claims,<div style="display:inline-block;width:2px">&nbsp;</div>substantial fines, penalties, and other liabilities </div><div id="a13664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">and expenses, costs for remediation and harm to our reputation. </div><div id="a13685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">Additionally, as electronic medical devices are increasingly connected to each other and to other technology, the </div><div id="a13717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">ability of these connected systems to safely and effectively exchange and use exchanged<div style="display:inline-block;width:2px">&nbsp;</div>information becomes </div><div id="a13747" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">increasingly important.<div style="display:inline-block;width:7px">&nbsp;</div>As a medical device manufacturer, we must manage risks including those associated with </div><div id="a13778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">an electronic interface that is incorporated into a medical device. </div><div id="a13799" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">There may be additional legislative or regulatory initiatives in the future impacting<div style="display:inline-block;width:2px">&nbsp;</div>health care. </div><div id="a13829" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:515px;">E-Commerce </div><div id="a13834" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">Electronic commerce solutions have become an integral part of traditional health<div style="display:inline-block;width:2px">&nbsp;</div>care supply and distribution </div><div id="a13864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">relationships.<div style="display:inline-block;width:7px">&nbsp;</div>Our distribution business is characterized by rapid technological<div style="display:inline-block;width:2px">&nbsp;</div>developments and intense </div><div id="a13888" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">competition.<div style="display:inline-block;width:7px">&nbsp;</div>The continuing advancement of online commerce requires<div style="display:inline-block;width:2px">&nbsp;</div>us to cost-effectively adapt to changing </div><div id="a13918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">technologies, to enhance existing services and to develop and introduce a<div style="display:inline-block;width:2px">&nbsp;</div>variety of new services to address the </div><div id="a13954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">changing demands of consumers and our customers on a timely basis, particularly<div style="display:inline-block;width:2px">&nbsp;</div>in response to competitive </div><div id="a13986" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">offerings.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a13990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">Through our proprietary, technologically-based suite of products, we offer customers a variety of competitive </div><div id="a14020" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">alternatives.<div style="display:inline-block;width:7px">&nbsp;</div>We believe that our tradition of reliable service, our name recognition and large customer base built </div><div id="a14055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">on solid customer relationships, position us well to participate in<div style="display:inline-block;width:2px">&nbsp;</div>this significant aspect of the distribution business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a14089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">We </div><div id="a14091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:718px;">continue to explore ways and means to improve and expand our online<div style="display:inline-block;width:2px">&nbsp;</div>presence and capabilities, including our </div><div id="a14126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">online commerce offerings and our use of various social media outlets. </div><div id="a14149" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:768px;">International Transactions </div><div id="a14154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">United States and foreign import and export laws and regulations require us to<div style="display:inline-block;width:2px">&nbsp;</div>abide by certain standards relating to </div><div id="a14192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">the importation and exportation of products.<div style="display:inline-block;width:7px">&nbsp;</div>We also are subject to certain laws and regulations concerning the </div><div id="a14226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">conduct of our foreign operations, including the U.S. Foreign Corrupt Practices<div style="display:inline-block;width:2px">&nbsp;</div>Act, the U.K. Bribery Act, German </div><div id="a14261" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">anti-corruption laws and other anti-bribery laws and laws pertaining<div style="display:inline-block;width:2px">&nbsp;</div>to the accuracy of our internal books and </div><div id="a14299" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">records, as well as other types of foreign requirements similar to those<div style="display:inline-block;width:2px">&nbsp;</div>imposed in the United States. </div><div id="a14334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">While we believe that we are substantially compliant with the foregoing laws<div style="display:inline-block;width:2px">&nbsp;</div>and regulations promulgated </div><div id="a14364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">thereunder and possess all material permits and licenses required for the conduct<div style="display:inline-block;width:2px">&nbsp;</div>of our business, there can be no </div><div id="a14403" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">assurance that laws and regulations that impact our business or laws and<div style="display:inline-block;width:2px">&nbsp;</div>regulations as they apply to our customers’ </div><div id="a14441" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">practices will not have a material adverse effect on our business.<div style="display:inline-block;width:6px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page19" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a14465" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a14468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">19 </div><div id="a14470" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">See “</div><div id="a14473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:99px;top:60px;"><a href="#a16164" style="color:#0000FF;text-decoration:underline;">Item 1A. Risk Factors</a></div><div id="a14474" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:228px;top:60px;"><a href="#a16164" style="color:#000000;text-decoration:none;">.</a></div><div id="a14475" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:232px;top:60px;">” for a discussion of additional burdens, risks and regulatory developments<div style="display:inline-block;width:2px">&nbsp;</div>that may </div><div id="a14502" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">affect our results of operations and financial condition. </div><div id="a14519" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:110px;">Proprietary Rights</div><div id="a14522" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">We hold trademarks relating to the “Henry Schein</div><div id="a14523" style="position:absolute;font-family:'Times New Roman';font-size:9.28px;left:362px;top:144px;">®</div><div id="a14524" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:369px;top:144px;">” name and logo, as well as certain other trademarks.<div style="display:inline-block;width:6px">&nbsp;</div>We intend </div><div id="a14525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">to protect our trademarks to the fullest extent practicable.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a14528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:195px;">Employees and Human Capital </div><div id="a14534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:228px;">Environment, Social and Governance </div><div id="a14537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Henry Schein has remained steadfastly committed over our nine-decade history<div style="display:inline-block;width:2px">&nbsp;</div>to the core philosophy that our </div><div id="a14571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">purpose-driven mission of "doing good" for our stakeholders is inextricably<div style="display:inline-block;width:2px">&nbsp;</div>linked to our Company "doing well" in </div><div id="a14607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">business through our stakeholder engagement model “our Mosaic of Success”.<div style="display:inline-block;width:6px">&nbsp;</div>We balance the needs of our five </div><div id="a14641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">key stakeholders – Team Schein Members (TSMs), our Customers, our Suppliers, our Stockholders, and Society – </div><div id="a14673" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">to continue to drive our sustainability and ESG efforts to foster a healthier planet and healthier<div style="display:inline-block;width:2px">&nbsp;</div>people.<div style="display:inline-block;width:7px">&nbsp;</div>Overseen </div><div id="a14711" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">by the Nominating and Governance Committee of our Board of Directors with the<div style="display:inline-block;width:2px">&nbsp;</div>Compensation Committee also </div><div id="a14743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">playing a role in ESG matters related to human capital engagement and executive<div style="display:inline-block;width:2px">&nbsp;</div>compensation, key 2022 </div><div id="a14775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">sustainability and ESG highlights included: </div><div id="a14787" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:415px;">●</div><div id="a14789" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:415px;">With the backdrop of the ongoing COVID-19 pandemic and the humanitarian crises in Ukraine and other </div><div id="a14823" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:433px;">regions, we continued our efforts to drive an overall culture of wellness and engagement<div style="display:inline-block;width:2px">&nbsp;</div>for our TSMs as </div><div id="a14859" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:451px;">we navigated a new hybrid work environment and ensure supply chain resiliency<div style="display:inline-block;width:2px">&nbsp;</div>to support our customers </div><div id="a14892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:469px;">and our communities.<div style="display:inline-block;width:7px">&nbsp;</div>Henry Schein was named Chair of the Private Sector Roundtable<div style="display:inline-block;width:2px">&nbsp;</div>on Global Health </div><div id="a14924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:486px;">Security, and continued its work across sectors to support the creation of market intelligence platforms that </div><div id="a14956" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:504px;">enable the appropriate sharing of real-time supply chain data, including through<div style="display:inline-block;width:2px">&nbsp;</div>the WHO's Pandemic </div><div id="a14986" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:522px;">Supply Chain Network and various national efforts, including the U.S. Supply Chain<div style="display:inline-block;width:2px">&nbsp;</div>Control Tower. </div><div id="a15015" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:559px;">●</div><div id="a15017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:559px;">(i) Publishing our annual Corporate Social Responsibility and Sustainability<div style="display:inline-block;width:2px">&nbsp;</div>Report according to the Global </div><div id="a15045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:577px;">Reporting Initiative and Sustainability Accounting Standards Board reporting<div style="display:inline-block;width:2px">&nbsp;</div>standards and issuing our </div><div id="a15069" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:595px;">first Taskforce for Climate-related Financial Disclosures report; (ii) committing to announcing our carbon </div><div id="a15098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:612px;">reduction goal by the end of 2023; (iii) continued initiatives and programs<div style="display:inline-block;width:2px">&nbsp;</div>to advance health equity efforts </div><div id="a15132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:630px;">to promote access to care for underserved and underrepresented communities,<div style="display:inline-block;width:2px">&nbsp;</div>investing in diversity for </div><div id="a15160" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:648px;">greater health equity in partnership with health care professionals, and<div style="display:inline-block;width:2px">&nbsp;</div>increasing awareness of health </div><div id="a15188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:666px;">equity needs globally; (iv) announced the top line findings of our pay equity<div style="display:inline-block;width:2px">&nbsp;</div>analysis across the U.S., which </div><div id="a15224" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:684px;">reviews compensation across gender and ethnic groups; (v) expanding our<div style="display:inline-block;width:2px">&nbsp;</div>Diversity and Inclusion (“D&amp;I”) </div><div id="a15252" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:702px;">learning journey, such as by educating global directors and vice presidents on more advanced topics of D&amp;I </div><div id="a15286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:720px;">including privilege and equity, as well as offering education to all global TSMs below director level on the </div><div id="a15323" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:737px;">importance of D&amp;I; and (vi) continuing to drive a culture of wellness for our<div style="display:inline-block;width:2px">&nbsp;</div>TSMs by fostering an </div><div id="a15359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:755px;">environment where they can feel engaged, included and psychologically<div style="display:inline-block;width:2px">&nbsp;</div>safe. </div><div id="a15380" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">At Henry Schein, our employees are our greatest asset.<div style="display:inline-block;width:6px">&nbsp;</div>We employ more than 22,000 people, approximately 50% </div><div id="a15384" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:818px;">of our workforce is based in the United States and approximately 50%<div style="display:inline-block;width:2px">&nbsp;</div>is based outside of the United States.</div><div id="a15385" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:700px;top:818px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15386" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:835px;">Approximately 12% of our employees are subject to collective bargaining agreements.<div style="display:inline-block;width:6px">&nbsp;</div>We believe that our </div><div id="a15388" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">relations with our employees are excellent. </div><div id="a15391" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">We refer to our employees as Team<div style="display:inline-block;width:5px">&nbsp;</div>Schein Members, or “TSMs.” Our TSMs are the cornerstone<div style="display:inline-block;width:2px">&nbsp;</div>of the Company.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">We have a strong values-based culture that cultivates a meaningful employee experience that is centered around </div><div id="a15396" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">people.<div style="display:inline-block;width:7px">&nbsp;</div>We know our business success is built on the engagement and commitment of our team, which is dedicated </div><div id="a15397" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:936px;">to meeting the needs of their fellow TSMs, our customers, supplier partners,<div style="display:inline-block;width:2px">&nbsp;</div>stockholders and society.<div style="display:inline-block;width:8px">&nbsp;</div>As part of </div><div id="a15399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:953px;">this commitment, our highlights in 2022 included: </div><div id="a15401" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:970px;"><div style="display:inline-block;width:192px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page20" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a15403" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a15406" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">20 </div><div id="a15408" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:61px;">●</div><div id="a15410" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:61px;">Nurturing a connected community for a happier, more engaged, collaborative work environment.<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a15412" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:695px;top:61px;">We </div><div id="a15413" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:78px;">continue to adapt to the new way of working for our TSMs by listening<div style="display:inline-block;width:2px">&nbsp;</div>to their needs.<div style="display:inline-block;width:7px">&nbsp;</div>With TSMs working </div><div id="a15416" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:94px;">remotely, hybrid and in-person, our goal is to continue to create a collaborative community where every </div><div id="a15420" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:111px;">TSM feels connected to our culture.<div style="display:inline-block;width:7px">&nbsp;</div>Through various virtual and in-person programming from our </div><div id="a15425" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:128px;">Employee Resource Groups, Wellness Committee and Team Schein Engagement team, we continue to </div><div id="a15427" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:145px;">bring TSMs together in a meaningful way through virtual education sessions<div style="display:inline-block;width:2px">&nbsp;</div>and networking events.<div style="display:inline-block;width:7px">&nbsp;</div>To </div><div id="a15430" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:162px;">help create a sense of connection and belonging amongst the team, we<div style="display:inline-block;width:2px">&nbsp;</div>launched “TSM Experience Panels,” </div><div id="a15431" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:179px;">which feature TSMs who share their authentic experiences and offer advice and<div style="display:inline-block;width:2px">&nbsp;</div>best practices on specific </div><div id="a15433" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:196px;">topics. We offer a variety of opportunities to volunteer for team-building and engaging in their local </div><div id="a15436" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:213px;">communities in which they live and work such as through the We Care Global Challenge, Back to School, </div><div id="a15438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:229px;">and Holiday Cheer. In addition, they can “help health happen” by participating in key programs and </div><div id="a15439" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:246px;">initiatives (e.g., Gives Kids A Smile, Healthy Lifestyles, Healthy Communities<div style="display:inline-block;width:2px">&nbsp;</div>and Release the Pressure) </div><div id="a15443" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:263px;">that partner with industry associations, customers, and suppliers to support<div style="display:inline-block;width:2px">&nbsp;</div>access to quality health care for </div><div id="a15445" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:280px;">underserved and underrepresented communities.<div style="display:inline-block;width:6px">&nbsp;</div>We continue to evaluate the engagement of our team </div><div id="a15448" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:297px;">through various listening mechanisms including roundtables, hosted<div style="display:inline-block;width:2px">&nbsp;</div>by our CEO and Executive </div><div id="a15450" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:314px;">Management Committee (“EMC”), and various surveys, including The<div style="display:inline-block;width:2px">&nbsp;</div>Pulse, our global culture survey that </div><div id="a15451" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:331px;">evaluates TSM engagement globally with results reviewed by senior leaders,<div style="display:inline-block;width:2px">&nbsp;</div>reported to the Board of </div><div id="a15452" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:347px;">Directors (“BOD”).<div style="display:inline-block;width:7px">&nbsp;</div>Throughout 2022, we held 10 solutions-focused roundtables<div style="display:inline-block;width:2px">&nbsp;</div>hosted by our EMC </div><div id="a15460" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:364px;">members with over 100 TSMs to dive in deeper and influence our<div style="display:inline-block;width:2px">&nbsp;</div>strategy on programs and processes </div><div id="a15461" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:381px;">designed to further enhance our culture.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15464" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:416px;">●</div><div id="a15466" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:416px;">Driving a culture of wellness for our team members and society.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15469" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:500px;top:416px;">In 2020, we launched a Mental Wellness </div><div id="a15470" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:434px;">Committee with a mission to drive a culture of wellness and empower<div style="display:inline-block;width:2px">&nbsp;</div>every TSM to be their best self, </div><div id="a15471" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:452px;">mentally, emotionally and physically.<div style="display:inline-block;width:9px">&nbsp;</div>The Committee provides resources, guidance and support,<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a15476" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:470px;">works across our businesses to establish enhanced workplace norms to<div style="display:inline-block;width:2px">&nbsp;</div>help improve and safeguard our </div><div id="a15477" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:488px;">TSMs’ wellness.<div style="display:inline-block;width:7px">&nbsp;</div>We actively engage leadership, including our CEO, EMC, BOD and TSMs alike in </div><div id="a15480" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:505px;">conversations around the importance of wellness in the workplace.<div style="display:inline-block;width:6px">&nbsp;</div>In 2022, we rolled-out an EMC video </div><div id="a15486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:523px;">series that focused on being more intentional in the way we work across<div style="display:inline-block;width:2px">&nbsp;</div>our business.<div style="display:inline-block;width:7px">&nbsp;</div>These new </div><div id="a15489" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:541px;">workplace norms focused on meeting and technology etiquette, successful<div style="display:inline-block;width:2px">&nbsp;</div>calendaring, establishing and </div><div id="a15491" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:559px;">communicating reasonable expectations and prioritization, the importance<div style="display:inline-block;width:2px">&nbsp;</div>of taking and respecting time </div><div id="a15493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:577px;">off, and the importance of making time for social connection. In addition to expanding<div style="display:inline-block;width:2px">&nbsp;</div>education on key </div><div id="a15495" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:595px;">mental health topics in partnership with our employee assistance vendor, we also rolled-out manager-</div><div id="a15500" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:612px;">specific education to provide tips on how to identify signs of burnout<div style="display:inline-block;width:2px">&nbsp;</div>and have conversations around </div><div id="a15501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:630px;">wellness with their teams.<div style="display:inline-block;width:7px">&nbsp;</div>With the rise of suicide rates around the world, the Wellness Committee held </div><div id="a15504" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:648px;">seminars for the team on suicide prevention and hosted in-person community walks<div style="display:inline-block;width:2px">&nbsp;</div>that resulted in </div><div id="a15508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:666px;">donations to local suicide prevention organizations globally.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15511" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:703px;">●</div><div id="a15513" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:703px;">Being committed to enhancing our D&amp;I initiatives.</div><div id="a15514" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:414px;top:703px;"><div style="display:inline-block;width:7px">&nbsp;</div>We believe a diverse workforce fosters innovation and </div><div id="a15517" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:721px;">cultivates an environment filled with unique perspectives.<div style="display:inline-block;width:6px">&nbsp;</div>As a result, D&amp;I helps us meet the needs of </div><div id="a15520" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:739px;">customers around the world and provide our TSMs an inclusive environment<div style="display:inline-block;width:2px">&nbsp;</div>where they feel they belong.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:756px;">We measure our success in D&amp;I through, among other things, our global culture survey, where results in </div><div id="a15525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:774px;">2021 showed D&amp;I is our top strength out of 14 focus areas. To guide our efforts and education related to </div><div id="a15526" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:792px;">D&amp;I, our Diversity and Inclusion Council, with engagement from our<div style="display:inline-block;width:2px">&nbsp;</div>BOD and EMC, drives the </div><div id="a15528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:810px;">Company’s overall D&amp;I strategy.<div style="display:inline-block;width:9px">&nbsp;</div>To deepen our commitment to D&amp;I across the Company, Global </div><div id="a15531" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:828px;">Directors and Vice Presidents each have a goal tied to their compensation to champion D&amp;I and attend </div><div id="a15532" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:846px;">education.<div style="display:inline-block;width:7px">&nbsp;</div>We continue to expand our D&amp;I learning journey, educating global Directors and Vice </div><div id="a15537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:864px;">Presidents on key D&amp;I topics including leading inclusively, bias and equity.<div style="display:inline-block;width:8px">&nbsp;</div>We also continue to educate </div><div id="a15540" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:881px;">our global TSMs on the importance of D&amp;I. Additionally, we promote engagement by utilizing our </div><div id="a15541" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:899px;">Employee Resource Groups (“ERGs”), which we continue to expand,<div style="display:inline-block;width:2px">&nbsp;</div>as an inclusive and diverse vehicle </div><div id="a15543" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:917px;">for all TSMs to share, connect, learn and develop both personally<div style="display:inline-block;width:2px">&nbsp;</div>and professionally.<div style="display:inline-block;width:8px">&nbsp;</div>Each of our ERGs </div><div id="a15546" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:935px;">has a sponsor from our Executive Management Committee and our BOD<div style="display:inline-block;width:2px">&nbsp;</div>and our CEO engages directly in </div><div id="a15548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:953px;">many of our ERG programs.<div style="display:inline-block;width:7px">&nbsp;</div>While inclusion continues to remain a top priority, we also understand the </div><div id="a15551" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:971px;">importance of ensuring our internal team reflects the diversity of our customers<div style="display:inline-block;width:2px">&nbsp;</div>and society.<div style="display:inline-block;width:8px">&nbsp;</div>In addition to </div><div id="a15555" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:988px;">our current gender parity by 2030 goal, we announced a new goal in 2022 with<div style="display:inline-block;width:2px">&nbsp;</div>an enhanced focus on </div></div>
</div>
<div style="padding: 7px">
<div id="Page21" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a15557" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a15560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">21 </div><div id="a15562" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:60px;">increasing the diversity of all underrepresented groups in senior leadership<div style="display:inline-block;width:2px">&nbsp;</div>levels through our talent </div><div id="a15563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:78px;">planning, compensation and recruitment processes, in alignment with<div style="display:inline-block;width:2px">&nbsp;</div>our corporate strategic planning </div><div id="a15566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:96px;">objectives to achieve concrete results.<div style="display:inline-block;width:7px">&nbsp;</div>We continue to disclose additional diversity data, with frequent </div><div id="a15569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:113px;">reporting to the EMC and BOD.<div style="display:inline-block;width:7px">&nbsp;</div>In 2022, we published our United States Equal Employment Opportunity </div><div id="a15572" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:131px;">Commission (“EEOC”) EEO-1 data for the U.S. for the first time.<div style="display:inline-block;width:6px">&nbsp;</div>We continue to enhance our recruiting </div><div id="a15580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:149px;">strategy by developing and investing in strategic hires who complement<div style="display:inline-block;width:2px">&nbsp;</div>our D&amp;I mission.<div style="display:inline-block;width:7px">&nbsp;</div>We believe that </div><div id="a15583" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:167px;">these efforts will serve as a critical steppingstone as we continue to strengthen our<div style="display:inline-block;width:2px">&nbsp;</div>D&amp;I initiatives in an </div><div id="a15584" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:185px;">effort to meet the evolving needs of our customers, supplier partners, TSMs, stockholders<div style="display:inline-block;width:2px">&nbsp;</div>and society.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15588" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:218px;">●</div><div id="a15590" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:115px;top:218px;">Understanding that growth, recognition and purpose are key pillars to TSM fulfillment.</div><div id="a15591" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:629px;top:218px;"><div style="display:inline-block;width:7px">&nbsp;</div>Personal and </div><div id="a15593" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:235px;">professional development of our TSMs is important to us.<div style="display:inline-block;width:6px">&nbsp;</div>As such, we invest in our employees by </div><div id="a15595" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:252px;">providing both formal and informal learning opportunities that are<div style="display:inline-block;width:2px">&nbsp;</div>focused on growing and enhancing </div><div id="a15596" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:269px;">knowledge, skills and abilities.<div style="display:inline-block;width:7px">&nbsp;</div>TSMs globally are offered a broad suite of professional development </div><div id="a15597" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:286px;">training programs targeted to specific learning opportunities based on their current<div style="display:inline-block;width:2px">&nbsp;</div>and potential future role </div><div id="a15599" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:302px;">within the Company.<div style="display:inline-block;width:8px">&nbsp;</div>We also offer over 50 organizational and development training courses designed to </div><div id="a15600" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:319px;">aid in the overall development and advancement of skills and competencies<div style="display:inline-block;width:2px">&nbsp;</div>to enable organizational </div><div id="a15602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:336px;">success.<div style="display:inline-block;width:7px">&nbsp;</div>Executive education, mentorship and coaching programs also<div style="display:inline-block;width:2px">&nbsp;</div>form an important part of our </div><div id="a15603" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:353px;">development and career support initiatives.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, we continued to see an increase in participation </div><div id="a15604" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:370px;">in our Organizational Development initiatives in 2022 with our TSMs reporting<div style="display:inline-block;width:2px">&nbsp;</div>a high utilization of skills </div><div id="a15606" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:387px;">learned.<div style="display:inline-block;width:7px">&nbsp;</div>Talent planning efforts are also an integral part of our commitment to ensure a strong diverse </div><div id="a15607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:404px;">leadership pipeline across the organization.<div style="display:inline-block;width:7px">&nbsp;</div>Through a formal global process, we strategically identify and </div><div id="a15609" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:421px;">develop talent through targeted development opportunities and intentional succession<div style="display:inline-block;width:2px">&nbsp;</div>plans.<div style="display:inline-block;width:7px">&nbsp;</div>We </div><div id="a15610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:438px;">continuously identify potential management successors as part<div style="display:inline-block;width:2px">&nbsp;</div>of our succession planning process.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15611" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:454px;">Information derived from talent planning efforts informs curriculum design and<div style="display:inline-block;width:2px">&nbsp;</div>content to help focus on the </div><div id="a15613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:471px;">right capabilities and help ensure alignment of career development<div style="display:inline-block;width:2px">&nbsp;</div>efforts with the future needs of the </div><div id="a15614" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:488px;">organization.<div style="display:inline-block;width:7px">&nbsp;</div>Our BOD is provided with periodic updates regarding our<div style="display:inline-block;width:2px">&nbsp;</div>talent and succession planning </div><div id="a15616" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:505px;">efforts and participates in professional development activities with our TSMs.<div style="display:inline-block;width:6px">&nbsp;</div>We know recognition and </div><div id="a15617" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:522px;">purpose are also key pillars to TSM engagement, so we continue to find<div style="display:inline-block;width:2px">&nbsp;</div>ways to recognize our TSMs </div><div id="a15618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:539px;">through our annual performance review process, and various recognition<div style="display:inline-block;width:2px">&nbsp;</div>opportunities including our Teddy </div><div id="a15620" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:555px;">Philson Team Schein Award,<div style="display:inline-block;width:6px">&nbsp;</div>which highlights TSMs who exemplify our Team Schein Values.<div style="display:inline-block;width:9px">&nbsp;</div>In addition, </div><div id="a15621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:572px;">we continue to focus on ensuring every TSM understands the importance<div style="display:inline-block;width:2px">&nbsp;</div>in the role they play within the </div><div id="a15623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:589px;">organization, how they contribute to a larger purpose of creating a healthier world, as well as<div style="display:inline-block;width:2px">&nbsp;</div>continue to </div><div id="a15624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:606px;">provide opportunities for TSMs to engage in meaningful ways<div style="display:inline-block;width:2px">&nbsp;</div>that connect back to their own personal </div><div id="a15625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:623px;">purpose, such as helping the community through CSR activities. </div><div id="a15629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:657px;">Available Information </div><div id="a15632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:691px;">We make available free of charge through our Internet website, www.henryschein.com, our annual report on Form </div><div id="a15635" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:707px;">10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements<div style="display:inline-block;width:2px">&nbsp;</div>of beneficial ownership of </div><div id="a15643" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:724px;">securities on Forms 3, 4 and 5 and amendments to these reports and statements<div style="display:inline-block;width:2px">&nbsp;</div>filed or furnished pursuant to </div><div id="a15644" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:741px;">Section 13(a) and Section 16 of the Securities Exchange Act of 1934<div style="display:inline-block;width:2px">&nbsp;</div>as soon as reasonably practicable after such </div><div id="a15645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:758px;">materials are electronically filed with, or furnished to, the United States Securities<div style="display:inline-block;width:2px">&nbsp;</div>and Exchange Commission, or </div><div id="a15647" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:775px;">SEC.<div style="display:inline-block;width:7px">&nbsp;</div>Our principal executive offices are located at 135 Duryea Road, Melville, New<div style="display:inline-block;width:2px">&nbsp;</div>York<div style="display:inline-block;width:5px">&nbsp;</div>11747, and our </div><div id="a15648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:792px;">telephone number is (631) 843-5500.<div style="display:inline-block;width:7px">&nbsp;</div>Unless the context specifically requires otherwise, the terms the<div style="display:inline-block;width:2px">&nbsp;</div>“Company,” </div><div id="a15652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:809px;">“Henry Schein,” “we,” “us” and “our” mean Henry Schein, Inc., a Delaware<div style="display:inline-block;width:2px">&nbsp;</div>corporation, and its consolidated </div><div id="a15653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:825px;">subsidiaries. </div></div>
</div>
<div style="padding: 7px">
<div id="Page22" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:163.1px; height:1px; left:66.8px; top:146.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:42.1px; height:1px; left:234.8px; top:146.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:461px; height:1px; left:281.9px; top:146.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:20px; left:67.2px; top:153px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16.2px; left:67.2px; top:156.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:20px; left:67.2px; top:193px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16.2px; left:67.2px; top:196.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:20px; left:67.2px; top:233px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16.2px; left:67.2px; top:236.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:20px; left:67.2px; top:273px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16.2px; left:67.2px; top:276.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:20px; left:67.2px; top:313px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:16.2px; left:67.2px; top:316.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a15655" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a15658" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">22 </div><div id="a15660" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Information about our Executive Officers </div><div id="a15663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">The following table sets forth certain information regarding our executive<div style="display:inline-block;width:2px">&nbsp;</div>officers: </div><div id="a15668" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:131px;top:131px;">Name </div><div id="a15671" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:245px;top:131px;">Age </div><div id="a15674" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:489px;top:131px;">Position </div><div id="a15681" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:157px;">Stanley M. Bergman<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15684" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:157px;">73 </div><div id="a15687" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:157px;">Chairman, Chief Executive Officer, Director </div><div id="a15689" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:177px;">James P.<div style="display:inline-block;width:5px">&nbsp;</div>Breslawski<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15692" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:177px;">69 </div><div id="a15695" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:177px;">Vice Chairman, President, Director </div><div id="a15697" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:197px;">David Brous </div><div id="a15700" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:197px;">54 </div><div id="a15703" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:197px;">Chief Executive Officer, Strategic Business Group </div><div id="a15706" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:217px;">Brad Connett </div><div id="a15709" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:217px;">64 </div><div id="a15712" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:217px;">Chief Executive Officer, North America Distribution Group </div><div id="a15714" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:237px;">Michael S. Ettinger<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15717" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:237px;">61 </div><div id="a15720" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:237px;">Executive Vice President and Chief Operating Officer </div><div id="a15722" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:257px;">Lorelei McGlynn<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15725" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:257px;">59 </div><div id="a15728" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:257px;">Senior Vice President, Chief Human Resources Officer </div><div id="a15731" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:277px;">Mark E. Mlotek<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15734" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:277px;">67 </div><div id="a15737" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:277px;">Executive Vice President, Chief Strategic Officer, Director </div><div id="a15739" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:297px;">Ronald N. South </div><div id="a15742" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:297px;">61 </div><div id="a15745" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:297px;">Senior Vice President, Chief Financial Officer </div><div id="a15747" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:317px;">Walter Siegel<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a15750" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:249px;top:317px;">63 </div><div id="a15753" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:317px;">Senior Vice President and Chief Legal Officer </div><div id="a15756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:350px;">Stanley M. Bergman</div><div id="a15757" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:197px;top:350px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Chairman and Chief Executive Officer since 1989 and a director<div style="display:inline-block;width:2px">&nbsp;</div>since 1982.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:367px;">Mr. Bergman held the position of President from 1989 to 2005.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. Bergman held the position of Executive Vice </div><div id="a15760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:384px;">President from 1985 to 1989 and Vice President of Finance and Administration from 1980 to 1985.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15764" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:418px;">James P. Breslawski</div><div id="a15765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:195px;top:418px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Vice Chairman since 2018, President since 2005 and a director since 1992.<div style="display:inline-block;width:6px">&nbsp;</div>Mr. </div><div id="a15770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:434px;">Breslawski was the Chief Executive Officer of our Henry Schein Global Dental<div style="display:inline-block;width:2px">&nbsp;</div>Group from 2005 to 2018.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. </div><div id="a15773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:451px;">Breslawski held the position of Executive Vice President and President of U.S. Dental from 1990 to 2005, with </div><div id="a15774" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:468px;">primary responsibility for the North American Dental Group.<div style="display:inline-block;width:6px">&nbsp;</div>Between 1980 and 1990, Mr. Breslawski held </div><div id="a15775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:485px;">various positions with us, including Chief Financial Officer, Vice President of Finance and Administration and </div><div id="a15777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:502px;">Corporate Controller. </div><div id="a15781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:536px;">David Brous</div><div id="a15782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:146px;top:536px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Chief Executive Officer, Strategic Business Group since 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. Brous joined us in </div><div id="a15784" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:552px;">2002 and has held many positions within the organization, including President, Strategic Business<div style="display:inline-block;width:2px">&nbsp;</div>Units Group and </div><div id="a15786" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:569px;">Asia Pacific &amp; Brazil Dental, leading and managing the Corporate Business<div style="display:inline-block;width:2px">&nbsp;</div>Development Group and the </div><div id="a15787" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:586px;">International Healthcare Group (managing our International Animal Health business,<div style="display:inline-block;width:2px">&nbsp;</div>International Medical </div><div id="a15805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:603px;">business and Australia / New Zealand Dental business). </div><div id="a15822" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:637px;">Brad Connett</div><div id="a15823" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:153px;top:637px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Chief Executive Officer, North American Distribution Group since 2021.<div style="display:inline-block;width:6px">&nbsp;</div>Previously </div><div id="a15825" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:654px;">Mr. Connett was the President of our U.S. Medical Group from 2018 to 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. Connett joined us in 1997 and </div><div id="a15826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:671px;">has held a number of roles of increasing responsibility at the Company.<div style="display:inline-block;width:7px">&nbsp;</div>Throughout his career, he has received </div><div id="a15828" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:687px;">numerous industry honors, including the John F. Sasen Leadership Award from the Health Industry Distributors </div><div id="a15829" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:704px;">Association (HIDA), in recognition of his service to the industry, and induction into the Medical Distribution Hall </div><div id="a15831" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:721px;">of Fame by Repertoire Magazine. </div><div id="a15834" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:755px;">Michael S. Ettinger</div><div id="a15835" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:189px;top:755px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Executive Vice President and Chief Operating Officer since July 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to </div><div id="a15837" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:772px;">his current position, Mr. Ettinger served as Senior Vice President, Corporate &amp; Legal Affairs, Chief of Staff and </div><div id="a15838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:789px;">Secretary from 2015 to July 2022, Senior Vice President, Corporate &amp; Legal Affairs and Secretary from 2013 to </div><div id="a15840" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:805px;">2015, Corporate Senior Vice President, General Counsel &amp; Secretary from 2006 to 2013, Vice President, General </div><div id="a15844" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:822px;">Counsel and Secretary from 2000 to 2006, Vice President and Associate General Counsel from 1998 to 2000<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a15846" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:839px;">Associate General Counsel from 1994 to 1998.<div style="display:inline-block;width:7px">&nbsp;</div>Before joining us, Mr. Ettinger served as a senior associate with </div><div id="a15847" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:856px;">Bower &amp; Gardner and as a member of the Tax Department at Arthur Andersen. </div><div id="a15850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:890px;">Lorelei McGlynn</div><div id="a15851" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:175px;top:890px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President, Chief Human Resources Officer since 2013.<div style="display:inline-block;width:7px">&nbsp;</div>Since joining </div><div id="a15854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:907px;">us in 1999, Ms. McGlynn has served as Vice President, Global Human Resources and Financial Operations from </div><div id="a15855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:924px;">2008 to 2013, Chief Financial Officer, International Group and Vice President of Global Financial Operations from </div><div id="a15857" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:940px;">2002 to 2008 and Vice President, Finance, North America from 1999 to 2002.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining us, Ms. McGlynn </div><div id="a15858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:957px;">served as Assistant Vice President of Finance at Adecco Corporation. </div></div>
</div>
<div style="padding: 7px">
<div id="Page23" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:163.1px; height:1px; left:64.1px; top:533.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:42.1px; height:1px; left:232.1px; top:533.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:461px; height:1px; left:279.2px; top:533.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:157.6px; height:16px; left:67.2px; top:543.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:36.7px; height:16px; left:235.2px; top:543.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:19.2px; left:64.5px; top:540.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:455.7px; height:16px; left:282.3px; top:543.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:157.6px; height:16px; left:67.2px; top:581.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:36.7px; height:16px; left:235.2px; top:581.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:19.2px; left:64.5px; top:578.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:455.7px; height:16px; left:282.3px; top:581.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:157.6px; height:16px; left:67.2px; top:620.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:36.7px; height:16px; left:235.2px; top:620.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:19.2px; left:64.5px; top:616.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:455.7px; height:16px; left:282.3px; top:620.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:157.6px; height:16px; left:67.2px; top:658.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:36.7px; height:16px; left:235.2px; top:658.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:676.1px; height:19.2px; left:64.5px; top:655.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:455.7px; height:16px; left:282.3px; top:658.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a15861" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a15864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">23 </div><div id="a15866" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Mark E. Mlotek</div><div id="a15867" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:169px;top:60px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Executive Vice President and Chief Strategic Officer since 2012.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. Mlotek was </div><div id="a15873" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Senior Vice President and subsequently Executive Vice President of the Corporate Business Development Group </div><div id="a15874" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">between 2000 and 2012.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to that, Mr. Mlotek was Vice President, General Counsel and Secretary from 1994 to </div><div id="a15879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">1999 and became a director in 1995.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining us, Mr. Mlotek was a partner in the law firm of Proskauer </div><div id="a15883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Rose LLP,<div style="display:inline-block;width:5px">&nbsp;</div>counsel to us, specializing in mergers and acquisitions, corporate reorganizations and tax law from<div style="display:inline-block;width:2px">&nbsp;</div>1989 </div><div id="a15884" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">to 1994. </div><div id="a15888" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:178px;">Ronald N. South</div><div id="a15889" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:171px;top:178px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President<div style="display:inline-block;width:4px">&nbsp;</div>and Chief Financial Officer (and principal financial officer </div><div id="a15895" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">and principal accounting officer) since April 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to holding his current position, Mr. South was our </div><div id="a15899" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">Corporate Finance and Chief Accounting Officer from 2013 until April 2022.<div style="display:inline-block;width:6px">&nbsp;</div>Prior to joining us in 2008 as our </div><div id="a15911" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Vice President, Corporate Finance, Mr. South held leadership roles at Bristol-Myers Squibb, where he served as </div><div id="a15914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">Vice President, Finance, for the Cardiovascular and Metabolic business lines, as well as Vice President, Controller, </div><div id="a15917" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">for its U.S. Pharmaceutical Division, and Vice President, Corporate General Auditor.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to Bristol-Myers </div><div id="a15920" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">Squibb, he served as North American Director of Corporate Audit at<div style="display:inline-block;width:2px">&nbsp;</div>PepsiCo, and held several roles of increasing </div><div id="a15922" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">responsibility with PricewaterhouseCoopers LLP, where he advised clients located in the United States, Europe, </div><div id="a15923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">and Latin America.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. South is a certified public accountant. </div><div id="a15926" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:346px;">Walter Siegel</div><div id="a15927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:152px;top:346px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President and Chief Legal Officer since 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Previously, Mr.<div style="display:inline-block;width:5px">&nbsp;</div>Siegel was </div><div id="a15929" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">our Senior Vice President and General Counsel from 2013 until 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining us, Mr. Siegel was employed </div><div id="a15935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">with Standard Microsystems Corporation, a publicly traded global semiconductor<div style="display:inline-block;width:2px">&nbsp;</div>company from 2005 to 2012, </div><div id="a15937" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">holding positions of increasing responsibility, most recently as Senior Vice President, General Counsel and </div><div id="a15938" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">Secretary. </div><div id="a15941" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:448px;">Other Executive Management </div><div id="a15944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">The following table sets forth certain information regarding other Executive<div style="display:inline-block;width:2px">&nbsp;</div>Management: </div><div id="a15950" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:129px;top:518px;">Name </div><div id="a15953" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:242px;top:518px;">Age </div><div id="a15956" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;font-weight:bold;left:486px;top:518px;">Position </div><div id="a15963" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:543px;">Andrea Albertini </div><div id="a15966" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:543px;">52 </div><div id="a15969" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:543px;">Chief Executive Officer, International Distribution Group </div><div id="a15971" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:563px;">Leigh Benowitz </div><div id="a15974" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:563px;">55 </div><div id="a15977" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:563px;">Senior Vice President and Chief Global Digital Transformation Officer<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a15979" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:582px;">Trinh Clark </div><div id="a15982" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:582px;">49 </div><div id="a15985" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:582px;">Senior Vice President and Chief Global Customer Experience Officer </div><div id="a15987" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:601px;">James Mullins </div><div id="a15990" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:601px;">58 </div><div id="a15993" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:601px;">Senior Vice President, Global Supply Chain </div><div id="a15995" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:620px;">Kelly Murphy </div><div id="a15998" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:620px;">42 </div><div id="a16001" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:620px;">Senior Vice President and General Counsel </div><div id="a16004" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:639px;">Christopher Pendergast </div><div id="a16007" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:639px;">60 </div><div id="a16010" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:639px;">Senior Vice President and Chief Technology Officer </div><div id="a16012" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:659px;">Michael Racioppi<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16015" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:659px;">68 </div><div id="a16018" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:659px;">Senior Vice President, Chief Merchandising Officer </div><div id="a16020" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:67px;top:678px;">René Willi, Ph.D. </div><div id="a16023" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:246px;top:678px;">55 </div><div id="a16026" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:282px;top:678px;">Chief Executive Officer, Global Oral Reconstruction Group </div><div id="a16030" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:711px;">Andrea Albertini</div><div id="a16031" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:175px;top:711px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been Chief Executive Officer, International Distribution Group since 2023.<div style="display:inline-block;width:6px">&nbsp;</div>Mr. Albertini </div><div id="a16033" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:728px;">joined us in 2013 and has held several positions within the organization including<div style="display:inline-block;width:2px">&nbsp;</div>President, International </div><div id="a16036" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:744px;">Distribution Group, President of our EMEA Dental Distribution Group,<div style="display:inline-block;width:2px">&nbsp;</div>and Vice-President of International Dental </div><div id="a16040" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:761px;">Equipment.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining Henry Schein, Mr. Albertini held leadership positions at Cefla Dental Group and </div><div id="a16042" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:778px;">Castellini. </div><div id="a16045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:812px;">Leigh Benowitz</div><div id="a16046" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:165px;top:812px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President and Chief Global Digital Transformation Officer since August </div><div id="a16050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:829px;">2022.<div style="display:inline-block;width:7px">&nbsp;</div>Ms. Benowitz joined us in 2017 and has held several key positions<div style="display:inline-block;width:2px">&nbsp;</div>including Vice President Digital &amp; </div><div id="a16051" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:846px;">Customer Experience and Global eCommerce Platform Digital Transformation Officer.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining Henry </div><div id="a16053" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:863px;">Schein, Ms. Benowitz held various positions with increasing responsibilities<div style="display:inline-block;width:2px">&nbsp;</div>at Citi. </div><div id="a16056" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:896px;">Trinh Clark </div><div id="a16057" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:148px;top:896px;">has been our Senior Vice President and Chief Global Customer Experience Officer since August </div><div id="a16058" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:913px;">2022.<div style="display:inline-block;width:7px">&nbsp;</div>Ms. Clark joined us in 2007 and has served as Vice President, Technology Enablement, North American </div><div id="a16061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:930px;">Distribution Group.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining Henry Schein, Ms. Clark held various positions of<div style="display:inline-block;width:2px">&nbsp;</div>increasing responsibilities at </div><div id="a16062" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:947px;">eSurg.</div></div>
</div>
<div style="padding: 7px">
<div id="Page24" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16065" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">24 </div><div id="a16070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">James Mullins</div><div id="a16071" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:158px;top:60px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President of Global Supply Chain since 2018.<div style="display:inline-block;width:7px">&nbsp;</div>Mr. Mullins joined us in </div><div id="a16076" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">1988 and has held a number of key positions with increasing responsibility, including Global Chief Customer </div><div id="a16079" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Service Officer. </div><div id="a16082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:127px;">Kelly Murphy</div><div id="a16083" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:157px;top:127px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President and General Counsel since 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Since joining us in 2011, Ms. </div><div id="a16086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">Murphy has held several key positions of increasing responsibility within<div style="display:inline-block;width:2px">&nbsp;</div>the legal function, most recently serving </div><div id="a16087" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">as Deputy General Counsel.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a16090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:195px;">Christopher Pendergast</div><div id="a16091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:218px;top:195px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President and Chief Technology Officer since 2018.<div style="display:inline-block;width:8px">&nbsp;</div>Prior to </div><div id="a16094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">joining us, Mr. Pendergast was the employed by VSP Global from 2008 to 2018, most recently as the Chief </div><div id="a16095" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Technology Officer and Chief Information Officer.<div style="display:inline-block;width:9px">&nbsp;</div>Prior to VSP Global, Mr. Pendergast served in roles of </div><div id="a16098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">increasing responsibility at Natural Organics, Inc., from 2006 to 2008, IdeaSphere Inc./Twinlab Corporation from </div><div id="a16099" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">2000 to 2006, IBM Corporation from 1987 to 1994 and 1998 to 2000<div style="display:inline-block;width:2px">&nbsp;</div>and Rohm and Haas from 1994 to 1998. </div><div id="a16102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:296px;">Michael Racioppi</div><div id="a16103" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:178px;top:296px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Senior Vice President, Chief Merchandising Officer since 2008.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to holding </div><div id="a16107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">his current position, Mr. Racioppi was President of the Medical Division from 2000 to 2008 and Interim President </div><div id="a16108" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">from 1999 to 2000, and Corporate Vice President from 1994 to 2008, with primary responsibility for the Medical </div><div id="a16112" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">Group, Marketing and Merchandising departments.<div style="display:inline-block;width:6px">&nbsp;</div>Mr. Racioppi served as Senior Director, Corporate </div><div id="a16116" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">Merchandising from 1992 to 1994.<div style="display:inline-block;width:7px">&nbsp;</div>Before joining us in 1992, Mr. Racioppi was employed by Ketchum </div><div id="a16118" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">Distributors, Inc. as the Vice President of Purchasing and Marketing.<div style="display:inline-block;width:7px">&nbsp;</div>He currently serves on the board of National </div><div id="a16121" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">Distribution and Contracting and previously served on the board of Health<div style="display:inline-block;width:2px">&nbsp;</div>Distribution Management Association </div><div id="a16122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">and Health Industry Distributors Association (HIDA). </div><div id="a16127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:448px;">René Willi, Ph.D.</div><div id="a16128" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:176px;top:448px;"><div style="display:inline-block;width:4px">&nbsp;</div>has been our Chief Executive Officer, Global Oral Reconstruction Group since 2021.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16130" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">Previously, Dr.<div style="display:inline-block;width:5px">&nbsp;</div>Willi was the President of our Global Dental Surgical Group.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to joining Henry Schein, Dr. </div><div id="a16138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">Willi held senior level roles with Institut Straumann AG as Executive Vice President, Surgical Business Unit from </div><div id="a16141" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">2005 to 2013.<div style="display:inline-block;width:7px">&nbsp;</div>Prior to Straumann, he held roles of increasing responsibility<div style="display:inline-block;width:2px">&nbsp;</div>in Medtronic Plc’s cardiovascular </div><div id="a16148" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">division from 2003 to 2005 and with McKinsey &amp; Company as<div style="display:inline-block;width:2px">&nbsp;</div>a management consultant from 2000 to 2003. </div></div>
</div>
<div style="padding: 7px">
<div id="Page25" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16159" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">25 </div><div id="a16164" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 1A. Risk Factors </div><div id="a16167" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Our business operations could be affected by factors that are not presently known<div style="display:inline-block;width:2px">&nbsp;</div>to us or that we currently </div><div id="a16168" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">consider not to be material to our operations, so you should not consider<div style="display:inline-block;width:2px">&nbsp;</div>the risks disclosed in this section to </div><div id="a16169" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">necessarily represent a complete statement of all risks and uncertainties.<div style="display:inline-block;width:6px">&nbsp;</div>The Company believes that the following </div><div id="a16173" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">risks could have a material adverse impact on our business, reputation, financial<div style="display:inline-block;width:2px">&nbsp;</div>results, financial condition and/or </div><div id="a16174" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">the trading price of our common stock.<div style="display:inline-block;width:7px">&nbsp;</div>The order in which these factors appear does not necessarily reflect<div style="display:inline-block;width:2px">&nbsp;</div>their </div><div id="a16176" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">relative importance or priority.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a16179" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:211px;">COMPANY RISKS </div><div id="a16182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:245px;">Our business, results of operations, cash flows, financial condition and<div style="display:inline-block;width:2px">&nbsp;</div>liquidity may be negatively impacted by </div><div id="a16183" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:262px;">the effects of disease outbreaks, epidemics, pandemics, or similar wide-spread public health<div style="display:inline-block;width:2px">&nbsp;</div>concerns and other </div><div id="a16187" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:279px;">natural disasters</div><div id="a16188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:168px;top:279px;">.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a16190" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:179px;top:279px;">The COVID-19 pandemic and the responses of governments<div style="display:inline-block;width:2px">&nbsp;</div>to it had, and may again have, a </div><div id="a16193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:296px;">material adverse effect on our business, results of operations and cash flows and may result<div style="display:inline-block;width:2px">&nbsp;</div>in a material </div><div id="a16195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:313px;">adverse effect on our financial condition and liquidity. </div><div id="a16198" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">Our business, results of operations, cash flows, financial condition and<div style="display:inline-block;width:2px">&nbsp;</div>liquidity may be negatively impacted by the<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16200" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">effects of disease outbreaks, epidemics, pandemics, similar wide-spread public health concerns<div style="display:inline-block;width:2px">&nbsp;</div>and other natural </div><div id="a16203" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">disasters. The COVID-19 pandemic has had, and continues to have, an<div style="display:inline-block;width:2px">&nbsp;</div>unprecedented impact on society, worldwide </div><div id="a16207" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">economic activity, and the health care sector (particularly, the dental market). As a global healthcare solutions </div><div id="a16208" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">company, the COVID-19 pandemic and the governmental responses to it had, and may again have, a material </div><div id="a16212" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">adverse effect on our business, results of operations and cash flows and may result<div style="display:inline-block;width:2px">&nbsp;</div>in a material adverse effect on </div><div id="a16213" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">our financial condition and liquidity. Even after the COVID-19 pandemic has begun to subside, we may again </div><div id="a16219" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">experience material adverse impacts to our business, results of operations<div style="display:inline-block;width:2px">&nbsp;</div>and cash flows as a result of, among other </div><div id="a16220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">things, its global economic impact, including any recession that<div style="display:inline-block;width:2px">&nbsp;</div>may occur in the future, or a prolonged period of </div><div id="a16221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">economic slowdown or the reluctance of patients to return for elective dental<div style="display:inline-block;width:2px">&nbsp;</div>or medical care. The impacts and </div><div id="a16224" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">potential impacts from the COVID-19 pandemic include, but are not<div style="display:inline-block;width:2px">&nbsp;</div>limited to: </div><div id="a16228" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:551px;">• </div><div id="a16230" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:76px;top:551px;">Significant volatility in supply, demand and selling prices for personal protective equipment (PPE), COVID-19 </div><div id="a16239" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:567px;">tests and other COVID-19 related products.</div><div id="a16248" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:326px;top:567px;"><div style="display:inline-block;width:4px">&nbsp;</div>Available supply,<div style="display:inline-block;width:5px">&nbsp;</div>customer demand and selling prices for PPE, </div><div id="a16250" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:584px;">COVID-19 tests and other COVID-19 related products<div style="display:inline-block;width:2px">&nbsp;</div>fluctuated in fiscal 2022 and we expect such volatility to </div><div id="a16260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:601px;">continue for the duration of the COVID-19 pandemic. This has resulted<div style="display:inline-block;width:2px">&nbsp;</div>in inventory reserves, fluctuating margins </div><div id="a16266" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:618px;">and increased revenue related to such products.<div style="display:inline-block;width:6px">&nbsp;</div>The volatility in sales of COVID-19 test kits has moderated,<div style="display:inline-block;width:2px">&nbsp;</div>albeit </div><div id="a16273" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:635px;">at a significantly lower level of sales compared with 2021, resulting in<div style="display:inline-block;width:2px">&nbsp;</div>us recording an inventory obsolescence </div><div id="a16276" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:652px;">reserve of $17 million for COVID-19 test kits during the year<div style="display:inline-block;width:2px">&nbsp;</div>ended December 31, 2022 and we expect further </div><div id="a16281" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:669px;">declines in sales volumes.<div style="display:inline-block;width:7px">&nbsp;</div>Our estimates for supply, demand and selling prices are inherently uncertain and if </div><div id="a16284" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:686px;">supply, demand, selling prices or other market dynamics significantly fluctuate in the future beyond our current </div><div id="a16286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:702px;">assumptions, additional inventory reserves may be required, margins may be reduced and/or<div style="display:inline-block;width:2px">&nbsp;</div>revenue may decline </div><div id="a16288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:719px;">for such products, each which could materially adversely impact our business,<div style="display:inline-block;width:2px">&nbsp;</div>results of operations and cash flows. </div><div id="a16289" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:736px;">Additionally, governmental policies designed to reduce the transmission of COVID-19 and variants thereof could </div><div id="a16292" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:753px;">once again lead to the closure of dental offices or deferral of elective procedures and<div style="display:inline-block;width:2px">&nbsp;</div>wellness exams by medical </div><div id="a16294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:770px;">and dental patients. Such previous closures and restrictions impacted our<div style="display:inline-block;width:2px">&nbsp;</div>customers’ spending with us and had, and </div><div id="a16295" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:787px;">if reinstated may again have, a material adverse effect on our business, results of operations<div style="display:inline-block;width:2px">&nbsp;</div>and cash flows.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16297" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:804px;">Although we believe that most practices currently are able to access<div style="display:inline-block;width:2px">&nbsp;</div>adequate supply, we still may be unable to </div><div id="a16298" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:820px;">supply our customers with the specific brand and/or quantity of certain PPE products,<div style="display:inline-block;width:2px">&nbsp;</div>COVID-19 tests and other </div><div id="a16305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:837px;">COVID-19 related products they demand, which may lead to our<div style="display:inline-block;width:2px">&nbsp;</div>customers seeking alternative sources of supply.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a16309" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:854px;">Healthcare professionals’ inability to obtain a sufficient quantity and/or brand of certain PPE, COVID-19<div style="display:inline-block;width:2px">&nbsp;</div>tests and </div><div id="a16316" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:871px;">other COVID-19 related products would adversely impact our business,<div style="display:inline-block;width:2px">&nbsp;</div>results of operations and cash flows, and </div><div id="a16321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:888px;">could materially adversely affect our financial condition and liquidity; </div></div>
</div>
<div style="padding: 7px">
<div id="Page26" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16323" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16326" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">26 </div><div id="a16328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">• </div><div id="a16330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:76px;top:60px;">Reduction in Peoples’ Ability and Willingness to be in Public.</div><div id="a16332" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:440px;top:60px;"><div style="display:inline-block;width:4px">&nbsp;</div>Restrictions recommended by several public health </div><div id="a16334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">organizations, and implemented, from time to time, by federal, state and local governments,<div style="display:inline-block;width:2px">&nbsp;</div>to slow and limit the </div><div id="a16335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">transmission of COVID-19 and variants thereof has caused and may in<div style="display:inline-block;width:2px">&nbsp;</div>the future cause some people to be less </div><div id="a16339" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">willing to go to elective medical and dental appointments, which could<div style="display:inline-block;width:2px">&nbsp;</div>again materially adversely affect demand </div><div id="a16340" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">for our products.<div style="display:inline-block;width:7px">&nbsp;</div>A lengthened period of materially suppressed demand could again cause<div style="display:inline-block;width:2px">&nbsp;</div>material adverse impacts </div><div id="a16343" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">on our business, results of operations and cash flows and could materially<div style="display:inline-block;width:2px">&nbsp;</div>adversely affect our financial condition </div><div id="a16345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">and liquidity; </div><div id="a16347" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:196px;">• </div><div id="a16349" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:76px;top:196px;">Negative impact on our workforce and impact of adapted business practices.</div><div id="a16350" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:527px;top:196px;"><div style="display:inline-block;width:4px">&nbsp;</div>The spread of COVID-19 and </div><div id="a16354" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:213px;">variants thereof caused us to modify our business practices (including<div style="display:inline-block;width:2px">&nbsp;</div>employee travel, employee work locations, </div><div id="a16356" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:230px;">and physical participation in meetings, events and conferences), and<div style="display:inline-block;width:2px">&nbsp;</div>we may take further actions as may be required </div><div id="a16357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:247px;">by government authorities or our customers or that we determine are in the<div style="display:inline-block;width:2px">&nbsp;</div>best interests of our employees. As the </div><div id="a16359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:264px;">COVID-19 pandemic continues to unfold, we continue to evaluate<div style="display:inline-block;width:2px">&nbsp;</div>appropriate actions for our business. At the onset </div><div id="a16362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:281px;">of the COVID-19 pandemic, many of our office-based workers shifted abruptly to<div style="display:inline-block;width:2px">&nbsp;</div>working remotely. As the </div><div id="a16368" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:298px;">COVID-19 pandemic has evolved, we have modified our work<div style="display:inline-block;width:2px">&nbsp;</div>arrangements to implement more flexible working </div><div id="a16371" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:314px;">arrangements for our office-based workers, including permanent work from home,<div style="display:inline-block;width:2px">&nbsp;</div>hybrid and office-based </div><div id="a16376" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:331px;">arrangements. Implementing these modified business practices<div style="display:inline-block;width:2px">&nbsp;</div>to include remote work arrangements could have a </div><div id="a16378" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:348px;">negative impact on employee morale, strain our business continuity plans,<div style="display:inline-block;width:2px">&nbsp;</div>introduce operational risk (including but </div><div id="a16379" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:365px;">not limited to cybersecurity risks), and impair our ability<div style="display:inline-block;width:3px">&nbsp;</div>to efficiently operate our business; </div><div id="a16382" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:401px;">• </div><div id="a16384" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:76px;top:401px;">Significant changes in political conditions.</div><div id="a16385" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:328px;top:401px;"><div style="display:inline-block;width:4px">&nbsp;</div>Significant changes in political conditions in markets in which<div style="display:inline-block;width:2px">&nbsp;</div>we </div><div id="a16387" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:418px;">purchase and distribute our products have occurred and are expected to<div style="display:inline-block;width:2px">&nbsp;</div>continue at least during the pendency of the </div><div id="a16389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:434px;">pandemic, including quarantines, governmental or regulatory actions, closures<div style="display:inline-block;width:2px">&nbsp;</div>or other restrictions that limit or </div><div id="a16390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:451px;">close our operating facilities, restrict our employees’ ability to<div style="display:inline-block;width:2px">&nbsp;</div>travel or perform necessary business functions, or </div><div id="a16392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:468px;">otherwise constrain the operations of our business partners, suppliers or<div style="display:inline-block;width:2px">&nbsp;</div>customers, which may materially adversely </div><div id="a16394" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:485px;">affect our business, results of operations, cash flows, financial condition<div style="display:inline-block;width:2px">&nbsp;</div>and liquidity; </div><div id="a16396" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:520px;">• </div><div id="a16398" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:76px;top:520px;">Volatility<div style="display:inline-block;width:5px">&nbsp;</div>in the financial markets.</div><div id="a16399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:277px;top:520px;"><div style="display:inline-block;width:4px">&nbsp;</div>Volatility<div style="display:inline-block;width:5px">&nbsp;</div>in the financial markets may materially adversely affect the </div><div id="a16402" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:538px;">availability and cost of credit to us; </div><div id="a16404" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:573px;">The impact of the COVID-19 pandemic may also exacerbate other risks discussed<div style="display:inline-block;width:2px">&nbsp;</div>below, any of which could have </div><div id="a16407" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:590px;">a material adverse effect on us. </div><div id="a16409" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:625px;">We are dependent upon third parties for the manufacture and supply of a significant volume of our products. </div><div id="a16415" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:659px;">We obtain a significant volume of the products we distribute from third parties, with whom we generally do not </div><div id="a16418" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:676px;">have long-term contracts.<div style="display:inline-block;width:7px">&nbsp;</div>While there is typically more than one source of supply, some key suppliers, in the </div><div id="a16424" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:693px;">aggregate, supply a significant portion of the products we sell.<div style="display:inline-block;width:6px">&nbsp;</div>In 2022, our top 10 health care distribution suppliers </div><div id="a16429" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:710px;">and our single largest supplier accounted for approximately 28% and 4%, respectively, of our aggregate purchases.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16434" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:727px;">Because of our dependence upon such suppliers, our operations are<div style="display:inline-block;width:2px">&nbsp;</div>subject to the suppliers’ ability and willingness </div><div id="a16435" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:743px;">to supply products in the quantities that we require, and the risks include delays<div style="display:inline-block;width:2px">&nbsp;</div>caused by interruption in </div><div id="a16437" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:760px;">production based on conditions outside of our control, including<div style="display:inline-block;width:2px">&nbsp;</div>a supplier’s failure to comply with applicable </div><div id="a16438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:777px;">government requirements (which may result in product recalls and/or<div style="display:inline-block;width:2px">&nbsp;</div>cessation of sales) or an interruption in the </div><div id="a16440" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:794px;">suppliers’ manufacturing capabilities.<div style="display:inline-block;width:7px">&nbsp;</div>In the event of any such interruption in supply, we would need to identify </div><div id="a16443" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:811px;">and obtain acceptable replacement sources on a timely basis.<div style="display:inline-block;width:6px">&nbsp;</div>There is no guarantee that we would be able to obtain </div><div id="a16446" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:828px;">such alternative sources of supply on a timely basis, if at all, and an extended<div style="display:inline-block;width:2px">&nbsp;</div>interruption in supply, particularly of </div><div id="a16448" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:845px;">a high sales volume product, could result in a significant disruption<div style="display:inline-block;width:2px">&nbsp;</div>in our sales and operations, as well as damage </div><div id="a16449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:861px;">to our relationships with customers and our reputation.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, certain of our suppliers have had their ability to </div><div id="a16452" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:878px;">service certain markets restricted or negatively impacted because<div style="display:inline-block;width:2px">&nbsp;</div>of allegations of forced labor in their supply </div><div id="a16453" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:895px;">chain.<div style="display:inline-block;width:7px">&nbsp;</div>Forced labor legislation affecting the supply chain has increased around the<div style="display:inline-block;width:2px">&nbsp;</div>world, and the United States </div><div id="a16457" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:912px;">recently passed the Uyghur Forced Labor Prevention Act.<div style="display:inline-block;width:6px">&nbsp;</div>Our supply chain could be materially disrupted if our </div><div id="a16458" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:929px;">suppliers fail to comply with, or are unable to satisfy our demand<div style="display:inline-block;width:2px">&nbsp;</div>for products, as a result of applicable forced labor </div><div id="a16460" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:946px;">legislation and regulations. </div></div>
</div>
<div style="padding: 7px">
<div id="Page27" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16463" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16466" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">27 </div><div id="a16468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:60px;">Our<div style="display:inline-block;width:6px">&nbsp;</div>future<div style="display:inline-block;width:6px">&nbsp;</div>growth<div style="display:inline-block;width:6px">&nbsp;</div>(especially<div style="display:inline-block;width:6px">&nbsp;</div>for<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:6px">&nbsp;</div>technology<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>value-added<div style="display:inline-block;width:6px">&nbsp;</div>services<div style="display:inline-block;width:6px">&nbsp;</div>segment)<div style="display:inline-block;width:6px">&nbsp;</div>is<div style="display:inline-block;width:6px">&nbsp;</div>dependent<div style="display:inline-block;width:6px">&nbsp;</div>upon<div style="display:inline-block;width:6px">&nbsp;</div>our </div><div id="a16471" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:76px;">ability<div style="display:inline-block;width:7px">&nbsp;</div>to<div style="display:inline-block;width:7px">&nbsp;</div>develop<div style="display:inline-block;width:6px">&nbsp;</div>or<div style="display:inline-block;width:7px">&nbsp;</div>acquire<div style="display:inline-block;width:7px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>maintain<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>protect<div style="display:inline-block;width:6px">&nbsp;</div>new<div style="display:inline-block;width:7px">&nbsp;</div>products<div style="display:inline-block;width:7px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>technologies<div style="display:inline-block;width:6px">&nbsp;</div>that<div style="display:inline-block;width:7px">&nbsp;</div>achieve<div style="display:inline-block;width:7px">&nbsp;</div>market </div><div id="a16473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:93px;">acceptance with acceptable margins. </div><div id="a16476" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Our future success depends on our ability to timely develop (or obtain the right<div style="display:inline-block;width:2px">&nbsp;</div>to sell) competitive and innovative </div><div id="a16477" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">(particularly for our technology and value-added services segment)<div style="display:inline-block;width:2px">&nbsp;</div>products and services and to market them </div><div id="a16481" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">quickly and cost-effectively.<div style="display:inline-block;width:8px">&nbsp;</div>Our ability to anticipate customer needs and emerging trends and develop or acquire </div><div id="a16486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">new products, services and technologies at competitive prices requires significant<div style="display:inline-block;width:2px">&nbsp;</div>resources, including employees </div><div id="a16487" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">with the requisite skills, experience and expertise, particularly in our technology<div style="display:inline-block;width:2px">&nbsp;</div>segment, including dental practice </div><div id="a16490" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">management, patient engagement and demand creation software solutions.<div style="display:inline-block;width:6px">&nbsp;</div>The failure to successfully address these </div><div id="a16494" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">challenges could materially disrupt our sales and operations.<div style="display:inline-block;width:6px">&nbsp;</div>Additionally, our software and e-services products, </div><div id="a16500" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">like software products generally, may contain undetected errors or bugs when introduced or as new versions are </div><div id="a16501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">released.<div style="display:inline-block;width:7px">&nbsp;</div>Any such defective software may result in increased expenses related<div style="display:inline-block;width:2px">&nbsp;</div>to the software and could adversely </div><div id="a16505" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">affect our relationships with customers as well as our reputation.<div style="display:inline-block;width:6px">&nbsp;</div>With respect to certain software and e-services </div><div id="a16512" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">that we develop, we rely primarily upon copyright, trademark and<div style="display:inline-block;width:2px">&nbsp;</div>trade secret laws, as well as contractual and </div><div id="a16514" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">common law protections and confidentiality obligations.<div style="display:inline-block;width:6px">&nbsp;</div>We cannot provide assurance that such legal protections </div><div id="a16517" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">will be available, adequate or enforceable in a timely manner to protect<div style="display:inline-block;width:2px">&nbsp;</div>our software or e-services products. </div><div id="a16522" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:363px;">Risks inherent in acquisitions,<div style="display:inline-block;width:3px">&nbsp;</div>dispositions and joint ventures could offset the anticipated benefits.</div><div id="a16533" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">One of our business strategies has been to expand our domestic and<div style="display:inline-block;width:2px">&nbsp;</div>international markets in part through </div><div id="a16534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">acquisitions and joint ventures and we expect to continue to make acquisitions<div style="display:inline-block;width:2px">&nbsp;</div>and enter into joint ventures in the </div><div id="a16536" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">future. Such transactions require significant management attention,<div style="display:inline-block;width:2px">&nbsp;</div>may place significant demands on our </div><div id="a16537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">operations, information systems, legal, regulatory, compliance-functions and financial resources, and there is risk </div><div id="a16543" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">that one or more may not succeed. We cannot be sure, for example, that we will achieve the benefits of revenue </div><div id="a16544" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">growth that we expect from these acquisitions or joint ventures or<div style="display:inline-block;width:2px">&nbsp;</div>that we will avoid unforeseen additional costs, </div><div id="a16547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">taxes or expenses. Our ability to successfully implement our acquisition<div style="display:inline-block;width:2px">&nbsp;</div>and joint venture strategy depends upon, </div><div id="a16550" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">among other things, the following: </div><div id="a16553" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:549px;">•</div><div id="a16555" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:549px;">the availability of suitable acquisition or joint venture candidates at<div style="display:inline-block;width:2px">&nbsp;</div>acceptable prices; </div><div id="a16557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:567px;">•</div><div id="a16559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:567px;">our ability to consummate such transactions, which could potentially<div style="display:inline-block;width:2px">&nbsp;</div>be prohibited due to U.S. or </div><div id="a16562" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:585px;">foreign antitrust regulations; </div><div id="a16564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:603px;">•</div><div id="a16566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:603px;">the liquidity of our investments and the availability of financing on<div style="display:inline-block;width:2px">&nbsp;</div>acceptable terms; </div><div id="a16568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:620px;">•</div><div id="a16570" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:620px;">our ability to retain customers or product lines of the acquired businesses or<div style="display:inline-block;width:2px">&nbsp;</div>joint ventures; </div><div id="a16573" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:638px;">•</div><div id="a16575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:638px;">our ability to retain, recruit and incentivize the management of the<div style="display:inline-block;width:2px">&nbsp;</div>companies we acquire; and </div><div id="a16577" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:656px;">•</div><div id="a16579" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:656px;">our ability to successfully integrate these companies’ operations, services,<div style="display:inline-block;width:2px">&nbsp;</div>products and personnel with </div><div id="a16580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:674px;">our culture, management policies, legal, regulatory and compliance policies,<div style="display:inline-block;width:2px">&nbsp;</div>cybersecurity systems and </div><div id="a16587" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:692px;">policies, internal procedures, working capital management, financial<div style="display:inline-block;width:2px">&nbsp;</div>and operational controls and </div><div id="a16589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:710px;">strategies. </div><div id="a16592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:755px;">Furthermore, some of our acquisitions and future acquisitions may give rise to<div style="display:inline-block;width:2px">&nbsp;</div>an obligation to make contingent </div><div id="a16594" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:772px;">payments or to satisfy certain repurchase obligations, which payments<div style="display:inline-block;width:2px">&nbsp;</div>could have material adverse impacts on our </div><div id="a16597" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:789px;">financial results individually or in the aggregate. </div><div id="a16602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:822px;">Additionally, when we decide to sell assets or a business, we may encounter difficulty in finding buyers or </div><div id="a16604" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:839px;">executing alternative exit strategies on acceptable terms in a timely manner, which could delay<div style="display:inline-block;width:2px">&nbsp;</div>the accomplishment </div><div id="a16605" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:856px;">of our strategic objectives. Alternatively, we may dispose of assets or a business at a price or on terms that are<div style="display:inline-block;width:2px">&nbsp;</div>less </div><div id="a16607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:873px;">than we had anticipated.<div style="display:inline-block;width:7px">&nbsp;</div>Dispositions may also involve continued financial involvement<div style="display:inline-block;width:2px">&nbsp;</div>in a divested business, </div><div id="a16610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:890px;">such as through transition service agreements, indemnities or other current<div style="display:inline-block;width:2px">&nbsp;</div>or contingent financial obligations. </div><div id="a16612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:907px;">Under these arrangements, performance by the acquired or divested<div style="display:inline-block;width:2px">&nbsp;</div>business, or other conditions outside our </div><div id="a16613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:924px;">control, could affect our future financial results. </div><div id="a16616" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:957px;">Certain provisions in our governing documents and other documents to which we<div style="display:inline-block;width:2px">&nbsp;</div>are a party may discourage </div><div id="a16618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:974px;">third parties from seeking to acquire us that might otherwise result in<div style="display:inline-block;width:2px">&nbsp;</div>our stockholders receiving a premium </div><div id="a16621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:991px;">over the market price of their shares. </div></div>
</div>
<div style="padding: 7px">
<div id="Page28" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16623" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16626" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">28 </div><div id="a16629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">The provisions of our certificate of incorporation and by-laws may<div style="display:inline-block;width:2px">&nbsp;</div>make it more difficult for a third-party to </div><div id="a16635" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">acquire us, may discourage acquisition bids and may impact the price<div style="display:inline-block;width:2px">&nbsp;</div>that certain investors might be willing to pay </div><div id="a16636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">in the future for shares of our common stock.<div style="display:inline-block;width:7px">&nbsp;</div>These provisions, among other things require (i) the affirmative vote </div><div id="a16642" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">of the holders of at least 60% of the shares of common stock entitled to vote<div style="display:inline-block;width:2px">&nbsp;</div>to approve a merger, consolidation, or </div><div id="a16643" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">a sale, lease, transfer or exchange of all or substantially all of our assets;<div style="display:inline-block;width:2px">&nbsp;</div>and (ii) the affirmative vote of the holders </div><div id="a16648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">of at least 66 2/3% of our common stock entitled to vote to (a) remove<div style="display:inline-block;width:2px">&nbsp;</div>a director; and (b) to amend or repeal our </div><div id="a16653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">by-laws, with certain limited exceptions.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, certain of our employee incentive plans provide<div style="display:inline-block;width:2px">&nbsp;</div>for </div><div id="a16659" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">accelerated vesting of stock options and other awards upon termination without cause<div style="display:inline-block;width:2px">&nbsp;</div>within two years following a </div><div id="a16667" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">change in control, or grant the plan committee discretion to accelerate<div style="display:inline-block;width:2px">&nbsp;</div>awards upon a change of control.<div style="display:inline-block;width:7px">&nbsp;</div>Further, </div><div id="a16668" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">certain agreements between us and our executive officers provide for increased severance<div style="display:inline-block;width:2px">&nbsp;</div>payments and certain </div><div id="a16670" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">benefits if those executive officers are terminated without cause by us or if they terminate<div style="display:inline-block;width:2px">&nbsp;</div>for good reason, in each </div><div id="a16671" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">case within two years following a change in control or within ninety days prior<div style="display:inline-block;width:2px">&nbsp;</div>to the effective date of the change in </div><div id="a16675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">control or after the first public announcement of the pendency of the change<div style="display:inline-block;width:2px">&nbsp;</div>in control. </div><div id="a16678" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:313px;">Adverse changes in supplier rebates or other purchasing incentives<div style="display:inline-block;width:2px">&nbsp;</div>could negatively affect our business. </div><div id="a16682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">The terms<div style="display:inline-block;width:6px">&nbsp;</div>on which<div style="display:inline-block;width:6px">&nbsp;</div>we purchase<div style="display:inline-block;width:6px">&nbsp;</div>or sell<div style="display:inline-block;width:6px">&nbsp;</div>products from<div style="display:inline-block;width:5px">&nbsp;</div>many suppliers<div style="display:inline-block;width:6px">&nbsp;</div>may entitle<div style="display:inline-block;width:6px">&nbsp;</div>us to<div style="display:inline-block;width:6px">&nbsp;</div>receive a<div style="display:inline-block;width:6px">&nbsp;</div>rebate or<div style="display:inline-block;width:6px">&nbsp;</div>other </div><div id="a16683" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">purchasing incentive based on<div style="display:inline-block;width:5px">&nbsp;</div>the attainment of<div style="display:inline-block;width:5px">&nbsp;</div>certain growth goals. Suppliers may<div style="display:inline-block;width:5px">&nbsp;</div>reduce or eliminate rebates<div style="display:inline-block;width:5px">&nbsp;</div>or </div><div id="a16684" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">incentives<div style="display:inline-block;width:6px">&nbsp;</div>offered<div style="display:inline-block;width:6px">&nbsp;</div>under<div style="display:inline-block;width:6px">&nbsp;</div>their<div style="display:inline-block;width:6px">&nbsp;</div>programs,<div style="display:inline-block;width:5px">&nbsp;</div>or<div style="display:inline-block;width:5px">&nbsp;</div>increase<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>growth<div style="display:inline-block;width:5px">&nbsp;</div>goals<div style="display:inline-block;width:6px">&nbsp;</div>or<div style="display:inline-block;width:5px">&nbsp;</div>other<div style="display:inline-block;width:6px">&nbsp;</div>conditions<div style="display:inline-block;width:5px">&nbsp;</div>we<div style="display:inline-block;width:6px">&nbsp;</div>must<div style="display:inline-block;width:5px">&nbsp;</div>meet<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>earn </div><div id="a16687" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">rebates<div style="display:inline-block;width:6px">&nbsp;</div>or<div style="display:inline-block;width:6px">&nbsp;</div>incentives<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>levels<div style="display:inline-block;width:6px">&nbsp;</div>that<div style="display:inline-block;width:6px">&nbsp;</div>we<div style="display:inline-block;width:6px">&nbsp;</div>cannot<div style="display:inline-block;width:6px">&nbsp;</div>achieve.<div style="display:inline-block;width:6px">&nbsp;</div>Increased<div style="display:inline-block;width:6px">&nbsp;</div>competition<div style="display:inline-block;width:6px">&nbsp;</div>either<div style="display:inline-block;width:6px">&nbsp;</div>from<div style="display:inline-block;width:6px">&nbsp;</div>generic<div style="display:inline-block;width:6px">&nbsp;</div>or<div style="display:inline-block;width:6px">&nbsp;</div>equivalent </div><div id="a16688" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">branded products<div style="display:inline-block;width:6px">&nbsp;</div>could result<div style="display:inline-block;width:6px">&nbsp;</div>in us<div style="display:inline-block;width:6px">&nbsp;</div>failing to<div style="display:inline-block;width:6px">&nbsp;</div>earn rebates<div style="display:inline-block;width:6px">&nbsp;</div>or incentives<div style="display:inline-block;width:6px">&nbsp;</div>that are<div style="display:inline-block;width:6px">&nbsp;</div>conditioned upon<div style="display:inline-block;width:6px">&nbsp;</div>achievement of </div><div id="a16691" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">growth goals. Additionally,<div style="display:inline-block;width:6px">&nbsp;</div>factors outside of<div style="display:inline-block;width:5px">&nbsp;</div>our control, such<div style="display:inline-block;width:5px">&nbsp;</div>as customer preferences,<div style="display:inline-block;width:5px">&nbsp;</div>consolidation of suppliers </div><div id="a16692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">or supply issues, can have a material impact on<div style="display:inline-block;width:5px">&nbsp;</div>our ability to achieve the growth goals established<div style="display:inline-block;width:5px">&nbsp;</div>by our suppliers, </div><div id="a16694" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">which may reduce the amount of rebates or incentives we receive. The occurrence of any of these events<div style="display:inline-block;width:2px">&nbsp;</div>could have </div><div id="a16695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">an adverse impact on our business, financial condition or operating<div style="display:inline-block;width:2px">&nbsp;</div>results. </div><div id="a16701" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:515px;">Sales of corporate brand products entail additional risks, including the risk that such sales could<div style="display:inline-block;width:2px">&nbsp;</div>adversely affect </div><div id="a16705" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:532px;">our relationships with suppliers. </div><div id="a16708" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">We<div style="display:inline-block;width:5px">&nbsp;</div>offer certain corporate brand products that are available exclusively from us. The sale<div style="display:inline-block;width:5px">&nbsp;</div>of such products subjects </div><div id="a16713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">us to the risks generally encountered by entities that source, market and sell corporate brand products, including but </div><div id="a16717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">not<div style="display:inline-block;width:5px">&nbsp;</div>limited to<div style="display:inline-block;width:6px">&nbsp;</div>potential product<div style="display:inline-block;width:6px">&nbsp;</div>liability risks,<div style="display:inline-block;width:6px">&nbsp;</div>mandatory or<div style="display:inline-block;width:6px">&nbsp;</div>voluntary product<div style="display:inline-block;width:6px">&nbsp;</div>recalls, potential<div style="display:inline-block;width:6px">&nbsp;</div>supply chain<div style="display:inline-block;width:6px">&nbsp;</div>and </div><div id="a16718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">distribution<div style="display:inline-block;width:7px">&nbsp;</div>chain<div style="display:inline-block;width:7px">&nbsp;</div>disruptions,<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>potential<div style="display:inline-block;width:7px">&nbsp;</div>intellectual<div style="display:inline-block;width:6px">&nbsp;</div>property<div style="display:inline-block;width:6px">&nbsp;</div>infringement<div style="display:inline-block;width:6px">&nbsp;</div>risks.<div style="display:inline-block;width:7px">&nbsp;</div>Any<div style="display:inline-block;width:6px">&nbsp;</div>failure<div style="display:inline-block;width:7px">&nbsp;</div>to<div style="display:inline-block;width:7px">&nbsp;</div>adequately </div><div id="a16720" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">address<div style="display:inline-block;width:5px">&nbsp;</div>some<div style="display:inline-block;width:5px">&nbsp;</div>or<div style="display:inline-block;width:5px">&nbsp;</div>all<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>these<div style="display:inline-block;width:5px">&nbsp;</div>risks<div style="display:inline-block;width:5px">&nbsp;</div>could<div style="display:inline-block;width:5px">&nbsp;</div>have<div style="display:inline-block;width:5px">&nbsp;</div>an<div style="display:inline-block;width:5px">&nbsp;</div>adverse<div style="display:inline-block;width:5px">&nbsp;</div>effect<div style="display:inline-block;width:5px">&nbsp;</div>on<div style="display:inline-block;width:5px">&nbsp;</div>our<div style="display:inline-block;width:5px">&nbsp;</div>business, financial<div style="display:inline-block;width:6px">&nbsp;</div>condition<div style="display:inline-block;width:5px">&nbsp;</div>or<div style="display:inline-block;width:5px">&nbsp;</div>operating </div><div id="a16724" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">results. </div><div id="a16728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">In<div style="display:inline-block;width:5px">&nbsp;</div>addition,<div style="display:inline-block;width:5px">&nbsp;</div>an<div style="display:inline-block;width:5px">&nbsp;</div>increase<div style="display:inline-block;width:5px">&nbsp;</div>in<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>sales<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>our<div style="display:inline-block;width:5px">&nbsp;</div>corporate<div style="display:inline-block;width:5px">&nbsp;</div>brand<div style="display:inline-block;width:5px">&nbsp;</div>products may<div style="display:inline-block;width:7px">&nbsp;</div>negatively<div style="display:inline-block;width:5px">&nbsp;</div>affect<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:5px">&nbsp;</div>sales<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>products </div><div id="a16733" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">owned<div style="display:inline-block;width:6px">&nbsp;</div>by<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:6px">&nbsp;</div>suppliers<div style="display:inline-block;width:6px">&nbsp;</div>which,<div style="display:inline-block;width:6px">&nbsp;</div>consequently,<div style="display:inline-block;width:7px">&nbsp;</div>could<div style="display:inline-block;width:6px">&nbsp;</div>adversely<div style="display:inline-block;width:6px">&nbsp;</div>impact<div style="display:inline-block;width:6px">&nbsp;</div>certain<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:6px">&nbsp;</div>supplier<div style="display:inline-block;width:6px">&nbsp;</div>relationships.<div style="display:inline-block;width:6px">&nbsp;</div>Our </div><div id="a16734" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">ability<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>locate<div style="display:inline-block;width:6px">&nbsp;</div>qualified,<div style="display:inline-block;width:5px">&nbsp;</div>economically<div style="display:inline-block;width:6px">&nbsp;</div>stable<div style="display:inline-block;width:6px">&nbsp;</div>suppliers<div style="display:inline-block;width:6px">&nbsp;</div>who<div style="display:inline-block;width:6px">&nbsp;</div>satisfy<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:6px">&nbsp;</div>requirements,<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>acquire<div style="display:inline-block;width:6px">&nbsp;</div>sufficient </div><div id="a16736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">products in<div style="display:inline-block;width:6px">&nbsp;</div>a timely<div style="display:inline-block;width:5px">&nbsp;</div>and effective<div style="display:inline-block;width:6px">&nbsp;</div>manner,<div style="display:inline-block;width:5px">&nbsp;</div>is critical<div style="display:inline-block;width:5px">&nbsp;</div>to ensuring,<div style="display:inline-block;width:6px">&nbsp;</div>among other<div style="display:inline-block;width:6px">&nbsp;</div>things, that<div style="display:inline-block;width:5px">&nbsp;</div>customer confidence<div style="display:inline-block;width:5px">&nbsp;</div>is </div><div id="a16737" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">not diminished.<div style="display:inline-block;width:10px">&nbsp;</div>Any failure<div style="display:inline-block;width:6px">&nbsp;</div>to develop<div style="display:inline-block;width:5px">&nbsp;</div>sourcing relationships<div style="display:inline-block;width:5px">&nbsp;</div>with a<div style="display:inline-block;width:6px">&nbsp;</div>broad and<div style="display:inline-block;width:5px">&nbsp;</div>deep supplier<div style="display:inline-block;width:6px">&nbsp;</div>base could<div style="display:inline-block;width:6px">&nbsp;</div>have an </div><div id="a16743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">adverse effect on our business, financial condition or operating results.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16751" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:802px;">INDUSTRY RISKS </div><div id="a16754" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:836px;">The health care products distribution industry is highly competitive<div style="display:inline-block;width:2px">&nbsp;</div>(including, without limitation, competition </div><div id="a16755" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:852px;">from third-party online commerce sites) and consolidating, and we may not<div style="display:inline-block;width:2px">&nbsp;</div>be able to compete successfully.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">We compete with numerous companies, including several major manufacturers and distributors.<div style="display:inline-block;width:7px">&nbsp;</div>Some of our </div><div id="a16764" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">competitors have greater financial and other resources than we do, which<div style="display:inline-block;width:2px">&nbsp;</div>could allow them to compete more </div><div id="a16765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">successfully.<div style="display:inline-block;width:8px">&nbsp;</div>Most of our products are available from several sources and our customers<div style="display:inline-block;width:2px">&nbsp;</div>tend to have relationships </div><div id="a16769" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">with several distributors.<div style="display:inline-block;width:7px">&nbsp;</div>Competitors could obtain exclusive rights to market particular<div style="display:inline-block;width:2px">&nbsp;</div>products, which we would </div><div id="a16772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">then be unable to market. Manufacturers also could increase their<div style="display:inline-block;width:2px">&nbsp;</div>efforts to sell directly to end-users and thereby </div><div id="a16777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">eliminate or reduce our role in distribution.<div style="display:inline-block;width:7px">&nbsp;</div>Industry consolidation among health care product distributors and </div><div id="a16780" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">manufacturers, price competition, product unavailability, whether due to our inability to gain access to products or </div></div>
</div>
<div style="padding: 7px">
<div id="Page29" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a16781" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a16784" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">29 </div><div id="a16786" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">to interruptions in manufacturing supply, or the emergence of new competitors, also could increase competition.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16789" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Consolidation has also increased among manufacturers of health care<div style="display:inline-block;width:2px">&nbsp;</div>products, which could have a material </div><div id="a16790" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">adverse effect on our margins and product availability.<div style="display:inline-block;width:8px">&nbsp;</div>We could be subject to charges and financial losses in the </div><div id="a16794" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">event we fail to satisfy minimum purchase commitments contained<div style="display:inline-block;width:2px">&nbsp;</div>in some of our contracts. Additionally, </div><div id="a16795" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">traditional health care supply and distribution relationships are being challenged<div style="display:inline-block;width:2px">&nbsp;</div>by electronic online commerce </div><div id="a16797" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">solutions.<div style="display:inline-block;width:7px">&nbsp;</div>The continued advancement of online commerce by third<div style="display:inline-block;width:2px">&nbsp;</div>parties will require us to cost-effectively adapt </div><div id="a16802" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">to changing technologies, to enhance existing services and to differentiate our business<div style="display:inline-block;width:2px">&nbsp;</div>(including with additional </div><div id="a16804" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">value-added services) to address changing demands of consumers and<div style="display:inline-block;width:2px">&nbsp;</div>our customers on a timely basis.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a16809" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">emergence of such potential competition and our inability to anticipate and<div style="display:inline-block;width:2px">&nbsp;</div>effectively respond to changes on a </div><div id="a16810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">timely basis could have a material adverse effect on our business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a16815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:245px;">The repeal or judicial prohibition on implementation of the Affordable Care Act<div style="display:inline-block;width:2px">&nbsp;</div>could materially adversely </div><div id="a16816" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:262px;">affect our business. </div><div id="a16819" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">The ACA greatly expanded health insurance coverage in the United States<div style="display:inline-block;width:2px">&nbsp;</div>and has been the target of litigation and </div><div id="a16824" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">Congressional reform efforts since its adoption.<div style="display:inline-block;width:7px">&nbsp;</div>The U.S. Supreme Court, in upholding the constitutionality of the </div><div id="a16828" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">ACA and its individual mandate provision in 2012, simultaneously<div style="display:inline-block;width:2px">&nbsp;</div>limited ACA provisions requiring Medicaid </div><div id="a16829" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">expansion, making such expansion a state-by-state decision.<div style="display:inline-block;width:6px">&nbsp;</div>In 2017, the U.S. Congress effectively repealed the </div><div id="a16838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">ACA’s<div style="display:inline-block;width:6px">&nbsp;</div>individual mandate provision by eliminating the financial penalty for non-compliance.<div style="display:inline-block;width:6px">&nbsp;</div>In the most recent </div><div id="a16849" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">ACA litigation, a federal appeals court found the individual mandate to be unconstitutional,<div style="display:inline-block;width:2px">&nbsp;</div>and returned the case to </div><div id="a16886" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">a lower federal court for consideration of whether the remainder of the ACA<div style="display:inline-block;width:2px">&nbsp;</div>could survive the excision of the </div><div id="a16924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">individual mandate.<div style="display:inline-block;width:7px">&nbsp;</div>This decision was appealed to the U.S. Supreme Court, and the Supreme<div style="display:inline-block;width:2px">&nbsp;</div>Court issued a </div><div id="a16959" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">decision on June 17, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Without reaching the merits of the case, the Supreme Court held that the plaintiffs in </div><div id="a16962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">the case did not have standing to challenge the ACA.<div style="display:inline-block;width:6px">&nbsp;</div>Any outcome of future cases that change the ACA, in </div><div id="a16985" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">addition to future legislation, regulation, guidance and/or Executive Orders<div style="display:inline-block;width:2px">&nbsp;</div>that do the same, could have a </div><div id="a17017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">significant impact on the U.S. healthcare industry.<div style="display:inline-block;width:8px">&nbsp;</div>For instance, the American Rescue Plan Act of 2021 enhanced </div><div id="a17051" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">premium tax credits, which has resulted in an expansion of the number of people<div style="display:inline-block;width:2px">&nbsp;</div>covered under the ACA.<div style="display:inline-block;width:7px">&nbsp;</div>These </div><div id="a17091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">changes are time-limited, with some enhancements in place for 2021<div style="display:inline-block;width:2px">&nbsp;</div>only and others available through the end of </div><div id="a17129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">2022. </div><div id="a17132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:566px;">The health care industry is experiencing changes due to political, economic and<div style="display:inline-block;width:2px">&nbsp;</div>regulatory influences that could </div><div id="a17135" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:583px;">materially adversely affect our business. </div><div id="a17138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">The health care industry is highly regulated and subject to changing<div style="display:inline-block;width:2px">&nbsp;</div>political, economic and regulatory influences.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17139" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">In recent years, the health care industry has undergone, and is in the process of undergoing,<div style="display:inline-block;width:2px">&nbsp;</div>significant changes </div><div id="a17141" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">driven by various efforts to reduce costs, including, among other factors: trends<div style="display:inline-block;width:2px">&nbsp;</div>toward managed care; collective </div><div id="a17142" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">purchasing arrangements and consolidation among office-based health care practitioners;<div style="display:inline-block;width:2px">&nbsp;</div>and changes in </div><div id="a17146" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">reimbursements to customers, including increased attention to value-based payment<div style="display:inline-block;width:2px">&nbsp;</div>arrangements, as well as </div><div id="a17149" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">growing enforcement activities (and related monetary recoveries) by governmental<div style="display:inline-block;width:2px">&nbsp;</div>officials.<div style="display:inline-block;width:8px">&nbsp;</div>Both our profitability </div><div id="a17153" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">and the profitability of our customers may be materially adversely affected by laws<div style="display:inline-block;width:2px">&nbsp;</div>and regulations reducing </div><div id="a17154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">reimbursement rates for pharmaceuticals, medical supplies and devices,<div style="display:inline-block;width:2px">&nbsp;</div>and/or medical treatments or services, or </div><div id="a17155" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">changes to the methodology by which reimbursement levels are determined.<div style="display:inline-block;width:6px">&nbsp;</div>If we are unable to react effectively to </div><div id="a17159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">these and other changes in the health care industry, our business could be materially adversely affected.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17163" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:802px;">Expansion of group purchasing organizations (“GPO”), dental support organizations<div style="display:inline-block;width:2px">&nbsp;</div>(“DSO”) or provider </div><div id="a17165" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:819px;">networks and the multi-tiered costing structure may place us at a competitive<div style="display:inline-block;width:2px">&nbsp;</div>disadvantage. </div><div id="a17170" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">The health care products industry is subject to a multi-tiered costing structure, which<div style="display:inline-block;width:2px">&nbsp;</div>can vary by manufacturer </div><div id="a17173" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">and/or product.<div style="display:inline-block;width:7px">&nbsp;</div>Under this structure, certain institutions can obtain more favorable<div style="display:inline-block;width:2px">&nbsp;</div>prices for health care products </div><div id="a17177" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">than we are able to obtain.<div style="display:inline-block;width:7px">&nbsp;</div>The multi-tiered costing structure continues to expand as many large integrated health </div><div id="a17182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">care providers and others with significant purchasing power, such as GPOs and DSOs, demand more favorable </div><div id="a17184" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">pricing terms.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, the formation of provider networks, GPOs and DSOs may shift purchasing decisions </div><div id="a17187" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">to entities or persons with whom we do not have a historical relationship<div style="display:inline-block;width:2px">&nbsp;</div>and may threaten our ability to compete </div><div id="a17189" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">effectively, which could in turn negatively impact our financial results.<div style="display:inline-block;width:7px">&nbsp;</div>Although we are seeking to obtain similar </div><div id="a17192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">terms from manufacturers to access lower prices demanded by GPO and<div style="display:inline-block;width:2px">&nbsp;</div>DSO contracts or other contracts, and to </div></div>
</div>
<div style="padding: 7px">
<div id="Page30" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a17194" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a17197" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">30 </div><div id="a17199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">develop relationships with existing and emerging provider networks, GPOs and DSOs,<div style="display:inline-block;width:2px">&nbsp;</div>we cannot guarantee that </div><div id="a17200" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">such terms will be obtained or contracts executed.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17204" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:110px;">Increases in shipping costs or service issues with our third-party shippers<div style="display:inline-block;width:2px">&nbsp;</div>could harm our business. </div><div id="a17210" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">Our ability to meet our customers’ expedited delivery expectations is an<div style="display:inline-block;width:2px">&nbsp;</div>integral component of our business </div><div id="a17211" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">strategy for which our customers rely.<div style="display:inline-block;width:8px">&nbsp;</div>Shipping is a significant expense in the operation of our business.<div style="display:inline-block;width:6px">&nbsp;</div>We ship </div><div id="a17216" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">almost all of our orders through third-party delivery services, and typically bear<div style="display:inline-block;width:2px">&nbsp;</div>the cost of shipment.<div style="display:inline-block;width:7px">&nbsp;</div>Accordingly, </div><div id="a17222" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">any significant increase in shipping rates could have a material adverse<div style="display:inline-block;width:2px">&nbsp;</div>effect on our business, financial condition </div><div id="a17223" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">or operating results.<div style="display:inline-block;width:7px">&nbsp;</div>While we have recently experienced increases in the cost of shipping,<div style="display:inline-block;width:2px">&nbsp;</div>we do not expect these </div><div id="a17226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">additional expenses to be material to our results.<div style="display:inline-block;width:6px">&nbsp;</div>However, it is possible that such costs could be material in the </div><div id="a17227" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">future.<div style="display:inline-block;width:7px">&nbsp;</div>Similarly, strikes or other service interruptions by those shippers, including at transportation centers or </div><div id="a17230" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">shipping ports, could cause our operating expenses to rise and materially<div style="display:inline-block;width:2px">&nbsp;</div>adversely affect our ability to deliver </div><div id="a17231" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">products on a timely basis. </div><div id="a17234" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:313px;">MACRO ECONOMIC AND POLITICAL RISKS </div><div id="a17238" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:346px;">Uncertain global and domestic macro-economic and political conditions<div style="display:inline-block;width:2px">&nbsp;</div>could materially adversely affect our </div><div id="a17243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:363px;">results of operations and financial condition. </div><div id="a17246" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">Uncertain global and domestic macro-economic and political conditions<div style="display:inline-block;width:2px">&nbsp;</div>that affect the economy and the economic </div><div id="a17252" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">outlook of the United States, Europe, Asia and other parts of the<div style="display:inline-block;width:2px">&nbsp;</div>world could materially adversely affect our results </div><div id="a17253" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">of operations and financial condition.<div style="display:inline-block;width:7px">&nbsp;</div>These uncertainties, include, among other things: </div><div id="a17258" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:465px;">•</div><div id="a17260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:465px;">election results; </div><div id="a17262" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:482px;">•</div><div id="a17264" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:482px;">changes to laws and policies governing foreign trade (including, without<div style="display:inline-block;width:2px">&nbsp;</div>limitation, the United States-</div><div id="a17267" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:500px;">Mexico-Canada Agreement (USMCA), the EU-UK Trade and Cooperation Agreement of December </div><div id="a17272" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:518px;">2020 (that went into effect in 2021) and other international trade agreements); </div><div id="a17276" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:536px;">•</div><div id="a17278" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:536px;">greater restrictions on imports and exports; </div><div id="a17281" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:554px;">•</div><div id="a17283" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:554px;">supply chain disruptions; </div><div id="a17285" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:572px;">•</div><div id="a17287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:572px;">changes in laws and policies governing health care or data privacy; </div><div id="a17289" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:590px;">•</div><div id="a17291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:590px;">tariffs and sanctions; </div><div id="a17293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:607px;">•</div><div id="a17295" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:607px;">changes to the relationship between the United States and China; </div><div id="a17297" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:625px;">•</div><div id="a17299" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:625px;">sovereign debt levels; </div><div id="a17301" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:643px;">•</div><div id="a17303" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:643px;">the inability of political institutions to effectively resolve actual or perceived<div style="display:inline-block;width:2px">&nbsp;</div>economic, currency or </div><div id="a17304" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:661px;">budgetary crises or issues; </div><div id="a17306" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:679px;">•</div><div id="a17308" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:679px;">consumer confidence; </div><div id="a17310" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:697px;">•</div><div id="a17312" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:697px;">unemployment levels (and a corresponding increase in the uninsured<div style="display:inline-block;width:2px">&nbsp;</div>and underinsured population); </div><div id="a17315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:715px;">•</div><div id="a17317" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:715px;">changes in regulatory and tax regulations; </div><div id="a17319" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:732px;">•</div><div id="a17321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:732px;">interest rate fluctuations,<div style="display:inline-block;width:3px">&nbsp;</div>and strengthening of the dollar, which have and will continue to impact our </div><div id="a17326" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:750px;">results of operations; </div><div id="a17328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:768px;">•</div><div id="a17330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:768px;">availability of capital; </div><div id="a17333" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:786px;">•</div><div id="a17335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:786px;">increases in fuel and energy costs; </div><div id="a17337" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:804px;">•</div><div id="a17339" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:804px;">the effect of inflation on our ability to procure products and our ability to increase<div style="display:inline-block;width:2px">&nbsp;</div>prices over time and </div><div id="a17342" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:822px;">pass through to our customers price increases we may receive; </div><div id="a17345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:840px;">•</div><div id="a17347" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:840px;">changes in tax rates and the availability of certain tax deductions; </div><div id="a17351" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:857px;">•</div><div id="a17353" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:857px;">increases in labor costs; </div><div id="a17355" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:875px;">•</div><div id="a17357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:875px;">increases in health care costs; </div><div id="a17359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:893px;">•</div><div id="a17361" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:893px;">our aspirations, goals and disclosures related to environmental, social and<div style="display:inline-block;width:2px">&nbsp;</div>governance (ESG) matters; </div><div id="a17363" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:911px;">•</div><div id="a17365" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:911px;">the threat or outbreak of war, terrorism or public unrest (including, without limitation, the war in </div><div id="a17369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:929px;">Ukraine and the possibility of a wider European or global conflict);<div style="display:inline-block;width:2px">&nbsp;</div>and<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17375" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:947px;">•</div><div id="a17377" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:947px;">changes in laws and policies governing manufacturing, development and<div style="display:inline-block;width:2px">&nbsp;</div>investment in territories and </div><div id="a17378" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:964px;">countries where we do business. </div></div>
</div>
<div style="padding: 7px">
<div id="Page31" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a17382" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a17385" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">31 </div><div id="a17387" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">Additionally, changes in government, government debt and/or budget crises may lead to reductions in government </div><div id="a17389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">spending in certain countries, which could reduce overall health care spending,<div style="display:inline-block;width:2px">&nbsp;</div>and/or higher income or corporate </div><div id="a17390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">taxes, which could depress spending overall.<div style="display:inline-block;width:7px">&nbsp;</div>Recessionary or inflationary conditions and depressed levels of </div><div id="a17396" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">consumer and commercial spending may also cause customers to<div style="display:inline-block;width:2px">&nbsp;</div>reduce, modify, delay or cancel plans to purchase </div><div id="a17397" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">our products and may cause suppliers to reduce their output or change<div style="display:inline-block;width:2px">&nbsp;</div>their terms of sale. We have experienced </div><div id="a17400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">inflationary pressures, including higher freight costs and interest expense.<div style="display:inline-block;width:6px">&nbsp;</div>Although inflation impacts both our </div><div id="a17401" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">revenues and costs, the depth and breadth of our product portfolio often<div style="display:inline-block;width:2px">&nbsp;</div>allows us to offer lower-cost national brand </div><div id="a17404" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">solutions or corporate brand alternatives to our more price-sensitive<div style="display:inline-block;width:2px">&nbsp;</div>customers who are unable to absorb price </div><div id="a17407" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">increases, thus positioning us to protect our gross profit.<div style="display:inline-block;width:6px">&nbsp;</div>The strengthening of the dollar, likewise, has impacted </div><div id="a17408" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">our revenues and costs, but neither inflation nor exchange rates have materially<div style="display:inline-block;width:2px">&nbsp;</div>impacted our results of operations </div><div id="a17410" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">in fiscal year 2022.<div style="display:inline-block;width:7px">&nbsp;</div>We generally sell products to customers with payment terms.<div style="display:inline-block;width:7px">&nbsp;</div>If customers’ cash flow or </div><div id="a17414" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">operating and financial performance deteriorate, or if they are unable to make scheduled<div style="display:inline-block;width:2px">&nbsp;</div>payments or obtain credit, </div><div id="a17416" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">they may not be able to, or may delay, payment to us.<div style="display:inline-block;width:7px">&nbsp;</div>Likewise, for similar reasons suppliers may restrict credit or </div><div id="a17419" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">impose different payment terms. </div><div id="a17422" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:313px;">REGULATORY<div style="display:inline-block;width:5px">&nbsp;</div>AND LITIGATION RISKS </div><div id="a17427" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:346px;">Failure to comply with existing and future regulatory requirements<div style="display:inline-block;width:2px">&nbsp;</div>could materially adversely affect our </div><div id="a17428" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:363px;">business. </div><div id="a17431" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">We strive to be compliant with the applicable laws, regulations and guidance described below in all material </div><div id="a17434" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">respects, and believe we have effective compliance programs and other controls<div style="display:inline-block;width:2px">&nbsp;</div>in place to ensure substantial </div><div id="a17438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">compliance.<div style="display:inline-block;width:7px">&nbsp;</div>However, compliance is not guaranteed either now or in the future as certain laws, regulations<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a17441" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">guidance may be subject to varying and evolving interpretations that could<div style="display:inline-block;width:2px">&nbsp;</div>affect our ability to comply, as well as, </div><div id="a17443" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">future changes, additions and enforcement approaches, including in light<div style="display:inline-block;width:2px">&nbsp;</div>of political changes.<div style="display:inline-block;width:7px">&nbsp;</div>When we discover </div><div id="a17445" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">situations of non-compliance we seek to remedy them and bring<div style="display:inline-block;width:2px">&nbsp;</div>the affected area back into compliance.<div style="display:inline-block;width:7px">&nbsp;</div>The Biden </div><div id="a17454" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">Administration has indicated that it will be more aggressive in its pursuing<div style="display:inline-block;width:2px">&nbsp;</div>alleged violations of law, and it has </div><div id="a17455" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">revoked certain guidance that would have limited governmental use of informal<div style="display:inline-block;width:2px">&nbsp;</div>agency guidance to pursue such </div><div id="a17456" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">violations, as well as indicating it was more prepared to pursue individuals<div style="display:inline-block;width:2px">&nbsp;</div>for corporate law violations, including </div><div id="a17458" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">an aggressive approach to anti-corruption activities.<div style="display:inline-block;width:6px">&nbsp;</div>Changes with respect to the applicable laws, regulations and </div><div id="a17461" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">guidance described below may require us to update or revise our operations,<div style="display:inline-block;width:2px">&nbsp;</div>services, marketing practices, and </div><div id="a17463" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">compliance programs and controls, and may impose additional and unforeseen<div style="display:inline-block;width:2px">&nbsp;</div>costs on us, pose new or previously </div><div id="a17464" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">immaterial risks to us, or may otherwise have a material adverse effect on our business.<div style="display:inline-block;width:6px">&nbsp;</div>There can be no assurance </div><div id="a17468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">that current and future government regulations will not adversely<div style="display:inline-block;width:2px">&nbsp;</div>affect our business, and we cannot predict new </div><div id="a17469" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">regulatory priorities, the form, content or timing of regulatory actions,<div style="display:inline-block;width:2px">&nbsp;</div>and their impact on the health care industry </div><div id="a17471" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">and on our business and operations. </div><div id="a17474" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">Global efforts toward healthcare cost containment continue to exert pressure on<div style="display:inline-block;width:2px">&nbsp;</div>product pricing.<div style="display:inline-block;width:7px">&nbsp;</div>In the United </div><div id="a17475" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">States, in addition to other government efforts to control health care costs, there has been increased<div style="display:inline-block;width:2px">&nbsp;</div>scrutiny on drug </div><div id="a17477" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">pricing and concurrent efforts to control or reduce drug costs by Congress, the President,<div style="display:inline-block;width:2px">&nbsp;</div>executive branch agencies </div><div id="a17478" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">and various states.<div style="display:inline-block;width:7px">&nbsp;</div>At the state level, several states have adopted laws that require drug manufacturers<div style="display:inline-block;width:2px">&nbsp;</div>to provide </div><div id="a17482" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">advance notice of certain price increases and to report information<div style="display:inline-block;width:2px">&nbsp;</div>relating to those price increases, while others </div><div id="a17483" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">have taken legislative or administrative action to establish prescription drug<div style="display:inline-block;width:2px">&nbsp;</div>affordability boards or multi-payer </div><div id="a17487" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">purchasing pools to reduce the cost of prescription drugs.<div style="display:inline-block;width:6px">&nbsp;</div>At the federal level, several related bills have been </div><div id="a17488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">introduced and regulations proposed which, if enacted or finalized,<div style="display:inline-block;width:2px">&nbsp;</div>respectively, would impact drug pricing and </div><div id="a17490" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">related costs. </div><div id="a17494" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">Under the Sunshine Act, we are required to collect and report detailed<div style="display:inline-block;width:2px">&nbsp;</div>information regarding certain financial </div><div id="a17495" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">relationships we have with covered recipients, including physicians, dentists,<div style="display:inline-block;width:2px">&nbsp;</div>teaching hospitals, and certain other </div><div id="a17496" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">non-physician practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>We and our subsidiaries may be required to report information under certain state </div><div id="a17501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">transparency laws that address circumstances not covered by the Sunshine<div style="display:inline-block;width:2px">&nbsp;</div>Act, and some of these state laws, as </div><div id="a17502" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">well as the federal law, can be unclear.<div style="display:inline-block;width:8px">&nbsp;</div>We are also subject to foreign regulations requiring transparency of certain </div><div id="a17504" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">interactions between suppliers and their customers.<div style="display:inline-block;width:6px">&nbsp;</div>While we believe we have substantially compliant programs </div><div id="a17505" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">and controls in place satisfying the above laws and requirements, such<div style="display:inline-block;width:2px">&nbsp;</div>compliance imposes additional costs on us </div><div id="a17507" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">and the requirements are sometimes unclear.<div style="display:inline-block;width:7px">&nbsp;</div>In the United States, government actions to seek to increase health-</div><div id="a17530" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">related price transparency may also affect our business. </div></div>
</div>
<div style="padding: 7px">
<div id="Page32" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a17546" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a17549" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">32 </div><div id="a17552" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">Our business is subject to additional requirements under various local, state,<div style="display:inline-block;width:2px">&nbsp;</div>federal and international laws and </div><div id="a17554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">regulations applicable to the sale and distribution of, and third-party payment<div style="display:inline-block;width:2px">&nbsp;</div>for, pharmaceuticals and medical </div><div id="a17557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">devices and HCT/P products.<div style="display:inline-block;width:7px">&nbsp;</div>Among the federal laws with which we must comply are the Controlled Substances </div><div id="a17559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Act, the FDC Act, the Federal Drug Quality and Security Act, including DSCSA,<div style="display:inline-block;width:2px">&nbsp;</div>Section 361 of the Public Health </div><div id="a17561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">Services Act and Section 401 of the Consolidated Appropriations Act<div style="display:inline-block;width:2px">&nbsp;</div>of the Social Security Act.<div style="display:inline-block;width:7px">&nbsp;</div>Among other </div><div id="a17567" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">things, such laws, and the regulations promulgated thereunder:<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a17571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:195px;">•</div><div id="a17573" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:195px;">regulate the introduction, manufacture, advertising, marketing and promotion,<div style="display:inline-block;width:2px">&nbsp;</div>sampling, pricing and </div><div id="a17574" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:213px;">reimbursement, labeling, packaging, storage, handling, returning or<div style="display:inline-block;width:2px">&nbsp;</div>recalling, reporting, and </div><div id="a17576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:230px;">distribution of, and record keeping for drugs, HCT/P products and<div style="display:inline-block;width:2px">&nbsp;</div>medical devices,<div style="display:inline-block;width:3px">&nbsp;</div>including </div><div id="a17581" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:248px;">requirements with respect to unique medical device identifiers; </div><div id="a17598" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:266px;">•</div><div id="a17600" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:266px;">subject us to inspection by the FDA and DEA and similar state authorities; </div><div id="a17605" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:284px;">•</div><div id="a17607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:284px;">regulate the storage, transportation and disposal of certain of our products<div style="display:inline-block;width:2px">&nbsp;</div>that are considered </div><div id="a17610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:302px;">hazardous materials; </div><div id="a17612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:320px;">•</div><div id="a17614" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:320px;">require us to advertise and promote our drugs and devices in accordance<div style="display:inline-block;width:2px">&nbsp;</div>with applicable FDA </div><div id="a17615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:338px;">requirements; </div><div id="a17617" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:355px;">•</div><div id="a17619" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:355px;">require us to report average sales price (ASP) for drugs or biologicals payable<div style="display:inline-block;width:2px">&nbsp;</div>under Medicare Part B to </div><div id="a17621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:373px;">CMS with or without a Medicaid drug rebate agreement; </div><div id="a17623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:391px;">•</div><div id="a17625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:391px;">require registration with the FDA and the DEA and various state agencies; </div><div id="a17627" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:409px;">•</div><div id="a17629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:409px;">require record keeping and documentation of transactions involving drug<div style="display:inline-block;width:2px">&nbsp;</div>products; </div><div id="a17631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:427px;">•</div><div id="a17633" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:427px;">require us to design and operate a system to identify and report suspicious<div style="display:inline-block;width:2px">&nbsp;</div>orders of controlled </div><div id="a17634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:445px;">substances to the DEA and certain states; </div><div id="a17639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:462px;">•</div><div id="a17641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:462px;">require us to manage returns of products that have been recalled and subject<div style="display:inline-block;width:2px">&nbsp;</div>us to inspection of our </div><div id="a17643" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:480px;">recall procedures and activities;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:498px;">•</div><div id="a17647" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:498px;">impose on us reporting requirements if a pharmaceutical, HCT/P product or<div style="display:inline-block;width:2px">&nbsp;</div>medical device causes </div><div id="a17648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:516px;">serious illness, injury or death; </div><div id="a17650" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:534px;">•</div><div id="a17652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:534px;">require manufacturers, wholesalers, repackagers and dispensers of prescription<div style="display:inline-block;width:2px">&nbsp;</div>drugs to identify and </div><div id="a17677" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:552px;">trace certain prescription drugs as they are distributed;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17694" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:570px;">•</div><div id="a17696" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:570px;">require the licensing of prescription drug wholesalers and third-party<div style="display:inline-block;width:2px">&nbsp;</div>logistics providers; and<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a17722" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:587px;">•</div><div id="a17724" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:587px;">mandate compliance with standards for the recordkeeping, storage<div style="display:inline-block;width:2px">&nbsp;</div>and handling of prescription drugs, </div><div id="a17750" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:605px;">and associated reporting requirements. </div><div id="a17759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:651px;">The FDA has become increasingly active in addressing the regulation of<div style="display:inline-block;width:2px">&nbsp;</div>computer software and digital health </div><div id="a17791" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">products intended for use in health care settings.<div style="display:inline-block;width:6px">&nbsp;</div>The Cures Act, signed into law on December 13, 2016, among </div><div id="a17830" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">other things, amended the medical device definition to exclude certain software<div style="display:inline-block;width:2px">&nbsp;</div>from FDA regulation, including </div><div id="a17860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">certain clinical decision support software.<div style="display:inline-block;width:7px">&nbsp;</div>On September 27, 2019, the FDA issued a suite of guidance documents </div><div id="a17895" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">on digital health products, which incorporated applicable Cures Act standards,<div style="display:inline-block;width:2px">&nbsp;</div>and on September 28, 2022, the </div><div id="a17928" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:735px;">FDA subsequently finalized certain of these guidance documents, including<div style="display:inline-block;width:2px">&nbsp;</div>regarding the types of clinical decision </div><div id="a17944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:752px;">support tools and other software that are exempt from regulation by the FDA as<div style="display:inline-block;width:2px">&nbsp;</div>medical devices, and the FDA </div><div id="a17982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:769px;">continues to issue new guidance in this area.<div style="display:inline-block;width:7px">&nbsp;</div>Certain of our businesses involve the development and<div style="display:inline-block;width:2px">&nbsp;</div>sale of </div><div id="a18018" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:786px;">software and related products to support physician and dental practice management,<div style="display:inline-block;width:2px">&nbsp;</div>and it is possible that the FDA </div><div id="a18055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">or foreign government authorities could determine that one or more of our products<div style="display:inline-block;width:2px">&nbsp;</div>is subject to regulation as a </div><div id="a18093" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">medical device, which could subject us or one or more of our businesses to<div style="display:inline-block;width:2px">&nbsp;</div>substantial additional requirements, </div><div id="a18128" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">costs and potential enforcement actions or liabilities for noncompliance with<div style="display:inline-block;width:2px">&nbsp;</div>respect to these products. </div><div id="a18157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:870px;">Applicable federal, state, local and foreign laws and regulations also may require<div style="display:inline-block;width:2px">&nbsp;</div>us to meet various standards </div><div id="a18159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:887px;">relating to, among other things, licensure or registration, program eligibility, procurement, third-party </div><div id="a18162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:904px;">reimbursement, sales and marketing practices, product integrity and<div style="display:inline-block;width:2px">&nbsp;</div>supply tracking to product manufacturers, </div><div id="a18163" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">product labeling, personnel, privacy and security of health or other personal<div style="display:inline-block;width:2px">&nbsp;</div>information, installation, maintenance </div><div id="a18165" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">and repair of equipment and the importation and exportation of products.<div style="display:inline-block;width:6px">&nbsp;</div>The FDA and DEA, as well as CMS </div><div id="a18168" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">(including with respect to complex Medicare reimbursement requirements<div style="display:inline-block;width:2px">&nbsp;</div>applicable to our specialty home medical </div><div id="a18170" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">supplies business), have recently increased their regulatory and enforcement<div style="display:inline-block;width:2px">&nbsp;</div>activities and, in particular, the DEA </div><div id="a18171" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:988px;">has heightened enforcement activities due to the opioid crisis in the United States.<div style="display:inline-block;width:6px">&nbsp;</div>One of our businesses was </div></div>
</div>
<div style="padding: 7px">
<div id="Page33" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a18176" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a18179" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">33 </div><div id="a18181" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">suspended in October 2021 by CMS from receiving payments from<div style="display:inline-block;width:2px">&nbsp;</div>Medicare, although it was permitted to continue </div><div id="a18182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">to perform and bill for Medicare services.<div style="display:inline-block;width:7px">&nbsp;</div>On September 30, 2022, CMS terminated the suspension of Medicare </div><div id="a18204" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">payments.<div style="display:inline-block;width:7px">&nbsp;</div>As a result of the termination of the suspension, we recognized $4<div style="display:inline-block;width:2px">&nbsp;</div>million of previously deferred </div><div id="a18238" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">revenue during the year ended December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Our business is also subject to requirements of similar and </div><div id="a18255" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">other foreign governmental laws and regulations affecting our operations abroad. </div><div id="a18259" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">The failure to comply with any of these laws or regulations, or new interpretations<div style="display:inline-block;width:2px">&nbsp;</div>of existing laws and regulations, </div><div id="a18263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">or the imposition of any additional laws and regulations, could<div style="display:inline-block;width:2px">&nbsp;</div>materially adversely affect our business.<div style="display:inline-block;width:7px">&nbsp;</div>The costs </div><div id="a18265" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">to us associated with complying with the various applicable statutes<div style="display:inline-block;width:2px">&nbsp;</div>and regulations, as they now exist and as they </div><div id="a18266" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">may be modified, could be material.<div style="display:inline-block;width:7px">&nbsp;</div>Allegations by a governmental body that we have not complied with<div style="display:inline-block;width:2px">&nbsp;</div>these </div><div id="a18268" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">laws could have a material adverse effect on our businesses.<div style="display:inline-block;width:6px">&nbsp;</div>While we believe that we are substantially compliant </div><div id="a18269" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">with applicable laws and regulations, and believe we have adequate<div style="display:inline-block;width:2px">&nbsp;</div>compliance programs and controls in place to </div><div id="a18270" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">ensure substantial compliance, if it is determined that we have not complied<div style="display:inline-block;width:2px">&nbsp;</div>with these laws, we are potentially </div><div id="a18272" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">subject to warning letters, substantial civil and criminal penalties,<div style="display:inline-block;width:2px">&nbsp;</div>mandatory recall of product, seizure of product </div><div id="a18275" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">and injunction, consent decrees and suspension or limitation of payments<div style="display:inline-block;width:2px">&nbsp;</div>to us, product sale and distribution.<div style="display:inline-block;width:6px">&nbsp;</div>If we </div><div id="a18279" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">enter into settlement agreements to resolve allegations of non-compliance, we<div style="display:inline-block;width:2px">&nbsp;</div>could be required to make settlement </div><div id="a18282" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">payments or be subject to civil and criminal penalties, including fines<div style="display:inline-block;width:2px">&nbsp;</div>and the loss of licenses.<div style="display:inline-block;width:7px">&nbsp;</div>Non-compliance </div><div id="a18287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">with government requirements could also adversely affect our ability to participate<div style="display:inline-block;width:2px">&nbsp;</div>in important federal and state </div><div id="a18288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">government health care programs, such as Medicare and Medicaid,<div style="display:inline-block;width:2px">&nbsp;</div>and damage our reputation. </div><div id="a18291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:397px;">The EU Medical Device Regulation may adversely affect our business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a18294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">The EU MDR, applicable since May 26, 2021, significantly modifies and intensifies<div style="display:inline-block;width:2px">&nbsp;</div>the regulatory compliance </div><div id="a18324" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">requirements for the medical device industry as a whole.<div style="display:inline-block;width:6px">&nbsp;</div>Among other things, the EU MDR: </div><div id="a18356" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:482px;">•</div><div id="a18358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:482px;">strengthens the rules on placing devices on the market and reinforce surveillance once<div style="display:inline-block;width:2px">&nbsp;</div>they are </div><div id="a18390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:499px;">available; </div><div id="a18392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:517px;">•</div><div id="a18394" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:517px;">establishes explicit provisions on manufacturers’<div style="display:inline-block;width:3px">&nbsp;</div>responsibilities for the follow-up of the quality, </div><div id="a18423" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:535px;">performance and safety of devices placed on the market; </div><div id="a18442" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:553px;">•</div><div id="a18444" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:553px;">improves the traceability of medical devices throughout the supply chain to the end-user<div style="display:inline-block;width:2px">&nbsp;</div>or patient </div><div id="a18478" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:571px;">through a unique identification number; </div><div id="a18488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:589px;">•</div><div id="a18490" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:589px;">sets up a central database to provide patients, healthcare professionals and<div style="display:inline-block;width:2px">&nbsp;</div>the public with </div><div id="a18520" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:607px;">comprehensive information on products available in the EU;<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a18537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:624px;">•</div><div id="a18539" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:624px;">strengthens rules for the assessment of certain high-risk devices, such<div style="display:inline-block;width:2px">&nbsp;</div>as implants, which may have to </div><div id="a18575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:642px;">undergo an additional check by experts before they are placed on the market; and </div><div id="a18603" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:660px;">•</div><div id="a18605" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:660px;">identifies importers and distributors and medical device products through<div style="display:inline-block;width:2px">&nbsp;</div>registration in a database </div><div id="a18611" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:678px;">(EUDAMED not due until 2024 and after as mentioned above).<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a18625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:723px;">In particular, the EU MDR imposes strict requirements for the confirmation that a product<div style="display:inline-block;width:2px">&nbsp;</div>meets the regulatory </div><div id="a18627" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:740px;">requirements, including regarding a product’s clinical evaluation and a company’s quality systems, and for the </div><div id="a18628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:757px;">distribution, marketing and sale of medical devices, including post-market surveillance.<div style="display:inline-block;width:2px">&nbsp;</div>Medical devices that have </div><div id="a18631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:774px;">been assessed and/or certified under the EU Medical Device Directive<div style="display:inline-block;width:2px">&nbsp;</div>may continue to be placed on the market </div><div id="a18633" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:791px;">until 2024 (or until the expiry of their certificates, if applicable and earlier).<div style="display:inline-block;width:2px">&nbsp;</div>However, on January 6, 2023, the EU </div><div id="a18634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:808px;">Commission submitted a proposed amendment to extend the MDR transitional<div style="display:inline-block;width:2px">&nbsp;</div>periods until December 31, 2028, </div><div id="a18636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:824px;">for certain medical devices to ensure continued access to medical devices<div style="display:inline-block;width:2px">&nbsp;</div>for patients and to allow medical devices </div><div id="a18637" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:841px;">already placed on the market in accordance with the current legal framework<div style="display:inline-block;width:2px">&nbsp;</div>to remain on the market. We continue </div><div id="a18639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:858px;">to monitor developments and whether the proposed amendment and<div style="display:inline-block;width:2px">&nbsp;</div>new deadlines will be approved by the </div><div id="a18640" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:875px;">European Parliament and Council. Nevertheless, EU MDR requirements<div style="display:inline-block;width:2px">&nbsp;</div>regarding the distribution, marketing and </div><div id="a18641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:892px;">sale including quality systems and post-market surveillance have to be observed<div style="display:inline-block;width:2px">&nbsp;</div>by manufacturers, importers and </div><div id="a18645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:909px;">distributors as of the application date (i.e., May 26, 2021). </div><div id="a18648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:942px;">The modifications created by the EU MDR may have an impact on the<div style="display:inline-block;width:2px">&nbsp;</div>way we design and manufacture products </div><div id="a18654" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:959px;">and the way we conduct our business in the European Economic Area. </div></div>
</div>
<div style="padding: 7px">
<div id="Page34" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a18657" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a18660" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">34 </div><div id="a18662" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:60px;">If we fail to comply with laws and regulations relating to health care<div style="display:inline-block;width:2px">&nbsp;</div>fraud or other laws and regulations, we </div><div id="a18663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:76px;">could suffer penalties or be required to make significant changes to our operations,<div style="display:inline-block;width:2px">&nbsp;</div>which could materially </div><div id="a18665" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:93px;">adversely affect our business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a18668" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Certain of our businesses are subject to federal and state (and similar<div style="display:inline-block;width:2px">&nbsp;</div>foreign) health care fraud and abuse, referral </div><div id="a18706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">and reimbursement laws and regulations with<div style="display:inline-block;width:3px">&nbsp;</div>respect to their operations.<div style="display:inline-block;width:7px">&nbsp;</div>Some of these laws, referred to as “false </div><div id="a18743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">claims laws,” prohibit the submission or causing the submission of false or fraudulent<div style="display:inline-block;width:2px">&nbsp;</div>claims for reimbursement to </div><div id="a18777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">federal, state and other health care payers and programs.<div style="display:inline-block;width:6px">&nbsp;</div>Other laws, referred to as “anti-kickback laws,” prohibit </div><div id="a18814" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">soliciting, offering, receiving or paying remuneration in order to induce the referral<div style="display:inline-block;width:2px">&nbsp;</div>of a patient or ordering, </div><div id="a18848" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">purchasing, leasing or arranging for, or recommending ordering, purchasing or leasing of, items or services<div style="display:inline-block;width:2px">&nbsp;</div>that are </div><div id="a18883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">paid for by federal, state and other health care payers and programs.<div style="display:inline-block;width:6px">&nbsp;</div>Certain additional state and federal laws, such </div><div id="a18921" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">as the federal Physician Self-Referral Law, commonly known as the “Stark Law,” prohibit physicians and other </div><div id="a18955" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">health professionals from referring a patient to an entity with which the<div style="display:inline-block;width:2px">&nbsp;</div>physician (or family member) has a </div><div id="a18992" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">financial relationship, for the furnishing of certain designated health services<div style="display:inline-block;width:2px">&nbsp;</div>(for example, durable medical </div><div id="a19020" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">equipment and medical supplies), unless an exception applies.<div style="display:inline-block;width:6px">&nbsp;</div>Violations of Anti-Kickback statutes or the Stark </div><div id="a19052" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">Law may be enforced as violations of the federal False Claims Act. </div><div id="a19077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">The fraud and abuse laws and regulations have been subject to heightened<div style="display:inline-block;width:2px">&nbsp;</div>enforcement activity over the past few </div><div id="a19113" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">years, and significant enforcement activity has been the result of “relators” who<div style="display:inline-block;width:2px">&nbsp;</div>serve as whistleblowers by filing </div><div id="a19147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">complaints in the name of the United States (and if applicable, particular states)<div style="display:inline-block;width:2px">&nbsp;</div>under applicable false claims laws, </div><div id="a19183" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">and who may receive up to 30% of total government recoveries.<div style="display:inline-block;width:6px">&nbsp;</div>Penalties under fraud and abuse laws may be </div><div id="a19222" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">severe, including treble damages and substantial civil penalties under<div style="display:inline-block;width:2px">&nbsp;</div>the federal False Claims Act, as well as </div><div id="a19256" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">potential loss of licenses and the ability to participate in federal and state<div style="display:inline-block;width:2px">&nbsp;</div>health care programs, criminal penalties, </div><div id="a19292" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">or imposition of a corporate compliance monitor, which could have a material adverse effect on our business.<div style="display:inline-block;width:6px">&nbsp;</div>Also, </div><div id="a19328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">these measures may be interpreted or applied by a prosecutorial, regulatory or<div style="display:inline-block;width:2px">&nbsp;</div>judicial authority in a manner that </div><div id="a19365" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">could require us to make changes in our operations or incur substantial defense<div style="display:inline-block;width:2px">&nbsp;</div>and settlement expenses.<div style="display:inline-block;width:7px">&nbsp;</div>Even </div><div id="a19399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">unsuccessful challenges by regulatory authorities or private relators could result<div style="display:inline-block;width:2px">&nbsp;</div>in reputational harm and the </div><div id="a19429" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">incurring of substantial costs.<div style="display:inline-block;width:7px">&nbsp;</div>Most states have adopted similar state false claims laws, and these state<div style="display:inline-block;width:2px">&nbsp;</div>laws have </div><div id="a19465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">their own penalties which may be in addition to federal False Claims<div style="display:inline-block;width:2px">&nbsp;</div>Act penalties, as well as other fraud and abuse </div><div id="a19507" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">laws.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a19511" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">With respect to measures of this type, the United States government (among others) has expressed concerns<div style="display:inline-block;width:2px">&nbsp;</div>about </div><div id="a19546" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">financial relationships between suppliers on the one hand and physicians,<div style="display:inline-block;width:2px">&nbsp;</div>dentists and other health care providers, </div><div id="a19579" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">on the other.<div style="display:inline-block;width:8px">&nbsp;</div>As a result, we regularly review and revise our marketing practices<div style="display:inline-block;width:2px">&nbsp;</div>as necessary to facilitate </div><div id="a19617" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">compliance. </div><div id="a19620" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">In the EU, the Directive No. 2019/1937 of October 23, 2019, </div><div id="a19622" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:429px;top:667px;">on the protection of persons who report breaches of </div><div id="a19623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:684px;">Union law,</div><div id="a19624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:133px;top:684px;"><div style="display:inline-block;width:7px">&nbsp;</div>organizes the legal protection of whistleblowers. This Directive covers whistleblowers<div style="display:inline-block;width:2px">&nbsp;</div>reporting </div><div id="a19628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">breaches of certain EU laws, in particular as regards public health, the above-mentioned<div style="display:inline-block;width:2px">&nbsp;</div>Directive No. 2001/83, </div><div id="a19631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">Regulation No. 726/2004 or, as regards data protection, the GDPR. The Directive protects a wide range of<div style="display:inline-block;width:2px">&nbsp;</div>people </div><div id="a19633" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">and includes former employees. All private companies with 50 or<div style="display:inline-block;width:2px">&nbsp;</div>more employees are required to create effective </div><div id="a19634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">internal reporting channels. Though it was required before December 17, 2021,<div style="display:inline-block;width:2px">&nbsp;</div>at the latest, the implementation of </div><div id="a19635" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">this Directive by EU member states is still underway for some of<div style="display:inline-block;width:2px">&nbsp;</div>them. At the end of January 2023 and according </div><div id="a19637" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">to information available on public sources, sixteen EU member states have<div style="display:inline-block;width:2px">&nbsp;</div>fully implemented it (France, Belgium, </div><div id="a19638" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">Denmark, Finland, Latvia, The Netherlands, Ireland, Croatia, Cyprus, Greece, Lithuania,<div style="display:inline-block;width:2px">&nbsp;</div>Romania, Malta, Portugal, </div><div id="a19640" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">Sweden and Bulgaria) while the process is ongoing in the others with varying<div style="display:inline-block;width:2px">&nbsp;</div>degrees of progress.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a19643" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">We also are subject to the requirements of the new Directive No. 2022/2464 on corporate sustainability reporting </div><div id="a19645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">("CSR Directive") adopted on December 14, 2022 and has to be<div style="display:inline-block;width:2px">&nbsp;</div>implemented by EU members states by July 6, </div><div id="a19646" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">2024, at the latest. By amending Directives No. 2004/109, No. 2006/43, No.<div style="display:inline-block;width:2px">&nbsp;</div>2013/34 and Regulation No. 537/2014, </div><div id="a19647" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">the CSR Directive strengthens the existing rules on non-financial<div style="display:inline-block;width:2px">&nbsp;</div>reporting by setting new requirements for large </div><div id="a19651" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">companies to publish sustainability-related information and, in particular, disclose details about their<div style="display:inline-block;width:2px">&nbsp;</div>risks and </div><div id="a19654" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">impacts on environmental matters. </div><div id="a19657" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">We </div><div id="a19659" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:971px;">also are subject to certain United States and foreign laws and regulations<div style="display:inline-block;width:2px">&nbsp;</div>concerning the conduct of our foreign </div><div id="a19695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">operations, including the U.S. Foreign Corrupt Practices Act, the U.K. Bribery<div style="display:inline-block;width:2px">&nbsp;</div>Act, German anti-corruption laws </div></div>
</div>
<div style="padding: 7px">
<div id="Page35" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a19727" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a19730" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">35 </div><div id="a19732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">and other anti-bribery laws and laws pertaining to the accuracy of our internal<div style="display:inline-block;width:2px">&nbsp;</div>books and records, which have been </div><div id="a19772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">the focus of increasing enforcement activity globally in recent years.<div style="display:inline-block;width:6px">&nbsp;</div>Our businesses are generally subject to </div><div id="a19804" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">numerous other laws and regulations that could impact our financial<div style="display:inline-block;width:2px">&nbsp;</div>results, including, without limitation, </div><div id="a19832" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">securities, antitrust, consumer protection, and marketing laws and regulations. </div><div id="a19851" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">In the EU, both active and passive bribery are criminalized.<div style="display:inline-block;width:6px">&nbsp;</div>The EU Council Framework Decision 2003/568/JHA </div><div id="a19883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">of 22 July 2003</div><div id="a19890" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:159px;top:161px;"><div style="display:inline-block;width:4px">&nbsp;</div>on combating corruption in the private sector </div><div id="a19905" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:434px;top:161px;">establishes more detailed rules on the liability of </div><div id="a19921" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">legal persons and deterrent sanctions.<div style="display:inline-block;width:7px">&nbsp;</div>However, the liability of legal persons is regulated at a national level. </div><div id="a19956" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">Failure to comply with fraud and abuse laws and regulations, and other<div style="display:inline-block;width:2px">&nbsp;</div>laws and regulations, could result in </div><div id="a19959" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">significant civil and criminal penalties and costs, including the loss of<div style="display:inline-block;width:2px">&nbsp;</div>licenses and the ability to participate in </div><div id="a19960" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">federal and state health care programs, and could have a material adverse<div style="display:inline-block;width:2px">&nbsp;</div>effect on our business.<div style="display:inline-block;width:7px">&nbsp;</div>We may </div><div id="a19962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">determine to enter into settlements, make payments, agree to consent decrees<div style="display:inline-block;width:2px">&nbsp;</div>or enter into other arrangements to </div><div id="a19963" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">resolve such matters.<div style="display:inline-block;width:7px">&nbsp;</div>Intentional or unintentional failure to comply with consent decrees could<div style="display:inline-block;width:2px">&nbsp;</div>materially adversely </div><div id="a19967" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">affect our business. </div><div id="a19970" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">While we believe that we are substantially compliant with applicable fraud and<div style="display:inline-block;width:2px">&nbsp;</div>abuse and other laws and </div><div id="a20004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">regulations, and believe we have adequate compliance programs and controls<div style="display:inline-block;width:2px">&nbsp;</div>in place to ensure substantial </div><div id="a20034" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">compliance, we cannot predict whether changes in applicable law, or interpretation of laws, or changes in our </div><div id="a20068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">services or marketing practices in response to changes in applicable law or<div style="display:inline-block;width:2px">&nbsp;</div>interpretation of laws, could have a </div><div id="a20104" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">material adverse effect on our business. </div><div id="a20117" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:431px;">If we fail to comply with laws and regulations relating to the collection,<div style="display:inline-block;width:2px">&nbsp;</div>storage and processing of sensitive </div><div id="a20120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:448px;">personal information or standards in electronic health records or transmissions,<div style="display:inline-block;width:2px">&nbsp;</div>we could be required to make </div><div id="a20121" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:464px;">significant changes to our products, or incur substantial fines, penalties or<div style="display:inline-block;width:2px">&nbsp;</div>other liabilities.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">Our businesses that involve physician and dental practice management<div style="display:inline-block;width:2px">&nbsp;</div>products, and our specialty home medical </div><div id="a20127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">supply business, include electronic information technology systems that<div style="display:inline-block;width:2px">&nbsp;</div>store and process personal health, clinical, </div><div id="a20129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">financial and other sensitive information of individuals.<div style="display:inline-block;width:6px">&nbsp;</div>These information technology systems may be vulnerable </div><div id="a20130" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">to breakdown, wrongful intrusions, data breaches and malicious attack,<div style="display:inline-block;width:2px">&nbsp;</div>which could require us to expend </div><div id="a20131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">significant resources to eliminate these problems and address related security<div style="display:inline-block;width:2px">&nbsp;</div>concerns, and could involve claims </div><div id="a20133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">against us by private parties and/or governmental agencies. </div><div id="a20136" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">We are directly or indirectly subject to numerous and evolving federal, state, local and foreign laws and regulations </div><div id="a20138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">that protect the privacy and security of personal information, such as HIPAA, the Controlling the Assault of Non-</div><div id="a20153" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">Solicited Pornography and Marketing Act, the Telephone Consumer Protection Act of 1991, Section 5 of the </div><div id="a20185" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">Federal Trade Commission Act, the CCPA, and the CPRA that becomes effective on January 1, 2023.<div style="display:inline-block;width:8px">&nbsp;</div>Laws and </div><div id="a20222" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">regulations relating to privacy and data protection are continually evolving<div style="display:inline-block;width:2px">&nbsp;</div>and subject to potentially differing </div><div id="a20252" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">interpretations.<div style="display:inline-block;width:7px">&nbsp;</div>These requirements<div style="display:inline-block;width:3px">&nbsp;</div>may not be harmonized, may be interpreted and applied in a<div style="display:inline-block;width:2px">&nbsp;</div>manner that is </div><div id="a20287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">inconsistent from one jurisdiction to another or may conflict with other<div style="display:inline-block;width:2px">&nbsp;</div>rules or our practices.<div style="display:inline-block;width:7px">&nbsp;</div>Our businesses’ </div><div id="a20321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">failure to comply with these laws and regulations could expose us to breach of<div style="display:inline-block;width:2px">&nbsp;</div>contract claims, substantial fines, </div><div id="a20357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">penalties and other liabilities and expenses, costs for remediation and harm to<div style="display:inline-block;width:2px">&nbsp;</div>our reputation.<div style="display:inline-block;width:7px">&nbsp;</div>Also, evolving laws </div><div id="a20391" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">and regulations in this area could restrict the ability of our customers to obtain,<div style="display:inline-block;width:2px">&nbsp;</div>use or disseminate patient </div><div id="a20427" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">information, or could require us to incur significant additional costs to<div style="display:inline-block;width:2px">&nbsp;</div>re-design our products to reflect these legal </div><div id="a20465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">requirements, which could have a material adverse effect on our operations. </div><div id="a20488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">In addition, the European Parliament and the Council of the EU adopted<div style="display:inline-block;width:2px">&nbsp;</div>the GDPR effective from May 25, 2018, </div><div id="a20490" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">which increased privacy rights for individuals (“Data Subjects”), including<div style="display:inline-block;width:2px">&nbsp;</div>individuals who are our customers, </div><div id="a20491" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">suppliers and employees.<div style="display:inline-block;width:7px">&nbsp;</div>The GDPR extended the scope of responsibilities for data controllers and data </div><div id="a20493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">processors, and generally imposes increased requirements and potential<div style="display:inline-block;width:2px">&nbsp;</div>penalties on companies, such as us, that are </div><div id="a20494" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">either established in the EU and process personal data of Data Subjects<div style="display:inline-block;width:2px">&nbsp;</div>(regardless the Data Subject location), or </div><div id="a20496" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">that are not established in the EU but that offer goods or services to Data Subjects<div style="display:inline-block;width:2px">&nbsp;</div>in the EU or monitor their </div><div id="a20497" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">behavior in the EU. Noncompliance can result in penalties of up to<div style="display:inline-block;width:2px">&nbsp;</div>the greater of EUR 20 million, or 4% of global </div><div id="a20498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">company revenues (sanction that may be public), and Data Subjects may<div style="display:inline-block;width:2px">&nbsp;</div>seek damages.<div style="display:inline-block;width:7px">&nbsp;</div>Member states may </div><div id="a20500" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">individually impose additional requirements and penalties regarding certain<div style="display:inline-block;width:2px">&nbsp;</div>limited matters (for which the GDPR </div><div id="a20501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">left some room of flexibility), such as employee personal data. With respect to the personal data it protects,<div style="display:inline-block;width:2px">&nbsp;</div>the </div></div>
</div>
<div style="padding: 7px">
<div id="Page36" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a20503" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a20506" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">36 </div><div id="a20508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">GDPR requires, among other things, controller accountability, consents from Data Subjects or another acceptable </div><div id="a20509" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">legal basis to process the personal data, notification within 72 hours of<div style="display:inline-block;width:2px">&nbsp;</div>a personal data breach where required, data </div><div id="a20511" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">integrity and security, and fairness and transparency regarding the storage, use or other processing of the personal </div><div id="a20512" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">data.<div style="display:inline-block;width:7px">&nbsp;</div>The GDPR also provides rights to Data Subjects relating notably<div style="display:inline-block;width:2px">&nbsp;</div>to information, access, rectification, erasure </div><div id="a20514" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">of the personal data and the right to object to the processing.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a20517" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">On August 20, 2021, China promulgated the PIPL, which took effect on November<div style="display:inline-block;width:2px">&nbsp;</div>1, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>The PIPL imposes </div><div id="a20518" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">specific rules for processing personal information and it also specifies<div style="display:inline-block;width:2px">&nbsp;</div>that the law shall also apply to personal </div><div id="a20520" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">information activities carried out outside China but for the purpose<div style="display:inline-block;width:2px">&nbsp;</div>of providing products or services to PRC </div><div id="a20521" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">citizens.<div style="display:inline-block;width:7px">&nbsp;</div>Any non-compliance with these laws and regulations may subject<div style="display:inline-block;width:2px">&nbsp;</div>us to fines, orders to rectify or terminate </div><div id="a20525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">any actions that are deemed illegal by regulatory authorities, other penalties,<div style="display:inline-block;width:2px">&nbsp;</div>as well as reputational damage or legal </div><div id="a20526" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">proceedings against us, which may affect our business, financial condition or results<div style="display:inline-block;width:2px">&nbsp;</div>of operations.<div style="display:inline-block;width:7px">&nbsp;</div>The PIPL </div><div id="a20527" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">carries maximum penalties of CNY50 million or 5% of the annual revenue of<div style="display:inline-block;width:2px">&nbsp;</div>entities that process personal data. </div><div id="a20531" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">In the United States, the CCPA, which increases the privacy protections afforded California residents, became </div><div id="a20532" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">effective January 1, 2020.<div style="display:inline-block;width:7px">&nbsp;</div>The CCPA generally requires companies, such as us, to institute additional protections </div><div id="a20534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">regarding the collection, use and disclosure of certain personal information<div style="display:inline-block;width:2px">&nbsp;</div>of California residents.<div style="display:inline-block;width:7px">&nbsp;</div>Compliance </div><div id="a20535" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">with the obligations imposed by the CCPA depends in part on how particular regulators interpret and apply them.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">Regulations were released in August of 2020, but there remains some<div style="display:inline-block;width:2px">&nbsp;</div>uncertainty about how the CCPA will be </div><div id="a20538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">interpreted by the courts and enforced by the regulators.<div style="display:inline-block;width:6px">&nbsp;</div>If we fail to comply with the CCPA or if regulators assert </div><div id="a20540" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">that we have failed to comply with the CCPA, we may be subject to certain fines or other penalties and litigation, </div><div id="a20541" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">any of which may negatively impact our reputation, require us to expend<div style="display:inline-block;width:2px">&nbsp;</div>significant resources, and harm our </div><div id="a20542" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">business.<div style="display:inline-block;width:7px">&nbsp;</div>Furthermore, California voters approved the CPRA on November 3,<div style="display:inline-block;width:2px">&nbsp;</div>2020, which will amend and expand </div><div id="a20547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">the CCPA, including by providing consumers with additional rights with respect to their personal information, and </div><div id="a20548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">creating a new state agency to enforce CCPA and CPRA.<div style="display:inline-block;width:8px">&nbsp;</div>The CPRA came into effect on January 1, 2023, applying </div><div id="a20553" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">to information collected by businesses on or after January 1, 2022. </div><div id="a20556" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">Other states, as well as the federal government, have increasingly<div style="display:inline-block;width:2px">&nbsp;</div>considered the adoption of similarly expansive </div><div id="a20557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">personal privacy laws, backed<div style="display:inline-block;width:3px">&nbsp;</div>by significant civil penalties for non-compliance.<div style="display:inline-block;width:6px">&nbsp;</div>Virginia and Colorado were both </div><div id="a20561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">successful in passing privacy legislation in 2021, becoming effective on January<div style="display:inline-block;width:2px">&nbsp;</div>1, 2023 and July 1, 2023, </div><div id="a20564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">respectively.<div style="display:inline-block;width:8px">&nbsp;</div>Connecticut and Utah also passed comprehensive privacy laws<div style="display:inline-block;width:2px">&nbsp;</div>that will go into effect in July 1, 2023 </div><div id="a20566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">and December 31, 2023.<div style="display:inline-block;width:7px">&nbsp;</div>While we believe we have substantially compliant programs and controls<div style="display:inline-block;width:2px">&nbsp;</div>in place to </div><div id="a20568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">comply with the GDPR, CCPA, PIPL and CPRA requirements, our compliance with data privacy and cybersecurity </div><div id="a20570" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">laws is likely to impose additional costs on us, and we cannot predict whether<div style="display:inline-block;width:2px">&nbsp;</div>the interpretations of the </div><div id="a20571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">requirements, or changes in our practices in response to new requirements<div style="display:inline-block;width:2px">&nbsp;</div>or interpretations of the requirements, </div><div id="a20572" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">could have a material adverse effect on our business. </div><div id="a20576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">We also sell products and services that health care providers, such as physicians and dentists, use to store and </div><div id="a20577" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">manage patient medical or dental records.<div style="display:inline-block;width:7px">&nbsp;</div>These customers and we are subject to laws, regulations and<div style="display:inline-block;width:2px">&nbsp;</div>industry </div><div id="a20578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">standards, such as HIPAA and the Payment Card Industry Data Security Standards, which require the protection of </div><div id="a20580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">the privacy and security of those records.<div style="display:inline-block;width:7px">&nbsp;</div>Our products or services may be used as part of these customers’ </div><div id="a20581" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">comprehensive data security programs, including in connection with their efforts to comply with<div style="display:inline-block;width:2px">&nbsp;</div>applicable data </div><div id="a20583" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">privacy and security laws and contractual requirements.<div style="display:inline-block;width:6px">&nbsp;</div>Perceived or actual security vulnerabilities in our products </div><div id="a20584" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">or services, or the perceived or actual failure by us or our customers who<div style="display:inline-block;width:2px">&nbsp;</div>use our products or services to comply </div><div id="a20586" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">with applicable legal or contractual data privacy and security requirements,<div style="display:inline-block;width:2px">&nbsp;</div>may not only cause us significant </div><div id="a20587" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">reputational harm, but may also lead to claims against us by our customers<div style="display:inline-block;width:2px">&nbsp;</div>and/or governmental agencies and </div><div id="a20589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">involve substantial fines, penalties and other liabilities and expenses<div style="display:inline-block;width:2px">&nbsp;</div>and costs for remediation. </div><div id="a20592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">Under the GDPR, health data belong to the category of “sensitive data” and benefit<div style="display:inline-block;width:2px">&nbsp;</div>from specific protections.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20593" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">Processing of such data is generally prohibited, except for specific exceptions. </div><div id="a20597" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">Certain of our businesses involve the manufacture and sale of EHR systems<div style="display:inline-block;width:2px">&nbsp;</div>and other products linked to </div><div id="a20598" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">government supported incentive programs, where the EHR systems<div style="display:inline-block;width:2px">&nbsp;</div>must be certified as having certain capabilities </div><div id="a20600" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">designated in evolving standards, such as those adopted by CMS and ONC.<div style="display:inline-block;width:6px">&nbsp;</div>In order to maintain certification of our </div><div id="a20601" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">EHR products, we must satisfy the changing governmental standards.<div style="display:inline-block;width:6px">&nbsp;</div>If any of our EHR systems do not meet these </div><div id="a20602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">standards, yet have been relied upon by health care providers to receive<div style="display:inline-block;width:2px">&nbsp;</div>federal incentive payments, we may be </div></div>
</div>
<div style="padding: 7px">
<div id="Page37" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a20604" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a20607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">37 </div><div id="a20609" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">exposed to risk, such as under federal health care fraud and abuse<div style="display:inline-block;width:2px">&nbsp;</div>laws, including the False Claims Act.<div style="display:inline-block;width:7px">&nbsp;</div>While we </div><div id="a20610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">believe we are substantially in compliance with such certifications and with applicable<div style="display:inline-block;width:2px">&nbsp;</div>fraud and abuse laws and </div><div id="a20612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">regulations and that we have adequate compliance programs and controls<div style="display:inline-block;width:2px">&nbsp;</div>in place to ensure substantial compliance, </div><div id="a20613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">we cannot predict whether changes in applicable law, or interpretation of laws, or resulting changes in our, could </div><div id="a20615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">have a material adverse effect on our business.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a20618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">Moreover, in order to satisfy our customers and comply with evolving legal requirements, our products<div style="display:inline-block;width:2px">&nbsp;</div>may need to </div><div id="a20619" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">incorporate increasingly complex functionality, such as with respect to reporting and information blocking.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">Although we believe we are positioned to accomplish this, the effort may involve<div style="display:inline-block;width:2px">&nbsp;</div>increased costs, and our failure to </div><div id="a20622" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">implement product modifications, or otherwise satisfy applicable standards,<div style="display:inline-block;width:2px">&nbsp;</div>could have a material adverse effect on </div><div id="a20624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">our business. </div><div id="a20627" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Additionally, as electronic medical devices are increasingly connected to each other and to other technology, the </div><div id="a20628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">ability of these connected systems to safely and effectively exchange and use exchanged<div style="display:inline-block;width:2px">&nbsp;</div>information becomes </div><div id="a20630" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">increasingly important.<div style="display:inline-block;width:7px">&nbsp;</div>As a medical device manufacturer, we must manage risks including those associated with </div><div id="a20631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">an electronic interface that is incorporated into a medical device. </div><div id="a20634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:346px;">Tax legislation could materially adversely affect our financial results and tax liabilities.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">We are subject to the tax laws and regulations of the United States federal, state and local governments, as well as </div><div id="a20640" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">foreign jurisdictions.<div style="display:inline-block;width:7px">&nbsp;</div>From time to time, various legislative initiatives may be proposed<div style="display:inline-block;width:2px">&nbsp;</div>that could materially </div><div id="a20643" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">adversely affect our tax positions.<div style="display:inline-block;width:7px">&nbsp;</div>There can be no assurance that our effective tax rate will not be<div style="display:inline-block;width:2px">&nbsp;</div>materially </div><div id="a20647" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">adversely affected by legislation resulting from these initiatives.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, tax laws and regulations are extremely </div><div id="a20651" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">complex and subject to varying interpretations.<div style="display:inline-block;width:7px">&nbsp;</div>Although we believe that our historical tax positions are sound and </div><div id="a20655" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">consistent with applicable laws, regulations and existing precedent,<div style="display:inline-block;width:2px">&nbsp;</div>there can be no assurance that our tax positions </div><div id="a20656" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">will not be challenged by relevant tax authorities or that we would be successful<div style="display:inline-block;width:2px">&nbsp;</div>in any such challenge. </div><div id="a20660" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:515px;">We face inherent risk of exposure to product liability, intellectual property infringement and other claims in the </div><div id="a20661" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:532px;">event that the use of the products we sell results in injury. </div><div id="a20664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">Our business involves a risk of product liability, intellectual property infringement and other claims in the ordinary </div><div id="a20666" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">course of business, and from time to time we are named as a defendant<div style="display:inline-block;width:2px">&nbsp;</div>in cases as a result of our distribution of </div><div id="a20667" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">products.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, we own interests in companies that manufacture certain dental products.<div style="display:inline-block;width:7px">&nbsp;</div>As a result, we </div><div id="a20673" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">could be subject to the potential risk of product liability, intellectual property infringement or other claims relating </div><div id="a20674" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">to the manufacture and distribution of products by those entities.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, as our corporate brand business </div><div id="a20680" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">continues to grow, purchasers of such products may increasingly seek recourse directly from us, rather than the </div><div id="a20683" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">ultimate product manufacturer, for product-related claims.<div style="display:inline-block;width:7px">&nbsp;</div>Another potential risk we face in the distribution of our </div><div id="a20688" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">products is liability resulting from counterfeit or tainted products infiltrating<div style="display:inline-block;width:2px">&nbsp;</div>the supply chain.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, some of </div><div id="a20690" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">the products that we transport and sell are considered hazardous materials.<div style="display:inline-block;width:6px">&nbsp;</div>The improper handling of such </div><div id="a20693" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">materials or accidents involving the transportation of such materials could<div style="display:inline-block;width:2px">&nbsp;</div>subject us to liability or at least legal </div><div id="a20695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">action that could harm our reputation.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a20699" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:768px;">Customs policies or legislative import restrictions could hinder the Company’s ability to import goods necessary </div><div id="a20700" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:785px;">to our operations on a timely basis and result in government enforcement<div style="display:inline-block;width:2px">&nbsp;</div>actions and/or sanctions. </div><div id="a20704" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">Government-imposed import policies and legislation regulating the<div style="display:inline-block;width:2px">&nbsp;</div>import of goods and prohibiting the use of </div><div id="a20708" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">forced labor or human trafficking could result in delays or the inability to import<div style="display:inline-block;width:2px">&nbsp;</div>goods in a timely manner that are </div><div id="a20709" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">necessary to our operations, and such policies or legislation could also<div style="display:inline-block;width:2px">&nbsp;</div>result in financial penalties, other sanctions, </div><div id="a20710" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">government enforcement actions and reputational harm.<div style="display:inline-block;width:6px">&nbsp;</div>While the Company has policies against and seeks to </div><div id="a20712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">avoid the import of goods that are manufactured in whole or in part by forced<div style="display:inline-block;width:2px">&nbsp;</div>labor or through human trafficking, </div><div id="a20713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">as a result of legislative and governmental policy initiatives, we may be subject<div style="display:inline-block;width:2px">&nbsp;</div>to increasing potential delays, </div><div id="a20715" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">added costs, supply chain disruption and other restrictions. </div></div>
</div>
<div style="padding: 7px">
<div id="Page38" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a20718" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a20721" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">38 </div><div id="a20723" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:60px;">GENERAL RISKS </div><div id="a20726" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:93px;">Security risks generally associated with our information systems and our<div style="display:inline-block;width:2px">&nbsp;</div>technology products and services could </div><div id="a20728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:110px;">materially adversely affect our business, and our results of operations could be<div style="display:inline-block;width:2px">&nbsp;</div>materially adversely affected if </div><div id="a20729" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:127px;">such products, services or systems (or third-party systems we rely on) are<div style="display:inline-block;width:2px">&nbsp;</div>interrupted, damaged by unforeseen </div><div id="a20732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:144px;">events, are subject to cyberattacks or fail for any extended period<div style="display:inline-block;width:2px">&nbsp;</div>of time. </div><div id="a20736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">We rely on information systems (IS) in our business to obtain, rapidly process, analyze, manage and store customer, </div><div id="a20737" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">product, supplier and employee data to, among other things: </div><div id="a20740" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:229px;">•</div><div id="a20742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:229px;">maintain and manage worldwide systems to facilitate the purchase and<div style="display:inline-block;width:2px">&nbsp;</div>distribution of thousands of </div><div id="a20744" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:246px;">inventory items from numerous distribution centers; </div><div id="a20746" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:264px;">•</div><div id="a20748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:264px;">receive, process and ship orders on a timely basis; </div><div id="a20750" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:282px;">•</div><div id="a20752" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:282px;">manage the accurate billing and collections for thousands of<div style="display:inline-block;width:2px">&nbsp;</div>customers; </div><div id="a20754" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:300px;">•</div><div id="a20756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:300px;">process payments to suppliers; and </div><div id="a20759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:318px;">•</div><div id="a20761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:318px;">provide products and services that maintain certain of our customers’ electronic<div style="display:inline-block;width:2px">&nbsp;</div>medical or dental </div><div id="a20762" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:336px;">records (including protected health information of their patients). </div><div id="a20765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:381px;">Information security risks have generally increased in recent years, and a cyberattack<div style="display:inline-block;width:2px">&nbsp;</div>that bypasses our IS security </div><div id="a20767" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:398px;">systems (including third-party systems we rely on) causing an IS security breach<div style="display:inline-block;width:2px">&nbsp;</div>may lead to a material disruption </div><div id="a20770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:415px;">of our IS business systems (including third-party systems we rely on) and/or<div style="display:inline-block;width:2px">&nbsp;</div>the loss of business information, as </div><div id="a20774" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">well as claims against us by affected parties and/or governmental agencies, and involve<div style="display:inline-block;width:2px">&nbsp;</div>fines and penalties, costs </div><div id="a20775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">for remediation, and substantial defense and settlement expenses.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, we develop products and provide </div><div id="a20778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:465px;">services to our customers that are technology-based, and a cyberattack<div style="display:inline-block;width:2px">&nbsp;</div>that bypasses the IS security systems of our </div><div id="a20782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:482px;">products or services causing a security breach and/or perceived security<div style="display:inline-block;width:2px">&nbsp;</div>vulnerabilities in our products or services </div><div id="a20783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:499px;">could also cause significant loss of business and reputational harm, and actual<div style="display:inline-block;width:2px">&nbsp;</div>or perceived vulnerabilities may lead </div><div id="a20785" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:516px;">to claims against us by our customers and/or governmental agencies.<div style="display:inline-block;width:6px">&nbsp;</div>In particular, certain of our practice </div><div id="a20786" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:533px;">management products and services purchased by health care providers, such<div style="display:inline-block;width:2px">&nbsp;</div>as physicians and dentists, are used to </div><div id="a20788" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:550px;">store and manage patient medical or dental records.<div style="display:inline-block;width:6px">&nbsp;</div>These customers are subject to laws and regulations which </div><div id="a20789" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">require that they protect the privacy and security of those records, and our<div style="display:inline-block;width:2px">&nbsp;</div>products may be used as part of these </div><div id="a20791" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">customers’ comprehensive data security programs, including in connection<div style="display:inline-block;width:2px">&nbsp;</div>with their efforts to comply with </div><div id="a20792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:600px;">applicable privacy and security laws.<div style="display:inline-block;width:7px">&nbsp;</div>Perceived or actual security vulnerabilities in our products or services,<div style="display:inline-block;width:2px">&nbsp;</div>or the </div><div id="a20795" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:617px;">perceived or actual failure by us or our customers who use our products<div style="display:inline-block;width:2px">&nbsp;</div>to comply with applicable legal </div><div id="a20797" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:634px;">requirements, may not only cause reputational harm and loss of business,<div style="display:inline-block;width:2px">&nbsp;</div>but may also lead to claims against us by </div><div id="a20798" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:651px;">our customers and/or governmental agencies and involve damages, fines and<div style="display:inline-block;width:2px">&nbsp;</div>penalties, costs for remediation, and </div><div id="a20800" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:668px;">substantial defense and settlement expenses.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, a cyberattack on a third-party that we use to manage<div style="display:inline-block;width:2px">&nbsp;</div>a </div><div id="a20805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">portion of our information systems could result in the same effects.<div style="display:inline-block;width:6px">&nbsp;</div>Additionally, legislative or regulatory action </div><div id="a20807" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">related to cybersecurity may increase our costs to develop or implement<div style="display:inline-block;width:2px">&nbsp;</div>new technology products and services.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:735px;">From time to time, we have had to address immaterial security incidents<div style="display:inline-block;width:2px">&nbsp;</div>(“security incidents”).<div style="display:inline-block;width:7px">&nbsp;</div>There can be no </div><div id="a20812" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:752px;">assurance that we will not experience material security incidents in the future. Security<div style="display:inline-block;width:2px">&nbsp;</div>incidents can be difficult to </div><div id="a20813" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:769px;">detect and any delay in identifying them could increase their harm.<div style="display:inline-block;width:6px">&nbsp;</div>While we have implemented measures to </div><div id="a20815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:786px;">protect our IS systems, such measures may not prevent these events.<div style="display:inline-block;width:6px">&nbsp;</div>Any such security incidents could disrupt our </div><div id="a20816" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:803px;">operations, harm our reputation or otherwise have a material adverse effect on our<div style="display:inline-block;width:2px">&nbsp;</div>business.<div style="display:inline-block;width:7px">&nbsp;</div>We have various </div><div id="a20817" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">insurance policies, including cybersecurity insurance, covering risks and<div style="display:inline-block;width:2px">&nbsp;</div>in amounts that we consider adequate.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20819" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">There can be no assurance that the insurance coverage we maintain is sufficient or<div style="display:inline-block;width:2px">&nbsp;</div>will be available in adequate </div><div id="a20820" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:853px;">amounts or at a reasonable cost to cover costs and expenses related<div style="display:inline-block;width:2px">&nbsp;</div>to security incidents. </div><div id="a20825" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:887px;">Furthermore, procedures and safeguards must continually evolve to meet new<div style="display:inline-block;width:2px">&nbsp;</div>IS challenges, and enhancing </div><div id="a20826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:904px;">protections, and conducting investigations and remediation, may impose additional<div style="display:inline-block;width:2px">&nbsp;</div>costs on us. </div><div id="a20829" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">Finally, our business may be interrupted by shortfalls of IS systems providers engaged by our customers, such<div style="display:inline-block;width:2px">&nbsp;</div>as </div><div id="a20830" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">Internet-based services upon which our customers depend to access certain of<div style="display:inline-block;width:2px">&nbsp;</div>our products.<div style="display:inline-block;width:7px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page39" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a20835" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a20838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">39 </div><div id="a20840" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:60px;">Our global operations are subject to inherent risks that could materially adversely<div style="display:inline-block;width:2px">&nbsp;</div>affect our business. </div><div id="a20844" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Our global operations are subject to risks that could materially adversely affect our business.<div style="display:inline-block;width:6px">&nbsp;</div>The risks that our </div><div id="a20850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">global operations are subject to include, among other things:<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a20853" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:144px;">•</div><div id="a20855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:144px;">difficulties and costs relating to staffing and managing foreign operations; </div><div id="a20858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:162px;">•</div><div id="a20860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:162px;">difficulties and delays inherent in sourcing products, establishing channels of distribution<div style="display:inline-block;width:2px">&nbsp;</div>and contract </div><div id="a20861" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:180px;">manufacturing in foreign markets; </div><div id="a20863" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:198px;">•</div><div id="a20865" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:198px;">fluctuations in the value of foreign currencies (including, without limitation,<div style="display:inline-block;width:2px">&nbsp;</div>in connection with </div><div id="a20867" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:216px;">Brexit); </div><div id="a20869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:233px;">•</div><div id="a20871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:233px;">uncertainties relating to the EU-UK Trade and Cooperation Agreement of December 2020, which<div style="display:inline-block;width:2px">&nbsp;</div>went </div><div id="a20874" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:251px;">into effect in 2021, including for example potential implementation issues, potential<div style="display:inline-block;width:2px">&nbsp;</div>disputes over the </div><div id="a20875" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:269px;">interpretation of the provisions of the Agreement and possible changes<div style="display:inline-block;width:2px">&nbsp;</div>to the Agreement restricting the </div><div id="a20877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:287px;">free movement of goods between the U.K. and the European Union; </div><div id="a20879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:304px;">•</div><div id="a20881" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:304px;">longer payment cycles of foreign customers and difficulty of collecting receivables<div style="display:inline-block;width:2px">&nbsp;</div>in foreign </div><div id="a20883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:322px;">jurisdictions; </div><div id="a20885" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:340px;">•</div><div id="a20887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:340px;">repatriation of cash from our foreign operations to the United States; </div><div id="a20889" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:358px;">•</div><div id="a20891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:358px;">regulatory requirements, including,<div style="display:inline-block;width:3px">&nbsp;</div>without limitation, anti-bribery, anti-corruption and laws pertaining </div><div id="a20899" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:376px;">to the accuracy of our internal books and records; </div><div id="a20901" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:394px;">•</div><div id="a20903" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:394px;">litigation risks, new or unanticipated litigation developments and<div style="display:inline-block;width:2px">&nbsp;</div>the status of litigation matters; </div><div id="a20905" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:411px;">•</div><div id="a20907" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:411px;">unexpected difficulties in importing or exporting our products and import/export<div style="display:inline-block;width:2px">&nbsp;</div>tariffs, quotas, </div><div id="a20908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:429px;">sanctions or penalties; </div><div id="a20910" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:447px;">•</div><div id="a20912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:447px;">limitations on our ability under local laws to protect our intellectual property; </div><div id="a20915" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:465px;">•</div><div id="a20917" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:465px;">unexpected regulatory, legal, economic and political changes in foreign markets; </div><div id="a20919" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:483px;">•</div><div id="a20921" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:483px;">changes in tax regulations that influence purchases of capital equipment; </div><div id="a20923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:501px;">•</div><div id="a20925" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:501px;">civil disturbances, geopolitical turmoil, including terrorism, war or political<div style="display:inline-block;width:2px">&nbsp;</div>or military coups;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a20928" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:518px;">•</div><div id="a20930" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:518px;">risks associated with climate change, including physical risks such as<div style="display:inline-block;width:2px">&nbsp;</div>impacts from extreme weather </div><div id="a20931" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:536px;">events and other potential physical consequences, regulatory and technological<div style="display:inline-block;width:2px">&nbsp;</div>requirements, market </div><div id="a20932" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:554px;">developments, stakeholder expectations and reputational risk; and </div><div id="a20935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:115px;top:572px;">•</div><div id="a20937" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:139px;top:572px;">public health emergencies, including COVID-19. </div><div id="a20942" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:618px;">Our future success is substantially dependent upon our senior<div style="display:inline-block;width:2px">&nbsp;</div>management, and our revenues and profitability </div><div id="a20945" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:635px;">depend on our relationships with capable sales personnel as well as<div style="display:inline-block;width:2px">&nbsp;</div>customers, suppliers and manufacturers of </div><div id="a20946" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:652px;">the products that we distribute. </div><div id="a20949" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:686px;">Our future success is substantially dependent upon the efforts and abilities of members<div style="display:inline-block;width:2px">&nbsp;</div>of our existing senior </div><div id="a20951" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:703px;">management, particularly Stanley M. Bergman, Chairman and Chief Executive Officer.<div style="display:inline-block;width:7px">&nbsp;</div>The loss of the services of </div><div id="a20954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:719px;">Mr. Bergman could have a material adverse effect on our business. We have an employment agreement with Mr. </div><div id="a20955" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:736px;">Bergman.<div style="display:inline-block;width:7px">&nbsp;</div>We do not currently have “key man” life insurance policies on any of our employees.<div style="display:inline-block;width:7px">&nbsp;</div>Competition for </div><div id="a20961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:753px;">senior management is intense, burnout and turn-over rates are increasing workplace<div style="display:inline-block;width:2px">&nbsp;</div>concerns during and after the </div><div id="a20968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:770px;">COVID-19 pandemic, and we may not be successful in attracting and<div style="display:inline-block;width:2px">&nbsp;</div>retaining key personnel.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, our </div><div id="a20975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:787px;">future revenues and profitability depend on our ability to maintain satisfactory<div style="display:inline-block;width:2px">&nbsp;</div>relationships with qualified sales </div><div id="a20976" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:804px;">personnel as well as customers, suppliers and manufacturers.<div style="display:inline-block;width:6px">&nbsp;</div>If we fail to maintain our existing relationships with </div><div id="a20980" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:821px;">such persons or fail to acquire relationships with such key persons in the<div style="display:inline-block;width:2px">&nbsp;</div>future, our business may be materially </div><div id="a20981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:838px;">adversely affected. </div><div id="a20984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:871px;">Disruptions in the financial markets may materially adversely affect the availability<div style="display:inline-block;width:2px">&nbsp;</div>and cost of credit to us. </div><div id="a20988" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:905px;">Our ability to make scheduled payments or refinance our obligations with<div style="display:inline-block;width:2px">&nbsp;</div>respect to indebtedness will depend on </div><div id="a20989" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:922px;">our operating and financial performance, which in turn is subject to prevailing<div style="display:inline-block;width:2px">&nbsp;</div>economic conditions and financial, </div><div id="a20991" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:939px;">business and other factors beyond our control.<div style="display:inline-block;width:6px">&nbsp;</div>Disruptions in the financial markets may materially adversely affect </div><div id="a20994" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:956px;">the availability and cost of credit to us. </div></div>
</div>
<div style="padding: 7px">
<div id="Page40" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a20997" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21000" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">40 </div><div id="a21002" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Item 1B.<div style="display:inline-block;width:7px">&nbsp;</div>Unresolved Staff Comments</div><div id="a21007" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">We have no unresolved comments from the staff of the SEC that were issued 180 days or more preceding the end of </div><div id="a21008" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">our 2022 fiscal year.</div><div id="a21014" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:144px;">ITEM 2. Properties </div><div id="a21017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">Within our health care distribution segment (for properties with more than 100,000 square feet) we lease<div style="display:inline-block;width:2px">&nbsp;</div>and/or </div><div id="a21025" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">own approximately 5.8 million square feet of properties, consisting of distribution,<div style="display:inline-block;width:2px">&nbsp;</div>office, showroom, </div><div id="a21032" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">manufacturing and sales space, in locations including the United States, Australia,<div style="display:inline-block;width:2px">&nbsp;</div>Austria, Belgium, Brazil, </div><div id="a21037" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Canada, Chile, China, the Czech Republic, France, Germany, Hong Kong SAR, Ireland, Israel, Italy, Japan, </div><div id="a21039" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">Liechtenstein, Luxembourg, Malaysia, Mexico, the Netherlands, New Zealand, Poland,<div style="display:inline-block;width:2px">&nbsp;</div>Portugal, Singapore, South </div><div id="a21048" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">Africa, Spain, Sweden, Switzerland, Thailand,<div style="display:inline-block;width:3px">&nbsp;</div>United Arab Emirates and the United Kingdom.<div style="display:inline-block;width:6px">&nbsp;</div>Lease expirations </div><div id="a21058" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">range from 2023 to 2041. </div><div id="a21061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">We believe that our properties are in good condition, are well maintained and are suitable and adequate to carry on </div><div id="a21064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">our business.<div style="display:inline-block;width:7px">&nbsp;</div>We have additional operating capacity at certain distribution center facilities. </div><div id="a21067" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:363px;">ITEM 3.<div style="display:inline-block;width:7px">&nbsp;</div>Legal Proceedings<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">For a discussion of Legal Proceedings, see </div><div id="a21071" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:321px;top:397px;"><a href="#a46741" style="color:#0000FF;text-decoration:underline;">Note 15 – Commitments and Contingencies</a></div><div id="a21075" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:578px;top:397px;"><div style="display:inline-block;width:4px">&nbsp;</div>of the Notes to the </div><div id="a21077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">Consolidated Financial Statements included under Item 8. </div><div id="a21080" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:448px;">ITEM 4.<div style="display:inline-block;width:7px">&nbsp;</div>Mine Safety Disclosures </div><div id="a21083" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">Not applicable. </div></div>
</div>
<div style="padding: 7px">
<div id="Page41" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:199.7px; height:14.6px; left:69.9px; top:655.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.8px; height:14.6px; left:284.9px; top:655.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:16.8px; left:381.2px; top:652.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:14.6px; left:407.9px; top:655.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:129.8px; height:14.6px; left:484.9px; top:655.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:695.2px; height:18.2px; left:67.2px; top:651.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:129.6px; height:14.6px; left:630.1px; top:655.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:205px; height:1px; left:66.8px; top:650.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:272.2px; top:650.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:99px; height:1px; left:281.9px; top:650.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:380.9px; top:650.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:390.9px; top:650.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:472.3px; top:650.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:135.1px; height:1px; left:481.9px; top:650.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:617px; top:650.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:135px; height:1px; left:626.9px; top:650.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:199.7px; height:14.6px; left:69.9px; top:693.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93.8px; height:14.6px; left:284.9px; top:693.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:16.8px; left:381.2px; top:691.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:14.6px; left:407.9px; top:693.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:129.8px; height:14.6px; left:484.9px; top:693.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:695.2px; height:19.2px; left:67.2px; top:688.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:129.6px; height:14.6px; left:630.1px; top:693.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:99px; height:1px; left:281.9px; top:707.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:135.1px; height:1px; left:481.9px; top:707.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99px; height:1px; left:282.3px; top:728.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99px; height:1px; left:282.3px; top:730px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:135.1px; height:1px; left:482.3px; top:728.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:135.1px; height:1px; left:482.3px; top:730px; background-color:#000000; ">&nbsp;</div>
<div id="a21085" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21088" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">41 </div><div id="a21090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:381px;top:60px;">PART<div style="display:inline-block;width:5px">&nbsp;</div>II </div><div id="a21093" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:93px;">ITEM 5.<div style="display:inline-block;width:11px">&nbsp;</div>Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of </div><div id="a21094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:110px;">Equity Securities </div><div id="a21097" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">Our common stock is traded on the Nasdaq Global Select Market tier of<div style="display:inline-block;width:2px">&nbsp;</div>the Nasdaq Stock Market, or Nasdaq, </div><div id="a21098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">under the symbol HSIC. </div><div id="a21101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">On February 7, 2023, there were approximately 88,000 holders of record of<div style="display:inline-block;width:2px">&nbsp;</div>our common stock and the last reported </div><div id="a21109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">sales price was $87.14.<div style="display:inline-block;width:7px">&nbsp;</div>A substantially greater number of holders of our common<div style="display:inline-block;width:2px">&nbsp;</div>stock are “street name” or </div><div id="a21115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">beneficial holders, whose shares are held by banks, brokers and other financial<div style="display:inline-block;width:2px">&nbsp;</div>institutions. </div><div id="a21119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:262px;">Purchases of Equity Securities by the Issuer </div><div id="a21122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">Our share repurchase program, announced on March 3, 2003, originally<div style="display:inline-block;width:2px">&nbsp;</div>allowed us to repurchase up to two million </div><div id="a21123" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">shares pre-stock splits (eight million shares post-stock splits) of our common<div style="display:inline-block;width:2px">&nbsp;</div>stock, which represented </div><div id="a21129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">approximately 2.3% of the shares outstanding at the commencement<div style="display:inline-block;width:2px">&nbsp;</div>of the program.<div style="display:inline-block;width:7px">&nbsp;</div>Subsequent additional </div><div id="a21130" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">increases totaling $4.5 billion, authorized by our Board of Directors,<div style="display:inline-block;width:2px">&nbsp;</div>to the repurchase program provide for a total </div><div id="a21133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">of $4.6 billion (including $400 million authorized on August 17, 2022) of shares<div style="display:inline-block;width:2px">&nbsp;</div>of our common stock to be </div><div id="a21134" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">repurchased under this program. </div><div id="a21137" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">As of December 31, 2022,<div style="display:inline-block;width:3px">&nbsp;</div>we had repurchased approximately $4.5 billion of common stock (87,180,669<div style="display:inline-block;width:2px">&nbsp;</div>shares) </div><div id="a21147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">under these initiatives, with $115 million available for future common stock share repurchases. </div><div id="a21157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">On February 8, 2023, our Board of Directors authorized the repurchase<div style="display:inline-block;width:2px">&nbsp;</div>of up to an additional $400 million in shares </div><div id="a21159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">of our common stock. </div><div id="a21162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">The following table summarizes repurchases of our common stock<div style="display:inline-block;width:2px">&nbsp;</div>under our stock repurchase program during the </div><div id="a21166" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">fiscal quarter ended December 31, 2022: </div><div id="a21179" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:511px;top:568px;">Total Number </div><div id="a21182" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:643px;top:568px;">Maximum Number </div><div id="a21188" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:317px;top:585px;">Total </div><div id="a21194" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:525px;top:585px;">of Shares </div><div id="a21197" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:670px;top:585px;">of Shares </div><div id="a21202" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:309px;top:602px;">Number </div><div id="a21205" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:409px;top:602px;">Average </div><div id="a21208" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:500px;top:602px;">Purchased as Part </div><div id="a21211" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:659px;top:602px;">that May Yet </div><div id="a21216" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:306px;top:619px;">of Shares </div><div id="a21219" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:404px;top:619px;">Price Paid </div><div id="a21222" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:508px;top:619px;">of Our Publicly </div><div id="a21225" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:639px;top:619px;">Be Purchased Under </div><div id="a21227" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:134px;top:636px;">Fiscal Month </div><div id="a21230" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:294px;top:636px;">Purchased (1) </div><div id="a21233" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:405px;top:636px;">Per Share </div><div id="a21236" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:493px;top:636px;">Announced Program </div><div id="a21239" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:649px;top:636px;">Our Program (2) </div><div id="a21241" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:92px;top:655px;">9/25/2022 through 10/29/2022 </div><div id="a21244" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:370px;top:655px;">- </div><div id="a21248" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:465px;top:655px;">- </div><div id="a21251" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:655px;">- </div><div id="a21254" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:709px;top:655px;">5,703,693 </div><div id="a21256" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:89px;top:675px;">10/30/2022 through 11/26/2022 </div><div id="a21259" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:328px;top:675px;">1,249,083 </div><div id="a21262" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:394px;top:675px;">$ </div><div id="a21264" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:441px;top:675px;">76.29 </div><div id="a21267" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:564px;top:675px;">1,249,083 </div><div id="a21270" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:709px;top:675px;">3,741,485 </div><div id="a21272" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:89px;top:694px;">11/27/2022 through 12/31/2022 </div><div id="a21275" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:328px;top:694px;">2,333,467 </div><div id="a21279" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:441px;top:694px;">81.30 </div><div id="a21282" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:564px;top:694px;">2,333,467 </div><div id="a21285" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:709px;top:694px;">1,439,841 </div><div id="a21289" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:328px;top:714px;">3,582,550 </div><div id="a21295" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:564px;top:714px;">3,582,550 </div><div id="a21321" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:70px;top:736px;">(1) </div><div id="a21323" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:736px;">All repurchases were executed in the open market under our existing publicly announced authorized program. </div><div id="a21336" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:70px;top:765px;">(2) </div><div id="a21338" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:771px;">The maximum number of shares that may yet be purchased under this program is determined at the end of each month based on the </div><div id="a21340" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:785px;">closing price of our common stock at that time.<div style="display:inline-block;width:6px">&nbsp;</div>This table excludes shares withheld from employees to satisfy minimum tax </div><div id="a21341" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:799px;">withholding requirements for equity-based transactions. </div><div id="a21346" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:830px;">Dividend Policy </div><div id="a21349" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:863px;">We have not declared any cash or stock dividends on our common stock during fiscal years 2022 or 2021.<div style="display:inline-block;width:6px">&nbsp;</div>We </div><div id="a21358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:880px;">currently do not anticipate declaring any cash or stock dividends on our common<div style="display:inline-block;width:2px">&nbsp;</div>stock in the foreseeable future.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:897px;">We intend to retain earnings to finance the expansion of our business and for general corporate purposes, including </div><div id="a21360" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:914px;">our share repurchase program.<div style="display:inline-block;width:7px">&nbsp;</div>Any declaration of dividends will be at the discretion of our Board of<div style="display:inline-block;width:2px">&nbsp;</div>Directors and </div><div id="a21365" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:931px;">will depend upon the earnings, financial condition, capital requirements,<div style="display:inline-block;width:2px">&nbsp;</div>level of indebtedness, contractual </div><div id="a21366" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:948px;">restrictions with respect to payment of dividends and other factors. </div></div>
</div>
<div style="padding: 7px">
<div id="Page42" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:16.9px; left:67.2px; top:722.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:535.1px; height:13.8px; left:213.1px; top:725.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:141px; height:17.9px; left:67.2px; top:721.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:146.1px; height:1px; left:66.8px; top:721px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:212.9px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:17.9px; left:298.3px; top:721.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:302.9px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5.1px; height:1px; left:387.8px; top:721px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:392.9px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:17.9px; left:478.3px; top:721.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:482.9px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5.1px; height:1px; left:567.9px; top:721px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:573px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:17.9px; left:658.4px; top:721.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:721px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:759.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.8px; left:67.2px; top:765.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:799.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.8px; left:67.2px; top:805.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:623.1px; height:427.5px; left:68.1px; top:195.3px; background-color:#FFFFFF; ">&nbsp;</div>
<div style="position:absolute; width:584px; height:221.2px; left:107.2px; top:229.6px; background-color:#FFFFFF; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:221.2px; left:106.8px; top:229.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:406.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:362px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:317.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:273.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:229.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:588px; height:1px; left:102.8px; top:450.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:155.5px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:252.9px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:350.2px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:447.4px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:544.9px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:642.2px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:3px; left:690.8px; top:447.5px; background-color:#000000; ">&nbsp;</div>
<img src="hsic-20221231p42i0.gif" alt="hsic-20221231p42i0" style="position:absolute;left:150.2px;top:331.2px;width:498px;height:81px;">
<div style="position:absolute; width:8.7px; height:8.7px; left:151.8px; top:402.5px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:150.4px; top:401.1px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:150.4px; top:410.8px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:150.4px; top:401.1px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:160.1px; top:401.1px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:8.7px; left:249.3px; top:398.4px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:247.9px; top:397px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:247.9px; top:406.6px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:247.9px; top:397px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:257.5px; top:397px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:8.7px; left:346.5px; top:376.6px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:345.1px; top:375.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:345.1px; top:384.9px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:345.1px; top:375.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:354.8px; top:375.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:8.7px; left:443.8px; top:360.6px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:442.4px; top:359.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:442.4px; top:368.9px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:442.4px; top:359.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:452.1px; top:359.2px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:8.7px; left:541.3px; top:328.8px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:539.9px; top:327.4px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:539.9px; top:337px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:539.9px; top:327.4px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:549.5px; top:327.4px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:8.7px; left:638.5px; top:335px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:637.1px; top:333.6px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:10px; height:1px; left:637.1px; top:343.3px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:637.1px; top:333.6px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:10px; left:646.8px; top:333.6px; background-color:#C0504D; ">&nbsp;</div>
<img src="hsic-20221231p42i1.gif" alt="hsic-20221231p42i1" style="position:absolute;left:150.1px;top:281.4px;width:498.2px;height:134.2px;">
<div style="position:absolute; width:251px; height:1px; left:252.8px; top:496.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:251px; height:1px; left:252.8px; top:594.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:98px; left:252.8px; top:496.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:98px; left:503.5px; top:496.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:25.6px; height:3.3px; left:275.4px; top:512.3px; background-color:#8064A2; ">&nbsp;</div>
<img src="hsic-20221231p42i2.gif" alt="hsic-20221231p42i2" style="position:absolute;left:285.1px;top:509.1px;width:8.7px;height:8.7px;">
<div style="position:absolute; width:25.6px; height:3.3px; left:275.4px; top:544.9px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:7.4px; height:7.4px; left:286.1px; top:542.7px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:1px; left:284.7px; top:541.3px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:8.7px; height:1px; left:284.7px; top:549.7px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:8.7px; left:284.7px; top:541.3px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:8.7px; left:293px; top:541.3px; background-color:#C0504D; ">&nbsp;</div>
<div style="position:absolute; width:25.6px; height:3.3px; left:275.4px; top:577.5px; background-color:#9BBB59; ">&nbsp;</div>
<img src="hsic-20221231p42i3.gif" alt="hsic-20221231p42i3" style="position:absolute;left:285px;top:574.5px;width:8.9px;height:8.7px;">
<div style="position:absolute; width:624.2px; height:1px; left:66.7px; top:193.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:624.2px; height:1px; left:66.7px; top:622.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:428.6px; left:66.7px; top:193.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:1px; height:428.6px; left:690.8px; top:193.9px; background-color:#000000; ">&nbsp;</div>
<div id="a21370" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21373" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">42 </div><div id="a21597" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:76px;top:443px;">$50</div><div id="a21598" style="position:absolute;font-family:'Times New Roman';font-size:13.312px;font-weight:bold;left:69px;top:399px;">$100</div><div id="a21599" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:69px;top:354px;">$150</div><div id="a21600" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:69px;top:310px;">$200</div><div id="a21601" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:69px;top:266px;">$250</div><div id="a21602" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:69px;top:222px;">$300</div><div id="a21603" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:127px;top:459px;">December</div><div id="a21604" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:143px;top:474px;">2017</div><div id="a21605" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:224px;top:459px;">December</div><div id="a21606" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:240px;top:474px;">2018</div><div id="a21607" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:322px;top:459px;">December</div><div id="a21608" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:337px;top:474px;">2019</div><div id="a21609" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:419px;top:459px;">December</div><div id="a21610" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:435px;top:474px;">2020</div><div id="a21611" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:516px;top:459px;">December</div><div id="a21612" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:532px;top:474px;">2021</div><div id="a21613" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:614px;top:459px;">December</div><div id="a21614" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:629px;top:474px;">2022</div><div id="a21615" style="position:absolute;font-family:'Times New Roman';left:305px;top:506px;">Henry Schein, Inc.</div><div id="a21616" style="position:absolute;font-family:'Times New Roman';left:305px;top:538px;">Dow Jones US Health Care Index</div><div id="a21617" style="position:absolute;font-family:'Times New Roman';left:305px;top:571px;">NASDAQ Composite Index</div><div id="a21375" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Stock Performance Graph </div><div id="a21378" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">The graph below compares the cumulative total stockholder return<div style="display:inline-block;width:2px">&nbsp;</div>on $100 invested, assuming the reinvestment of </div><div id="a21379" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">all dividends, on December 30, 2017, the last trading day before the<div style="display:inline-block;width:2px">&nbsp;</div>beginning of our 2018 fiscal year, through the </div><div id="a21386" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">end of our 2022 fiscal year with the cumulative total return on $100<div style="display:inline-block;width:2px">&nbsp;</div>invested for the same period in the Dow Jones </div><div id="a21391" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">U.S. Health Care Index and the Nasdaq Stock Market Composite Index. </div><div id="a21397" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:203px;top:178px;">COMPARISON OF 5-YEAR CUMULATIVE TOTAL<div style="display:inline-block;width:6px">&nbsp;</div>RETURN </div><div id="a21403" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:233px;top:645px;">ASSUMES $100 INVESTED ON DECEMBER 30, 2017 </div><div id="a21405" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:281px;top:665px;">ASSUMES DIVIDENDS REINVESTED </div><div id="a21428" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:221px;top:691px;">December 30, </div><div id="a21431" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:311px;top:691px;">December 29, </div><div id="a21434" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:401px;top:691px;">December 28, </div><div id="a21437" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:491px;top:691px;">December 26, </div><div id="a21440" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:581px;top:691px;">December 25, </div><div id="a21443" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:671px;top:691px;">December 31, </div><div id="a21447" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:244px;top:708px;">2017 </div><div id="a21450" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:334px;top:708px;">2018 </div><div id="a21453" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:424px;top:708px;">2019 </div><div id="a21456" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:514px;top:708px;">2020 </div><div id="a21459" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:604px;top:708px;">2021 </div><div id="a21462" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:694px;top:708px;">2022 </div><div id="a21464" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:726px;">Henry Schein, Inc.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21467" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:213px;top:726px;">$ </div><div id="a21469" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:244px;top:726px;">100.00 </div><div id="a21473" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:303px;top:726px;">$ </div><div id="a21475" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:334px;top:726px;">111.49 </div><div id="a21478" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:393px;top:726px;">$ </div><div id="a21480" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:424px;top:726px;">122.98 </div><div id="a21483" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:483px;top:726px;">$ </div><div id="a21485" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:514px;top:726px;">121.58 </div><div id="a21488" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:573px;top:726px;">$ </div><div id="a21490" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:604px;top:726px;">138.37 </div><div id="a21493" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:663px;top:726px;">$ </div><div id="a21495" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:694px;top:726px;">147.48 </div><div id="a21497" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:746px;">Dow Jones U.S. Health </div><div id="a21517" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:766px;"><div style="display:inline-block;width:9px">&nbsp;</div>Care Index<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21522" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:244px;top:766px;">100.00 </div><div id="a21526" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:334px;top:766px;">104.72 </div><div id="a21530" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:424px;top:766px;">129.31 </div><div id="a21534" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:514px;top:766px;">147.48 </div><div id="a21538" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:604px;top:766px;">183.33 </div><div id="a21542" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:694px;top:766px;">176.40 </div><div id="a21544" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:786px;">NASDAQ Stock Market </div><div id="a21564" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:806px;"><div style="display:inline-block;width:9px">&nbsp;</div>Composite Index<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21569" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:244px;top:806px;">100.00 </div><div id="a21573" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:337px;top:806px;">96.41 </div><div id="a21577" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:424px;top:806px;">133.30 </div><div id="a21581" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:514px;top:806px;">191.21 </div><div id="a21585" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:604px;top:806px;">235.27 </div><div id="a21589" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:694px;top:806px;">158.65 </div><div id="a21592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:836px;">ITEM 6. </div><div id="a21595" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:870px;">[Reserved] </div></div>
</div>
<div style="padding: 7px">
<div id="Page43" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a21618" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">43 </div><div id="a21623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 7.<div style="display:inline-block;width:7px">&nbsp;</div>Management’s Discussion and Analysis of Financial Condition and Results of<div style="display:inline-block;width:2px">&nbsp;</div>Operations </div><div id="a21628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:93px;">Cautionary Note Regarding Forward-Looking Statements<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a21633" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">In accordance with the “Safe Harbor” provisions of the Private Securities<div style="display:inline-block;width:2px">&nbsp;</div>Litigation Reform Act of 1995, we </div><div id="a21634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">provide the following cautionary remarks regarding important factors<div style="display:inline-block;width:2px">&nbsp;</div>that, among others, could cause future results </div><div id="a21636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">to differ materially from the forward-looking statements, expectations and assumptions<div style="display:inline-block;width:2px">&nbsp;</div>expressed or implied </div><div id="a21639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">herein.<div style="display:inline-block;width:7px">&nbsp;</div>All forward-looking statements made by us are subject to<div style="display:inline-block;width:2px">&nbsp;</div>risks and uncertainties and are not guarantees of </div><div id="a21646" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">future performance.<div style="display:inline-block;width:7px">&nbsp;</div>These forward-looking statements involve known and unknown<div style="display:inline-block;width:2px">&nbsp;</div>risks, uncertainties and other </div><div id="a21652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">factors that may cause our actual results, performance and achievements<div style="display:inline-block;width:2px">&nbsp;</div>or industry results to be materially </div><div id="a21653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">different from any future results, performance or achievements expressed or implied by such forward-looking </div><div id="a21657" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">statements.<div style="display:inline-block;width:7px">&nbsp;</div>These statements are generally identified by the use of such<div style="display:inline-block;width:2px">&nbsp;</div>terms as “may,” “could,” “expect,” </div><div id="a21661" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">“intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,”<div style="display:inline-block;width:2px">&nbsp;</div>“to be,” “to make” or other comparable </div><div id="a21663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">terms.<div style="display:inline-block;width:7px">&nbsp;</div>Factors that could cause or contribute to such differences include, but are not limited<div style="display:inline-block;width:2px">&nbsp;</div>to, those discussed in </div><div id="a21668" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">this Annual Report on Form 10-K, and in particular the risks discussed under<div style="display:inline-block;width:2px">&nbsp;</div>the caption “Risk Factors” in Item 1A </div><div id="a21675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">of this report and those that may be discussed in other documents we<div style="display:inline-block;width:2px">&nbsp;</div>file with the Securities and Exchange </div><div id="a21679" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">Commission (SEC).<div style="display:inline-block;width:7px">&nbsp;</div>Forward looking statements include the overall impact of the Novel Coronavirus<div style="display:inline-block;width:2px">&nbsp;</div>Disease 2019 </div><div id="a21682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">(COVID-19) on us, our results of operations, liquidity and financial condition<div style="display:inline-block;width:2px">&nbsp;</div>(including any estimates of the </div><div id="a21688" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">impact on these items), the rate and consistency with which dental<div style="display:inline-block;width:2px">&nbsp;</div>and other practices resume or maintain normal </div><div id="a21689" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">operations in the United States and internationally, expectations regarding personal protective equipment (“PPE”) </div><div id="a21691" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">products and COVID-19 related product sales and inventory levels, whether<div style="display:inline-block;width:2px">&nbsp;</div>additional resurgences or variants of </div><div id="a21695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">the virus will adversely impact the resumption of normal operations, whether<div style="display:inline-block;width:2px">&nbsp;</div>supply chain disruptions will </div><div id="a21697" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">adversely impact our business, the impact of integration and restructuring<div style="display:inline-block;width:2px">&nbsp;</div>programs as well as of any future </div><div id="a21700" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">acquisitions, general economic conditions including exchange rates,<div style="display:inline-block;width:2px">&nbsp;</div>inflation and recession, and more generally </div><div id="a21705" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">current expectations regarding performance in current and future periods.<div style="display:inline-block;width:6px">&nbsp;</div>Forward looking statements also include </div><div id="a21707" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">the (i) our ability to have continued access to a variety of COVID-19<div style="display:inline-block;width:2px">&nbsp;</div>test types, expectations regarding COVID-19 </div><div id="a21713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">test sales, demand and inventory levels, as well as the efficacy or relative efficacy of the test<div style="display:inline-block;width:2px">&nbsp;</div>results given that the </div><div id="a21715" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">test efficacy has not been, or will not have been, independently verified under<div style="display:inline-block;width:2px">&nbsp;</div>normal FDA procedures and (ii) </div><div id="a21717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">potential for us to distribute the COVID-19 vaccines and ancillary supplies.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a21726" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">Risk factors and uncertainties that could cause actual results to differ materially from<div style="display:inline-block;width:2px">&nbsp;</div>current and historical results </div><div id="a21727" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">include, but are not limited to: risks associated with COVID-19<div style="display:inline-block;width:2px">&nbsp;</div>and any variants thereof, as well as other disease </div><div id="a21730" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">outbreaks, epidemics, pandemics, or similar wide-spread public health concerns<div style="display:inline-block;width:2px">&nbsp;</div>and other natural disasters; our </div><div id="a21734" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">dependence on third parties for the manufacture and supply of our products;<div style="display:inline-block;width:2px">&nbsp;</div>our ability to develop or acquire and </div><div id="a21736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">maintain and protect new products (particularly technology products) and<div style="display:inline-block;width:2px">&nbsp;</div>technologies that achieve market </div><div id="a21740" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">acceptance with acceptable margins; transitional challenges associated with acquisitions,<div style="display:inline-block;width:2px">&nbsp;</div>dispositions and joint </div><div id="a21742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">ventures, including the failure to achieve anticipated synergies/benefits; legal, regulatory, compliance, </div><div id="a21744" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">cybersecurity, financial and tax risks associated with acquisitions, dispositions and joint ventures; certain provisions </div><div id="a21745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">in our governing documents that may discourage third-party acquisitions<div style="display:inline-block;width:2px">&nbsp;</div>of us; adverse changes in supplier rebates </div><div id="a21749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">or other purchasing incentives; risks related to the sale of corporate brand<div style="display:inline-block;width:2px">&nbsp;</div>products; effects of a highly competitive </div><div id="a21750" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">(including, without limitation, competition from third-party online commerce<div style="display:inline-block;width:2px">&nbsp;</div>sites) and consolidating market; the </div><div id="a21755" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">repeal or judicial prohibition on implementation of the Affordable Care Act; changes in the health<div style="display:inline-block;width:2px">&nbsp;</div>care industry; </div><div id="a21759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">risks from expansion of customer purchasing power and multi-tiered<div style="display:inline-block;width:2px">&nbsp;</div>costing structures; increases in shipping costs </div><div id="a21762" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">for our products or other service issues with our third-party shippers; general<div style="display:inline-block;width:2px">&nbsp;</div>global and domestic macro-economic </div><div id="a21768" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">and political conditions, including inflation, deflation, recession, fluctuations<div style="display:inline-block;width:2px">&nbsp;</div>in energy pricing and the value of the </div><div id="a21769" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">U.S. dollar as compared to foreign currencies, and changes to other economic<div style="display:inline-block;width:2px">&nbsp;</div>indicators, international trade </div><div id="a21771" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">agreements, potential trade barriers and terrorism; failure to comply with existing<div style="display:inline-block;width:2px">&nbsp;</div>and future regulatory </div><div id="a21773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">requirements; risks associated with the EU Medical Device Regulation; failure<div style="display:inline-block;width:2px">&nbsp;</div>to comply with laws and regulations </div><div id="a21778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">relating to health care fraud or other laws and regulations; failure to comply with<div style="display:inline-block;width:2px">&nbsp;</div>laws and regulations relating to </div><div id="a21780" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">the collection, storage and processing of sensitive personal information<div style="display:inline-block;width:2px">&nbsp;</div>or standards in electronic health records or </div><div id="a21781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">transmissions; changes in tax legislation; risks related to product liability, intellectual property and other claims; </div><div id="a21783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">litigation risks;<div style="display:inline-block;width:7px">&nbsp;</div>new or unanticipated litigation developments and the status of litigation<div style="display:inline-block;width:2px">&nbsp;</div>matters; risks associated </div><div id="a21788" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">with customs policies or legislative import restrictions; cyberattacks<div style="display:inline-block;width:2px">&nbsp;</div>or other privacy or data security breaches; risks </div><div id="a21790" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">associated with our global operations; our dependence on our senior management,<div style="display:inline-block;width:2px">&nbsp;</div>employee hiring and retention, </div><div id="a21791" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">and our relationships with customers, suppliers and manufacturers;<div style="display:inline-block;width:2px">&nbsp;</div>and disruptions in financial markets.<div style="display:inline-block;width:7px">&nbsp;</div>The order </div><div id="a21793" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:987px;">in which these factors appear should not be construed to indicate their<div style="display:inline-block;width:2px">&nbsp;</div>relative importance or priority.</div></div>
</div>
<div style="padding: 7px">
<div id="Page44" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a21795" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21798" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">44 </div><div id="a21800" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control </div><div id="a21802" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">or predict.<div style="display:inline-block;width:7px">&nbsp;</div>Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction </div><div id="a21808" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">of actual results.<div style="display:inline-block;width:7px">&nbsp;</div>We undertake no duty and have no obligation to update forward-looking statements except as </div><div id="a21815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">required by law.</div><div id="a21818" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:144px;">Where You<div style="display:inline-block;width:6px">&nbsp;</div>Can Find Important Information </div><div id="a21821" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">We may disclose important information through one or more of the following channels: SEC filings, public </div><div id="a21822" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">conference calls and webcasts, press releases, the investor relations<div style="display:inline-block;width:2px">&nbsp;</div>page of our website (www.henryschein.com) </div><div id="a21826" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">and the social media channels identified on the Newsroom page of our website. </div><div id="a21829" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:245px;">Recent Developments </div><div id="a21832" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:277px;">The COVID-19 pandemic negatively impacted the global economy, disrupted global supply chains and created </div><div id="a21835" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:294px;">significant volatility and disruption of global financial markets in<div style="display:inline-block;width:2px">&nbsp;</div>2020 and 2021.<div style="display:inline-block;width:7px">&nbsp;</div>The impact of COVID-19 had a </div><div id="a21838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:311px;">material adverse effect on our business, results of operations and cash flows in 2020.<div style="display:inline-block;width:6px">&nbsp;</div>During the year ended </div><div id="a21840" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:328px;">December 25, 2021, patient traffic levels returned to levels approaching pre-pandemic<div style="display:inline-block;width:2px">&nbsp;</div>levels.<div style="display:inline-block;width:7px">&nbsp;</div>Demand for dental </div><div id="a21843" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:345px;">products and certain medical products throughout 2021 was driven<div style="display:inline-block;width:2px">&nbsp;</div>by sales of PPE and COVID-19 test kits.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21847" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:362px;">During the year ended December 31, 2022 we experienced a decrease<div style="display:inline-block;width:2px">&nbsp;</div>in the sales volume of PPE and COVID-19 </div><div id="a21850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:379px;">test kits.<div style="display:inline-block;width:7px">&nbsp;</div>The volatility in sales of COVID-19 test kits has moderated, albeit at a significantly<div style="display:inline-block;width:2px">&nbsp;</div>lower level of sales </div><div id="a21854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:395px;">compared with 2021, resulting in us recording an inventory obsolescence<div style="display:inline-block;width:2px">&nbsp;</div>reserve of $17 million for COVID-19 test </div><div id="a21857" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:412px;">kits during the year ended December 31, 2022. </div><div id="a21860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:446px;">While the U.S. economy has recently experienced inflationary<div style="display:inline-block;width:2px">&nbsp;</div>pressures and strengthening of the U.S dollar, their </div><div id="a21862" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:463px;">impacts have not been material to our results of operations in the<div style="display:inline-block;width:2px">&nbsp;</div>fourth quarter or full year ended December 31, </div><div id="a21863" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:480px;">2022, and we currently expect moderating of inflation and foreign currency<div style="display:inline-block;width:2px">&nbsp;</div>fluctuations.<div style="display:inline-block;width:7px">&nbsp;</div>Though inflation impacts </div><div id="a21864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:497px;">both our revenues and costs, the depth and breadth of our product portfolio<div style="display:inline-block;width:2px">&nbsp;</div>often allows us to offer lower-cost </div><div id="a21868" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:514px;">national brand solutions or corporate brand alternatives to our more<div style="display:inline-block;width:2px">&nbsp;</div>price-sensitive customers who are unable to </div><div id="a21871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:530px;">absorb price increases, thus positioning us to protect our gross profit. </div><div id="a21875" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:564px;">Our consolidated financial statements reflect estimates and assumptions<div style="display:inline-block;width:2px">&nbsp;</div>made by us that affect, among other things, </div><div id="a21876" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:581px;">our goodwill, long-lived asset and definite-lived intangible asset valuation;<div style="display:inline-block;width:2px">&nbsp;</div>inventory valuation; equity investment </div><div id="a21882" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:598px;">valuation; assessment of the annual effective tax rate; valuation of deferred income<div style="display:inline-block;width:2px">&nbsp;</div>taxes and income tax </div><div id="a21883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:615px;">contingencies; the allowance for doubtful accounts; hedging activity; supplier<div style="display:inline-block;width:2px">&nbsp;</div>rebates; measurement of </div><div id="a21884" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:632px;">compensation cost for certain share-based performance awards and cash<div style="display:inline-block;width:2px">&nbsp;</div>bonus plans; and pension plan </div><div id="a21888" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:648px;">assumptions.<div style="display:inline-block;width:7px">&nbsp;</div>Due to the significant uncertainty surrounding the future impact<div style="display:inline-block;width:2px">&nbsp;</div>of COVID-19, our judgments </div><div id="a21891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:665px;">regarding estimates and impairments could change in the future.<div style="display:inline-block;width:6px">&nbsp;</div>There is an ongoing risk that the COVID-19 </div><div id="a21895" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:682px;">pandemic may again have a material adverse effect on our business, results of operations<div style="display:inline-block;width:2px">&nbsp;</div>and cash flows and may </div><div id="a21896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:699px;">result in a material adverse effect on our financial condition and liquidity.<div style="display:inline-block;width:7px">&nbsp;</div>However, the extent of the potential </div><div id="a21897" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:716px;">impact cannot be reasonably estimated at this time. </div></div>
</div>
<div style="padding: 7px">
<div id="Page45" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a21899" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a21902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">45 </div><div id="a21904" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Executive-Level Overview<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a21912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:92px;">Henry Schein, Inc. is a solutions company for health care professionals powered<div style="display:inline-block;width:2px">&nbsp;</div>by a network of people and </div><div id="a21948" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:109px;">technology.<div style="display:inline-block;width:8px">&nbsp;</div>We believe we are the world’s<div style="display:inline-block;width:5px">&nbsp;</div>largest provider of health care products and services primarily to office-</div><div id="a21985" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:126px;">based dental and medical practitioners, as well as alternate sites of care.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a22009" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:495px;top:126px;">We </div><div id="a22011" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:519px;top:126px;">serve more than one million customers </div><div id="a22023" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:142px;">worldwide including dental practitioners, laboratories, physician practices, and<div style="display:inline-block;width:2px">&nbsp;</div>ambulatory surgery centers, as well </div><div id="a22050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:159px;">as government, institutional health care clinics and other alternate care clinics.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a22072" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:534px;top:159px;">We </div><div id="a22074" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:558px;top:159px;">believe that we have a strong </div><div id="a22086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:176px;">brand identity due to our more than 90 years of experience distributing health<div style="display:inline-block;width:2px">&nbsp;</div>care products. </div><div id="a22117" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:210px;">We are headquartered in Melville, New York,<div style="display:inline-block;width:6px">&nbsp;</div>employ approximately 22,000 people (of which approximately </div><div id="a22119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:227px;">10,700 are based outside of the United States) and have operations or<div style="display:inline-block;width:2px">&nbsp;</div>affiliates in 32 countries and territories.<div style="display:inline-block;width:7px">&nbsp;</div>Our </div><div id="a22120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:244px;">broad global footprint has evolved over time through our organic success as well as<div style="display:inline-block;width:2px">&nbsp;</div>through contribution from </div><div id="a22122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:261px;">strategic acquisitions. </div><div id="a22125" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:294px;">We </div><div id="a22127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:294px;">have established strategically located distribution centers around<div style="display:inline-block;width:2px">&nbsp;</div>the world to enable us to better serve our </div><div id="a22159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:311px;">customers and increase our operating efficiency.<div style="display:inline-block;width:8px">&nbsp;</div>This infrastructure, together with broad product and service </div><div id="a22187" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:328px;">offerings at competitive prices, and a strong commitment to customer service, enables<div style="display:inline-block;width:2px">&nbsp;</div>us to be a single source of </div><div id="a22225" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:345px;">supply for our customers’ needs. </div><div id="a22236" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:379px;">While our primary go-to-market strategy is in our capacity as a distributor, we also market and sell under<div style="display:inline-block;width:2px">&nbsp;</div>our own </div><div id="a22265" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:395px;">corporate brand portfolio of cost-effective, high-quality consumable merchandise products,<div style="display:inline-block;width:2px">&nbsp;</div>and manufacture certain </div><div id="a22276" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:412px;">dental specialty products in the areas of implants, orthodontics and endodontics.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a22298" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:545px;top:412px;">We </div><div id="a22300" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:569px;top:412px;">have achieved scale in these </div><div id="a22310" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:429px;">global businesses primarily through acquisitions as manufacturers of these<div style="display:inline-block;width:2px">&nbsp;</div>products typically do not utilize a </div><div id="a22340" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:446px;">distribution channel to serve customers. </div><div id="a22351" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:480px;">We </div><div id="a22353" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:480px;">conduct our business through two reportable segments: (i) health<div style="display:inline-block;width:2px">&nbsp;</div>care distribution and (ii) technology and </div><div id="a22383" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:497px;">value-added services.<div style="display:inline-block;width:7px">&nbsp;</div>These segments offer different products and services to the same customer base.<div style="display:inline-block;width:6px">&nbsp;</div>Our global </div><div id="a22417" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:514px;">dental businesses serve office-based dental practitioners, dental laboratories, schools, government<div style="display:inline-block;width:2px">&nbsp;</div>and other </div><div id="a22443" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:530px;">institutions.<div style="display:inline-block;width:7px">&nbsp;</div>Our medical businesses serve physician offices, urgent care centers, ambulatory care sites, emergency </div><div id="a22447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:547px;">medical technicians, dialysis centers, home health, federal and state governments<div style="display:inline-block;width:2px">&nbsp;</div>and large enterprises, such as </div><div id="a22448" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:564px;">group practices and integrated delivery networks, among other providers<div style="display:inline-block;width:2px">&nbsp;</div>across a wide range of specialties.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a22453" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:598px;">The health care distribution reportable segment, combining our global dental and<div style="display:inline-block;width:2px">&nbsp;</div>medical operating segments, </div><div id="a22481" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:615px;">distributes consumable products, small equipment, laboratory products, large equipment, equipment<div style="display:inline-block;width:2px">&nbsp;</div>repair services, </div><div id="a22505" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:632px;">branded and generic pharmaceuticals, vaccines, surgical products, dental specialty<div style="display:inline-block;width:2px">&nbsp;</div>products (including implant, </div><div id="a22530" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:648px;">orthodontic and endodontic products), diagnostic tests, infection-control products,<div style="display:inline-block;width:2px">&nbsp;</div>PPE products and vitamins.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a22558" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:682px;">Our global technology and value-added services business provides software, technology<div style="display:inline-block;width:2px">&nbsp;</div>and other value-added </div><div id="a22589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:699px;">services to health care practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Our technology business offerings include practice management software </div><div id="a22615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:716px;">systems for dental and medical practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Our value-added practice solutions include practice consultancy, </div><div id="a22640" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:733px;">education, revenue cycle management and financial services on a non-recourse<div style="display:inline-block;width:2px">&nbsp;</div>basis, e-services, practice </div><div id="a22661" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:750px;">technology, network and hardware services, as well as consulting, and continuing education services for </div><div id="a22689" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:767px;">practitioners. </div><div id="a22692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:800px;">A key element to grow closer to our customers is our One Schein initiative, which<div style="display:inline-block;width:2px">&nbsp;</div>is a unified go-to-market </div><div id="a22735" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:817px;">approach that enables practitioners to work synergistically with our supply chain,<div style="display:inline-block;width:2px">&nbsp;</div>equipment sales and service and </div><div id="a22767" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:834px;">other value-added services, allowing our customers to leverage the<div style="display:inline-block;width:2px">&nbsp;</div>combined value that we offer through a single </div><div id="a22803" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:851px;">program.<div style="display:inline-block;width:7px">&nbsp;</div>Specifically, One Schein provides customers with streamlined access to our comprehensive offering of </div><div id="a22831" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:868px;">national brand products, our corporate brand products and proprietary specialty<div style="display:inline-block;width:2px">&nbsp;</div>products and solutions (including </div><div id="a22860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:885px;">implant, orthodontic and endodontic products).<div style="display:inline-block;width:7px">&nbsp;</div>In addition, customers have access to a wide range of services, </div><div id="a22892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:901px;">including software and other value-added services.<div style="display:inline-block;width:3px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page46" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a22908" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a22911" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">46 </div><div id="a22913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Industry Overview</div><div id="a22918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">In recent years, the health care industry has increasingly focused on cost containment.<div style="display:inline-block;width:6px">&nbsp;</div>This trend has benefited </div><div id="a22952" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">distributors capable of providing a broad array of products and services at low<div style="display:inline-block;width:2px">&nbsp;</div>prices.<div style="display:inline-block;width:7px">&nbsp;</div>It also has accelerated the </div><div id="a22990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">growth of HMOs, group practices, other managed care accounts and collective buying<div style="display:inline-block;width:2px">&nbsp;</div>groups, which, in addition to </div><div id="a23024" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">their emphasis on obtaining products at competitive prices, tend to favor distributors<div style="display:inline-block;width:2px">&nbsp;</div>capable of providing </div><div id="a23054" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">specialized management information support.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a23062" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:343px;top:161px;">We </div><div id="a23064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:367px;top:161px;">believe that the trend towards cost containment has the potential </div><div id="a23085" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">to favorably affect demand for technology solutions, including software, which can<div style="display:inline-block;width:2px">&nbsp;</div>enhance the efficiency and </div><div id="a23115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">facilitation of practice management. </div><div id="a23124" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Our operating results in recent years have been significantly affected by strategies<div style="display:inline-block;width:2px">&nbsp;</div>and transactions that we </div><div id="a23157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">undertook to expand our business, domestically and internationally, in part to address significant changes in the </div><div id="a23189" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">health care industry, including consolidation of health care distribution companies, health care reform, trends </div><div id="a23218" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">toward managed care, cuts in Medicare and collective purchasing arrangements. </div><div id="a23239" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">Our current and future results have been and could be impacted by the COVID-19<div style="display:inline-block;width:2px">&nbsp;</div>pandemic, the current economic </div><div id="a23277" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">environment and continued economic and public health uncertainty.<div style="display:inline-block;width:7px">&nbsp;</div>Since the onset of the COVID-19 pandemic in </div><div id="a23312" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">early 2020, we have been carefully monitoring its impact on our global<div style="display:inline-block;width:2px">&nbsp;</div>operations and have taken appropriate steps </div><div id="a23348" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">to minimize the risk to our employees.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a23362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:301px;top:363px;">We </div><div id="a23364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:325px;top:363px;">have seen and expect to continue to see changes in demand trends<div style="display:inline-block;width:2px">&nbsp;</div>for </div><div id="a23391" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">some of our products and services, supply chain challenges and labor<div style="display:inline-block;width:2px">&nbsp;</div>challenges, as rates of infection fluctuate, new </div><div id="a23427" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">strains or variants of COVID-19 emerge and spread, governments adapt their approaches<div style="display:inline-block;width:2px">&nbsp;</div>to combatting the virus, </div><div id="a23461" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">and local conditions change across geographies.<div style="display:inline-block;width:7px">&nbsp;</div>As a result, we expect to see continued volatility. </div><div id="a23493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:448px;">Industry Consolidation</div><div id="a23498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">The health care products distribution industry, as it relates to office-based health care practitioners, is fragmented </div><div id="a23532" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">and diverse.<div style="display:inline-block;width:7px">&nbsp;</div>The industry ranges from sole practitioners working out of<div style="display:inline-block;width:2px">&nbsp;</div>relatively small offices to group practices </div><div id="a23566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">or service organizations ranging in size from a few practitioners to a large number of practitioners who have </div><div id="a23602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">combined or otherwise associated their practices. </div><div id="a23615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">Due in part to the inability of office-based health care practitioners to store and manage<div style="display:inline-block;width:2px">&nbsp;</div>large quantities of supplies </div><div id="a23655" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">in their offices, the distribution of health care supplies and small equipment to office-based health<div style="display:inline-block;width:2px">&nbsp;</div>care practitioners </div><div id="a23692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">has been characterized by frequent, small quantity orders, and a need for rapid,<div style="display:inline-block;width:2px">&nbsp;</div>reliable and substantially complete </div><div id="a23726" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">order fulfillment.<div style="display:inline-block;width:7px">&nbsp;</div>The purchasing decisions within an office-based health care practice are typically<div style="display:inline-block;width:2px">&nbsp;</div>made by the </div><div id="a23761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">practitioner or an administrative assistant.<div style="display:inline-block;width:7px">&nbsp;</div>Supplies and small equipment are generally purchased from more<div style="display:inline-block;width:2px">&nbsp;</div>than </div><div id="a23791" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">one distributor, with one generally serving as the primary supplier. </div><div id="a23813" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">The trend of consolidation extends to our customer base.<div style="display:inline-block;width:6px">&nbsp;</div>Health care practitioners are increasingly seeking to </div><div id="a23845" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">partner, affiliate or combine with larger entities such as hospitals, health systems, group practices or physician </div><div id="a23877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">hospital organizations.<div style="display:inline-block;width:7px">&nbsp;</div>In many cases, purchasing decisions for consolidated groups<div style="display:inline-block;width:2px">&nbsp;</div>are made at a centralized or </div><div id="a23910" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">professional staff level; however, orders are delivered to the practitioners’ offices. </div><div id="a23933" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">We </div><div id="a23935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:91px;top:768px;">believe that consolidation within the industry will continue to<div style="display:inline-block;width:2px">&nbsp;</div>result in a number of distributors, particularly </div><div id="a23968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">those with limited financial, operating and marketing resources, seeking to<div style="display:inline-block;width:2px">&nbsp;</div>combine with larger companies that can </div><div id="a24000" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">provide growth opportunities.<div style="display:inline-block;width:7px">&nbsp;</div>This consolidation also may continue to result in distributors seeking<div style="display:inline-block;width:2px">&nbsp;</div>to acquire </div><div id="a24030" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">companies that can enhance their current product and service offerings or provide<div style="display:inline-block;width:2px">&nbsp;</div>opportunities to serve a broader </div><div id="a24064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">customer base. </div><div id="a24069" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:869px;">Our approach to acquisitions and joint ventures has been to expand our role as<div style="display:inline-block;width:2px">&nbsp;</div>a provider of products and services </div><div id="a24109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">to the health care industry.<div style="display:inline-block;width:8px">&nbsp;</div>This trend has resulted in our expansion into service areas that complement<div style="display:inline-block;width:2px">&nbsp;</div>our existing </div><div id="a24147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">operations and provide opportunities for us to develop synergies with, and thus strengthen, the acquired<div style="display:inline-block;width:2px">&nbsp;</div>businesses. </div><div id="a24180" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">As industry<div style="display:inline-block;width:4px">&nbsp;</div>consolidation continues, we believe that we are positioned to capitalize<div style="display:inline-block;width:2px">&nbsp;</div>on this trend, as we believe we </div><div id="a24219" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">have the ability to support increased sales through our existing infrastructure, although<div style="display:inline-block;width:2px">&nbsp;</div>there can be no assurances </div><div id="a24253" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:971px;">that we will be able to successfully accomplish this.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a24272" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:379px;top:971px;">We </div><div id="a24274" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:403px;top:971px;">also have invested in expanding our sales/marketing </div></div>
</div>
<div style="padding: 7px">
<div id="Page47" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a24288" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a24291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">47 </div><div id="a24293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">infrastructure to include a focus on building relationships with decision<div style="display:inline-block;width:2px">&nbsp;</div>makers who do not reside in the office-</div><div id="a24329" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:76px;">based practitioner setting. </div><div id="a24336" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">As the health care industry continues to change, we continually evaluate possible<div style="display:inline-block;width:2px">&nbsp;</div>candidates for joint venture or </div><div id="a24371" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">acquisition and intend to continue to seek opportunities to expand our<div style="display:inline-block;width:2px">&nbsp;</div>role as a provider of products and services to </div><div id="a24411" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">the health care industry.<div style="display:inline-block;width:8px">&nbsp;</div>There can be no assurance that we will be able to successfully pursue<div style="display:inline-block;width:2px">&nbsp;</div>any such </div><div id="a24449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">opportunity or consummate any such transaction, if pursued.<div style="display:inline-block;width:6px">&nbsp;</div>If additional transactions are entered into or </div><div id="a24479" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">consummated, we would incur merger and/or acquisition-related costs, and there<div style="display:inline-block;width:2px">&nbsp;</div>can be no assurance that the </div><div id="a24514" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">integration efforts associated with any such transaction would be successful. </div><div id="a24535" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:228px;">Aging Population and Other Market Influences</div><div id="a24548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">The health care products distribution industry continues to experience growth<div style="display:inline-block;width:2px">&nbsp;</div>due to the aging population, </div><div id="a24549" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">increased health care awareness, the proliferation of medical technology<div style="display:inline-block;width:2px">&nbsp;</div>and testing, new pharmacology treatments, </div><div id="a24551" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">and expanded third-party insurance coverage, partially offset by the effects of unemployment on insurance </div><div id="a24554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">coverage.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, the physician market continues to benefit from<div style="display:inline-block;width:2px">&nbsp;</div>the shift of procedures and diagnostic testing </div><div id="a24556" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">from acute care settings to alternate-care sites, particularly physicians’<div style="display:inline-block;width:2px">&nbsp;</div>offices. </div><div id="a24561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">According to the U.S. Census Bureau’s International Database, between 2022 and 2032, the 45 and older </div><div id="a24563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">population is expected to grow by approximately 11%.<div style="display:inline-block;width:7px">&nbsp;</div>Between 2022 and 2042, this age group is expected to grow </div><div id="a24564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">by approximately 21%.<div style="display:inline-block;width:7px">&nbsp;</div>This compares with expected total U.S. population growth<div style="display:inline-block;width:2px">&nbsp;</div>rates of approximately 6% </div><div id="a24565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">between 2022 and 2032 and approximately 12% between 2022 and 2042. </div><div id="a24569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">According to the U.S. Census Bureau’s International Database, in 2022 there are approximately seven million </div><div id="a24570" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">Americans aged 85 years or older, the segment of the population most in need of long-term care<div style="display:inline-block;width:2px">&nbsp;</div>and elder-care </div><div id="a24575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">services.<div style="display:inline-block;width:7px">&nbsp;</div>By the year 2050, that number is projected to nearly triple to approximately<div style="display:inline-block;width:2px">&nbsp;</div>19 million.<div style="display:inline-block;width:7px">&nbsp;</div>The population </div><div id="a24577" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">aged 65 to 84 years is projected to increase by approximately 27% during<div style="display:inline-block;width:2px">&nbsp;</div>the same period. </div><div id="a24580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">As a result of these market dynamics, annual expenditures for health care services<div style="display:inline-block;width:2px">&nbsp;</div>continue to increase in the </div><div id="a24582" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">United States.<div style="display:inline-block;width:7px">&nbsp;</div>We believe that demand for our products and services will grow while continuing to be impacted by </div><div id="a24583" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">current and future operating, economic, and industry conditions.<div style="display:inline-block;width:6px">&nbsp;</div>The Centers for Medicare and Medicaid Services, </div><div id="a24585" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">or CMS, published “National Health Expenditure Data” indicating<div style="display:inline-block;width:2px">&nbsp;</div>that total national health care spending reached </div><div id="a24586" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">approximately $4.3 trillion in 2021, or 18.3% of the nation’s gross domestic product, the benchmark<div style="display:inline-block;width:2px">&nbsp;</div>measure for </div><div id="a24587" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">annual production of goods and services in the United States.<div style="display:inline-block;width:6px">&nbsp;</div>Health care spending is projected to reach </div><div id="a24589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">approximately $6.2 trillion in 2028, or 19.7% of the nation’s projected gross domestic product. </div><div id="a24592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:667px;">Government<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a24596" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">Our businesses are generally subject to numerous laws and regulations that could<div style="display:inline-block;width:2px">&nbsp;</div>impact our financial performance, </div><div id="a24598" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">and failure to comply with such laws or regulations could have a<div style="display:inline-block;width:2px">&nbsp;</div>material adverse effect on our business.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a24601" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">See “</div><div id="a24602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:99px;top:751px;"><a href="#a1979" style="color:#0000FF;text-decoration:underline;">Item 1. Business – Governmental Regulations</a></div><div id="a24607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:368px;top:751px;">” for a discussion of laws, regulations and governmental activity </div><div id="a24608" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">that may affect our results of operations and financial condition. </div></div>
</div>
<div style="padding: 7px">
<div id="Page48" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:298px; height:1px; left:449.9px; top:225.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:258.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:259.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:383.1px; height:1px; left:66.8px; top:257.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:17px; left:440.3px; top:257.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:449.9px; top:257.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:542.9px; top:257.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553px; top:257.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17px; left:646.4px; top:257.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:655.9px; top:257.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:290.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:291.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:449.9px; top:306.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553px; top:306.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:655.9px; top:306.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:322.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:323.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:354.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:355.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:388.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:390.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:18.1px; left:67.2px; top:387.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:383.1px; height:1px; left:66.8px; top:387.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:440.3px; top:387.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:449.9px; top:387.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:542.9px; top:387.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553px; top:387.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:646.4px; top:387.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:655.9px; top:387.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:450.3px; top:405.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:450.3px; top:407.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553.4px; top:405.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553.4px; top:407.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:656.3px; top:405.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:656.3px; top:407.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:423.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:425.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:457.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:459.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:491.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:493.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:298px; height:1px; left:449.9px; top:539.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:449.9px; top:571.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:553px; top:571.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:655.9px; top:571.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:587.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:588.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:619.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:620.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a24610" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a24613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">48 </div><div id="a24615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Results of Operations </div><div id="a24618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:92px;">Refer to Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations in </div><div id="a24620" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:109px;">our 2021 Annual Report on Form 10-K for management’s discussion and analysis of financial condition and results </div><div id="a24628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:126px;">of operations for the fiscal year 2021 compared to fiscal year 2020. </div><div id="a24636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:159px;">The following tables summarize the significant components of our operating<div style="display:inline-block;width:2px">&nbsp;</div>results and cash flows from continuing </div><div id="a24638" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:176px;">operations: </div><div id="a24645" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:562px;top:211px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a24651" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:458px;top:227px;">December 31, </div><div id="a24654" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:561px;top:227px;">December 25, </div><div id="a24657" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:663px;top:227px;">December 26, </div><div id="a24663" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:483px;top:243px;">2022 </div><div id="a24666" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:586px;top:243px;">2021 </div><div id="a24669" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:689px;top:243px;">2020 </div><div id="a24671" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:260px;">Operating results: </div><div id="a24682" style="position:absolute;font-family:'Times New Roman';left:67px;top:276px;">Net sales </div><div id="a24685" style="position:absolute;font-family:'Times New Roman';left:450px;top:276px;">$ </div><div id="a24687" style="position:absolute;font-family:'Times New Roman';left:507px;top:276px;">12,647 </div><div id="a24690" style="position:absolute;font-family:'Times New Roman';left:553px;top:276px;">$ </div><div id="a24692" style="position:absolute;font-family:'Times New Roman';left:610px;top:276px;">12,401 </div><div id="a24695" style="position:absolute;font-family:'Times New Roman';left:656px;top:276px;">$ </div><div id="a24697" style="position:absolute;font-family:'Times New Roman';left:712px;top:276px;">10,119 </div><div id="a24699" style="position:absolute;font-family:'Times New Roman';left:67px;top:292px;">Cost of sales </div><div id="a24703" style="position:absolute;font-family:'Times New Roman';left:513px;top:292px;">8,816 </div><div id="a24707" style="position:absolute;font-family:'Times New Roman';left:616px;top:292px;">8,727 </div><div id="a24711" style="position:absolute;font-family:'Times New Roman';left:718px;top:292px;">7,303 </div><div id="a24714" style="position:absolute;font-family:'Times New Roman';left:82px;top:308px;">Gross profit<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a24718" style="position:absolute;font-family:'Times New Roman';left:513px;top:308px;">3,831 </div><div id="a24722" style="position:absolute;font-family:'Times New Roman';left:616px;top:308px;">3,674 </div><div id="a24726" style="position:absolute;font-family:'Times New Roman';left:718px;top:308px;">2,816 </div><div id="a24728" style="position:absolute;font-family:'Times New Roman';left:67px;top:324px;">Operating expenses: </div><div id="a24740" style="position:absolute;font-family:'Times New Roman';left:82px;top:340px;">Selling, general and administrative<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a24744" style="position:absolute;font-family:'Times New Roman';left:513px;top:340px;">2,771 </div><div id="a24748" style="position:absolute;font-family:'Times New Roman';left:616px;top:340px;">2,634 </div><div id="a24752" style="position:absolute;font-family:'Times New Roman';left:718px;top:340px;">2,086 </div><div id="a24755" style="position:absolute;font-family:'Times New Roman';left:82px;top:356px;">Depreciation and amortization </div><div id="a24759" style="position:absolute;font-family:'Times New Roman';left:523px;top:356px;">182 </div><div id="a24763" style="position:absolute;font-family:'Times New Roman';left:626px;top:356px;">180 </div><div id="a24767" style="position:absolute;font-family:'Times New Roman';left:728px;top:356px;">163 </div><div id="a24770" style="position:absolute;font-family:'Times New Roman';left:82px;top:373px;">Restructuring and integration costs </div><div id="a24774" style="position:absolute;font-family:'Times New Roman';left:523px;top:373px;">131 </div><div id="a24778" style="position:absolute;font-family:'Times New Roman';left:640px;top:373px;">8 </div><div id="a24782" style="position:absolute;font-family:'Times New Roman';left:735px;top:373px;">32 </div><div id="a24786" style="position:absolute;font-family:'Times New Roman';left:97px;top:391px;">Operating income </div><div id="a24789" style="position:absolute;font-family:'Times New Roman';left:450px;top:391px;">$ </div><div id="a24791" style="position:absolute;font-family:'Times New Roman';left:523px;top:391px;">747 </div><div id="a24794" style="position:absolute;font-family:'Times New Roman';left:553px;top:391px;">$ </div><div id="a24796" style="position:absolute;font-family:'Times New Roman';left:626px;top:391px;">852 </div><div id="a24799" style="position:absolute;font-family:'Times New Roman';left:656px;top:391px;">$ </div><div id="a24801" style="position:absolute;font-family:'Times New Roman';left:728px;top:391px;">535 </div><div id="a24813" style="position:absolute;font-family:'Times New Roman';left:67px;top:426px;">Other expense, net<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a24816" style="position:absolute;font-family:'Times New Roman';left:450px;top:426px;">$ </div><div id="a24818" style="position:absolute;font-family:'Times New Roman';left:521px;top:426px;">(26) </div><div id="a24821" style="position:absolute;font-family:'Times New Roman';left:553px;top:426px;">$ </div><div id="a24823" style="position:absolute;font-family:'Times New Roman';left:624px;top:426px;">(21) </div><div id="a24826" style="position:absolute;font-family:'Times New Roman';left:656px;top:426px;">$ </div><div id="a24828" style="position:absolute;font-family:'Times New Roman';left:726px;top:426px;">(35) </div><div id="a24830" style="position:absolute;font-family:'Times New Roman';left:67px;top:443px;">Gain on sale of equity investments, net of tax </div><div id="a24834" style="position:absolute;font-family:'Times New Roman';left:539px;top:443px;">- </div><div id="a24838" style="position:absolute;font-family:'Times New Roman';left:640px;top:443px;">7 </div><div id="a24842" style="position:absolute;font-family:'Times New Roman';left:742px;top:443px;">2 </div><div id="a24844" style="position:absolute;font-family:'Times New Roman';left:67px;top:460px;">Net income from continuing operations </div><div id="a24848" style="position:absolute;font-family:'Times New Roman';left:523px;top:460px;">566 </div><div id="a24852" style="position:absolute;font-family:'Times New Roman';left:626px;top:460px;">660 </div><div id="a24856" style="position:absolute;font-family:'Times New Roman';left:728px;top:460px;">419 </div><div id="a24858" style="position:absolute;font-family:'Times New Roman';left:67px;top:477px;">Income from discontinued operations, net of tax </div><div id="a24863" style="position:absolute;font-family:'Times New Roman';left:539px;top:477px;">- </div><div id="a24867" style="position:absolute;font-family:'Times New Roman';left:642px;top:477px;">- </div><div id="a24871" style="position:absolute;font-family:'Times New Roman';left:742px;top:477px;">1 </div><div id="a24873" style="position:absolute;font-family:'Times New Roman';left:67px;top:494px;">Net income attributable to Henry Schein, Inc. </div><div id="a24877" style="position:absolute;font-family:'Times New Roman';left:523px;top:494px;">538 </div><div id="a24881" style="position:absolute;font-family:'Times New Roman';left:626px;top:494px;">631 </div><div id="a24885" style="position:absolute;font-family:'Times New Roman';left:728px;top:494px;">404 </div><div id="a24903" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:562px;top:525px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a24909" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:458px;top:541px;">December 31, </div><div id="a24912" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:561px;top:541px;">December 25, </div><div id="a24915" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:663px;top:541px;">December 26, </div><div id="a24921" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:483px;top:557px;">2022 </div><div id="a24924" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:586px;top:557px;">2021 </div><div id="a24927" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:689px;top:557px;">2020 </div><div id="a24941" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:67px;top:589px;">Cash flows:<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a24952" style="position:absolute;font-family:'Times New Roman';left:67px;top:605px;">Net cash provided by operating activities from continuing operations </div><div id="a24955" style="position:absolute;font-family:'Times New Roman';left:450px;top:605px;">$ </div><div id="a24957" style="position:absolute;font-family:'Times New Roman';left:523px;top:605px;">602 </div><div id="a24960" style="position:absolute;font-family:'Times New Roman';left:553px;top:605px;">$ </div><div id="a24962" style="position:absolute;font-family:'Times New Roman';left:626px;top:605px;">710 </div><div id="a24965" style="position:absolute;font-family:'Times New Roman';left:656px;top:605px;">$ </div><div id="a24967" style="position:absolute;font-family:'Times New Roman';left:728px;top:605px;">594 </div><div id="a24969" style="position:absolute;font-family:'Times New Roman';left:67px;top:621px;">Net cash used in investing activities from continuing operations </div><div id="a24974" style="position:absolute;font-family:'Times New Roman';left:514px;top:621px;">(276) </div><div id="a24978" style="position:absolute;font-family:'Times New Roman';left:617px;top:621px;">(677) </div><div id="a24982" style="position:absolute;font-family:'Times New Roman';left:719px;top:621px;">(115) </div><div id="a24984" style="position:absolute;font-family:'Times New Roman';left:67px;top:637px;">Net cash used in financing activities from continuing operations </div><div id="a24988" style="position:absolute;font-family:'Times New Roman';left:514px;top:637px;">(315) </div><div id="a24992" style="position:absolute;font-family:'Times New Roman';left:617px;top:637px;">(333) </div><div id="a24996" style="position:absolute;font-family:'Times New Roman';left:719px;top:637px;">(182) </div></div>
</div>
<div style="padding: 7px">
<div id="Page49" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a24998" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a25001" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">49 </div><div id="a25003" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Plans of Restructuring and Integration Costs</div><div id="a25006" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">On August 1, 2022, we committed to a restructuring plan focused on<div style="display:inline-block;width:2px">&nbsp;</div>funding the priorities of the strategic plan and </div><div id="a25007" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">streamlining operations and other initiatives to increase efficiency.<div style="display:inline-block;width:7px">&nbsp;</div>We expect this initiative to extend through </div><div id="a25008" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">2023.<div style="display:inline-block;width:7px">&nbsp;</div>We are currently unable in good faith to make a determination of an estimate of the amount or range of </div><div id="a25010" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">amounts expected to be incurred in connection with these activities, both with<div style="display:inline-block;width:2px">&nbsp;</div>respect to each major type of cost </div><div id="a25011" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">associated therewith and with respect to the total cost, or an estimate of the<div style="display:inline-block;width:2px">&nbsp;</div>amount or range of amounts that will </div><div id="a25013" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">result in future cash expenditures. </div><div id="a25016" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">During the year ended December 31, 2022, we recorded restructuring charges of $128<div style="display:inline-block;width:2px">&nbsp;</div>million primarily related to </div><div id="a25019" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">severance and employee-related costs, accelerated amortization of right-of-use<div style="display:inline-block;width:2px">&nbsp;</div>lease assets, impairment of other </div><div id="a25026" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">long-lived assets and lease exit costs.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a25031" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">During the three months ended December 31, 2022, in connection with our restructuring<div style="display:inline-block;width:2px">&nbsp;</div>plan, we vacated one of </div><div id="a25033" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">the buildings at our corporate headquarters in Melville NY, which resulted in an accelerated amortization of right-</div><div id="a25035" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">of-use lease asset of $34 million.<div style="display:inline-block;width:7px">&nbsp;</div>We also initiated the disposal of a non-profitable US business and recorded </div><div id="a25041" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">related costs of $49 million which primarily consisted of impairment of<div style="display:inline-block;width:2px">&nbsp;</div>intangible assets and goodwill, inventory </div><div id="a25042" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">impairment, and severance and employee-related costs.<div style="display:inline-block;width:6px">&nbsp;</div>These expenses are included in the $128 million of </div><div id="a25045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">restructuring charges discussed above.<div style="display:inline-block;width:7px">&nbsp;</div>The disposal is expected to be completed in the first quarter of 2023.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a25049" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">On August 26, 2022, we acquired Midway Dental Supply.<div style="display:inline-block;width:7px">&nbsp;</div>In connection with this acquisition, during the year </div><div id="a25050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">ended December 31, 2022, we recorded integration costs of $3 million related<div style="display:inline-block;width:2px">&nbsp;</div>to one-time employee and other </div><div id="a25055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">costs, as well as restructuring charges of $9 million, which are included in the<div style="display:inline-block;width:2px">&nbsp;</div>$128 million of restructuring charges </div><div id="a25056" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">discussed above. </div><div id="a25059" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">On November 20, 2019, we committed to a contemplated restructuring<div style="display:inline-block;width:2px">&nbsp;</div>initiative intended to mitigate stranded costs </div><div id="a25063" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">associated with the spin-off of our animal health business and to rationalize operations<div style="display:inline-block;width:2px">&nbsp;</div>and provide expense </div><div id="a25066" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">efficiencies.<div style="display:inline-block;width:7px">&nbsp;</div>These activities were originally expected to be completed by<div style="display:inline-block;width:2px">&nbsp;</div>the end of 2020 but we extended them to </div><div id="a25068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">the end of 2021 in light of the changes to the business environment brought<div style="display:inline-block;width:2px">&nbsp;</div>on by the COVID-19 pandemic.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a25071" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">restructuring activities under this prior initiative were completed<div style="display:inline-block;width:2px">&nbsp;</div>in 2021. </div></div>
</div>
<div style="padding: 7px">
<div id="Page50" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:142.1px; height:1px; left:618.9px; top:173.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:14px; left:67.2px; top:188.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:13.9px; left:67.2px; top:188.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:242.1px; height:1px; left:66.8px; top:186.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:308.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:388.9px; top:186.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:55.1px; height:1px; left:398.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:15px; left:454.3px; top:187.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:463.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15px; left:544.3px; top:187.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:55.1px; height:1px; left:553.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:609px; top:186.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:618.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:15px; left:698.4px; top:187.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:53.1px; height:1px; left:707.9px; top:186.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:15px; left:67.2px; top:217.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:674px; height:13.8px; left:87.2px; top:218.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:308.9px; top:231.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:398.9px; top:231.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:463.9px; top:231.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:553.9px; top:231.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:618.9px; top:231.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:15px; left:67.2px; top:247.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:13.9px; left:67.2px; top:248.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:308.9px; top:261.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:398.9px; top:261.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:463.9px; top:261.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:553.9px; top:261.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:618.9px; top:261.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:309.3px; top:277.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:309.3px; top:279.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:399.3px; top:277.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:399.3px; top:279.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:464.3px; top:277.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:464.3px; top:279.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:554.3px; top:277.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:1px; left:554.3px; top:279.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:619.3px; top:277.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:619.3px; top:279.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:235.1px; height:1px; left:521.9px; top:321.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:705.1px; height:14px; left:67.2px; top:375.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:705.1px; height:13.8px; left:67.2px; top:376.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:199.1px; height:1px; left:66.8px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:265.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:340.9px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:350.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:15px; left:426.3px; top:374.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:76px; height:1px; left:435.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15px; left:512.3px; top:374.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:521.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:15px; left:602.4px; top:374.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.1px; height:1px; left:611.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:15px; left:686.4px; top:374.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:76px; height:1px; left:695.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:240px; height:13.8px; left:82.3px; top:406px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:166.9px; height:13.8px; left:326.3px; top:406px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:13.8px; left:497.2px; top:406px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:13.8px; left:587.3px; top:406px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:13.8px; left:671.3px; top:406px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:705.1px; height:14.9px; left:67.2px; top:404.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:265.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:350.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:435.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:521.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:59px; height:1px; left:611.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:695.9px; top:419.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:255.1px; height:13.8px; left:67.2px; top:436.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:166.9px; height:13.8px; left:326.3px; top:436.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:13.8px; left:497.2px; top:436.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:13.8px; left:587.3px; top:436.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:13.8px; left:671.3px; top:436.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:705.1px; height:15px; left:67.2px; top:434.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:265.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:350.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:435.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:521.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:59px; height:1px; left:611.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:695.9px; top:449.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:255.1px; height:13.8px; left:67.2px; top:466px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:166.9px; height:13.8px; left:326.3px; top:466px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:13.8px; left:497.2px; top:466px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:13.8px; left:587.3px; top:466px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:13.8px; left:671.3px; top:466px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:705.1px; height:14.9px; left:67.2px; top:464.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:265.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:350.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:435.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:521.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:59px; height:1px; left:611.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61.1px; height:1px; left:695.9px; top:479.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61px; height:1px; left:264.9px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:61px; height:1px; left:349.9px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.1px; height:1px; left:434.9px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65.9px; height:1px; left:521px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:610.9px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.1px; height:1px; left:694.9px; top:494.4px; background-color:#000000; ">&nbsp;</div>
<div id="a25074" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a25077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">50 </div><div id="a25079" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">2022 Compared to 2021 </div><div id="a25082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:93px;">Net Sales </div><div id="a25085" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">Net sales were as follows: </div><div id="a25095" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:414px;top:161px;">% of </div><div id="a25100" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:569px;top:161px;">% of </div><div id="a25103" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:637px;top:161px;">Increase / (Decrease) </div><div id="a25109" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:337px;top:175px;">2022 </div><div id="a25112" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:413px;top:175px;">Total </div><div id="a25115" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:492px;top:175px;">2021 </div><div id="a25118" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:568px;top:175px;">Total </div><div id="a25121" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:656px;top:175px;">$ </div><div id="a25124" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:729px;top:175px;">% </div><div id="a25126" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:189px;">Health care distribution </div><div id="a25128" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:184px;top:188px;">(1)</div><div id="a25149" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:87px;top:204px;">Dental<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a25152" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:309px;top:204px;">$ </div><div id="a25154" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:362px;top:204px;">7,473 </div><div id="a25157" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:418px;top:204px;">59.1 </div><div id="a25159" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:439px;top:204px;">% </div><div id="a25162" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:464px;top:204px;">$ </div><div id="a25164" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:517px;top:204px;">7,544 </div><div id="a25167" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:573px;top:204px;">60.8 </div><div id="a25169" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:594px;top:204px;">% </div><div id="a25172" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:619px;top:204px;">$ </div><div id="a25174" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:678px;top:204px;">(71) </div><div id="a25177" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:723px;top:204px;">(0.9) </div><div id="a25179" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:746px;top:204px;">% </div><div id="a25182" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:87px;top:219px;">Medical<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a25186" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:362px;top:219px;">4,451 </div><div id="a25189" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:418px;top:219px;">35.2 </div><div id="a25194" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:517px;top:219px;">4,210 </div><div id="a25197" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:573px;top:219px;">34.0 </div><div id="a25202" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:680px;top:219px;">241 </div><div id="a25205" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:731px;top:219px;">5.7 </div><div id="a25210" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:234px;">Total health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a25214" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:356px;top:234px;">11,924 </div><div id="a25217" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:418px;top:234px;">94.3 </div><div id="a25222" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:511px;top:234px;">11,754 </div><div id="a25225" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:573px;top:234px;">94.8 </div><div id="a25230" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:680px;top:234px;">170 </div><div id="a25233" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:731px;top:234px;">1.4 </div><div id="a25236" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:249px;">Technology and value-added services </div><div id="a25239" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:251px;top:248px;">(2)</div><div id="a25243" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:371px;top:249px;">723 </div><div id="a25246" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:424px;top:249px;">5.7 </div><div id="a25251" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:526px;top:249px;">647 </div><div id="a25254" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:579px;top:249px;">5.2 </div><div id="a25259" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:686px;top:249px;">76 </div><div id="a25262" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:725px;top:249px;">11.8 </div><div id="a25267" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:102px;top:264px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a25270" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:309px;top:264px;">$ </div><div id="a25272" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:356px;top:264px;">12,647 </div><div id="a25275" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:412px;top:264px;">100.0 </div><div id="a25279" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:464px;top:264px;">$ </div><div id="a25281" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:511px;top:264px;">12,401 </div><div id="a25284" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:567px;top:264px;">100.0 </div><div id="a25288" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:619px;top:264px;">$ </div><div id="a25290" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:680px;top:264px;">246 </div><div id="a25293" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:731px;top:264px;">2.0 </div><div id="a25359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:292px;">The components of our sales growth were as follows: </div><div id="a25374" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:578px;top:309px;">Local Currency Growth </div><div id="a25381" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:276px;top:348px;">Total Sales </div><div id="a25382" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:284px;top:361px;">Growth </div><div id="a25385" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:369px;top:334px;">Foreign </div><div id="a25386" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:364px;top:348px;">Exchange </div><div id="a25387" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:370px;top:361px;">Impact </div><div id="a25390" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:445px;top:334px;">Total Local </div><div id="a25391" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:450px;top:348px;">Currency </div><div id="a25392" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:454px;top:361px;">Growth </div><div id="a25395" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:533px;top:348px;">Acquisition </div><div id="a25396" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:542px;top:361px;">Growth </div><div id="a25399" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:618px;top:348px;">Extra Week </div><div id="a25400" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:631px;top:361px;">Impact </div><div id="a25403" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:697px;top:348px;">Local Internal </div><div id="a25404" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:714px;top:361px;">Growth </div><div id="a25406" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:376px;">Health care distribution </div><div id="a25407" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:184px;top:376px;">(1)</div><div id="a25428" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:82px;top:391px;">Dental Merchandise </div><div id="a25431" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:303px;top:391px;">(2.6) </div><div id="a25433" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:326px;top:391px;">% </div><div id="a25436" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:391px;">(3.5) </div><div id="a25438" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:411px;top:391px;">% </div><div id="a25441" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:391px;">0.9 </div><div id="a25443" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:497px;top:391px;">% </div><div id="a25446" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:391px;">1.3 </div><div id="a25448" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:587px;top:391px;">% </div><div id="a25451" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:391px;">1.0 </div><div id="a25453" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:671px;top:391px;">% </div><div id="a25456" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:734px;top:391px;">(1.4) </div><div id="a25458" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:757px;top:391px;">% </div><div id="a25461" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:82px;top:406px;">Dental Equipment </div><div id="a25464" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:307px;top:406px;">4.7 </div><div id="a25468" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:406px;">(4.6) </div><div id="a25472" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:406px;">9.3 </div><div id="a25476" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:406px;">0.6 </div><div id="a25480" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:406px;">2.3 </div><div id="a25484" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:406px;">6.4 </div><div id="a25487" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:421px;">Total Dental </div><div id="a25490" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:303px;top:421px;">(0.9) </div><div id="a25494" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:421px;">(3.7) </div><div id="a25498" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:421px;">2.8 </div><div id="a25502" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:421px;">1.2 </div><div id="a25506" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:421px;">1.2 </div><div id="a25510" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:421px;">0.4 </div><div id="a25513" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:436px;">Medical </div><div id="a25516" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:307px;top:436px;">5.7 </div><div id="a25520" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:436px;">(0.3) </div><div id="a25524" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:436px;">6.0 </div><div id="a25528" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:436px;">2.4 </div><div id="a25532" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:436px;">1.5 </div><div id="a25536" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:436px;">2.1 </div><div id="a25539" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:451px;">Total Health Care Distribution </div><div id="a25542" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:307px;top:451px;">1.4 </div><div id="a25546" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:451px;">(2.5) </div><div id="a25550" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:451px;">3.9 </div><div id="a25554" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:451px;">1.6 </div><div id="a25558" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:451px;">1.3 </div><div id="a25562" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:451px;">1.0 </div><div id="a25565" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:466px;">Technology and value-added services </div><div id="a25568" style="position:absolute;font-family:'Times New Roman';font-size:8px;left:251px;top:466px;">(2)</div><div id="a25571" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:301px;top:466px;">11.8 </div><div id="a25575" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:466px;">(1.5) </div><div id="a25579" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:472px;top:466px;">13.3 </div><div id="a25583" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:466px;">5.4 </div><div id="a25587" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:466px;">0.8 </div><div id="a25591" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:466px;">7.1 </div><div id="a25594" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:481px;">Total </div><div id="a25597" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:307px;top:481px;">2.0 </div><div id="a25601" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:388px;top:481px;">(2.4) </div><div id="a25605" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:478px;top:481px;">4.4 </div><div id="a25609" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:481px;">1.8 </div><div id="a25613" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:652px;top:481px;">1.3 </div><div id="a25617" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:481px;">1.3 </div><div id="a25620" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:514px;">Note: Percentages for Net Sales; Gross Profit; Selling, General and Administrative; Other Expense, Net; and Income Taxes are based on </div><div id="a25622" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:528px;">actual values and may not recalculate due to rounding. </div><div id="a25625" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:80px;top:561px;">(1)</div><div id="a25627" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:561px;">Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and </div><div id="a25629" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:574px;">generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic </div><div id="a25631" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:588px;">products), diagnostic tests, infection-control products, PPE products and vitamins. </div><div id="a25635" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:80px;top:602px;">(2)</div><div id="a25637" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:602px;">Consists of practice management software and other value-added products, which are distributed primarily to health care providers, </div><div id="a25640" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:616px;">practice consultancy, education, revenue cycle management and financial services on a non-recourse basis, e-services, continuing </div><div id="a25647" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:630px;">education services for practitioners, consulting and other services. </div><div id="a25650" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:660px;">Global Sales </div><div id="a25653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:694px;">Global net sales for the year ended December 31, 2022 increased 2.0% based<div style="display:inline-block;width:2px">&nbsp;</div>upon the components presented in the </div><div id="a25663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:711px;">table above.<div style="display:inline-block;width:7px">&nbsp;</div>We estimate that sales for the year ended<div style="display:inline-block;width:4px">&nbsp;</div>December 31, 2022 of PPE products and COVID-19 test kits </div><div id="a25673" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:728px;">were approximately $1,245 million, an estimated decrease of 34.7% versus the prior<div style="display:inline-block;width:2px">&nbsp;</div>year.<div style="display:inline-block;width:8px">&nbsp;</div>Excluding PPE products </div><div id="a25682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:745px;">and COVID-19 test kits,<div style="display:inline-block;width:3px">&nbsp;</div>the estimated increase in internally generated local currency sales was 6.7%. </div><div id="a25692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:778px;">Dental </div><div id="a25695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:812px;">Dental net sales for the year ended December 31, 2022 decreased 0.9% based<div style="display:inline-block;width:2px">&nbsp;</div>upon the components presented in the </div><div id="a25697" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:829px;">table above.<div style="display:inline-block;width:7px">&nbsp;</div>Our sales growth in local currency for dental merchandise decreased<div style="display:inline-block;width:2px">&nbsp;</div>primarily due to a decrease in </div><div id="a25704" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:846px;">PPE product sales.<div style="display:inline-block;width:7px">&nbsp;</div>We estimate that global dental sales for the year ended December 31, 2022 of PPE products </div><div id="a25718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:863px;">were approximately $447 million, an estimated decrease of 32.5% versus the prior<div style="display:inline-block;width:2px">&nbsp;</div>year.<div style="display:inline-block;width:8px">&nbsp;</div>Excluding PPE products, </div><div id="a25730" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:880px;">the estimated increase in internally generated local currency dental sales<div style="display:inline-block;width:2px">&nbsp;</div>was 3.8%.<div style="display:inline-block;width:7px">&nbsp;</div>Dental equipment sales in local </div><div id="a25737" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:896px;">currency increased in both our North American and international markets,<div style="display:inline-block;width:2px">&nbsp;</div>primarily due to increased demand.<div style="display:inline-block;width:7px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page51" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:136px; height:1px; left:611.9px; top:392.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:407.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:407.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:406.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:287.3px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:291.8px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:372.2px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:381.9px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:442.3px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:451.9px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:532.3px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:541.9px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:602.4px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.1px; height:1px; left:611.9px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:686.4px; top:406.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:52px; height:1px; left:695.9px; top:406.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:439.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666px; height:13.8px; left:82.3px; top:440.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:16px; left:67.2px; top:438.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:438.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:291.8px; top:438.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:16px; left:372.2px; top:438.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:371.8px; top:438.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:451.9px; top:438.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:16px; left:532.3px; top:438.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:531.9px; top:438.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.1px; height:1px; left:611.9px; top:438.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:686.4px; top:438.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.9px; height:1px; left:686px; top:438.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:291.3px; top:456.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:291.3px; top:454.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:451.3px; top:456.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:451.3px; top:454.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:611.3px; top:456.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:611.3px; top:454.6px; background-color:#000000; ">&nbsp;</div>
<div id="a25748" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a25751" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">51 </div><div id="a25753" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Medical </div><div id="a25756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Medical net sales for the year ended December 31, 2022 increased 5.7% based<div style="display:inline-block;width:2px">&nbsp;</div>upon the components presented in </div><div id="a25758" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">the table above.<div style="display:inline-block;width:7px">&nbsp;</div>Globally, we estimate our medical business recorded sales of approximately $798 million of<div style="display:inline-block;width:2px">&nbsp;</div>sales </div><div id="a25760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">of PPE products<div style="display:inline-block;width:7px">&nbsp;</div>and COVID-19 test kits for the year ended December 31, 2022, an estimated<div style="display:inline-block;width:2px">&nbsp;</div>decrease of </div><div id="a25766" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">approximately 27.4% compared to the prior year.<div style="display:inline-block;width:7px">&nbsp;</div>Excluding PPE products and COVID-19 test kits, the estimated </div><div id="a25769" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">increase in internally generated local currency medical sales was<div style="display:inline-block;width:2px">&nbsp;</div>2.1%. </div><div id="a25772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:195px;letter-spacing:0.66px;">Te</div><div id="a25773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:82px;top:195px;">chnology and value-added services </div><div id="a25778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Technology and value-added services net sales for the year ended December 31, 2022 increased 11.8% based upon </div><div id="a25783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">the components presented in the table above.<div style="display:inline-block;width:6px">&nbsp;</div>During the year ended December 31, 2022, the trend for transactional </div><div id="a25792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">software sales improved as we increased the number of users, generating demand<div style="display:inline-block;width:2px">&nbsp;</div>for our sales cycle management </div><div id="a25814" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">solutions, and also from cloud-based solutions that drive practice efficiency and patient engagement. </div><div id="a25827" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:313px;">Gross Profit </div><div id="a25830" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">Gross profit and gross margin percentages by segment and in total were as follows: </div><div id="a25839" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:397px;top:380px;">Gross </div><div id="a25844" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:557px;top:380px;">Gross </div><div id="a25847" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:659px;top:380px;">Increase </div><div id="a25852" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:320px;top:394px;">2022 </div><div id="a25855" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:386px;top:394px;">Margin % </div><div id="a25858" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:480px;top:394px;">2021 </div><div id="a25861" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:546px;top:394px;">Margin % </div><div id="a25864" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:646px;top:394px;">$ </div><div id="a25867" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:716px;top:394px;">% </div><div id="a25869" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:409px;">Health care distribution<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a25873" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:409px;">$ </div><div id="a25875" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:345px;top:409px;">3,357 </div><div id="a25878" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:409px;">28.2 </div><div id="a25880" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:427px;top:409px;">% </div><div id="a25883" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:409px;">$ </div><div id="a25885" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:505px;top:409px;">3,239 </div><div id="a25888" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:409px;">27.6 </div><div id="a25890" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:587px;top:409px;">% </div><div id="a25893" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:612px;top:409px;">$ </div><div id="a25895" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:668px;top:409px;">118 </div><div id="a25898" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:718px;top:409px;">3.6 </div><div id="a25900" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:733px;top:409px;">% </div><div id="a25902" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:425px;">Technology and value-added services </div><div id="a25908" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:354px;top:425px;">474 </div><div id="a25911" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:425px;">65.5 </div><div id="a25916" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:514px;top:425px;">435 </div><div id="a25919" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:425px;">67.2 </div><div id="a25924" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:674px;top:425px;">39 </div><div id="a25927" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:718px;top:425px;">9.0 </div><div id="a25931" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:82px;top:441px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a25934" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:441px;">$ </div><div id="a25936" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:345px;top:441px;">3,831 </div><div id="a25939" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:441px;">30.3 </div><div id="a25943" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:441px;">$ </div><div id="a25945" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:505px;top:441px;">3,674 </div><div id="a25948" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:441px;">29.6 </div><div id="a25952" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:612px;top:441px;">$ </div><div id="a25954" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:668px;top:441px;">157 </div><div id="a25957" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:718px;top:441px;">4.3 </div><div id="a25961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:474px;">As a result of different practices of categorizing costs associated with distribution networks<div style="display:inline-block;width:2px">&nbsp;</div>throughout our </div><div id="a25962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:491px;">industry, our gross margins may not necessarily be comparable to other distribution companies.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, we </div><div id="a25965" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:508px;">realize substantially higher gross margin percentages in our technology and value-added services<div style="display:inline-block;width:2px">&nbsp;</div>segment than in </div><div id="a25969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:525px;">our health care distribution segment.<div style="display:inline-block;width:7px">&nbsp;</div>These higher gross margins result from being both the developer and seller of </div><div id="a25972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:542px;">software products and services, as well as certain financial services.<div style="display:inline-block;width:6px">&nbsp;</div>The software industry typically realizes higher </div><div id="a25974" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:559px;">gross margins to recover investments in research and development. </div><div id="a25979" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:593px;">Within our health care distribution segment, gross profit margins may vary from one period to the next.<div style="display:inline-block;width:6px">&nbsp;</div>Changes in </div><div id="a25982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:610px;">the mix of products sold as well as changes in our customer mix have<div style="display:inline-block;width:2px">&nbsp;</div>been the most significant drivers affecting </div><div id="a25984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:626px;">our gross profit margin.<div style="display:inline-block;width:7px">&nbsp;</div>For example, sales of our corporate brand products achieve<div style="display:inline-block;width:2px">&nbsp;</div>gross profit margins that are </div><div id="a25990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:643px;">higher than average total gross profit margins of all products.<div style="display:inline-block;width:7px">&nbsp;</div>With respect to customer mix, sales to our large-</div><div id="a25998" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:660px;">group customers are typically completed at lower gross margins due to the higher<div style="display:inline-block;width:2px">&nbsp;</div>volumes sold as opposed to the </div><div id="a25999" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:677px;">gross margin on sales to office-based practitioners, who normally purchase lower volumes.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a26006" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:711px;">Health care distribution gross profit increased primarily due to the increase<div style="display:inline-block;width:2px">&nbsp;</div>in net sales discussed above.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a26009" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:728px;">overall increase in our health care distribution gross profit was attributable to<div style="display:inline-block;width:2px">&nbsp;</div>$67 million of gross profit from </div><div id="a26017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:744px;">acquisitions and gross margin expansion, mainly as a result of increased sales<div style="display:inline-block;width:2px">&nbsp;</div>mix of higher-margin products. </div><div id="a26026" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:778px;">Technology and value-added services gross profit increased as a result of an increase in gross profit from internally </div><div id="a26032" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:795px;">generated sales and gross profit from acquisitions, partially offset by a decrease in<div style="display:inline-block;width:2px">&nbsp;</div>gross margin rates.<div style="display:inline-block;width:7px">&nbsp;</div>Gross </div><div id="a26038" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:812px;">margin rates decreased primarily due to lower gross margins of recently acquired companies in<div style="display:inline-block;width:2px">&nbsp;</div>the business </div><div id="a26040" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:829px;">services sector and our continued investment in product development and customer<div style="display:inline-block;width:2px">&nbsp;</div>service. </div></div>
</div>
<div style="padding: 7px">
<div id="Page52" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:136px; height:1px; left:611.9px; top:174.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:188.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:188.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:187.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:287.3px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:291.8px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:372.2px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:381.9px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:442.3px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:451.9px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:532.3px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:60px; height:1px; left:541.9px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:602.4px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.1px; height:1px; left:611.9px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:686.4px; top:187.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:52px; height:1px; left:695.9px; top:187.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:220.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666px; height:13.9px; left:82.3px; top:221.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:16px; left:67.2px; top:219.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:219.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:291.8px; top:219.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:16px; left:372.2px; top:219.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:371.8px; top:219.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:451.9px; top:219.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:16px; left:532.3px; top:219.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:531.9px; top:219.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.1px; height:1px; left:611.9px; top:219.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:686.4px; top:219.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.9px; height:1px; left:686px; top:219.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:291.3px; top:237.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:291.3px; top:235.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:451.3px; top:237.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81px; height:1px; left:451.3px; top:235.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:611.3px; top:237.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:611.3px; top:235.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:15px; left:67.2px; top:319.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:15px; left:67.2px; top:319.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:318.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:287.3px; top:318.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107px; height:1px; left:291.8px; top:318.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:398.9px; top:318.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.9px; height:1px; left:408.9px; top:318.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:516.3px; top:318.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107.1px; height:1px; left:525.9px; top:318.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:633px; top:318.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107px; height:1px; left:642.9px; top:318.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:15px; left:67.2px; top:351.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:668.1px; height:13.8px; left:82.3px; top:353.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:16px; left:67.2px; top:350.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:225px; height:1px; left:66.8px; top:350.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107px; height:1px; left:291.8px; top:350.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:398.9px; top:350.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.9px; height:1px; left:408.9px; top:350.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:516.3px; top:350.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107.1px; height:1px; left:525.9px; top:350.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:633px; top:350.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:107px; height:1px; left:642.9px; top:350.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:291.3px; top:369px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:291.3px; top:367.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:107.9px; height:1px; left:408.4px; top:369px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:107.9px; height:1px; left:408.4px; top:367.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:525.4px; top:369px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:525.4px; top:367.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:642.4px; top:369px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:108px; height:1px; left:642.4px; top:367.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:180px; height:1px; left:567.9px; top:600.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:615.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:615.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:1px; left:66.8px; top:613.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:357.9px; top:613.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:453px; top:613.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95px; height:1px; left:462.9px; top:613.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:558.3px; top:614.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:567.9px; top:613.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:662.9px; top:613.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:74.9px; height:1px; left:673px; top:613.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:13.9px; left:67.2px; top:648.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:646.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:357.9px; top:661.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95px; height:1px; left:462.9px; top:661.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:567.9px; top:661.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:357.3px; top:680.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:357.3px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:462.3px; top:680.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:462.3px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:567.3px; top:680.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:567.3px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div id="a26043" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a26046" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">52 </div><div id="a26048" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:60px;">Operating Expenses </div><div id="a26051" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Operating expenses (consisting of selling, general and administrative<div style="display:inline-block;width:2px">&nbsp;</div>expenses; depreciation and amortization, </div><div id="a26052" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">restructuring and integration costs) by segment and in total were as follows: </div><div id="a26061" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:400px;top:148px;">% of </div><div id="a26067" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:560px;top:148px;">% of </div><div id="a26080" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:385px;top:162px;">Respective </div><div id="a26085" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:545px;top:162px;">Respective </div><div id="a26088" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:659px;top:162px;">Increase </div><div id="a26093" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:320px;top:175px;">2022 </div><div id="a26096" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:389px;top:175px;">Net Sales </div><div id="a26099" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:480px;top:175px;">2021 </div><div id="a26102" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:549px;top:175px;">Net Sales </div><div id="a26105" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:646px;top:175px;">$ </div><div id="a26108" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:716px;top:175px;">% </div><div id="a26110" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:190px;">Health care distribution<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26114" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:190px;">$ </div><div id="a26116" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:345px;top:190px;">2,738 </div><div id="a26119" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:190px;">23.0 </div><div id="a26121" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:427px;top:190px;">% </div><div id="a26124" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:190px;">$ </div><div id="a26126" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:505px;top:190px;">2,512 </div><div id="a26129" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:190px;">21.4 </div><div id="a26131" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:587px;top:190px;">% </div><div id="a26134" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:612px;top:190px;">$ </div><div id="a26136" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:668px;top:190px;">226 </div><div id="a26139" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:718px;top:190px;">9.0 </div><div id="a26141" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:733px;top:190px;">% </div><div id="a26143" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:206px;">Technology and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26149" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:354px;top:206px;">346 </div><div id="a26152" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:206px;">47.8 </div><div id="a26157" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:514px;top:206px;">310 </div><div id="a26160" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:206px;">48.0 </div><div id="a26165" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:674px;top:206px;">36 </div><div id="a26168" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:712px;top:206px;">11.4 </div><div id="a26172" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:82px;top:222px;">Total<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a26175" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:222px;">$ </div><div id="a26177" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:345px;top:222px;">3,084 </div><div id="a26180" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:406px;top:222px;">24.4 </div><div id="a26184" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:452px;top:222px;">$ </div><div id="a26186" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:505px;top:222px;">2,822 </div><div id="a26189" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:566px;top:222px;">22.8 </div><div id="a26193" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:612px;top:222px;">$ </div><div id="a26195" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:668px;top:222px;">262 </div><div id="a26198" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:718px;top:222px;">9.3 </div><div id="a26202" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:256px;">The net increase in operating expenses is attributable to the<div style="display:inline-block;width:2px">&nbsp;</div>following: </div><div id="a26208" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:319px;top:278px;">Change in </div><div id="a26209" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:298px;top:292px;">Restructuring and </div><div id="a26210" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:301px;top:305px;">Integration Costs </div><div id="a26213" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:434px;top:292px;">Increase in </div><div id="a26214" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:421px;top:305px;">Operating Costs </div><div id="a26217" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:548px;top:305px;">Acquisitions </div><div id="a26220" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:683px;top:305px;">Total </div><div id="a26222" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:321px;">Health care distribution<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26225" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:321px;">$ </div><div id="a26227" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:381px;top:321px;">121 </div><div id="a26230" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:409px;top:321px;">$ </div><div id="a26232" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:504px;top:321px;">39 </div><div id="a26235" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:526px;top:321px;">$ </div><div id="a26237" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:621px;top:321px;">66 </div><div id="a26240" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:643px;top:321px;">$ </div><div id="a26242" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:732px;top:321px;">226 </div><div id="a26244" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:337px;">Technology and value-added services </div><div id="a26250" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:393px;top:337px;">2 </div><div id="a26254" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:504px;top:337px;">20 </div><div id="a26258" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:621px;top:337px;">14 </div><div id="a26262" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:738px;top:337px;">36 </div><div id="a26265" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:82px;top:353px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26268" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:292px;top:353px;">$ </div><div id="a26270" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:381px;top:353px;">123 </div><div id="a26273" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:409px;top:353px;">$ </div><div id="a26275" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:504px;top:353px;">59 </div><div id="a26278" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:526px;top:353px;">$ </div><div id="a26280" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:621px;top:353px;">80 </div><div id="a26283" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:643px;top:353px;">$ </div><div id="a26285" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:732px;top:353px;">262 </div><div id="a26288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:387px;">The increase in restructuring and integration costs is attributable to our disposal<div style="display:inline-block;width:2px">&nbsp;</div>of an unprofitable business, </div><div id="a26320" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:404px;">acceleration of amortization of right-of-use lease assets related<div style="display:inline-block;width:2px">&nbsp;</div>to the exit from one of the properties at our </div><div id="a26360" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:421px;">corporate headquarters, severance costs, and other costs relating to<div style="display:inline-block;width:2px">&nbsp;</div>the exit of some facilities.<div style="display:inline-block;width:7px">&nbsp;</div>The increase in </div><div id="a26394" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:438px;">operating costs includes a $20 million intangible assets impairment charge within<div style="display:inline-block;width:2px">&nbsp;</div>our health care distribution </div><div id="a26403" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:454px;">segment, and increases in payroll and payroll related costs and travel and convention<div style="display:inline-block;width:2px">&nbsp;</div>expenses in both of our </div><div id="a26436" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:471px;">reportable segments.<div style="display:inline-block;width:7px">&nbsp;</div>While the U.S. economy has recently experienced inflationary<div style="display:inline-block;width:2px">&nbsp;</div>pressures and strengthening of </div><div id="a26441" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:488px;">the U.S dollar, their impacts have not been material to our results of operations.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26444" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:522px;">Other Expense, Net </div><div id="a26447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:554px;">Other expense, net was as follows: </div><div id="a26457" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:635px;top:588px;">Variance </div><div id="a26462" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:394px;top:602px;">2022 </div><div id="a26465" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:499px;top:602px;">2021 </div><div id="a26468" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:613px;top:602px;">$ </div><div id="a26471" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:705px;top:602px;">% </div><div id="a26473" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:617px;">Interest income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26476" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:358px;top:617px;">$ </div><div id="a26478" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:441px;top:617px;">17 </div><div id="a26481" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:463px;top:617px;">$ </div><div id="a26483" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:552px;top:617px;">7 </div><div id="a26486" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:617px;">$ </div><div id="a26488" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:651px;top:617px;">10 </div><div id="a26491" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:706px;top:617px;">158.9 </div><div id="a26493" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:733px;top:617px;">% </div><div id="a26495" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:633px;">Interest expense<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26499" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:433px;top:633px;">(44) </div><div id="a26503" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:538px;top:633px;">(28) </div><div id="a26507" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:643px;top:633px;">(16) </div><div id="a26510" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:704px;top:633px;">(59.1) </div><div id="a26513" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:67px;top:649px;">Other, net<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26517" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:447px;top:649px;">1 </div><div id="a26521" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:554px;top:649px;">- </div><div id="a26525" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:657px;top:649px;">1 </div><div id="a26528" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:719px;top:649px;">n/a </div><div id="a26532" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:92px;top:665px;">Other expense, net<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26535" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:358px;top:665px;">$ </div><div id="a26537" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:433px;top:665px;">(26) </div><div id="a26540" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:463px;top:665px;">$ </div><div id="a26542" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:538px;top:665px;">(21) </div><div id="a26545" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:568px;top:665px;">$ </div><div id="a26547" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:649px;top:665px;">(5) </div><div id="a26550" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:704px;top:665px;">(26.0) </div><div id="a26554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:698px;">Interest income increased primarily due to increased interest rates.<div style="display:inline-block;width:6px">&nbsp;</div>Interest expense increased primarily due to </div><div id="a26559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:715px;">increased borrowings and increased interest rates. </div><div id="a26564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:749px;">Income Taxes</div><div id="a26567" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:781px;">For the year ended December 31, 2022, our effective tax rate was 23.5% compared to 23.8%<div style="display:inline-block;width:2px">&nbsp;</div>for the prior year </div><div id="a26607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:798px;">period.<div style="display:inline-block;width:7px">&nbsp;</div>In 2022, the difference between our effective tax rate and the federal statutory tax rate primarily<div style="display:inline-block;width:2px">&nbsp;</div>relates to </div><div id="a26641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:815px;">state and foreign income taxes and interest expense.<div style="display:inline-block;width:6px">&nbsp;</div>In 2021, the difference between our effective tax rate and the </div><div id="a26666" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:832px;">federal statutory tax rate was primarily due to state and foreign income<div style="display:inline-block;width:2px">&nbsp;</div>taxes and interest expense. </div><div id="a26677" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;left:67px;top:865px;">Gain on Sale of Equity Investment </div><div id="a26680" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:899px;">In the third quarter of 2021, we received contingent proceeds of $10 million<div style="display:inline-block;width:2px">&nbsp;</div>from the 2019 sale of Hu-Friedy </div><div id="a26685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:916px;">resulting in the recognition of an additional after-tax gain of $7<div style="display:inline-block;width:2px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>No further proceeds are expected from this </div><div id="a26689" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:933px;">sale. </div></div>
</div>
<div style="padding: 7px">
<div id="Page53" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a26691" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a26694" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">53 </div><div id="a26696" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Liquidity and Capital Resources </div><div id="a26699" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Our principal capital requirements have included funding of acquisitions, purchases<div style="display:inline-block;width:2px">&nbsp;</div>of additional noncontrolling </div><div id="a26701" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">interests, repayments of debt principal, the funding of working capital needs,<div style="display:inline-block;width:2px">&nbsp;</div>purchases of fixed assets and </div><div id="a26702" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">repurchases of common stock.<div style="display:inline-block;width:7px">&nbsp;</div>Working capital requirements generally result from increased sales, special </div><div id="a26706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">inventory forward buy-in opportunities and payment terms for receivables<div style="display:inline-block;width:2px">&nbsp;</div>and payables.<div style="display:inline-block;width:7px">&nbsp;</div>Historically, sales have </div><div id="a26711" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">tended to be stronger during the second half of the year and special inventory<div style="display:inline-block;width:2px">&nbsp;</div>forward buy-in opportunities have </div><div id="a26714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">been most prevalent just before the end of the year, and have caused our working capital requirements<div style="display:inline-block;width:2px">&nbsp;</div>to be higher </div><div id="a26716" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">from the end of the third quarter to the end of the first quarter of<div style="display:inline-block;width:2px">&nbsp;</div>the following year. </div><div id="a26719" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">We finance our business primarily through cash generated from our operations, revolving credit facilities and debt </div><div id="a26722" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">placements.<div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a26723" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:208px;top:245px;"><a href="#a41804" style="color:#0000FF;text-decoration:underline;">Note 12 – Debt</a></div><div id="a26727" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:298px;top:245px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information.<div style="display:inline-block;width:7px">&nbsp;</div>Our ability to generate sufficient cash flows from </div><div id="a26729" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">operations is dependent on the continued demand of our customers for our<div style="display:inline-block;width:2px">&nbsp;</div>products and services, and access to </div><div id="a26731" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">products and services from our suppliers. </div><div id="a26734" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">Our business requires a substantial investment in working capital, which<div style="display:inline-block;width:2px">&nbsp;</div>is susceptible to fluctuations during the </div><div id="a26736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">year as a result of inventory purchase patterns and seasonal demands.<div style="display:inline-block;width:6px">&nbsp;</div>Inventory purchase activity is a function of </div><div id="a26739" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">sales activity, special inventory forward buy-in opportunities and our desired level of inventory.<div style="display:inline-block;width:7px">&nbsp;</div>We anticipate </div><div id="a26744" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">future increases in our working capital requirements. </div><div id="a26748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">We finance our business to provide adequate funding for at least 12 months.<div style="display:inline-block;width:7px">&nbsp;</div>Funding requirements are based on </div><div id="a26751" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">forecasted profitability and working capital needs, which, on occasion, may<div style="display:inline-block;width:2px">&nbsp;</div>change.<div style="display:inline-block;width:7px">&nbsp;</div>Consequently, we may change </div><div id="a26755" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">our funding structure to reflect any new requirements. </div><div id="a26758" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">We believe that our cash and cash equivalents, our ability to access private debt markets and public equity markets, </div><div id="a26759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:481px;">and our available funds under existing credit facilities provide us with<div style="display:inline-block;width:2px">&nbsp;</div>sufficient liquidity to meet our currently </div><div id="a26761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">foreseeable short-term and long-term capital needs.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26768" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">Net cash provided by operating activities was $602 million for the<div style="display:inline-block;width:2px">&nbsp;</div>year ended December 31, 2022, compared to net </div><div id="a26769" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">cash from continuing operations provided by operating activities of $710 million<div style="display:inline-block;width:2px">&nbsp;</div>for the prior year.<div style="display:inline-block;width:8px">&nbsp;</div>The net change </div><div id="a26772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">of $108 million was primarily due to unfavorable net cash used by our working<div style="display:inline-block;width:2px">&nbsp;</div>capital accounts, net of </div><div id="a26773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">acquisitions, driven by an impact of timing of payments which<div style="display:inline-block;width:2px">&nbsp;</div>resulted in an increase in other current assets and </div><div id="a26775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">relative decreases in accounts payable and accrued expenses, partially offset by the<div style="display:inline-block;width:2px">&nbsp;</div>relative year over year impact </div><div id="a26776" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">of inventory increases (2021 increase was more significant than the<div style="display:inline-block;width:2px">&nbsp;</div>2022 increase). </div><div id="a26779" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">Net cash used in investing activities was $276 million for the year<div style="display:inline-block;width:2px">&nbsp;</div>ended December 31, 2022, compared to $677 </div><div id="a26781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">million for the prior year.<div style="display:inline-block;width:8px">&nbsp;</div>The net change of $401 million was primarily attributable to decreased payments<div style="display:inline-block;width:2px">&nbsp;</div>for </div><div id="a26795" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">equity investments and business acquisitions. </div><div id="a26806" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">Net cash used in financing activities was $315 million for the year<div style="display:inline-block;width:2px">&nbsp;</div>ended December 31, 2022, compared to net cash </div><div id="a26809" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">used in financing activities of $333 million for the prior year.<div style="display:inline-block;width:7px">&nbsp;</div>The net change of $18 million was primarily due to </div><div id="a26810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">increased net borrowings from debt, partially offset by increased repurchases of common<div style="display:inline-block;width:2px">&nbsp;</div>stock. </div></div>
</div>
<div style="padding: 7px">
<div id="Page54" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:425.7px; height:15.4px; left:69.9px; top:129.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:515.9px; top:129.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.6px; height:15.4px; left:531px; top:129.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:640.9px; top:129.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.3px; left:67.2px; top:128.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.8px; height:15.4px; left:656px; top:129.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:446.2px; height:1px; left:66.8px; top:126.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110px; height:1px; left:513px; top:126.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:17.3px; left:623.3px; top:127.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:1px; left:638px; top:126.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:425.7px; height:15.4px; left:69.9px; top:163.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.3px; left:67.2px; top:161.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:250px; height:15.4px; left:498.3px; top:163.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:400.7px; height:15.4px; left:94.9px; top:198.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:498.3px; top:198.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.6px; height:15.4px; left:531px; top:198.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:623.3px; top:198.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.3px; left:67.2px; top:196.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.8px; height:15.4px; left:656px; top:198.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50px; height:15.2px; left:67.2px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:375.7px; height:15.2px; left:119.9px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.2px; left:515.9px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.6px; height:15.2px; left:531px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.2px; left:640.9px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.3px; left:67.2px; top:231.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.8px; height:15.2px; left:656px; top:232.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:446.2px; height:1px; left:66.8px; top:230.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110px; height:1px; left:513px; top:230.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:622.9px; top:230.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:1px; left:638px; top:230.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:110px; height:1px; left:513.4px; top:248px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:110px; height:1px; left:513.4px; top:249.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:1px; left:638.4px; top:248px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:1px; left:638.4px; top:249.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:400.7px; height:15.4px; left:94.9px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:515.9px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.6px; height:15.4px; left:531px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:640.9px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.3px; left:67.2px; top:265.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.8px; height:15.4px; left:656px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:430px; height:1px; left:317.9px; top:673.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:694.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:699.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:251.1px; height:20px; left:67.2px; top:693.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:317.9px; top:693.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:396.2px; top:693.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:405.9px; top:693.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:484.3px; top:693.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:493.9px; top:693.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:572.3px; top:693.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78px; height:1px; left:581.9px; top:693.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:660.3px; top:693.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:670px; top:693.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:733.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:739.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:773.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:779.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:814.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:820.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:251.1px; height:21px; left:67.2px; top:813.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:317.9px; top:813.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21px; left:396.2px; top:813.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:405.9px; top:813.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21px; left:484.3px; top:813.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:493.9px; top:813.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21px; left:572.3px; top:813.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78px; height:1px; left:581.9px; top:813.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21px; left:660.3px; top:813.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.9px; height:1px; left:670px; top:813.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:317.3px; top:836.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:317.3px; top:834.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:405.3px; top:836.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:405.3px; top:834.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:493.4px; top:836.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:493.4px; top:834.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:581.4px; top:836.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:581.4px; top:834.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:669.4px; top:836.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:669.4px; top:834.9px; background-color:#000000; ">&nbsp;</div>
<div id="a26815" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a26818" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">54 </div><div id="a26820" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:60px;">The following table summarizes selected measures of liquidity and capital<div style="display:inline-block;width:2px">&nbsp;</div>resources: </div><div id="a26827" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:529px;top:95px;">December 31, </div><div id="a26830" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:654px;top:95px;">December 25, </div><div id="a26836" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:555px;top:112px;">2022 </div><div id="a26839" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:680px;top:112px;">2021 </div><div id="a26841" style="position:absolute;font-family:'Times New Roman';left:70px;top:130px;">Cash and cash equivalents<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26844" style="position:absolute;font-family:'Times New Roman';left:516px;top:130px;">$ </div><div id="a26846" style="position:absolute;font-family:'Times New Roman';left:601px;top:130px;">117 </div><div id="a26849" style="position:absolute;font-family:'Times New Roman';left:641px;top:130px;">$ </div><div id="a26851" style="position:absolute;font-family:'Times New Roman';left:726px;top:130px;">118 </div><div id="a26853" style="position:absolute;font-family:'Times New Roman';left:70px;top:147px;">Working<div style="display:inline-block;width:5px">&nbsp;</div>capital </div><div id="a26854" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:160px;top:146px;">(1)</div><div id="a26858" style="position:absolute;font-family:'Times New Roman';left:590px;top:147px;">1,764 </div><div id="a26862" style="position:absolute;font-family:'Times New Roman';left:715px;top:147px;">1,537 </div><div id="a26864" style="position:absolute;font-family:'Times New Roman';left:70px;top:164px;">Debt: </div><div id="a26873" style="position:absolute;font-family:'Times New Roman';left:95px;top:181px;">Bank credit lines<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26876" style="position:absolute;font-family:'Times New Roman';left:516px;top:181px;">$ </div><div id="a26878" style="position:absolute;font-family:'Times New Roman';left:601px;top:181px;">103 </div><div id="a26881" style="position:absolute;font-family:'Times New Roman';left:641px;top:181px;">$ </div><div id="a26883" style="position:absolute;font-family:'Times New Roman';left:732px;top:181px;">51 </div><div id="a26886" style="position:absolute;font-family:'Times New Roman';left:95px;top:199px;">Current maturities of long-term debt<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26892" style="position:absolute;font-family:'Times New Roman';left:614px;top:199px;">6 </div><div id="a26896" style="position:absolute;font-family:'Times New Roman';left:732px;top:199px;">11 </div><div id="a26899" style="position:absolute;font-family:'Times New Roman';left:95px;top:216px;">Long-term debt<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26905" style="position:absolute;font-family:'Times New Roman';left:590px;top:216px;">1,040 </div><div id="a26909" style="position:absolute;font-family:'Times New Roman';left:726px;top:216px;">811 </div><div id="a26913" style="position:absolute;font-family:'Times New Roman';left:120px;top:233px;">Total debt<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a26916" style="position:absolute;font-family:'Times New Roman';left:516px;top:233px;">$ </div><div id="a26918" style="position:absolute;font-family:'Times New Roman';left:590px;top:233px;">1,149 </div><div id="a26921" style="position:absolute;font-family:'Times New Roman';left:641px;top:233px;">$ </div><div id="a26923" style="position:absolute;font-family:'Times New Roman';left:726px;top:233px;">873 </div><div id="a26925" style="position:absolute;font-family:'Times New Roman';left:70px;top:251px;">Leases: </div><div id="a26935" style="position:absolute;font-family:'Times New Roman';left:95px;top:268px;">Current operating lease liabilities </div><div id="a26938" style="position:absolute;font-family:'Times New Roman';left:516px;top:268px;">$ </div><div id="a26940" style="position:absolute;font-family:'Times New Roman';left:607px;top:268px;">73 </div><div id="a26943" style="position:absolute;font-family:'Times New Roman';left:641px;top:268px;">$ </div><div id="a26945" style="position:absolute;font-family:'Times New Roman';left:732px;top:268px;">76 </div><div id="a26948" style="position:absolute;font-family:'Times New Roman';left:95px;top:285px;">Non-current operating lease liabilities </div><div id="a26954" style="position:absolute;font-family:'Times New Roman';left:601px;top:285px;">275 </div><div id="a26958" style="position:absolute;font-family:'Times New Roman';left:726px;top:285px;">268 </div><div id="a26969" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:70px;top:317px;">(1)<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a26971" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:95px;top:317px;">Includes $327 million and $138 million of certain accounts receivable which serve as security for U.S. trade accounts receivable </div><div id="a26973" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:95px;top:331px;">securitization at December 31, 2022 and December 25, 2021, respectively. </div><div id="a26976" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:370px;">Our cash and cash equivalents consist of bank balances and investments<div style="display:inline-block;width:2px">&nbsp;</div>in money market funds representing </div><div id="a26977" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:387px;">overnight investments with a high degree of liquidity. </div><div id="a26981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:419px;">Accounts receivable days sales outstanding and inventory turns </div><div id="a26984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:451px;">Our accounts receivable days sales outstanding from operations<div style="display:inline-block;width:2px">&nbsp;</div>increased to 41.9 days as of December 31, 2022 </div><div id="a26986" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:468px;">from 41.8 days as of December 25, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>During the years ended December 31, 2022 and December<div style="display:inline-block;width:2px">&nbsp;</div>25, 2021, we </div><div id="a26988" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:485px;">wrote off approximately $10 million and $8 million, respectively, of fully reserved accounts receivable against our </div><div id="a26989" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:502px;">trade receivable reserve.<div style="display:inline-block;width:7px">&nbsp;</div>Our inventory turns from operations was 4.7 as of December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022 and 5.2 as of </div><div id="a26994" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:519px;">December 25, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>Our working capital accounts may be impacted by current and<div style="display:inline-block;width:2px">&nbsp;</div>future economic conditions. </div><div id="a26997" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:553px;">Contractual obligations </div><div id="a27000" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:587px;">The following table summarizes our contractual obligations related<div style="display:inline-block;width:2px">&nbsp;</div>to fixed and variable rate long-term debt and </div><div id="a27004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:603px;">finance lease obligations, including interest (assuming a weighted<div style="display:inline-block;width:2px">&nbsp;</div>average interest rate of 4.3%), as well as </div><div id="a27005" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:620px;">inventory purchase commitments and operating lease obligations<div style="display:inline-block;width:2px">&nbsp;</div>as of December 31, 2022: </div><div id="a27009" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:468px;top:659px;">Payments due by period </div><div id="a27013" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:335px;top:679px;">&lt; 1 year </div><div id="a27016" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:418px;top:679px;">2 - 3 years </div><div id="a27022" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:506px;top:679px;">4 - 5 years </div><div id="a27028" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:597px;top:679px;">&gt; 5 years </div><div id="a27031" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:695px;top:679px;">Total </div><div id="a27033" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:699px;">Contractual obligations: </div><div id="a27049" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:719px;">Long-term debt, including interest<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27053" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:318px;top:719px;">$ </div><div id="a27055" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:384px;top:719px;">41 </div><div id="a27058" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:406px;top:719px;">$ </div><div id="a27060" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:465px;top:719px;">508 </div><div id="a27063" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:494px;top:719px;">$ </div><div id="a27065" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:553px;top:719px;">134 </div><div id="a27068" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:582px;top:719px;">$ </div><div id="a27070" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:641px;top:719px;">538 </div><div id="a27073" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:670px;top:719px;">$ </div><div id="a27075" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:719px;">1,221 </div><div id="a27077" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:739px;">Inventory purchase commitments<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a27081" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:390px;top:739px;">5 </div><div id="a27085" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:478px;top:739px;">8 </div><div id="a27089" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:739px;">8 </div><div id="a27093" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:656px;top:739px;">- </div><div id="a27097" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:739px;">21 </div><div id="a27099" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:759px;">Operating lease obligations<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27102" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:384px;top:759px;">82 </div><div id="a27106" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:465px;top:759px;">122 </div><div id="a27110" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:560px;top:759px;">79 </div><div id="a27114" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:648px;top:759px;">98 </div><div id="a27118" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:759px;">381 </div><div id="a27120" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:779px;">Transition tax obligations<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a27124" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:384px;top:779px;">19 </div><div id="a27128" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:472px;top:779px;">23 </div><div id="a27132" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:568px;top:779px;">- </div><div id="a27136" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:656px;top:779px;">- </div><div id="a27140" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:779px;">42 </div><div id="a27142" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:799px;">Finance lease obligations, including interest<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27146" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:390px;top:799px;">5 </div><div id="a27150" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:478px;top:799px;">4 </div><div id="a27154" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:799px;">1 </div><div id="a27158" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:654px;top:799px;">1 </div><div id="a27162" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:799px;">11 </div><div id="a27164" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:820px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a27166" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:318px;top:820px;">$ </div><div id="a27168" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:377px;top:820px;">152 </div><div id="a27171" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:406px;top:820px;">$ </div><div id="a27173" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:465px;top:820px;">665 </div><div id="a27176" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:494px;top:820px;">$ </div><div id="a27178" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:553px;top:820px;">222 </div><div id="a27181" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:582px;top:820px;">$ </div><div id="a27183" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:641px;top:820px;">637 </div><div id="a27186" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:670px;top:820px;">$ </div><div id="a27188" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:820px;">1,676 </div><div id="a27191" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:855px;">For information relating to our debt please see </div><div id="a27193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:343px;top:855px;"><a href="#a41804" style="color:#0000FF;text-decoration:underline;">Note 12 – Debt</a></div><div id="a27197" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:433px;top:855px;">.<div style="display:inline-block;width:11px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page55" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a27200" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a27203" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">55 </div><div id="a27205" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Leases </div><div id="a27208" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">We have operating and finance leases for corporate offices, office space, distribution and other facilities, vehicles </div><div id="a27209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">and certain equipment.<div style="display:inline-block;width:7px">&nbsp;</div>Our leases have remaining terms of less than one year to approximately<div style="display:inline-block;width:2px">&nbsp;</div>19 years, some of </div><div id="a27211" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">which may include options to extend the leases for up to 15 years.<div style="display:inline-block;width:6px">&nbsp;</div>As of December 31, 2022, our right-of-use </div><div id="a27226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">assets related to operating leases were $284 million and our current and non-current<div style="display:inline-block;width:2px">&nbsp;</div>operating lease liabilities were </div><div id="a27262" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">$73 million and $275 million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>Please see </div><div id="a27276" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:392px;top:161px;"><a href="#a39241" style="color:#0000FF;text-decoration:underline;">Note 6 – Leases</a></div><div id="a27280" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:486px;top:161px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information. </div><div id="a27286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:195px;">Stock Repurchases </div><div id="a27289" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">On March 8, 2021, we announced the reinstatement of our share repurchase<div style="display:inline-block;width:2px">&nbsp;</div>program, which had been temporarily </div><div id="a27291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">suspended in April of 2020. </div><div id="a27294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">From March 3, 2003 through December 31, 2022, we repurchased $4.5<div style="display:inline-block;width:2px">&nbsp;</div>billion, or 87,180,669 shares, under our </div><div id="a27297" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">common stock repurchase programs, with $115 million available as of December 31, 2022 for future<div style="display:inline-block;width:2px">&nbsp;</div>common stock </div><div id="a27299" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">share repurchases. </div><div id="a27302" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">On February 8, 2023, our Board of Directors authorized the repurchase<div style="display:inline-block;width:2px">&nbsp;</div>of up to an additional $400 million in shares </div><div id="a27303" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">of our common stock. </div><div id="a27306" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:397px;">Redeemable Noncontrolling Interests </div><div id="a27312" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:429px;">Some minority stockholders in certain of our consolidated subsidiaries have<div style="display:inline-block;width:2px">&nbsp;</div>the right, at certain times, to require us </div><div id="a27318" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:446px;">to acquire their ownership interest in those entities.<div style="display:inline-block;width:6px">&nbsp;</div>Accounting Standards Codification (“ASC”) Topic 480-10 is </div><div id="a27325" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:463px;">applicable for noncontrolling interests where we are or may be required<div style="display:inline-block;width:2px">&nbsp;</div>to purchase all or a portion of the </div><div id="a27326" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:480px;">outstanding interest in a consolidated subsidiary from the noncontrolling<div style="display:inline-block;width:2px">&nbsp;</div>interest holder under the terms of a put </div><div id="a27327" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:497px;">option contained in contractual agreements.<div style="display:inline-block;width:7px">&nbsp;</div>As of December 31, 2022 and December 25, 2021, our balance<div style="display:inline-block;width:2px">&nbsp;</div>for </div><div id="a27335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:514px;">redeemable noncontrolling interests was $576 million and $613 million, respectively.<div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a27342" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:640px;top:514px;"><a href="#a48747" style="color:#0000FF;text-decoration:underline;">Note 18 –</a></div><div id="a27345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:530px;"><a href="#a48747" style="color:#0000FF;text-decoration:underline;">Redeemable Noncontrolling Interests</a></div><div id="a27346" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:286px;top:530px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information. </div><div id="a27350" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:564px;">Unrecognized tax benefits<div style="display:inline-block;width:11px">&nbsp;</div></div><div id="a27353" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:596px;">As more fully disclosed in </div><div id="a27354" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:226px;top:596px;"><a href="#a42428" style="color:#0000FF;text-decoration:underline;">Note 13 – Income Taxes</a></div><div id="a27358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:370px;top:596px;"><div style="display:inline-block;width:4px">&nbsp;</div>of “Notes to Consolidated Financial Statements,” we cannot </div><div id="a27363" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:613px;">reasonably estimate the timing of future cash flows related to the unrecognized<div style="display:inline-block;width:2px">&nbsp;</div>tax benefits, including accrued </div><div id="a27365" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:630px;">interest, of $94 million as of December 31, 2022.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27373" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:664px;">Critical Accounting Policies and Estimates</div><div id="a27376" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:698px;">Our accounting policies are more fully described in </div><div id="a27377" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:373px;top:698px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Note 1 – Basis of Presentation and Significant Accounting </a></div><div id="a27382" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:714px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Policies</a></div><div id="a27383" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:114px;top:714px;"><div style="display:inline-block;width:4px">&nbsp;</div>of the consolidated financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>The preparation of consolidated financial statements requires us </div><div id="a27387" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:731px;">to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues<div style="display:inline-block;width:2px">&nbsp;</div>and expenses and </div><div id="a27389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:748px;">related disclosures of contingent assets and liabilities.<div style="display:inline-block;width:6px">&nbsp;</div>We base our estimates on historical data, when available, </div><div id="a27390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:765px;">experience, industry and market trends, and on various other assumptions<div style="display:inline-block;width:2px">&nbsp;</div>that are believed to be reasonable under </div><div id="a27392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:782px;">the circumstances, the combined results of which form the basis for<div style="display:inline-block;width:2px">&nbsp;</div>making judgments about the carrying values of </div><div id="a27393" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:799px;">assets and liabilities that are not readily apparent from other sources.<div style="display:inline-block;width:6px">&nbsp;</div>We believe that the estimates, judgments and </div><div id="a27395" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:816px;">assumptions upon which we rely are reasonable based upon information<div style="display:inline-block;width:2px">&nbsp;</div>available to us at the time that these </div><div id="a27398" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:832px;">estimates, judgments and assumptions are made.<div style="display:inline-block;width:6px">&nbsp;</div>However, by their nature, estimates are subject to various </div><div id="a27400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:849px;">assumptions and uncertainties.<div style="display:inline-block;width:7px">&nbsp;</div>Therefore, reported results may differ from estimates and any such differences may </div><div id="a27409" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:866px;">be material to our consolidated financial statements.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27419" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:900px;">We believe that the following critical accounting estimates, which have been discussed with the Audit Committee </div><div id="a27422" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:917px;">of our Board of Directors, affect the significant estimates and judgments used in<div style="display:inline-block;width:2px">&nbsp;</div>the preparation of our financial </div><div id="a27424" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:934px;">statements: </div></div>
</div>
<div style="padding: 7px">
<div id="Page56" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a27427" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a27430" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">56 </div><div id="a27432" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Inventories and Reserves</div><div id="a27435" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Inventories consist primarily of finished goods and are valued at<div style="display:inline-block;width:2px">&nbsp;</div>the lower of cost or net realizable value.<div style="display:inline-block;width:7px">&nbsp;</div>Cost is </div><div id="a27438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">determined by the first-in, first-out method for merchandise or actual cost<div style="display:inline-block;width:2px">&nbsp;</div>for large equipment and high tech </div><div id="a27444" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">equipment.<div style="display:inline-block;width:7px">&nbsp;</div>In estimating carrying value of inventory, we consider many factors including the condition and </div><div id="a27445" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">salability of the inventory by reviewing on-hand quantities, historical sales,<div style="display:inline-block;width:2px">&nbsp;</div>forecasted sales and market and </div><div id="a27449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">economic trends.<div style="display:inline-block;width:7px">&nbsp;</div>Certain of our products, specifically PPE and COVID-19 test kits, have experienced<div style="display:inline-block;width:2px">&nbsp;</div>changes in </div><div id="a27452" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">net realizable value, due to volatility of pricing and changes in demand<div style="display:inline-block;width:2px">&nbsp;</div>for these products.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27459" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:211px;">Business Combinations </div><div id="a27462" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">The estimated fair value of acquired identifiable intangible assets (trademarks<div style="display:inline-block;width:2px">&nbsp;</div>and trade names, customer </div><div id="a27463" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">relationships and lists, non-compete agreements and product development)<div style="display:inline-block;width:2px">&nbsp;</div>is based on critical estimates, judgments </div><div id="a27467" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">and assumptions derived from: analysis of market conditions; discount<div style="display:inline-block;width:2px">&nbsp;</div>rates; projected cash flows; customer </div><div id="a27468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">retention rates; and estimated useful lives.<div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a27469" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:385px;top:296px;"><a href="#a38269" style="color:#0000FF;text-decoration:underline;">Note 4 – Business Acquisitions and Divestitures</a></div><div id="a27473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:669px;top:296px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further </div><div id="a27476" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">discussion of our acquisitions. </div><div id="a27479" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:346px;">Goodwill </div><div id="a27482" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">Goodwill is subject to impairment analysis at least once annually as of<div style="display:inline-block;width:2px">&nbsp;</div>the first day of our fourth quarter, or if an </div><div id="a27486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">event occurs or circumstances change that would more likely than<div style="display:inline-block;width:2px">&nbsp;</div>not reduce the fair value of a reporting unit </div><div id="a27488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">below its carrying value.<div style="display:inline-block;width:7px">&nbsp;</div>Such impairment analyses for goodwill require a comparison of<div style="display:inline-block;width:2px">&nbsp;</div>the fair value to the </div><div id="a27492" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">carrying value of reporting units.<div style="display:inline-block;width:7px">&nbsp;</div>We regard our reporting units to be our operating segments: global dental,<div style="display:inline-block;width:3px">&nbsp;</div>global </div><div id="a27498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">medical, and technology and value-added services.<div style="display:inline-block;width:7px">&nbsp;</div>Goodwill is allocated to such reporting units, for the purposes </div><div id="a27506" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">of preparing our impairment analyses, based on a specific identification<div style="display:inline-block;width:2px">&nbsp;</div>basis.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a27511" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">Application of the goodwill impairment test requires judgment, including<div style="display:inline-block;width:2px">&nbsp;</div>the identification of reporting units, </div><div id="a27513" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">assignment of assets and liabilities that are considered shared services<div style="display:inline-block;width:2px">&nbsp;</div>to the reporting units, and ultimately the </div><div id="a27514" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">determination of the fair value of each reporting unit.<div style="display:inline-block;width:6px">&nbsp;</div>The fair value of each reporting unit is calculated by </div><div id="a27516" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">applying the discounted cash flow methodology and confirming with<div style="display:inline-block;width:2px">&nbsp;</div>a market approach.<div style="display:inline-block;width:7px">&nbsp;</div>There are inherent </div><div id="a27519" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">uncertainties, however, related to fair value models, the inputs and our judgments in applying them<div style="display:inline-block;width:2px">&nbsp;</div>to this analysis.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">The most significant inputs include estimation of detailed future cash flows based<div style="display:inline-block;width:2px">&nbsp;</div>on budget expectations, and </div><div id="a27526" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">determination of comparable companies to develop a weighted average<div style="display:inline-block;width:2px">&nbsp;</div>cost of capital for each reporting unit.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27529" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">On an annual basis, we prepare annual and<div style="display:inline-block;width:3px">&nbsp;</div>medium-term financial projections.<div style="display:inline-block;width:6px">&nbsp;</div>These projections are based on </div><div id="a27533" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">input from our leadership and are presented annually to our Board of Directors.<div style="display:inline-block;width:6px">&nbsp;</div>Influences on this year's forecasted </div><div id="a27534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">financial information and the fair value model include: the impact of planned<div style="display:inline-block;width:2px">&nbsp;</div>strategic initiatives, the continued </div><div id="a27537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">integration of recent acquisitions and overall market conditions.<div style="display:inline-block;width:6px">&nbsp;</div>The estimates used to calculate the fair value of a </div><div id="a27538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">reporting unit change from year to year based on operating results,<div style="display:inline-block;width:2px">&nbsp;</div>market conditions, and other factors.</div><div id="a27542" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">Our third-party valuation specialists provide inputs into our determination<div style="display:inline-block;width:2px">&nbsp;</div>of the discount rate.<div style="display:inline-block;width:7px">&nbsp;</div>The rate is </div><div id="a27545" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">dependent on a number of underlying assumptions, including the risk-free rate,<div style="display:inline-block;width:2px">&nbsp;</div>tax rate, equity risk premium, debt </div><div id="a27548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">to equity ratio<div style="display:inline-block;width:3px">&nbsp;</div>and pre-tax cost of debt. </div><div id="a27554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">Long-term growth rates are applied to our estimation of future cash flows.<div style="display:inline-block;width:6px">&nbsp;</div>The long-term growth rates are tied to </div><div id="a27561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">growth rates we expect to achieve beyond the years for which we have<div style="display:inline-block;width:2px">&nbsp;</div>forecasted operating results.<div style="display:inline-block;width:7px">&nbsp;</div>We also </div><div id="a27564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">consider external benchmarks, and other data points which we believe are<div style="display:inline-block;width:2px">&nbsp;</div>applicable to our industry and the </div><div id="a27565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:852px;">composition of our global operations. </div><div id="a27568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">Based on our quantitative assessment for the year ended December 31, 2022,<div style="display:inline-block;width:2px">&nbsp;</div>we recorded a $20 million impairment </div><div id="a27571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">of goodwill relating to the disposal of an unprofitable business whose<div style="display:inline-block;width:2px">&nbsp;</div>estimated fair value was lower than its </div><div id="a27575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">carrying value.<div style="display:inline-block;width:7px">&nbsp;</div>As part of our analysis for the rest of the goodwill balance,<div style="display:inline-block;width:2px">&nbsp;</div>we performed a sensitivity analysis on </div><div id="a27580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">the discount rate and long-term growth rate assumptions.<div style="display:inline-block;width:6px">&nbsp;</div>The sensitivities did not result in any additional </div><div id="a27583" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:954px;">impairment charges.<div style="display:inline-block;width:7px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page57" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a27586" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a27589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">57 </div><div id="a27591" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Definite-Lived Intangible Assets </div><div id="a27596" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Annually, definite-lived intangible assets such as non-compete agreements, trademarks, trade names, customer </div><div id="a27602" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">relationships and lists, and product development are reviewed for impairment<div style="display:inline-block;width:2px">&nbsp;</div>indicators.<div style="display:inline-block;width:7px">&nbsp;</div>If any impairment </div><div id="a27603" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">indicators exist, quantitative testing is performed on the asset. </div><div id="a27606" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">The quantitative impairment model is a two-step test under which we<div style="display:inline-block;width:2px">&nbsp;</div>first calculate the recoverability of the </div><div id="a27610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">carrying value by comparing the undiscounted, probability-weighted value<div style="display:inline-block;width:2px">&nbsp;</div>of the projected cash flows associated </div><div id="a27613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">with the asset or asset group, including its estimated residual value, to<div style="display:inline-block;width:2px">&nbsp;</div>the carrying amount.<div style="display:inline-block;width:7px">&nbsp;</div>If the cash flows </div><div id="a27615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">associated with the asset or asset group are less than the carrying value,<div style="display:inline-block;width:2px">&nbsp;</div>we would perform a fair value assessment </div><div id="a27616" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">of the asset, or asset group.<div style="display:inline-block;width:7px">&nbsp;</div>If the carrying amount is found to be greater than the fair value, we record an </div><div id="a27618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">impairment loss for the excess of book value over the fair value.<div style="display:inline-block;width:6px">&nbsp;</div>In addition, in all cases of an impairment review, </div><div id="a27619" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">we re-evaluate the remaining useful lives of the assets and modify them,<div style="display:inline-block;width:2px">&nbsp;</div>as appropriate.<div style="display:inline-block;width:7px">&nbsp;</div>Although we believe our </div><div id="a27623" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">judgments, estimates and/or assumptions used in estimating cash flows<div style="display:inline-block;width:2px">&nbsp;</div>and determining fair value are reasonable, </div><div id="a27624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">making material changes to such judgments, estimates and/or assumptions<div style="display:inline-block;width:2px">&nbsp;</div>could materially affect such impairment </div><div id="a27625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">analyses and our financial results.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a27631" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">During the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and December 26, 2020, we recorded total </div><div id="a27632" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">impairment charges on intangible assets of approximately $49 million ($34 million<div style="display:inline-block;width:2px">&nbsp;</div>related to impairment of </div><div id="a27637" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">customer lists and relationships attributable to customer attrition rates being higher<div style="display:inline-block;width:2px">&nbsp;</div>than expected in certain </div><div id="a27639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">businesses and $15 million due to the disposal of an unprofitable<div style="display:inline-block;width:2px">&nbsp;</div>business), $1 million and $20 million, </div><div id="a27641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">respectively.<div style="display:inline-block;width:8px">&nbsp;</div>For the year ended December 31, 2022 impairment charges were recorded<div style="display:inline-block;width:2px">&nbsp;</div>within our health care </div><div id="a27644" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">distribution segment.<div style="display:inline-block;width:7px">&nbsp;</div>For the years ended December 25, 2021 and December 26,<div style="display:inline-block;width:2px">&nbsp;</div>2020, impairment charges were </div><div id="a27645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">recorded within our health care distribution and technology and value-added services<div style="display:inline-block;width:2px">&nbsp;</div>segments.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a27650" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:481px;">Income Tax </div><div id="a27653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">When determining if the realization of the deferred tax asset is likely by assessing<div style="display:inline-block;width:2px">&nbsp;</div>the need for a valuation </div><div id="a27691" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">allowance, estimates and judgement are required.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a27704" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:364px;top:532px;">We </div><div id="a27706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:388px;top:532px;">consider all available evidence, both positive and negative, </div><div id="a27722" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">including estimated future taxable earnings, ongoing planning strategies,<div style="display:inline-block;width:2px">&nbsp;</div>future reversals of existing temporary </div><div id="a27749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">differences and historical operating results.<div style="display:inline-block;width:7px">&nbsp;</div>Additionally, changes to tax laws and statutory tax rates can have an </div><div id="a27784" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">impact on our determination.<div style="display:inline-block;width:7px">&nbsp;</div>Our intention is to evaluate the realizability of our deferred tax assets quarterly.<div style="display:inline-block;width:14px">&nbsp;</div></div><div id="a27822" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:616px;">ASC Topic 740 prescribes the accounting for uncertainty in income taxes recognized in the financial statements in </div><div id="a27856" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:633px;">accordance with other provisions contained within this guidance.<div style="display:inline-block;width:6px">&nbsp;</div>This topic prescribes a recognition threshold and </div><div id="a27887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:650px;">a measurement attribute for the financial statement recognition and measurement<div style="display:inline-block;width:2px">&nbsp;</div>of tax positions taken or expected </div><div id="a27920" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">to be taken in a tax return.<div style="display:inline-block;width:7px">&nbsp;</div>For those benefits to be recognized, a tax position must be more likely<div style="display:inline-block;width:2px">&nbsp;</div>than not to be </div><div id="a27969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">sustained upon examination by the taxing authorities.<div style="display:inline-block;width:6px">&nbsp;</div>The amount recognized is measured as the largest amount of </div><div id="a28005" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">benefit that has a greater than 50% likely of being realized upon ultimate<div style="display:inline-block;width:2px">&nbsp;</div>audit settlement.<div style="display:inline-block;width:7px">&nbsp;</div>In the normal course of </div><div id="a28046" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">business, our tax returns are subject to examination by various taxing<div style="display:inline-block;width:2px">&nbsp;</div>authorities.<div style="display:inline-block;width:7px">&nbsp;</div>Such examinations may result in </div><div id="a28082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">future tax and interest assessments by these taxing authorities for uncertain<div style="display:inline-block;width:2px">&nbsp;</div>tax positions taken in respect of certain </div><div id="a28118" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">tax matters.<div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a28123" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:207px;top:751px;"><a href="#a42428" style="color:#0000FF;text-decoration:underline;">Note 13 – Income Taxes</a></div><div id="a28127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:351px;top:751px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further discussion. </div><div id="a28132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">The FASB Staff Q&amp;A, Topic<div style="display:inline-block;width:6px">&nbsp;</div>740 No. 5, Accounting for Global Intangible Low-Taxed Income (“GILTI”), states </div><div id="a28138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">that an entity can make an accounting policy election to either recognize deferred<div style="display:inline-block;width:2px">&nbsp;</div>taxes for temporary differences </div><div id="a28139" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is </div><div id="a28141" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:836px;">incurred.<div style="display:inline-block;width:7px">&nbsp;</div>We elected to recognize the tax on GILTI<div style="display:inline-block;width:5px">&nbsp;</div>as a period expense in the period the tax is incurred.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a28144" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:869px;">Accounting Standards Update</div><div id="a28147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">For a discussion of accounting standards updates that have been adopted<div style="display:inline-block;width:2px">&nbsp;</div>or will be adopted in the future, please see </div><div id="a28187" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:920px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Note 1 – Basis of Presentation and Significant Accounting Policies</a></div><div id="a28192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:461px;top:920px;"><div style="display:inline-block;width:4px">&nbsp;</div>included under Item 8. </div></div>
</div>
<div style="padding: 7px">
<div id="Page58" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a28201" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a28204" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">58 </div><div id="a28206" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 7A.<div style="display:inline-block;width:7px">&nbsp;</div>Quantitative and Qualitative Disclosures About Market Risk<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a28209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">We are exposed to market risks as well as changes in foreign currency exchange rates as measured against the U.S. </div><div id="a28211" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">dollar and each other, and changes to the credit markets.<div style="display:inline-block;width:7px">&nbsp;</div>We attempt to minimize these risks by primarily using </div><div id="a28212" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:127px;">foreign currency forward contracts and by maintaining counter-party credit limits.<div style="display:inline-block;width:6px">&nbsp;</div>These hedging activities provide </div><div id="a28215" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">only limited protection against currency exchange and credit risks.<div style="display:inline-block;width:6px">&nbsp;</div>Factors that could influence the effectiveness of </div><div id="a28217" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">our hedging programs include currency markets and availability of hedging<div style="display:inline-block;width:2px">&nbsp;</div>instruments and liquidity of the credit </div><div id="a28218" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">markets.<div style="display:inline-block;width:7px">&nbsp;</div>All foreign currency forward contracts that we enter into are components<div style="display:inline-block;width:2px">&nbsp;</div>of hedging programs and are </div><div id="a28220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">entered into for the sole purpose of hedging an existing or anticipated<div style="display:inline-block;width:2px">&nbsp;</div>currency exposure.<div style="display:inline-block;width:7px">&nbsp;</div>We do not enter into such </div><div id="a28221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:211px;">contracts for speculative purposes and we manage our credit risks by diversifying<div style="display:inline-block;width:2px">&nbsp;</div>our investments, maintaining a </div><div id="a28223" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">strong balance sheet and having multiple sources of capital. </div><div id="a28226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:262px;">Foreign Currency Agreements </div><div id="a28229" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">The value of certain foreign currencies as compared to the U.S. dollar<div style="display:inline-block;width:2px">&nbsp;</div>and the value of certain underlying functional </div><div id="a28233" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">currencies of the Company, including its foreign subsidiaries, may affect our financial results.<div style="display:inline-block;width:7px">&nbsp;</div>Fluctuations in </div><div id="a28234" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">exchange rates may positively or negatively affect our revenues, gross margins, operating expenses<div style="display:inline-block;width:2px">&nbsp;</div>and retained </div><div id="a28235" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:346px;">earnings, all of which are<div style="display:inline-block;width:3px">&nbsp;</div>expressed in U.S. dollars.<div style="display:inline-block;width:7px">&nbsp;</div>Where we deem it prudent, we engage in hedging programs </div><div id="a28239" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">using primarily foreign currency forward contracts aimed at limiting<div style="display:inline-block;width:2px">&nbsp;</div>the impact of foreign currency exchange rate </div><div id="a28240" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:380px;">fluctuations on earnings.<div style="display:inline-block;width:7px">&nbsp;</div>We purchase short-term (i.e., generally 18 months or less) foreign currency forward </div><div id="a28247" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:397px;">contracts to protect against currency exchange risks associated with intercompany<div style="display:inline-block;width:2px">&nbsp;</div>loans due from our international </div><div id="a28248" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:414px;">subsidiaries and the payment of merchandise purchases to foreign<div style="display:inline-block;width:2px">&nbsp;</div>suppliers.<div style="display:inline-block;width:7px">&nbsp;</div>We do not hedge the translation of </div><div id="a28253" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:431px;">foreign currency profits into U.S. dollars, as we regard this as an accounting<div style="display:inline-block;width:2px">&nbsp;</div>exposure, not an economic </div><div id="a28254" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:448px;">exposure.<div style="display:inline-block;width:7px">&nbsp;</div>A hypothetical 5% change in the average value of the U.S. dollar<div style="display:inline-block;width:2px">&nbsp;</div>in 2022 compared to foreign currencies </div><div id="a28257" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:464px;">would have changed our 2022 reported Net income attributable to Henry<div style="display:inline-block;width:2px">&nbsp;</div>Schein, Inc. by approximately $7 million. </div><div id="a28265" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:498px;">As of December 31, 2022, we had forward foreign currency exchange<div style="display:inline-block;width:2px">&nbsp;</div>agreements, which expire through November </div><div id="a28288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:515px;">16, 2023, with a fair value of $23 million as determined by quoted market<div style="display:inline-block;width:2px">&nbsp;</div>prices.<div style="display:inline-block;width:7px">&nbsp;</div>Included in the forward foreign </div><div id="a28329" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:532px;">currency exchange agreements, Henry Schein, Inc. had net investment<div style="display:inline-block;width:2px">&nbsp;</div>designated EUR/USD forward contracts </div><div id="a28355" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">with notional values of approximately €200 million, with a reported fair value<div style="display:inline-block;width:2px">&nbsp;</div>of these contracts of $20 million.<div style="display:inline-block;width:7px">&nbsp;</div>A </div><div id="a28393" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">5% increase in the value of the Euro to the USD from December 31, 2022,<div style="display:inline-block;width:2px">&nbsp;</div>with all other variables held constant, </div><div id="a28432" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">would have had an unfavorable effect on the fair value of these forward contracts<div style="display:inline-block;width:2px">&nbsp;</div>by decreasing the value of these </div><div id="a28472" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:599px;">instruments by $10 million. </div><div id="a28481" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:633px;">Total<div style="display:inline-block;width:5px">&nbsp;</div>Return Swaps </div><div id="a28484" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:667px;">On March 20, 2020, we entered into a total return swap for the purpose<div style="display:inline-block;width:2px">&nbsp;</div>of economically hedging our unfunded non-</div><div id="a28486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:684px;">qualified supplemental retirement plan (“SERP”) and our deferred compensation<div style="display:inline-block;width:2px">&nbsp;</div>plan (“DCP”).<div style="display:inline-block;width:7px">&nbsp;</div>This swap will </div><div id="a28488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:701px;">offset changes in our SERP and DCP liabilities.<div style="display:inline-block;width:7px">&nbsp;</div>At the inception, the notional value of the investments in these </div><div id="a28489" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:718px;">plans was $43 million.<div style="display:inline-block;width:7px">&nbsp;</div>At December 31, 2022, the notional value of the investments<div style="display:inline-block;width:2px">&nbsp;</div>in these plans was $78 </div><div id="a28491" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:734px;">million.<div style="display:inline-block;width:7px">&nbsp;</div>At December 31, 2022, the financing blended rate for<div style="display:inline-block;width:2px">&nbsp;</div>this swap was based on LIBOR of 4.03% plus </div><div id="a28492" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:751px;">0.55%, for a combined rate of 4.58%.<div style="display:inline-block;width:7px">&nbsp;</div>For the years ended December 31, 2022 ended and December<div style="display:inline-block;width:2px">&nbsp;</div>25, 2021, we </div><div id="a28494" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:768px;">have recorded a gain/(loss), within the selling, general and administrative<div style="display:inline-block;width:2px">&nbsp;</div>line item in our consolidated statement of </div><div id="a28496" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:785px;">income, of approximately $(17) million and $12 million, respectively, net of transaction costs, related to this </div><div id="a28499" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:802px;">undesignated swap.<div style="display:inline-block;width:7px">&nbsp;</div>This swap is expected to be renewed on an annual basis after its current<div style="display:inline-block;width:2px">&nbsp;</div>expiration date of </div><div id="a28501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:819px;">March 31, 2023, and is expected to result in a neutral impact to our results<div style="display:inline-block;width:2px">&nbsp;</div>of operations.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a28508" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:852px;">Short-Term Investments </div><div id="a28513" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:886px;">We limit our credit risk with respect to our cash equivalents, short-term investments and derivative instruments, by </div><div id="a28517" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:903px;">monitoring the credit worthiness of the financial institutions who are<div style="display:inline-block;width:2px">&nbsp;</div>the counterparties to such financial </div><div id="a28518" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:920px;">instruments.<div style="display:inline-block;width:7px">&nbsp;</div>As a risk management policy, we limit the amount of credit exposure by diversifying and utilizing </div><div id="a28521" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">numerous investment grade counterparties. </div></div>
</div>
<div style="padding: 7px">
<div id="Page59" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a28525" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a28528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">59 </div><div id="a28530" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:60px;">Variable<div style="display:inline-block;width:5px">&nbsp;</div>Interest Rate Debt </div><div id="a28533" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">As of December 31, 2022, we had variable interest rate exposure for certain<div style="display:inline-block;width:2px">&nbsp;</div>of our revolving credit facilities and </div><div id="a28534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:110px;">our U.S. trade accounts receivable securitization. </div><div id="a28537" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:144px;">Our revolving credit facility which we entered into on August 20, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and expires on August 20, 2026, has an </div><div id="a28540" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:161px;">interest rate that is based on the U.S. Dollar LIBOR plus a spread based on<div style="display:inline-block;width:2px">&nbsp;</div>our leverage ratio at the end of each </div><div id="a28545" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:178px;">financial reporting quarter.<div style="display:inline-block;width:8px">&nbsp;</div>As of December 31, 2022, there was $0 million outstanding under this<div style="display:inline-block;width:2px">&nbsp;</div>revolving credit </div><div id="a28547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:195px;">facility.<div style="display:inline-block;width:8px">&nbsp;</div>During the year ended December 31, 2022, we had no borrowings under<div style="display:inline-block;width:2px">&nbsp;</div>this revolving credit facility. </div><div id="a28554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:228px;">Our U.S trade accounts receivable securitization, which we entered<div style="display:inline-block;width:2px">&nbsp;</div>into on April 17, 2013 and expires on </div><div id="a28556" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:245px;">December 15, 2025, has an interest rate that is based upon the asset-backed<div style="display:inline-block;width:2px">&nbsp;</div>commercial paper rate.<div style="display:inline-block;width:7px">&nbsp;</div>As of </div><div id="a28559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:262px;">December 31, 2022, the commercial paper rate was 4.58% plus 0.75%,<div style="display:inline-block;width:2px">&nbsp;</div>for a combined rate of 5.33%.<div style="display:inline-block;width:7px">&nbsp;</div>At </div><div id="a28560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:279px;">December 31, 2022 the outstanding balance was $330 million under<div style="display:inline-block;width:2px">&nbsp;</div>this securitization facility.<div style="display:inline-block;width:8px">&nbsp;</div>During the year </div><div id="a28564" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:296px;">ended December 31, 2022, the average outstanding balance under this securitization<div style="display:inline-block;width:2px">&nbsp;</div>facility was approximately </div><div id="a28565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:313px;">$166 million.<div style="display:inline-block;width:7px">&nbsp;</div>Based upon our average outstanding balance for this securitization<div style="display:inline-block;width:2px">&nbsp;</div>facility, for each hypothetical </div><div id="a28569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:330px;">increase of 25 basis points, our interest expense thereunder would have<div style="display:inline-block;width:2px">&nbsp;</div>increased by $0.4 million. </div></div>
</div>
<div style="padding: 7px">
<div id="Page60" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:45.3px; height:1px; left:66.8px; top:183.8px; background-color:#0000FF; ">&nbsp;</div>
<div style="position:absolute; width:70.9px; height:1px; left:669.8px; top:154px; background-color:#000000; ">&nbsp;</div>
<div id="a28571" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a28574" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">60 </div><div id="a28576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 8. Financial Statements and Supplementary Data </div><div id="a28582" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:297px;top:85px;">INDEX TO FINANCIAL STATEMENTS </div><div id="a28587" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:353px;top:103px;">HENRY SCHEIN, INC. </div><div id="a28592" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:692px;top:120px;">Page </div><div id="a28595" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:682px;top:137px;">Number</div><div id="a28597" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:155px;"><a href="#a28992" style="color:#0000FF;text-decoration:underline;">Report of Independent Registered Public Accounting Firm (</a></div><div id="a28599" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:388px;top:155px;">BDO USA, LLP; New York,<div style="display:inline-block;width:5px">&nbsp;</div>NY; PCAOB </div><div id="a28600" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:171px;">ID#</div><div id="a28600_3_3" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:88px;top:171px;"><ix:nonnumeric id="ID_1318" name="dei:AuditorFirmId" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">243</ix:nonnumeric></div><div id="a28600_6_2" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:108px;top:171px;">) </div><div id="a28604" style="position:absolute;font-family:'Times New Roman';left:699px;top:155px;">61 </div><div id="a28606" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:185px;"><a href="#a29184" style="color:#0000FF;text-decoration:underline;">Consolidated Financial Statements</a></div><div id="a28607" style="position:absolute;font-family:'Times New Roman';left:252px;top:185px;"><a href="#a29184" style="color:#000000;text-decoration:none;">:</a></div><div id="a28611" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:203px;"><a href="#a29182" style="color:#0000FF;text-decoration:underline;">Balance Sheets as of December 31, 2022 and December 25, 2021</a></div><div id="a28612" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:454px;top:201px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28615" style="position:absolute;font-family:'Times New Roman';left:699px;top:203px;">63 </div><div id="a28618" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:220px;"><a href="#a29744" style="color:#0000FF;text-decoration:underline;">Statements of Income for the years ended December 31, 2022,</a></div><div id="a28623" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:122px;top:237px;"><a href="#a29744" style="color:#0000FF;text-decoration:underline;">December 25, 2021 and December 26, 2020</a></div><div id="a28627" style="position:absolute;font-family:'Times New Roman';left:699px;top:237px;">64 </div><div id="a28630" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:254px;"><a href="#a30469" style="color:#0000FF;text-decoration:underline;">Statements of Comprehensive Income for the years ended December<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>31, 2022,</a></div><div id="a28635" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:122px;top:272px;"><a href="#a30469" style="color:#0000FF;text-decoration:underline;">December 25, 2021 and December 26, 2020</a></div><div id="a28639" style="position:absolute;font-family:'Times New Roman';left:699px;top:272px;">65 </div><div id="a28642" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:289px;"><a href="#a30735" style="color:#0000FF;text-decoration:underline;">Statements of Changes in Stockholders’ Equity for the years ended</a></div><div id="a28643" style="position:absolute;font-family:'Times New Roman';left:462px;top:289px;"><div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a28648" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:122px;top:306px;"><a href="#a30735" style="color:#0000FF;text-decoration:underline;">December 31, 2022, December 25, 2021 and December 26, 2020</a></div><div id="a28652" style="position:absolute;font-family:'Times New Roman';left:699px;top:306px;">66 </div><div id="a28655" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:323px;"><a href="#a32269" style="color:#0000FF;text-decoration:underline;">Statements of Cash Flows for the years ended December 31, 2022,</a></div><div id="a28660" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:122px;top:341px;"><a href="#a32269" style="color:#0000FF;text-decoration:underline;">December 25, 2021 and December 26, 2020</a></div><div id="a28664" style="position:absolute;font-family:'Times New Roman';left:699px;top:341px;">67 </div><div id="a28667" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:104px;top:358px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Notes to Consolidated Financial Statements</a></div><div id="a28671" style="position:absolute;font-family:'Times New Roman';left:699px;top:358px;">68 </div><div id="a28674" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:374px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28675" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:375px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Note 1 – Basis of Presentation and Significant Accounting Policies </a></div><div id="a28683" style="position:absolute;font-family:'Times New Roman';left:699px;top:375px;">68 </div><div id="a28686" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:391px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28687" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:393px;"><a href="#a36381" style="color:#0000FF;text-decoration:underline;">Note 2 – Net Sales from Contracts with Customers</a></div><div id="a28697" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:408px;top:391px;"><div style="display:inline-block;width:32px">&nbsp;</div></div><div id="a28699" style="position:absolute;font-family:'Times New Roman';left:699px;top:393px;">78 </div><div id="a28702" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:409px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28703" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:410px;"><a href="#a36932" style="color:#0000FF;text-decoration:underline;">Note 3 – Segment and Geographic Data</a></div><div id="a28707" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:346px;top:409px;"><div style="display:inline-block;width:46px">&nbsp;</div></div><div id="a28710" style="position:absolute;font-family:'Times New Roman';left:699px;top:410px;">79 </div><div id="a28713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:426px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28714" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:427px;"><a href="#a38269" style="color:#0000FF;text-decoration:underline;">Note 4 – Business Acquisitions and Divestiture</a></div><div id="a28722" style="position:absolute;font-family:'Times New Roman';left:699px;top:427px;">81 </div><div id="a28725" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:443px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28726" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:444px;"><a href="#a39000" style="color:#0000FF;text-decoration:underline;">Note 5 – Property and Equipment, Net</a></div><div id="a28731" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:343px;top:443px;"><div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a28733" style="position:absolute;font-family:'Times New Roman';left:699px;top:444px;">85 </div><div id="a28736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:460px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28737" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:462px;"><a href="#a39241" style="color:#0000FF;text-decoration:underline;">Note 6 – Leases</a></div><div id="a28741" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:219px;top:460px;"><div style="display:inline-block;width:29px">&nbsp;</div></div><div id="a28744" style="position:absolute;font-family:'Times New Roman';left:699px;top:462px;">86 </div><div id="a28747" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:478px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28748" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:479px;"><a href="#a40026" style="color:#0000FF;text-decoration:underline;">Note 7 – Goodwill and Other Intangibles, Net</a></div><div id="a28753" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:378px;top:478px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28756" style="position:absolute;font-family:'Times New Roman';left:699px;top:479px;">88 </div><div id="a28759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:495px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28760" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:496px;"><a href="#a40615" style="color:#0000FF;text-decoration:underline;">Note 8 – Investments and Other</a></div><div id="a28765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:307px;top:495px;"><div style="display:inline-block;width:37px">&nbsp;</div></div><div id="a28767" style="position:absolute;font-family:'Times New Roman';left:699px;top:496px;">89 </div><div id="a28770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:512px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28771" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:513px;"><a href="#a40800" style="color:#0000FF;text-decoration:underline;">Note 9 – Fair Value<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Measurements</a></div><div id="a28776" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:321px;top:512px;"><div style="display:inline-block;width:24px">&nbsp;</div></div><div id="a28779" style="position:absolute;font-family:'Times New Roman';left:699px;top:513px;">90 </div><div id="a28782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:529px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28783" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:531px;"><a href="#a41556" style="color:#0000FF;text-decoration:underline;">Note 10 – Concentrations of Risk</a></div><div id="a28789" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:313px;top:529px;"><div style="display:inline-block;width:32px">&nbsp;</div></div><div id="a28792" style="position:absolute;font-family:'Times New Roman';left:699px;top:531px;">92 </div><div id="a28795" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:547px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28796" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:548px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Note 11 – Derivatives and Hedging Activities</a></div><div id="a28801" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:378px;top:547px;"><div style="display:inline-block;width:14px">&nbsp;</div></div><div id="a28804" style="position:absolute;font-family:'Times New Roman';left:699px;top:548px;">92 </div><div id="a28807" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:564px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28808" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:565px;"><a href="#a41804" style="color:#0000FF;text-decoration:underline;">Note 12 – Debt</a></div><div id="a28813" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:219px;top:564px;"><div style="display:inline-block;width:29px">&nbsp;</div></div><div id="a28815" style="position:absolute;font-family:'Times New Roman';left:699px;top:565px;">94 </div><div id="a28818" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:581px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28819" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:583px;"><a href="#a42428" style="color:#0000FF;text-decoration:underline;">Note 13 – Income Taxes</a></div><div id="a28825" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:265px;top:581px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28828" style="position:absolute;font-family:'Times New Roman';left:699px;top:583px;">97 </div><div id="a28831" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:599px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28832" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:600px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Note 14 – Plans of Restructuring and Integration Costs</a></div><div id="a28836" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:426px;top:599px;"><div style="display:inline-block;width:14px">&nbsp;</div></div><div id="a28839" style="position:absolute;font-family:'Times New Roman';left:695px;top:600px;">101 </div><div id="a28842" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:616px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28843" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:617px;"><a href="#a46741" style="color:#0000FF;text-decoration:underline;">Note 15 – Commitments and Contingencies</a></div><div id="a28848" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:367px;top:616px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28851" style="position:absolute;font-family:'Times New Roman';left:695px;top:617px;">103 </div><div id="a28854" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:633px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28855" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:634px;"><a href="#a46943" style="color:#0000FF;text-decoration:underline;">Note 16 – Stock-Based Compensation</a></div><div id="a28861" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:338px;top:633px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28864" style="position:absolute;font-family:'Times New Roman';left:695px;top:634px;">105 </div><div id="a28867" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:650px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28868" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:652px;"><a href="#a47908" style="color:#0000FF;text-decoration:underline;">Note 17 – Employee Benefit Plans</a></div><div id="a28873" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:318px;top:650px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28876" style="position:absolute;font-family:'Times New Roman';left:695px;top:652px;">108 </div><div id="a28879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:668px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28880" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:669px;"><a href="#a48747" style="color:#0000FF;text-decoration:underline;">Note 18 – Redeemable Noncontrolling Interests</a></div><div id="a28885" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:389px;top:668px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28888" style="position:absolute;font-family:'Times New Roman';left:695px;top:669px;">111 </div><div id="a28891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:685px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28892" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:686px;"><a href="#a48922" style="color:#0000FF;text-decoration:underline;">Note 19 – Comprehensive Income</a></div><div id="a28896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:317px;top:685px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28899" style="position:absolute;font-family:'Times New Roman';left:695px;top:686px;">111 </div><div id="a28902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:702px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28903" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:703px;"><a href="#a49559" style="color:#0000FF;text-decoration:underline;">Note 20 – Discontinued Operations</a></div><div id="a28908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:326px;top:702px;"><div style="display:inline-block;width:18px">&nbsp;</div></div><div id="a28910" style="position:absolute;font-family:'Times New Roman';left:695px;top:703px;">113 </div><div id="a28913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:719px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28914" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:721px;"><a href="#a50874" style="color:#0000FF;text-decoration:underline;">Note 21 – Earnings Per Share</a></div><div id="a28920" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:292px;top:719px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a28923" style="position:absolute;font-family:'Times New Roman';left:695px;top:721px;">114 </div><div id="a28926" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:737px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28927" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:738px;"><a href="#a51044" style="color:#0000FF;text-decoration:underline;">Note 22 – Supplemental Cash Flow Information</a></div><div id="a28935" style="position:absolute;font-family:'Times New Roman';left:695px;top:738px;">115 </div><div id="a28938" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:754px;"><div style="display:inline-block;width:26px">&nbsp;</div></div><div id="a28939" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:134px;top:755px;"><a href="#a51119" style="color:#0000FF;text-decoration:underline;">Note 23 – Related Party Transactions</a></div><div id="a28946" style="position:absolute;font-family:'Times New Roman';left:695px;top:755px;">115 </div><div id="a28953" style="position:absolute;font-family:'Times New Roman';left:67px;top:807px;">All other schedules are omitted because the required information is either<div style="display:inline-block;width:5px">&nbsp;</div>inapplicable or is included in the consolidated </div><div id="a28955" style="position:absolute;font-family:'Times New Roman';left:67px;top:822px;">financial statements or the notes thereto.</div></div>
</div>
<div style="padding: 7px">
<div id="Page61" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a28959" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a28962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">61 </div><div id="a28964" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Report Of Independent Registered Public Accounting Firm </div><div id="a28984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:93px;">Shareholders and Board of Directors<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a28988" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:109px;">Henry Schein, Inc. </div><div id="a28990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:126px;">Melville, NY </div><div id="a28992" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:159px;">Opinion on the Consolidated Financial Statements<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a28994" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:192px;">We<div style="display:inline-block;width:8px">&nbsp;</div>have<div style="display:inline-block;width:6px">&nbsp;</div>audited<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>accompanying<div style="display:inline-block;width:6px">&nbsp;</div>consolidated<div style="display:inline-block;width:6px">&nbsp;</div>balance<div style="display:inline-block;width:6px">&nbsp;</div>sheets<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>Henry<div style="display:inline-block;width:6px">&nbsp;</div>Schein,<div style="display:inline-block;width:6px">&nbsp;</div>Inc.<div style="display:inline-block;width:6px">&nbsp;</div>(the<div style="display:inline-block;width:6px">&nbsp;</div>“Company”)<div style="display:inline-block;width:6px">&nbsp;</div>as<div style="display:inline-block;width:6px">&nbsp;</div>of </div><div id="a28995" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:209px;">December 31, 2022 and December 25, 2021, the related consolidated statements of income, comprehensive income, </div><div id="a29005" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:226px;">stockholders’ equity,<div style="display:inline-block;width:7px">&nbsp;</div>and cash<div style="display:inline-block;width:6px">&nbsp;</div>flows for<div style="display:inline-block;width:6px">&nbsp;</div>each of<div style="display:inline-block;width:6px">&nbsp;</div>the three<div style="display:inline-block;width:6px">&nbsp;</div>years in<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>period ended<div style="display:inline-block;width:6px">&nbsp;</div>December 31,<div style="display:inline-block;width:6px">&nbsp;</div>2022, and<div style="display:inline-block;width:6px">&nbsp;</div>the </div><div id="a29012" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:243px;">related notes<div style="display:inline-block;width:5px">&nbsp;</div>(collectively referred to<div style="display:inline-block;width:6px">&nbsp;</div>as the<div style="display:inline-block;width:5px">&nbsp;</div>“consolidated financial statements”).<div style="display:inline-block;width:10px">&nbsp;</div>In our<div style="display:inline-block;width:5px">&nbsp;</div>opinion, the<div style="display:inline-block;width:5px">&nbsp;</div>consolidated </div><div id="a29014" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:259px;">financial statements<div style="display:inline-block;width:5px">&nbsp;</div>present fairly,<div style="display:inline-block;width:6px">&nbsp;</div>in all<div style="display:inline-block;width:5px">&nbsp;</div>material respects, the<div style="display:inline-block;width:6px">&nbsp;</div>financial position of<div style="display:inline-block;width:6px">&nbsp;</div>the Company<div style="display:inline-block;width:5px">&nbsp;</div>at December<div style="display:inline-block;width:5px">&nbsp;</div>31, </div><div id="a29020" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:276px;">2022 and<div style="display:inline-block;width:5px">&nbsp;</div>December 25, 2021,<div style="display:inline-block;width:6px">&nbsp;</div>and the<div style="display:inline-block;width:5px">&nbsp;</div>results of its<div style="display:inline-block;width:6px">&nbsp;</div>operations and its<div style="display:inline-block;width:6px">&nbsp;</div>cash flows for<div style="display:inline-block;width:6px">&nbsp;</div>each of<div style="display:inline-block;width:5px">&nbsp;</div>the three<div style="display:inline-block;width:5px">&nbsp;</div>years in the </div><div id="a29029" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:293px;">period ended December 31,<div style="display:inline-block;width:5px">&nbsp;</div>2022, in conformity with<div style="display:inline-block;width:5px">&nbsp;</div>accounting principles generally accepted in<div style="display:inline-block;width:5px">&nbsp;</div>the United States </div><div id="a29034" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:310px;">of America. </div><div id="a29036" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:343px;">We<div style="display:inline-block;width:8px">&nbsp;</div>also<div style="display:inline-block;width:7px">&nbsp;</div>have<div style="display:inline-block;width:6px">&nbsp;</div>audited,<div style="display:inline-block;width:6px">&nbsp;</div>in<div style="display:inline-block;width:7px">&nbsp;</div>accordance<div style="display:inline-block;width:7px">&nbsp;</div>with<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>standards<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>Public<div style="display:inline-block;width:6px">&nbsp;</div>Company<div style="display:inline-block;width:6px">&nbsp;</div>Accounting<div style="display:inline-block;width:6px">&nbsp;</div>Oversight<div style="display:inline-block;width:6px">&nbsp;</div>Board </div><div id="a29038" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:360px;">(United<div style="display:inline-block;width:6px">&nbsp;</div>States)<div style="display:inline-block;width:6px">&nbsp;</div>(“PCAOB”),<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>Company's<div style="display:inline-block;width:6px">&nbsp;</div>internal<div style="display:inline-block;width:6px">&nbsp;</div>control<div style="display:inline-block;width:6px">&nbsp;</div>over<div style="display:inline-block;width:6px">&nbsp;</div>financial<div style="display:inline-block;width:6px">&nbsp;</div>reporting<div style="display:inline-block;width:6px">&nbsp;</div>as<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>December<div style="display:inline-block;width:6px">&nbsp;</div>31,<div style="display:inline-block;width:6px">&nbsp;</div>2022, </div><div id="a29043" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:377px;">based<div style="display:inline-block;width:7px">&nbsp;</div>on<div style="display:inline-block;width:7px">&nbsp;</div>criteria<div style="display:inline-block;width:7px">&nbsp;</div>established<div style="display:inline-block;width:7px">&nbsp;</div>in<div style="display:inline-block;width:7px">&nbsp;</div>Internal<div style="display:inline-block;width:7px">&nbsp;</div>Control<div style="display:inline-block;width:7px">&nbsp;</div>–<div style="display:inline-block;width:7px">&nbsp;</div>Integrated<div style="display:inline-block;width:7px">&nbsp;</div>Framework<div style="display:inline-block;width:7px">&nbsp;</div>(2013)<div style="display:inline-block;width:7px">&nbsp;</div>issued<div style="display:inline-block;width:7px">&nbsp;</div>by<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>Committee<div style="display:inline-block;width:7px">&nbsp;</div>of </div><div id="a29047" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:394px;">Sponsoring<div style="display:inline-block;width:7px">&nbsp;</div>Organizations<div style="display:inline-block;width:7px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>Treadway<div style="display:inline-block;width:8px">&nbsp;</div>Commission<div style="display:inline-block;width:7px">&nbsp;</div>(“COSO”)<div style="display:inline-block;width:7px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>our<div style="display:inline-block;width:7px">&nbsp;</div>report<div style="display:inline-block;width:7px">&nbsp;</div>dated<div style="display:inline-block;width:7px">&nbsp;</div>February<div style="display:inline-block;width:7px">&nbsp;</div>21,<div style="display:inline-block;width:7px">&nbsp;</div>2023, </div><div id="a29054" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:410px;">expressed an unqualified opinion thereon. </div><div id="a29056" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:443px;">Basis for Opinion </div><div id="a29058" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:476px;">These consolidated financial statements are<div style="display:inline-block;width:6px">&nbsp;</div>the responsibility of the<div style="display:inline-block;width:5px">&nbsp;</div>Company’s management. Our<div style="display:inline-block;width:5px">&nbsp;</div>responsibility is </div><div id="a29059" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:493px;">to<div style="display:inline-block;width:6px">&nbsp;</div>express<div style="display:inline-block;width:5px">&nbsp;</div>an<div style="display:inline-block;width:5px">&nbsp;</div>opinion<div style="display:inline-block;width:5px">&nbsp;</div>on<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>Company’s<div style="display:inline-block;width:6px">&nbsp;</div>consolidated<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>statements<div style="display:inline-block;width:5px">&nbsp;</div>based<div style="display:inline-block;width:5px">&nbsp;</div>on<div style="display:inline-block;width:5px">&nbsp;</div>our<div style="display:inline-block;width:5px">&nbsp;</div>audits.<div style="display:inline-block;width:5px">&nbsp;</div>We<div style="display:inline-block;width:7px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>a<div style="display:inline-block;width:5px">&nbsp;</div>public </div><div id="a29060" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:510px;">accounting<div style="display:inline-block;width:5px">&nbsp;</div>firm<div style="display:inline-block;width:5px">&nbsp;</div>registered<div style="display:inline-block;width:5px">&nbsp;</div>with<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>PCAOB<div style="display:inline-block;width:5px">&nbsp;</div>and<div style="display:inline-block;width:5px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>required<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>be<div style="display:inline-block;width:5px">&nbsp;</div>independent<div style="display:inline-block;width:5px">&nbsp;</div>with<div style="display:inline-block;width:5px">&nbsp;</div>respect<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>Company<div style="display:inline-block;width:5px">&nbsp;</div>in </div><div id="a29062" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:527px;">accordance<div style="display:inline-block;width:6px">&nbsp;</div>with<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>U.S.<div style="display:inline-block;width:6px">&nbsp;</div>federal<div style="display:inline-block;width:6px">&nbsp;</div>securities<div style="display:inline-block;width:6px">&nbsp;</div>laws<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>applicable<div style="display:inline-block;width:6px">&nbsp;</div>rules<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>regulations<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>Securities<div style="display:inline-block;width:6px">&nbsp;</div>and </div><div id="a29063" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:544px;">Exchange Commission and the PCAOB. </div><div id="a29065" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:576px;">We<div style="display:inline-block;width:5px">&nbsp;</div>conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and </div><div id="a29067" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:593px;">perform<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>audit<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>obtain<div style="display:inline-block;width:5px">&nbsp;</div>reasonable<div style="display:inline-block;width:5px">&nbsp;</div>assurance<div style="display:inline-block;width:5px">&nbsp;</div>about<div style="display:inline-block;width:5px">&nbsp;</div>whether<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>consolidated<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>statements<div style="display:inline-block;width:5px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>free<div style="display:inline-block;width:5px">&nbsp;</div>of </div><div id="a29068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:610px;">material misstatement, whether due to error or fraud.<div style="display:inline-block;width:8px">&nbsp;</div>Our audits included performing procedures to assess the risks </div><div id="a29070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:627px;">of<div style="display:inline-block;width:5px">&nbsp;</div>material<div style="display:inline-block;width:5px">&nbsp;</div>misstatement<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>consolidated<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>statements,<div style="display:inline-block;width:5px">&nbsp;</div>whether<div style="display:inline-block;width:5px">&nbsp;</div>due<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>error<div style="display:inline-block;width:5px">&nbsp;</div>or<div style="display:inline-block;width:5px">&nbsp;</div>fraud,<div style="display:inline-block;width:5px">&nbsp;</div>and<div style="display:inline-block;width:5px">&nbsp;</div>performing </div><div id="a29071" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:644px;">procedures that respond to those risks.<div style="display:inline-block;width:8px">&nbsp;</div>Such procedures included examining, on a test basis, evidence regarding the </div><div id="a29073" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:661px;">amounts<div style="display:inline-block;width:8px">&nbsp;</div>and<div style="display:inline-block;width:8px">&nbsp;</div>disclosures<div style="display:inline-block;width:8px">&nbsp;</div>in<div style="display:inline-block;width:8px">&nbsp;</div>the<div style="display:inline-block;width:8px">&nbsp;</div>consolidated<div style="display:inline-block;width:8px">&nbsp;</div>financial<div style="display:inline-block;width:8px">&nbsp;</div>statements.<div style="display:inline-block;width:16px">&nbsp;</div>Our<div style="display:inline-block;width:8px">&nbsp;</div>audits<div style="display:inline-block;width:8px">&nbsp;</div>also<div style="display:inline-block;width:8px">&nbsp;</div>included<div style="display:inline-block;width:8px">&nbsp;</div>evaluating<div style="display:inline-block;width:8px">&nbsp;</div>the </div><div id="a29074" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:678px;">accounting<div style="display:inline-block;width:7px">&nbsp;</div>principles<div style="display:inline-block;width:7px">&nbsp;</div>used<div style="display:inline-block;width:7px">&nbsp;</div>and<div style="display:inline-block;width:7px">&nbsp;</div>significant<div style="display:inline-block;width:7px">&nbsp;</div>estimates<div style="display:inline-block;width:7px">&nbsp;</div>made<div style="display:inline-block;width:7px">&nbsp;</div>by<div style="display:inline-block;width:7px">&nbsp;</div>management,<div style="display:inline-block;width:7px">&nbsp;</div>as<div style="display:inline-block;width:7px">&nbsp;</div>well<div style="display:inline-block;width:7px">&nbsp;</div>as<div style="display:inline-block;width:7px">&nbsp;</div>evaluating<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>overall </div><div id="a29075" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:695px;">presentation of the consolidated financial<div style="display:inline-block;width:5px">&nbsp;</div>statements.<div style="display:inline-block;width:8px">&nbsp;</div>We<div style="display:inline-block;width:5px">&nbsp;</div>believe that our audits provide<div style="display:inline-block;width:5px">&nbsp;</div>a reasonable basis for our </div><div id="a29078" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:711px;">opinion. </div><div id="a29081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:745px;">Critical Audit Matter </div><div id="a29084" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:787px;">The critical audit matter communicated below is a matter arising from the<div style="display:inline-block;width:2px">&nbsp;</div>current period audit of the consolidated </div><div id="a29085" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:804px;">financial statements that was communicated or required to be communicated<div style="display:inline-block;width:2px">&nbsp;</div>to the audit committee and that: (1) </div><div id="a29090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:821px;">relates to accounts or disclosures that are material to the consolidated<div style="display:inline-block;width:2px">&nbsp;</div>financial statements and (2) involved our </div><div id="a29092" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:838px;">especially challenging, subjective,<div style="display:inline-block;width:3px">&nbsp;</div>or complex judgments. The communication of the critical<div style="display:inline-block;width:2px">&nbsp;</div>audit matter does not </div><div id="a29096" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:855px;">alter in any way our opinion on the consolidated financial statements, taken<div style="display:inline-block;width:2px">&nbsp;</div>as a whole, and we are not, by </div><div id="a29098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:872px;">communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the </div><div id="a29101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:889px;">accounts or disclosures to which it relates. </div></div>
</div>
<div style="padding: 7px">
<div id="Page62" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a29104" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a29107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">62 </div><div id="a29109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Revenue growth rates utilized in<div style="display:inline-block;width:5px">&nbsp;</div>the determination of the fair<div style="display:inline-block;width:5px">&nbsp;</div>value of acquired customer relationships<div style="display:inline-block;width:5px">&nbsp;</div>for a </div><div id="a29112" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:76px;">certain acquisition </div><div id="a29115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:119px;">As described in<div style="display:inline-block;width:5px">&nbsp;</div>Note 4 of<div style="display:inline-block;width:5px">&nbsp;</div>the consolidated financial<div style="display:inline-block;width:5px">&nbsp;</div>statements, the Company<div style="display:inline-block;width:5px">&nbsp;</div>acquired several companies in<div style="display:inline-block;width:5px">&nbsp;</div>the </div><div id="a29119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:136px;">current year.<div style="display:inline-block;width:6px">&nbsp;</div>As a<div style="display:inline-block;width:5px">&nbsp;</div>result of<div style="display:inline-block;width:5px">&nbsp;</div>the acquisitions,<div style="display:inline-block;width:5px">&nbsp;</div>management was<div style="display:inline-block;width:5px">&nbsp;</div>required to<div style="display:inline-block;width:5px">&nbsp;</div>determine estimated<div style="display:inline-block;width:5px">&nbsp;</div>fair values<div style="display:inline-block;width:5px">&nbsp;</div>of the </div><div id="a29121" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:152px;">assets<div style="display:inline-block;width:8px">&nbsp;</div>acquired<div style="display:inline-block;width:8px">&nbsp;</div>and<div style="display:inline-block;width:8px">&nbsp;</div>liabilities<div style="display:inline-block;width:8px">&nbsp;</div>assumed,<div style="display:inline-block;width:8px">&nbsp;</div>including<div style="display:inline-block;width:8px">&nbsp;</div>certain<div style="display:inline-block;width:8px">&nbsp;</div>identifiable<div style="display:inline-block;width:8px">&nbsp;</div>intangible<div style="display:inline-block;width:8px">&nbsp;</div>assets.<div style="display:inline-block;width:8px">&nbsp;</div>In<div style="display:inline-block;width:8px">&nbsp;</div>some<div style="display:inline-block;width:8px">&nbsp;</div>instances, </div><div id="a29122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:169px;">management<div style="display:inline-block;width:7px">&nbsp;</div>utilized<div style="display:inline-block;width:7px">&nbsp;</div>third-party<div style="display:inline-block;width:7px">&nbsp;</div>valuation<div style="display:inline-block;width:7px">&nbsp;</div>specialists<div style="display:inline-block;width:7px">&nbsp;</div>to<div style="display:inline-block;width:7px">&nbsp;</div>assist<div style="display:inline-block;width:7px">&nbsp;</div>in<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>preparation<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>valuation<div style="display:inline-block;width:7px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>certain </div><div id="a29126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:186px;">identifiable intangible assets.<div style="display:inline-block;width:5px">&nbsp;</div>Management exercised judgment to<div style="display:inline-block;width:6px">&nbsp;</div>develop and select<div style="display:inline-block;width:5px">&nbsp;</div>revenue growth rates<div style="display:inline-block;width:5px">&nbsp;</div>in the </div><div id="a29127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:203px;">measurement of the fair value of the customer relationships. </div><div id="a29130" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:253px;">We<div style="display:inline-block;width:8px">&nbsp;</div>identified<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>revenue<div style="display:inline-block;width:6px">&nbsp;</div>growth<div style="display:inline-block;width:6px">&nbsp;</div>rates<div style="display:inline-block;width:7px">&nbsp;</div>utilized<div style="display:inline-block;width:6px">&nbsp;</div>in<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>determination<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>fair<div style="display:inline-block;width:7px">&nbsp;</div>value<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>acquired<div style="display:inline-block;width:6px">&nbsp;</div>customer </div><div id="a29132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:270px;">relationships<div style="display:inline-block;width:10px">&nbsp;</div>for<div style="display:inline-block;width:10px">&nbsp;</div>a<div style="display:inline-block;width:10px">&nbsp;</div>certain<div style="display:inline-block;width:10px">&nbsp;</div>acquisition,<div style="display:inline-block;width:9px">&nbsp;</div>as<div style="display:inline-block;width:10px">&nbsp;</div>a<div style="display:inline-block;width:10px">&nbsp;</div>critical<div style="display:inline-block;width:10px">&nbsp;</div>audit<div style="display:inline-block;width:9px">&nbsp;</div>matter.<div style="display:inline-block;width:11px">&nbsp;</div>The<div style="display:inline-block;width:10px">&nbsp;</div>principal<div style="display:inline-block;width:9px">&nbsp;</div>considerations<div style="display:inline-block;width:10px">&nbsp;</div>for<div style="display:inline-block;width:10px">&nbsp;</div>our </div><div id="a29135" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:286px;">determination included the<div style="display:inline-block;width:5px">&nbsp;</div>subjectivity and judgment<div style="display:inline-block;width:5px">&nbsp;</div>required to determine<div style="display:inline-block;width:5px">&nbsp;</div>the revenue growth<div style="display:inline-block;width:5px">&nbsp;</div>rates used<div style="display:inline-block;width:5px">&nbsp;</div>in the </div><div id="a29138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:303px;">fair<div style="display:inline-block;width:7px">&nbsp;</div>value<div style="display:inline-block;width:6px">&nbsp;</div>measurement<div style="display:inline-block;width:7px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>acquired<div style="display:inline-block;width:7px">&nbsp;</div>customer<div style="display:inline-block;width:6px">&nbsp;</div>relationships<div style="display:inline-block;width:7px">&nbsp;</div>for<div style="display:inline-block;width:7px">&nbsp;</div>a<div style="display:inline-block;width:7px">&nbsp;</div>certain<div style="display:inline-block;width:7px">&nbsp;</div>acquisition.<div style="display:inline-block;width:6px">&nbsp;</div>Auditing<div style="display:inline-block;width:7px">&nbsp;</div>these<div style="display:inline-block;width:7px">&nbsp;</div>revenue </div><div id="a29143" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:320px;">growth rates involved especially subjective auditor judgment due to<div style="display:inline-block;width:2px">&nbsp;</div>the nature and extent of audit effort required. </div><div id="a29148" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:370px;">The primary procedures we performed to address this critical audit matter<div style="display:inline-block;width:2px">&nbsp;</div>included: </div><div id="a29152" style="position:absolute;font-family:'Times New Roman';font-size:14.08px;left:117px;top:419px;">●</div><div id="a29154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:141px;top:419px;">Evaluating the reasonableness of the revenue growth rates by i)<div style="display:inline-block;width:2px">&nbsp;</div>reviewing the historical performance </div><div id="a29155" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:141px;top:435px;">of the acquired company using its audited financial statements and<div style="display:inline-block;width:2px">&nbsp;</div>(ii) assessing revenue projections </div><div id="a29157" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:141px;top:452px;">against industry metrics and peer-group companies. </div><div id="a29164" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:527px;">/s/ </div><div id="a29164_4_12" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:85px;top:527px;"><ix:nonnumeric id="ID_1319" name="dei:AuditorName" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">BDO USA, LLP</ix:nonnumeric></div><div id="a29166" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:560px;">We have served as the Company's auditor since 1984. </div><div id="a29168" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:593px;"><ix:nonnumeric id="ID_1320" name="dei:AuditorLocation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228">New York, NY</ix:nonnumeric></div><div id="a29170" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:610px;">February 21, 2023 </div></div>
</div>
<div style="padding: 7px">
<div id="Page63" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:163.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:163.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:181px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:209px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:237px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.1px; left:67.2px; top:266px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:14.1px; left:67.2px; top:265px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:431.1px; height:14.1px; left:112.2px; top:265px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:476.1px; height:1px; left:66.8px; top:264.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:264.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:638px; top:264.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:264.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:293px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:321px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.1px; left:67.2px; top:350px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:14.1px; left:67.2px; top:349px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:431.1px; height:14.1px; left:112.2px; top:349px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:476.1px; height:1px; left:66.8px; top:348.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:348.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:638px; top:348.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:348.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:543.3px; top:363.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:543.3px; top:365px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653.4px; top:363.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653.4px; top:365px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:32px; left:67.2px; top:377px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:32px; left:67.2px; top:377px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:423.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:451.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:479.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:507.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:12.9px; left:67.2px; top:536.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:13.9px; left:67.2px; top:535.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:431.1px; height:13.9px; left:112.2px; top:535.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:476.1px; height:1px; left:66.8px; top:534.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:534.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:638px; top:534.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:534.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:563.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:591.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:604.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:604.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:619.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:647.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:675.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:703.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:731.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:759.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:787.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:800.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:800.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:815.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:828.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:828.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:12.9px; left:67.2px; top:844.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:13.9px; left:67.2px; top:843.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:476.1px; height:1px; left:66.8px; top:842.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:13.9px; left:538.3px; top:843.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:542.9px; top:842.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:638px; top:842.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:842.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:542.3px; top:859.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:542.3px; top:857.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.8px; height:1px; left:652.5px; top:859.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.8px; height:1px; left:652.5px; top:857.3px; background-color:#000000; ">&nbsp;</div>
<div id="a29175" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a29178" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">63 </div><div id="a29180" style="position:absolute;font-family:'Times New Roman';font-size:17.28px;font-weight:bold;left:319px;top:60px;">HENRY SCHEIN, INC. </div><div id="a29182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:281px;top:80px;">CONSOLIDATED BALANCE SHEETS </div><div id="a29184" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:312px;top:97px;">(in millions, except share data) </div><div id="a29193" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:554px;top:133px;">December 31, </div><div id="a29196" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:664px;top:133px;">December 25, </div><div id="a29203" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:578px;top:150px;">2022 </div><div id="a29206" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:688px;top:150px;">2021 </div><div id="a29218" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:181px;">ASSETS </div><div id="a29226" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:195px;">Current assets: </div><div id="a29235" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:209px;">Cash and cash equivalents<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29238" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:543px;top:209px;">$ </div><div id="a29240" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:209px;"><ix:nonfraction id="ID_1413" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">117</ix:nonfraction></div><div id="a29243" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:209px;">$ </div><div id="a29245" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:209px;"><ix:nonfraction id="ID_1414" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">118</ix:nonfraction></div><div id="a29248" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:223px;">Accounts receivable, net of reserves of $</div><div id="a29248_41_2" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:289px;top:223px;"><ix:nonfraction id="ID_575" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">65</ix:nonfraction></div><div id="a29248_43_6" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:301px;top:223px;"><div style="display:inline-block;width:3px">&nbsp;</div>and $</div><div id="a29248_49_2" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:332px;top:223px;"><ix:nonfraction id="ID_576" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">67</ix:nonfraction></div><div id="a29252" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:223px;"><ix:nonfraction id="ID_504" name="us-gaap:AccountsReceivableNetCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,442</ix:nonfraction></div><div id="a29256" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:223px;"><ix:nonfraction id="ID_505" name="us-gaap:AccountsReceivableNetCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,452</ix:nonfraction></div><div id="a29259" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:237px;">Inventories, net </div><div id="a29263" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:237px;"><ix:nonfraction id="ID_506" name="us-gaap:InventoryNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,963</ix:nonfraction></div><div id="a29267" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:237px;"><ix:nonfraction id="ID_507" name="us-gaap:InventoryNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,861</ix:nonfraction></div><div id="a29270" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:251px;">Prepaid expenses and other<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29274" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:251px;"><ix:nonfraction id="ID_508" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">466</ix:nonfraction></div><div id="a29278" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:251px;"><ix:nonfraction id="ID_509" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">413</ix:nonfraction></div><div id="a29283" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:112px;top:266px;">Total current assets<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29287" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:266px;"><ix:nonfraction id="ID_510" name="us-gaap:AssetsCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,988</ix:nonfraction></div><div id="a29291" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:266px;"><ix:nonfraction id="ID_511" name="us-gaap:AssetsCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,844</ix:nonfraction></div><div id="a29293" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:279px;">Property and equipment, net<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29297" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:279px;"><ix:nonfraction id="ID_439" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">383</ix:nonfraction></div><div id="a29301" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:279px;"><ix:nonfraction id="ID_379" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">366</ix:nonfraction></div><div id="a29303" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:293px;">Operating lease right-of-use assets </div><div id="a29311" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:293px;"><ix:nonfraction id="ID_537" name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">284</ix:nonfraction></div><div id="a29315" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:293px;"><ix:nonfraction id="ID_538" name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">325</ix:nonfraction></div><div id="a29317" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:307px;">Goodwill<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29321" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:307px;"><ix:nonfraction id="ID_144" name="us-gaap:Goodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,893</ix:nonfraction></div><div id="a29325" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:307px;"><ix:nonfraction id="ID_280" name="us-gaap:Goodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,854</ix:nonfraction></div><div id="a29327" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:321px;">Other intangibles, net<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29331" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:321px;"><ix:nonfraction id="ID_373" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">587</ix:nonfraction></div><div id="a29335" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:321px;"><ix:nonfraction id="ID_292" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">668</ix:nonfraction></div><div id="a29337" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:335px;">Investments and other </div><div id="a29341" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:335px;"><ix:nonfraction id="ID_272" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">472</ix:nonfraction></div><div id="a29345" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:335px;"><ix:nonfraction id="ID_191" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">424</ix:nonfraction></div><div id="a29350" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:112px;top:350px;">Total assets<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29353" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:543px;top:350px;">$ </div><div id="a29355" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:350px;"><ix:nonfraction id="ID_36" name="us-gaap:Assets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,607</ix:nonfraction></div><div id="a29358" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:350px;">$ </div><div id="a29360" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:350px;"><ix:nonfraction id="ID_459" name="us-gaap:Assets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,481</ix:nonfraction></div><div id="a29372" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:380px;">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND </div><div id="a29373" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:395px;">STOCKHOLDERS' EQUITY </div><div id="a29381" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:409px;">Current liabilities: </div><div id="a29390" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:423px;">Accounts payable<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29393" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:543px;top:423px;">$ </div><div id="a29395" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:423px;"><ix:nonfraction id="ID_515" name="us-gaap:AccountsPayableCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,004</ix:nonfraction></div><div id="a29398" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:423px;">$ </div><div id="a29400" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:423px;"><ix:nonfraction id="ID_516" name="us-gaap:AccountsPayableCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,054</ix:nonfraction></div><div id="a29403" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:437px;">Bank credit lines<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29407" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:437px;"><ix:nonfraction id="ID_517" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a29411" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:437px;"><ix:nonfraction id="ID_518" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction></div><div id="a29414" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:451px;">Current maturities of long-term debt<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29420" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:632px;top:451px;"><ix:nonfraction id="ID_271" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a29424" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:451px;"><ix:nonfraction id="ID_372" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a29427" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:465px;">Operating lease liabilities </div><div id="a29431" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:626px;top:465px;"><ix:nonfraction id="ID_519" name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">73</ix:nonfraction></div><div id="a29435" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:465px;"><ix:nonfraction id="ID_520" name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">76</ix:nonfraction></div><div id="a29438" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:479px;">Accrued expenses: </div><div id="a29448" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:493px;">Payroll and related<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29452" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:493px;"><ix:nonfraction id="ID_521" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">314</ix:nonfraction></div><div id="a29456" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:493px;"><ix:nonfraction id="ID_522" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">385</ix:nonfraction></div><div id="a29460" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:507px;">Taxes<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29464" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:507px;"><ix:nonfraction id="ID_523" name="us-gaap:TaxesPayableCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">132</ix:nonfraction></div><div id="a29468" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:507px;"><ix:nonfraction id="ID_524" name="us-gaap:TaxesPayableCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">137</ix:nonfraction></div><div id="a29472" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:521px;">Other<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29476" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:521px;"><ix:nonfraction id="ID_525" name="us-gaap:OtherLiabilitiesCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">592</ix:nonfraction></div><div id="a29480" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:521px;"><ix:nonfraction id="ID_526" name="us-gaap:OtherLiabilitiesCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">593</ix:nonfraction></div><div id="a29485" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:112px;top:536px;">Total current liabilities<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29489" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:536px;"><ix:nonfraction id="ID_527" name="us-gaap:LiabilitiesCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,224</ix:nonfraction></div><div id="a29493" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:536px;"><ix:nonfraction id="ID_528" name="us-gaap:LiabilitiesCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,307</ix:nonfraction></div><div id="a29495" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:549px;">Long-term debt<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29501" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:549px;"><ix:nonfraction id="ID_1175" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,040</ix:nonfraction></div><div id="a29505" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:549px;"><ix:nonfraction id="ID_1176" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">811</ix:nonfraction></div><div id="a29507" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:563px;">Deferred income taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29511" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:626px;top:563px;"><ix:nonfraction id="ID_529" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction></div><div id="a29515" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:563px;"><ix:nonfraction id="ID_530" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">42</ix:nonfraction></div><div id="a29517" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:577px;">Operating lease liabilities </div><div id="a29521" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:577px;"><ix:nonfraction id="ID_531" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">275</ix:nonfraction></div><div id="a29525" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:577px;"><ix:nonfraction id="ID_532" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">268</ix:nonfraction></div><div id="a29527" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:591px;">Other liabilities<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29531" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:591px;"><ix:nonfraction id="ID_533" name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">361</ix:nonfraction></div><div id="a29535" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:591px;"><ix:nonfraction id="ID_534" name="us-gaap:OtherLiabilitiesNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">377</ix:nonfraction></div><div id="a29540" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:112px;top:606px;">Total liabilities<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29544" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:606px;"><ix:nonfraction id="ID_535" name="us-gaap:Liabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,936</ix:nonfraction></div><div id="a29548" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:606px;"><ix:nonfraction id="ID_536" name="us-gaap:Liabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,805</ix:nonfraction></div><div id="a29560" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:633px;">Redeemable noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29564" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:633px;"><ix:nonfraction id="ID_336" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">576</ix:nonfraction></div><div id="a29568" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:633px;"><ix:nonfraction id="ID_908" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">613</ix:nonfraction></div><div id="a29570" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:647px;">Commitments and contingencies<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29574" style="position:absolute;font-family:'Times New Roman';font-size:1.28px;color:#FFFFFF;left:636px;top:660px;-sec-ix-hidden:ID_1420;">(nil)</div><div id="a29578" style="position:absolute;font-family:'Times New Roman';font-size:1.28px;color:#FFFFFF;left:746px;top:660px;-sec-ix-hidden:ID_1421;">(nil)</div><div id="a29590" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:675px;">Stockholders' equity: </div><div id="a29599" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:689px;">Preferred stock, $</div><div id="a29599_18_4" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:172px;top:689px;"><ix:nonfraction id="ID_577" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction></div><div id="a29599_22_12" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:194px;top:689px;"><div style="display:inline-block;width:3px">&nbsp;</div>par value, </div><div id="a29599_34_9" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:250px;top:689px;"><ix:nonfraction id="ID_579" name="us-gaap:PreferredStockSharesAuthorized" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">1,000,000</ix:nonfraction></div><div id="a29599_43_20" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:301px;top:689px;"><div style="display:inline-block;width:3px">&nbsp;</div>shares authorized, </div><div id="a29609" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:703px;"><ix:nonfraction id="ID_581" name="us-gaap:PreferredStockSharesOutstanding" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="shares" decimals="INF" format="ixt-sec:numwordsen">none</ix:nonfraction></div><div id="a29609_4_13" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:122px;top:703px;"><div style="display:inline-block;width:3px">&nbsp;</div>outstanding </div><div id="a29613" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:634px;top:703px;"><ix:nonfraction id="ID_634" name="us-gaap:PreferredStockValueOutstanding" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a29617" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:744px;top:703px;"><ix:nonfraction id="ID_635" name="us-gaap:PreferredStockValueOutstanding" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a29620" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:717px;">Common stock, $</div><div id="a29620_15_4" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:172px;top:717px;"><ix:nonfraction id="ID_706" name="us-gaap:CommonStockParOrStatedValuePerShare" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction></div><div id="a29620_19_12" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:194px;top:717px;"><div style="display:inline-block;width:3px">&nbsp;</div>par value, </div><div id="a29620_31_11" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:251px;top:717px;"><ix:nonfraction id="ID_708" name="us-gaap:CommonStockSharesAuthorized" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">480,000,000</ix:nonfraction></div><div id="a29620_42_20" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:314px;top:717px;"><div style="display:inline-block;width:3px">&nbsp;</div>shares authorized, </div><div id="a29631" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:731px;"><ix:nonfraction id="ID_710" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">131,792,817</ix:nonfraction></div><div id="a29631_11_38" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:161px;top:731px;"><div style="display:inline-block;width:3px">&nbsp;</div>outstanding on December 31, 2022 and </div><div id="a29641" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:745px;"><ix:nonfraction id="ID_711" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">137,145,558</ix:nonfraction></div><div id="a29641_11_34" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:161px;top:745px;"><div style="display:inline-block;width:3px">&nbsp;</div>outstanding on December 25, 2021 </div><div id="a29645" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:632px;top:745px;"><ix:nonfraction id="ID_636" name="us-gaap:CommonStockValueOutstanding" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a29649" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:742px;top:745px;"><ix:nonfraction id="ID_637" name="us-gaap:CommonStockValueOutstanding" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a29652" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:759px;">Additional paid-in capital </div><div id="a29658" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:634px;top:759px;"><ix:nonfraction id="ID_1746" name="us-gaap:AdditionalPaidInCapital" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a29662" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:744px;top:759px;"><ix:nonfraction id="ID_1747" name="us-gaap:AdditionalPaidInCapital" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a29665" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:773px;">Retained earnings<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29669" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:773px;"><ix:nonfraction id="ID_638" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,678</ix:nonfraction></div><div id="a29673" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:773px;"><ix:nonfraction id="ID_639" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,595</ix:nonfraction></div><div id="a29676" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:787px;">Accumulated other comprehensive loss<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29680" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:611px;top:787px;display:flex;">(<ix:nonfraction id="ID_169" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">233</ix:nonfraction>)</div><div id="a29684" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:721px;top:787px;display:flex;">(<ix:nonfraction id="ID_438" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">171</ix:nonfraction>)</div><div id="a29688" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:802px;">Total Henry Schein, Inc. stockholders' equity </div><div id="a29692" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:802px;"><ix:nonfraction id="ID_640" name="us-gaap:StockholdersEquity" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,446</ix:nonfraction></div><div id="a29696" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:802px;"><ix:nonfraction id="ID_641" name="us-gaap:StockholdersEquity" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,425</ix:nonfraction></div><div id="a29699" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:82px;top:815px;">Noncontrolling interests </div><div id="a29703" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:619px;top:815px;"><ix:nonfraction id="ID_642" name="us-gaap:MinorityInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">649</ix:nonfraction></div><div id="a29707" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:815px;"><ix:nonfraction id="ID_643" name="us-gaap:MinorityInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">638</ix:nonfraction></div><div id="a29712" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:112px;top:830px;">Total stockholders' equity<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29716" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:830px;"><ix:nonfraction id="ID_348" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,095</ix:nonfraction></div><div id="a29720" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:830px;"><ix:nonfraction id="ID_415" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,063</ix:nonfraction></div><div id="a29724" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:844px;">Total liabilities, redeemable noncontrolling<div style="display:inline-block;width:5px">&nbsp;</div>interests and stockholders' equity </div><div id="a29728" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:543px;top:844px;">$ </div><div id="a29730" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:610px;top:844px;"><ix:nonfraction id="ID_644" name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,607</ix:nonfraction></div><div id="a29733" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:844px;">$ </div><div id="a29735" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:844px;"><ix:nonfraction id="ID_645" name="us-gaap:LiabilitiesAndStockholdersEquity" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,481</ix:nonfraction></div></div>
</div>
<div style="padding: 7px">
<div id="Page64" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:262px; height:1px; left:485.9px; top:142.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:174.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:174.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:174.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:191.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:223.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:224px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:16px; left:67.2px; top:222.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:1px; left:66.8px; top:222.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:222.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:570.3px; top:222.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:222.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:659.3px; top:222.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:222.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:254.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:255.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:286.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:287.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:302.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:302.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:302.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:318.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:319.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:350.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:351.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:429.1px; height:14.6px; left:67.2px; top:384.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:383.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:252px; height:14.6px; left:496.3px; top:384.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:16px; left:67.2px; top:382.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:1px; left:66.8px; top:382.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:382.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:570.3px; top:382.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:382.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:659.3px; top:382.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:382.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:414.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:415.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:446.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:447.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:462.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:462.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:462.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:479.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:494.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:494.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:494.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:510.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:511.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:526.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:526.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:526.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:8.1px; left:67.2px; top:546.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:12px; left:67.2px; top:542.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:3px; left:67.2px; top:542.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:9.1px; left:486.3px; top:545.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:542.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:544.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:545.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:570.3px; top:542.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:542.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:544.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:545.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:659.3px; top:542.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:9.1px; left:664.3px; top:545.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:542.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:544.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:545.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:571px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:571.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:604px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:604.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:1px; left:66.8px; top:602.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:602.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:570.3px; top:603px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:602.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:659.3px; top:603px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:602.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:619px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:620.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:619px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:620.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:619px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:620.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:33.1px; left:67.2px; top:631px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:267.1px; height:14.6px; left:481.2px; top:640.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:678.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:679.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:694.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:696.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:694.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:696.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:694.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:696.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:9.1px; left:67.2px; top:713.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:12px; left:67.2px; top:710.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:2.9px; left:67.2px; top:710.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:712.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:713.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:570.3px; top:710.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:712.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:713.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:659.3px; top:710.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:712.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:713.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:754.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.1px; left:67.2px; top:788.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:16px; left:67.2px; top:785.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:2.9px; left:67.2px; top:785.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:785.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:787.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:787.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:570.3px; top:785.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:785.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:787.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:787.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:659.3px; top:785.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:785.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:787.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:787.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:801.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:803.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:801.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:803.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:801.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:803.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:813.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:813.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:843.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:14.6px; left:67.2px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:861.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:861.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:861.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:9.1px; left:67.2px; top:878.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9px; height:12px; left:67.2px; top:875.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:419.1px; height:2.9px; left:67.2px; top:875.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:875.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:877.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:485.9px; top:878.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:570.3px; top:875.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:875.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:877.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:574.9px; top:878.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:12px; left:659.3px; top:875.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:875.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:877.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:878.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:903.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.6px; left:67.2px; top:904.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:919.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:486.3px; top:921.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:919.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:575.3px; top:921.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:919.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:664.3px; top:921.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:485.4px; top:937.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:485.4px; top:935.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:574.3px; top:937.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:574.3px; top:935.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:937.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:935.8px; background-color:#000000; ">&nbsp;</div>
<div id="a29737" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a29740" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">64 </div><div id="a29742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:333px;top:60px;">HENRY SCHEIN, INC. </div><div id="a29744" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:252px;top:76px;">CONSOLIDATED STATEMENTS<div style="display:inline-block;width:6px">&nbsp;</div>OF INCOME </div><div id="a29746" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:267px;top:93px;">(in millions, except share and per share data) </div><div id="a29758" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:582px;top:129px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a29765" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:491px;top:145px;">December 31, </div><div id="a29768" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:580px;top:145px;">December 25, </div><div id="a29771" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:669px;top:145px;">December 26, </div><div id="a29778" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:516px;top:161px;">2022 </div><div id="a29781" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:605px;top:161px;">2021 </div><div id="a29784" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:694px;top:161px;">2020 </div><div id="a29799" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:192px;">Net sales<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29802" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:192px;">$ </div><div id="a29804" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:535px;top:192px;"><ix:nonfraction id="ID_479" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,647</ix:nonfraction></div><div id="a29807" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:575px;top:192px;">$ </div><div id="a29809" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:624px;top:192px;"><ix:nonfraction id="ID_493" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,401</ix:nonfraction></div><div id="a29812" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:192px;">$ </div><div id="a29814" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:714px;top:192px;"><ix:nonfraction id="ID_826" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,119</ix:nonfraction></div><div id="a29816" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:208px;">Cost of sales<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29820" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:542px;top:208px;"><ix:nonfraction id="ID_730" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,816</ix:nonfraction></div><div id="a29824" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:631px;top:208px;"><ix:nonfraction id="ID_609" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,727</ix:nonfraction></div><div id="a29828" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:208px;"><ix:nonfraction id="ID_610" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,303</ix:nonfraction></div><div id="a29832" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:85px;top:224px;">Gross profit<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29836" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:542px;top:224px;"><ix:nonfraction id="ID_731" name="us-gaap:GrossProfit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,831</ix:nonfraction></div><div id="a29840" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:631px;top:224px;"><ix:nonfraction id="ID_611" name="us-gaap:GrossProfit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,674</ix:nonfraction></div><div id="a29844" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:224px;"><ix:nonfraction id="ID_612" name="us-gaap:GrossProfit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,816</ix:nonfraction></div><div id="a29846" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:240px;">Operating expenses: </div><div id="a29858" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:256px;">Selling, general and administrative<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29862" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:542px;top:256px;"><ix:nonfraction id="ID_811" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,771</ix:nonfraction></div><div id="a29866" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:631px;top:256px;"><ix:nonfraction id="ID_812" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,634</ix:nonfraction></div><div id="a29870" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:720px;top:256px;"><ix:nonfraction id="ID_813" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,086</ix:nonfraction></div><div id="a29873" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:272px;">Depreciation and amortization </div><div id="a29877" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:272px;"><ix:nonfraction id="ID_1422" name="us-gaap:DepreciationAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">182</ix:nonfraction></div><div id="a29881" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:272px;"><ix:nonfraction id="ID_1423" name="us-gaap:DepreciationAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">180</ix:nonfraction></div><div id="a29885" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:272px;"><ix:nonfraction id="ID_1424" name="us-gaap:DepreciationAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">163</ix:nonfraction></div><div id="a29888" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:288px;">Restructuring and integration costs </div><div id="a29892" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:288px;"><ix:nonfraction id="ID_162" name="hsic:RestructuringAndIntegrationRelatedCosts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">131</ix:nonfraction></div><div id="a29896" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:288px;"><ix:nonfraction id="ID_265" name="hsic:RestructuringAndIntegrationRelatedCosts" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a29900" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:288px;"><ix:nonfraction id="ID_456" name="hsic:RestructuringAndIntegrationRelatedCosts" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction></div><div id="a29904" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:85px;top:304px;">Operating income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29908" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:304px;"><ix:nonfraction id="ID_587" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">747</ix:nonfraction></div><div id="a29912" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:304px;"><ix:nonfraction id="ID_714" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">852</ix:nonfraction></div><div id="a29916" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:304px;"><ix:nonfraction id="ID_588" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">535</ix:nonfraction></div><div id="a29918" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:320px;">Other income (expense): </div><div id="a29930" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:336px;">Interest income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29934" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:558px;top:336px;"><ix:nonfraction id="ID_682" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">17</ix:nonfraction></div><div id="a29938" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:336px;"><ix:nonfraction id="ID_599" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a29942" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:336px;"><ix:nonfraction id="ID_683" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a29945" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:352px;">Interest expense<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a29949" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:549px;top:352px;display:flex;">(<ix:nonfraction id="ID_723" name="us-gaap:InterestExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction>)</div><div id="a29953" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:638px;top:352px;display:flex;">(<ix:nonfraction id="ID_725" name="us-gaap:InterestExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction>)</div><div id="a29957" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:727px;top:352px;display:flex;">(<ix:nonfraction id="ID_724" name="us-gaap:InterestExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction>)</div><div id="a29960" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:368px;">Other, net<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29964" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:564px;top:368px;"><ix:nonfraction id="ID_732" name="us-gaap:OtherNonoperatingIncomeExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a29968" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:655px;top:368px;"><ix:nonfraction id="ID_613" name="us-gaap:OtherNonoperatingIncomeExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a29972" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:734px;top:368px;display:flex;">(<ix:nonfraction id="ID_614" name="us-gaap:OtherNonoperatingIncomeExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a29976" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:85px;top:384px;">Income from continuing operations before taxes, equity in<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a29990" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:94px;top:400px;">earnings of affiliates and noncontrolling interests </div><div id="a29995" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:400px;"><ix:nonfraction id="ID_251" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">721</ix:nonfraction></div><div id="a29999" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:400px;"><ix:nonfraction id="ID_239" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">831</ix:nonfraction></div><div id="a30003" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:400px;"><ix:nonfraction id="ID_2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">500</ix:nonfraction></div><div id="a30005" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:416px;">Income taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30009" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:543px;top:416px;display:flex;">(<ix:nonfraction id="ID_60" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">170</ix:nonfraction>)</div><div id="a30013" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:632px;top:416px;display:flex;">(<ix:nonfraction id="ID_437" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">198</ix:nonfraction>)</div><div id="a30017" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:727px;top:416px;display:flex;">(<ix:nonfraction id="ID_198" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">95</ix:nonfraction>)</div><div id="a30019" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:432px;">Equity in earnings of affiliates<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30023" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:558px;top:432px;"><ix:nonfraction id="ID_539" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a30027" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:647px;top:432px;"><ix:nonfraction id="ID_540" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a30031" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:432px;"><ix:nonfraction id="ID_541" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a30033" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:448px;">Gain on sale of equity investment </div><div id="a30037" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:448px;"><ix:nonfraction id="ID_646" name="hsic:EquityMethodInvestmentNonOperatingGainLossOnDisposal" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30041" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:653px;top:448px;"><ix:nonfraction id="ID_647" name="hsic:EquityMethodInvestmentNonOperatingGainLossOnDisposal" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a30045" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:742px;top:448px;"><ix:nonfraction id="ID_648" name="hsic:EquityMethodInvestmentNonOperatingGainLossOnDisposal" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a30047" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:464px;">Net income from continuing operations </div><div id="a30051" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:464px;"><ix:nonfraction id="ID_512" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a30055" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:464px;"><ix:nonfraction id="ID_513" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a30059" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:464px;"><ix:nonfraction id="ID_514" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">419</ix:nonfraction></div><div id="a30061" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:480px;">Income from discontinued operations, net of tax </div><div id="a30065" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:480px;"><ix:nonfraction id="ID_1404" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30069" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:655px;top:480px;"><ix:nonfraction id="ID_1405" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30073" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:742px;top:480px;"><ix:nonfraction id="ID_1406" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a30075" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:496px;">Net Income </div><div id="a30079" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:496px;"><ix:nonfraction id="ID_885" name="us-gaap:ProfitLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a30083" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:496px;"><ix:nonfraction id="ID_886" name="us-gaap:ProfitLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a30087" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:496px;"><ix:nonfraction id="ID_887" name="us-gaap:ProfitLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">420</ix:nonfraction></div><div id="a30090" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:512px;">Less: Net income attributable to noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30094" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:549px;top:512px;display:flex;">(<ix:nonfraction id="ID_800" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction>)</div><div id="a30098" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:638px;top:512px;display:flex;">(<ix:nonfraction id="ID_801" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction>)</div><div id="a30102" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:727px;top:512px;display:flex;">(<ix:nonfraction id="ID_802" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction>)</div><div id="a30104" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:528px;">Net income attributable to Henry Schein, Inc.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30107" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:528px;">$ </div><div id="a30109" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:528px;"><ix:nonfraction id="ID_615" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">538</ix:nonfraction></div><div id="a30112" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:575px;top:528px;">$ </div><div id="a30114" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:528px;"><ix:nonfraction id="ID_616" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">631</ix:nonfraction></div><div id="a30117" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:528px;">$ </div><div id="a30119" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:528px;"><ix:nonfraction id="ID_617" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">404</ix:nonfraction></div><div id="a30134" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:556px;">Amounts attributable to Henry Schein, Inc.: </div><div id="a30145" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:572px;">Continuing operations </div><div id="a30148" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:572px;">$ </div><div id="a30150" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:572px;"><ix:nonfraction id="ID_618" name="us-gaap:IncomeLossFromContinuingOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">538</ix:nonfraction></div><div id="a30153" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:575px;top:572px;">$ </div><div id="a30155" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:572px;"><ix:nonfraction id="ID_619" name="us-gaap:IncomeLossFromContinuingOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">631</ix:nonfraction></div><div id="a30158" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:572px;">$ </div><div id="a30160" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:572px;"><ix:nonfraction id="ID_620" name="us-gaap:IncomeLossFromContinuingOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">403</ix:nonfraction></div><div id="a30162" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:588px;">Discontinued operations </div><div id="a30166" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:588px;"><ix:nonfraction id="ID_621" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30170" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:655px;top:588px;"><ix:nonfraction id="ID_622" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30174" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:742px;top:588px;"><ix:nonfraction id="ID_623" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a30176" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:604px;">Net income attributable to Henry Schein, Inc. </div><div id="a30179" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:604px;">$ </div><div id="a30181" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:551px;top:604px;"><ix:nonfraction id="ID_615A" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">538</ix:nonfraction></div><div id="a30184" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:575px;top:604px;">$ </div><div id="a30186" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:640px;top:604px;"><ix:nonfraction id="ID_616A" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">631</ix:nonfraction></div><div id="a30189" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:604px;">$ </div><div id="a30191" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:604px;"><ix:nonfraction id="ID_617A" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">404</ix:nonfraction></div><div id="a30206" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:633px;">Earnings per share from continuing operations attributable to </div><div id="a30208" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:648px;">Henry Schein, Inc.: </div><div id="a30230" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:680px;">Basic<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30233" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:680px;">$ </div><div id="a30235" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:548px;top:680px;"><ix:nonfraction id="ID_733" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">3.95</ix:nonfraction></div><div id="a30238" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:680px;">$ </div><div id="a30240" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:637px;top:680px;"><ix:nonfraction id="ID_734" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">4.51</ix:nonfraction></div><div id="a30243" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:680px;">$ </div><div id="a30245" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:726px;top:680px;"><ix:nonfraction id="ID_735" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">2.83</ix:nonfraction></div><div id="a30248" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:698px;">Diluted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30251" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:698px;">$ </div><div id="a30253" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:548px;top:698px;"><ix:nonfraction id="ID_736" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">3.91</ix:nonfraction></div><div id="a30256" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:698px;">$ </div><div id="a30258" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:637px;top:698px;"><ix:nonfraction id="ID_737" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">4.45</ix:nonfraction></div><div id="a30261" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:698px;">$ </div><div id="a30263" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:726px;top:698px;"><ix:nonfraction id="ID_738" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">2.81</ix:nonfraction></div><div id="a30278" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:724px;">Earnings per share from discontinued operations attributable to Henry </div><div id="a30279" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:739px;">Schein, Inc.: </div><div id="a30301" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:770px;">Basic<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30304" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:770px;">$ </div><div id="a30306" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:770px;"><ix:nonfraction id="ID_739" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2" format="ixt:zerodash">-</ix:nonfraction></div><div id="a30309" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:770px;">$ </div><div id="a30311" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:655px;top:770px;"><ix:nonfraction id="ID_740" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2" format="ixt:zerodash">-</ix:nonfraction></div><div id="a30314" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:770px;">$ </div><div id="a30316" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:722px;top:770px;"><ix:nonfraction id="ID_741" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction></div><div id="a30319" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:788px;">Diluted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30322" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:788px;">$ </div><div id="a30324" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:566px;top:788px;"><ix:nonfraction id="ID_742" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2" format="ixt:zerodash">-</ix:nonfraction></div><div id="a30327" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:788px;">$ </div><div id="a30329" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:655px;top:788px;"><ix:nonfraction id="ID_743" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2" format="ixt:zerodash">-</ix:nonfraction></div><div id="a30332" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:788px;">$ </div><div id="a30334" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:722px;top:788px;"><ix:nonfraction id="ID_744" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">0.01</ix:nonfraction></div><div id="a30349" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:67px;top:814px;">Earnings per share attributable to Henry Schein, Inc.: </div><div id="a30371" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:845px;">Basic<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30374" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:845px;">$ </div><div id="a30376" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:548px;top:845px;"><ix:nonfraction id="ID_745" name="us-gaap:EarningsPerShareBasic" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">3.95</ix:nonfraction></div><div id="a30379" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:845px;">$ </div><div id="a30381" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:637px;top:845px;"><ix:nonfraction id="ID_746" name="us-gaap:EarningsPerShareBasic" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">4.51</ix:nonfraction></div><div id="a30384" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:845px;">$ </div><div id="a30386" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:722px;top:845px;"><ix:nonfraction id="ID_747" name="us-gaap:EarningsPerShareBasic" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">2.83</ix:nonfraction></div><div id="a30389" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:863px;">Diluted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30392" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:486px;top:863px;">$ </div><div id="a30394" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:548px;top:863px;"><ix:nonfraction id="ID_748" name="us-gaap:EarningsPerShareDiluted" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myUSDperShare" decimals="2">3.91</ix:nonfraction></div><div id="a30397" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:579px;top:863px;">$ </div><div id="a30399" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:637px;top:863px;"><ix:nonfraction id="ID_749" name="us-gaap:EarningsPerShareDiluted" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="myUSDperShare" decimals="2">4.45</ix:nonfraction></div><div id="a30402" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:863px;">$ </div><div id="a30404" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:722px;top:863px;"><ix:nonfraction id="ID_750" name="us-gaap:EarningsPerShareDiluted" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="myUSDperShare" decimals="2">2.82</ix:nonfraction></div><div id="a30419" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:889px;">Weighted-average common<div style="display:inline-block;width:5px">&nbsp;</div>shares outstanding: </div><div id="a30433" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:905px;">Basic<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30437" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:507px;top:905px;"><ix:nonfraction id="ID_263" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">136,064,221</ix:nonfraction></div><div id="a30441" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:596px;top:905px;"><ix:nonfraction id="ID_96" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">140,090,889</ix:nonfraction></div><div id="a30445" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:685px;top:905px;"><ix:nonfraction id="ID_269" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">142,504,193</ix:nonfraction></div><div id="a30448" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:76px;top:923px;">Diluted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30452" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:507px;top:923px;"><ix:nonfraction id="ID_368" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">137,755,670</ix:nonfraction></div><div id="a30456" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:596px;top:923px;"><ix:nonfraction id="ID_426" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">141,772,781</ix:nonfraction></div><div id="a30460" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:685px;top:923px;"><ix:nonfraction id="ID_155" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">143,403,682</ix:nonfraction></div></div>
</div>
<div style="padding: 7px">
<div id="Page65" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:272px; height:1px; left:475.9px; top:144.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:475.9px; top:184.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:569.9px; top:184.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:184.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:194.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:194.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.9px; left:67.2px; top:234.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.9px; left:67.2px; top:234.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:270.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:270.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:475.9px; top:290.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:569.9px; top:290.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:290.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:311.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:311.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:409.1px; height:18px; left:67.2px; top:310.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:409.1px; height:1px; left:66.8px; top:310.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:475.9px; top:310.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18px; left:560.3px; top:310.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:569.9px; top:310.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18px; left:654.4px; top:310.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:310.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:348.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:348.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:389.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:389.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:20px; left:471.3px; top:388.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:409.1px; height:1px; left:66.8px; top:388.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:475.9px; top:388.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:560.3px; top:388.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:569.9px; top:388.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:654.4px; top:388.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:388.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:475.9px; top:408.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:569.9px; top:408.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:84px; height:1px; left:663.9px; top:408.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:475.3px; top:431.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:475.3px; top:429.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:569.4px; top:431.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:569.4px; top:429.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:431.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:429.8px; background-color:#000000; ">&nbsp;</div>
<div id="a30462" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a30465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">65 </div><div id="a30467" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:326px;top:60px;">HENRY SCHEIN, INC. </div><div id="a30469" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:164px;top:78px;">CONSOLIDATED STATEMENTS<div style="display:inline-block;width:8px">&nbsp;</div>OF COMPREHENSIVE INCOME </div><div id="a30471" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:367px;top:97px;">(in millions) </div><div id="a30506" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:577px;top:130px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a30513" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:481px;top:150px;">December 31, </div><div id="a30516" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:575px;top:150px;">December 25, </div><div id="a30519" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:669px;top:150px;">December 26, </div><div id="a30526" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:506px;top:170px;">2022 </div><div id="a30529" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:600px;top:170px;">2021 </div><div id="a30532" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;left:694px;top:170px;">2020 </div><div id="a30547" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:200px;">Net income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30550" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:476px;top:200px;">$ </div><div id="a30552" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:541px;top:200px;"><ix:nonfraction id="ID_885A" name="us-gaap:ProfitLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a30555" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:570px;top:200px;">$ </div><div id="a30557" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:635px;top:200px;"><ix:nonfraction id="ID_886A" name="us-gaap:ProfitLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a30560" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:200px;">$ </div><div id="a30562" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:200px;"><ix:nonfraction id="ID_887A" name="us-gaap:ProfitLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">420</ix:nonfraction></div><div id="a30564" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:220px;">Other comprehensive income, net of tax: </div><div id="a30576" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:77px;top:238px;">Foreign currency translation gain (loss)<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30580" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:539px;top:238px;display:flex;">(<ix:nonfraction id="ID_317" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">88</ix:nonfraction>)</div><div id="a30584" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:633px;top:238px;display:flex;">(<ix:nonfraction id="ID_275" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">84</ix:nonfraction>)</div><div id="a30588" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:238px;"><ix:nonfraction id="ID_310" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">63</ix:nonfraction></div><div id="a30591" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:77px;top:256px;">Unrealized gain (loss) from foreign currency hedging activities<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30595" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:554px;top:256px;"><ix:nonfraction id="ID_112" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a30599" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:648px;top:256px;"><ix:nonfraction id="ID_400" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a30603" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:734px;top:256px;display:flex;">(<ix:nonfraction id="ID_43" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">7</ix:nonfraction>)</div><div id="a30606" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:77px;top:276px;">Pension adjustment gain<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30610" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:548px;top:276px;"><ix:nonfraction id="ID_404" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction></div><div id="a30614" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:648px;top:276px;"><ix:nonfraction id="ID_226" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a30618" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:744px;top:276px;"><ix:nonfraction id="ID_68" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30620" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:296px;">Other comprehensive income (loss), net of tax<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a30624" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:539px;top:296px;display:flex;">(<ix:nonfraction id="ID_89" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">69</ix:nonfraction>)</div><div id="a30628" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:633px;top:296px;display:flex;">(<ix:nonfraction id="ID_424" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">69</ix:nonfraction>)</div><div id="a30632" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:736px;top:296px;"><ix:nonfraction id="ID_205" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">56</ix:nonfraction></div><div id="a30634" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:314px;">Comprehensive income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30638" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:541px;top:314px;"><ix:nonfraction id="ID_186" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">497</ix:nonfraction></div><div id="a30642" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:635px;top:314px;"><ix:nonfraction id="ID_255" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">591</ix:nonfraction></div><div id="a30646" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:314px;"><ix:nonfraction id="ID_78" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">476</ix:nonfraction></div><div id="a30649" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:77px;top:334px;">Comprehensive income attributable to noncontrolling interests:<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30662" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:87px;top:354px;">Net income<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30666" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:539px;top:354px;display:flex;">(<ix:nonfraction id="ID_419" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction>)</div><div id="a30670" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:633px;top:354px;display:flex;">(<ix:nonfraction id="ID_321" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction>)</div><div id="a30674" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:727px;top:354px;display:flex;">(<ix:nonfraction id="ID_457" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction>)</div><div id="a30678" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:87px;top:374px;">Foreign currency translation loss<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30682" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:554px;top:374px;"><ix:nonfraction id="ID_34" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">7</ix:nonfraction></div><div id="a30686" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:648px;top:374px;"><ix:nonfraction id="ID_163" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a30690" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:742px;top:374px;"><ix:nonfraction id="ID_38" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction></div><div id="a30695" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:97px;top:394px;">Comprehensive income attributable to noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30699" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:539px;top:394px;display:flex;">(<ix:nonfraction id="ID_237" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction>)</div><div id="a30703" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:633px;top:394px;display:flex;">(<ix:nonfraction id="ID_386" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction>)</div><div id="a30707" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:727px;top:394px;display:flex;">(<ix:nonfraction id="ID_347" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction>)</div><div id="a30709" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:67px;top:415px;">Comprehensive income attributable to Henry Schein, Inc.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a30712" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:476px;top:415px;">$ </div><div id="a30714" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:541px;top:415px;"><ix:nonfraction id="ID_421" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">476</ix:nonfraction></div><div id="a30717" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:570px;top:415px;">$ </div><div id="a30719" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:635px;top:415px;"><ix:nonfraction id="ID_268" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">568</ix:nonfraction></div><div id="a30722" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:664px;top:415px;">$ </div><div id="a30724" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;left:729px;top:415px;"><ix:nonfraction id="ID_170" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">463</ix:nonfraction></div></div>
</div>
<div style="padding: 7px">
<div id="Page66" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:151.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:37.9px; height:1px; left:389.9px; top:151.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:9.9px; left:382.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.6px; height:9.9px; left:434px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.7px; height:9.9px; left:500.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:9.9px; left:567.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.6px; height:9.9px; left:634.1px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.7px; height:9.9px; left:700.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:11px; left:67.2px; top:165.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:166.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:243.1px; height:1px; left:66.8px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:376.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:427.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:494.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:561.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:627.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:694.9px; top:164.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:164.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:227.7px; height:9.9px; left:79.8px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:188.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:190.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:227.7px; height:9.9px; left:79.8px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:212.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:227.7px; height:9.9px; left:79.8px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:236.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:238.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:260.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:262.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:286.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:284.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:286.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:308.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:310.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:332.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:334.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:356.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:358.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:368.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:8.1px; left:67.2px; top:384.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:243.1px; height:12px; left:67.2px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:310.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:310.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:3px; left:377.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:9.1px; left:380.2px; top:383.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:380.2px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:380.2px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:428.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:431.3px; top:383.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:431.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:431.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:495.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:498.3px; top:383.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:498.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:498.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:3px; left:562.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565.4px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565.4px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:628.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:631.3px; top:383.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:631.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:631.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:695.3px; top:380.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:698.4px; top:383.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698.4px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698.4px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:383.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:406.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:404.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:406.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:430.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:428.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:430.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:452.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:454.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:476.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:227.7px; height:9.9px; left:79.8px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:500.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:524.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:526.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:548.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:550.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:560.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:8.1px; left:67.2px; top:576.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:243.1px; height:12px; left:67.2px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:310.3px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:310.3px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:3px; left:377.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:9.1px; left:380.2px; top:575.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:380.2px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:380.2px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:428.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:431.3px; top:575.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:431.3px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:431.3px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:495.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:498.3px; top:575.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:498.3px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:498.3px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:3px; left:562.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565.4px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565.4px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:628.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:631.3px; top:575.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:631.3px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:631.3px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:12px; left:695.3px; top:572.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:9.1px; left:698.4px; top:575.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698.4px; top:572.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698.4px; top:574.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:575.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:599px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:596.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:599px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:623px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:620.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:623px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:644.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:647px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:668.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:671px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:695px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:692.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:450.9px; height:9.9px; left:310.3px; top:695px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:716.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:719px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:9.9px; left:377.2px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:428.3px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:442px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:495.3px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:9.9px; left:562.3px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:628.3px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:9.9px; left:695.3px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:740.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:743px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:10px; left:69.9px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:10px; left:312.9px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.1px; height:10px; left:377.2px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:10px; left:392.9px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:10px; left:428.3px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:10px; left:442px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:10px; left:495.3px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:10px; left:508.9px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13px; height:10px; left:562.3px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:10px; left:578px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:10px; left:628.3px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:10px; left:642.1px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:10px; left:695.3px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:12px; left:67.2px; top:764.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:10px; left:708.9px; top:767px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:237.7px; height:9.9px; left:69.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:61.8px; height:9.9px; left:312.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:9.9px; left:382.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:32.8px; height:9.9px; left:392.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.6px; height:9.9px; left:434px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:442px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.7px; height:9.9px; left:500.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.7px; height:9.9px; left:508.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:9.9px; left:567.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:47.7px; height:9.9px; left:578px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.6px; height:9.9px; left:634.1px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:50.6px; height:9.9px; left:642.1px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:2.7px; height:9.9px; left:700.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:694.1px; height:11px; left:67.2px; top:789.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:49.8px; height:9.9px; left:708.9px; top:791px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:243.1px; height:1px; left:66.8px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67px; height:1px; left:309.9px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:376.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:48px; height:1px; left:379.8px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:427.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:430.9px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:494.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:497.9px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:561.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:62.9px; height:1px; left:565px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:627.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:630.9px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:694.9px; top:788.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:63px; height:1px; left:698px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:68px; height:1px; left:309.3px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:68px; height:1px; left:309.3px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:49px; height:1px; left:379.3px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:49px; height:1px; left:379.3px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:430.3px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:430.3px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:497.4px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:497.4px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63.9px; height:1px; left:564.4px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:63.9px; height:1px; left:564.4px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:630.4px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:65px; height:1px; left:630.4px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:697.4px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:64px; height:1px; left:697.4px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div id="a30726" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a30729" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">66 </div><div id="a30731" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:346px;top:60px;">HENRY SCHEIN, INC. </div><div id="a30733" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;left:189px;top:74px;">CONSOLIDATED STATEMENTS<div style="display:inline-block;width:6px">&nbsp;</div>OF CHANGES IN STOCKHOLDERS' EQUITY </div><div id="a30735" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:305px;top:87px;">(In millions, except share and per share data) </div><div id="a30753" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:574px;top:118px;">Accumulated </div><div id="a30763" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:342px;top:130px;">Common Stock </div><div id="a30766" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:445px;top:130px;">Additional<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a30772" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:586px;top:130px;"><div style="display:inline-block;width:2px">&nbsp;</div>Other </div><div id="a30779" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:721px;top:130px;">Total<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30783" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:343px;top:142px;">$.01 Par Value </div><div id="a30786" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:451px;top:142px;">Paid-in </div><div id="a30791" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:515px;top:142px;">Retained<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a30794" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:570px;top:142px;">Comprehensive </div><div id="a30797" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:637px;top:142px;">Noncontrolling<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a30800" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:706px;top:142px;">Stockholders' </div><div id="a30804" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:332px;top:155px;">Shares </div><div id="a30808" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:395px;top:155px;">Amount </div><div id="a30811" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:450px;top:155px;"><div style="display:inline-block;width:2px">&nbsp;</div>Capital </div><div id="a30815" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:515px;top:155px;">Earnings </div><div id="a30818" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:570px;top:155px;"><div style="display:inline-block;width:2px">&nbsp;</div>Income (Loss) </div><div id="a30822" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:649px;top:155px;">Interests </div><div id="a30825" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:718px;top:155px;">Equity </div><div id="a30827" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:167px;">Balance, December 28, 2019<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30829" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:331px;top:167px;"><ix:nonfraction id="ID_1456" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">143,353,459</ix:nonfraction></div><div id="a30832" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:383px;top:167px;">$ </div><div id="a30834" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:421px;top:167px;"><ix:nonfraction id="ID_1437" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a30837" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:434px;top:167px;">$ </div><div id="a30839" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:484px;top:167px;"><ix:nonfraction id="ID_1438" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">48</ix:nonfraction></div><div id="a30842" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:501px;top:167px;">$ </div><div id="a30844" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:540px;top:167px;"><ix:nonfraction id="ID_1439" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,116</ix:nonfraction></div><div id="a30847" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:568px;top:167px;">$ </div><div id="a30849" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:607px;top:167px;display:flex;">(<ix:nonfraction id="ID_1440" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">167</ix:nonfraction>)</div><div id="a30852" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:634px;top:167px;">$ </div><div id="a30854" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:680px;top:167px;"><ix:nonfraction id="ID_1441" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">632</ix:nonfraction></div><div id="a30857" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:701px;top:167px;">$ </div><div id="a30859" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:739px;top:167px;"><ix:nonfraction id="ID_1442" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec28_2019_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,630</ix:nonfraction></div><div id="a30861" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:179px;">Net income (excluding $</div><div id="a30861_23_2" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:156px;top:179px;"><ix:nonfraction id="ID_1127" name="us-gaap:TemporaryEquityNetIncome" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentContinuingOperationsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a30861_25_28" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:164px;top:179px;"><div style="display:inline-block;width:2px">&nbsp;</div>attributable to Redeemable </div><div id="a30883" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:191px;">noncontrolling interests from continuing operations) </div><div id="a30885" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:191px;">- </div><div id="a30889" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:191px;"><ix:nonfraction id="ID_1146" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30893" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:191px;"><ix:nonfraction id="ID_1147" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30897" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:547px;top:191px;"><ix:nonfraction id="ID_1148" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">404</ix:nonfraction></div><div id="a30901" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:191px;"><ix:nonfraction id="ID_1149" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30905" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:191px;"><ix:nonfraction id="ID_1150" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a30909" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:746px;top:191px;"><ix:nonfraction id="ID_1145" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">406</ix:nonfraction></div><div id="a30911" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:203px;">Foreign currency translation gain (excluding loss of $</div><div id="a30911_54_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:256px;top:203px;"><ix:nonfraction id="ID_907" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction></div><div id="a30933" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:215px;">attributable to Redeemable noncontrolling interests) </div><div id="a30935" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:215px;">- </div><div id="a30939" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:215px;"><ix:nonfraction id="ID_935" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30943" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:215px;"><ix:nonfraction id="ID_936" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30947" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:215px;"><ix:nonfraction id="ID_937" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30951" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:617px;top:215px;"><ix:nonfraction id="ID_938" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">66</ix:nonfraction></div><div id="a30955" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:215px;"><ix:nonfraction id="ID_939" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a30959" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:750px;top:215px;"><ix:nonfraction id="ID_933" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">67</ix:nonfraction></div><div id="a30961" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:227px;">Unrealized loss from foreign currency hedging activities,<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a30983" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:239px;">net of tax benefit of $</div><div id="a30983_23_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:155px;top:239px;"><ix:nonfraction id="ID_61" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction></div><div id="a30985" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:239px;">- </div><div id="a30989" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:239px;"><ix:nonfraction id="ID_940" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30993" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:239px;"><ix:nonfraction id="ID_941" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a30997" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:239px;"><ix:nonfraction id="ID_942" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31001" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:616px;top:239px;display:flex;">(<ix:nonfraction id="ID_943" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">7</ix:nonfraction>)</div><div id="a31005" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:239px;"><ix:nonfraction id="ID_944" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31009" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:239px;display:flex;">(<ix:nonfraction id="ID_43A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">7</ix:nonfraction>)</div><div id="a31011" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:251px;">Dividends paid<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a31013" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:251px;">- </div><div id="a31017" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:251px;"><ix:nonfraction id="ID_945" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31021" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:251px;"><ix:nonfraction id="ID_946" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31025" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:251px;"><ix:nonfraction id="ID_947" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31029" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:251px;"><ix:nonfraction id="ID_948" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31033" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:683px;top:251px;display:flex;">(<ix:nonfraction id="ID_949" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a31037" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:251px;display:flex;">(<ix:nonfraction id="ID_934" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a31039" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:263px;">Purchase of noncontrolling interests<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31041" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:263px;">- </div><div id="a31045" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:263px;"><ix:nonfraction id="ID_1443" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31049" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:483px;top:263px;display:flex;">(<ix:nonfraction id="ID_1444" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction>)</div><div id="a31053" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:263px;"><ix:nonfraction id="ID_1445" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31057" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:263px;"><ix:nonfraction id="ID_1446" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31061" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:683px;top:263px;display:flex;">(<ix:nonfraction id="ID_1447" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a31065" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:263px;display:flex;">(<ix:nonfraction id="ID_1448" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a31067" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:275px;">Change in fair value of redeemable securities<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31069" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:275px;">- </div><div id="a31073" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:275px;"><ix:nonfraction id="ID_956" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31077" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:275px;display:flex;">(<ix:nonfraction id="ID_957" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">33</ix:nonfraction>)</div><div id="a31081" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:275px;"><ix:nonfraction id="ID_958" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31085" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:275px;"><ix:nonfraction id="ID_959" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31089" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:275px;"><ix:nonfraction id="ID_960" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31093" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:275px;display:flex;">(<ix:nonfraction id="ID_950" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">33</ix:nonfraction>)</div><div id="a31095" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:287px;">Noncontrolling interests and adjustments related to<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31117" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:299px;">business acquisitions<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a31119" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:299px;">- </div><div id="a31123" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:299px;"><ix:nonfraction id="ID_1282" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31127" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:299px;"><ix:nonfraction id="ID_1283" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31131" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:299px;"><ix:nonfraction id="ID_1284" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31135" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:299px;"><ix:nonfraction id="ID_1285" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31139" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:299px;"><ix:nonfraction id="ID_1286" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a31143" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:299px;"><ix:nonfraction id="ID_1287" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a31145" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:311px;">Repurchase and retirement of common stock<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31147" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:334px;top:311px;display:flex;">(<ix:nonfraction id="ID_992" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">1,200,000</ix:nonfraction>)</div><div id="a31151" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:311px;"><ix:nonfraction id="ID_961" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31155" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:311px;display:flex;">(<ix:nonfraction id="ID_962" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction>)</div><div id="a31159" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:545px;top:311px;display:flex;">(<ix:nonfraction id="ID_963" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">63</ix:nonfraction>)</div><div id="a31163" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:311px;"><ix:nonfraction id="ID_964" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31167" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:311px;"><ix:nonfraction id="ID_965" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31171" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:311px;display:flex;">(<ix:nonfraction id="ID_951" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction>)</div><div id="a31173" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:323px;">Stock-based compensation expense<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31177" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:346px;top:323px;"><ix:nonfraction id="ID_993" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">545,864</ix:nonfraction></div><div id="a31181" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:323px;"><ix:nonfraction id="ID_966" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31185" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:323px;"><ix:nonfraction id="ID_967" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a31189" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:323px;"><ix:nonfraction id="ID_968" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31193" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:323px;"><ix:nonfraction id="ID_969" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31197" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:323px;"><ix:nonfraction id="ID_970" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31201" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:323px;"><ix:nonfraction id="ID_952" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a31203" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:335px;">Shares withheld for payroll taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31205" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:341px;top:335px;display:flex;">(<ix:nonfraction id="ID_994" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">236,752</ix:nonfraction>)</div><div id="a31209" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:335px;"><ix:nonfraction id="ID_986" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31213" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:335px;display:flex;">(<ix:nonfraction id="ID_987" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction>)</div><div id="a31217" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:335px;"><ix:nonfraction id="ID_988" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31221" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:335px;"><ix:nonfraction id="ID_989" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31225" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:335px;"><ix:nonfraction id="ID_990" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31229" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:335px;display:flex;">(<ix:nonfraction id="ID_991" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction>)</div><div id="a31231" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:347px;">Separation of Animal Health business </div><div id="a31233" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:347px;">- </div><div id="a31237" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:347px;"><ix:nonfraction id="ID_971" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31241" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:347px;"><ix:nonfraction id="ID_972" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a31245" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:347px;"><ix:nonfraction id="ID_973" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31249" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:347px;"><ix:nonfraction id="ID_974" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31253" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:347px;"><ix:nonfraction id="ID_975" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31257" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:347px;"><ix:nonfraction id="ID_953" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a31259" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:359px;">Transfer of charges in excess of capital<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31261" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:359px;">- </div><div id="a31265" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:359px;"><ix:nonfraction id="ID_976" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31269" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:359px;"><ix:nonfraction id="ID_977" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a31273" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:550px;top:359px;display:flex;">(<ix:nonfraction id="ID_978" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a31277" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:359px;"><ix:nonfraction id="ID_979" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31281" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:359px;"><ix:nonfraction id="ID_980" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31285" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:756px;top:359px;"><ix:nonfraction id="ID_954" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31287" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:371px;">Balance, December 26, 2020<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31289" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:331px;top:371px;"><ix:nonfraction id="ID_1457" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">142,462,571</ix:nonfraction></div><div id="a31293" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:421px;top:371px;"><ix:nonfraction id="ID_981" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a31297" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:487px;top:371px;"><ix:nonfraction id="ID_982" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31301" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:540px;top:371px;"><ix:nonfraction id="ID_983" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,455</ix:nonfraction></div><div id="a31305" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:607px;top:371px;display:flex;">(<ix:nonfraction id="ID_984" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">108</ix:nonfraction>)</div><div id="a31309" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:680px;top:371px;"><ix:nonfraction id="ID_985" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">636</ix:nonfraction></div><div id="a31313" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:739px;top:371px;"><ix:nonfraction id="ID_955" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,984</ix:nonfraction></div><div id="a31315" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:384px;">Net income (excluding $</div><div id="a31315_23_2" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:156px;top:384px;"><ix:nonfraction id="ID_1126" name="us-gaap:TemporaryEquityNetIncome" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a31315_25_28" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:164px;top:384px;"><div style="display:inline-block;width:2px">&nbsp;</div>attributable to Redeemable </div><div id="a31337" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:395px;">noncontrolling interests from continuing operations) </div><div id="a31339" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:395px;">- </div><div id="a31343" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:395px;"><ix:nonfraction id="ID_995" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31347" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:395px;"><ix:nonfraction id="ID_996" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31351" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:547px;top:395px;"><ix:nonfraction id="ID_997" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">631</ix:nonfraction></div><div id="a31355" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:395px;"><ix:nonfraction id="ID_998" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31359" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:395px;"><ix:nonfraction id="ID_999" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a31363" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:746px;top:395px;"><ix:nonfraction id="ID_1005" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">637</ix:nonfraction></div><div id="a31365" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:407px;">Foreign currency translation loss (excluding loss of $</div><div id="a31365_54_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:255px;top:407px;"><ix:nonfraction id="ID_906" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a31387" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:419px;">attributable to Redeemable noncontrolling interests) </div><div id="a31389" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:419px;">- </div><div id="a31393" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:419px;"><ix:nonfraction id="ID_1000" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31397" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:419px;"><ix:nonfraction id="ID_1001" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31401" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:419px;"><ix:nonfraction id="ID_1002" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31405" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:611px;top:419px;display:flex;">(<ix:nonfraction id="ID_1003" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">78</ix:nonfraction>)</div><div id="a31409" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:419px;"><ix:nonfraction id="ID_1004" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31413" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:419px;display:flex;">(<ix:nonfraction id="ID_1006" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">78</ix:nonfraction>)</div><div id="a31415" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:431px;">Unrealized gain from foreign currency hedging activities,<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31437" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:443px;">net of tax of $</div><div id="a31437_15_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:129px;top:443px;"><ix:nonfraction id="ID_352" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a31439" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:443px;">- </div><div id="a31443" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:443px;"><ix:nonfraction id="ID_1009" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31447" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:443px;"><ix:nonfraction id="ID_1010" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31451" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:443px;"><ix:nonfraction id="ID_1011" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31455" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:621px;top:443px;"><ix:nonfraction id="ID_1012" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a31459" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:443px;"><ix:nonfraction id="ID_1013" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31463" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:443px;"><ix:nonfraction id="ID_400A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a31465" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:455px;">Pension adjustment gain, including tax of $</div><div id="a31465_43_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:221px;top:455px;"><ix:nonfraction id="ID_387" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction></div><div id="a31468" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:455px;">- </div><div id="a31472" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:455px;"><ix:nonfraction id="ID_1014" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31476" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:455px;"><ix:nonfraction id="ID_1015" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31480" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:455px;"><ix:nonfraction id="ID_1016" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31484" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:621px;top:455px;"><ix:nonfraction id="ID_1017" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a31488" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:455px;"><ix:nonfraction id="ID_1018" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31492" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:455px;"><ix:nonfraction id="ID_226A" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a31494" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:467px;">Dividends paid<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a31496" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:467px;">- </div><div id="a31500" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:467px;"><ix:nonfraction id="ID_1019" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31504" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:467px;"><ix:nonfraction id="ID_1020" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31508" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:467px;"><ix:nonfraction id="ID_1021" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31512" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:467px;"><ix:nonfraction id="ID_1022" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31516" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:678px;top:467px;display:flex;">(<ix:nonfraction id="ID_1023" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction>)</div><div id="a31520" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:467px;display:flex;">(<ix:nonfraction id="ID_1007" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction>)</div><div id="a31522" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:479px;">Change in fair value of redeemable securities<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31524" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:479px;">- </div><div id="a31528" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:479px;"><ix:nonfraction id="ID_1024" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31532" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:474px;top:479px;display:flex;">(<ix:nonfraction id="ID_1025" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">160</ix:nonfraction>)</div><div id="a31536" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:479px;"><ix:nonfraction id="ID_1026" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31540" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:479px;"><ix:nonfraction id="ID_1027" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31544" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:479px;"><ix:nonfraction id="ID_1028" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31548" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:740px;top:479px;display:flex;">(<ix:nonfraction id="ID_1008" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">160</ix:nonfraction>)</div><div id="a31550" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:491px;">Noncontrolling interests and adjustments related to<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31572" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:503px;">business acquisitions<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a31574" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:503px;">- </div><div id="a31578" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:503px;"><ix:nonfraction id="ID_1276" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31582" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:503px;"><ix:nonfraction id="ID_1277" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31586" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:503px;"><ix:nonfraction id="ID_1278" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31590" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:503px;"><ix:nonfraction id="ID_1279" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31594" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:503px;"><ix:nonfraction id="ID_1280" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a31598" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:503px;"><ix:nonfraction id="ID_1281" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a31600" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:515px;">Repurchase and retirement of common stock<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31602" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:334px;top:515px;display:flex;">(<ix:nonfraction id="ID_1054" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">5,505,704</ix:nonfraction>)</div><div id="a31606" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:515px;"><ix:nonfraction id="ID_1449" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31610" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:515px;display:flex;">(<ix:nonfraction id="ID_1032" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">53</ix:nonfraction>)</div><div id="a31614" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:541px;top:515px;display:flex;">(<ix:nonfraction id="ID_1033" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">348</ix:nonfraction>)</div><div id="a31618" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:515px;"><ix:nonfraction id="ID_1034" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31622" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:515px;"><ix:nonfraction id="ID_1035" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31626" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:740px;top:515px;display:flex;">(<ix:nonfraction id="ID_1029" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">401</ix:nonfraction>)</div><div id="a31628" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:527px;">Stock-based compensation expense<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31632" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:346px;top:527px;"><ix:nonfraction id="ID_1051" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">303,643</ix:nonfraction></div><div id="a31636" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:527px;"><ix:nonfraction id="ID_1036" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31640" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:484px;top:527px;"><ix:nonfraction id="ID_1037" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonfraction></div><div id="a31644" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:527px;"><ix:nonfraction id="ID_1038" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31648" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:527px;"><ix:nonfraction id="ID_1039" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31652" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:527px;"><ix:nonfraction id="ID_1040" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31656" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:750px;top:527px;"><ix:nonfraction id="ID_1030" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonfraction></div><div id="a31658" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:539px;">Shares withheld for payroll taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31660" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:341px;top:539px;display:flex;">(<ix:nonfraction id="ID_1052" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">114,952</ix:nonfraction>)</div><div id="a31664" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:539px;"><ix:nonfraction id="ID_1450" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31668" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:483px;top:539px;display:flex;">(<ix:nonfraction id="ID_1451" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction>)</div><div id="a31672" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:539px;"><ix:nonfraction id="ID_1452" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31676" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:539px;"><ix:nonfraction id="ID_1453" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31680" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:539px;"><ix:nonfraction id="ID_1454" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31684" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:539px;display:flex;">(<ix:nonfraction id="ID_1455" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction>)</div><div id="a31686" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:551px;">Transfer of charges in excess of capital<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31688" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:551px;">- </div><div id="a31692" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:551px;"><ix:nonfraction id="ID_1041" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31696" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:480px;top:551px;"><ix:nonfraction id="ID_1042" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">143</ix:nonfraction></div><div id="a31700" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:541px;top:551px;display:flex;">(<ix:nonfraction id="ID_1043" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">143</ix:nonfraction>)</div><div id="a31704" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:551px;"><ix:nonfraction id="ID_1044" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31708" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:551px;"><ix:nonfraction id="ID_1045" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31712" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:756px;top:551px;"><ix:nonfraction id="ID_1031" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31714" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:563px;">Balance, December 25, 2021<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31716" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:331px;top:563px;"><ix:nonfraction id="ID_1053" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">137,145,558</ix:nonfraction></div><div id="a31720" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:421px;top:563px;"><ix:nonfraction id="ID_1046" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a31724" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:487px;top:563px;"><ix:nonfraction id="ID_1047" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31728" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:540px;top:563px;"><ix:nonfraction id="ID_1048" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,595</ix:nonfraction></div><div id="a31732" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:607px;top:563px;display:flex;">(<ix:nonfraction id="ID_1049" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">171</ix:nonfraction>)</div><div id="a31736" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:680px;top:563px;"><ix:nonfraction id="ID_1050" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">638</ix:nonfraction></div><div id="a31740" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:739px;top:563px;"><ix:nonfraction id="ID_415A" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,063</ix:nonfraction></div><div id="a31742" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:576px;">Net income (excluding $</div><div id="a31742_23_2" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:156px;top:576px;"><ix:nonfraction id="ID_1125" name="us-gaap:TemporaryEquityNetIncome" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a31742_25_28" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:164px;top:576px;"><div style="display:inline-block;width:2px">&nbsp;</div>attributable to Redeemable </div><div id="a31764" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:587px;">noncontrolling interests from continuing operations) </div><div id="a31766" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:587px;">- </div><div id="a31770" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:587px;"><ix:nonfraction id="ID_1055" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31774" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:587px;"><ix:nonfraction id="ID_1056" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31778" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:547px;top:587px;"><ix:nonfraction id="ID_1057" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">538</ix:nonfraction></div><div id="a31782" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:587px;"><ix:nonfraction id="ID_1058" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31786" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:688px;top:587px;"><ix:nonfraction id="ID_1059" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a31790" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:746px;top:587px;"><ix:nonfraction id="ID_1070" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">545</ix:nonfraction></div><div id="a31792" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:599px;">Foreign currency translation loss (excluding loss of $</div><div id="a31792_54_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:255px;top:599px;"><ix:nonfraction id="ID_66" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a31814" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:611px;">attributable to Redeemable noncontrolling interests) </div><div id="a31816" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:611px;">- </div><div id="a31820" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:611px;"><ix:nonfraction id="ID_1060" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31824" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:611px;"><ix:nonfraction id="ID_1061" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31828" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:611px;"><ix:nonfraction id="ID_1062" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31832" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:611px;top:611px;display:flex;">(<ix:nonfraction id="ID_1063" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">81</ix:nonfraction>)</div><div id="a31836" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:683px;top:611px;display:flex;">(<ix:nonfraction id="ID_1064" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a31840" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:611px;display:flex;">(<ix:nonfraction id="ID_1071" name="hsic:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxExcludingPortionAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">82</ix:nonfraction>)</div><div id="a31842" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:623px;">Unrealized gain from foreign currency hedging activities,<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31864" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:635px;">net of tax of $</div><div id="a31864_15_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:129px;top:635px;"><ix:nonfraction id="ID_418" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a31866" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:635px;">- </div><div id="a31870" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:635px;"><ix:nonfraction id="ID_1065" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31874" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:635px;"><ix:nonfraction id="ID_1066" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31878" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:635px;"><ix:nonfraction id="ID_1067" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31882" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:621px;top:635px;"><ix:nonfraction id="ID_1068" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a31886" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:635px;"><ix:nonfraction id="ID_1069" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31890" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:635px;"><ix:nonfraction id="ID_1072" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a31892" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:647px;">Pension adjustment gain, including tax of $</div><div id="a31892_43_1" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:220px;top:647px;"><ix:nonfraction id="ID_202" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction></div><div id="a31894" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:647px;">- </div><div id="a31898" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:647px;"><ix:nonfraction id="ID_1076" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31902" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:647px;"><ix:nonfraction id="ID_1077" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31906" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:647px;"><ix:nonfraction id="ID_1078" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31910" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:617px;top:647px;"><ix:nonfraction id="ID_1079" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction></div><div id="a31914" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:647px;"><ix:nonfraction id="ID_1080" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31918" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:750px;top:647px;"><ix:nonfraction id="ID_1073" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction></div><div id="a31920" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:659px;">Dividends paid<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a31922" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:659px;">- </div><div id="a31926" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:659px;"><ix:nonfraction id="ID_1081" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31930" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:659px;"><ix:nonfraction id="ID_1082" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31934" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:659px;"><ix:nonfraction id="ID_1083" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31938" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:659px;"><ix:nonfraction id="ID_1084" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31942" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:683px;top:659px;display:flex;">(<ix:nonfraction id="ID_1085" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a31946" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:659px;display:flex;">(<ix:nonfraction id="ID_1074" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a31948" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:671px;">Purchase of noncontrolling interests<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31950" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:671px;">- </div><div id="a31954" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:671px;"><ix:nonfraction id="ID_1458" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31958" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:671px;"><ix:nonfraction id="ID_1459" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31962" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:671px;"><ix:nonfraction id="ID_1460" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31966" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:671px;"><ix:nonfraction id="ID_1461" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31970" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:683px;top:671px;display:flex;">(<ix:nonfraction id="ID_1462" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a31974" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:748px;top:671px;display:flex;">(<ix:nonfraction id="ID_1463" name="us-gaap:MinorityInterestDecreaseFromRedemptions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a31976" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:683px;">Change in fair value of redeemable securities<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a31978" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:683px;">- </div><div id="a31982" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:683px;"><ix:nonfraction id="ID_1086" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31986" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:683px;"><ix:nonfraction id="ID_1087" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a31990" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:683px;"><ix:nonfraction id="ID_1088" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31994" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:683px;"><ix:nonfraction id="ID_1089" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a31998" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:683px;"><ix:nonfraction id="ID_1090" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32002" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:683px;"><ix:nonfraction id="ID_1075" name="us-gaap:MinorityInterestChangeInRedemptionValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a32004" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:695px;">Noncontrolling interests and adjustments related to<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32026" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:80px;top:707px;">business acquisitions<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32028" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:707px;">- </div><div id="a32032" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:707px;"><ix:nonfraction id="ID_1271" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32036" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:490px;top:707px;"><ix:nonfraction id="ID_1272" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32040" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:707px;"><ix:nonfraction id="ID_1273" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32044" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:707px;"><ix:nonfraction id="ID_1274" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32048" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:684px;top:707px;"><ix:nonfraction id="ID_1275" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a32052" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:750px;top:707px;"><ix:nonfraction id="ID_1270" name="hsic:NoncontrollingInterestsAndAdjustmentsRelatedToBusinessAcquisitions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a32054" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:719px;">Repurchase and retirement of common stock<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32056" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:334px;top:719px;display:flex;">(<ix:nonfraction id="ID_1121" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">6,111,676</ix:nonfraction>)</div><div id="a32060" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:719px;"><ix:nonfraction id="ID_1096" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32064" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:719px;display:flex;">(<ix:nonfraction id="ID_1097" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">65</ix:nonfraction>)</div><div id="a32068" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:541px;top:719px;display:flex;">(<ix:nonfraction id="ID_1098" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">420</ix:nonfraction>)</div><div id="a32072" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:719px;"><ix:nonfraction id="ID_1099" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32076" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:719px;"><ix:nonfraction id="ID_1100" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32080" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:740px;top:719px;display:flex;">(<ix:nonfraction id="ID_1091" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">485</ix:nonfraction>)</div><div id="a32082" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:731px;">Stock issued upon exercise of stock options </div><div id="a32084" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:351px;top:731px;"><ix:nonfraction id="ID_1470" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">35,792</ix:nonfraction></div><div id="a32088" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:731px;"><ix:nonfraction id="ID_1464" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32092" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:731px;"><ix:nonfraction id="ID_1465" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a32096" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:731px;"><ix:nonfraction id="ID_1466" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32100" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:731px;"><ix:nonfraction id="ID_1467" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32104" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:731px;"><ix:nonfraction id="ID_1468" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32108" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:731px;"><ix:nonfraction id="ID_1469" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a32110" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:743px;">Stock-based compensation expense<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32114" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:340px;top:743px;"><ix:nonfraction id="ID_1122" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">1,102,108</ix:nonfraction></div><div id="a32118" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:743px;"><ix:nonfraction id="ID_1101" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32122" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:484px;top:743px;"><ix:nonfraction id="ID_1102" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">54</ix:nonfraction></div><div id="a32126" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:743px;"><ix:nonfraction id="ID_1103" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32130" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:743px;"><ix:nonfraction id="ID_1104" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32134" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:743px;"><ix:nonfraction id="ID_1105" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32138" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:750px;top:743px;"><ix:nonfraction id="ID_1092" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">54</ix:nonfraction></div><div id="a32140" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:755px;">Shares withheld for payroll taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32142" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:341px;top:755px;display:flex;">(<ix:nonfraction id="ID_1123" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">376,034</ix:nonfraction>)</div><div id="a32146" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:755px;"><ix:nonfraction id="ID_1106" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32150" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:478px;top:755px;display:flex;">(<ix:nonfraction id="ID_1107" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction>)</div><div id="a32154" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:755px;"><ix:nonfraction id="ID_1108" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32158" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:755px;"><ix:nonfraction id="ID_1109" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32162" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:755px;"><ix:nonfraction id="ID_1110" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32166" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:744px;top:755px;display:flex;">(<ix:nonfraction id="ID_1093" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction>)</div><div id="a32168" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:767px;">Settlement of stock-based compensation awards<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32172" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:349px;top:767px;display:flex;">(<ix:nonfraction id="ID_1471" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCashShares" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">2,931</ix:nonfraction>)</div><div id="a32176" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:767px;"><ix:nonfraction id="ID_1203" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32180" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:488px;top:767px;"><ix:nonfraction id="ID_1204" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction></div><div id="a32184" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:557px;top:767px;"><ix:nonfraction id="ID_1205" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32188" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:767px;"><ix:nonfraction id="ID_1206" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32192" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:767px;"><ix:nonfraction id="ID_1207" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32196" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:754px;top:767px;"><ix:nonfraction id="ID_1202" name="hsic:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationOtherLongtermIncentivePlansSettledInCash" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction></div><div id="a32198" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:779px;">Transfer of charges in excess of capital<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32200" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:372px;top:779px;">- </div><div id="a32204" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:423px;top:779px;"><ix:nonfraction id="ID_1111" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32208" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:484px;top:779px;"><ix:nonfraction id="ID_1112" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">35</ix:nonfraction></div><div id="a32212" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:545px;top:779px;display:flex;">(<ix:nonfraction id="ID_1113" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">35</ix:nonfraction>)</div><div id="a32216" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:623px;top:779px;"><ix:nonfraction id="ID_1114" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32220" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:690px;top:779px;"><ix:nonfraction id="ID_1115" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32224" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:756px;top:779px;"><ix:nonfraction id="ID_1094" name="hsic:ReclassificationOfAdditionalPaidInCapitalToRetainedEarnings" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32226" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:70px;top:791px;">Balance, December 31, 2022<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a32228" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:331px;top:791px;"><ix:nonfraction id="ID_1124" name="us-gaap:CommonStockSharesOutstanding" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">131,792,817</ix:nonfraction></div><div id="a32231" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:383px;top:791px;">$ </div><div id="a32233" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:421px;top:791px;"><ix:nonfraction id="ID_1116" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a32236" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:434px;top:791px;">$ </div><div id="a32238" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:487px;top:791px;"><ix:nonfraction id="ID_1117" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32241" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:501px;top:791px;">$ </div><div id="a32243" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:540px;top:791px;"><ix:nonfraction id="ID_1118" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,678</ix:nonfraction></div><div id="a32246" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:568px;top:791px;">$ </div><div id="a32248" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:607px;top:791px;display:flex;">(<ix:nonfraction id="ID_1119" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">233</ix:nonfraction>)</div><div id="a32251" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:634px;top:791px;">$ </div><div id="a32253" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:680px;top:791px;"><ix:nonfraction id="ID_1120" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_us-gaap_StatementEquityComponentsAxis_us-gaap_NoncontrollingInterestMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">649</ix:nonfraction></div><div id="a32256" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:701px;top:791px;">$ </div><div id="a32258" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;left:739px;top:791px;"><ix:nonfraction id="ID_1095" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_CumulativeEffectPeriodOfAdoptionAxis_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,095</ix:nonfraction></div></div>
</div>
<div style="padding: 7px">
<div id="Page67" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:266px; height:1px; left:517.9px; top:144.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12px; left:67.2px; top:171.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:451.1px; height:1px; left:66.8px; top:170.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:170.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:600.3px; top:170.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:170.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:692.3px; top:170.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:170.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:196.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:197.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:209.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:209.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:209.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:222.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:223.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:248.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:249.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:274.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:275.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:300.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:301.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:326.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.4px; left:67.2px; top:327.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:352.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:353.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:378.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:379.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:404.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:405.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:430.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:431.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:443.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:443.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:443.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:456.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:469.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:469.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:469.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12px; left:67.2px; top:483.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:13px; left:67.2px; top:482.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:13px; left:112.2px; top:482.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:451.1px; height:1px; left:66.8px; top:482.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:482.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:600.3px; top:482.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:482.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:692.3px; top:482.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:482.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:508.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:509.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:534.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:535.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:560.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:561.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12px; left:67.2px; top:587.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:451.1px; height:1px; left:66.8px; top:586.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:586.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:600.3px; top:586.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:586.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:692.3px; top:586.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:586.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:599.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:599.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:599.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:612.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:613.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:638.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:639.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:664.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:665.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:690.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:691.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:716.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:717.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13px; left:67.2px; top:742.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:743.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.2px; left:67.2px; top:768.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.4px; left:67.2px; top:769.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:781.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:781.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:781.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12px; left:67.2px; top:795.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:451.1px; height:1px; left:66.8px; top:794.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:794.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:600.3px; top:794.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:794.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:13px; left:692.3px; top:794.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:794.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:13.1px; left:67.2px; top:820.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:717.1px; height:12.3px; left:67.2px; top:821.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:82px; height:1px; left:517.9px; top:833.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:610px; top:833.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:81.9px; height:1px; left:702px; top:833.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:517.4px; top:848.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:517.4px; top:846.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:609.4px; top:848.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:609.4px; top:846.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:701.4px; top:848.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:82.9px; height:1px; left:701.4px; top:846.9px; background-color:#000000; ">&nbsp;</div>
<div id="a32260" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a32263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">67 </div><div id="a32265" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:326px;top:60px;">HENRY SCHEIN, INC. </div><div id="a32267" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:218px;top:78px;">CONSOLIDATED STATEMENTS<div style="display:inline-block;width:8px">&nbsp;</div>OF CASH FLOWS </div><div id="a32269" style="position:absolute;font-family:'Times New Roman';font-size:16px;font-weight:bold;left:367px;top:97px;">(in millions) </div><div id="a32279" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:622px;top:132px;">Years Ended </div><div id="a32287" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:528px;top:146px;">December 31, </div><div id="a32290" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:620px;top:146px;">December 25, </div><div id="a32293" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:712px;top:146px;">December 26, </div><div id="a32301" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:549px;top:159px;">2022 </div><div id="a32304" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:641px;top:159px;">2021 </div><div id="a32307" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:733px;top:159px;">2020 </div><div id="a32309" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:67px;top:172px;">Cash flows from operating activities: </div><div id="a32321" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:184px;">Net income<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32324" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:518px;top:184px;">$ </div><div id="a32326" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:184px;"><ix:nonfraction id="ID_885AA" name="us-gaap:ProfitLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a32329" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:610px;top:184px;">$ </div><div id="a32331" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:184px;"><ix:nonfraction id="ID_886AA" name="us-gaap:ProfitLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a32334" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:702px;top:184px;">$ </div><div id="a32336" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:184px;"><ix:nonfraction id="ID_887AA" name="us-gaap:ProfitLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">420</ix:nonfraction></div><div id="a32339" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:198px;">Income from discontinued operations </div><div id="a32343" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:198px;"><ix:nonfraction id="ID_1404A" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32347" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:198px;"><ix:nonfraction id="ID_1405A" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32351" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:779px;top:198px;"><ix:nonfraction id="ID_1406A" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a32354" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:211px;">Income from continuing operations </div><div id="a32358" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:211px;"><ix:nonfraction id="ID_512A" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a32362" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:211px;"><ix:nonfraction id="ID_513A" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a32366" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:211px;"><ix:nonfraction id="ID_514A" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">419</ix:nonfraction></div><div id="a32369" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:224px;">Adjustments to reconcile net income to net cash provided<div style="display:inline-block;width:1px">&nbsp;</div>by operating activities: </div><div id="a32383" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:236px;">Depreciation and amortization<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32387" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:236px;"><ix:nonfraction id="ID_58" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">212</ix:nonfraction></div><div id="a32391" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:236px;"><ix:nonfraction id="ID_253" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">210</ix:nonfraction></div><div id="a32395" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:236px;"><ix:nonfraction id="ID_97" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">186</ix:nonfraction></div><div id="a32400" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:250px;">Impairment charge on intangible assets </div><div id="a32404" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:250px;"><ix:nonfraction id="ID_832" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">34</ix:nonfraction></div><div id="a32408" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:687px;top:250px;"><ix:nonfraction id="ID_833" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a32412" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:250px;"><ix:nonfraction id="ID_834" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a32417" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:263px;">Non-cash restructuring charges </div><div id="a32423" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:263px;"><ix:nonfraction id="ID_1768" name="hsic:NonCashRestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">93</ix:nonfraction></div><div id="a32427" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:263px;"><ix:nonfraction id="ID_1769" name="hsic:NonCashRestructuringCharges" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32431" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:781px;top:263px;"><ix:nonfraction id="ID_1770" name="hsic:NonCashRestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32436" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:276px;">Gain on sale of equity investment </div><div id="a32440" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:276px;"><ix:nonfraction id="ID_821" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32444" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:276px;display:flex;">(<ix:nonfraction id="ID_822" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction>)</div><div id="a32448" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:276px;display:flex;">(<ix:nonfraction id="ID_823" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction>)</div><div id="a32453" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:288px;">Stock-based compensation expense<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32459" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:288px;"><ix:nonfraction id="ID_649" name="us-gaap:ShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">54</ix:nonfraction></div><div id="a32463" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:682px;top:288px;"><ix:nonfraction id="ID_650" name="us-gaap:ShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonfraction></div><div id="a32467" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:779px;top:288px;"><ix:nonfraction id="ID_651" name="us-gaap:ShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a32472" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:302px;">Provision for (benefits from) losses on trade and other<div style="display:inline-block;width:1px">&nbsp;</div>accounts receivable<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32476" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:595px;top:302px;"><ix:nonfraction id="ID_652" name="us-gaap:ProvisionForDoubtfulAccounts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a32480" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:302px;display:flex;">(<ix:nonfraction id="ID_653" name="us-gaap:ProvisionForDoubtfulAccounts" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">8</ix:nonfraction>)</div><div id="a32484" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:302px;"><ix:nonfraction id="ID_654" name="us-gaap:ProvisionForDoubtfulAccounts" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">35</ix:nonfraction></div><div id="a32489" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:315px;">Benefit from deferred income taxes<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32493" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:315px;display:flex;">(<ix:nonfraction id="ID_827" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">73</ix:nonfraction>)</div><div id="a32497" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:315px;display:flex;">(<ix:nonfraction id="ID_828" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a32501" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:315px;display:flex;">(<ix:nonfraction id="ID_829" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">53</ix:nonfraction>)</div><div id="a32506" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:328px;">Equity in earnings of affiliates<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32510" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:328px;display:flex;">(<ix:nonfraction id="ID_539A" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction>)</div><div id="a32514" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:328px;display:flex;">(<ix:nonfraction id="ID_540A" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction>)</div><div id="a32518" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:328px;display:flex;">(<ix:nonfraction id="ID_541A" name="us-gaap:IncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction>)</div><div id="a32523" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:341px;">Distributions from equity affiliates<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32527" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:341px;"><ix:nonfraction id="ID_542" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a32531" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:682px;top:341px;"><ix:nonfraction id="ID_543" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">18</ix:nonfraction></div><div id="a32535" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:341px;"><ix:nonfraction id="ID_544" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction></div><div id="a32540" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:354px;">Changes in unrecognized tax benefits<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32544" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:354px;"><ix:nonfraction id="ID_545" name="hsic:AdjustmentForChangesInUnrecognizedTaxBenefits" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a32548" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:354px;display:flex;">(<ix:nonfraction id="ID_546" name="hsic:AdjustmentForChangesInUnrecognizedTaxBenefits" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a32552" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:354px;display:flex;">(<ix:nonfraction id="ID_547" name="hsic:AdjustmentForChangesInUnrecognizedTaxBenefits" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">25</ix:nonfraction>)</div><div id="a32557" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:367px;">Other<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32561" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:367px;display:flex;">(<ix:nonfraction id="ID_548" name="us-gaap:OtherNoncashIncomeExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction>)</div><div id="a32565" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:367px;display:flex;">(<ix:nonfraction id="ID_549" name="us-gaap:OtherNoncashIncomeExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction>)</div><div id="a32569" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:367px;"><ix:nonfraction id="ID_550" name="us-gaap:OtherNoncashIncomeExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">32</ix:nonfraction></div><div id="a32574" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:112px;top:380px;">Changes in operating assets and liabilities, net of acquisitions: </div><div id="a32590" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:127px;top:393px;">Accounts receivable<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32594" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:588px;top:393px;display:flex;">(<ix:nonfraction id="ID_655" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a32598" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:687px;top:393px;"><ix:nonfraction id="ID_656" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction></div><div id="a32602" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:761px;top:393px;display:flex;">(<ix:nonfraction id="ID_657" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">189</ix:nonfraction>)</div><div id="a32608" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:127px;top:406px;">Inventories<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32612" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:406px;display:flex;">(<ix:nonfraction id="ID_658" name="us-gaap:IncreaseDecreaseInInventories" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">126</ix:nonfraction>)</div><div id="a32616" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:406px;display:flex;">(<ix:nonfraction id="ID_659" name="us-gaap:IncreaseDecreaseInInventories" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">295</ix:nonfraction>)</div><div id="a32620" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:406px;display:flex;">(<ix:nonfraction id="ID_660" name="us-gaap:IncreaseDecreaseInInventories" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction>)</div><div id="a32626" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:127px;top:419px;">Other current assets<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32630" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:419px;display:flex;">(<ix:nonfraction id="ID_661" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">52</ix:nonfraction>)</div><div id="a32634" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:687px;top:419px;"><ix:nonfraction id="ID_662" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">9</ix:nonfraction></div><div id="a32638" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:419px;display:flex;">(<ix:nonfraction id="ID_663" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a32644" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:127px;top:432px;">Accounts payable and accrued expenses<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32648" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:432px;display:flex;">(<ix:nonfraction id="ID_664" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">96</ix:nonfraction>)</div><div id="a32652" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:682px;top:432px;"><ix:nonfraction id="ID_665" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">86</ix:nonfraction></div><div id="a32656" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:432px;"><ix:nonfraction id="ID_666" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">196</ix:nonfraction></div><div id="a32658" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:445px;">Net cash provided by operating activities from continuing<div style="display:inline-block;width:1px">&nbsp;</div>operations </div><div id="a32662" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:445px;"><ix:nonfraction id="ID_697" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">602</ix:nonfraction></div><div id="a32666" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:445px;"><ix:nonfraction id="ID_698" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">710</ix:nonfraction></div><div id="a32670" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:445px;"><ix:nonfraction id="ID_699" name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">594</ix:nonfraction></div><div id="a32672" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:458px;">Net cash provided by operating activities from discontinued operations </div><div id="a32676" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:458px;"><ix:nonfraction id="ID_667" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32680" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:458px;"><ix:nonfraction id="ID_668" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32684" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:779px;top:458px;"><ix:nonfraction id="ID_669" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a32686" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:471px;">Net cash provided by operating activities<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32690" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:471px;"><ix:nonfraction id="ID_670" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">602</ix:nonfraction></div><div id="a32694" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:471px;"><ix:nonfraction id="ID_671" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">710</ix:nonfraction></div><div id="a32698" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:471px;"><ix:nonfraction id="ID_672" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">599</ix:nonfraction></div><div id="a32714" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:67px;top:497px;">Cash flows from investing activities: </div><div id="a32726" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:510px;">Purchases of fixed assets<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32730" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:510px;display:flex;">(<ix:nonfraction id="ID_76" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction>)</div><div id="a32734" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:510px;display:flex;">(<ix:nonfraction id="ID_182" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">79</ix:nonfraction>)</div><div id="a32738" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:510px;display:flex;">(<ix:nonfraction id="ID_211" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction>)</div><div id="a32741" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:523px;">Payments related to equity investments and business </div><div id="a32754" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:97px;top:536px;">acquisitions, net of cash acquired<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32758" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:536px;display:flex;">(<ix:nonfraction id="ID_700" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">158</ix:nonfraction>)</div><div id="a32762" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:536px;display:flex;">(<ix:nonfraction id="ID_701" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">571</ix:nonfraction>)</div><div id="a32766" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:536px;display:flex;">(<ix:nonfraction id="ID_702" name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">60</ix:nonfraction>)</div><div id="a32769" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:549px;">Proceeds from sale of equity investment<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32773" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:549px;"><ix:nonfraction id="ID_303" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32777" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:682px;top:549px;"><ix:nonfraction id="ID_22" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a32781" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:549px;"><ix:nonfraction id="ID_175" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a32784" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:562px;">Proceeds from (repayments to) loan to affiliate </div><div id="a32788" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:562px;"><ix:nonfraction id="ID_703" name="us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a32792" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:562px;display:flex;">(<ix:nonfraction id="ID_704" name="us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a32796" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:562px;display:flex;">(<ix:nonfraction id="ID_705" name="us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a32799" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:575px;">Other<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32803" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:575px;display:flex;">(<ix:nonfraction id="ID_65" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">33</ix:nonfraction>)</div><div id="a32807" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:575px;display:flex;">(<ix:nonfraction id="ID_287" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">33</ix:nonfraction>)</div><div id="a32811" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:575px;display:flex;">(<ix:nonfraction id="ID_19" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction>)</div><div id="a32813" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:588px;">Net cash used in investing activities<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32817" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:588px;display:flex;">(<ix:nonfraction id="ID_1800" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">276</ix:nonfraction>)</div><div id="a32821" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:588px;display:flex;">(<ix:nonfraction id="ID_1801" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">677</ix:nonfraction>)</div><div id="a32825" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:761px;top:588px;display:flex;">(<ix:nonfraction id="ID_1802" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">115</ix:nonfraction>)</div><div id="a32841" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;left:67px;top:614px;">Cash flows from financing activities: </div><div id="a32853" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:627px;">Net change in bank borrowings<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32857" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:590px;top:627px;"><ix:nonfraction id="ID_551" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">48</ix:nonfraction></div><div id="a32861" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:627px;display:flex;">(<ix:nonfraction id="ID_552" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">18</ix:nonfraction>)</div><div id="a32865" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:627px;"><ix:nonfraction id="ID_553" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">45</ix:nonfraction></div><div id="a32868" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:640px;">Proceeds from issuance of long-term debt<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32874" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:640px;"><ix:nonfraction id="ID_554" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">270</ix:nonfraction></div><div id="a32878" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:640px;"><ix:nonfraction id="ID_555" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">305</ix:nonfraction></div><div id="a32882" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:640px;"><ix:nonfraction id="ID_556" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">501</ix:nonfraction></div><div id="a32885" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:653px;">Principal payments for long-term debt<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32891" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:653px;display:flex;">(<ix:nonfraction id="ID_557" name="us-gaap:RepaymentsOfLongTermDebt" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">59</ix:nonfraction>)</div><div id="a32895" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:653px;display:flex;">(<ix:nonfraction id="ID_558" name="us-gaap:RepaymentsOfLongTermDebt" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">122</ix:nonfraction>)</div><div id="a32899" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:761px;top:653px;display:flex;">(<ix:nonfraction id="ID_559" name="us-gaap:RepaymentsOfLongTermDebt" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">611</ix:nonfraction>)</div><div id="a32902" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:666px;">Debt issuance costs<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32906" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:666px;"><ix:nonfraction id="ID_560" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32910" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:666px;display:flex;">(<ix:nonfraction id="ID_561" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a32914" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:666px;display:flex;">(<ix:nonfraction id="ID_562" name="us-gaap:PaymentsOfDebtIssuanceCosts" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction>)</div><div id="a32917" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:679px;">Proceeds from issuance of stock upon exercise of stock options<div style="display:inline-block;width:1px">&nbsp;</div></div><div id="a32921" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:595px;top:679px;"><ix:nonfraction id="ID_860" name="us-gaap:ProceedsFromStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a32925" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:679px;"><ix:nonfraction id="ID_861" name="us-gaap:ProceedsFromStockOptionsExercised" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32929" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:781px;top:679px;"><ix:nonfraction id="ID_349" name="us-gaap:ProceedsFromStockOptionsExercised" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a32932" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:692px;">Payments for repurchases of common stock<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a32936" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:692px;display:flex;">(<ix:nonfraction id="ID_862" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">485</ix:nonfraction>)</div><div id="a32940" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:692px;display:flex;">(<ix:nonfraction id="ID_863" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">401</ix:nonfraction>)</div><div id="a32944" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:692px;display:flex;">(<ix:nonfraction id="ID_864" name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction>)</div><div id="a32947" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:705px;">Payments for taxes related to shares withheld for employee<div style="display:inline-block;width:1px">&nbsp;</div>taxes </div><div id="a32951" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:705px;display:flex;">(<ix:nonfraction id="ID_865" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction>)</div><div id="a32955" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:705px;display:flex;">(<ix:nonfraction id="ID_866" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction>)</div><div id="a32959" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:705px;display:flex;">(<ix:nonfraction id="ID_867" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction>)</div><div id="a32962" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:718px;">Distributions to noncontrolling shareholders </div><div id="a32966" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:718px;display:flex;">(<ix:nonfraction id="ID_868" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">21</ix:nonfraction>)</div><div id="a32970" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:718px;display:flex;">(<ix:nonfraction id="ID_869" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">26</ix:nonfraction>)</div><div id="a32974" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:718px;display:flex;">(<ix:nonfraction id="ID_870" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">8</ix:nonfraction>)</div><div id="a32977" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:731px;">Acquisitions of noncontrolling interests in subsidiaries<div style="display:inline-block;width:1px">&nbsp;</div></div><div id="a32981" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:731px;display:flex;">(<ix:nonfraction id="ID_871" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction>)</div><div id="a32985" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:675px;top:731px;display:flex;">(<ix:nonfraction id="ID_872" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">60</ix:nonfraction>)</div><div id="a32989" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:767px;top:731px;display:flex;">(<ix:nonfraction id="ID_873" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction>)</div><div id="a32992" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:82px;top:744px;">Proceeds from Henry Schein Animal Health Business </div><div id="a32996" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:744px;"><ix:nonfraction id="ID_888" name="hsic:ProceedsFromPaymentsToAffiliates" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a33000" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:744px;"><ix:nonfraction id="ID_889" name="hsic:ProceedsFromPaymentsToAffiliates" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a33004" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:779px;top:744px;"><ix:nonfraction id="ID_890" name="hsic:ProceedsFromPaymentsToAffiliates" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction></div><div id="a33006" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:757px;">Net cash used in financing activities from continuing<div style="display:inline-block;width:1px">&nbsp;</div>operations </div><div id="a33010" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:757px;display:flex;">(<ix:nonfraction id="ID_563" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">315</ix:nonfraction>)</div><div id="a33014" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:757px;display:flex;">(<ix:nonfraction id="ID_564" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">333</ix:nonfraction>)</div><div id="a33018" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:761px;top:757px;display:flex;">(<ix:nonfraction id="ID_565" name="us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">182</ix:nonfraction>)</div><div id="a33020" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:770px;">Net cash used in financing activities from discontinued<div style="display:inline-block;width:1px">&nbsp;</div>operations </div><div id="a33024" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:597px;top:770px;"><ix:nonfraction id="ID_566" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a33028" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:689px;top:770px;"><ix:nonfraction id="ID_567" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a33032" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:772px;top:770px;display:flex;">(<ix:nonfraction id="ID_568" name="us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">5</ix:nonfraction>)</div><div id="a33034" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:783px;">Net cash used in financing activities </div><div id="a33038" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:577px;top:783px;display:flex;">(<ix:nonfraction id="ID_569" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">315</ix:nonfraction>)</div><div id="a33042" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:783px;display:flex;">(<ix:nonfraction id="ID_570" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">333</ix:nonfraction>)</div><div id="a33046" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:761px;top:783px;display:flex;">(<ix:nonfraction id="ID_571" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">187</ix:nonfraction>)</div><div id="a33048" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:796px;">Effect of exchange rate changes on cash and cash equivalents from continuing<div style="display:inline-block;width:1px">&nbsp;</div>operations </div><div id="a33052" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:583px;top:796px;display:flex;">(<ix:nonfraction id="ID_572" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction>)</div><div id="a33056" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:680px;top:796px;display:flex;">(<ix:nonfraction id="ID_573" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction>)</div><div id="a33060" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:774px;top:796px;"><ix:nonfraction id="ID_574" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">18</ix:nonfraction></div><div id="a33062" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:809px;">Net change in cash and cash equivalents from continuing<div style="display:inline-block;width:1px">&nbsp;</div>operations </div><div id="a33066" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:588px;top:809px;display:flex;">(<ix:nonfraction id="ID_673" name="hsic:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a33070" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:669px;top:809px;display:flex;">(<ix:nonfraction id="ID_674" name="hsic:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">303</ix:nonfraction>)</div><div id="a33074" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:809px;"><ix:nonfraction id="ID_675" name="hsic:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">315</ix:nonfraction></div><div id="a33076" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:822px;">Cash and cash equivalents, beginning of period<div style="display:inline-block;width:1px">&nbsp;</div></div><div id="a33080" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:822px;"><ix:nonfraction id="ID_1394" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">118</ix:nonfraction></div><div id="a33084" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:822px;"><ix:nonfraction id="ID_1395" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">421</ix:nonfraction></div><div id="a33088" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:822px;"><ix:nonfraction id="ID_1396" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec28_2019_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">106</ix:nonfraction></div><div id="a33090" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:67px;top:835px;">Cash and cash equivalents, end of period<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a33093" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:518px;top:835px;">$ </div><div id="a33095" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:584px;top:835px;"><ix:nonfraction id="ID_1397" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">117</ix:nonfraction></div><div id="a33098" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:610px;top:835px;">$ </div><div id="a33100" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:676px;top:835px;"><ix:nonfraction id="ID_1394A" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">118</ix:nonfraction></div><div id="a33103" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:702px;top:835px;">$ </div><div id="a33105" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;left:768px;top:835px;"><ix:nonfraction id="ID_1395A" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">421</ix:nonfraction></div></div>
</div>
<div style="padding: 7px">
<div id="Page68" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a33107" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a33109" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a33111" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a33113" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a33116" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">68 </div><div id="div_525_XBRL_TS_ceedfa2381bd4c2c9bc9d423717845cf" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_ceedfa2381bd4c2c9bc9d423717845cf" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_5985552c28a44b849da3672d60ebd378" escape="true"><div id="TextBlockContainer528" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:286px;"><div id="a33118" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 1 –Basis of Presentation and Significant Accounting Policies<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a33123" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="div_526_XBRL_TS_a8bbbb74eb93464ebc62f07c8171ace4" style="position:absolute;left:0px;top:34px;float:left;"><ix:nonnumeric id="ID_1808" name="us-gaap:NatureOfOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer527" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:252px;"><div id="a33124" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Nature of Operations </div><div id="a33127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We distribute health care products and services primarily to office-based dental and medical practitioners, across </div><div id="a33137" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">dental practices, laboratories, physician practices, and ambulatory surgery centers,<div style="display:inline-block;width:2px">&nbsp;</div>as well as government, </div><div id="a33138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">institutional health care clinics and alternate care clinics.<div style="display:inline-block;width:6px">&nbsp;</div>We also provide software, technology and other value-</div><div id="a33142" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">added services to health care practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Our dental businesses serve office-based dental practitioners, dental </div><div id="a33146" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">laboratories, schools, government and other institutions.<div style="display:inline-block;width:6px">&nbsp;</div>Our medical businesses serve physician offices, urgent </div><div id="a33150" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">care centers, ambulatory care sites, emergency medical technicians, dialysis centers,<div style="display:inline-block;width:2px">&nbsp;</div>home health, federal and state </div><div id="a33151" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">governments and large enterprises, such as group practices and integrated delivery networks,<div style="display:inline-block;width:2px">&nbsp;</div>among other providers </div><div id="a33153" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:150px;">across a wide range of specialties. </div><div id="a33156" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">We have operations or affiliates in the United States, Australia, Austria, Belgium, Brazil, Canada, Chile, China, the </div><div id="a33158" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:201px;">Czech Republic, France, Germany, Hong Kong SAR, Ireland, Israel, Italy, Japan, Liechtenstein, Luxembourg, </div><div id="a33162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:218px;">Malaysia, Mexico, the Netherlands, New Zealand, Poland, Portugal, Singapore, South<div style="display:inline-block;width:2px">&nbsp;</div>Africa, Spain, Sweden, </div><div id="a33168" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:235px;">Switzerland, Thailand, United Arab Emirates and the United Kingdom.</div></div></ix:nonnumeric></div></div></ix:nonnumeric></div><div id="div_529_XBRL_CS_5985552c28a44b849da3672d60ebd378" style="position:absolute;left:62px;top:414px;float:left;"><ix:continuation id="XBRL_CS_5985552c28a44b849da3672d60ebd378" continuedat="XBRL_TS_5577b96075804daabc0856c6210ef2b1"><div id="TextBlockContainer532" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:285px;"><div id="div_530_XBRL_CS_aea3b0896b59474ca5ca368bed9a5dfc" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_189" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer531" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:285px;"><div id="a33172" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Basis of Presentation </div><div id="a33175" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Our consolidated financial statements include the accounts of Henry<div style="display:inline-block;width:2px">&nbsp;</div>Schein, Inc. and all of our controlled </div><div id="a33177" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">subsidiaries.<div style="display:inline-block;width:7px">&nbsp;</div>All intercompany accounts and transactions are eliminated in<div style="display:inline-block;width:2px">&nbsp;</div>consolidation.<div style="display:inline-block;width:7px">&nbsp;</div>Investments in </div><div id="a33178" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">unconsolidated affiliates in which we have the ability to influence the operating or<div style="display:inline-block;width:2px">&nbsp;</div>financial decisions are accounted </div><div id="a33182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">for under the equity method.<div style="display:inline-block;width:7px">&nbsp;</div>Certain prior period amounts have been reclassified to conform to<div style="display:inline-block;width:2px">&nbsp;</div>the current period </div><div id="a33183" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">presentation.<div style="display:inline-block;width:7px">&nbsp;</div>These reclassifications, individually and in the aggregate, did<div style="display:inline-block;width:2px">&nbsp;</div>not have a material impact on our </div><div id="a33186" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:116px;">consolidated financial condition, results of operations or cash flows. </div><div id="a33189" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:149px;">We consolidate the results of operations and financial position of a trade accounts receivable securitization which </div><div id="a33190" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:166px;">we consider a Variable Interest Entity (“VIE”) because we are the primary beneficiary, and we have the power to </div><div id="a33192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:183px;">direct activities that most significantly affect the economic performance and have<div style="display:inline-block;width:2px">&nbsp;</div>the obligation to absorb the </div><div id="a33193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">majority of the losses or benefits.<div style="display:inline-block;width:7px">&nbsp;</div>For this VIE, the trade accounts receivable transferred to the VIE are<div style="display:inline-block;width:2px">&nbsp;</div>pledged as </div><div id="a33195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">collateral to the related debt.<div style="display:inline-block;width:7px">&nbsp;</div>The creditors have recourse to us for losses on these trade accounts receivable.<div style="display:inline-block;width:6px">&nbsp;</div>At </div><div id="a33197" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:233px;">December 31, 2022 and December 25, 2021, certain trade accounts receivable that<div style="display:inline-block;width:2px">&nbsp;</div>can only be used to settle </div><div id="a33213" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:250px;">obligations of this VIE were $</div><div id="a33213_30_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:182px;top:250px;"><ix:nonfraction id="ID_1425" name="us-gaap:OtherAssetsFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_PledgedStatusAxis_us-gaap_AssetPledgedAsCollateralMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">327</ix:nonfraction></div><div id="a33213_33_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:204px;top:250px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33213_47_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:286px;top:250px;"><ix:nonfraction id="ID_1426" name="us-gaap:OtherAssetsFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_PledgedStatusAxis_us-gaap_AssetPledgedAsCollateralMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">138</ix:nonfraction></div><div id="a33213_50_66" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:250px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively, and the liabilities of this VIE where the </div><div id="a33228" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:267px;">creditors have recourse to us were $</div><div id="a33228_36_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:216px;top:267px;"><ix:nonfraction id="ID_1427" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_RecourseStatusAxis_us-gaap_RecourseMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">255</ix:nonfraction></div><div id="a33228_39_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:238px;top:267px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33228_53_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:320px;top:267px;"><ix:nonfraction id="ID_1428" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_ConsolidatedEntitiesAxis_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_us-gaap_RecourseStatusAxis_us-gaap_RecourseMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">105</ix:nonfraction></div><div id="a33228_56_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:267px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_533_XBRL_TS_5577b96075804daabc0856c6210ef2b1" style="position:absolute;left:62px;top:714px;float:left;"><ix:continuation id="XBRL_TS_5577b96075804daabc0856c6210ef2b1" continuedat="XBRL_TS_5577b96075804daabc0856c6210ef2b1_1"><div id="TextBlockContainer536" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:689px;height:287px;"><div id="div_534_XBRL_TS_c839b03dec4842e5a6102015ea15c261" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_835" name="us-gaap:UseOfEstimates" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_c839b03dec4842e5a6102015ea15c261_1" escape="true"><div id="TextBlockContainer535" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:689px;height:287px;"><div id="a33255" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Use of Estimates </div><div id="a33259" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">The preparation of financial statements in conformity with accounting principles<div style="display:inline-block;width:2px">&nbsp;</div>generally accepted in the United </div><div id="a33260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">States requires us to make estimates and assumptions that affect the reported amounts of<div style="display:inline-block;width:2px">&nbsp;</div>assets and liabilities and </div><div id="a33261" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">disclosure of contingent assets and liabilities at the date of the financial<div style="display:inline-block;width:2px">&nbsp;</div>statements and the reported amounts of </div><div id="a33263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">revenues and expenses during the reporting period.<div style="display:inline-block;width:6px">&nbsp;</div>Actual results could differ from those estimates. </div><div id="a33266" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">In March 2020, the World Health Organization declared the Novel Coronavirus Disease 2019 (“COVID-19”) a </div><div id="a33272" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">pandemic.<div style="display:inline-block;width:7px">&nbsp;</div>The COVID-19 pandemic negatively impacted the global economy, disrupted global supply chains and </div><div id="a33277" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">created significant volatility and disruption<div style="display:inline-block;width:3px">&nbsp;</div>of global financial markets.<div style="display:inline-block;width:7px">&nbsp;</div>In response, many countries implemented </div><div id="a33281" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">business closures and restrictions, stay-at-home and social distancing ordinances<div style="display:inline-block;width:2px">&nbsp;</div>and similar measures to combat </div><div id="a33286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">the pandemic, which significantly impacted global business and dramatically<div style="display:inline-block;width:2px">&nbsp;</div>reduced demand for dental products </div><div id="a33288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">and certain medical products in the second quarter of 2020.<div style="display:inline-block;width:6px">&nbsp;</div>Demand for these non-PPE products increased in the </div><div id="a33296" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">second half of 2020 and continued throughout the years ended December 25,<div style="display:inline-block;width:2px">&nbsp;</div>2021 and December 31, 2022, </div><div id="a33301" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">resulting in growth over the prior years.<div style="display:inline-block;width:7px">&nbsp;</div>Demand for PPE products declined during the year ended<div style="display:inline-block;width:2px">&nbsp;</div>December 31, </div><div id="a33305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">2022.<div style="display:inline-block;width:7px">&nbsp;</div></div></div></ix:nonnumeric></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page69" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a33309" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a33311" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a33313" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a33315" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a33318" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">69 </div><div id="div_537_XBRL_TS_c839b03dec4842e5a6102015ea15c261_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_c839b03dec4842e5a6102015ea15c261_1"><div id="TextBlockContainer540" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:170px;"><div id="div_538_XBRL_TS_5577b96075804daabc0856c6210ef2b1_1" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_5577b96075804daabc0856c6210ef2b1_1" continuedat="XBRL_CS_61681f8e9c224299ae938e75b59fb086"><div id="TextBlockContainer539" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:170px;"><div id="a33320" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Our consolidated financial statements reflect estimates and assumptions<div style="display:inline-block;width:2px">&nbsp;</div>made by us that affect, among other things, </div><div id="a33323" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">our goodwill, long-lived asset and definite-lived intangible asset valuation;<div style="display:inline-block;width:2px">&nbsp;</div>inventory valuation; equity investment </div><div id="a33328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">valuation; assessment of the annual effective tax rate; valuation of deferred income<div style="display:inline-block;width:2px">&nbsp;</div>taxes and income tax </div><div id="a33330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">contingencies; the allowance for doubtful accounts; hedging activity; supplier<div style="display:inline-block;width:2px">&nbsp;</div>rebates; measurement of </div><div id="a33331" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">compensation cost for certain share-based performance awards and cash bonus<div style="display:inline-block;width:2px">&nbsp;</div>plans; and pension plan </div><div id="a33334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">assumptions.<div style="display:inline-block;width:7px">&nbsp;</div>Due to the significant uncertainty surrounding the future impact of<div style="display:inline-block;width:2px">&nbsp;</div>COVID-19, our judgments </div><div id="a33338" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">regarding estimates and impairments could change in the future.<div style="display:inline-block;width:6px">&nbsp;</div>There is an ongoing risk that the COVID-19 </div><div id="a33341" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">pandemic may again have a material adverse effect on our business, results of operations<div style="display:inline-block;width:2px">&nbsp;</div>and cash flows and may </div><div id="a33343" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">result in a material adverse effect on our financial condition and liquidity.<div style="display:inline-block;width:7px">&nbsp;</div>However, the extent of the potential </div><div id="a33344" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">impact cannot be reasonably estimated at this time.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_541_XBRL_CS_61681f8e9c224299ae938e75b59fb086" style="position:absolute;left:62px;top:297px;float:left;"><ix:continuation id="XBRL_CS_61681f8e9c224299ae938e75b59fb086" continuedat="XBRL_CS_58abeaaedbc740a7a06b37d4400403a3"><div id="TextBlockContainer544" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:692px;height:83px;"><div id="div_542_XBRL_CS_d8078567911d4c408a7a3459316ee071" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_130" name="us-gaap:FiscalPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer543" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:692px;height:83px;"><div id="a33347" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Fiscal Year </div><div id="a33350" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We report our results of operations and cash flows on a </div><div id="a33350_56_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:333px;top:32px;"><ix:nonnumeric id="ID_126" name="us-gaap:FiscalPeriodDuration" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:durweek">52</ix:nonnumeric></div><div id="a33350_58_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:32px;">-</div><div id="a33350_59_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:352px;top:32px;"><ix:nonnumeric id="ID_376" name="us-gaap:FiscalPeriodDuration" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:durweek">53</ix:nonnumeric></div><div id="a33350_61_53" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:367px;top:32px;"><div style="display:inline-block;width:4px">&nbsp;</div>week basis ending on the last Saturday of December. </div><div id="a33358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">The year ended December 31, 2022 consisted of </div><div id="a33358_46_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:292px;top:49px;"><ix:nonnumeric id="ID_1429" name="us-gaap:FiscalPeriodDuration" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:durweek">53</ix:nonnumeric></div><div id="a33358_48_60" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:307px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>weeks, and the years ended, December 25, 2021 and December </div><div id="a33364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">26, 2020 consisted of </div><div id="a33364_22_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:134px;top:66px;"><ix:nonnumeric id="ID_232" name="us-gaap:FiscalPeriodDuration" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" format="ixt-sec:durweek"><ix:nonnumeric id="ID_884" name="us-gaap:FiscalPeriodDuration" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" format="ixt-sec:durweek">52</ix:nonnumeric></ix:nonnumeric></div><div id="a33364_24_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:149px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>weeks.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_545_XBRL_CS_58abeaaedbc740a7a06b37d4400403a3" style="position:absolute;left:62px;top:397px;float:left;"><ix:continuation id="XBRL_CS_58abeaaedbc740a7a06b37d4400403a3" continuedat="XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46"><div id="TextBlockContainer548" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:352px;"><div id="div_546_XBRL_CS_94df5de2fba94d3cb605a906343d49ac" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_94df5de2fba94d3cb605a906343d49ac" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac" escape="true"><div id="TextBlockContainer547" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:352px;"><div id="a33369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Revenue Recognition<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a33372" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Revenue is recognized when a customer obtains control of promised goods<div style="display:inline-block;width:2px">&nbsp;</div>or services in an amount that reflects the </div><div id="a33410" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">consideration that we expect to receive for those goods or services.<div style="display:inline-block;width:6px">&nbsp;</div>To recognize revenue, we do the following: </div><div id="a33447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:53px;top:84px;">•<div style="display:inline-block;width:18px">&nbsp;</div>identify the contract(s) with a customer;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a33451" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:53px;top:118px;">•<div style="display:inline-block;width:18px">&nbsp;</div>identify the performance obligations in the contract;<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a33454" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:53px;top:153px;">•<div style="display:inline-block;width:18px">&nbsp;</div>determine the transaction price;<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a33457" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:53px;top:187px;">•<div style="display:inline-block;width:18px">&nbsp;</div>allocate the transaction price to the performance obligations in the contract;<div style="display:inline-block;width:2px">&nbsp;</div>and<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a33460" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:53px;top:221px;">•<div style="display:inline-block;width:18px">&nbsp;</div>recognize revenue when, or as, the entity satisfies a performance obligation. </div><div id="a33464" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:266px;">We generate revenue from the sale of dental and medical consumable products, equipment (Health care distribution </div><div id="a33465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:283px;">revenues), software products and services and other sources (Technology and value-added services revenues).<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a33469" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:300px;">Provisions for discounts, rebates to customers, customer returns and other<div style="display:inline-block;width:2px">&nbsp;</div>contra revenue adjustments are included </div><div id="a33470" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:317px;">in the transaction price at contract inception by estimating the most likely<div style="display:inline-block;width:2px">&nbsp;</div>amount based upon historical data and </div><div id="a33471" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:334px;">estimates and are provided for in the period in which the related sales are<div style="display:inline-block;width:2px">&nbsp;</div>recognized.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_549_XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac" style="position:absolute;left:62px;top:765px;float:left;"><ix:continuation id="XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac" continuedat="XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac_1"><div id="TextBlockContainer552" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:233px;"><div id="div_550_XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46" continuedat="XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46_1"><div id="TextBlockContainer551" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:233px;"><div id="a33475" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Revenue derived from the sale of consumable products is recognized at a point<div style="display:inline-block;width:2px">&nbsp;</div>in time when control transfers to the </div><div id="a33476" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">customer.<div style="display:inline-block;width:8px">&nbsp;</div>Such sales typically entail high-volume, low-dollar orders shipped<div style="display:inline-block;width:2px">&nbsp;</div>using third-party common carriers.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a33484" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We believe that the shipment date is the most appropriate point in time indicating control has transferred to the </div><div id="a33485" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">customer because we have no post-shipment obligations and this is when<div style="display:inline-block;width:2px">&nbsp;</div>legal title and risks and rewards of </div><div id="a33489" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">ownership transfer to the customer and the point at which we have an<div style="display:inline-block;width:2px">&nbsp;</div>enforceable right to payment.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a33492" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">Revenue derived from the sale of equipment is recognized when control<div style="display:inline-block;width:2px">&nbsp;</div>transfers to the customer.<div style="display:inline-block;width:8px">&nbsp;</div>This occurs </div><div id="a33493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:116px;">when the equipment is delivered.<div style="display:inline-block;width:7px">&nbsp;</div>Such sales typically entail scheduled deliveries of large equipment primarily<div style="display:inline-block;width:2px">&nbsp;</div>by </div><div id="a33495" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">equipment service technicians.<div style="display:inline-block;width:7px">&nbsp;</div>Most equipment requires minimal installation, which is<div style="display:inline-block;width:2px">&nbsp;</div>typically completed at the </div><div id="a33496" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:150px;">time of delivery.<div style="display:inline-block;width:8px">&nbsp;</div>Our product generally carries standard warranty terms provided<div style="display:inline-block;width:2px">&nbsp;</div>by the manufacturer, however, in </div><div id="a33498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:167px;">instances where we provide warranty labor services, the warranty costs<div style="display:inline-block;width:2px">&nbsp;</div>are accrued in accordance with Accounting </div><div id="a33499" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">Standards Codification (“ASC”) 460 “Guarantees”.<div style="display:inline-block;width:6px">&nbsp;</div>At December 31, 2022 and December 25, 2021, we had </div><div id="a33501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:201px;">accrued approximately $</div><div id="a33501_23_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:150px;top:201px;"><ix:nonfraction id="ID_1472" name="us-gaap:ExtendedProductWarrantyAccrual" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a33501_24_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:157px;top:201px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33501_38_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:239px;top:201px;"><ix:nonfraction id="ID_1321" name="us-gaap:ExtendedProductWarrantyAccrual" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a33501_39_45" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:247px;top:201px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively, for warranty costs.<div style="display:inline-block;width:4px">&nbsp;</div></div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page70" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a33504" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a33506" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a33508" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a33510" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a33513" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:1011px;">70 </div><div id="div_553_XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_5eb3a63cb3fb49a3ab7762f1afc4fb46_1" continuedat="XBRL_CS_b3ad6a922d64497e8708f08dd4e7dcae"><div id="TextBlockContainer556" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:452px;"><div id="div_554_XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac_1" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_67fc26bd53644cd0a9a72bb47e4b48ac_1" continuedat="XBRL_TS_393bb51230d644dc947acdb39f5673a3"><div id="TextBlockContainer555" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:452px;"><div id="a33515" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Revenue derived from the sale of software products is recognized when<div style="display:inline-block;width:2px">&nbsp;</div>products are delivered to customers or </div><div id="a33516" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">made available electronically.<div style="display:inline-block;width:8px">&nbsp;</div>Such software is generally installed by customers and does not<div style="display:inline-block;width:2px">&nbsp;</div>require extensive </div><div id="a33519" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">training due to the nature of its design.<div style="display:inline-block;width:7px">&nbsp;</div>Revenue derived from post-contract customer support for software, </div><div id="a33522" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">including annual support and/or training, is generally recognized over<div style="display:inline-block;width:2px">&nbsp;</div>time using time elapsed as the input method </div><div id="a33524" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">that best depicts the transfer of control to the customer.<div style="display:inline-block;width:7px">&nbsp;</div>Revenue derived from software sold on Software-as-a -</div><div id="a33531" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">Service basis is recognized ratably over the subscription period as<div style="display:inline-block;width:2px">&nbsp;</div>control is transferred to the customer. </div><div id="a33534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">Revenue derived from other sources, including freight charges, equipment repairs<div style="display:inline-block;width:2px">&nbsp;</div>and financial services, is </div><div id="a33535" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">recognized when the related product revenue is recognized or when<div style="display:inline-block;width:2px">&nbsp;</div>the services are provided.<div style="display:inline-block;width:7px">&nbsp;</div>We apply the </div><div id="a33536" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:150px;">practical expedient to treat shipping and handling activities performed after the<div style="display:inline-block;width:2px">&nbsp;</div>customer obtains control as </div><div id="a33538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:167px;">fulfillment activities, rather than a separate performance obligation in the<div style="display:inline-block;width:2px">&nbsp;</div>contract. </div><div id="a33541" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">Sales, value-add and other taxes we collect concurrent with revenue-producing<div style="display:inline-block;width:2px">&nbsp;</div>activities are excluded from </div><div id="a33547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">revenue. </div><div id="a33550" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:249px;">Certain of our revenue is derived from bundled arrangements that include<div style="display:inline-block;width:2px">&nbsp;</div>multiple distinct performance obligations, </div><div id="a33551" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:265px;">which are accounted for separately.<div style="display:inline-block;width:7px">&nbsp;</div>When we sell software products together with related services (i.e.,<div style="display:inline-block;width:2px">&nbsp;</div>training </div><div id="a33552" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:282px;">and technical support), we allocate revenue to software using the residual<div style="display:inline-block;width:2px">&nbsp;</div>method, using an estimate of the </div><div id="a33554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:299px;">standalone selling price to estimate the fair value of the undelivered<div style="display:inline-block;width:2px">&nbsp;</div>elements.<div style="display:inline-block;width:7px">&nbsp;</div>Bundled arrangements that include </div><div id="a33555" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:316px;">elements that are not considered software consist primarily of equipment<div style="display:inline-block;width:2px">&nbsp;</div>and the related installation service.<div style="display:inline-block;width:7px">&nbsp;</div>We </div><div id="a33557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:333px;">allocate revenue for such arrangements based on the relative selling<div style="display:inline-block;width:2px">&nbsp;</div>prices of the goods or services.<div style="display:inline-block;width:7px">&nbsp;</div>If an </div><div id="a33558" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:350px;">observable selling price is not available (i.e., we do not sell the goods or<div style="display:inline-block;width:2px">&nbsp;</div>services separately), we use one of the </div><div id="a33560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:367px;">following techniques to estimate the standalone selling price: adjusted<div style="display:inline-block;width:2px">&nbsp;</div>market approach; cost-plus approach; or the </div><div id="a33563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:383px;">residual method.<div style="display:inline-block;width:7px">&nbsp;</div>There is no specific hierarchy for the use of these methods,<div style="display:inline-block;width:2px">&nbsp;</div>but the estimated selling price reflects </div><div id="a33565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:400px;">our best estimate of what the selling prices of each deliverable would be<div style="display:inline-block;width:2px">&nbsp;</div>if it were sold regularly on a standalone </div><div id="a33566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:417px;">basis taking into consideration the cost structure of our business, technical skill<div style="display:inline-block;width:2px">&nbsp;</div>required, customer location and </div><div id="a33568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:434px;">other market conditions.</div></div></ix:continuation></div></div></ix:continuation></div><div id="a33571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:578px;">See </div><div id="a33572" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:92px;top:578px;"><a href="#a36381" style="color:#0000FF;text-decoration:underline;">Note 2 – Revenue from Contracts with Customers</a></div><div id="a33576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:578px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional disclosures of disaggregated net sales and </div><div id="a33578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:595px;"><a href="#a36932" style="color:#0000FF;text-decoration:underline;">Note 3 – Segment and Geographic Data</a></div><div id="a33582" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:301px;top:595px;"><div style="display:inline-block;width:4px">&nbsp;</div>for disclosures of net sales by segment and geographic data. </div><div id="div_557_XBRL_TS_393bb51230d644dc947acdb39f5673a3" style="position:absolute;left:62px;top:629px;float:left;"><ix:continuation id="XBRL_TS_393bb51230d644dc947acdb39f5673a3" continuedat="XBRL_TS_8b286c2263a94bc18ffcc507942d90c7"><div id="TextBlockContainer560" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:286px;"><div id="div_558_XBRL_CS_b3ad6a922d64497e8708f08dd4e7dcae" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_b3ad6a922d64497e8708f08dd4e7dcae" continuedat="XBRL_TS_b65071c3b7e04ee692b2a5b8b7ee79d6"><div id="TextBlockContainer559" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:286px;"><div id="a33604" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Sales Returns </div><div id="a33609" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Sales returns are recognized as a reduction of revenue by the amount<div style="display:inline-block;width:2px">&nbsp;</div>of expected returns and are recorded as refund </div><div id="a33610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">liability within current liabilities.<div style="display:inline-block;width:7px">&nbsp;</div>We estimate the amount of revenue expected to be reversed to calculate the sales </div><div id="a33611" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">return liability based on historical data for specific products, adjusted<div style="display:inline-block;width:2px">&nbsp;</div>as necessary for new products.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a33613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">allowance for returns is presented gross as a refund liability and we<div style="display:inline-block;width:2px">&nbsp;</div>record an inventory asset (and a corresponding </div><div id="a33614" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">adjustment to cost of sales) for any products that we expect to be returned. </div><div id="a33618" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:135px;">Cost of Sales </div><div id="a33621" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:167px;">The primary components of cost of sales include the cost of the product<div style="display:inline-block;width:2px">&nbsp;</div>(net of purchase discounts, supplier </div><div id="a33622" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">chargebacks and rebates) and inbound and outbound freight charges. </div><div id="a33625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:218px;">Costs related to purchasing, receiving, inspections, warehousing, internal<div style="display:inline-block;width:2px">&nbsp;</div>inventory transfers and other costs of our </div><div id="a33627" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:235px;">distribution network are included in selling, general and administrative<div style="display:inline-block;width:2px">&nbsp;</div>expenses along with other operating costs.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a33629" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:251px;">Total distribution network costs were $</div><div id="a33629_39_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:235px;top:251px;"><ix:nonfraction id="ID_244" name="hsic:DistributionNetworkCosts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a33629_42_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:257px;top:251px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a33629_53_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:318px;top:251px;"><ix:nonfraction id="ID_26" name="hsic:DistributionNetworkCosts" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">89</ix:nonfraction></div><div id="a33629_55_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:251px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33629_69_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:251px;"><ix:nonfraction id="ID_110" name="hsic:DistributionNetworkCosts" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">72</ix:nonfraction></div><div id="a33629_71_42" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:251px;"><div style="display:inline-block;width:4px">&nbsp;</div>million for the years ended December 31, </div><div id="a33638" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:268px;">2022, December 25, 2021 and December 26, 2020.</div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page71" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a33646" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a33648" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a33650" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a33652" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a33655" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">71 </div><div id="div_561_XBRL_TS_8b286c2263a94bc18ffcc507942d90c7" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_8b286c2263a94bc18ffcc507942d90c7" continuedat="XBRL_TS_9f48f19767d04f86b14bb0c5404923a2"><div id="TextBlockContainer566" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:102px;"><div id="div_562_XBRL_TS_b65071c3b7e04ee692b2a5b8b7ee79d6" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_b65071c3b7e04ee692b2a5b8b7ee79d6" continuedat="XBRL_TS_4ad97241a08e4f2bbd21ec259ead8956"><div id="TextBlockContainer563" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:109px;height:18px;"><div id="a33657" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Supplier Rebates</div></div></ix:continuation></div><div id="a33659" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:italic;color:#000000;left:5px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="div_564_XBRL_TS_4ad97241a08e4f2bbd21ec259ead8956" style="position:absolute;left:0px;top:34px;float:left;"><ix:continuation id="XBRL_TS_4ad97241a08e4f2bbd21ec259ead8956" continuedat="XBRL_CS_c0c499b453bc4fd88fed1fb0dbf470b5"><div id="TextBlockContainer565" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:68px;"><div id="a33661" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Supplier rebates are included as a reduction of cost of sales and are recognized<div style="display:inline-block;width:2px">&nbsp;</div>over the period they are earned.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a33662" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">factors we consider in estimating supplier rebate accruals include forecasted<div style="display:inline-block;width:2px">&nbsp;</div>inventory purchases and sales, in </div><div id="a33663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">conjunction with supplier rebate contract terms, which generally provide<div style="display:inline-block;width:2px">&nbsp;</div>for increasing rebates based on either </div><div id="a33664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">increased purchase or sales volume.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_567_XBRL_TS_9f48f19767d04f86b14bb0c5404923a2" style="position:absolute;left:62px;top:230px;float:left;"><ix:continuation id="XBRL_TS_9f48f19767d04f86b14bb0c5404923a2"><div id="TextBlockContainer570" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:118px;"><div id="div_568_XBRL_CS_c0c499b453bc4fd88fed1fb0dbf470b5" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_c0c499b453bc4fd88fed1fb0dbf470b5" continuedat="XBRL_CS_9755ee3eedb74112942803ac63c7cd82"><div id="TextBlockContainer569" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:118px;"><div id="a33668" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Direct Shipping and Handling Costs </div><div id="a33671" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Freight and other direct shipping costs are included in cost of sales.<div style="display:inline-block;width:6px">&nbsp;</div>Direct handling costs, which represent </div><div id="a33672" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">primarily direct compensation costs of employees who pick, pack and otherwise<div style="display:inline-block;width:2px">&nbsp;</div>prepare, if necessary, merchandise </div><div id="a33674" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">for shipment to our customers are reflected in selling, general and administrative<div style="display:inline-block;width:2px">&nbsp;</div>expenses.<div style="display:inline-block;width:7px">&nbsp;</div>Direct handling costs </div><div id="a33675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">were $</div><div id="a33675_6_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:45px;top:83px;"><ix:nonfraction id="ID_696" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction></div><div id="a33675_8_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:83px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a33675_19_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:83px;"><ix:nonfraction id="ID_769" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">97</ix:nonfraction></div><div id="a33675_21_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:135px;top:83px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33675_35_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:83px;"><ix:nonfraction id="ID_632" name="us-gaap:CostOfGoodsAndServicesSold" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_ProductOrServiceAxis_us-gaap_ShippingAndHandlingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">79</ix:nonfraction></div><div id="a33675_37_70" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:231px;top:83px;"><div style="display:inline-block;width:4px">&nbsp;</div>million for the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a33690" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">December 26, 2020.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_571_XBRL_CS_9755ee3eedb74112942803ac63c7cd82" style="position:absolute;left:62px;top:363px;float:left;"><ix:continuation id="XBRL_CS_9755ee3eedb74112942803ac63c7cd82" continuedat="XBRL_TS_85d0bb4dfb594a94bca331d2967eff71"><div id="TextBlockContainer574" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:683px;height:83px;"><div id="div_572_XBRL_CS_80006649fe7c46b998a4ad6030ba85e9" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_262" name="us-gaap:AdvertisingCostsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer573" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:683px;height:83px;"><div id="a33695" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Advertising and Promotional Costs </div><div id="a33698" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We generally expense advertising and promotional costs as incurred.<div style="display:inline-block;width:7px">&nbsp;</div>Total advertising and promotional expenses </div><div id="a33699" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">were $</div><div id="a33699_6_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:45px;top:49px;"><ix:nonfraction id="ID_247" name="us-gaap:MarketingAndAdvertisingExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction></div><div id="a33699_8_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a33699_19_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:49px;"><ix:nonfraction id="ID_187" name="us-gaap:MarketingAndAdvertisingExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">48</ix:nonfraction></div><div id="a33699_21_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:135px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33699_35_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:49px;"><ix:nonfraction id="ID_75" name="us-gaap:MarketingAndAdvertisingExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction></div><div id="a33699_37_70" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:231px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million for the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a33712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">December 26, 2020.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_575_XBRL_TS_85d0bb4dfb594a94bca331d2967eff71" style="position:absolute;left:62px;top:463px;float:left;"><ix:continuation id="XBRL_TS_85d0bb4dfb594a94bca331d2967eff71" continuedat="XBRL_TS_37c28774e32e42a29080e60e4dfe4606"><div id="TextBlockContainer578" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:686px;height:136px;"><div id="div_576_XBRL_TS_04113458a6274ad484cdbe8ca2a6b885" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1430" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer577" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:686px;height:136px;"><div id="a33715" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Stock Compensation Costs</div><div id="a33718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We </div><div id="a33720" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:34px;">measure stock-based compensation at the grant date, based on the estimated<div style="display:inline-block;width:2px">&nbsp;</div>fair value of the award, and </div><div id="a33756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">recognize the cost (net of estimated forfeitures) as compensation expense on<div style="display:inline-block;width:2px">&nbsp;</div>a straight-line basis over the requisite </div><div id="a33792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">service period for time-based restricted stock units and on a graded vesting<div style="display:inline-block;width:2px">&nbsp;</div>basis for the option awards.<div style="display:inline-block;width:7px">&nbsp;</div>For </div><div id="a33830" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">performance-based awards, at each reporting date, we reassess whether achievement<div style="display:inline-block;width:2px">&nbsp;</div>of the performance condition </div><div id="a33833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">is probable and accrue compensation expense when achievement of<div style="display:inline-block;width:2px">&nbsp;</div>the performance condition is probable.<div style="display:inline-block;width:7px">&nbsp;</div>Our </div><div id="a33837" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">stock-based compensation expense is reflected in selling, general and administrative<div style="display:inline-block;width:2px">&nbsp;</div>expenses.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a33837_94_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:622px;top:581px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_579_XBRL_TS_37c28774e32e42a29080e60e4dfe4606" style="position:absolute;left:62px;top:615px;float:left;"><ix:continuation id="XBRL_TS_37c28774e32e42a29080e60e4dfe4606" continuedat="XBRL_CS_999561569b1a42e59da8f74d7e3c7c90"><div id="TextBlockContainer582" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:203px;"><div id="div_580_XBRL_TS_3f8340dab75a4fcc997592c59181883b" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1431" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer581" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:203px;"><div id="a33863" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Employment Benefit Plans and other Postretirement Benefit Plans</div><div id="a33866" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Certain of our employees in our international markets participate<div style="display:inline-block;width:2px">&nbsp;</div>in various noncontributory defined benefit plans.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a33868" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">We recognize the funded status, measured as the difference between the fair value of plan assets and the benefit </div><div id="a33869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">obligation, of each applicable plan, within accumulated other comprehensive<div style="display:inline-block;width:2px">&nbsp;</div>income in the consolidated balance </div><div id="a33871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">sheets, whereby each unfunded plan is recognized as a liability and<div style="display:inline-block;width:2px">&nbsp;</div>each funded plan is recognized as either an </div><div id="a33872" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">asset or liability based on its funded status.<div style="display:inline-block;width:7px">&nbsp;</div>We measure our plan assets and liabilities at the end of our fiscal year. </div><div id="a33876" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">Net periodic pension costs and valuations are dependent on assumptions<div style="display:inline-block;width:2px">&nbsp;</div>used by third-party actuaries in calculating </div><div id="a33879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">those amounts.<div style="display:inline-block;width:7px">&nbsp;</div>These assumptions include discount rates, expected return on plan<div style="display:inline-block;width:2px">&nbsp;</div>assets, rate of future </div><div id="a33880" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">compensation levels, retirement rates, mortality rates, and other factors.<div style="display:inline-block;width:6px">&nbsp;</div>We record the service cost component of </div><div id="a33882" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:185px;">net pension cost in selling, general and administrative expenses within<div style="display:inline-block;width:2px">&nbsp;</div>our consolidated statements of income.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_583_XBRL_CS_999561569b1a42e59da8f74d7e3c7c90" style="position:absolute;left:62px;top:834px;float:left;"><ix:continuation id="XBRL_CS_999561569b1a42e59da8f74d7e3c7c90" continuedat="XBRL_CS_5573f8a94b4c4b2584a3f151bf7e433d"><div id="TextBlockContainer586" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:101px;"><div id="div_584_XBRL_CS_3bf7c3ce98ac481c9f0d8255846b2bc4" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_86" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer585" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:101px;"><div id="a33885" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Cash and Cash Equivalents<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a33888" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We consider all highly liquid short-term investments with an original maturity of three months or less to be cash </div><div id="a33891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">equivalents.<div style="display:inline-block;width:7px">&nbsp;</div>Due to the short-term maturity of such investments,<div style="display:inline-block;width:2px">&nbsp;</div>the carrying amounts are a reasonable estimate of </div><div id="a33897" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">fair value.<div style="display:inline-block;width:7px">&nbsp;</div>Outstanding checks in excess of funds on deposit of $</div><div id="a33897_66_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:388px;top:66px;"><ix:nonfraction id="ID_252" name="us-gaap:BankOverdrafts" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">54</ix:nonfraction></div><div id="a33897_68_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a33897_82_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:484px;top:66px;"><ix:nonfraction id="ID_243" name="us-gaap:BankOverdrafts" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a33897_83_31" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:492px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, primarily related to </div><div id="a33904" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">payments for inventory, were classified as accounts payable as of December 31, 2022 and December 25, 2021.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a33904_106_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:717px;top:917px;"><div style="display:inline-block;width:7px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page72" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a33911" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a33913" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a33915" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a33917" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a33920" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">72 </div><div id="div_587_XBRL_TS_badcdbd6e3f14a52ae4279eda491e3a8" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_1474" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer590" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:811px;"><div id="div_588_XBRL_CS_5573f8a94b4c4b2584a3f151bf7e433d" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_5573f8a94b4c4b2584a3f151bf7e433d" continuedat="XBRL_CS_56685380fa2c48b4a964a3151cb8b361"><div id="TextBlockContainer589" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:811px;"><div id="a33922" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Contract Balances </div><div id="a33927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Contract balances represent amounts presented in our consolidated balance<div style="display:inline-block;width:2px">&nbsp;</div>sheets when either we have transferred </div><div id="a33957" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">goods or services to the customer or the customer has paid consideration to us<div style="display:inline-block;width:2px">&nbsp;</div>under the contract.<div style="display:inline-block;width:7px">&nbsp;</div>These contract </div><div id="a33995" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">balances include accounts receivable,<div style="display:inline-block;width:3px">&nbsp;</div>contract assets and contract liabilities. </div><div id="a34015" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:101px;">Accounts Receivable and Allowance for Credit Losses </div><div id="a34030" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">Accounts receivable are generally recognized when health care distribution<div style="display:inline-block;width:2px">&nbsp;</div>and technology and value-added </div><div id="a34060" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">services revenues are recognized.<div style="display:inline-block;width:7px">&nbsp;</div>In accordance with<div style="display:inline-block;width:3px">&nbsp;</div>the “expected credit loss” model, the carrying amount of </div><div id="a34094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">accounts receivable is reduced by a valuation allowance that reflects<div style="display:inline-block;width:2px">&nbsp;</div>our best estimate of the amounts that we do </div><div id="a34132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">not expect to collect.<div style="display:inline-block;width:7px">&nbsp;</div>In addition to reviewing delinquent accounts receivable, we consider many<div style="display:inline-block;width:2px">&nbsp;</div>factors in </div><div id="a34165" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">estimating our reserve, including types of customers and their credit worthiness,<div style="display:inline-block;width:2px">&nbsp;</div>experience and historical data </div><div id="a34195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">adjusted for current conditions and reasonable supportable forecasts.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a34213" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">We </div><div id="a34215" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:253px;">record allowances for credit losses based upon a specific review of all<div style="display:inline-block;width:2px">&nbsp;</div>significant outstanding invoices.<div style="display:inline-block;width:7px">&nbsp;</div>For </div><div id="a34247" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">those invoices not specifically reviewed, provisions are provided at differing rates,<div style="display:inline-block;width:2px">&nbsp;</div>based upon the age of the </div><div id="a34281" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">receivable, the collection history associated with the geographic region<div style="display:inline-block;width:2px">&nbsp;</div>that the receivable was recorded in, current </div><div id="a34315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">economic trends and reasonable supportable forecasts.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a34328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:304px;">We </div><div id="a34330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:356px;top:304px;">write-off a receivable and charge it against its recorded </div><div id="a34350" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">allowance when we deem them uncollectible. </div><div id="a34364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">Our allowance for doubtful accounts was $</div><div id="a34364_41_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:258px;top:354px;"><ix:nonfraction id="ID_1476" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">65</ix:nonfraction></div><div id="a34364_43_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:272px;top:354px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a34364_54_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:354px;"><ix:nonfraction id="ID_1477" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">67</ix:nonfraction></div><div id="a34364_56_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:354px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a34364_70_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:354px;"><ix:nonfraction id="ID_1478" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">88</ix:nonfraction></div><div id="a34364_72_34" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:354px;"><div style="display:inline-block;width:4px">&nbsp;</div>million as of December 31, 2022, </div><div id="a34400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">December 25, 2021 and December 26, 2020, respectively.<div style="display:inline-block;width:7px">&nbsp;</div>Additions to the allowance for the years ended </div><div id="a34432" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">December 31, 2022, December 25, 2021 and December 26, 2020 were $</div><div id="a34432_65_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:388px;"><ix:nonfraction id="ID_1479" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a34432_66_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:388px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a34432_77_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:388px;"><ix:nonfraction id="ID_1480" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a34432_78_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:388px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a34432_92_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:587px;top:388px;"><ix:nonfraction id="ID_1481" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction></div><div id="a34432_94_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:602px;top:388px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a34468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">Deductions to the allowance for the years ended December 31, 2022, December<div style="display:inline-block;width:2px">&nbsp;</div>25, 2021 and December 26, 2020 </div><div id="a34504" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">were $</div><div id="a34504_6_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:45px;top:422px;"><ix:nonfraction id="ID_1482" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a34504_8_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a34504_19_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:422px;"><ix:nonfraction id="ID_1483" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a34504_21_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:135px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a34504_35_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:422px;"><ix:nonfraction id="ID_1484" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a34504_36_12" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:224px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a34522" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:455px;">Contract Assets </div><div id="a34527" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">Contract assets include amounts related to any conditional right to consideration<div style="display:inline-block;width:2px">&nbsp;</div>for work completed but not billed </div><div id="a34561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">as of the reporting date, and generally represent amounts owed to us by<div style="display:inline-block;width:2px">&nbsp;</div>customers, but not yet billed.<div style="display:inline-block;width:7px">&nbsp;</div>Contract </div><div id="a34599" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">assets are transferred to accounts receivable when the right becomes unconditional.<div style="display:inline-block;width:6px">&nbsp;</div>The contract assets primarily </div><div id="a34630" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:540px;">relate to our bundled arrangements for the sale of equipment and consumables<div style="display:inline-block;width:2px">&nbsp;</div>and sales of term software licenses.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a34666" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:557px;">Current contract assets are included in Prepaid expenses and other and the non-current<div style="display:inline-block;width:2px">&nbsp;</div>contract assets are included </div><div id="a34702" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:574px;">in investments and other within our consolidated balance sheets.<div style="display:inline-block;width:6px">&nbsp;</div>Current and non-current contract asset balances as </div><div id="a34737" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:590px;">of December 31, 2022 and December 25, 2021 were not material. </div><div id="a34760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:624px;">Contract Liabilities </div><div id="a34765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:658px;">Contract liabilities are comprised of advance payments and upfront payments<div style="display:inline-block;width:2px">&nbsp;</div>for service arrangements provided </div><div id="a34793" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:675px;">over time that are accounted for as deferred revenue amounts.<div style="display:inline-block;width:6px">&nbsp;</div>Contract liabilities are transferred to revenue once </div><div id="a34827" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:692px;">the performance obligation has been satisfied.<div style="display:inline-block;width:7px">&nbsp;</div>Current contract liabilities are included in accrued expenses: Other </div><div id="a34857" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:709px;">and the non-current contract liabilities are included in other liabilities<div style="display:inline-block;width:2px">&nbsp;</div>within our consolidated balance sheets.<div style="display:inline-block;width:6px">&nbsp;</div>At </div><div id="a34891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:725px;">December 25, 2021, the current portion of contract liabilities of $</div><div id="a34891_67_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:725px;"><ix:nonfraction id="ID_768" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">89</ix:nonfraction></div><div id="a34891_69_43" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:725px;"><div style="display:inline-block;width:4px">&nbsp;</div>million was reported in accrued expenses: </div><div id="a34927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:742px;">Other, and $</div><div id="a34927_12_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:78px;top:742px;"><ix:nonfraction id="ID_1432" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a34927_14_105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:93px;top:742px;"><div style="display:inline-block;width:4px">&nbsp;</div>million related to non-current contract liabilities was reported<div style="display:inline-block;width:2px">&nbsp;</div>in other liabilities.<div style="display:inline-block;width:7px">&nbsp;</div>During the year </div><div id="a34965" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:759px;">ended December 31, 2022,<div style="display:inline-block;width:3px">&nbsp;</div>we recognized substantially all of the current contract liability amounts<div style="display:inline-block;width:2px">&nbsp;</div>that were </div><div id="a34999" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:776px;">previously deferred at December 25, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>At December 31, 2022, the current and non-current portion of contract </div><div id="a35037" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:793px;">liabilities were $</div><div id="a35037_18_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:103px;top:793px;"><ix:nonfraction id="ID_1433" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">86</ix:nonfraction></div><div id="a35037_20_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:118px;top:793px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a35037_34_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:199px;top:793px;"><ix:nonfraction id="ID_1434" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a35037_35_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:207px;top:793px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.</div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page73" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a35055" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a35057" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a35059" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a35061" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a35064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">73 </div><div id="div_591_XBRL_CS_56685380fa2c48b4a964a3151cb8b361" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_CS_56685380fa2c48b4a964a3151cb8b361" continuedat="XBRL_TS_390a7b010feb49218779d8d8286ed0ea"><div id="TextBlockContainer594" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:681px;height:134px;"><div id="div_592_XBRL_CS_48c3a6203cd94e3fb59390c17ec3eda5" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_328" name="us-gaap:InventoryPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer593" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:681px;height:134px;"><div id="a35066" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Inventories and Reserves<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a35069" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Inventories consist primarily of finished goods and are valued at the<div style="display:inline-block;width:2px">&nbsp;</div>lower of cost or net realizable value.<div style="display:inline-block;width:7px">&nbsp;</div>Cost is </div><div id="a35076" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">determined by the first-in, first-out method for merchandise or actual cost<div style="display:inline-block;width:2px">&nbsp;</div>for large equipment and high tech </div><div id="a35081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">equipment.<div style="display:inline-block;width:7px">&nbsp;</div>In accordance with our policy for inventory valuation, we<div style="display:inline-block;width:2px">&nbsp;</div>consider many factors including the </div><div id="a35083" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">condition and salability of the inventory, historical sales, forecasted sales and market and economic trends.<div style="display:inline-block;width:6px">&nbsp;</div>From </div><div id="a35087" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">time to time, we adjust our assumptions for anticipated changes in any<div style="display:inline-block;width:2px">&nbsp;</div>of these or other factors expected to affect </div><div id="a35089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">the value of inventory.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_595_XBRL_TS_390a7b010feb49218779d8d8286ed0ea" style="position:absolute;left:62px;top:262px;float:left;"><ix:continuation id="XBRL_TS_390a7b010feb49218779d8d8286ed0ea" continuedat="XBRL_TS_7eba20e6ab0d47bba445427651894f30"><div id="TextBlockContainer598" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:646px;height:67px;"><div id="div_596_XBRL_TS_c0f32ab13189411fb614f0a4ab9847f1" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_c0f32ab13189411fb614f0a4ab9847f1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_406e1455f8ce45d69a43d5087acf6c5a" escape="true"><div id="TextBlockContainer597" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:646px;height:67px;"><div id="a35092" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Property and Equipment</div><div id="a35095" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Property and equipment are stated at cost, net of accumulated depreciation or<div style="display:inline-block;width:2px">&nbsp;</div>amortization.<div style="display:inline-block;width:7px">&nbsp;</div>Depreciation is </div><div id="a35096" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">computed primarily under the straight-line method</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a35096_49_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:364px;top:311px;"><div style="display:inline-block;width:4px">&nbsp;</div>(see </div><div id="a35101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:395px;top:311px;"><a href="#a39000" style="color:#0000FF;text-decoration:underline;">Note 5 – Property and Equipment, Net</a></div><div id="a35105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:622px;top:311px;"><div style="display:inline-block;width:4px">&nbsp;</div>for estimated useful </div><div id="a35107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:328px;">lives).<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_599_XBRL_TS_406e1455f8ce45d69a43d5087acf6c5a" style="position:absolute;left:62px;top:328px;float:left;"><ix:continuation id="XBRL_TS_406e1455f8ce45d69a43d5087acf6c5a" continuedat="XBRL_TS_fe82aae3852c42bfbd8db6778c1ea0d3"><div id="TextBlockContainer602" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:679px;height:35px;"><div id="div_600_XBRL_TS_7eba20e6ab0d47bba445427651894f30" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_7eba20e6ab0d47bba445427651894f30" continuedat="XBRL_TS_b0f67d7cb5e143379526fcdfa552841e"><div id="TextBlockContainer601" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:679px;height:35px;"><div id="a35107_9_105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:49px;top:0px;">Amortization of leasehold improvements is computed using<div style="display:inline-block;width:2px">&nbsp;</div>the straight-line method over the lesser of the </div><div id="a35112" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">useful life of the assets or the lease term.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_603_XBRL_TS_b0f67d7cb5e143379526fcdfa552841e" style="position:absolute;left:62px;top:379px;float:left;"><ix:continuation id="XBRL_TS_b0f67d7cb5e143379526fcdfa552841e" continuedat="XBRL_TS_0c4083ee345d46b8ad0eccec55878e9f"><div id="TextBlockContainer606" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:136px;"><div id="div_604_XBRL_TS_fe82aae3852c42bfbd8db6778c1ea0d3" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_fe82aae3852c42bfbd8db6778c1ea0d3"><div id="TextBlockContainer605" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:136px;"><div id="a35115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Capitalized Software Development Costs </div><div id="a35125" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Capitalized internal-use software costs consist of costs to purchase and<div style="display:inline-block;width:2px">&nbsp;</div>develop software.<div style="display:inline-block;width:7px">&nbsp;</div>For software to be used </div><div id="a35128" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">solely to meet internal needs and cloud-based applications used to deliver<div style="display:inline-block;width:2px">&nbsp;</div>our services, we capitalize costs incurred </div><div id="a35132" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">during the application development stage and include such costs within<div style="display:inline-block;width:2px">&nbsp;</div>property and equipment, net within our </div><div id="a35133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">consolidated balance sheets.<div style="display:inline-block;width:7px">&nbsp;</div>For software to be sold, leased, or marketed to external users, we capitalize<div style="display:inline-block;width:2px">&nbsp;</div>software </div><div id="a35135" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">development costs when technological feasibility is reached and<div style="display:inline-block;width:2px">&nbsp;</div>include such costs in Investments and other within </div><div id="a35139" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">our consolidated balance sheets.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_607_XBRL_TS_0c4083ee345d46b8ad0eccec55878e9f" style="position:absolute;left:62px;top:530px;float:left;"><ix:continuation id="XBRL_TS_0c4083ee345d46b8ad0eccec55878e9f" continuedat="XBRL_TS_bca3a30585b744b99478b33e33d0bb20"><div id="TextBlockContainer610" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:451px;"><div id="div_608_XBRL_TS_ab9fc91b57bc4725ac5f0bdf61b782e8" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_633" name="us-gaap:LesseeLeasesPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer609" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:451px;"><div id="a35143" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Leases </div><div id="a35145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;"><div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a35147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We </div><div id="a35149" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:32px;">determine if an arrangement contains a lease at inception.<div style="display:inline-block;width:6px">&nbsp;</div>An arrangement contains a lease if it implicitly or </div><div id="a35185" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">explicitly identifies an asset to be used and conveys the right to control<div style="display:inline-block;width:2px">&nbsp;</div>the use of the identified asset in exchange </div><div id="a35227" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">for consideration.<div style="display:inline-block;width:7px">&nbsp;</div>As a lessee, we include operating leases in operating lease right-of-use<div style="display:inline-block;width:2px">&nbsp;</div>(“ROU”) assets, </div><div id="a35261" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">operating lease liabilities, and non-current operating lease liabilities in our<div style="display:inline-block;width:2px">&nbsp;</div>consolidated balance sheets.<div style="display:inline-block;width:7px">&nbsp;</div>Finance </div><div id="a35291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">leases are included in property and equipment, current maturities<div style="display:inline-block;width:2px">&nbsp;</div>of long-term debt, and long-term debt in our </div><div id="a35330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">consolidated balance sheets.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a35338" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:149px;">ROU assets represent our right to use an underlying asset for the lease<div style="display:inline-block;width:2px">&nbsp;</div>term and lease liabilities represent our </div><div id="a35376" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:166px;">obligation to make lease payments arising from the lease.<div style="display:inline-block;width:6px">&nbsp;</div>Operating lease ROU assets and liabilities are recognized </div><div id="a35411" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:183px;">upon commencement of the lease based on the present value of the lease payments<div style="display:inline-block;width:2px">&nbsp;</div>over the lease term.<div style="display:inline-block;width:7px">&nbsp;</div>As most of </div><div id="a35453" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">our leases do not provide an implicit interest rate, we generally use our incremental<div style="display:inline-block;width:2px">&nbsp;</div>borrowing rate based on the </div><div id="a35492" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">estimated rate of interest for fully collateralized and fully amortizing borrowings<div style="display:inline-block;width:2px">&nbsp;</div>over a similar term of the lease </div><div id="a35528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:233px;">payments at commencement date to determine the present value of<div style="display:inline-block;width:2px">&nbsp;</div>lease payments.<div style="display:inline-block;width:7px">&nbsp;</div>When readily determinable, we </div><div id="a35561" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:250px;">use the implicit rate.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a35561_24_91" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:132px;top:250px;"><ix:nonnumeric id="ID_1754" name="us-gaap:LesseeOperatingLeaseOptionToExtend" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_2d364f0bf7f44d6f82162c684f84e0b3_1">Our lease terms may include options to extend or terminate the lease when it is reasonably </ix:nonnumeric></div><div id="a35601" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:5px;top:267px;"><ix:continuation id="XBRL_CS_2d364f0bf7f44d6f82162c684f84e0b3_1">certain that we will exercise that option.</ix:continuation></div><div id="a35601_42_74" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:240px;top:267px;"><div style="display:inline-block;width:7px">&nbsp;</div>Lease expense for lease payments is recognized on a straight-line<div style="display:inline-block;width:2px">&nbsp;</div>basis </div><div id="a35639" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:284px;">over the lease term.<div style="display:inline-block;width:7px">&nbsp;</div>Expenses associated with operating leases and finance leases<div style="display:inline-block;width:2px">&nbsp;</div>are included in “selling, general </div><div id="a35675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:301px;">and administrative”<div style="display:inline-block;width:4px">&nbsp;</div>and “interest expense”, respectively within our consolidated statement<div style="display:inline-block;width:2px">&nbsp;</div>of income.<div style="display:inline-block;width:7px">&nbsp;</div>Short-term </div><div id="a35704" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:318px;">leases with a term of 12 months or less are not capitalized.<div style="display:inline-block;width:6px">&nbsp;</div>During the years ended December 31, 2022, December </div><div id="a35745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:334px;">25, 2021 and December 26, 2020, such short-term lease expense was<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a35745_67_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:421px;top:334px;"><ix:nonfraction id="ID_1473" name="us-gaap:ShortTermLeaseCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a35745_68_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:334px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a35745_79_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:488px;top:334px;"><ix:nonfraction id="ID_1435" name="us-gaap:ShortTermLeaseCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a35745_80_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:334px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, and $</div><div id="a35745_95_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:334px;"><ix:nonfraction id="ID_1436" name="us-gaap:ShortTermLeaseCost" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a35745_96_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:334px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a35783" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:351px;">respectively. </div><div id="a35786" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:383px;">We </div><div id="a35788" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:383px;">have lease agreements with lease and non-lease components, which are<div style="display:inline-block;width:2px">&nbsp;</div>generally accounted for as a single </div><div id="a35823" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:400px;">lease component, except non-lease components for leases of vehicles, which<div style="display:inline-block;width:2px">&nbsp;</div>are accounted for separately.<div style="display:inline-block;width:8px">&nbsp;</div>When a </div><div id="a35857" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:417px;">vehicle lease contains both lease and non-lease components, we allocate the<div style="display:inline-block;width:2px">&nbsp;</div>transaction price based on the relative </div><div id="a35893" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:434px;">standalone selling price.</div></div></ix:nonnumeric></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page74" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a35899" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a35901" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a35903" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a35905" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a35908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">74 </div><div id="div_611_XBRL_TS_bca3a30585b744b99478b33e33d0bb20" style="position:absolute;left:62px;top:129px;float:left;"><ix:continuation id="XBRL_TS_bca3a30585b744b99478b33e33d0bb20" continuedat="XBRL_TS_c3bd102d11bd4d238394746ef1d38175"><div id="TextBlockContainer614" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:456px;"><div id="div_612_XBRL_TS_cdbb1e529b18497292e38e305f788ca2" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_cdbb1e529b18497292e38e305f788ca2" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_beee858e71d34abdacab583fe7d3f279" escape="true"><div id="TextBlockContainer613" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:456px;"><div id="a35911" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Goodwill<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a35914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Goodwill represents the excess of the purchase price over the estimated fair<div style="display:inline-block;width:2px">&nbsp;</div>value of the net assets acquired, </div><div id="a35915" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">including the amount assigned to identifiable intangible assets.<div style="display:inline-block;width:6px">&nbsp;</div>Goodwill is subject to impairment analysis annually </div><div id="a35916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">or more frequently if needed.<div style="display:inline-block;width:7px">&nbsp;</div>Such impairment analyses for goodwill requires a comparison of the<div style="display:inline-block;width:2px">&nbsp;</div>fair value to the </div><div id="a35918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">carrying value of reporting units.<div style="display:inline-block;width:7px">&nbsp;</div>We regard our reporting units to be our operating segments: global dental; global </div><div id="a35919" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">medical; and technology and value-added services.<div style="display:inline-block;width:7px">&nbsp;</div>Goodwill was allocated to such reporting units, for the </div><div id="a35924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">purposes of preparing our impairment analyses, based on a specific identification<div style="display:inline-block;width:2px">&nbsp;</div>basis. </div><div id="a35927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">For the years ended December 31, 2022 and December 25, 2021, we tested goodwill<div style="display:inline-block;width:2px">&nbsp;</div>for impairment, on the first </div><div id="a35935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">day of the fourth quarter, using a quantitative analysis comparing the carrying value of our reporting<div style="display:inline-block;width:2px">&nbsp;</div>units, </div><div id="a35936" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:185px;">including goodwill, to the estimated fair value of our reporting units using<div style="display:inline-block;width:2px">&nbsp;</div>a discounted cash flow methodology.<div style="display:inline-block;width:7px">&nbsp;</div>If </div><div id="a35939" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">the fair value of a reporting unit exceeds its carrying amount, goodwill<div style="display:inline-block;width:2px">&nbsp;</div>of the reporting unit is considered not </div><div id="a35941" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">impaired.<div style="display:inline-block;width:7px">&nbsp;</div>Conversely, impairment loss would be equivalent to the excess of a reporting unit’s carrying value over </div><div id="a35945" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">its fair value limited to the total amount of goodwill allocated to that<div style="display:inline-block;width:2px">&nbsp;</div>reporting unit. </div><div id="a35949" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">Application of the goodwill impairment test requires judgment, including<div style="display:inline-block;width:2px">&nbsp;</div>the identification of reporting units, </div><div id="a35950" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">assignment of assets and liabilities that are considered shared services<div style="display:inline-block;width:2px">&nbsp;</div>to the reporting units, and ultimately the </div><div id="a35952" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">determination of the fair value of each reporting unit.<div style="display:inline-block;width:6px">&nbsp;</div>The fair value of each reporting unit is calculated by </div><div id="a35953" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">applying the discounted cash flow methodology and confirming with<div style="display:inline-block;width:2px">&nbsp;</div>a market approach.<div style="display:inline-block;width:7px">&nbsp;</div>There are inherent </div><div id="a35954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">uncertainties related to fair value models, the inputs and our judgments<div style="display:inline-block;width:2px">&nbsp;</div>in applying them to this analysis.<div style="display:inline-block;width:7px">&nbsp;</div>The most </div><div id="a35956" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">significant inputs include estimation of future cash flows based on budget<div style="display:inline-block;width:2px">&nbsp;</div>expectations, and determination of </div><div id="a35957" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">comparable companies to develop a weighted average cost of capital for each<div style="display:inline-block;width:2px">&nbsp;</div>reporting unit. </div><div id="a35961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">For the year ended December 31, 2022, we recorded a $</div><div id="a35961_53_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:405px;"><ix:nonfraction id="ID_1764" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a35961_55_57" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:405px;"><div style="display:inline-block;width:4px">&nbsp;</div>million impairment of goodwill relating to the disposal </div><div id="a35962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">of an unprofitable business whose estimated fair value was lower than<div style="display:inline-block;width:2px">&nbsp;</div>its carrying value.<div style="display:inline-block;width:7px">&nbsp;</div>The disposal of this </div><div id="a35963" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:438px;">business is part of our restructuring initiative as more fully discussed<div style="display:inline-block;width:2px">&nbsp;</div>in</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a35964" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:490px;top:567px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Note 14 – Plans of Restructuring and </a></div><div id="a35968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:584px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Integration Costs</a></div><div id="a35969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:168px;top:584px;">.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_615_XBRL_TS_c3bd102d11bd4d238394746ef1d38175" style="position:absolute;left:62px;top:584px;float:left;"><ix:continuation id="XBRL_TS_c3bd102d11bd4d238394746ef1d38175" continuedat="XBRL_TS_216ffb2ccd6d4473bf8cb3649f1ca08b"><div id="TextBlockContainer618" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:684px;height:35px;"><div id="div_616_XBRL_TS_beee858e71d34abdacab583fe7d3f279" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_beee858e71d34abdacab583fe7d3f279"><div id="TextBlockContainer617" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:684px;height:35px;"><div id="a35969_3_90" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:117px;top:0px;">For the year ended December 25, 2021, the results of our goodwill<div style="display:inline-block;width:2px">&nbsp;</div>impairment analysis did </div><div id="a35969_93_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:0px;"><ix:nonfraction id="ID_1227" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonfraction></div><div id="a35969_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:0px;">t </div><div id="a35971" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">result in any impairments.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_619_XBRL_TS_216ffb2ccd6d4473bf8cb3649f1ca08b" style="position:absolute;left:62px;top:635px;float:left;"><ix:continuation id="XBRL_TS_216ffb2ccd6d4473bf8cb3649f1ca08b" continuedat="XBRL_CS_af030544b0684306b7fd4153bf4bd3d7"><div id="TextBlockContainer622" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:688px;height:251px;"><div id="div_620_XBRL_TS_f0d6fbfcf6994300a2a4622081c43d95" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_910" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer621" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:688px;height:251px;"><div id="a35975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Intangible Assets</div><div id="a35979" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Intangible assets, other than goodwill, are evaluated for impairment whenever<div style="display:inline-block;width:2px">&nbsp;</div>events or changes in circumstances </div><div id="a35981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">indicate that the carrying amount of the assets may not be recoverable<div style="display:inline-block;width:2px">&nbsp;</div>through the estimated undiscounted future </div><div id="a35982" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">cash flows to be derived from such assets. </div><div id="a35987" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:98px;">Definite-lived intangible assets primarily consist of non-compete agreements,<div style="display:inline-block;width:2px">&nbsp;</div>trademarks, trade names, customer </div><div id="a35993" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:115px;">lists, customer relationships and product development.<div style="display:inline-block;width:6px">&nbsp;</div>For long-lived assets used in operations, impairment losses </div><div id="a35998" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:132px;">are only recorded if the asset’s<div style="display:inline-block;width:3px">&nbsp;</div>carrying amount is not recoverable through its undiscounted, probability-weighted </div><div id="a36002" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:149px;">future cash flows.<div style="display:inline-block;width:7px">&nbsp;</div>We measure the impairment loss based on the difference between the carrying amount and the </div><div id="a36003" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:166px;">estimated fair value.<div style="display:inline-block;width:7px">&nbsp;</div>When an impairment exists, the related assets are written down to fair value. </div><div id="a36008" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">During the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and December 26, 2020, we recorded total </div><div id="a36009" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">impairment charges on intangible assets of $</div><div id="a36009_44_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:267px;top:216px;"><ix:nonfraction id="ID_832A" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">34</ix:nonfraction></div><div id="a36009_46_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:281px;top:216px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a36009_57_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:216px;"><ix:nonfraction id="ID_833A" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a36009_58_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:349px;top:216px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a36009_72_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:431px;top:216px;"><ix:nonfraction id="ID_834A" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a36009_74_38" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:216px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively, as more fully </div><div id="a36015" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:233px;">discussed in</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a36017" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:142px;top:868px;"><a href="#a40026" style="color:#0000FF;text-decoration:underline;">Note 7 – Goodwill and Other Intangibles, Net</a></div><div id="a36021" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:411px;top:868px;"><a href="#a40026" style="color:#000000;text-decoration:none;">.</a></div><div id="div_623_XBRL_CS_2dde8fc8b7d54516b4c48a8841f9542a" style="position:absolute;left:62px;top:901px;float:left;"><ix:nonnumeric id="ID_2dde8fc8b7d54516b4c48a8841f9542a" name="us-gaap:IncomeTaxPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_2dde8fc8b7d54516b4c48a8841f9542a_1" escape="true"><div id="TextBlockContainer626" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:85px;"><div id="div_624_XBRL_CS_af030544b0684306b7fd4153bf4bd3d7" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_af030544b0684306b7fd4153bf4bd3d7" continuedat="XBRL_CS_af030544b0684306b7fd4153bf4bd3d7_1"><div id="TextBlockContainer625" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:85px;"><div id="a36024" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Income Taxes</div><div id="a36027" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We account for income taxes under an asset and liability approach that requires the recognition of deferred income </div><div id="a36029" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">tax assets and liabilities for the expected future tax consequences of events<div style="display:inline-block;width:2px">&nbsp;</div>that have been recognized in our </div><div id="a36031" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">financial statements or tax returns.<div style="display:inline-block;width:7px">&nbsp;</div>In estimating future tax consequences, we generally consider all expected<div style="display:inline-block;width:2px">&nbsp;</div>future </div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page75" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a36034" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a36036" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a36038" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a36040" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a36043" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">75 </div><div id="div_627_XBRL_CS_af030544b0684306b7fd4153bf4bd3d7_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_CS_af030544b0684306b7fd4153bf4bd3d7_1" continuedat="XBRL_TS_128eeeda6aa241489d5b0281c77ba85c"><div id="TextBlockContainer630" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:697px;height:51px;"><div id="div_628_XBRL_CS_2dde8fc8b7d54516b4c48a8841f9542a_1" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_2dde8fc8b7d54516b4c48a8841f9542a_1" continuedat="XBRL_TS_f7d4e6f6f9a745dd95815537504b6498"><div id="TextBlockContainer629" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:697px;height:51px;"><div id="a36045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">events other than enactments of changes in tax laws or rates.<div style="display:inline-block;width:6px">&nbsp;</div>The effect on deferred income tax assets and </div><div id="a36049" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">liabilities of a change in tax rates is recognized as income or expense in<div style="display:inline-block;width:2px">&nbsp;</div>the period that includes the enactment date.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We file a consolidated U.S. federal income tax return with our 80% or greater owned U.S. subsidiaries</div></div></ix:continuation></div></div></ix:continuation></div><div id="a36050_101_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:670px;top:145px;">. </div><div id="div_631_XBRL_TS_128eeeda6aa241489d5b0281c77ba85c" style="position:absolute;left:62px;top:179px;float:left;"><ix:continuation id="XBRL_TS_128eeeda6aa241489d5b0281c77ba85c" continuedat="XBRL_CS_676c49470d24467d9852ef67aedf9f93"><div id="TextBlockContainer634" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:339px;"><div id="div_632_XBRL_TS_a5df2d07684445acb953d1f050965a41" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_101" name="hsic:RedeemableNoncontrollingInterestsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer633" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:339px;"><div id="a36055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Redeemable Noncontrolling Interests </div><div id="a36058" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Some minority stockholders in certain of our consolidated subsidiaries have<div style="display:inline-block;width:2px">&nbsp;</div>the right, at certain times, to require us </div><div id="a36064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">to acquire their ownership interest in those entities at fair value.<div style="display:inline-block;width:6px">&nbsp;</div>Their interests in these subsidiaries are classified </div><div id="a36067" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">outside permanent equity on our consolidated balance sheets and are<div style="display:inline-block;width:2px">&nbsp;</div>carried at the estimated redemption amounts.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">The redemption amounts have been estimated based on expected future<div style="display:inline-block;width:2px">&nbsp;</div>earnings and cash flow and, if such </div><div id="a36070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">earnings and cash flow are not achieved, the value of the redeemable noncontrolling<div style="display:inline-block;width:2px">&nbsp;</div>interests might be impacted.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36071" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">Changes in the estimated redemption amounts of the noncontrolling<div style="display:inline-block;width:2px">&nbsp;</div>interests subject to put options are reflected at </div><div id="a36073" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">each reporting period with a corresponding adjustment to Additional paid-in<div style="display:inline-block;width:2px">&nbsp;</div>capital.<div style="display:inline-block;width:7px">&nbsp;</div>Future reductions in the </div><div id="a36076" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">carrying amounts are subject to a “floor” amount that is equal to the<div style="display:inline-block;width:2px">&nbsp;</div>fair value of the redeemable noncontrolling </div><div id="a36077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">interests at the time they were originally recorded.<div style="display:inline-block;width:7px">&nbsp;</div>The recorded value of the redeemable noncontrolling interests </div><div id="a36079" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">cannot go below the floor level.<div style="display:inline-block;width:7px">&nbsp;</div>Adjustments to the carrying amount of noncontrolling interests<div style="display:inline-block;width:2px">&nbsp;</div>to<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">reflect a fair value redemption feature do not impact the calculation of earnings<div style="display:inline-block;width:2px">&nbsp;</div>per share.<div style="display:inline-block;width:7px">&nbsp;</div>Our net income is </div><div id="a36083" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">reduced by the portion of the subsidiaries’ net income that is attributable<div style="display:inline-block;width:2px">&nbsp;</div>to redeemable noncontrolling interests. </div><div id="a36086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:253px;">Noncontrolling Interests </div><div id="a36089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">Non-controlling interest represents the ownership interests of certain<div style="display:inline-block;width:2px">&nbsp;</div>minority owners of our consolidated </div><div id="a36095" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">subsidiaries.<div style="display:inline-block;width:7px">&nbsp;</div>Our net income is reduced by the portion of the subsidiaries<div style="display:inline-block;width:2px">&nbsp;</div>net income that is attributable to </div><div id="a36097" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">noncontrolling interests.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_635_XBRL_CS_676c49470d24467d9852ef67aedf9f93" style="position:absolute;left:62px;top:534px;float:left;"><ix:continuation id="XBRL_CS_676c49470d24467d9852ef67aedf9f93" continuedat="XBRL_TS_6bbae93467e445c1ba1256d485771e38"><div id="TextBlockContainer638" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:100px;"><div id="div_636_XBRL_CS_82b96a1f53004274b227aca645b8bdcc" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_32" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer637" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:100px;"><div id="a36100" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Comprehensive Income </div><div id="a36103" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Comprehensive income includes certain gains and losses that, under accounting<div style="display:inline-block;width:2px">&nbsp;</div>principles generally accepted in the </div><div id="a36105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">United States, are excluded from net income as such amounts are recorded<div style="display:inline-block;width:2px">&nbsp;</div>directly as an adjustment to </div><div id="a36106" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">stockholders’ equity.<div style="display:inline-block;width:8px">&nbsp;</div>Our comprehensive income is primarily comprised of net income,<div style="display:inline-block;width:2px">&nbsp;</div>foreign currency </div><div id="a36109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">translation gain (loss), unrealized gain (loss) from foreign currency<div style="display:inline-block;width:2px">&nbsp;</div>hedging activities and pension adjustment gain.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_639_XBRL_TS_3103571ca5574be397c1f464cadc9247" style="position:absolute;left:62px;top:650px;float:left;"><ix:nonnumeric id="ID_836" name="us-gaap:DerivativesPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_3103571ca5574be397c1f464cadc9247_1" escape="true"><div id="TextBlockContainer642" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:339px;"><div id="div_640_XBRL_TS_6bbae93467e445c1ba1256d485771e38" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_6bbae93467e445c1ba1256d485771e38" continuedat="XBRL_TS_6bbae93467e445c1ba1256d485771e38_1"><div id="TextBlockContainer641" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:339px;"><div id="a36112" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Risk Management and Derivative Financial Instruments</div><div id="a36114" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36116" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We use derivative instruments to minimize our exposure to fluctuations in foreign currency exchange rates.<div style="display:inline-block;width:6px">&nbsp;</div>Our </div><div id="a36118" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">objective is to manage the impact that foreign currency exchange rate fluctuations<div style="display:inline-block;width:2px">&nbsp;</div>could have on recognized asset </div><div id="a36119" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">and liability fair values, earnings and cash flows, as well as our net<div style="display:inline-block;width:2px">&nbsp;</div>investments in foreign subsidiaries.<div style="display:inline-block;width:7px">&nbsp;</div>Our risk </div><div id="a36123" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">management policy requires that derivative contracts used as hedges be<div style="display:inline-block;width:2px">&nbsp;</div>effective at reducing the risks associated </div><div id="a36124" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">with the exposure being hedged and be designated as a hedge at the inception<div style="display:inline-block;width:2px">&nbsp;</div>of the contract.<div style="display:inline-block;width:7px">&nbsp;</div>We do not enter into </div><div id="a36127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">derivative instruments for speculative purposes.<div style="display:inline-block;width:7px">&nbsp;</div>Our derivative instruments primarily include foreign currency </div><div id="a36128" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">forward agreements related to certain intercompany loans, certain forecasted<div style="display:inline-block;width:2px">&nbsp;</div>inventory purchase commitments with </div><div id="a36129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">foreign suppliers and foreign currency forward contracts to hedge a portion of<div style="display:inline-block;width:2px">&nbsp;</div>our euro-denominated foreign </div><div id="a36133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">operations which are designated as net investment hedges.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a36136" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">Foreign currency forward agreements related to forecasted inventory<div style="display:inline-block;width:2px">&nbsp;</div>purchase commitments with foreign suppliers </div><div id="a36139" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">and foreign currency swaps related to foreign currency denominated debt are designated<div style="display:inline-block;width:2px">&nbsp;</div>as cash flow hedges.<div style="display:inline-block;width:7px">&nbsp;</div>For </div><div id="a36143" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">derivatives that are designated and qualify as cash flow hedges, the changes<div style="display:inline-block;width:2px">&nbsp;</div>in the fair value of the derivative is </div><div id="a36145" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">recorded as a component of Accumulated other comprehensive income<div style="display:inline-block;width:2px">&nbsp;</div>in stockholders’ equity and subsequently </div><div id="a36147" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">reclassified into earnings in the period(s) during which the hedged transaction<div style="display:inline-block;width:2px">&nbsp;</div>affects earnings.<div style="display:inline-block;width:7px">&nbsp;</div>We classify the </div><div id="a36149" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">cash flows related to our hedging activities in the same category on our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>statements of cash flows as the </div><div id="a36151" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">cash flows related to the hedged item. </div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page76" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a36154" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a36156" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a36158" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a36160" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a36163" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">76 </div><div id="div_643_XBRL_TS_6bbae93467e445c1ba1256d485771e38_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_6bbae93467e445c1ba1256d485771e38_1" continuedat="XBRL_CS_11df9a53bfae4d96ae1ea3b22500a250"><div id="TextBlockContainer646" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:254px;"><div id="div_644_XBRL_TS_3103571ca5574be397c1f464cadc9247_1" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_3103571ca5574be397c1f464cadc9247_1"><div id="TextBlockContainer645" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:254px;"><div id="a36165" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Foreign currency forward contracts related to our euro-denominated<div style="display:inline-block;width:2px">&nbsp;</div>foreign operations are designated as net </div><div id="a36171" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">investment hedges.<div style="display:inline-block;width:7px">&nbsp;</div>For derivatives that are designated and qualify as net investment<div style="display:inline-block;width:2px">&nbsp;</div>hedges, the changes in the fair </div><div id="a36173" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">value of the derivative is recorded in the foreign currency translation<div style="display:inline-block;width:2px">&nbsp;</div>gain (loss) component of Accumulated other </div><div id="a36174" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">comprehensive income in stockholders’ equity until the net investment<div style="display:inline-block;width:2px">&nbsp;</div>is sold or substantially liquidated. </div><div id="a36178" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">Our foreign currency forward agreements related to foreign currency<div style="display:inline-block;width:2px">&nbsp;</div>balance sheet exposure provide economic </div><div id="a36179" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">hedges but are not designated as hedges for accounting purposes. </div><div id="a36182" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">For agreements not designated as hedges, changes in the value of the derivative,<div style="display:inline-block;width:2px">&nbsp;</div>along with the transaction gain or </div><div id="a36184" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">loss on the hedged item, are recorded in other, net, within our consolidated statements of income. </div><div id="a36191" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">Total return swaps are entered into for the purpose of economically hedging our unfunded non-qualified </div><div id="a36194" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">supplemental retirement plan (“SERP”) and our deferred compensation plan<div style="display:inline-block;width:2px">&nbsp;</div>(“DCP”).<div style="display:inline-block;width:7px">&nbsp;</div>This swap will offset </div><div id="a36201" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">changes in our SERP and DCP liabilities.<div style="display:inline-block;width:7px">&nbsp;</div>This swap is expected to be renewed on an annual basis and is<div style="display:inline-block;width:2px">&nbsp;</div>recorded </div><div id="a36206" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">in selling, general, and administrative expenses within our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>statements of income.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_647_XBRL_CS_11df9a53bfae4d96ae1ea3b22500a250" style="position:absolute;left:62px;top:382px;float:left;"><ix:continuation id="XBRL_CS_11df9a53bfae4d96ae1ea3b22500a250" continuedat="XBRL_TS_0ddb7d8aede44ba69788568cc057e243"><div id="TextBlockContainer650" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:697px;height:134px;"><div id="div_648_XBRL_CS_8e3f091e7ccb4dd9adeec32d12385c40" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_241" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer649" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:697px;height:134px;"><div id="a36209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Foreign Currency Translation<div style="display:inline-block;width:5px">&nbsp;</div>and Transactions</div><div id="a36212" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">The financial position and results of operations of our foreign subsidiaries<div style="display:inline-block;width:2px">&nbsp;</div>are determined using local currency as </div><div id="a36215" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">the functional currency.<div style="display:inline-block;width:8px">&nbsp;</div>Assets and liabilities of these subsidiaries are translated at the exchange<div style="display:inline-block;width:2px">&nbsp;</div>rate in effect at </div><div id="a36216" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">each year-end.<div style="display:inline-block;width:7px">&nbsp;</div>Income statement accounts are translated at the average rate<div style="display:inline-block;width:2px">&nbsp;</div>of exchange prevailing during the year.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">Translation adjustments arising from the use of differing exchange rates from period to period are included<div style="display:inline-block;width:2px">&nbsp;</div>in </div><div id="a36221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">Accumulated other comprehensive income in stockholders’ equity.<div style="display:inline-block;width:7px">&nbsp;</div>Gains and losses resulting from foreign </div><div id="a36223" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:116px;">currency transactions are included in earnings.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_651_XBRL_TS_0ddb7d8aede44ba69788568cc057e243" style="position:absolute;left:62px;top:532px;float:left;"><ix:continuation id="XBRL_TS_0ddb7d8aede44ba69788568cc057e243" continuedat="XBRL_TS_0ddb7d8aede44ba69788568cc057e243_1"><div id="TextBlockContainer654" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:440px;"><div id="div_652_XBRL_TS_b11186078ee143c484c514497b32bc6d" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_350" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_b11186078ee143c484c514497b32bc6d_1" escape="true"><div id="TextBlockContainer653" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:440px;"><div id="a36226" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Accounting Pronouncements Adopted </div><div id="a36232" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36234" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">On December 26, 2021 we adopted Accounting Standards Update<div style="display:inline-block;width:2px">&nbsp;</div>(“ASU”) No. 2021 – 08, “Accounting for </div><div id="a36240" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">Contract Assets and Contract Liabilities from Contracts with Customers”<div style="display:inline-block;width:2px">&nbsp;</div>(Subtopic 805).<div style="display:inline-block;width:7px">&nbsp;</div>ASU 2021 – 08 requires </div><div id="a36244" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">an acquirer to recognize and measure contract assets and contract liabilities acquired<div style="display:inline-block;width:2px">&nbsp;</div>in a business combination in </div><div id="a36247" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">accordance with ASU No. 2014 - 09, “Revenue from Contracts with Customers”<div style="display:inline-block;width:2px">&nbsp;</div>(Topic 606).<div style="display:inline-block;width:8px">&nbsp;</div>At the acquisition </div><div id="a36256" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">date, an acquirer should account for the related revenue contracts in accordance<div style="display:inline-block;width:2px">&nbsp;</div>with Topic 606 as if it had </div><div id="a36258" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">originated the contracts.<div style="display:inline-block;width:7px">&nbsp;</div>To achieve this, an acquirer may assess how the acquiree applied Topic 606 to determine </div><div id="a36259" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">what to record for the acquired revenue contracts.<div style="display:inline-block;width:7px">&nbsp;</div>Generally, this should result in an acquirer recognizing and </div><div id="a36260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">measuring the acquired contract assets and contract liabilities consistent with how<div style="display:inline-block;width:2px">&nbsp;</div>they were recognized and </div><div id="a36262" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">measured in the acquiree’s financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>Our adoption of ASU 2021 - 08 did not have a material impact on </div><div id="a36266" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">our consolidated financial statements. </div><div id="a36269" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">On December 27, 2020 we adopted ASU No. 2019-12, “Income Taxes” (Topic 740): Simplifying the Accounting </div><div id="a36277" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">for Income Taxes (“ASU 2019-12”).<div style="display:inline-block;width:8px">&nbsp;</div>ASU 2019-12 simplifies the accounting for income taxes by<div style="display:inline-block;width:2px">&nbsp;</div>removing certain </div><div id="a36282" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">exceptions to the general principles in Topic 740.<div style="display:inline-block;width:7px">&nbsp;</div>The amendments also improve consistent application of and </div><div id="a36285" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance.<div style="display:inline-block;width:6px">&nbsp;</div>Our adoption of </div><div id="a36286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">ASU 2019-12 did not have a material impact on our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>financial statements. </div><div id="a36291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:321px;">Recently Issued Accounting Standards </div><div id="a36294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">In September 2022, the FASB issued ASU No. 2022-04, “Liabilities – Supplier Finance Programs (Subtopic 405-</div><div id="a36301" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">50): Disclosure of Supplier Finance Program Obligations” which will<div style="display:inline-block;width:2px">&nbsp;</div>increase transparency of supplier finance </div><div id="a36302" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">programs by requiring entities that use such programs in connection with<div style="display:inline-block;width:2px">&nbsp;</div>the purchase of goods and services to </div><div id="a36304" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">disclose certain qualitative and quantitative information about such<div style="display:inline-block;width:2px">&nbsp;</div>programs.<div style="display:inline-block;width:7px">&nbsp;</div>ASU 2022-04 is effective for fiscal </div><div id="a36307" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">years beginning after December 15, 2022, including interim periods within<div style="display:inline-block;width:2px">&nbsp;</div>those fiscal years, except for amended </div></div></ix:nonnumeric></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page77" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a36310" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a36312" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a36314" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a36316" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a36319" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">77 </div><div id="div_655_XBRL_TS_b11186078ee143c484c514497b32bc6d_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_b11186078ee143c484c514497b32bc6d_1"><div id="TextBlockContainer658" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:288px;"><div id="div_656_XBRL_TS_0ddb7d8aede44ba69788568cc057e243_1" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_0ddb7d8aede44ba69788568cc057e243_1"><div id="TextBlockContainer657" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:288px;"><div id="a36321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">rollforward information, which is effective for fiscal years beginning after December<div style="display:inline-block;width:2px">&nbsp;</div>15, 2023.<div style="display:inline-block;width:7px">&nbsp;</div>We do not expect </div><div id="a36322" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">that the requirements of this guidance will have a material impact on our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>financial statements. </div><div id="a36327" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">In March 2020, the FASB issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the </div><div id="a36330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Effects of Reference Rate Reform on Financial Reporting” which provides optional expedients<div style="display:inline-block;width:2px">&nbsp;</div>and exceptions for </div><div id="a36332" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">applying GAAP to contracts, hedging relationships and other transactions affected<div style="display:inline-block;width:2px">&nbsp;</div>by the discontinuation of the </div><div id="a36333" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">London Interbank Offered Rate (“LIBOR”) or by another reference rate expected<div style="display:inline-block;width:2px">&nbsp;</div>to be discontinued because of </div><div id="a36334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">reference rate reform.<div style="display:inline-block;width:7px">&nbsp;</div>The guidance was effective beginning March 12, 2020 and can be applied prospectively </div><div id="a36336" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">through December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic </div><div id="a36339" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">848): Scope (“ASU 2021-01”).<div style="display:inline-block;width:7px">&nbsp;</div>ASU 2021-01 provides temporary optional expedients and exceptions<div style="display:inline-block;width:2px">&nbsp;</div>to certain </div><div id="a36345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">guidance in U.S. GAAP to ease the financial reporting burdens related<div style="display:inline-block;width:2px">&nbsp;</div>to the expected market transition from </div><div id="a36346" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">LIBOR and other interbank offered rates to alternative reference rates, such as<div style="display:inline-block;width:2px">&nbsp;</div>the Secured Overnight Financing </div><div id="a36348" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">Rate.<div style="display:inline-block;width:7px">&nbsp;</div>The guidance became effective upon issuance, on January 7, 2021, and can<div style="display:inline-block;width:2px">&nbsp;</div>be applied through December 31, </div><div id="a36349" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">2022.<div style="display:inline-block;width:7px">&nbsp;</div>In December 2022, the FASB issued ASU No. 2022-06, “Reference Rate Reform (Topic 848): Deferral of </div><div id="a36352" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">the Sunset Date of Topic 848,” which extends the period of application of temporary optional expedients from </div><div id="a36355" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">December 21, 2022 to December 31, 2024.<div style="display:inline-block;width:6px">&nbsp;</div>We do not expect that the requirements of this guidance will have a </div><div id="a36356" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">material impact on our consolidated financial statements.</div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page78" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:366px; height:1px; left:381.9px; top:291.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:309.7px; height:15.2px; left:69.9px; top:311.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15.6px; left:67.2px; top:311.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:370px; height:15.2px; left:382.3px; top:311.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:309.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:309.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:309.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:309.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:309.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:309.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16.6px; left:748.3px; top:310.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:15.2px; left:67.2px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:285.6px; height:15.2px; left:94px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.8px; height:15.2px; left:384.9px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.2px; left:394.9px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.2px; left:507.9px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.2px; left:518px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.2px; left:631px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.8px; height:15.2px; left:640.9px; top:343.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:16px; left:67.2px; top:342.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:375.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:374.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:747.9px; top:374.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:407.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:406.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:406.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:406.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:406.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:406.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:406.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:747.9px; top:406.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:422.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:424.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:422.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:424.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:422.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:424.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:366px; height:1px; left:381.9px; top:463.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:482.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:481.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:481.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:481.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:481.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:481.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:481.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16px; left:748.3px; top:481.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:15.4px; left:67.2px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:285.6px; height:15.4px; left:94px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.8px; height:15.4px; left:384.9px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:394.9px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:507.9px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:518px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:631px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.8px; height:15.4px; left:640.9px; top:514.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:16px; left:67.2px; top:513.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:546.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:16px; left:67.2px; top:545.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:545.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:545.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:545.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:545.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:545.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:545.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16px; left:748.3px; top:545.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:15.4px; left:67.2px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:285.6px; height:15.4px; left:94px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.8px; height:15.4px; left:384.9px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:394.9px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:507.9px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:518px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:631px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.8px; height:15.4px; left:640.9px; top:580.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:17.4px; left:67.2px; top:578.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:18.4px; left:67.2px; top:577.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:577.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:577.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:577.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:577.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:577.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:577.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:18.4px; left:748.3px; top:577.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:595.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:597.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:595.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:597.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:595.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:597.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:366px; height:1px; left:381.9px; top:636.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:655.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:654.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:654.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:654.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:654.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:654.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:654.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16px; left:748.3px; top:654.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:15.4px; left:67.2px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:285.6px; height:15.4px; left:94px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.8px; height:15.4px; left:384.9px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:394.9px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:507.9px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:518px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:631px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.8px; height:15.4px; left:640.9px; top:687.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:16px; left:67.2px; top:686.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:719.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:16px; left:67.2px; top:718.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:718.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:718.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:718.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:718.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:718.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:718.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16px; left:748.3px; top:718.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:15px; left:67.2px; top:751.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:16px; left:67.2px; top:750.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:750.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:750.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:750.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:750.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:750.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:750.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:16px; left:748.3px; top:750.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:24px; height:15.4px; left:67.2px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:285.6px; height:15.4px; left:94px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.8px; height:15.4px; left:384.9px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:394.9px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:507.9px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.7px; height:15.4px; left:518px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:4.6px; height:15.4px; left:631px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:104.8px; height:15.4px; left:640.9px; top:785.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:685.1px; height:17.4px; left:67.2px; top:783.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:18.4px; left:67.2px; top:782.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:315.1px; height:1px; left:66.8px; top:782.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:381.9px; top:782.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:3px; height:1px; left:501.9px; top:782.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505px; top:782.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:2.9px; height:1px; left:625px; top:782.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:627.9px; top:782.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:18.4px; left:748.3px; top:782.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:382.3px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:505.4px; top:803px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:801.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:628.3px; top:803px; background-color:#000000; ">&nbsp;</div>
<div id="a36361" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a36363" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a36365" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a36367" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a36370" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">78 </div><div id="div_659_XBRL_TS_edfa3dd0051e47f9ad01460c4d893120" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_edfa3dd0051e47f9ad01460c4d893120" name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_80d48673349c42c7b324114a8c543222" escape="true"><div id="TextBlockContainer660" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:379px;height:51px;"><div id="a36372" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 2 – Net Sales from Contracts with Customers </div><div id="a36381" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Net sales is recognized in accordance with policies disclosed in</div></div></ix:nonnumeric></div><div id="a36384" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:443px;top:145px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Note 1 – Basis of Presentation and Significant </a></div><div id="a36389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:162px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Accounting Policies</a></div><div id="a36390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:186px;top:162px;"><a href="#a33123" style="color:#000000;text-decoration:none;">.</a></div><div id="div_661_XBRL_TS_80d48673349c42c7b324114a8c543222" style="position:absolute;left:62px;top:196px;float:left;"><ix:continuation id="XBRL_TS_80d48673349c42c7b324114a8c543222" continuedat="XBRL_TS_98e7c0aa6e244bb294b92f36d0013a62"><div id="TextBlockContainer662" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:550px;height:50px;"><div id="a36393" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Disaggregation of Net sales </div><div id="a36396" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">The following table disaggregates our Net sales by reportable segment and<div style="display:inline-block;width:2px">&nbsp;</div>geographic area:</div></div></ix:continuation></div><div id="div_663_XBRL_TS_c7754ddcf21f493ea47366c1d01a78a2" style="position:absolute;left:65px;top:262px;float:left;"><ix:nonnumeric id="ID_473" name="us-gaap:DisaggregationOfRevenueTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer666" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:682px;height:586px;"><div id="div_664_XBRL_TS_98e7c0aa6e244bb294b92f36d0013a62" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_98e7c0aa6e244bb294b92f36d0013a62"><div id="TextBlockContainer665" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:682px;height:586px;"><div id="a36405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:0px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:446px;top:15px;">December 31, 2022 </div><div id="a36423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:33px;">North America </div><div id="a36427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:33px;">International </div><div id="a36430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:33px;">Global </div><div id="a36433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:50px;">Net Sales: </div><div id="a36445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:66px;">Health care distribution </div><div id="a36459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:82px;">Dental<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:82px;">$ </div><div id="a36463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:82px;"><ix:nonfraction id="ID_474" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,628</ix:nonfraction></div><div id="a36466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:82px;">$ </div><div id="a36468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:82px;"><ix:nonfraction id="ID_475" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,845</ix:nonfraction></div><div id="a36471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:82px;">$ </div><div id="a36473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:82px;"><ix:nonfraction id="ID_494" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,473</ix:nonfraction></div><div id="a36478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:98px;">Medical<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:98px;"><ix:nonfraction id="ID_476" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,375</ix:nonfraction></div><div id="a36485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:98px;"><ix:nonfraction id="ID_477" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">76</ix:nonfraction></div><div id="a36489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:98px;"><ix:nonfraction id="ID_495" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,451</ix:nonfraction></div><div id="a36496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:36px;top:114px;">Total health care distribution </div><div id="a36499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:114px;"><ix:nonfraction id="ID_482" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,003</ix:nonfraction></div><div id="a36503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:114px;"><ix:nonfraction id="ID_483" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,921</ix:nonfraction></div><div id="a36507" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:114px;"><ix:nonfraction id="ID_478" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11,924</ix:nonfraction></div><div id="a36511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:130px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services </div><div id="a36516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:130px;"><ix:nonfraction id="ID_489" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">633</ix:nonfraction></div><div id="a36520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:130px;"><ix:nonfraction id="ID_490" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">90</ix:nonfraction></div><div id="a36524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:660px;top:130px;"><ix:nonfraction id="ID_503" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">723</ix:nonfraction></div><div id="a36529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:146px;">Net sales </div><div id="a36531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:146px;">$ </div><div id="a36533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:146px;"><ix:nonfraction id="ID_496" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,636</ix:nonfraction></div><div id="a36536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:146px;">$ </div><div id="a36538" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:146px;"><ix:nonfraction id="ID_497" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,011</ix:nonfraction></div><div id="a36541" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:146px;">$ </div><div id="a36543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:146px;"><ix:nonfraction id="ID_479A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,647</ix:nonfraction></div><div id="a36567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:172px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a36576" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:446px;top:187px;">December 25, 2021 </div><div id="a36585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:204px;">North America </div><div id="a36588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:204px;">International </div><div id="a36591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:204px;">Global </div><div id="a36594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:220px;">Net Sales: </div><div id="a36606" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:236px;">Health care distribution </div><div id="a36619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:252px;">Dental<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:252px;">$ </div><div id="a36623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:252px;"><ix:nonfraction id="ID_484" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,506</ix:nonfraction></div><div id="a36626" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:252px;">$ </div><div id="a36628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:252px;"><ix:nonfraction id="ID_485" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,038</ix:nonfraction></div><div id="a36631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:252px;">$ </div><div id="a36633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:252px;"><ix:nonfraction id="ID_480" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,544</ix:nonfraction></div><div id="a36638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:268px;">Medical<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:268px;"><ix:nonfraction id="ID_486" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,107</ix:nonfraction></div><div id="a36645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:268px;"><ix:nonfraction id="ID_487" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a36649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:268px;"><ix:nonfraction id="ID_481" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,210</ix:nonfraction></div><div id="a36656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:36px;top:284px;">Total health care distribution </div><div id="a36659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:284px;"><ix:nonfraction id="ID_498" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,613</ix:nonfraction></div><div id="a36663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:284px;"><ix:nonfraction id="ID_499" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,141</ix:nonfraction></div><div id="a36667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:284px;"><ix:nonfraction id="ID_488" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11,754</ix:nonfraction></div><div id="a36671" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:300px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services </div><div id="a36676" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:300px;"><ix:nonfraction id="ID_500" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">560</ix:nonfraction></div><div id="a36680" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:300px;"><ix:nonfraction id="ID_501" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">87</ix:nonfraction></div><div id="a36684" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:660px;top:300px;"><ix:nonfraction id="ID_502" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">647</ix:nonfraction></div><div id="a36689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:319px;">Net sales </div><div id="a36691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:319px;">$ </div><div id="a36693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:319px;"><ix:nonfraction id="ID_491" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,173</ix:nonfraction></div><div id="a36696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:319px;">$ </div><div id="a36698" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:319px;"><ix:nonfraction id="ID_492" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,228</ix:nonfraction></div><div id="a36701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:319px;">$ </div><div id="a36703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:319px;"><ix:nonfraction id="ID_493A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,401</ix:nonfraction></div><div id="a36727" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:345px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a36736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:446px;top:360px;">December 26, 2020 </div><div id="a36745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:334px;top:378px;">North America </div><div id="a36748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:378px;">International </div><div id="a36751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:378px;">Global </div><div id="a36754" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:394px;">Net Sales: </div><div id="a36766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:410px;">Health care distribution </div><div id="a36779" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:426px;">Dental<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a36781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:426px;">$ </div><div id="a36783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:426px;"><ix:nonfraction id="ID_1361" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,472</ix:nonfraction></div><div id="a36786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:426px;">$ </div><div id="a36788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:426px;"><ix:nonfraction id="ID_1362" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,441</ix:nonfraction></div><div id="a36791" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:426px;">$ </div><div id="a36793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:426px;"><ix:nonfraction id="ID_803" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5,913</ix:nonfraction></div><div id="a36798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:442px;">Medical<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a36801" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:442px;"><ix:nonfraction id="ID_1365" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,515</ix:nonfraction></div><div id="a36805" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:442px;"><ix:nonfraction id="ID_1366" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">102</ix:nonfraction></div><div id="a36809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:442px;"><ix:nonfraction id="ID_804" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,617</ix:nonfraction></div><div id="a36816" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:36px;top:458px;">Total health care distribution </div><div id="a36819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:458px;"><ix:nonfraction id="ID_1363" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6,987</ix:nonfraction></div><div id="a36823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:458px;"><ix:nonfraction id="ID_1364" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,543</ix:nonfraction></div><div id="a36827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:458px;"><ix:nonfraction id="ID_806" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,530</ix:nonfraction></div><div id="a36831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:474px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services </div><div id="a36836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:414px;top:474px;"><ix:nonfraction id="ID_1367" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">447</ix:nonfraction></div><div id="a36840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:474px;"><ix:nonfraction id="ID_1368" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">67</ix:nonfraction></div><div id="a36844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:660px;top:474px;"><ix:nonfraction id="ID_805" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">514</ix:nonfraction></div><div id="a36848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:490px;">Total excluding<div style="display:inline-block;width:5px">&nbsp;</div>Corporate TSA net sales</div><div id="a36849" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:243px;top:489px;"><div style="display:inline-block;width:2px">&nbsp;</div>(1)</div><div id="a36853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:490px;"><ix:nonfraction id="ID_1369" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,434</ix:nonfraction></div><div id="a36857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:490px;"><ix:nonfraction id="ID_1370" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,610</ix:nonfraction></div><div id="a36861" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:490px;"><ix:nonfraction id="ID_807" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,044</ix:nonfraction></div><div id="a36865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:506px;">Corporate TSA net sales</div><div id="a36866" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:155px;top:505px;"><div style="display:inline-block;width:2px">&nbsp;</div>(1)</div><div id="a36870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:506px;"><ix:nonfraction id="ID_1371" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a36874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:506px;"><ix:nonfraction id="ID_1372" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a36878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:506px;"><ix:nonfraction id="ID_810" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a36883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:28px;top:524px;">Net sales </div><div id="a36885" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:524px;">$ </div><div id="a36887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:524px;"><ix:nonfraction id="ID_1373" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_srt_NorthAmericaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,434</ix:nonfraction></div><div id="a36890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:524px;">$ </div><div id="a36892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:527px;top:524px;"><ix:nonfraction id="ID_1374" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_InternationalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,685</ix:nonfraction></div><div id="a36895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:524px;">$ </div><div id="a36897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:524px;"><ix:nonfraction id="ID_826A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,119</ix:nonfraction></div><div id="a36901" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:556px;">(1) </div><div id="a36903" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:556px;">Corporate TSA net sales represents sales of certain animal health products to Covetrus under the transition services agreement </div><div id="a36908" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:572px;">entered into in connection with the Animal Health Spin-off, which ended in December 2020.</div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page79" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:300px; height:1px; left:447.9px; top:498.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:531.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:531.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:1px; left:66.8px; top:530.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:447.9px; top:530.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:537.9px; top:530.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:553px; top:530.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:642.9px; top:530.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:530.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:562.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14px; left:67.2px; top:593.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:15px; left:67.2px; top:592.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:1px; left:66.8px; top:591.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:447.9px; top:591.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:537.9px; top:591.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:553px; top:591.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15px; left:643.3px; top:592.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:591.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:623.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:14.9px; left:67.2px; top:622.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:1px; left:66.8px; top:621.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:447.9px; top:621.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:537.9px; top:621.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:553px; top:621.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:14.9px; left:643.3px; top:622.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:621.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:653.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:653.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:17px; left:67.2px; top:652.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:381.1px; height:1px; left:66.8px; top:651.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.1px; height:1px; left:447.9px; top:651.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:537.9px; top:651.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:553px; top:651.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:17px; left:643.3px; top:652.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:651.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:91px; height:1px; left:447.3px; top:671.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:91px; height:1px; left:447.3px; top:669.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:552.4px; top:671.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:552.4px; top:669.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:657.4px; top:671.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:657.4px; top:669.4px; background-color:#000000; ">&nbsp;</div>
<div id="a36913" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a36915" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a36917" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a36919" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a36922" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">79 </div><div id="div_667_XBRL_CS_5a1b07b4d8a04cc9a94f0a51b839b175" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_5a1b07b4d8a04cc9a94f0a51b839b175" name="us-gaap:SegmentReportingDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_91c2abc9be684420a13bca8c6a83045c" escape="true"><div id="TextBlockContainer668" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:370px;"><div id="a36924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 3 – Segment and Geographic Data </div><div id="a36932" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We conduct our business through </div><div id="a36932_32_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:205px;top:32px;"><ix:nonfraction id="ID_174" name="us-gaap:NumberOfReportableSegments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="myNumber" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonfraction></div><div id="a36932_35_75" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:227px;top:32px;"><div style="display:inline-block;width:4px">&nbsp;</div>reportable segments: (i) health care distribution and (ii) technology<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a36935" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">value-added services.<div style="display:inline-block;width:7px">&nbsp;</div>These segments offer different products and services to the same customer base.<div style="display:inline-block;width:6px">&nbsp;</div>Our global </div><div id="a36944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">dental businesses serve office-based dental practitioners, dental laboratories, schools, government<div style="display:inline-block;width:2px">&nbsp;</div>and other </div><div id="a36970" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">institutions.<div style="display:inline-block;width:7px">&nbsp;</div>Our medical businesses serve physician offices, urgent care centers, ambulatory care sites,<div style="display:inline-block;width:2px">&nbsp;</div>emergency </div><div id="a36973" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">medical technicians, dialysis centers, home health, federal and state governments<div style="display:inline-block;width:2px">&nbsp;</div>and large enterprises, such as </div><div id="a36975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">group practices and integrated delivery networks, among other providers<div style="display:inline-block;width:2px">&nbsp;</div>across a wide range of specialties.<div style="display:inline-block;width:7px">&nbsp;</div>Our </div><div id="a36978" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">global dental and medical groups serve practitioners in </div><div id="a36978_56_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:330px;top:133px;"><ix:nonfraction id="ID_767" name="us-gaap:NumberOfCountriesInWhichEntityOperates" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="myCountries" decimals="INF">32</ix:nonfraction></div><div id="a36978_58_22" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:133px;"><div style="display:inline-block;width:4px">&nbsp;</div>countries worldwide. </div><div id="a36981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:167px;">The health care distribution reportable segment aggregates our global dental<div style="display:inline-block;width:2px">&nbsp;</div>and medical operating segments.<div style="display:inline-block;width:7px">&nbsp;</div>This </div><div id="a37012" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">segment distributes consumable products, dental specialty products, small<div style="display:inline-block;width:2px">&nbsp;</div>equipment, laboratory products, large </div><div id="a37036" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:201px;">equipment, equipment repair services, branded and generic pharmaceuticals,<div style="display:inline-block;width:2px">&nbsp;</div>vaccines, surgical products, diagnostic </div><div id="a37061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:218px;">tests, infection-control products, PPE and vitamins.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a37077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:252px;">Our global technology and value-added services reportable segment provides<div style="display:inline-block;width:2px">&nbsp;</div>software, technology and other value-</div><div id="a37107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:268px;">added services to health care practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Our technology offerings include practice management software </div><div id="a37133" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:285px;">systems for dental and medical practitioners.<div style="display:inline-block;width:7px">&nbsp;</div>Our value-added practice solutions include practice consultancy, </div><div id="a37158" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:302px;">education, revenue cycle management and financial services on a non-recourse<div style="display:inline-block;width:2px">&nbsp;</div>basis, e-services, practice </div><div id="a37180" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:319px;">technology, network and hardware services, as well as continuing education services for practitioners. </div><div id="a37207" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:353px;">The following tables present information about our reportable and operating<div style="display:inline-block;width:2px">&nbsp;</div>segments:</div></div></ix:nonnumeric></div><div id="a37207_85_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:576px;top:464px;"><div style="display:inline-block;width:11px">&nbsp;</div></div><div id="div_669_XBRL_TS_91c2abc9be684420a13bca8c6a83045c" style="position:absolute;left:63px;top:486px;float:left;"><ix:continuation id="XBRL_TS_91c2abc9be684420a13bca8c6a83045c" continuedat="XBRL_TS_b301ec913c574fd7826a1b1b64f1dbbd"><div id="TextBlockContainer672" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:184px;"><div id="div_670_XBRL_TS_40943a0c20ef404a91adaf74a3c87aac" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_40943a0c20ef404a91adaf74a3c87aac" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_0ed14b1c0c2743ef970de0d62483b5a2" escape="true"><div id="TextBlockContainer671" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:184px;"><div id="a37227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:499px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a37234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:392px;top:14px;">December 31, </div><div id="a37237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:497px;top:14px;">December 25, </div><div id="a37240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:602px;top:14px;">December 26, </div><div id="a37247" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:417px;top:30px;">2022 </div><div id="a37250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:522px;top:30px;">2021 </div><div id="a37253" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:627px;top:30px;">2020 </div><div id="a37255" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:47px;">Net Sales: </div><div id="a37267" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:32px;top:63px;">Health care distribution </div><div id="a37268" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:162px;top:62px;">(1)</div><div id="a37281" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:47px;top:77px;">Dental<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a37284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:77px;">$ </div><div id="a37286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:77px;"><ix:nonfraction id="ID_494A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,473</ix:nonfraction></div><div id="a37289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:77px;">$ </div><div id="a37291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:77px;"><ix:nonfraction id="ID_480A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,544</ix:nonfraction></div><div id="a37294" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:77px;">$ </div><div id="a37296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:77px;"><ix:nonfraction id="ID_803A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_DentalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5,913</ix:nonfraction></div><div id="a37300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:47px;top:92px;">Medical<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37304" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:92px;"><ix:nonfraction id="ID_495A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,451</ix:nonfraction></div><div id="a37308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:92px;"><ix:nonfraction id="ID_481A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,210</ix:nonfraction></div><div id="a37312" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:92px;"><ix:nonfraction id="ID_804A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_MedicalMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,617</ix:nonfraction></div><div id="a37316" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:108px;">Total health care distribution </div><div id="a37320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:439px;top:108px;"><ix:nonfraction id="ID_478A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11,924</ix:nonfraction></div><div id="a37324" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:108px;"><ix:nonfraction id="ID_488A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11,754</ix:nonfraction></div><div id="a37328" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:108px;"><ix:nonfraction id="ID_806A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,530</ix:nonfraction></div><div id="a37331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:32px;top:122px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services </div><div id="a37334" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:237px;top:122px;">(2)</div><div id="a37338" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:122px;"><ix:nonfraction id="ID_503A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">723</ix:nonfraction></div><div id="a37342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:122px;"><ix:nonfraction id="ID_502A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">647</ix:nonfraction></div><div id="a37346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:122px;"><ix:nonfraction id="ID_805A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">514</ix:nonfraction></div><div id="a37350" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:47px;top:138px;">Total excluding<div style="display:inline-block;width:5px">&nbsp;</div>Corporate TSA net sales </div><div id="a37354" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:439px;top:138px;"><ix:nonfraction id="ID_776" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,647</ix:nonfraction></div><div id="a37358" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:138px;"><ix:nonfraction id="ID_770" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,401</ix:nonfraction></div><div id="a37362" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:649px;top:138px;"><ix:nonfraction id="ID_807A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthCareDistributionAndTechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,044</ix:nonfraction></div><div id="a37365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:32px;top:152px;">Corporate TSA net sales</div><div id="a37366" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:163px;top:152px;">(3)</div><div id="a37370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:152px;"><ix:nonfraction id="ID_808" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a37374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:576px;top:152px;"><ix:nonfraction id="ID_809" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a37378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:152px;"><ix:nonfraction id="ID_810A" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_CorporateTsaMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a37382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:47px;top:169px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:169px;">$ </div><div id="a37387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:439px;top:169px;"><ix:nonfraction id="ID_479AA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,647</ix:nonfraction></div><div id="a37390" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:169px;">$ </div><div id="a37392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:169px;"><ix:nonfraction id="ID_493AA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,401</ix:nonfraction></div><div id="a37395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:169px;">$ </div><div id="a37397" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:649px;top:169px;"><ix:nonfraction id="ID_826AA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,119</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a37400" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:80px;top:689px;">(1)</div><div id="div_673_XBRL_TS_0ed14b1c0c2743ef970de0d62483b5a2" style="position:absolute;left:76px;top:689px;float:left;"><ix:continuation id="XBRL_TS_0ed14b1c0c2743ef970de0d62483b5a2" continuedat="XBRL_CS_de44dfe88c674edb92883c1dcf0e4345"><div id="TextBlockContainer676" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:673px;height:111px;"><div id="div_674_XBRL_TS_b301ec913c574fd7826a1b1b64f1dbbd" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_b301ec913c574fd7826a1b1b64f1dbbd" continuedat="XBRL_CS_982144cb24cb48a68142cf58ec6e43de"><div id="TextBlockContainer675" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:673px;height:111px;"><div id="a37402" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:0px;">Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and </div><div id="a37404" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:14px;">generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic </div><div id="a37406" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:28px;">products), diagnostic tests, infection-control products, PPE and vitamins. </div><div id="a37411" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:41px;">(2)</div><div id="a37413" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:41px;">Consists of practice management software and other value-added products, which are distributed primarily to health care providers, </div><div id="a37416" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:55px;">practice consultancy, education, revenue cycle management and financial services on a non-recourse basis, e-services, continuing </div><div id="a37423" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:69px;">education services for practitioners, consulting and other services. </div><div id="a37425" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:83px;">(3)</div><div id="a37427" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:83px;">Corporate TSA net sales represents sales of certain products to Covetrus under the transition services agreement entered into in </div><div id="a37429" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:97px;">connection with the Animal Health Spin-off, which ended in December 2020.</div></div></ix:continuation></div></div></ix:continuation></div><div id="a37429_73_6" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:483px;top:786px;"><div style="display:inline-block;width:6px">&nbsp;</div>See </div><div id="a37433" style="position:absolute;font-family:'Times New Roman';font-size:12px;color:#0000FF;left:509px;top:786px;"><a href="#a51119" style="color:#0000FF;text-decoration:underline;">Note-23 Related Party Transactions</a></div><div id="a37436" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:681px;top:786px;"><div style="display:inline-block;width:3px">&nbsp;</div>for further </div><div id="a37438" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:109px;top:800px;">information. </div></div>
</div>
<div style="padding: 7px">
<div id="Page80" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:130.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:170.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:170.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:169.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:169.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:527.9px; top:169.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:169.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:638px; top:169.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:169.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:205.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:208.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:223.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:223.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:223.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.2px; left:67.2px; top:245.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:18.1px; left:67.2px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:3px; left:67.2px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:428.3px; top:244.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:241.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:243.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:244.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:528.3px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:241.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:243.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:244.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:648.3px; top:244.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:241.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:243.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:244.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:277.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:277.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:313.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:316.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:331.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:331.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:331.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.2px; left:67.2px; top:353.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:18.1px; left:67.2px; top:350px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:3px; left:67.2px; top:350px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:428.3px; top:352.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:350px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:351.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:352.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:528.3px; top:350px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:350px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:351.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:352.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:350px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:648.3px; top:352.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:350px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:351.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:352.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:386px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:388.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:16.8px; left:67.2px; top:423.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:423px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:641.1px; height:15.4px; left:107.2px; top:424.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:421.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:421.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:527.9px; top:421.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:421.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:638px; top:421.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:421.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:440.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:442px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:440.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:442px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:440.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:442px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:458px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:458px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:494px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:496.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:511.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:511.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:511.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.2px; left:67.2px; top:533.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:18.1px; left:67.2px; top:530px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:3px; left:67.2px; top:530px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:428.3px; top:532.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:530px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:531.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:532.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:528.3px; top:530px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:530px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:531.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:532.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:530px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:648.3px; top:532.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:530px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:531.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:532.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:566px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:568.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:583.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:583.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:583.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.2px; left:67.2px; top:605.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:18.1px; left:67.2px; top:602px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:3px; left:67.2px; top:602px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:428.3px; top:604.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:602px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:603.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:604.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:528.3px; top:602px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:602px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:603.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:604.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:602px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:15.2px; left:648.3px; top:604.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:602px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:603.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:604.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:638px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:640.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:40px; height:16.8px; left:67.2px; top:675.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:675px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:641.1px; height:15.4px; left:107.2px; top:676.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:673.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:673.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:527.9px; top:673.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:673.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:638px; top:673.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:673.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:692.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:694px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:692.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:694px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:692.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:694px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:710px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:710px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:747.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:751.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:766.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:766.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:766.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:786.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:428.3px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:786.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:786.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:788.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:811.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.2px; left:67.2px; top:850.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.2px; left:67.2px; top:850.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:849.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:418.3px; top:849.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:849.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:528.3px; top:849.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:849.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:638.4px; top:849.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:849.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.9px; left:67.2px; top:887.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:889.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:904.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:904.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:904.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:925.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:923.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:925.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:923.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:925.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:923.2px; background-color:#000000; ">&nbsp;</div>
<div id="a37440" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a37442" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a37444" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a37446" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a37449" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">80 </div><div id="div_677_XBRL_CS_de44dfe88c674edb92883c1dcf0e4345" style="position:absolute;left:63px;top:116px;float:left;"><ix:continuation id="XBRL_CS_de44dfe88c674edb92883c1dcf0e4345"><div id="TextBlockContainer680" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:808px;"><div id="div_678_XBRL_CS_982144cb24cb48a68142cf58ec6e43de" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_982144cb24cb48a68142cf58ec6e43de" continuedat="XBRL_TS_2b84e7d32f7c4fbd81d6b6f0cce7e830"><div id="TextBlockContainer679" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:808px;"><div id="a37455" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:490px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>ended </div><div id="a37461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:19px;">December 31, </div><div id="a37464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:19px;">December 25, </div><div id="a37467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:19px;">December 26, </div><div id="a37473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:39px;">2022 </div><div id="a37476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:39px;">2021 </div><div id="a37479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:39px;">2020 </div><div id="a37481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:57px;">Operating Income: </div><div id="a37493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:75px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:75px;">$ </div><div id="a37498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:75px;"><ix:nonfraction id="ID_583" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">619</ix:nonfraction></div><div id="a37501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:75px;">$ </div><div id="a37503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:75px;"><ix:nonfraction id="ID_712" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">727</ix:nonfraction></div><div id="a37506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:75px;">$ </div><div id="a37508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:75px;"><ix:nonfraction id="ID_584" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">436</ix:nonfraction></div><div id="a37511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:93px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:93px;"><ix:nonfraction id="ID_585" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a37521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:93px;"><ix:nonfraction id="ID_713" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">125</ix:nonfraction></div><div id="a37525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:93px;"><ix:nonfraction id="ID_586" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">99</ix:nonfraction></div><div id="a37529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:111px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:111px;">$ </div><div id="a37534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:111px;"><ix:nonfraction id="ID_587A" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">747</ix:nonfraction></div><div id="a37537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:111px;">$ </div><div id="a37539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:111px;"><ix:nonfraction id="ID_714A" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">852</ix:nonfraction></div><div id="a37542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:111px;">$ </div><div id="a37544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:111px;"><ix:nonfraction id="ID_588A" name="us-gaap:OperatingIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">535</ix:nonfraction></div><div id="a37558" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:147px;">Income from continuing operations before<div style="display:inline-block;width:5px">&nbsp;</div>taxes<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a37570" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:24px;top:165px;"><div style="display:inline-block;width:3px">&nbsp;</div>and equity in earnings of affiliates: </div><div id="a37583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:183px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:183px;">$ </div><div id="a37588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:183px;"><ix:nonfraction id="ID_715" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">592</ix:nonfraction></div><div id="a37591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:183px;">$ </div><div id="a37593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:183px;"><ix:nonfraction id="ID_719" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">706</ix:nonfraction></div><div id="a37596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:183px;">$ </div><div id="a37598" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:183px;"><ix:nonfraction id="ID_716" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">400</ix:nonfraction></div><div id="a37601" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:201px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:201px;"><ix:nonfraction id="ID_717" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">129</ix:nonfraction></div><div id="a37611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:201px;"><ix:nonfraction id="ID_720" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">125</ix:nonfraction></div><div id="a37615" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:201px;"><ix:nonfraction id="ID_718" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a37619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:219px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37622" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:219px;">$ </div><div id="a37624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:219px;"><ix:nonfraction id="ID_251A" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">721</ix:nonfraction></div><div id="a37627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:219px;">$ </div><div id="a37629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:219px;"><ix:nonfraction id="ID_239A" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">831</ix:nonfraction></div><div id="a37632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:219px;">$ </div><div id="a37634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:219px;"><ix:nonfraction id="ID_2A" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">500</ix:nonfraction></div><div id="a37648" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:255px;">Depreciation and Amortization: </div><div id="a37660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:273px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:273px;">$ </div><div id="a37665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:273px;"><ix:nonfraction id="ID_589" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">160</ix:nonfraction></div><div id="a37668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:273px;">$ </div><div id="a37670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:273px;"><ix:nonfraction id="ID_721" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">157</ix:nonfraction></div><div id="a37673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:273px;">$ </div><div id="a37675" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:273px;"><ix:nonfraction id="ID_590" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">143</ix:nonfraction></div><div id="a37678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:291px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37684" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:291px;"><ix:nonfraction id="ID_591" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">52</ix:nonfraction></div><div id="a37688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:291px;"><ix:nonfraction id="ID_722" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">53</ix:nonfraction></div><div id="a37692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:291px;"><ix:nonfraction id="ID_592" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">43</ix:nonfraction></div><div id="a37696" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:309px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:309px;">$ </div><div id="a37701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:309px;"><ix:nonfraction id="ID_58A" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">212</ix:nonfraction></div><div id="a37704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:309px;">$ </div><div id="a37706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:309px;"><ix:nonfraction id="ID_253A" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">210</ix:nonfraction></div><div id="a37709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:309px;">$ </div><div id="a37711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:309px;"><ix:nonfraction id="ID_97A" name="us-gaap:DepreciationDepletionAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">186</ix:nonfraction></div><div id="a37725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:345px;">Interest Income: </div><div id="a37737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:363px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:363px;">$ </div><div id="a37742" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:363px;"><ix:nonfraction id="ID_593" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction></div><div id="a37745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:363px;">$ </div><div id="a37747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:363px;"><ix:nonfraction id="ID_597" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a37750" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:363px;">$ </div><div id="a37752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:363px;"><ix:nonfraction id="ID_594" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a37755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:381px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37761" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:381px;"><ix:nonfraction id="ID_595" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a37765" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:381px;"><ix:nonfraction id="ID_598" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a37769" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:381px;"><ix:nonfraction id="ID_596" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a37773" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:399px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:399px;">$ </div><div id="a37778" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:399px;"><ix:nonfraction id="ID_682A" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">17</ix:nonfraction></div><div id="a37781" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:399px;">$ </div><div id="a37783" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:399px;"><ix:nonfraction id="ID_599A" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a37786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:399px;">$ </div><div id="a37788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:399px;"><ix:nonfraction id="ID_683A" name="us-gaap:InvestmentIncomeInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a37802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:435px;">Interest Expense: </div><div id="a37814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:453px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:453px;">$ </div><div id="a37819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:453px;"><ix:nonfraction id="ID_684" name="us-gaap:InterestExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a37822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:453px;">$ </div><div id="a37824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:453px;"><ix:nonfraction id="ID_600" name="us-gaap:InterestExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction></div><div id="a37827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:453px;">$ </div><div id="a37829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:453px;"><ix:nonfraction id="ID_685" name="us-gaap:InterestExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a37833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:471px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:471px;">$ </div><div id="a37838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:471px;"><ix:nonfraction id="ID_723A" name="us-gaap:InterestExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a37841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:471px;">$ </div><div id="a37843" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:471px;"><ix:nonfraction id="ID_725A" name="us-gaap:InterestExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction></div><div id="a37846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:471px;">$ </div><div id="a37848" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:471px;"><ix:nonfraction id="ID_724A" name="us-gaap:InterestExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a37862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:507px;">Income Tax<div style="display:inline-block;width:5px">&nbsp;</div>Expense: </div><div id="a37874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:525px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:525px;">$ </div><div id="a37879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:525px;"><ix:nonfraction id="ID_676" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">141</ix:nonfraction></div><div id="a37882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:525px;">$ </div><div id="a37884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:525px;"><ix:nonfraction id="ID_680" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">168</ix:nonfraction></div><div id="a37887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:525px;">$ </div><div id="a37889" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:525px;"><ix:nonfraction id="ID_677" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">71</ix:nonfraction></div><div id="a37892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:543px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:543px;"><ix:nonfraction id="ID_678" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction></div><div id="a37902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:543px;"><ix:nonfraction id="ID_681" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">30</ix:nonfraction></div><div id="a37906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:543px;"><ix:nonfraction id="ID_679" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">24</ix:nonfraction></div><div id="a37910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:561px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:561px;">$ </div><div id="a37915" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:561px;"><ix:nonfraction id="ID_60A" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">170</ix:nonfraction></div><div id="a37918" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:561px;">$ </div><div id="a37920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:561px;"><ix:nonfraction id="ID_437A" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">198</ix:nonfraction></div><div id="a37923" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:561px;">$ </div><div id="a37925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:561px;"><ix:nonfraction id="ID_198A" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">95</ix:nonfraction></div><div id="a37939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:597px;">Purchases of Fixed Assets: </div><div id="a37951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:617px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:617px;">$ </div><div id="a37956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:617px;"><ix:nonfraction id="ID_726" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">86</ix:nonfraction></div><div id="a37959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:617px;">$ </div><div id="a37961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:617px;"><ix:nonfraction id="ID_688" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction></div><div id="a37964" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:617px;">$ </div><div id="a37966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:617px;"><ix:nonfraction id="ID_727" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a37969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:636px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:636px;"><ix:nonfraction id="ID_728" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a37979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:636px;"><ix:nonfraction id="ID_689" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a37983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:636px;"><ix:nonfraction id="ID_729" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a37987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:656px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a37990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:656px;">$ </div><div id="a37992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:656px;"><ix:nonfraction id="ID_76A" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction></div><div id="a37995" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:656px;">$ </div><div id="a37997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:656px;"><ix:nonfraction id="ID_182A" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">79</ix:nonfraction></div><div id="a38000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:656px;">$ </div><div id="a38002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:656px;"><ix:nonfraction id="ID_211A" name="us-gaap:PaymentsToAcquireProductiveAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a38020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:511px;top:681px;">As of </div><div id="a38026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:700px;">December 31, </div><div id="a38029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:700px;">December 25, </div><div id="a38032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:700px;">December 26, </div><div id="a38038" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:719px;">2022 </div><div id="a38041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:719px;">2021 </div><div id="a38044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:719px;">2020 </div><div id="a38046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:738px;">Total<div style="display:inline-block;width:5px">&nbsp;</div>Assets: </div><div id="a38058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:756px;">Health care distribution<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:756px;">$ </div><div id="a38063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:756px;"><ix:nonfraction id="ID_602" name="us-gaap:Assets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,287</ix:nonfraction></div><div id="a38066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:756px;">$ </div><div id="a38068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:756px;"><ix:nonfraction id="ID_603" name="us-gaap:Assets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,157</ix:nonfraction></div><div id="a38071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:756px;">$ </div><div id="a38073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:756px;"><ix:nonfraction id="ID_604" name="us-gaap:Assets" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6,503</ix:nonfraction></div><div id="a38076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:774px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and value-added services<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:774px;"><ix:nonfraction id="ID_605" name="us-gaap:Assets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,320</ix:nonfraction></div><div id="a38086" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:774px;"><ix:nonfraction id="ID_606" name="us-gaap:Assets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,324</ix:nonfraction></div><div id="a38090" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:774px;"><ix:nonfraction id="ID_607" name="us-gaap:Assets" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,270</ix:nonfraction></div><div id="a38094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:44px;top:792px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38097" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:792px;">$ </div><div id="a38099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:792px;"><ix:nonfraction id="ID_36A" name="us-gaap:Assets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,607</ix:nonfraction></div><div id="a38102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:792px;">$ </div><div id="a38104" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:792px;"><ix:nonfraction id="ID_459A" name="us-gaap:Assets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,481</ix:nonfraction></div><div id="a38107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:792px;">$ </div><div id="a38109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:792px;"><ix:nonfraction id="ID_608" name="us-gaap:Assets" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,773</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page81" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:162px; height:1px; left:245.9px; top:215.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:162.1px; height:1px; left:415.8px; top:215.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:162px; height:1px; left:585.9px; top:215.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:249.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:249.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:179.1px; height:1px; left:66.8px; top:248.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:20px; left:238.3px; top:248.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:245.9px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:324.9px; top:248.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:328.9px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:20px; left:408.2px; top:248.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:415.8px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:20px; left:495.3px; top:248.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:498.9px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:20px; left:578.3px; top:248.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:585.9px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:665px; top:248.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:669px; top:248.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:289.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:294.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:179.1px; height:21px; left:67.2px; top:288.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:179.1px; height:1px; left:66.8px; top:288.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:245.9px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:324.9px; top:288.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:328.9px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:21px; left:408.2px; top:288.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:415.8px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:21px; left:495.3px; top:288.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79px; height:1px; left:498.9px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:21px; left:578.3px; top:288.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:79.1px; height:1px; left:585.9px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:4px; height:1px; left:665px; top:288.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.9px; height:1px; left:669px; top:288.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:245.3px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:245.3px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79.8px; height:1px; left:328.4px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79.8px; height:1px; left:328.4px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:415.3px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:415.3px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:498.3px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:498.3px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:585.4px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:1px; left:585.4px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79.8px; height:1px; left:668.5px; top:311.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:79.8px; height:1px; left:668.5px; top:309.8px; background-color:#000000; ">&nbsp;</div>
<div id="a38111" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a38113" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a38115" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a38117" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a38120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">81 </div><div id="div_681_XBRL_TS_2b84e7d32f7c4fbd81d6b6f0cce7e830" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_2b84e7d32f7c4fbd81d6b6f0cce7e830" continuedat="XBRL_CS_6786a97dd3a34889b5de367d006d9f9c"><div id="TextBlockContainer682" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:686px;height:85px;"><div id="a38122" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table presents information about our operations by geographic<div style="display:inline-block;width:2px">&nbsp;</div>area as of and for the three years </div><div id="a38123" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">ended December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Net sales by geographic area are based on the respective locations<div style="display:inline-block;width:2px">&nbsp;</div>of our subsidiaries.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a38126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">No country, except for the United States, generated net sales greater than </div><div id="a38126_75_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:34px;"><ix:nonfraction id="ID_341" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_srt_StatementGeographicalAxis_country_US_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">10</ix:nonfraction></div><div id="a38126_77_36" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:451px;top:34px;">% of consolidated net sales.<div style="display:inline-block;width:7px">&nbsp;</div>There </div><div id="a38127" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">were no material amounts of sales or transfers among geographic areas<div style="display:inline-block;width:2px">&nbsp;</div>and there were no material amounts of </div><div id="a38129" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">export sales.</div></div></ix:continuation></div><div id="div_683_XBRL_CS_f648f13f1c3e4af8b60351eba2d998bb" style="position:absolute;left:63px;top:201px;float:left;"><ix:nonnumeric id="ID_25" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer686" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:110px;"><div id="div_684_XBRL_CS_6786a97dd3a34889b5de367d006d9f9c" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_6786a97dd3a34889b5de367d006d9f9c"><div id="TextBlockContainer685" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:110px;"><div id="a38134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:251px;top:0px;">2022 </div><div id="a38137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:421px;top:0px;">2021 </div><div id="a38140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:591px;top:0px;">2020 </div><div id="a38145" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:202px;top:36px;">Net Sales </div><div id="a38148" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:279px;top:23px;">Long-Lived </div><div id="a38151" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:292px;top:36px;">Assets </div><div id="a38154" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:372px;top:36px;">Net Sales </div><div id="a38157" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:449px;top:23px;">Long-Lived </div><div id="a38160" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:36px;">Assets </div><div id="a38163" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:542px;top:36px;">Net Sales </div><div id="a38166" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:619px;top:23px;">Long-Lived </div><div id="a38169" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:632px;top:36px;">Assets </div><div id="a38171" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">United States<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:53px;">$ </div><div id="a38176" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:232px;top:53px;"><ix:nonfraction id="ID_815" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9,190</ix:nonfraction></div><div id="a38180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:266px;top:53px;">$ </div><div id="a38182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:315px;top:53px;"><ix:nonfraction id="ID_327" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,891</ix:nonfraction></div><div id="a38185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:353px;top:53px;">$ </div><div id="a38187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:53px;"><ix:nonfraction id="ID_816" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8,722</ix:nonfraction></div><div id="a38190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:53px;">$ </div><div id="a38192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:53px;"><ix:nonfraction id="ID_183" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,981</ix:nonfraction></div><div id="a38195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:53px;">$ </div><div id="a38197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:53px;"><ix:nonfraction id="ID_817" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7,090</ix:nonfraction></div><div id="a38200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:53px;">$ </div><div id="a38202" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:53px;"><ix:nonfraction id="ID_159" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_country_US" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,363</ix:nonfraction></div><div id="a38204" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:73px;">Other<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:232px;top:73px;"><ix:nonfraction id="ID_818" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,457</ix:nonfraction></div><div id="a38212" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:315px;top:73px;"><ix:nonfraction id="ID_173" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,256</ix:nonfraction></div><div id="a38216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:73px;"><ix:nonfraction id="ID_819" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,679</ix:nonfraction></div><div id="a38220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:73px;"><ix:nonfraction id="ID_434" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,232</ix:nonfraction></div><div id="a38224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:73px;"><ix:nonfraction id="ID_820" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,029</ix:nonfraction></div><div id="a38228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:73px;"><ix:nonfraction id="ID_235" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228_srt_StatementGeographicalAxis_hsic_LocationsOtherThanUnitedStatesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,252</ix:nonfraction></div><div id="a38231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:94px;">Consolidated total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:94px;">$ </div><div id="a38236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:226px;top:94px;"><ix:nonfraction id="ID_479AAA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,647</ix:nonfraction></div><div id="a38239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:266px;top:94px;">$ </div><div id="a38241" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:315px;top:94px;"><ix:nonfraction id="ID_194" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,147</ix:nonfraction></div><div id="a38244" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:353px;top:94px;">$ </div><div id="a38246" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:94px;"><ix:nonfraction id="ID_493AAA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12,401</ix:nonfraction></div><div id="a38249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:94px;">$ </div><div id="a38251" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:94px;"><ix:nonfraction id="ID_364" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4,213</ix:nonfraction></div><div id="a38254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:94px;">$ </div><div id="a38256" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:94px;"><ix:nonfraction id="ID_826AAA" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10,119</ix:nonfraction></div><div id="a38259" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:94px;">$ </div><div id="a38261" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:94px;"><ix:nonfraction id="ID_176" name="us-gaap:NoncurrentAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3,615</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_687_XBRL_CS_c48e6b4a444c4276b53cc30a30d3bc48" style="position:absolute;left:62px;top:330px;float:left;"><ix:nonnumeric id="ID_c48e6b4a444c4276b53cc30a30d3bc48" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_c48e6b4a444c4276b53cc30a30d3bc48_1" escape="true"><div id="TextBlockContainer688" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:557px;"><div id="a38264" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 4 – Business Acquisitions and Divestiture </div><div id="a38269" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38271" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:34px;">Acquisitions </div><div id="a38273" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38275" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">We account for business acquisitions and combinations under the acquisition method of accounting, where the net </div><div id="a38276" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">assets of acquired businesses are recorded at their fair value at the acquisition<div style="display:inline-block;width:2px">&nbsp;</div>date and our consolidated financial </div><div id="a38277" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">statements include their results of operations from that date.<div style="display:inline-block;width:6px">&nbsp;</div>Any excess of acquisition consideration over the fair </div><div id="a38279" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">value of identifiable net assets acquired is recorded as goodwill.<div style="display:inline-block;width:6px">&nbsp;</div>Goodwill is an asset representing the future </div><div id="a38280" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">economic benefits arising from other assets acquired in a business combination<div style="display:inline-block;width:2px">&nbsp;</div>that are not individually identified </div><div id="a38282" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">and separately recognized, such as future customers and technology, as well as the assembled workforce.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a38283" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">Excluding goodwill, the major classes of assets and liabilities to which<div style="display:inline-block;width:2px">&nbsp;</div>we generally allocate acquisition </div><div id="a38285" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">consideration include identifiable intangible assets (i.e., customer<div style="display:inline-block;width:2px">&nbsp;</div>relationships and lists, trademarks and trade </div><div id="a38286" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">names, product development, and non-compete agreements), inventory<div style="display:inline-block;width:2px">&nbsp;</div>and accounts receivable.<div style="display:inline-block;width:7px">&nbsp;</div>The estimated fair </div><div id="a38289" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">value of identifiable intangible assets is based on critical judgments and<div style="display:inline-block;width:2px">&nbsp;</div>assumptions derived from analysis of </div><div id="a38292" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">market conditions, including discount rates, projected revenue growth rates<div style="display:inline-block;width:2px">&nbsp;</div>(which are based on historical trends </div><div id="a38293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">and assessment of financial projections), estimated customer attrition and projected<div style="display:inline-block;width:2px">&nbsp;</div>cash flows.<div style="display:inline-block;width:7px">&nbsp;</div>These assumptions </div><div id="a38295" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">are forward-looking and could be affected by future economic and market conditions. </div><div id="a38299" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38301" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">Some prior owners of acquired subsidiaries are eligible to receive additional<div style="display:inline-block;width:2px">&nbsp;</div>purchase price cash consideration, or </div><div id="a38304" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">we may be entitled to recoup a portion of purchase price cash consideration<div style="display:inline-block;width:2px">&nbsp;</div>if certain financial targets are met.<div style="display:inline-block;width:7px">&nbsp;</div>We </div><div id="a38305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">have accrued liabilities for the estimated fair value of additional purchase<div style="display:inline-block;width:2px">&nbsp;</div>price consideration at the time of the </div><div id="a38307" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">acquisition, using the income approach, including a probability-weighted<div style="display:inline-block;width:2px">&nbsp;</div>discounted cash flow method or an option </div><div id="a38310" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">pricing method, where applicable.<div style="display:inline-block;width:7px">&nbsp;</div>Any adjustments to these accrual amounts are recorded<div style="display:inline-block;width:2px">&nbsp;</div>in selling, general and </div><div id="a38311" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">administrative expenses within our consolidated statements of income.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a38315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">While we use our best estimates and assumptions to accurately value<div style="display:inline-block;width:2px">&nbsp;</div>assets acquired and liabilities assumed at the </div><div id="a38316" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">acquisition date as well as contingent consideration, where applicable,<div style="display:inline-block;width:2px">&nbsp;</div>our estimates are inherently uncertain and </div><div id="a38318" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">subject to refinement.<div style="display:inline-block;width:7px">&nbsp;</div>As a result, within 12 months following the date of acquisition,<div style="display:inline-block;width:2px">&nbsp;</div>or the measurement period, </div><div id="a38319" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:472px;">we may record adjustments to the assets acquired and liabilities assumed<div style="display:inline-block;width:2px">&nbsp;</div>with the corresponding offset to goodwill </div><div id="a38320" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">within our consolidated balance sheets.<div style="display:inline-block;width:7px">&nbsp;</div>At the end of the measurement period or final determination<div style="display:inline-block;width:2px">&nbsp;</div>of the values </div><div id="a38328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">of such assets acquired or liabilities assumed, whichever comes first,<div style="display:inline-block;width:2px">&nbsp;</div>any subsequent adjustments are recognized in </div><div id="a38329" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">our consolidated statements of operations. </div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page82" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:79.1px; height:1px; left:414.9px; top:331.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:349.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:386.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:384.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:386.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.4px; left:67.2px; top:420.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:1px; left:66.8px; top:419.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:419.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:438px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:439.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:450.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:18.7px; left:67.2px; top:447.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:15.4px; left:396.2px; top:450.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:486.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:483.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:486.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:519.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.4px; left:418px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:556.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:554.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.4px; left:418px; top:556.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:571.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:591.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:589.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:591.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:606.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:627.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:625.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:18.2px; left:67.2px; top:754.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:19.2px; left:67.2px; top:753.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:1px; left:66.8px; top:753.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:163.1px; height:1px; left:414.9px; top:753.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19.2px; left:67.2px; top:792px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.1px; height:15.4px; left:76.2px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.4px; left:398.9px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19px; left:67.2px; top:831.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:20px; left:67.2px; top:830.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.8px; top:830px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:83px; height:20px; left:495.3px; top:830.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:852.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:850.5px; background-color:#000000; ">&nbsp;</div>
<div id="a38334" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a38336" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a38338" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a38340" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a38343" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">82 </div><div id="div_689_XBRL_CS_c48e6b4a444c4276b53cc30a30d3bc48_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_CS_c48e6b4a444c4276b53cc30a30d3bc48_1" continuedat="XBRL_TS_072e4eebba7a440099997a226b333636"><div id="TextBlockContainer690" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:187px;"><div id="a38345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">2022 Acquisitions </div><div id="a38349" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We completed several acquisitions during the year ended December 31, 2022, which were immaterial to our </div><div id="a38350" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">consolidated financial statements. Our acquired ownership interest ranged between </div><div id="a38350_82_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:51px;"><ix:nonfraction id="ID_1487" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">55</ix:nonfraction></div><div id="a38350_84_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:51px;">% to </div><div id="a38350_89_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:51px;"><ix:nonfraction id="ID_1488" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">100</ix:nonfraction></div><div id="a38350_92_17" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:51px;">%.<div style="display:inline-block;width:7px">&nbsp;</div>Acquisitions </div><div id="a38351" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">within our health care distribution segment included companies that<div style="display:inline-block;width:2px">&nbsp;</div>specialize in the distribution of dental products. </div><div id="a38354" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">Within our technology and value-added services segment, we acquired a company that educates and<div style="display:inline-block;width:2px">&nbsp;</div>connects </div><div id="a38357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">dental office managers, practice administrators and dental business leaders across<div style="display:inline-block;width:2px">&nbsp;</div>North America.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a38361" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">The following table aggregates the estimated fair value, as of the<div style="display:inline-block;width:2px">&nbsp;</div>date of acquisition, of consideration paid and net </div><div id="a38362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">assets acquired for acquisitions during the year ended December 31, 2022.<div style="display:inline-block;width:6px">&nbsp;</div>Approximately half of the acquired </div><div id="a38364" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">goodwill is deductible for tax purposes.</div></div></ix:continuation></div><div id="div_691_XBRL_TS_c96f0585c735404f8f8f0790499ee3a1" style="position:absolute;left:65px;top:317px;float:left;"><ix:nonnumeric id="ID_c96f0585c735404f8f8f0790499ee3a1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_84dfa9de008041e1812fc4a53570faa1" escape="true"><div id="TextBlockContainer694" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:310px;"><div id="div_692_XBRL_TS_072e4eebba7a440099997a226b333636" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_072e4eebba7a440099997a226b333636" continuedat="XBRL_TS_c35e8915dbd64a1e98c62f6c7b22fdc1"><div id="TextBlockContainer693" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:310px;"><div id="a38369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:376px;top:0px;">2022 </div><div id="a38371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">Acquisition consideration: </div><div id="a38375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Cash </div><div id="a38377" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:35px;">$ </div><div id="a38379" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:35px;"><ix:nonfraction id="ID_913" name="us-gaap:PaymentsToAcquireBusinessesGross" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">158</ix:nonfraction></div><div id="a38381" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Deferred consideration </div><div id="a38384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:53px;"><ix:nonfraction id="ID_1216" name="hsic:BusinessCombinationConsiderationTransferredDeferredConsideration" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a38386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Fair value of previously held equity method investment </div><div id="a38389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:70px;"><ix:nonfraction id="ID_1217" name="hsic:BusinessCombinationConsiderationTransferredFairValuePreviouslyHeldEquity" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction></div><div id="a38391" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Redeemable noncontrolling interests </div><div id="a38394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:88px;"><ix:nonfraction id="ID_914" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">17</ix:nonfraction></div><div id="a38396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Total consideration </div><div id="a38398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:106px;">$ </div><div id="a38400" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:106px;"><ix:nonfraction id="ID_915" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">193</ix:nonfraction></div><div id="a38405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:135px;">Identifiable assets acquired and liabilities assumed: </div><div id="a38409" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:152px;">Current assets </div><div id="a38411" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:152px;">$ </div><div id="a38413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:152px;"><ix:nonfraction id="ID_916" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a38415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">Intangible assets </div><div id="a38418" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:170px;"><ix:nonfraction id="ID_917" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction></div><div id="a38420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:188px;">Other noncurrent assets </div><div id="a38423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:188px;"><ix:nonfraction id="ID_918" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a38425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:205px;">Current liabilities </div><div id="a38428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:205px;display:flex;">(<ix:nonfraction id="ID_919" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction>)</div><div id="a38430" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">Deferred income taxes </div><div id="a38433" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:223px;display:flex;">(<ix:nonfraction id="ID_920" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a38435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:240px;">Other noncurrent liabilities </div><div id="a38438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:240px;display:flex;">(<ix:nonfraction id="ID_921" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction>)</div><div id="a38440" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:258px;">Total identifiable<div style="display:inline-block;width:5px">&nbsp;</div>net assets </div><div id="a38443" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:258px;"><ix:nonfraction id="ID_922" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">107</ix:nonfraction></div><div id="a38445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:276px;">Goodwill </div><div id="a38448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:276px;"><ix:nonfraction id="ID_923" name="us-gaap:Goodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">86</ix:nonfraction></div><div id="a38450" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:294px;">Total net assets acquired </div><div id="a38452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:294px;">$ </div><div id="a38454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:294px;"><ix:nonfraction id="ID_924" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">193</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_695_XBRL_TS_c35e8915dbd64a1e98c62f6c7b22fdc1" style="position:absolute;left:62px;top:646px;float:left;"><ix:continuation id="XBRL_TS_c35e8915dbd64a1e98c62f6c7b22fdc1" continuedat="XBRL_TS_ff802b5dab3944ceba21071fffad0dbe"><div id="TextBlockContainer696" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:668px;height:34px;"><div id="a38457" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes the identifiable intangible assets acquired during<div style="display:inline-block;width:2px">&nbsp;</div>the year ended December 31, </div><div id="a38459" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">2022 and their estimated useful lives as of the date of the acquisition:</div></div></ix:continuation></div><div id="a38459_72_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:474px;top:662px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_697_XBRL_TS_ff802b5dab3944ceba21071fffad0dbe" style="position:absolute;left:74px;top:700px;float:left;"><ix:continuation id="XBRL_TS_ff802b5dab3944ceba21071fffad0dbe" continuedat="XBRL_TS_c2aec3eed0a54eecb0c5bbc11ad646a1"><div id="TextBlockContainer700" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:151px;"><div id="div_698_XBRL_TS_df2616dc66834ef0b8c27437ea313704" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_df2616dc66834ef0b8c27437ea313704" name="us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_9fe868e9bfd44f8ca3848e905ee87a1e" escape="true"><div id="TextBlockContainer699" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:151px;"><div id="a38467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:0px;">Estimated </div><div id="a38472" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:19px;">Useful Lives </div><div id="a38476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:368px;top:38px;">2022 </div><div id="a38478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:38px;">(in years) </div><div id="a38480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:58px;">Customer relationships and lists </div><div id="a38483" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:58px;"><ix:nonfraction id="ID_927" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">81</ix:nonfraction></div><div id="a38485" style="position:absolute;font-family:'Times New Roman';left:450px;top:58px;"><ix:nonnumeric id="ID_931" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">8</ix:nonnumeric></div><div id="a38485_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:58px;">-</div><div id="a38485_2_2" style="position:absolute;font-family:'Times New Roman';left:461px;top:58px;"><ix:nonnumeric id="ID_932" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">12</ix:nonnumeric></div><div id="a38489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Trademark / Tradename </div><div id="a38492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:77px;"><ix:nonfraction id="ID_925" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a38494" style="position:absolute;font-family:'Times New Roman';left:459px;top:77px;"><ix:nonnumeric id="ID_1485" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Non-compete agreements </div><div id="a38501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:96px;"><ix:nonfraction id="ID_926" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a38503" style="position:absolute;font-family:'Times New Roman';left:453px;top:96px;"><ix:nonnumeric id="ID_1486" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">2</ix:nonnumeric></div><div id="a38503_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:460px;top:96px;">-</div><div id="a38503_2_1" style="position:absolute;font-family:'Times New Roman';left:465px;top:96px;"><ix:nonnumeric id="ID_930" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38507" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Other </div><div id="a38510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:115px;"><ix:nonfraction id="ID_928" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a38512" style="position:absolute;font-family:'Times New Roman';left:456px;top:115px;"><ix:nonnumeric id="ID_1375" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a38515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:135px;">$ </div><div id="a38517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:135px;"><ix:nonfraction id="ID_929" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_701_XBRL_TS_c2aec3eed0a54eecb0c5bbc11ad646a1" style="position:absolute;left:62px;top:870px;float:left;"><ix:continuation id="XBRL_TS_c2aec3eed0a54eecb0c5bbc11ad646a1" continuedat="XBRL_TS_b8f9dabb43e241a0ad02240e718ea1a4"><div id="TextBlockContainer702" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:102px;"><div id="a38521" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The accounting for certain of our acquisitions during the year ended December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022 had not been completed in </div><div id="a38522" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">several areas, including but not limited to pending assessments of accounts<div style="display:inline-block;width:2px">&nbsp;</div>receivable, inventory, intangible assets, </div><div id="a38523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">right-of-use lease assets,<div style="display:inline-block;width:3px">&nbsp;</div>accrued liabilities and income and non-income based taxes. </div><div id="a38532" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">The pro forma financial information has not been presented because the impact<div style="display:inline-block;width:2px">&nbsp;</div>of the acquisitions during the year </div><div id="a38536" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">ended December 31, 2022 to our consolidated financial statements was immaterial.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page83" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:79.1px; height:1px; left:414.9px; top:364.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:385.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.4px; left:398.9px; top:385.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:382.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:385.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:420.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:418.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.4px; left:418px; top:420.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:455.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:453.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:455.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:470.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:5.7px; left:67.2px; top:493.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:9.6px; left:67.2px; top:489.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19px; height:6.7px; left:396.2px; top:492.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:489.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:491.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:491.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:519.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:519.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:517.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:519.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:555.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:552.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:555.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:590.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:587.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.2px; left:418px; top:590.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:625.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:16.6px; left:67.2px; top:624.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:625.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:1px; left:66.8px; top:622.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:622.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:661.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:661.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.4px; left:67.2px; top:659.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:661.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:1px; left:66.8px; top:657.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:657.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:678.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:676.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:808.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.4px; left:398.9px; top:808.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:808.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:18.2px; left:67.2px; top:805.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:808.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:19.2px; left:67.2px; top:804.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:1px; left:66.8px; top:804.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:163.1px; height:1px; left:414.9px; top:804.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:847.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:847.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19.2px; left:67.2px; top:843.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:847.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:885.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:885.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19.2px; left:67.2px; top:881.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:885.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.8px; top:900.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:923px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:921.1px; background-color:#000000; ">&nbsp;</div>
<div id="a38539" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a38541" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a38543" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a38545" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a38548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">83 </div><div id="div_703_XBRL_TS_b8f9dabb43e241a0ad02240e718ea1a4" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_b8f9dabb43e241a0ad02240e718ea1a4" continuedat="XBRL_TS_788bff0062c145cd859f1190911d6650"><div id="TextBlockContainer704" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:685px;height:220px;"><div id="a38550" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">2021 Acquisitions</div><div id="a38555" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We completed several acquisitions during the year ended December 25, 2021, which were immaterial to our </div><div id="a38559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>Our acquired ownership interests ranged from between approximately </div><div id="a38559_90_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:51px;"><ix:nonfraction id="ID_1489" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">51</ix:nonfraction></div><div id="a38559_92_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:51px;">% to </div><div id="a38559_97_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:51px;"><ix:nonfraction id="ID_1490" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">100</ix:nonfraction></div><div id="a38559_100_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:615px;top:51px;">%.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Acquisitions within our health care distribution segment included companies<div style="display:inline-block;width:2px">&nbsp;</div>that specialize in the distribution and </div><div id="a38562" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">manufacturing of dental and medical products, a provider of home<div style="display:inline-block;width:2px">&nbsp;</div>medical supplies, and a provider of product </div><div id="a38563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">kitting and sterile packaging.<div style="display:inline-block;width:7px">&nbsp;</div>Within our technology and value-added services segment, we acquired companies </div><div id="a38566" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">that focus on dental marketing and website solutions, practice transition<div style="display:inline-block;width:2px">&nbsp;</div>services, revenue cycle management, and </div><div id="a38568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">business analytics and intelligence software.<div style="display:inline-block;width:7px">&nbsp;</div>Approximately half of the acquired goodwill is deductible for tax </div><div id="a38569" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">purposes.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a38574" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">The following table aggregates the estimated fair value, as of the date of<div style="display:inline-block;width:2px">&nbsp;</div>acquisition, of consideration paid and net </div><div id="a38576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">assets acquired for acquisitions during the year ended December 25, 2021.</div></div></ix:continuation></div><div id="div_705_XBRL_TS_84dfa9de008041e1812fc4a53570faa1" style="position:absolute;left:65px;top:350px;float:left;"><ix:continuation id="XBRL_TS_84dfa9de008041e1812fc4a53570faa1" continuedat="XBRL_TS_27f0cb84190341629d7c10c584d248a3"><div id="TextBlockContainer708" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:327px;"><div id="div_706_XBRL_TS_788bff0062c145cd859f1190911d6650" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_788bff0062c145cd859f1190911d6650" continuedat="XBRL_TS_5ce765dd72d44b73a1a830ef62a3ff3f"><div id="TextBlockContainer707" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:327px;"><div id="a38581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:376px;top:0px;">2021 </div><div id="a38583" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">Acquisition consideration: </div><div id="a38587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Cash </div><div id="a38589" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:35px;">$ </div><div id="a38591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:35px;"><ix:nonfraction id="ID_1491" name="us-gaap:PaymentsToAcquireBusinessesGross" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">579</ix:nonfraction></div><div id="a38593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Deferred consideration </div><div id="a38596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:53px;"><ix:nonfraction id="ID_1492" name="hsic:BusinessCombinationConsiderationTransferredDeferredConsideration" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a38598" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Estimated fair value of contingent consideration receivable </div><div id="a38602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:70px;display:flex;">(<ix:nonfraction id="ID_1493" name="hsic:BusinessCombinationConsiderationTransferredContingentConsiderationReceivable" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction>)</div><div id="a38604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Fair value of previously held equity method investment </div><div id="a38607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:88px;"><ix:nonfraction id="ID_1494" name="hsic:BusinessCombinationConsiderationTransferredFairValuePreviouslyHeldEquity" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a38609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Redeemable noncontrolling interests </div><div id="a38612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:106px;"><ix:nonfraction id="ID_1495" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">181</ix:nonfraction></div><div id="a38614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:124px;">Total consideration </div><div id="a38616" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:124px;">$ </div><div id="a38618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:124px;"><ix:nonfraction id="ID_1496" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">774</ix:nonfraction></div><div id="a38623" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:152px;">Identifiable assets acquired and liabilities assumed: </div><div id="a38627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">Current assets </div><div id="a38629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:170px;">$ </div><div id="a38631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:170px;"><ix:nonfraction id="ID_1497" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">195</ix:nonfraction></div><div id="a38633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:187px;">Intangible assets </div><div id="a38636" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:187px;"><ix:nonfraction id="ID_1498" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">317</ix:nonfraction></div><div id="a38638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:205px;">Other noncurrent assets </div><div id="a38641" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:205px;"><ix:nonfraction id="ID_1499" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction></div><div id="a38643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">Current liabilities </div><div id="a38646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:223px;display:flex;">(<ix:nonfraction id="ID_1500" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">93</ix:nonfraction>)</div><div id="a38648" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:240px;">Deferred income taxes </div><div id="a38651" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:240px;display:flex;">(<ix:nonfraction id="ID_1501" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">26</ix:nonfraction>)</div><div id="a38653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:258px;">Other noncurrent liabilities </div><div id="a38656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:258px;display:flex;">(<ix:nonfraction id="ID_1502" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction>)</div><div id="a38658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:275px;">Total identifiable<div style="display:inline-block;width:5px">&nbsp;</div>net assets </div><div id="a38661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:275px;"><ix:nonfraction id="ID_1503" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">398</ix:nonfraction></div><div id="a38663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:293px;">Goodwill </div><div id="a38666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:293px;"><ix:nonfraction id="ID_1504" name="us-gaap:Goodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">376</ix:nonfraction></div><div id="a38668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:311px;">Total net assets acquired </div><div id="a38670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:311px;">$ </div><div id="a38672" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:402px;top:311px;"><ix:nonfraction id="ID_1505" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">774</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div><div id="div_709_XBRL_TS_5ce765dd72d44b73a1a830ef62a3ff3f" style="position:absolute;left:62px;top:697px;float:left;"><ix:continuation id="XBRL_TS_5ce765dd72d44b73a1a830ef62a3ff3f" continuedat="XBRL_TS_00debb4f9d884d7aa16594a035cbd014"><div id="TextBlockContainer710" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:668px;height:35px;"><div id="a38675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes the identifiable intangible assets acquired during<div style="display:inline-block;width:2px">&nbsp;</div>the year ended December 25, </div><div id="a38677" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">2021 and their estimated useful lives as of the date of the acquisition:</div></div></ix:continuation></div><div id="a38677_72_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:474px;top:714px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_711_XBRL_TS_9fe868e9bfd44f8ca3848e905ee87a1e" style="position:absolute;left:74px;top:751px;float:left;"><ix:continuation id="XBRL_TS_9fe868e9bfd44f8ca3848e905ee87a1e" continuedat="XBRL_TS_cdf4a18f186f4dedab2bf646f0d6a33d"><div id="TextBlockContainer714" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:171px;"><div id="div_712_XBRL_TS_00debb4f9d884d7aa16594a035cbd014" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_00debb4f9d884d7aa16594a035cbd014" continuedat="XBRL_TS_30f3213eeb7649258775c0ec5e0f7619"><div id="TextBlockContainer713" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:171px;"><div id="a38684" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:0px;">Estimated </div><div id="a38689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:19px;">Useful Lives </div><div id="a38693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:368px;top:38px;">2021 </div><div id="a38695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:38px;">(in years) </div><div id="a38697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:58px;">Customer relationships and lists </div><div id="a38700" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:58px;">$ </div><div id="a38702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:58px;"><ix:nonfraction id="ID_1522" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">220</ix:nonfraction></div><div id="a38704" style="position:absolute;font-family:'Times New Roman';left:450px;top:58px;"><ix:nonnumeric id="ID_1536" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38704_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:58px;">-</div><div id="a38704_2_2" style="position:absolute;font-family:'Times New Roman';left:461px;top:58px;"><ix:nonnumeric id="ID_1537" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">12</ix:nonnumeric></div><div id="a38708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Trademark / Tradename </div><div id="a38711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:77px;"><ix:nonfraction id="ID_1520" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">58</ix:nonfraction></div><div id="a38713" style="position:absolute;font-family:'Times New Roman';left:450px;top:77px;"><ix:nonnumeric id="ID_1532" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38713_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:77px;">-</div><div id="a38713_2_2" style="position:absolute;font-family:'Times New Roman';left:461px;top:77px;"><ix:nonnumeric id="ID_1533" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" format="ixt-sec:duryear">12</ix:nonnumeric></div><div id="a38717" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Product development </div><div id="a38720" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:96px;"><ix:nonfraction id="ID_1523" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction></div><div id="a38722" style="position:absolute;font-family:'Times New Roman';left:450px;top:96px;"><ix:nonnumeric id="ID_1538" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38722_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:96px;">-</div><div id="a38722_2_2" style="position:absolute;font-family:'Times New Roman';left:461px;top:96px;"><ix:nonnumeric id="ID_1539" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a38726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Non-compete agreements </div><div id="a38731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:115px;"><ix:nonfraction id="ID_1521" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a38733" style="position:absolute;font-family:'Times New Roman';left:453px;top:115px;"><ix:nonnumeric id="ID_1534" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">3</ix:nonnumeric></div><div id="a38733_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:460px;top:115px;">-</div><div id="a38733_2_1" style="position:absolute;font-family:'Times New Roman';left:465px;top:115px;"><ix:nonnumeric id="ID_1535" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38737" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:134px;">Other </div><div id="a38740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:134px;"><ix:nonfraction id="ID_1524" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a38742" style="position:absolute;font-family:'Times New Roman';left:456px;top:134px;"><ix:nonnumeric id="ID_1531" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" format="ixt-sec:duryear">18</ix:nonnumeric></div><div id="a38745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:154px;">$ </div><div id="a38747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:154px;"><ix:nonfraction id="ID_1525" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">317</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page84" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:79.1px; height:1px; left:414.9px; top:331.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:349.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:351.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:386.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:384.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:386.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.2px; left:69.9px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.2px; left:398.9px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.4px; left:67.2px; top:420.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.2px; left:418px; top:422.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:1px; left:66.8px; top:419.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:419.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:438px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:396.2px; top:439.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:450.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:18.7px; left:67.2px; top:447.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:15.4px; left:396.2px; top:450.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:486.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:483.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:486.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:519.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.4px; left:418px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:556.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:554.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:73.6px; height:15.4px; left:418px; top:556.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:571.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:323.7px; height:15.4px; left:69.9px; top:591.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:427.1px; height:17.6px; left:67.2px; top:589.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.6px; height:15.4px; left:418px; top:591.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:98.1px; height:1px; left:395.8px; top:606.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:627.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.3px; top:625.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.4px; left:398.9px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:18.2px; left:67.2px; top:754.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:757.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:19.2px; left:67.2px; top:753.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:348.1px; height:1px; left:66.8px; top:753.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:163.1px; height:1px; left:414.9px; top:753.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:314.8px; height:15.4px; left:78.9px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19.2px; left:67.2px; top:792px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77.6px; height:15.4px; left:498px; top:795.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.1px; height:15.4px; left:76.2px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:13.6px; height:15.4px; left:398.9px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.6px; height:15.4px; left:418px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:511.1px; height:19px; left:67.2px; top:831.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:329px; height:20px; left:67.2px; top:830.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:99.1px; height:1px; left:395.8px; top:830px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:83px; height:20px; left:495.3px; top:830.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:852.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:395.3px; top:850.5px; background-color:#000000; ">&nbsp;</div>
<div id="a38750" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a38752" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a38754" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a38756" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a38759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">84 </div><div id="div_715_XBRL_TS_30f3213eeb7649258775c0ec5e0f7619" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_30f3213eeb7649258775c0ec5e0f7619" continuedat="XBRL_TS_3e1c6b4d691241c18a8ad8f2d918555d"><div id="TextBlockContainer716" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:187px;"><div id="a38761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">2020 Acquisitions</div><div id="a38764" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We completed several acquisitions during the year ended December 26, 2020, which were immaterial to our </div><div id="a38765" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>Our acquired ownership interests ranged from between approximately </div><div id="a38765_90_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:51px;"><ix:nonfraction id="ID_1546" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">51</ix:nonfraction></div><div id="a38765_92_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:51px;">% to </div><div id="a38765_97_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:51px;"><ix:nonfraction id="ID_1547" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextref="AS_OF_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">100</ix:nonfraction></div><div id="a38765_100_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:615px;top:51px;">%.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38766" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Acquisitions within our health care distribution segment included companies<div style="display:inline-block;width:2px">&nbsp;</div>that manufacture endodontic files and </div><div id="a38769" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">companies that distribute dental supplies.<div style="display:inline-block;width:7px">&nbsp;</div>Within our technology and value-added services segment, we acquired </div><div id="a38772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">companies that focus on practice management software and provide software<div style="display:inline-block;width:2px">&nbsp;</div>as a solution for dental practices.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a38775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">Approximately half of the acquired goodwill is deductible for tax purposes.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a38777" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a38780" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">The following table aggregates the estimated fair value, as of the<div style="display:inline-block;width:2px">&nbsp;</div>date of acquisition, of consideration paid and net </div><div id="a38781" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">assets acquired for acquisitions during the year ended December 26, 2020:</div></div></ix:continuation></div><div id="div_717_XBRL_TS_3e1c6b4d691241c18a8ad8f2d918555d" style="position:absolute;left:65px;top:317px;float:left;"><ix:continuation id="XBRL_TS_3e1c6b4d691241c18a8ad8f2d918555d" continuedat="XBRL_TS_8e2ba06a793a4f22b765405699d80a01"><div id="TextBlockContainer720" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:310px;"><div id="div_718_XBRL_TS_27f0cb84190341629d7c10c584d248a3" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_27f0cb84190341629d7c10c584d248a3"><div id="TextBlockContainer719" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:431px;height:310px;"><div id="a38787" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:376px;top:0px;">2020 </div><div id="a38789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:18px;">Acquisition consideration: </div><div id="a38793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:35px;">Cash </div><div id="a38795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:35px;">$ </div><div id="a38797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:35px;"><ix:nonfraction id="ID_1506" name="us-gaap:PaymentsToAcquireBusinessesGross" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">52</ix:nonfraction></div><div id="a38799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Deferred consideration </div><div id="a38802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:53px;"><ix:nonfraction id="ID_1507" name="hsic:BusinessCombinationConsiderationTransferredDeferredConsideration" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a38804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Fair value of previously held equity method investment </div><div id="a38807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:70px;"><ix:nonfraction id="ID_1508" name="hsic:BusinessCombinationConsiderationTransferredFairValuePreviouslyHeldEquity" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a38809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Redeemable noncontrolling interests </div><div id="a38812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:88px;"><ix:nonfraction id="ID_1509" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">26</ix:nonfraction></div><div id="a38814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Total consideration </div><div id="a38817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:106px;">$ </div><div id="a38819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:106px;"><ix:nonfraction id="ID_1510" name="us-gaap:BusinessCombinationConsiderationTransferred1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">93</ix:nonfraction></div><div id="a38824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:135px;">Identifiable assets acquired and liabilities assumed: </div><div id="a38828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:152px;">Current assets </div><div id="a38830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:152px;">$ </div><div id="a38832" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:152px;"><ix:nonfraction id="ID_1511" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction></div><div id="a38834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:170px;">Intangible assets </div><div id="a38837" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:170px;"><ix:nonfraction id="ID_1512" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction></div><div id="a38839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:188px;">Other noncurrent assets </div><div id="a38842" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:188px;"><ix:nonfraction id="ID_1513" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">22</ix:nonfraction></div><div id="a38844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:205px;">Current liabilities </div><div id="a38847" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:205px;display:flex;">(<ix:nonfraction id="ID_1514" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction>)</div><div id="a38849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:223px;">Deferred income taxes </div><div id="a38852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:223px;display:flex;">(<ix:nonfraction id="ID_1515" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction>)</div><div id="a38854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:240px;">Other noncurrent liabilities </div><div id="a38857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:240px;display:flex;">(<ix:nonfraction id="ID_1516" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a38859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:258px;">Total identifiable<div style="display:inline-block;width:5px">&nbsp;</div>net assets </div><div id="a38863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:258px;"><ix:nonfraction id="ID_1517" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">70</ix:nonfraction></div><div id="a38865" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:276px;">Goodwill </div><div id="a38868" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:276px;"><ix:nonfraction id="ID_1518" name="us-gaap:Goodwill" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a38870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:294px;">Total net assets acquired </div><div id="a38872" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:333px;top:294px;">$ </div><div id="a38874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:409px;top:294px;"><ix:nonfraction id="ID_1519" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">93</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div><div id="div_721_XBRL_TS_8e2ba06a793a4f22b765405699d80a01" style="position:absolute;left:62px;top:646px;float:left;"><ix:continuation id="XBRL_TS_8e2ba06a793a4f22b765405699d80a01" continuedat="XBRL_TS_3303cce665c44f388737d980c34e7c45"><div id="TextBlockContainer722" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:668px;height:34px;"><div id="a38877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes the identifiable intangible assets acquired during<div style="display:inline-block;width:2px">&nbsp;</div>the year ended December 26, </div><div id="a38879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">2020 and their estimated useful lives as of the date of the acquisition:</div></div></ix:continuation></div><div id="a38879_72_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:474px;top:662px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_723_XBRL_TS_cdf4a18f186f4dedab2bf646f0d6a33d" style="position:absolute;left:74px;top:700px;float:left;"><ix:continuation id="XBRL_TS_cdf4a18f186f4dedab2bf646f0d6a33d"><div id="TextBlockContainer726" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:151px;"><div id="div_724_XBRL_TS_3303cce665c44f388737d980c34e7c45" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_3303cce665c44f388737d980c34e7c45" continuedat="XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7"><div id="TextBlockContainer725" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:505px;height:151px;"><div id="a38887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:0px;">Estimated </div><div id="a38892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:19px;">Useful Lives </div><div id="a38896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:368px;top:38px;">2020 </div><div id="a38898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:437px;top:38px;">(in years) </div><div id="a38900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:58px;">Customer relationships and lists </div><div id="a38902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:58px;">$ </div><div id="a38904" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:58px;"><ix:nonfraction id="ID_1528" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a38906" style="position:absolute;font-family:'Times New Roman';left:447px;top:58px;"><ix:nonnumeric id="ID_1542" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a38906_2_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:460px;top:58px;">-</div><div id="a38906_3_2" style="position:absolute;font-family:'Times New Roman';left:465px;top:58px;"><ix:nonnumeric id="ID_1543" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">12</ix:nonnumeric></div><div id="a38910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Product development </div><div id="a38913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:77px;"><ix:nonfraction id="ID_1529" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a38915" style="position:absolute;font-family:'Times New Roman';left:450px;top:77px;"><ix:nonnumeric id="ID_1544" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" format="ixt-sec:duryear">7</ix:nonnumeric></div><div id="a38915_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:77px;">-</div><div id="a38915_2_2" style="position:absolute;font-family:'Times New Roman';left:461px;top:77px;"><ix:nonnumeric id="ID_1545" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_ProductDevelopmentMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a38919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Trademark / Tradename </div><div id="a38922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:96px;"><ix:nonfraction id="ID_1526" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a38924" style="position:absolute;font-family:'Times New Roman';left:459px;top:96px;"><ix:nonnumeric id="ID_1540" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_hsic_TrademarkAndTradenameMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Non-compete agreements </div><div id="a38931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:115px;"><ix:nonfraction id="ID_1527" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a38933" style="position:absolute;font-family:'Times New Roman';left:459px;top:115px;"><ix:nonnumeric id="ID_1541" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a38936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:324px;top:135px;">$ </div><div id="a38938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:135px;"><ix:nonfraction id="ID_1530" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div><div id="div_727_XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7" style="position:absolute;left:62px;top:870px;float:left;"><ix:continuation id="XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7" continuedat="XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7_1"><div id="TextBlockContainer728" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:102px;"><div id="a38942" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">For the years ended December 31, 2022, December 25, 2021 and December 26,<div style="display:inline-block;width:2px">&nbsp;</div>2020, there were no material </div><div id="a38944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">adjustments recorded in our consolidated balance sheets relating to<div style="display:inline-block;width:2px">&nbsp;</div>accounting for acquisitions incomplete in prior </div><div id="a38945" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">periods.<div style="display:inline-block;width:7px">&nbsp;</div>At December 25, 2021 we recorded an estimated contingent<div style="display:inline-block;width:2px">&nbsp;</div>consideration receivable of $</div><div id="a38945_96_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:585px;top:34px;"><ix:nonfraction id="ID_1740" name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a38945_97_16" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, which </div><div id="a38947" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">was subsequently increased by additional $</div><div id="a38947_42_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:259px;top:51px;"><ix:nonfraction id="ID_1741" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a38947_43_70" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:266px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million during 2022 based on delays in timing of government approval </div><div id="a38948" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">of a certain product. </div><div id="a38950" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page85" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:370.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:370.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:368.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:528.3px; top:369.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:368.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:638.4px; top:369.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:368.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:409.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:409.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:449.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:449.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:16.8px; left:67.2px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:490.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:571.1px; height:15.4px; left:177.1px; top:494px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:27.1px; height:20px; left:67.2px; top:489.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:488.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:528.3px; top:489.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:488.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:638.4px; top:489.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:488.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:530.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:654px; height:15.2px; left:94.3px; top:535.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:21px; left:67.2px; top:529.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:528.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:528.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:21px; left:638.4px; top:529.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:528.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:550.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:552.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:550.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:552.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:612.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:612.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:611.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:528.3px; top:611.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:611.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:20px; left:638.4px; top:611.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:109.9px; height:1px; left:638px; top:611.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:651.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:651.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a38952" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a38954" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a38956" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a38958" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a38961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">85 </div><div id="div_729_XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_6e9754d37fd846c6a9ce656df2c325c7_1"><div id="TextBlockContainer730" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:153px;"><div id="a38963" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">During the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and December 26, 2020 we incurred $</div><div id="a38963_95_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:0px;"><ix:nonfraction id="ID_1548" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a38963_96_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a38963_107_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:0px;"><ix:nonfraction id="ID_1549" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a38968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">million and $</div><div id="a38968_13_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:83px;top:17px;"><ix:nonfraction id="ID_1550" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a38968_14_81" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:91px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million in acquisition costs reported within income from continuing<div style="display:inline-block;width:2px">&nbsp;</div>operations. </div><div id="a38970" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:51px;">Divestiture </div><div id="a38974" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a38976" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">In the third quarter of 2021 we received contingent proceeds of $</div><div id="a38976_65_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:387px;top:84px;"><ix:nonfraction id="ID_1551" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextref="FROM_Jun27_2021_TO_Sep25_2021_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a38976_67_42" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>million from the 2019 sale of Hu-Friedy, </div><div id="a38981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">resulting in the recognition of an additional after-tax gain of $</div><div id="a38981_65_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:368px;top:101px;"><ix:nonfraction id="ID_1552" name="hsic:EquityMethodInvestmentNonOperatingGainLossOnDisposal" contextref="FROM_Jun27_2021_TO_Sep25_2021_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a38981_66_48" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:101px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>During the fourth quarter of 2020 we </div><div id="a38984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">received contingent proceeds of $</div><div id="a38984_33_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:203px;top:118px;"><ix:nonfraction id="ID_1553" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" contextref="FROM_Sep27_2020_TO_Dec26_2020_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a38984_34_77" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:210px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>million from the 2019 sale of Hu-Friedy, resulting in the recognition of an </div><div id="a38988" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">additional after-tax gain of $</div><div id="a38988_30_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:173px;top:135px;"><ix:nonfraction id="ID_1554" name="hsic:EquityMethodInvestmentNonOperatingGainLossOnDisposal" contextref="FROM_Sep27_2020_TO_Dec26_2020_Entity_0001000228_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_hsic_HuFriedyMfgCoLlcMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a38988_31_86" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:180px;top:135px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>We do expect to receive any additional proceeds from the sale of Hu-Friedy.</div></div></ix:continuation></div><div id="div_731_XBRL_CS_f5066ceaefcf4d18852e3d49d44fae93" style="position:absolute;left:62px;top:281px;float:left;"><ix:nonnumeric id="ID_f5066ceaefcf4d18852e3d49d44fae93" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_2e1cb73675e548bf9a9439e9df6ca399" escape="true"><div id="TextBlockContainer732" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:553px;height:50px;"><div id="a38995" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 5 – Property and Equipment, Net </div><div id="a39000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a39001" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Property and equipment, including related estimated useful lives, consisted<div style="display:inline-block;width:2px">&nbsp;</div>of the following:</div></div></ix:nonnumeric></div><div id="div_733_XBRL_CS_3f20417dc437445d9bf1ed95c4e69a65" style="position:absolute;left:63px;top:334px;float:left;"><ix:nonnumeric id="ID_62" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer736" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:357px;"><div id="div_734_XBRL_CS_2e1cb73675e548bf9a9439e9df6ca399" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_2e1cb73675e548bf9a9439e9df6ca399" continuedat="XBRL_CS_27c9dd75a0574678b2dc8dba7005425b"><div id="TextBlockContainer735" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:357px;"><div id="a39011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:0px;">December 31, </div><div id="a39014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">December 25, </div><div id="a39020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:20px;">2022 </div><div id="a39023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:20px;">2021 </div><div id="a39025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">Land<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a39028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:40px;">$ </div><div id="a39030" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:40px;"><ix:nonfraction id="ID_119" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a39033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:40px;">$ </div><div id="a39035" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:40px;"><ix:nonfraction id="ID_103" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a39037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Buildings and permanent improvements<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:60px;"><ix:nonfraction id="ID_399" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">135</ix:nonfraction></div><div id="a39045" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:60px;"><ix:nonfraction id="ID_296" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">140</ix:nonfraction></div><div id="a39047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Leasehold improvements<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:80px;"><ix:nonfraction id="ID_365" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">94</ix:nonfraction></div><div id="a39055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:80px;"><ix:nonfraction id="ID_309" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">98</ix:nonfraction></div><div id="a39057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Machinery and warehouse equipment<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:100px;"><ix:nonfraction id="ID_192" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">169</ix:nonfraction></div><div id="a39065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:100px;"><ix:nonfraction id="ID_121" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">153</ix:nonfraction></div><div id="a39067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">Furniture, fixtures and other<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:120px;"><ix:nonfraction id="ID_149" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">127</ix:nonfraction></div><div id="a39075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:120px;"><ix:nonfraction id="ID_420" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">119</ix:nonfraction></div><div id="a39077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:140px;">Computer equipment and software<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:140px;"><ix:nonfraction id="ID_392" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">411</ix:nonfraction></div><div id="a39085" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:140px;"><ix:nonfraction id="ID_333" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">385</ix:nonfraction></div><div id="a39092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:160px;"><ix:nonfraction id="ID_382" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">956</ix:nonfraction></div><div id="a39096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:160px;"><ix:nonfraction id="ID_37" name="us-gaap:PropertyPlantAndEquipmentGross" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">916</ix:nonfraction></div><div id="a39098" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:180px;">Less accumulated depreciation<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:180px;display:flex;">(<ix:nonfraction id="ID_115" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">573</ix:nonfraction>)</div><div id="a39106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:180px;display:flex;">(<ix:nonfraction id="ID_137" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">550</ix:nonfraction>)</div><div id="a39109" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:201px;">Property and equipment, net<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39112" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:201px;">$ </div><div id="a39114" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:201px;"><ix:nonfraction id="ID_439A" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">383</ix:nonfraction></div><div id="a39117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:201px;">$ </div><div id="a39119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:201px;"><ix:nonfraction id="ID_379A" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">366</ix:nonfraction></div><div id="a39134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:242px;">Estimated Useful </div><div id="a39143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:484px;top:262px;">Lives (in years) </div><div id="a39149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:282px;">Buildings and permanent improvements<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39152" style="position:absolute;font-family:'Times New Roman';left:519px;top:282px;"><ix:nonnumeric id="ID_431" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" format="ixt-sec:duryear">40</ix:nonnumeric></div><div id="a39157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:302px;">Machinery and warehouse equipment<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39160" style="position:absolute;font-family:'Times New Roman';left:513px;top:302px;"><ix:nonnumeric id="ID_285" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear">5</ix:nonnumeric></div><div id="a39160_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:302px;">-</div><div id="a39160_2_2" style="position:absolute;font-family:'Times New Roman';left:525px;top:302px;"><ix:nonnumeric id="ID_124" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a39167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:322px;">Furniture, fixtures and other<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39170" style="position:absolute;font-family:'Times New Roman';left:513px;top:322px;"><ix:nonnumeric id="ID_270" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear">3</ix:nonnumeric></div><div id="a39170_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:322px;">-</div><div id="a39170_2_2" style="position:absolute;font-family:'Times New Roman';left:525px;top:322px;"><ix:nonnumeric id="ID_98" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear">10</ix:nonnumeric></div><div id="a39177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:342px;">Computer equipment and software<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39180" style="position:absolute;font-family:'Times New Roman';left:513px;top:342px;"><ix:nonnumeric id="ID_140" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember" format="ixt-sec:duryear">3</ix:nonnumeric></div><div id="a39180_1_1" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:520px;top:342px;">-</div><div id="a39180_2_2" style="position:absolute;font-family:'Times New Roman';left:525px;top:342px;"><ix:nonnumeric id="ID_16" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_hsic_ComputerEquipmentAndSoftwareMember" format="ixt-sec:duryear">10</ix:nonnumeric></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_737_XBRL_CS_27c9dd75a0574678b2dc8dba7005425b" style="position:absolute;left:62px;top:708px;float:left;"><ix:continuation id="XBRL_CS_27c9dd75a0574678b2dc8dba7005425b"><div id="TextBlockContainer738" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:684px;height:85px;"><div id="a39188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Amortization of leasehold improvements is computed using the straight-line<div style="display:inline-block;width:2px">&nbsp;</div>method over the lesser of the useful </div><div id="a39192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">life of the assets or the lease term. </div><div id="a39195" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">Property and equipment related depreciation expense for the years<div style="display:inline-block;width:2px">&nbsp;</div>ended December 31, 2022, December 25, 2021 </div><div id="a39200" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">and December 26, 2020 was $</div><div id="a39200_27_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:68px;"><ix:nonfraction id="ID_188" name="us-gaap:Depreciation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">68</ix:nonfraction></div><div id="a39200_29_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:197px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a39200_40_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:258px;top:68px;"><ix:nonfraction id="ID_12" name="us-gaap:Depreciation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">71</ix:nonfraction></div><div id="a39200_42_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>million<div style="display:inline-block;width:7px">&nbsp;</div>and $</div><div id="a39200_57_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:358px;top:68px;"><ix:nonfraction id="ID_145" name="us-gaap:Depreciation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">64</ix:nonfraction></div><div id="a39200_59_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.</div></div></ix:continuation></div><div id="a39200_82_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:563px;top:776px;"><div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a39216" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:634px;top:776px;"><a href="#a39241" style="color:#0000FF;text-decoration:underline;">Note 6 – Leases</a></div><div id="a39220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:728px;top:776px;"><div style="display:inline-block;width:4px">&nbsp;</div>for </div><div id="a39222" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:793px;">finance lease amounts included in property and equipment, net within our<div style="display:inline-block;width:2px">&nbsp;</div>consolidated balance sheets. </div></div>
</div>
<div style="padding: 7px">
<div id="Page86" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:306.1px; height:1px; left:426.9px; top:228.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:349.7px; height:15.4px; left:69.9px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:430px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:444.9px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:536.9px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:551.9px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:644px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:16.6px; left:67.2px; top:268.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:659px; top:269.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:360.1px; height:17.6px; left:67.2px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:360.1px; height:1px; left:66.8px; top:266.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:426.9px; top:266.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:17.6px; left:519.3px; top:267.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:266.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:266.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:266.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:329.6px; height:15.4px; left:90px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:15.4px; left:422.3px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:444.9px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:519.3px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:551.9px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:17.6px; left:67.2px; top:302.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:659px; top:304.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:426.9px; top:319.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:319.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:319.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:427.3px; top:338.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:427.3px; top:340.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:338.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:340.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:338.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:340.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:199.1px; height:1px; left:533.9px; top:528.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:570.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:570.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:568.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:568.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:568.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:568.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:14.9px; height:1px; left:733px; top:568.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:603.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:603.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:555.2px; height:15.2px; left:67.2px; top:638.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:102.9px; height:15.2px; left:626.4px; top:638.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:637.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:653.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:653.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.1px; left:67.2px; top:674.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:16px; left:67.2px; top:671.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:2.9px; left:67.2px; top:671.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:671.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:673.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:673.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:2.9px; left:626.4px; top:671.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:671.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:673.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:673.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:14.9px; height:2.9px; left:733.4px; top:671.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:704.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:704.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:739px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:739px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:737.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:737.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:737.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:737.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:14.9px; height:1px; left:733px; top:737.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:755.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:757.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:755.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:757.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:772.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:772.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:807.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:807.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:805.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:805.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:805.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:805.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:14.9px; height:1px; left:733px; top:805.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:823.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:534.3px; top:825.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:823.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641.4px; top:825.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:840.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:840.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:874.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:874.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:908.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:908.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:21.3px; left:67.2px; top:942.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:21.3px; left:67.2px; top:942.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a39224" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a39226" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a39228" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a39230" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a39233" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">86 </div><div id="div_739_XBRL_TS_cba67cea9cc34aea9f2eeea1e5731a83" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_cba67cea9cc34aea9f2eeea1e5731a83" name="us-gaap:LesseeOperatingLeasesTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_b5e98bdcecea4b37b0fd7b65e365563a" escape="true"><div id="TextBlockContainer740" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:683px;height:101px;"><div id="a39235" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 6 – Leases </div><div id="a39241" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We have operating and finance leases for corporate offices, office space, distribution and other facilities, vehicles </div><div id="a39243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">and certain equipment.<div style="display:inline-block;width:7px">&nbsp;</div>Our leases have remaining terms of less than </div><div id="a39243_69_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:413px;top:49px;"><ix:nonnumeric id="ID_1132" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:durwordsen">one year</ix:nonnumeric></div><div id="a39243_77_18" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:463px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>to approximately </div><div id="a39243_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:570px;top:49px;"><ix:nonnumeric id="ID_1555" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">19</ix:nonnumeric></div><div id="a39243_97_16" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:585px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>years, some of </div><div id="a39244" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">which may include options to extend the leases for up to </div><div id="a39244_57_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:339px;top:66px;"><ix:nonnumeric id="ID_1755" name="hsic:LesseeOperatingLeaseOptionToExtendTerm" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:duryear">15</ix:nonnumeric></div><div id="a39244_59_49" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:354px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>years.<div style="display:inline-block;width:7px">&nbsp;</div>The components of lease expense were as </div><div id="a39247" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">follows:</div></div></ix:nonnumeric></div><div id="div_741_XBRL_TS_d0d5fa77e4cf4ed18657e500c8342af0" style="position:absolute;left:65px;top:214px;float:left;"><ix:nonnumeric id="ID_d0d5fa77e4cf4ed18657e500c8342af0" name="us-gaap:LeaseCostTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_02ea7e18801742c6b50a5b66340baa07" escape="true"><div id="TextBlockContainer744" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:189px;"><div id="div_742_XBRL_TS_b5e98bdcecea4b37b0fd7b65e365563a" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_b5e98bdcecea4b37b0fd7b65e365563a" continuedat="XBRL_TS_b7b705ea670e4d56b6556864815b752c"><div id="TextBlockContainer743" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:189px;"><div id="a39254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:478px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a39259" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:369px;top:19px;">December 31, </div><div id="a39262" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:19px;">December 25, </div><div id="a39265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:19px;">December 26, </div><div id="a39270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:394px;top:38px;">2022 </div><div id="a39273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:38px;">2021 </div><div id="a39276" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:608px;top:38px;">2020 </div><div id="a39279" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:56px;">Operating lease cost:</div><div id="a39280" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:116px;top:56px;"><div style="display:inline-block;width:2px">&nbsp;</div>(1) (2)</div><div id="a39284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:56px;">$ </div><div id="a39286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:431px;top:56px;"><ix:nonfraction id="ID_627" name="us-gaap:OperatingLeaseCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">150</ix:nonfraction></div><div id="a39289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:56px;">$ </div><div id="a39291" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:56px;"><ix:nonfraction id="ID_841" name="us-gaap:OperatingLeaseCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a39294" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:56px;">$ </div><div id="a39296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:652px;top:56px;"><ix:nonfraction id="ID_1135" name="us-gaap:OperatingLeaseCost" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">87</ix:nonfraction></div><div id="a39299" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:74px;">Finance<div style="display:inline-block;width:4px">&nbsp;</div>lease cost: </div><div id="a39313" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:91px;">Amortization of right-of-use assets<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39321" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:91px;"><ix:nonfraction id="ID_628" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:91px;"><ix:nonfraction id="ID_842" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:91px;"><ix:nonfraction id="ID_1136" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a39332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:110px;">Total finance<div style="display:inline-block;width:5px">&nbsp;</div>lease cost </div><div id="a39335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:110px;">$ </div><div id="a39337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:110px;"><ix:nonfraction id="ID_629" name="hsic:Financeleasecost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39340" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:110px;">$ </div><div id="a39342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:110px;"><ix:nonfraction id="ID_843" name="hsic:Financeleasecost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39345" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:110px;">$ </div><div id="a39347" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:110px;"><ix:nonfraction id="ID_1137" name="hsic:Financeleasecost" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a39364" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:130px;">(1) </div><div id="a39366" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:130px;">Includes variable lease expenses. </div><div id="a39369" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:148px;">(2) </div><div id="a39371" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:148px;">Operating lease cost for the years ended December 31, 2022, December 25, 2021, and December 26, 2020, include accelerated </div><div id="a39373" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:162px;">amortization of right-of-use assets of $</div><div id="a39373_40_2" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:211px;top:162px;"><ix:nonfraction id="ID_1134" name="hsic:OperatingLeaseRightOfUseAssetAmortizationExpenseIncludingOperatingLeaseCredit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">42</ix:nonfraction></div><div id="a39373_42_11" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:223px;top:162px;"><div style="display:inline-block;width:3px">&nbsp;</div>million, $</div><div id="a39373_53_1" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:162px;"><ix:nonfraction id="ID_1133" name="hsic:OperatingLeaseRightOfUseAssetAmortizationExpenseIncludingOperatingLeaseCredit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a39373_54_14" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:279px;top:162px;"><div style="display:inline-block;width:3px">&nbsp;</div>million and $</div><div id="a39373_68_1" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:162px;"><ix:nonfraction id="ID_1387" name="hsic:OperatingLeaseRightOfUseAssetAmortizationExpenseIncludingOperatingLeaseCredit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a39373_69_63" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:162px;"><div style="display:inline-block;width:3px">&nbsp;</div>million, respectively, related to facility leases recorded in </div><div id="a39378" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:176px;">“Restructuring and integration costs” within our consolidated statements of income.</div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_745_XBRL_TS_b7b705ea670e4d56b6556864815b752c" style="position:absolute;left:62px;top:430px;float:left;"><ix:continuation id="XBRL_TS_b7b705ea670e4d56b6556864815b752c" continuedat="XBRL_TS_33a2c7e0aec94a37b1fcb6abc1b991ad"><div id="TextBlockContainer746" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:671px;height:85px;"><div id="a39382" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Further, for the years ended December 31, 2022,<div style="display:inline-block;width:3px">&nbsp;</div>December 25, 2021 and December 26, 2020, we recognized </div><div id="a39390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">impairment of right-of-use assets of $</div><div id="a39390_38_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:226px;top:17px;"><ix:nonfraction id="ID_1556" name="us-gaap:OperatingLeaseImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39390_39_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:234px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a39390_50_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:294px;top:17px;"><ix:nonfraction id="ID_1557" name="us-gaap:OperatingLeaseImpairmentLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a39390_51_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, and $</div><div id="a39390_66_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:387px;top:17px;"><ix:nonfraction id="ID_1558" name="us-gaap:OperatingLeaseImpairmentLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a39390_67_50" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million respectively, related to facility leases </div><div id="a39395" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">recorded in “Restructuring and integration costs” within our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>statement of income. </div><div id="a39399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Supplemental balance sheet information related to leases is as follows:</div></div></ix:continuation></div><div id="div_747_XBRL_TS_33a2c7e0aec94a37b1fcb6abc1b991ad" style="position:absolute;left:63px;top:514px;float:left;"><ix:continuation id="XBRL_TS_33a2c7e0aec94a37b1fcb6abc1b991ad" continuedat="XBRL_TS_30cc231f79a947f4bfcb847c0051402b"><div id="TextBlockContainer750" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:450px;"><div id="div_748_XBRL_TS_02ea7e18801742c6b50a5b66340baa07" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_02ea7e18801742c6b50a5b66340baa07" continuedat="XBRL_TS_72e222caf3e8427999a3c90f5c8c6024"><div id="TextBlockContainer749" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:450px;"><div id="a39406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:534px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a39414" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:479px;top:20px;">December 31, </div><div id="a39417" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:586px;top:20px;">December 25, </div><div id="a39425" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:504px;top:40px;">2022 </div><div id="a39428" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:611px;top:40px;">2021 </div><div id="a39431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:57px;">Operating Leases: </div><div id="a39440" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:74px;">Operating lease right-of-use assets </div><div id="a39447" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:74px;">$ </div><div id="a39449" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:74px;"><ix:nonfraction id="ID_537A" name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">284</ix:nonfraction></div><div id="a39452" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:74px;">$ </div><div id="a39454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:646px;top:74px;"><ix:nonfraction id="ID_538A" name="us-gaap:OperatingLeaseRightOfUseAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">325</ix:nonfraction></div><div id="a39468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">Current operating lease liabilities </div><div id="a39472" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:108px;"><ix:nonfraction id="ID_519A" name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">73</ix:nonfraction></div><div id="a39476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:653px;top:108px;"><ix:nonfraction id="ID_520A" name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">76</ix:nonfraction></div><div id="a39479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:125px;">Non-current operating lease liabilities </div><div id="a39485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:125px;"><ix:nonfraction id="ID_531A" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">275</ix:nonfraction></div><div id="a39489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:646px;top:125px;"><ix:nonfraction id="ID_532A" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">268</ix:nonfraction></div><div id="a39493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:142px;">Total operating lease liabilities </div><div id="a39496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:142px;">$ </div><div id="a39498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:142px;"><ix:nonfraction id="ID_751" name="us-gaap:OperatingLeaseLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">348</ix:nonfraction></div><div id="a39501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:142px;">$ </div><div id="a39503" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:646px;top:142px;"><ix:nonfraction id="ID_852" name="us-gaap:OperatingLeaseLiability" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">344</ix:nonfraction></div><div id="a39517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:175px;">Finance Leases: </div><div id="a39526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">Property and equipment, at cost </div><div id="a39529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:192px;">$ </div><div id="a39531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:192px;"><ix:nonfraction id="ID_1774" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction></div><div id="a39534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:192px;">$ </div><div id="a39536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:192px;"><ix:nonfraction id="ID_1775" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a39539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:209px;">Accumulated depreciation </div><div id="a39543" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:209px;display:flex;">(<ix:nonfraction id="ID_1776" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a39547" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:209px;display:flex;">(<ix:nonfraction id="ID_1777" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction>)</div><div id="a39551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:226px;">Property and equipment, net of accumulated depreciation </div><div id="a39554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:226px;">$ </div><div id="a39556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:226px;"><ix:nonfraction id="ID_1381" name="us-gaap:FinanceLeaseRightOfUseAsset" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a39559" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:226px;">$ </div><div id="a39561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:226px;"><ix:nonfraction id="ID_1382" name="us-gaap:FinanceLeaseRightOfUseAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a39575" style="position:absolute;font-family:'Times New Roman';left:4px;top:260px;-sec-ix-hidden:ID_1810;"><div id="XBRL_CS_50be940fada74d0fa1fb4feb28e7f7bd" style="position:relative;left:0px;top:0px;display:inline-block;">Current maturities of long-term debt</div></div><div id="a39580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:260px;">$ </div><div id="a39582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:260px;"><ix:nonfraction id="ID_1383" name="us-gaap:FinanceLeaseLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a39585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:260px;">$ </div><div id="a39587" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:260px;"><ix:nonfraction id="ID_1384" name="us-gaap:FinanceLeaseLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:277px;">Long-term debt </div><div id="a39596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:277px;"><ix:nonfraction id="ID_1385" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a39600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:277px;"><ix:nonfraction id="ID_1386" name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a39604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:294px;">Total finance<div style="display:inline-block;width:5px">&nbsp;</div>lease liabilities </div><div id="a39607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:294px;">$ </div><div id="a39609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:294px;"><ix:nonfraction id="ID_752" name="us-gaap:FinanceLeaseLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a39612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:294px;">$ </div><div id="a39614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:294px;"><ix:nonfraction id="ID_814" name="us-gaap:FinanceLeaseLiability" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a39628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:328px;">Weighted Average<div style="display:inline-block;width:6px">&nbsp;</div>Remaining Lease Term in<div style="display:inline-block;width:5px">&nbsp;</div>Years: </div><div id="a39638" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:345px;">Operating leases </div><div id="a39642" style="position:absolute;font-family:'Times New Roman';left:547px;top:345px;"><ix:nonnumeric id="ID_753" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextref="AS_OF_Dec31_2022_Entity_0001000228" format="ixt-sec:duryear">6.7</ix:nonnumeric></div><div id="a39646" style="position:absolute;font-family:'Times New Roman';left:654px;top:345px;"><ix:nonnumeric id="ID_853" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextref="AS_OF_Dec25_2021_Entity_0001000228" format="ixt-sec:duryear">7.3</ix:nonnumeric></div><div id="a39650" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:362px;">Finance leases </div><div id="a39654" style="position:absolute;font-family:'Times New Roman';left:547px;top:362px;"><ix:nonnumeric id="ID_754" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextref="AS_OF_Dec31_2022_Entity_0001000228" format="ixt-sec:duryear">3.1</ix:nonnumeric></div><div id="a39658" style="position:absolute;font-family:'Times New Roman';left:654px;top:362px;"><ix:nonnumeric id="ID_854" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" contextref="AS_OF_Dec25_2021_Entity_0001000228" format="ixt-sec:duryear">3.6</ix:nonnumeric></div><div id="a39672" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:396px;">Weighted<div style="display:inline-block;width:5px">&nbsp;</div>Average Discount<div style="display:inline-block;width:5px">&nbsp;</div>Rate: </div><div id="a39683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:413px;">Operating leases </div><div id="a39687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:413px;"><ix:nonfraction id="ID_630" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">2.8</ix:nonfraction></div><div id="a39689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:413px;">% </div><div id="a39692" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:413px;"><ix:nonfraction id="ID_855" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">2.4</ix:nonfraction></div><div id="a39694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:413px;">% </div><div id="a39697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:434px;">Finance leases </div><div id="a39701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:434px;"><ix:nonfraction id="ID_631" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">3.3</ix:nonfraction></div><div id="a39703" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:564px;top:434px;">% </div><div id="a39706" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:434px;"><ix:nonfraction id="ID_856" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">1.7</ix:nonfraction></div><div id="a39708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:434px;">%</div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page87" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:199.1px; height:1px; left:533.9px; top:148.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:184.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:16.1px; left:67.2px; top:183.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:204px; height:15.4px; left:529.2px; top:184.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:182px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:182px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:182px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:182px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:436.7px; height:15.4px; left:90px; top:218.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:15.4px; left:529.2px; top:218.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:218.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:218.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:17px; left:67.2px; top:216.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:218.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:436.7px; height:15.4px; left:90px; top:252.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:536.9px; top:252.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:252.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:252.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:17.1px; left:67.2px; top:250.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:252.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:199.1px; height:1px; left:533.9px; top:339.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:376.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:536.9px; top:376.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:376.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:644px; top:376.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:16.9px; left:67.2px; top:375.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:376.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:373.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:373.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:373.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:373.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:410.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:15.4px; left:529.2px; top:410.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:410.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:410.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:17.1px; left:67.2px; top:409.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:410.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:444.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:15.4px; left:529.2px; top:444.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:444.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:444.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:17px; left:67.2px; top:443.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:444.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:15.4px; left:529.2px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:29.9px; height:15.4px; left:626.4px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:16.1px; left:67.2px; top:478.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:478.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:476.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:476.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:476.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:476.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:456.7px; height:15.4px; left:69.9px; top:512.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:536.9px; top:512.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:551.9px; top:512.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:15.4px; left:644px; top:512.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:666.1px; height:16px; left:67.2px; top:512.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:67.7px; height:15.4px; left:659px; top:512.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:467.1px; height:1px; left:66.8px; top:510.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:533.9px; top:510.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:626px; top:510.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:641px; top:510.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:533.4px; top:530.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:533.4px; top:528.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:640.5px; top:530.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:640.5px; top:528.4px; background-color:#000000; ">&nbsp;</div>
<div id="a39710" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a39712" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a39714" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a39716" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a39719" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">87 </div><div id="div_751_XBRL_TS_30cc231f79a947f4bfcb847c0051402b" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_30cc231f79a947f4bfcb847c0051402b" continuedat="XBRL_TS_3b8fb0e89a2f401e90cfb0b11262062d"><div id="TextBlockContainer752" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:403px;height:18px;"><div id="a39721" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Supplemental cash flow information related to leases is as follows:</div></div></ix:continuation></div><div id="div_753_XBRL_TS_72e222caf3e8427999a3c90f5c8c6024" style="position:absolute;left:65px;top:134px;float:left;"><ix:continuation id="XBRL_TS_72e222caf3e8427999a3c90f5c8c6024"><div id="TextBlockContainer756" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:151px;"><div id="div_754_XBRL_TS_3b8fb0e89a2f401e90cfb0b11262062d" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_3b8fb0e89a2f401e90cfb0b11262062d" continuedat="XBRL_TS_0795e223cf724990bb892557c6535f68"><div id="TextBlockContainer755" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:151px;"><div id="a39728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:531px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a39736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:476px;top:17px;">December 31, </div><div id="a39739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:17px;">December 25, </div><div id="a39747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:501px;top:34px;">2022 </div><div id="a39750" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:608px;top:34px;">2021 </div><div id="a39753" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Cash paid for amounts included in the measurement of lease liabilities: </div><div id="a39763" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:68px;">Operating cash flows for operating leases </div><div id="a39766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:68px;">$ </div><div id="a39768" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:68px;"><ix:nonfraction id="ID_844" name="us-gaap:OperatingLeasePayments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">87</ix:nonfraction></div><div id="a39772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:68px;"><ix:nonfraction id="ID_845" name="us-gaap:OperatingLeasePayments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">85</ix:nonfraction></div><div id="a39776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:85px;">Financing cash flows for finance leases </div><div id="a39780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:85px;"><ix:nonfraction id="ID_846" name="us-gaap:FinanceLeasePrincipalPayments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:85px;"><ix:nonfraction id="ID_847" name="us-gaap:FinanceLeasePrincipalPayments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39787" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Right-of-use assets obtained in exchange for lease obligations: </div><div id="a39802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:119px;">Operating leases<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a39805" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:119px;">$ </div><div id="a39807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:119px;"><ix:nonfraction id="ID_848" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">88</ix:nonfraction></div><div id="a39811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:119px;"><ix:nonfraction id="ID_849" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">121</ix:nonfraction></div><div id="a39815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:135px;">Finance leases </div><div id="a39819" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:135px;"><ix:nonfraction id="ID_850" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a39823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:135px;"><ix:nonfraction id="ID_851" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div></div></ix:continuation></div></div></ix:continuation></div><div id="div_757_XBRL_TS_0795e223cf724990bb892557c6535f68" style="position:absolute;left:62px;top:305px;float:left;"><ix:continuation id="XBRL_TS_0795e223cf724990bb892557c6535f68" continuedat="XBRL_TS_9d01975ef74b448d8a3a65a124b16bca"><div id="TextBlockContainer758" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:267px;height:17px;"><div id="a39838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Maturities of lease liabilities are as follows:</div></div></ix:continuation></div><div id="div_759_XBRL_TS_9d868d6417ed47afbb52d2ab6f5777d8" style="position:absolute;left:65px;top:325px;float:left;"><ix:nonnumeric id="ID_1143" name="hsic:FinanceAndOperatingLeaseLiabilityFiscalYearMaturityTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer762" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:204px;"><div id="div_760_XBRL_TS_9d01975ef74b448d8a3a65a124b16bca" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_9d01975ef74b448d8a3a65a124b16bca" continuedat="XBRL_TS_ae8eef854aac4444a3459669e92b500c"><div id="TextBlockContainer761" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:670px;height:204px;"><div id="a39845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:514px;top:0px;">December 31, 2022 </div><div id="a39854" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:493px;top:18px;">Operating </div><div id="a39858" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:607px;top:18px;">Finance </div><div id="a39867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:503px;top:34px;">Leases </div><div id="a39871" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:610px;top:34px;">Leases </div><div id="a39874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">2023 </div><div id="a39877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:52px;">$ </div><div id="a39879" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:52px;"><ix:nonfraction id="ID_755" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">82</ix:nonfraction></div><div id="a39882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:52px;">$ </div><div id="a39884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:52px;"><ix:nonfraction id="ID_761" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a39887" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:69px;">2024 </div><div id="a39891" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:69px;"><ix:nonfraction id="ID_756" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">66</ix:nonfraction></div><div id="a39895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:69px;"><ix:nonfraction id="ID_762" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a39898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:86px;">2025 </div><div id="a39902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:86px;"><ix:nonfraction id="ID_757" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">56</ix:nonfraction></div><div id="a39906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:86px;"><ix:nonfraction id="ID_763" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a39909" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:103px;">2026 </div><div id="a39913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:103px;"><ix:nonfraction id="ID_758" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction></div><div id="a39917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:103px;"><ix:nonfraction id="ID_764" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a39920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">2027 </div><div id="a39924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:120px;"><ix:nonfraction id="ID_759" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">33</ix:nonfraction></div><div id="a39928" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:120px;"><ix:nonfraction id="ID_765" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a39931" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Thereafter </div><div id="a39935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:541px;top:137px;"><ix:nonfraction id="ID_760" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">98</ix:nonfraction></div><div id="a39939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:137px;"><ix:nonfraction id="ID_766" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a39942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Total future<div style="display:inline-block;width:5px">&nbsp;</div>lease payments </div><div id="a39946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:154px;"><ix:nonfraction id="ID_692" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">381</ix:nonfraction></div><div id="a39950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:154px;"><ix:nonfraction id="ID_694" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a39953" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:171px;">Less imputed interest </div><div id="a39957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:171px;display:flex;">(<ix:nonfraction id="ID_693" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">33</ix:nonfraction>)</div><div id="a39961" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:650px;top:171px;display:flex;">(<ix:nonfraction id="ID_695" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a39964" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:188px;">Total </div><div id="a39967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:188px;">$ </div><div id="a39969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:534px;top:188px;"><ix:nonfraction id="ID_751A" name="us-gaap:OperatingLeaseLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">348</ix:nonfraction></div><div id="a39972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:188px;">$ </div><div id="a39974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:188px;"><ix:nonfraction id="ID_752A" name="us-gaap:FinanceLeaseLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_763_XBRL_TS_ae8eef854aac4444a3459669e92b500c" style="position:absolute;left:62px;top:548px;float:left;"><ix:continuation id="XBRL_TS_ae8eef854aac4444a3459669e92b500c"><div id="TextBlockContainer764" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:169px;"><div id="a39978" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">As of December 31, 2022, we have additional operating leases with<div style="display:inline-block;width:2px">&nbsp;</div>total lease payments of $</div><div id="a39978_91_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:0px;"><ix:nonfraction id="ID_1773" name="hsic:OperatingLeaseAssetsLeaseNotYetCommenced" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a39978_92_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million for buildings </div><div id="a39979" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">and vehicles that have not yet commenced.<div style="display:inline-block;width:7px">&nbsp;</div>These operating leases will commence subsequent to December 31, </div><div id="a39981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">2022, with lease terms of </div><div id="a39981_26_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:157px;top:34px;"><ix:nonnumeric id="ID_1138" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember" format="ixt-sec:durwordsen">two years</ix:nonnumeric></div><div id="a39981_35_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:213px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>to </div><div id="a39981_39_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:232px;top:34px;"><ix:nonnumeric id="ID_1139" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember" format="ixt-sec:durwordsen">five years</ix:nonnumeric></div><div id="a39981_49_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:289px;top:34px;">. </div><div id="a39984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Certain of our facilities related to our acquisitions are leased from<div style="display:inline-block;width:2px">&nbsp;</div>employees and minority shareholders.<div style="display:inline-block;width:7px">&nbsp;</div>These </div><div id="a39989" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">leases are classified as operating leases and have a remaining lease term<div style="display:inline-block;width:2px">&nbsp;</div>ranging from </div><div id="a39989_87_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:512px;top:84px;"><ix:nonnumeric id="ID_1559" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember" format="ixt-sec:durwordsen">4 months</ix:nonnumeric></div><div id="a39989_95_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>to </div><div id="a39989_99_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:585px;top:84px;"><ix:nonnumeric id="ID_1560" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember" format="ixt-sec:durwordsen">9 years</ix:nonnumeric></div><div id="a39989_106_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:627px;top:84px;">.<div style="display:inline-block;width:7px">&nbsp;</div>As of </div><div id="a39998" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">December 31, 2022, current and non-current liabilities associated with<div style="display:inline-block;width:2px">&nbsp;</div>related party operating leases were $</div><div id="a39998_108_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:636px;top:101px;"><ix:nonfraction id="ID_1561" name="us-gaap:OperatingLeaseLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a40001" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">million and $</div><div id="a40001_13_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:83px;top:118px;"><ix:nonfraction id="ID_1562" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a40001_15_58" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:98px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>Related party leases represented </div><div id="a40001_73_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:118px;"><ix:nonfraction id="ID_1771" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_CurrentOperatingLeaseLiabilitiesMember_us-gaap_ConcentrationRiskByTypeAxis_hsic_RelatedPartyConcentrationRiskMember" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">5.0</ix:nonfraction></div><div id="a40001_76_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:118px;">% and </div><div id="a40001_82_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:484px;top:118px;"><ix:nonfraction id="ID_1772" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_hsic_PropertyOwnedByEmployeesAndShareholdersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_NonCurrentOperatingLeaseLiabilitiesMember_us-gaap_ConcentrationRiskByTypeAxis_hsic_RelatedPartyConcentrationRiskMember" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">5.3</ix:nonfraction></div><div id="a40001_85_31" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:118px;">% of the total current and non-</div><div id="a40004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">current operating lease liabilities, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>The present value of lease payments under these related party<div style="display:inline-block;width:2px">&nbsp;</div>leases </div><div id="a40006" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">is not material to our consolidated financial statements.</div></div></ix:continuation></div><div id="a40006_57_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:392px;top:700px;"><div style="display:inline-block;width:4px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page88" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:227.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:226.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:418.3px; top:226.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:226.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:528.3px; top:226.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:226.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:638.4px; top:226.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:226.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:15.4px; left:428.3px; top:259.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:15.4px; left:538.3px; top:259.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:258.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:15.4px; left:648.3px; top:259.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:291.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:290.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:418.3px; top:290.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:290.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:528.3px; top:290.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:290.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:638.4px; top:290.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:290.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:322.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:651.1px; height:15.4px; left:97.2px; top:323.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:354.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:651.1px; height:15.4px; left:97.2px; top:355.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:370.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:370.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:370.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:388.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:386.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:388.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:386.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:388.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:386.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:226.1px; height:1px; left:290.9px; top:540.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:226px; height:1px; left:521.9px; top:540.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:296.1px; height:13.8px; left:67.2px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:13.8px; left:368.2px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:13.8px; left:445.2px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:13.8px; left:522.3px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:13.8px; left:599.3px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:573.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:13.8px; left:676.3px; top:574.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:224.1px; height:16px; left:67.2px; top:572.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:290.9px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:363.3px; top:572.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:367.8px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5.1px; height:1px; left:439.9px; top:572.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:445px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:1px; left:517px; top:572.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:521.9px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:594.3px; top:572.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:598.9px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:671.3px; top:572.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:675.9px; top:572.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:604.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.8px; left:67.2px; top:606.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:636.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.8px; left:67.2px; top:638.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:290.9px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:367.8px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:445px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:521.9px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:598.9px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:72px; height:1px; left:675.9px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:290.3px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:290.3px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:367.3px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:367.3px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:444.4px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:444.4px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:521.4px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:521.4px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:598.3px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:598.3px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:675.3px; top:670.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:73px; height:1px; left:675.3px; top:668.7px; background-color:#000000; ">&nbsp;</div>
<div id="a40010" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a40012" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a40014" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a40016" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a40019" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">88 </div><div id="div_765_XBRL_CS_b8645e6f29fd442a86756c449559ebbb" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_b8645e6f29fd442a86756c449559ebbb" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_f05e6379671947f791abb46d3d217e0b" escape="true"><div id="TextBlockContainer766" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:675px;height:67px;"><div id="a40021" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 7 – Goodwill and Other Intangibles, Net </div><div id="a40026" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a40027" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">The changes in the carrying amount of goodwill for the years ended December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022 and December 25, 2021 </div><div id="a40033" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">were as follows:</div></div></ix:nonnumeric></div><div id="div_767_XBRL_CS_f05e6379671947f791abb46d3d217e0b" style="position:absolute;left:63px;top:181px;float:left;"><ix:continuation id="XBRL_CS_f05e6379671947f791abb46d3d217e0b" continuedat="XBRL_TS_c38210dd05a34ad984817863c535091a"><div id="TextBlockContainer770" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:207px;"><div id="div_768_XBRL_CS_268632a2b7a54c8199427cfb6c021887" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_403" name="us-gaap:ScheduleOfGoodwillTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer769" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:207px;"><div id="a40039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:380px;top:15px;">Health Care </div><div id="a40040" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:381px;top:31px;">Distribution </div><div id="a40043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:480px;top:0px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and </div><div id="a40044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:15px;">Value-Added </div><div id="a40047" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:502px;top:31px;">Services </div><div id="a40050" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:620px;top:31px;">Total </div><div id="a40052" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Balance as of December 26, 2020<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:47px;">$ </div><div id="a40057" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:47px;"><ix:nonfraction id="ID_90" name="us-gaap:Goodwill" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,501</ix:nonfraction></div><div id="a40060" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:47px;">$ </div><div id="a40062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:47px;"><ix:nonfraction id="ID_351" name="us-gaap:Goodwill" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,003</ix:nonfraction></div><div id="a40065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:47px;">$ </div><div id="a40067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:47px;"><ix:nonfraction id="ID_248" name="us-gaap:Goodwill" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,504</ix:nonfraction></div><div id="a40070" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:63px;">Adjustments to goodwill: </div><div id="a40083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:79px;">Acquisitions<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:79px;"><ix:nonfraction id="ID_52" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">359</ix:nonfraction></div><div id="a40091" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:79px;"><ix:nonfraction id="ID_254" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">24</ix:nonfraction></div><div id="a40095" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:79px;"><ix:nonfraction id="ID_31" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">383</ix:nonfraction></div><div id="a40099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:95px;">Foreign currency translation<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:95px;display:flex;">(<ix:nonfraction id="ID_340" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">29</ix:nonfraction>)</div><div id="a40107" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:95px;display:flex;">(<ix:nonfraction id="ID_393" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a40111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:95px;display:flex;">(<ix:nonfraction id="ID_143" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">33</ix:nonfraction>)</div><div id="a40113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:111px;">Balance as of December 25, 2021<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:111px;"><ix:nonfraction id="ID_129" name="us-gaap:Goodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,831</ix:nonfraction></div><div id="a40121" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:111px;"><ix:nonfraction id="ID_17" name="us-gaap:Goodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,023</ix:nonfraction></div><div id="a40125" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:111px;"><ix:nonfraction id="ID_280A" name="us-gaap:Goodwill" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,854</ix:nonfraction></div><div id="a40128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:127px;">Adjustments to goodwill: </div><div id="a40141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:143px;">Acquisitions<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40145" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:143px;"><ix:nonfraction id="ID_41" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">86</ix:nonfraction></div><div id="a40149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:143px;display:flex;">(<ix:nonfraction id="ID_164" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a40153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:143px;"><ix:nonfraction id="ID_435" name="us-gaap:GoodwillAcquiredDuringPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">85</ix:nonfraction></div><div id="a40157" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:159px;">Impairment </div><div id="a40161" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:159px;display:flex;">(<ix:nonfraction id="ID_1563" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction>)</div><div id="a40165" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:159px;"><ix:nonfraction id="ID_1564" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a40169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:159px;display:flex;">(<ix:nonfraction id="ID_1475" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction>)</div><div id="a40173" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:175px;">Foreign currency translation<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:175px;display:flex;">(<ix:nonfraction id="ID_447" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">22</ix:nonfraction>)</div><div id="a40181" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:175px;display:flex;">(<ix:nonfraction id="ID_50" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a40185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:175px;display:flex;">(<ix:nonfraction id="ID_139" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">26</ix:nonfraction>)</div><div id="a40187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:191px;">Balance as of December 31, 2022<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:191px;">$ </div><div id="a40192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:435px;top:191px;"><ix:nonfraction id="ID_64" name="us-gaap:Goodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,875</ix:nonfraction></div><div id="a40195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:191px;">$ </div><div id="a40197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:545px;top:191px;"><ix:nonfraction id="ID_276" name="us-gaap:Goodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,018</ix:nonfraction></div><div id="a40200" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:191px;">$ </div><div id="a40202" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:191px;"><ix:nonfraction id="ID_144A" name="us-gaap:Goodwill" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2,893</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_771_XBRL_TS_c38210dd05a34ad984817863c535091a" style="position:absolute;left:62px;top:407px;float:left;"><ix:continuation id="XBRL_TS_c38210dd05a34ad984817863c535091a" continuedat="XBRL_CS_f02fec16fbee4a6f856463bc67c128f6"><div id="TextBlockContainer772" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:51px;"><div id="a40205" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">For the year<div style="display:inline-block;width:6px">&nbsp;</div>ended December 31,<div style="display:inline-block;width:5px">&nbsp;</div>2022, we recorded<div style="display:inline-block;width:5px">&nbsp;</div>a $</div><div id="a40205_53_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:0px;"><ix:nonfraction id="ID_1764A" name="us-gaap:GoodwillImpairmentLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a40205_55_57" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million impairment of<div style="display:inline-block;width:5px">&nbsp;</div>goodwill relating to<div style="display:inline-block;width:5px">&nbsp;</div>the disposal </div><div id="a40209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">of<div style="display:inline-block;width:6px">&nbsp;</div>an<div style="display:inline-block;width:6px">&nbsp;</div>unprofitable<div style="display:inline-block;width:6px">&nbsp;</div>business<div style="display:inline-block;width:6px">&nbsp;</div>whose<div style="display:inline-block;width:6px">&nbsp;</div>estimated<div style="display:inline-block;width:6px">&nbsp;</div>fair<div style="display:inline-block;width:6px">&nbsp;</div>value<div style="display:inline-block;width:6px">&nbsp;</div>was<div style="display:inline-block;width:6px">&nbsp;</div>lower<div style="display:inline-block;width:6px">&nbsp;</div>than<div style="display:inline-block;width:6px">&nbsp;</div>its<div style="display:inline-block;width:6px">&nbsp;</div>carrying<div style="display:inline-block;width:6px">&nbsp;</div>value.<div style="display:inline-block;width:12px">&nbsp;</div>The<div style="display:inline-block;width:6px">&nbsp;</div>disposal<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>this </div><div id="a40215" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">business<div style="display:inline-block;width:6px">&nbsp;</div>is<div style="display:inline-block;width:6px">&nbsp;</div>part<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>our<div style="display:inline-block;width:6px">&nbsp;</div>restructuring<div style="display:inline-block;width:6px">&nbsp;</div>initiative<div style="display:inline-block;width:6px">&nbsp;</div>as<div style="display:inline-block;width:6px">&nbsp;</div>more<div style="display:inline-block;width:6px">&nbsp;</div>fully<div style="display:inline-block;width:6px">&nbsp;</div>discussed<div style="display:inline-block;width:6px">&nbsp;</div>in</div></div></ix:continuation></div><div id="a40216" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:518px;top:440px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Note<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>14<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>–<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Plans<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>of<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Restructuring<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>and </a></div><div id="a40221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:457px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Integration Costs</a></div><div id="a40222" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:168px;top:457px;"><a href="#a45998" style="color:#000000;text-decoration:none;">.</a></div><div id="div_773_XBRL_CS_f02fec16fbee4a6f856463bc67c128f6" style="position:absolute;left:62px;top:491px;float:left;"><ix:continuation id="XBRL_CS_f02fec16fbee4a6f856463bc67c128f6" continuedat="XBRL_CS_ee2316a43f8d47c9a02db52e0cf1934e"><div id="TextBlockContainer774" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:305px;height:18px;"><div id="a40225" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Other intangible assets consisted of the following:</div></div></ix:continuation></div><div id="div_775_XBRL_CS_ee2316a43f8d47c9a02db52e0cf1934e" style="position:absolute;left:63px;top:527px;float:left;"><ix:continuation id="XBRL_CS_ee2316a43f8d47c9a02db52e0cf1934e" continuedat="XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2"><div id="TextBlockContainer778" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:687px;height:142px;"><div id="div_776_XBRL_CS_72f252b8a4b941cabfd62d66e5b83562" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_44" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer777" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:687px;height:142px;"><div id="a40229" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:293px;top:0px;">December 31, 2022 </div><div id="a40232" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:524px;top:0px;">December 25, 2021 </div><div id="a40238" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:307px;top:16px;">Accumulated </div><div id="a40247" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:538px;top:16px;">Accumulated </div><div id="a40252" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:252px;top:32px;">Cost </div><div id="a40255" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:307px;top:32px;">Amortization </div><div id="a40258" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:409px;top:32px;">Net </div><div id="a40261" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:483px;top:32px;">Cost </div><div id="a40264" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:538px;top:32px;">Amortization </div><div id="a40267" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:640px;top:32px;">Net </div><div id="a40269" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Customer lists and relationships </div><div id="a40271" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:228px;top:48px;">$ </div><div id="a40273" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:282px;top:48px;"><ix:nonfraction id="ID_302" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">826</ix:nonfraction></div><div id="a40276" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:48px;">$ </div><div id="a40278" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:48px;display:flex;">(<ix:nonfraction id="ID_314" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">387</ix:nonfraction>)</div><div id="a40281" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:48px;">$ </div><div id="a40283" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:48px;"><ix:nonfraction id="ID_185" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">439</ix:nonfraction></div><div id="a40286" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:48px;">$ </div><div id="a40288" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:48px;"><ix:nonfraction id="ID_371" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">853</ix:nonfraction></div><div id="a40291" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:48px;">$ </div><div id="a40293" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:48px;display:flex;">(<ix:nonfraction id="ID_9" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">353</ix:nonfraction>)</div><div id="a40296" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:48px;">$ </div><div id="a40298" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:48px;"><ix:nonfraction id="ID_354" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">500</ix:nonfraction></div><div id="a40300" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Trademarks / trade names - definite lived<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40306" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:282px;top:64px;"><ix:nonfraction id="ID_70" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">125</ix:nonfraction></div><div id="a40310" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:64px;display:flex;">(<ix:nonfraction id="ID_231" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction>)</div><div id="a40314" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:64px;"><ix:nonfraction id="ID_448" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction></div><div id="a40318" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:64px;"><ix:nonfraction id="ID_125" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">129</ix:nonfraction></div><div id="a40322" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:64px;display:flex;">(<ix:nonfraction id="ID_94" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction>)</div><div id="a40326" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:64px;"><ix:nonfraction id="ID_109" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">85</ix:nonfraction></div><div id="a40328" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Product Development </div><div id="a40331" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:288px;top:80px;"><ix:nonfraction id="ID_180" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">90</ix:nonfraction></div><div id="a40335" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:80px;display:flex;">(<ix:nonfraction id="ID_295" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">56</ix:nonfraction>)</div><div id="a40339" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:80px;"><ix:nonfraction id="ID_283" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">34</ix:nonfraction></div><div id="a40343" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:80px;"><ix:nonfraction id="ID_449" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">114</ix:nonfraction></div><div id="a40347" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:588px;top:80px;display:flex;">(<ix:nonfraction id="ID_181" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">70</ix:nonfraction>)</div><div id="a40351" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:80px;"><ix:nonfraction id="ID_152" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a40353" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Non-compete agreements<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40358" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:288px;top:96px;"><ix:nonfraction id="ID_23" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">25</ix:nonfraction></div><div id="a40362" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:96px;display:flex;">(<ix:nonfraction id="ID_298" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a40366" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:96px;"><ix:nonfraction id="ID_405" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction></div><div id="a40370" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:96px;"><ix:nonfraction id="ID_369" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">25</ix:nonfraction></div><div id="a40374" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:96px;display:flex;">(<ix:nonfraction id="ID_150" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a40378" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:96px;"><ix:nonfraction id="ID_444" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction></div><div id="a40380" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:112px;">Other<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40383" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:288px;top:112px;"><ix:nonfraction id="ID_394" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a40387" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:112px;display:flex;">(<ix:nonfraction id="ID_359" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction>)</div><div id="a40391" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:112px;"><ix:nonfraction id="ID_199" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a40395" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:112px;"><ix:nonfraction id="ID_323" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction></div><div id="a40399" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:112px;display:flex;">(<ix:nonfraction id="ID_29" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction>)</div><div id="a40403" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:112px;"><ix:nonfraction id="ID_80" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a40405" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:128px;"><div style="display:inline-block;width:18px">&nbsp;</div>Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40408" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:228px;top:128px;">$ </div><div id="a40410" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:128px;"><ix:nonfraction id="ID_1762" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,097</ix:nonfraction></div><div id="a40413" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:128px;">$ </div><div id="a40415" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:351px;top:128px;display:flex;">(<ix:nonfraction id="ID_79" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">510</ix:nonfraction>)</div><div id="a40418" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:128px;">$ </div><div id="a40420" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:128px;"><ix:nonfraction id="ID_1763" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">587</ix:nonfraction></div><div id="a40423" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:128px;">$ </div><div id="a40425" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:504px;top:128px;"><ix:nonfraction id="ID_1760" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,149</ix:nonfraction></div><div id="a40428" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:128px;">$ </div><div id="a40430" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:128px;display:flex;">(<ix:nonfraction id="ID_82" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">481</ix:nonfraction>)</div><div id="a40433" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:128px;">$ </div><div id="a40435" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:128px;"><ix:nonfraction id="ID_1761" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">668</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_779_XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2" style="position:absolute;left:62px;top:689px;float:left;"><ix:continuation id="XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2" continuedat="XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2_1"><div id="TextBlockContainer780" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:700px;height:304px;"><div id="a40438" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Trademarks, trade names, customer lists and customer relationships were established through<div style="display:inline-block;width:2px">&nbsp;</div>business acquisitions.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40439" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">Definite-lived trademarks and trade names are amortized on a straight-line<div style="display:inline-block;width:2px">&nbsp;</div>basis over a weighted-average period of </div><div id="a40447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">approximately </div><div id="a40447_14_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:93px;top:34px;"><ix:nonnumeric id="ID_624" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear">8.4</ix:nonnumeric></div><div id="a40447_17_94" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:112px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>years as of December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Customer lists and customer relationships are definite-lived </div><div id="a40457" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">intangible assets that are amortized on a straight-line basis over a weighted-average<div style="display:inline-block;width:2px">&nbsp;</div>period of approximately </div><div id="a40457_110_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:644px;top:51px;"><ix:nonnumeric id="ID_690" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelatedIntangibleAssetsMember" format="ixt-sec:duryear">10.0</ix:nonnumeric></div><div id="a40464" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">years as of December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>Product development is a definite-lived intangible asset that is amortized<div style="display:inline-block;width:2px">&nbsp;</div>on a </div><div id="a40471" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">straight-line basis over a weighted-average period of approximately </div><div id="a40471_68_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:406px;top:84px;"><ix:nonnumeric id="ID_691" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" format="ixt-sec:duryear">8.6</ix:nonnumeric></div><div id="a40471_71_33" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>years as of December 31, 2022.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40482" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">Non-compete agreements represent amounts paid primarily to prior owners of<div style="display:inline-block;width:2px">&nbsp;</div>acquired businesses, as well as </div><div id="a40486" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">certain sales persons, in exchange for placing restrictions on their ability<div style="display:inline-block;width:2px">&nbsp;</div>to pose a competitive risk to us.<div style="display:inline-block;width:7px">&nbsp;</div>Such </div><div id="a40487" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">amounts are amortized, on a straight-line basis over the respective non-compete<div style="display:inline-block;width:2px">&nbsp;</div>period, which generally </div><div id="a40493" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">commences upon termination of employment or separation from us.<div style="display:inline-block;width:6px">&nbsp;</div>The weighted-average non-compete period for </div><div id="a40498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:185px;">agreements currently being amortized was approximately </div><div id="a40498_55_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:346px;top:185px;"><ix:nonnumeric id="ID_1218" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_WeightedAverageMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear">5.3</ix:nonnumeric></div><div id="a40498_58_32" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:364px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>years as of December 31, 2022. </div><div id="a40506" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">Amortization expense, excluding impairment charges, related to definite-lived intangible assets<div style="display:inline-block;width:2px">&nbsp;</div>for the years ended </div><div id="a40513" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">December 31, 2022, December 25, 2021 and December 26, 2020 was $</div><div id="a40513_64_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:236px;"><ix:nonfraction id="ID_427" name="us-gaap:AmortizationOfIntangibleAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">126</ix:nonfraction></div><div id="a40513_67_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a40513_78_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:507px;top:236px;"><ix:nonfraction id="ID_367" name="us-gaap:AmortizationOfIntangibleAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">124</ix:nonfraction></div><div id="a40513_81_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a40513_95_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:236px;"><ix:nonfraction id="ID_320" name="us-gaap:AmortizationOfIntangibleAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">106</ix:nonfraction></div><div id="a40513_98_12" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:633px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a40520" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">During the year ended December 31, 2022, we recorded $</div><div id="a40520_54_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:345px;top:270px;"><ix:nonfraction id="ID_1806" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_BusinessesWithinMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a40520_56_53" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:270px;"><div style="display:inline-block;width:4px">&nbsp;</div>million of impairment charges related to businesses </div><div id="a40523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">within our health care distribution segment, represented by an intangible asset<div style="display:inline-block;width:2px">&nbsp;</div>impairment of $</div><div id="a40523_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:287px;"><ix:nonfraction id="ID_1807" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember_us-gaap_SubsegmentsAxis_hsic_BusinessesWithinMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a40523_97_20" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:287px;"><div style="display:inline-block;width:4px">&nbsp;</div>million related to </div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page89" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:523.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:527.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:477.1px; height:1px; left:66.8px; top:522.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:97.2px; height:1px; left:543.9px; top:522.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:641px; top:522.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:97px; height:1px; left:650.9px; top:522.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:562.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:567.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:602.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:607.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:642.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:647.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20.1px; left:67.2px; top:683.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:688.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:477.1px; height:1px; left:66.8px; top:682.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:97.2px; height:1px; left:543.9px; top:682.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:641px; top:682.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:97px; height:1px; left:650.9px; top:682.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:97.2px; height:1px; left:544.3px; top:703.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:97.2px; height:1px; left:544.3px; top:705.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:97px; height:1px; left:651.3px; top:703.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:97px; height:1px; left:651.3px; top:705.7px; background-color:#000000; ">&nbsp;</div>
<div id="a40527" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a40529" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a40531" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a40533" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a40536" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">89 </div><div id="div_781_XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_296b9e65b3684d1da91450fe6e1aeaa2_1" continuedat="XBRL_TS_cf43ece06f7047dbb2fb9721fc91ca68"><div id="TextBlockContainer782" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:687px;height:68px;"><div id="a40538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">the disposal of an unprofitable business and a $</div><div id="a40538_48_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:283px;top:0px;"><ix:nonfraction id="ID_832AA" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">34</ix:nonfraction></div><div id="a40538_50_56" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:298px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million impairment of customer lists and relationships </div><div id="a40546" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">attributable to customer attrition rates being higher than expected in certain other<div style="display:inline-block;width:2px">&nbsp;</div>businesses.<div style="display:inline-block;width:7px">&nbsp;</div>Our impairment loss </div><div id="a40549" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">was calculated as the difference between the carrying value and the estimated<div style="display:inline-block;width:2px">&nbsp;</div>fair value of the intangible assets, </div><div id="a40550" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">using a discounted estimate of future cash flows.</div></div></ix:continuation></div><div id="a40550_49_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:353px;top:162px;"><div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a40552" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:424px;top:162px;"><a href="#a45998" style="color:#0000FF;text-decoration:underline;">Note 14 – Plans of Restructuring and Integration Costs</a></div><div id="a40557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:179px;">for additional details. </div><div id="div_783_XBRL_TS_cf43ece06f7047dbb2fb9721fc91ca68" style="position:absolute;left:62px;top:213px;float:left;"><ix:continuation id="XBRL_TS_cf43ece06f7047dbb2fb9721fc91ca68"><div id="TextBlockContainer784" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:203px;"><div id="a40560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">During the year ended December 25, 2021, we recorded a $</div><div id="a40560_56_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:0px;"><ix:nonfraction id="ID_833AA" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a40560_57_48" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million impairment charge related ratably to a </div><div id="a40562" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">business within our health care distribution segment and a business within<div style="display:inline-block;width:2px">&nbsp;</div>our technology and value-added services </div><div id="a40565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">segment. </div><div id="a40568" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">During the year ended December 26, 2020, we recorded a $</div><div id="a40568_56_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:355px;top:68px;"><ix:nonfraction id="ID_834AA" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a40568_58_49" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>million impairment charge related to businesses </div><div id="a40571" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">within our technology and value-added services segment due to customer<div style="display:inline-block;width:2px">&nbsp;</div>attrition rates being higher than expected. </div><div id="a40576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">The above intangible asset impairment charges were recorded within selling, general<div style="display:inline-block;width:2px">&nbsp;</div>and administrative expenses; </div><div id="a40578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">and restructuring and integration charges in our consolidated statement of income. </div><div id="a40581" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">The annual amortization expense expected to be recorded for existing<div style="display:inline-block;width:2px">&nbsp;</div>intangibles assets for the years 2023 through </div><div id="a40589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:185px;">2027 is $</div><div id="a40589_9_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:59px;top:185px;"><ix:nonfraction id="ID_114" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">120</ix:nonfraction></div><div id="a40589_12_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:81px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a40589_23_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:142px;top:185px;"><ix:nonfraction id="ID_77" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">96</ix:nonfraction></div><div id="a40589_25_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:156px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a40589_36_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:217px;top:185px;"><ix:nonfraction id="ID_148" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">84</ix:nonfraction></div><div id="a40589_38_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:232px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a40589_49_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:292px;top:185px;"><ix:nonfraction id="ID_51" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">68</ix:nonfraction></div><div id="a40589_51_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:307px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a40589_65_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:389px;top:185px;"><ix:nonfraction id="ID_299" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">55</ix:nonfraction></div><div id="a40589_67_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:185px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.</div></div></ix:continuation></div><div id="div_785_XBRL_CS_db605d93b6bf4380be1ea81f3c1c336b" style="position:absolute;left:62px;top:432px;float:left;"><ix:nonnumeric id="ID_db605d93b6bf4380be1ea81f3c1c336b" name="us-gaap:InvestmentsAndOtherNoncurrentAssetsTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_5aae2287a58441a1a84f6e45df5eb8fe" escape="true"><div id="TextBlockContainer786" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:301px;height:51px;"><div id="a40610" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 8 – Investments and Other </div><div id="a40615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a40616" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Investments and other consisted of the following:</div></div></ix:nonnumeric></div><div id="div_787_XBRL_CS_5aae2287a58441a1a84f6e45df5eb8fe" style="position:absolute;left:63px;top:488px;float:left;"><ix:continuation id="XBRL_CS_5aae2287a58441a1a84f6e45df5eb8fe" continuedat="XBRL_CS_36c499feae134cae8d29533faeafc476"><div id="TextBlockContainer790" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:258px;"><div id="div_788_XBRL_CS_22bea385c9a64f77a368cf0cfc9ae2f8" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_458" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer789" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:258px;"><div id="a40621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:0px;">December 31, </div><div id="a40624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:598px;top:0px;">December 25, </div><div id="a40629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:517px;top:20px;">2022 </div><div id="a40632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:624px;top:20px;">2021 </div><div id="a40634" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">Investment in unconsolidated affiliates<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:40px;">$ </div><div id="a40639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:40px;"><ix:nonfraction id="ID_339" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">161</ix:nonfraction></div><div id="a40642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:40px;">$ </div><div id="a40644" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:40px;"><ix:nonfraction id="ID_107" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">168</ix:nonfraction></div><div id="a40646" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Non-current deferred foreign, state and local income taxes<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a40652" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:60px;"><ix:nonfraction id="ID_81" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">88</ix:nonfraction></div><div id="a40656" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:60px;"><ix:nonfraction id="ID_297" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">35</ix:nonfraction></div><div id="a40658" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Notes receivable </div><div id="a40659" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:97px;top:80px;">(1)</div><div id="a40663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:80px;"><ix:nonfraction id="ID_312" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction></div><div id="a40667" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:80px;"><ix:nonfraction id="ID_344" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction></div><div id="a40669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Capitalized costs for software to be sold, leased or marketed to external<div style="display:inline-block;width:5px">&nbsp;</div>users </div><div id="a40673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:100px;"><ix:nonfraction id="ID_378" name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">79</ix:nonfraction></div><div id="a40677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:100px;"><ix:nonfraction id="ID_414" name="us-gaap:CapitalizedComputerSoftwareNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">65</ix:nonfraction></div><div id="a40679" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">Security deposits<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:120px;"><ix:nonfraction id="ID_1742" name="us-gaap:DepositsAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a40687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:120px;"><ix:nonfraction id="ID_1743" name="us-gaap:DepositsAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a40689" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:140px;">Acquisition-related indemnification<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40695" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:140px;"><ix:nonfraction id="ID_1780" name="hsic:AcquisitionRelatedIndemnification" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">59</ix:nonfraction></div><div id="a40699" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:140px;"><ix:nonfraction id="ID_1781" name="hsic:AcquisitionRelatedIndemnification" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">66</ix:nonfraction></div><div id="a40701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:160px;">Non-current pension assets </div><div id="a40707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:160px;"><ix:nonfraction id="ID_1566" name="us-gaap:DeferredCompensationPlanAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a40711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:160px;"><ix:nonfraction id="ID_1567" name="us-gaap:DeferredCompensationPlanAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a40713" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:180px;">Other long-term assets </div><div id="a40719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:180px;"><ix:nonfraction id="ID_116" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction></div><div id="a40723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:180px;"><ix:nonfraction id="ID_366" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">52</ix:nonfraction></div><div id="a40726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:201px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a40729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:481px;top:201px;">$ </div><div id="a40731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:559px;top:201px;"><ix:nonfraction id="ID_272A" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">472</ix:nonfraction></div><div id="a40734" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:589px;top:201px;">$ </div><div id="a40736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:201px;"><ix:nonfraction id="ID_191A" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">424</ix:nonfraction></div><div id="a40746" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:228px;">(1) </div><div id="a40748" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:228px;">Long-term notes receivable carry interest rates ranging from </div><div id="a40748_61_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:327px;top:228px;"><ix:nonfraction id="ID_360" name="hsic:NotesReceivableNoncurrentEffectiveInterestRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">3.0</ix:nonfraction></div><div id="a40748_64_5" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:228px;">% to </div><div id="a40748_69_3" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:367px;top:228px;"><ix:nonfraction id="ID_11" name="hsic:NotesReceivableNoncurrentEffectiveInterestRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_us-gaap_FinanceReceivablesMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">7.5</ix:nonfraction></div><div id="a40748_72_46" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:228px;">% and are due in varying installments through </div><div id="a40753_1_12" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:37px;top:244px;-sec-ix-hidden:ID_259;">May 11, 2028</div><div id="a40753_13_1" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:104px;top:244px;">.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_791_XBRL_CS_36c499feae134cae8d29533faeafc476" style="position:absolute;left:62px;top:762px;float:left;"><ix:continuation id="XBRL_CS_36c499feae134cae8d29533faeafc476"><div id="TextBlockContainer792" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:685px;height:52px;"><div id="a40757" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Amortization expense, primarily related to capitalized costs for software to<div style="display:inline-block;width:2px">&nbsp;</div>be sold, leased or marketed to external </div><div id="a40761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">users, for the years ended December 31, 2022, December 25, 2021 and<div style="display:inline-block;width:2px">&nbsp;</div>December 26, 2020 was $</div><div id="a40761_91_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:17px;"><ix:nonfraction id="ID_306" name="us-gaap:OtherDepreciationAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">18</ix:nonfraction></div><div id="a40761_93_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a40761_104_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:653px;top:17px;"><ix:nonfraction id="ID_450" name="us-gaap:OtherDepreciationAndAmortization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a40776" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">million and $</div><div id="a40776_13_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:83px;top:34px;"><ix:nonfraction id="ID_258" name="us-gaap:OtherDepreciationAndAmortization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">16</ix:nonfraction></div><div id="a40776_15_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:98px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page90" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:685.6px; height:202.4px; left:65.3px; top:786.4px; background-color:#FFFFFF; ">&nbsp;</div>
<div id="a40782" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a40784" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a40786" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a40788" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a40791" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">90 </div><div id="div_793_XBRL_TS_684d5e0fb4b24d0da4460fb20be4540e" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_684d5e0fb4b24d0da4460fb20be4540e" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_60a3a7ce3c3a4166a4a537d402082195" escape="true"><div id="TextBlockContainer794" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:698px;height:861px;"><div id="a40793" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 9 – Fair Value Measurements</div><div id="a40800" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a40801" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Fair value is defined as the price that would be received to sell an asset or<div style="display:inline-block;width:2px">&nbsp;</div>paid to transfer a liability in an orderly </div><div id="a40802" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">transaction between market participants at the measurement date.<div style="display:inline-block;width:6px">&nbsp;</div>The fair value hierarchy distinguishes between </div><div id="a40803" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">(1) market participant assumptions developed based on market data obtained<div style="display:inline-block;width:2px">&nbsp;</div>from independent sources (observable </div><div id="a40808" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best </div><div id="a40811" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">information available in the circumstances (unobservable inputs). </div><div id="a40815" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">The fair value hierarchy consists of three broad levels, which gives the<div style="display:inline-block;width:2px">&nbsp;</div>highest priority to unadjusted quoted prices </div><div id="a40816" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">in active markets for identical assets or liabilities (Level 1) and the lowest priority<div style="display:inline-block;width:2px">&nbsp;</div>to unobservable inputs (Level 3).<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40817" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">The three levels of the fair value hierarchy are described as follows: </div><div id="a40821" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">•<div style="display:inline-block;width:18px">&nbsp;</div>Level 1— Unadjusted quoted prices in active markets for identical assets<div style="display:inline-block;width:2px">&nbsp;</div>or liabilities that are accessible at the </div><div id="a40825" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">measurement date. </div><div id="a40828" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">•<div style="display:inline-block;width:18px">&nbsp;</div>Level 2— Inputs other than quoted prices included within Level 1 that are observable<div style="display:inline-block;width:2px">&nbsp;</div>for the asset or liability, </div><div id="a40833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">either directly or indirectly.<div style="display:inline-block;width:8px">&nbsp;</div>Level 2 inputs include: quoted prices for similar assets or liabilities<div style="display:inline-block;width:2px">&nbsp;</div>in active markets; </div><div id="a40834" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">quoted prices for identical or similar assets or liabilities in markets that are<div style="display:inline-block;width:2px">&nbsp;</div>not active; inputs other than quoted </div><div id="a40837" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">prices that are observable for the asset or liability; and inputs that are<div style="display:inline-block;width:2px">&nbsp;</div>derived principally from or corroborated by </div><div id="a40838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">observable market data by correlation or other means. </div><div id="a40841" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">•<div style="display:inline-block;width:18px">&nbsp;</div>Level 3— Inputs that are unobservable for the asset or liability. </div><div id="a40848" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">The following section describes the fair values of our financial instruments<div style="display:inline-block;width:2px">&nbsp;</div>and the methodologies that we used to </div><div id="a40849" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">measure their fair values.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40852" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:439px;">Investments and notes receivable </div><div id="a40855" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:472px;">There are no quoted market prices available for investments in unconsolidated<div style="display:inline-block;width:2px">&nbsp;</div>affiliates and notes receivable.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a40858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">Certain of our notes receivable contain variable interest rates.<div style="display:inline-block;width:6px">&nbsp;</div>We believe the carrying amounts are a reasonable </div><div id="a40860" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">estimate of fair value based on the interest rates in the applicable markets.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a40866" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:540px;">Debt </div><div id="a40869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:574px;">The fair value of our debt (including bank credit lines, current maturities<div style="display:inline-block;width:2px">&nbsp;</div>of long-term debt and long-term debt) is </div><div id="a40876" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:590px;">classified as Level 3 within the fair value hierarchy, and as of December 31, 2022 and December 25, 2021 was </div><div id="a40880" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:607px;">estimated at $</div><div id="a40880_14_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:87px;top:607px;"><ix:nonfraction id="ID_401" name="us-gaap:DebtInstrumentFairValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,149</ix:nonfraction></div><div id="a40880_19_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:607px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a40880_33_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:201px;top:607px;"><ix:nonfraction id="ID_406" name="us-gaap:DebtInstrumentFairValue" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">873</ix:nonfraction></div><div id="a40880_36_77" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:223px;top:607px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>Factors that we considered when estimating the fair </div><div id="a40881" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:624px;">value of our debt include market conditions, such as interest rates and credit<div style="display:inline-block;width:2px">&nbsp;</div>spreads. </div><div id="a40884" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:658px;">Derivative contracts </div><div id="a40887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:692px;">Derivative contracts are valued using quoted market prices and<div style="display:inline-block;width:2px">&nbsp;</div>significant other observable inputs.<div style="display:inline-block;width:7px">&nbsp;</div>We use </div><div id="a40892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:709px;">derivative instruments to minimize our exposure to fluctuations in foreign<div style="display:inline-block;width:2px">&nbsp;</div>currency exchange rates.<div style="display:inline-block;width:7px">&nbsp;</div>Our derivative </div><div id="a40895" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:725px;">instruments primarily include foreign currency forward agreements related<div style="display:inline-block;width:2px">&nbsp;</div>to certain intercompany loans, certain </div><div id="a40897" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:742px;">forecasted inventory purchase commitments with foreign suppliers,<div style="display:inline-block;width:2px">&nbsp;</div>foreign currency forward contracts to hedge a </div><div id="a40898" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:759px;">portion of our euro-denominated foreign operations which are designated<div style="display:inline-block;width:2px">&nbsp;</div>as net investment hedges and a total </div><div id="a40902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:776px;">return swap for the purpose of economically hedging our unfunded<div style="display:inline-block;width:2px">&nbsp;</div>non-qualified SERP and our DCP. </div><div id="a40907" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:810px;">The fair values for the majority of our foreign currency derivative contracts<div style="display:inline-block;width:2px">&nbsp;</div>are obtained by comparing our contract </div><div id="a40908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:827px;">rate to a published forward price of the underlying market rates, which<div style="display:inline-block;width:2px">&nbsp;</div>is based on market rates for comparable </div><div id="a40910" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:843px;">transactions and are classified within Level 2 of the fair value hierarchy.</div></div></ix:nonnumeric></div><div id="a40910_75_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:492px;top:955px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a40911" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:524px;top:955px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Note 11-Derivatives and Hedging </a></div><div id="a40914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:972px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Activities</a></div><div id="a40915" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:972px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information. </div></div>
</div>
<div style="padding: 7px">
<div id="Page91" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:370px; height:1px; left:377.9px; top:429.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:444.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:444.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:444.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:444.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:459.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:489.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:503.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:503.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:503.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:503.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:11px; left:67.2px; top:522.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:14.9px; left:67.2px; top:518.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:311.1px; height:3px; left:67.2px; top:518.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:518.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:520.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:3px; left:463.3px; top:518.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:518.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:520.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:558.3px; top:518.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:568.3px; top:521.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:518.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:520.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:3px; left:653.4px; top:518.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:663.3px; top:521.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:518.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:520.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:521.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:548.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:578px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:592.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:592.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:592.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:592.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:11px; left:67.2px; top:611.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:14.9px; left:67.2px; top:607.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:311.1px; height:3px; left:67.2px; top:607.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:607.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:609.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:610.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:3px; left:463.3px; top:607.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:607.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:609.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:610.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:558.3px; top:607.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:568.3px; top:610.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:607.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:609.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:610.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:3px; left:653.4px; top:607.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:663.3px; top:610.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:607.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:609.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:610.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:637.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:639.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:637.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:639.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:637.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:639.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:637.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:639.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:370px; height:1px; left:377.9px; top:666.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:681.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:681.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:681.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:681.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:696.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:726px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:756.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:14.9px; left:67.2px; top:755.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:311.1px; height:1px; left:66.8px; top:755.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:462.9px; top:755.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:558.3px; top:755.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:755.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:755.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:770.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:772.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:770.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:772.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:770.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:772.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:770.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:772.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:785.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:814.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:829.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:829.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:829.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:829.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:11px; left:67.2px; top:848.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:14.9px; left:67.2px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:311.1px; height:3px; left:67.2px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:844.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:378.3px; top:846.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:377.9px; top:847px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:3px; left:463.3px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:844.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473.4px; top:846.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:847px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:558.3px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:568.3px; top:847.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:844.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:568.3px; top:846.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:847px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:3px; left:653.4px; top:844.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:12px; left:663.3px; top:847.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:844.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:663.3px; top:846.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:847px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:377.3px; top:876.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:377.3px; top:874.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:876.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:874.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:876.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:874.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:876.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:874.2px; background-color:#000000; ">&nbsp;</div>
<div id="a40919" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a40921" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a40923" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a40925" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a40928" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">91 </div><div id="div_795_XBRL_TS_60a3a7ce3c3a4166a4a537d402082195" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_60a3a7ce3c3a4166a4a537d402082195" continuedat="XBRL_TS_5573b738d5dd4687918526a37988ff70"><div id="TextBlockContainer796" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:170px;"><div id="a40930" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Total<div style="display:inline-block;width:5px">&nbsp;</div>Return Swaps</div><div id="a40933" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">The fair value for the Total Return Swap is measured by valuing the underlying ETFs of the swap using market-on-</div><div id="a40937" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">close pricing by industry providers as of the valuation date and are<div style="display:inline-block;width:2px">&nbsp;</div>classified within Level 2 of the fair value </div><div id="a40939" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">hierarchy. </div><div id="a40942" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:101px;">Redeemable noncontrolling interests </div><div id="a40945" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">The values for Redeemable noncontrolling interests are classified within<div style="display:inline-block;width:2px">&nbsp;</div>Level 3 of the fair value hierarchy and are </div><div id="a40946" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">based on recent transactions and/or implied multiples of earnings.</div></div></ix:continuation></div><div id="a40946_66_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:453px;top:264px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a40947" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:485px;top:264px;"><a href="#a48747" style="color:#0000FF;text-decoration:underline;">Note 18 – Redeemable Noncontrolling </a></div><div id="a40951" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:281px;"><a href="#a48747" style="color:#0000FF;text-decoration:underline;">Interests</a></div><div id="a40952" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:117px;top:281px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional information. </div><div id="div_797_XBRL_TS_5573b738d5dd4687918526a37988ff70" style="position:absolute;left:62px;top:314px;float:left;"><ix:continuation id="XBRL_TS_5573b738d5dd4687918526a37988ff70" continuedat="XBRL_TS_7e7f062a42f94611a58fbd253258bbc5"><div id="TextBlockContainer798" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:644px;height:35px;"><div id="a40956" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Assets measured on a non-recurring basis at fair value include Goodwill<div style="display:inline-block;width:2px">&nbsp;</div>and Other intangibles, net, and are </div><div id="a40959" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">classified as Level 3 within the fair value hierarchy.</div></div></ix:continuation></div><div id="a40959_54_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:372px;top:331px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a40961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:404px;top:331px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Note 1 – Basis of Presentation and Significant Accounting </a></div><div id="a40965" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:348px;"><a href="#a33123" style="color:#0000FF;text-decoration:underline;">Policies</a></div><div id="a40966" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:114px;top:348px;"><div style="display:inline-block;width:4px">&nbsp;</div>and </div><div id="a40968" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:142px;top:348px;"><a href="#a40026" style="color:#0000FF;text-decoration:underline;">Note 7 – Goodwill and Other Intangibles, Net</a></div><div id="a40972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:411px;top:348px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional information.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_799_XBRL_TS_7e7f062a42f94611a58fbd253258bbc5" style="position:absolute;left:62px;top:348px;float:left;"><ix:continuation id="XBRL_TS_7e7f062a42f94611a58fbd253258bbc5" continuedat="XBRL_CS_2756253943cb40b29465b77a1beaf4f9"><div id="TextBlockContainer800" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:52px;"><div id="a40972_30_29" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:0px;">The following table presents </div><div id="a40975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">our assets and liabilities that are measured and recognized at fair value on<div style="display:inline-block;width:2px">&nbsp;</div>a recurring basis classified under the </div><div id="a40978" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">appropriate level of the fair value hierarchy as of December 31, 2022 and<div style="display:inline-block;width:2px">&nbsp;</div>December 25, 2021:</div></div></ix:continuation></div><div id="div_801_XBRL_CS_3c93659429804815945d723e80630d44" style="position:absolute;left:63px;top:416px;float:left;"><ix:nonnumeric id="ID_380" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer804" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:460px;"><div id="div_802_XBRL_CS_2756253943cb40b29465b77a1beaf4f9" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_2756253943cb40b29465b77a1beaf4f9"><div id="TextBlockContainer803" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:460px;"><div id="a40985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:447px;top:0px;">December 31, 2022 </div><div id="a40992" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:345px;top:15px;">Level 1 </div><div id="a40996" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:15px;">Level 2 </div><div id="a41000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:15px;">Level 3 </div><div id="a41004" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:635px;top:15px;">Total </div><div id="a41021" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:44px;">Assets: </div><div id="a41036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:59px;">Derivative contracts designated as hedges </div><div id="a41039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:59px;">$ </div><div id="a41041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:59px;"><ix:nonfraction id="ID_1241" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:59px;">$ </div><div id="a41046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:59px;"><ix:nonfraction id="ID_1242" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a41049" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:59px;">$ </div><div id="a41051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:59px;"><ix:nonfraction id="ID_1243" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41054" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:59px;">$ </div><div id="a41056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:59px;"><ix:nonfraction id="ID_1239" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a41059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:74px;">Derivative contracts undesignated </div><div id="a41063" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:74px;"><ix:nonfraction id="ID_1244" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41067" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:74px;"><ix:nonfraction id="ID_1245" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a41071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:74px;"><ix:nonfraction id="ID_1246" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41075" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:74px;"><ix:nonfraction id="ID_1240" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a41079" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:39px;top:89px;">Total assets<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41082" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:89px;">$ </div><div id="a41084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:89px;"><ix:nonfraction id="ID_136" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:89px;">$ </div><div id="a41089" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:89px;"><ix:nonfraction id="ID_278" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">27</ix:nonfraction></div><div id="a41092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:89px;">$ </div><div id="a41094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:89px;"><ix:nonfraction id="ID_45" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41097" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:89px;">$ </div><div id="a41099" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:89px;"><ix:nonfraction id="ID_220" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">27</ix:nonfraction></div><div id="a41116" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:118px;">Liabilities: </div><div id="a41131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:133px;">Derivative contracts designated as hedges </div><div id="a41134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:133px;">$ </div><div id="a41136" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:133px;"><ix:nonfraction id="ID_1256" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:133px;">$ </div><div id="a41141" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:133px;"><ix:nonfraction id="ID_1257" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:133px;">$ </div><div id="a41146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:133px;"><ix:nonfraction id="ID_1258" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41149" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:133px;">$ </div><div id="a41151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:133px;"><ix:nonfraction id="ID_1254" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41154" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:148px;">Derivative contracts undesignated </div><div id="a41158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:148px;"><ix:nonfraction id="ID_1259" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41162" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:148px;"><ix:nonfraction id="ID_1260" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41166" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:148px;"><ix:nonfraction id="ID_1261" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:148px;"><ix:nonfraction id="ID_1255" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41173" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:163px;">Total return<div style="display:inline-block;width:5px">&nbsp;</div>swaps </div><div id="a41177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:163px;"><ix:nonfraction id="ID_1568" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41181" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:163px;"><ix:nonfraction id="ID_1569" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:163px;"><ix:nonfraction id="ID_1570" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41189" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:163px;"><ix:nonfraction id="ID_1571" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:39px;top:178px;">Total liabilities<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a41196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:178px;">$ </div><div id="a41198" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:178px;"><ix:nonfraction id="ID_377" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41201" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:178px;">$ </div><div id="a41203" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:178px;"><ix:nonfraction id="ID_374" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a41206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:178px;">$ </div><div id="a41208" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:178px;"><ix:nonfraction id="ID_14" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41211" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:178px;">$ </div><div id="a41213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:178px;"><ix:nonfraction id="ID_355" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a41230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:207px;">Redeemable noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41233" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:207px;">$ </div><div id="a41235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:207px;"><ix:nonfraction id="ID_315" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41238" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:207px;">$ </div><div id="a41240" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:207px;"><ix:nonfraction id="ID_212" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:207px;">$ </div><div id="a41245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:207px;"><ix:nonfraction id="ID_455" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">576</ix:nonfraction></div><div id="a41248" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:207px;">$ </div><div id="a41250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:207px;"><ix:nonfraction id="ID_308" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">576</ix:nonfraction></div><div id="a41271" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:447px;top:237px;">December 25, 2021 </div><div id="a41278" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:345px;top:252px;">Level 1 </div><div id="a41282" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:252px;">Level 2 </div><div id="a41286" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:252px;">Level 3 </div><div id="a41290" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:635px;top:252px;">Total </div><div id="a41307" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:281px;">Assets: </div><div id="a41322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:296px;">Derivative contracts designated as hedges </div><div id="a41325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:296px;">$ </div><div id="a41327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:296px;"><ix:nonfraction id="ID_1249" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41330" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:296px;">$ </div><div id="a41332" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:296px;"><ix:nonfraction id="ID_1250" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a41335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:296px;">$ </div><div id="a41337" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:296px;"><ix:nonfraction id="ID_1251" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41340" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:296px;">$ </div><div id="a41342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:296px;"><ix:nonfraction id="ID_1247" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a41345" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:311px;">Derivative contracts undesignated </div><div id="a41349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:311px;"><ix:nonfraction id="ID_1252" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:311px;"><ix:nonfraction id="ID_1253" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41357" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:311px;"><ix:nonfraction id="ID_1572" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41361" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:311px;"><ix:nonfraction id="ID_1248" name="us-gaap:DerivativeAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41364" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:326px;">Total return<div style="display:inline-block;width:5px">&nbsp;</div>swap </div><div id="a41368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:326px;"><ix:nonfraction id="ID_1221" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:326px;"><ix:nonfraction id="ID_1222" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:326px;"><ix:nonfraction id="ID_1223" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:326px;"><ix:nonfraction id="ID_1219" name="us-gaap:FairValueDisclosureOffbalanceSheetRisksAmountAsset" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:39px;top:341px;">Total assets<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41387" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:341px;">$ </div><div id="a41389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:341px;"><ix:nonfraction id="ID_1224" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:341px;">$ </div><div id="a41394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:341px;"><ix:nonfraction id="ID_1225" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a41397" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:341px;">$ </div><div id="a41399" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:341px;"><ix:nonfraction id="ID_1226" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41402" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:341px;">$ </div><div id="a41404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:341px;"><ix:nonfraction id="ID_1220" name="us-gaap:AssetsFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a41421" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:370px;">Liabilities: </div><div id="a41436" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:385px;">Derivative contracts designated as hedges </div><div id="a41439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:385px;">$ </div><div id="a41441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:385px;"><ix:nonfraction id="ID_1264" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41444" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:385px;">$ </div><div id="a41446" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:385px;"><ix:nonfraction id="ID_1265" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41449" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:385px;">$ </div><div id="a41451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:385px;"><ix:nonfraction id="ID_1266" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:385px;">$ </div><div id="a41456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:385px;"><ix:nonfraction id="ID_1262" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a41459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:400px;">Derivative contracts undesignated </div><div id="a41463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:400px;"><ix:nonfraction id="ID_1267" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:400px;"><ix:nonfraction id="ID_1268" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a41471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:400px;"><ix:nonfraction id="ID_1269" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:400px;"><ix:nonfraction id="ID_1263" name="us-gaap:DerivativeLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_FairValueDisclosureItemAmountsDomain_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a41479" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:39px;top:415px;">Total liabilities<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a41482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:415px;">$ </div><div id="a41484" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:415px;"><ix:nonfraction id="ID_245" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:415px;">$ </div><div id="a41489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:415px;"><ix:nonfraction id="ID_33" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:415px;">$ </div><div id="a41494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:415px;"><ix:nonfraction id="ID_24" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:415px;">$ </div><div id="a41499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:415px;"><ix:nonfraction id="ID_48" name="us-gaap:LiabilitiesFairValueDisclosure" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a41516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:444px;">Redeemable noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:316px;top:444px;">$ </div><div id="a41521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:444px;"><ix:nonfraction id="ID_246" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:444px;">$ </div><div id="a41526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:444px;"><ix:nonfraction id="ID_279" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41529" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:444px;">$ </div><div id="a41531" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:444px;"><ix:nonfraction id="ID_190" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">613</ix:nonfraction></div><div id="a41534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:444px;">$ </div><div id="a41536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:444px;"><ix:nonfraction id="ID_260" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">613</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page92" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a41538" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a41540" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a41542" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a41544" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a41547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">92 </div><div id="div_805_XBRL_CS_446c131317654915805b9867a7dfca0a" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_307" name="us-gaap:ConcentrationRiskDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer806" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:450px;"><div id="a41549" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 10 – Concentrations of Risk </div><div id="a41556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a41557" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Certain financial instruments potentially subject us to concentrations of<div style="display:inline-block;width:2px">&nbsp;</div>credit risk.<div style="display:inline-block;width:7px">&nbsp;</div>These financial instruments </div><div id="a41560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">consist primarily of cash equivalents, trade receivables, long-term investments,<div style="display:inline-block;width:2px">&nbsp;</div>notes receivable and derivative </div><div id="a41563" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">instruments.<div style="display:inline-block;width:7px">&nbsp;</div>In all cases, our maximum exposure to loss from credit<div style="display:inline-block;width:2px">&nbsp;</div>risk equals the gross fair value of the financial </div><div id="a41565" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">instruments.<div style="display:inline-block;width:7px">&nbsp;</div>We routinely maintain cash balances at financial institutions in excess of insured amounts.<div style="display:inline-block;width:7px">&nbsp;</div>We have </div><div id="a41570" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">not experienced any loss in such accounts and we manage this risk through<div style="display:inline-block;width:2px">&nbsp;</div>maintaining cash deposits and other </div><div id="a41573" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">highly liquid investments in high quality financial institutions.<div style="display:inline-block;width:6px">&nbsp;</div>We continuously assess the need for reserves for </div><div id="a41577" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">such losses, which have been within our expectations.<div style="display:inline-block;width:6px">&nbsp;</div>We do not require collateral or other security to support </div><div id="a41578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:150px;">financial instruments subject to credit risk, except for long-term notes receivable. </div><div id="a41584" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:183px;">We limit our credit risk with respect to our cash equivalents, short-term and long-term investments and derivative </div><div id="a41589" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">instruments, by monitoring the credit worthiness of the financial institutions<div style="display:inline-block;width:2px">&nbsp;</div>who are the counter-parties to such </div><div id="a41593" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">financial instruments.<div style="display:inline-block;width:7px">&nbsp;</div>As a risk management policy, we limit the amount of credit exposure by diversifying and </div><div id="a41594" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:233px;">utilizing numerous investment grade counter-parties. </div><div id="a41600" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:265px;">With respect to our trade receivables, our credit risk is somewhat limited due to a relatively large customer base<div style="display:inline-block;width:2px">&nbsp;</div>and </div><div id="a41603" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:282px;">its dispersion across different types of health care professionals and geographic areas.<div style="display:inline-block;width:6px">&nbsp;</div>No single customer </div><div id="a41607" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:299px;">accounted for more than </div><div id="a41607_24_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:152px;top:299px;"><ix:nonfraction id="ID_1565" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_MajorCustomersAxis_hsic_AnySingleCustomerMember_srt_RangeAxis_srt_MaximumMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">2</ix:nonfraction></div><div id="a41607_25_87" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:159px;top:299px;">% of our net sales in 2022 or 2021.<div style="display:inline-block;width:7px">&nbsp;</div>With respect to our sources of supply, our top 10 </div><div id="a41613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:316px;">health care distribution suppliers and our single largest supplier accounted for approximately </div><div id="a41613_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:316px;"><ix:nonfraction id="ID_429" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CounterpartyNameAxis_hsic_TopTenHealthCareDistributionSuppliersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_PurchasesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">28</ix:nonfraction></div><div id="a41613_97_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:316px;">% and </div><div id="a41613_103_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:316px;"><ix:nonfraction id="ID_375" name="us-gaap:ConcentrationRiskPercentage1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_CounterpartyNameAxis_hsic_SingleLargestSupplierMember_us-gaap_ConcentrationRiskByBenchmarkAxis_hsic_PurchasesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">4</ix:nonfraction></div><div id="a41613_104_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:616px;top:316px;">%, </div><div id="a41624" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:333px;">respectively, of our aggregate purchases in each of the years ended December 31, 2022 and December 25, 2021. </div><div id="a41628" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:365px;">Our long-term notes receivable primarily represent strategic financing arrangements<div style="display:inline-block;width:2px">&nbsp;</div>with certain affiliates.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41634" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:382px;">Generally, these notes are secured by certain assets of the counterparty; however, in most cases our security is </div><div id="a41635" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:399px;">subordinate to other commercial financial institutions.<div style="display:inline-block;width:6px">&nbsp;</div>While we have exposure to credit loss in the event of non-</div><div id="a41638" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:416px;">performance by these counter-parties, we conduct ongoing assessments<div style="display:inline-block;width:2px">&nbsp;</div>of their financial and operational </div><div id="a41641" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:433px;">performance.</div></div></ix:nonnumeric></div><div id="div_807_XBRL_TS_9eb85431afd04c0d93656a25b8be18a9" style="position:absolute;left:62px;top:578px;float:left;"><ix:nonnumeric id="ID_9eb85431afd04c0d93656a25b8be18a9" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_dd951a10e60f46c98b62204254b7d20c" escape="true"><div id="TextBlockContainer808" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:289px;height:17px;"><div id="a41644" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 11 – Derivatives and Hedging Activities</div></div></ix:nonnumeric></div><div id="a41650" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:595px;">&nbsp;</div><div id="div_809_XBRL_TS_dd951a10e60f46c98b62204254b7d20c" style="position:absolute;left:62px;top:612px;float:left;"><ix:continuation id="XBRL_TS_dd951a10e60f46c98b62204254b7d20c" continuedat="XBRL_TS_650a0ec603764dcd9a9b53ea59942a0e"><div id="TextBlockContainer810" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:321px;"><div id="a41651" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">We are exposed to market risks as well as changes in foreign currency exchange rates as measured against the U.S. </div><div id="a41652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">dollar and each other, and changes to the credit risk of the derivative counterparties.<div style="display:inline-block;width:6px">&nbsp;</div>We attempt to minimize these </div><div id="a41653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">risks by primarily using foreign currency forward contracts and by<div style="display:inline-block;width:2px">&nbsp;</div>maintaining counter-party credit limits.<div style="display:inline-block;width:6px">&nbsp;</div>These </div><div id="a41658" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">hedging activities provide only limited protection against currency exchange<div style="display:inline-block;width:2px">&nbsp;</div>and credit risks.<div style="display:inline-block;width:7px">&nbsp;</div>Factors that could </div><div id="a41659" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">influence the effectiveness of our hedging programs include currency markets and<div style="display:inline-block;width:2px">&nbsp;</div>availability of hedging </div><div id="a41661" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">instruments and liquidity of the credit markets.<div style="display:inline-block;width:6px">&nbsp;</div>All foreign currency forward contracts that we enter into are </div><div id="a41662" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">components of hedging programs and are entered into for the sole purpose<div style="display:inline-block;width:2px">&nbsp;</div>of hedging an existing or anticipated </div><div id="a41664" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">currency exposure.<div style="display:inline-block;width:7px">&nbsp;</div>We do not enter into such contracts for speculative purposes and we manage our credit risks by </div><div id="a41665" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">diversifying our counterparties, maintaining a strong balance sheet and<div style="display:inline-block;width:2px">&nbsp;</div>having multiple sources of capital. </div><div id="a41668" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">During 2019 we entered into foreign currency forward contracts to hedge<div style="display:inline-block;width:2px">&nbsp;</div>a portion of our euro-denominated </div><div id="a41672" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">foreign operations which are designated as net investment hedges.<div style="display:inline-block;width:6px">&nbsp;</div>These net investment hedges offset the change </div><div id="a41673" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">in the U.S. dollar value of our investment in certain euro-functional currency<div style="display:inline-block;width:2px">&nbsp;</div>subsidiaries due to fluctuating foreign </div><div id="a41677" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">exchange rates.<div style="display:inline-block;width:7px">&nbsp;</div>Gains and losses related to these net investment hedges are recorded<div style="display:inline-block;width:2px">&nbsp;</div>in accumulated other </div><div id="a41678" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">comprehensive loss within our consolidated balance sheets.<div style="display:inline-block;width:6px">&nbsp;</div>Amounts excluded from the assessment of hedge </div><div id="a41680" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">effectiveness are included in interest expense within our consolidated statements<div style="display:inline-block;width:2px">&nbsp;</div>of income.<div style="display:inline-block;width:7px">&nbsp;</div>The aggregate </div><div id="a41681" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">notional value of this net investment hedge, which matures on </div><div id="a41681_62_17" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:373px;top:270px;"><ix:nonnumeric id="ID_1140" name="us-gaap:DerivativeMaturityDates" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember" format="ixt:datemonthdayyearen">November 16, 2023</ix:nonnumeric></div><div id="a41681_79_20" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:490px;top:270px;">, is approximately €</div><div id="a41681_99_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:270px;"><ix:nonfraction id="ID_1141" name="us-gaap:DerivativeNotionalAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember" unitref="EUR" decimals="-6" format="ixt:numdotdecimal" scale="6">200</ix:nonfraction></div><div id="a41681_102_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:270px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">During the years ended December 31, 2022 and December 25, 2021, we<div style="display:inline-block;width:2px">&nbsp;</div>recorded losses of $</div><div id="a41682_87_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:549px;top:287px;"><ix:nonfraction id="ID_1573" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_OtherComprehensiveIncomeLocationAxis_us-gaap_OtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">9</ix:nonfraction></div><div id="a41682_88_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:557px;top:287px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a41682_102_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:287px;"><ix:nonfraction id="ID_1574" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_OtherComprehensiveIncomeLocationAxis_us-gaap_OtherComprehensiveIncomeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction></div><div id="a41688" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">million, respectively, within other comprehensive income related to these foreign currency forward contracts.</div></div></ix:continuation></div><div id="a41688_109_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:709px;top:915px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a41689" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:932px;"><a href="#a40800" style="color:#0000FF;text-decoration:underline;">Note 9 – Fair Value<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Measurements</a></div><div id="a41693" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:273px;top:932px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional information. </div></div>
</div>
<div style="padding: 7px">
<div id="Page93" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a41697" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a41699" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a41701" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a41703" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a41706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">93 </div><div id="div_811_XBRL_TS_650a0ec603764dcd9a9b53ea59942a0e" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_650a0ec603764dcd9a9b53ea59942a0e" continuedat="XBRL_TS_effb51d0545f43f7bf4c890a832b0826"><div id="TextBlockContainer812" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:187px;"><div id="a41708" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">On </div><div id="a41708_3_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:27px;top:0px;"><ix:nonnumeric id="ID_1144" name="us-gaap:DerivativeInceptionDates" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember" format="ixt:datemonthdayyearen">March 20, 2020</ix:nonnumeric></div><div id="a41708_17_95" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:120px;top:0px;">, we entered into a total return swap for the purpose of economically hedging<div style="display:inline-block;width:2px">&nbsp;</div>our unfunded non-</div><div id="a41711" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">qualified SERP and our DCP.<div style="display:inline-block;width:8px">&nbsp;</div>This swap will offset changes in our SERP and DCP liabilities.<div style="display:inline-block;width:7px">&nbsp;</div>At the inception, the </div><div id="a41712" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">notional value of the investments in these plans was $</div><div id="a41712_54_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:34px;"><ix:nonfraction id="ID_1142" name="us-gaap:DerivativeNotionalAmount" contextref="AS_OF_Mar20_2020_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">43</ix:nonfraction></div><div id="a41712_56_59" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:335px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>At December 31, 2022, the notional value of the </div><div id="a41714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">investments in these plans was $</div><div id="a41714_32_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:196px;top:51px;"><ix:nonfraction id="ID_1575" name="us-gaap:DerivativeNotionalAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonfraction></div><div id="a41714_34_78" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:211px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>At December 31, 2022, the financing blended rate for<div style="display:inline-block;width:2px">&nbsp;</div>this swap was </div><div id="a41718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">based on the Secured Overnight Financing Rate (“SOFR”) of </div><div id="a41718_58_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:368px;top:68px;"><ix:nonfraction id="ID_1576" name="us-gaap:DerivativeBasisSpreadOnVariableRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember_us-gaap_VariableRateAxis_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">4.03</ix:nonfraction></div><div id="a41718_62_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:68px;">% plus </div><div id="a41718_69_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:68px;"><ix:nonfraction id="ID_1577" name="us-gaap:DerivativeFixedInterestRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember_us-gaap_VariableRateAxis_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">0.55</ix:nonfraction></div><div id="a41718_73_26" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:463px;top:68px;">%, for a combined rate of </div><div id="a41718_99_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:617px;top:68px;"><ix:nonfraction id="ID_1578" name="us-gaap:DerivativeVariableInterestRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember_us-gaap_VariableRateAxis_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">4.58</ix:nonfraction></div><div id="a41718_103_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:643px;top:68px;">%.<div style="display:inline-block;width:7px">&nbsp;</div>For </div><div id="a41732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">the years ended December 31, 2022 and December 25, 2021, we have<div style="display:inline-block;width:2px">&nbsp;</div>recorded a gain/(loss), within selling, general </div><div id="a41737" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">and administrative in our consolidated statement of income, of approximately<div style="display:inline-block;width:2px">&nbsp;</div>($</div><div id="a41737_79_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:101px;"><ix:nonfraction id="ID_1744" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">17</ix:nonfraction></div><div id="a41737_81_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:101px;">) million and $</div><div id="a41737_96_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:578px;top:101px;"><ix:nonfraction id="ID_1745" name="us-gaap:DerivativeGainLossOnDerivativeNet" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_FinancialInstrumentAxis_us-gaap_TotalReturnSwapMember_us-gaap_RetirementPlanTypeAxis_hsic_SerpAndDcpMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a41737_98_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:593px;top:101px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a41743" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">respectively, net of transaction costs, related to this undesignated swap.<div style="display:inline-block;width:7px">&nbsp;</div>During the years ended December 31, 2022 </div><div id="a41745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">and December 25, 2021, the swap resulted in a neutral impact to our<div style="display:inline-block;width:2px">&nbsp;</div>results of operations.<div style="display:inline-block;width:7px">&nbsp;</div>This swap is expected to </div><div id="a41746" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">be renewed on an annual basis after its current expiration date of March 31, 2023,<div style="display:inline-block;width:2px">&nbsp;</div>and is expected to result in a </div><div id="a41748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">neutral impact to our results of operations.</div></div></ix:continuation></div><div id="a41748_44_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:316px;top:281px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a41749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:349px;top:281px;"><a href="#a47908" style="color:#0000FF;text-decoration:underline;">Note 17 – Employee Benefit Plans</a></div><div id="a41753" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:552px;top:281px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional information.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_813_XBRL_TS_effb51d0545f43f7bf4c890a832b0826" style="position:absolute;left:62px;top:314px;float:left;"><ix:continuation id="XBRL_TS_effb51d0545f43f7bf4c890a832b0826"><div id="TextBlockContainer814" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:204px;"><div id="a41757" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Fluctuations in the value of certain foreign currencies as compared<div style="display:inline-block;width:2px">&nbsp;</div>to the U.S. dollar may positively or negatively </div><div id="a41759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">affect our revenues, gross margins, operating expenses and retained earnings, all of which are expressed<div style="display:inline-block;width:2px">&nbsp;</div>in U.S. </div><div id="a41760" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">dollars.<div style="display:inline-block;width:7px">&nbsp;</div>Where we deem it prudent, we engage in hedging programs using primarily<div style="display:inline-block;width:2px">&nbsp;</div>foreign currency forward </div><div id="a41764" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">contracts aimed at limiting the impact of foreign currency exchange<div style="display:inline-block;width:2px">&nbsp;</div>rate fluctuations on earnings.<div style="display:inline-block;width:7px">&nbsp;</div>We purchase </div><div id="a41767" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">short-term (i.e., generally 18 months or less) foreign currency forward contracts<div style="display:inline-block;width:2px">&nbsp;</div>to protect against currency </div><div id="a41770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">exchange risks associated with intercompany loans due from our international<div style="display:inline-block;width:2px">&nbsp;</div>subsidiaries and the payment of </div><div id="a41772" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">merchandise purchases to our foreign suppliers.<div style="display:inline-block;width:7px">&nbsp;</div>We do not hedge the translation of foreign currency profits into </div><div id="a41775" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">U.S. dollars, as we regard this as an accounting exposure, not an economic<div style="display:inline-block;width:2px">&nbsp;</div>exposure.<div style="display:inline-block;width:7px">&nbsp;</div>Amounts related to our </div><div id="a41779" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">hedging activities are recorded in prepaid expenses and other and/or accrued<div style="display:inline-block;width:2px">&nbsp;</div>expenses: other within our </div><div id="a41780" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">consolidated balance sheets.<div style="display:inline-block;width:7px">&nbsp;</div>Our hedging activities have historically not had a material impact on our consolidated </div><div id="a41782" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>Accordingly, additional disclosures related to derivatives and hedging activities required by </div><div id="a41785" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">ASC 815 have been omitted.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page94" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:435.8px; height:15.4px; left:69.9px; top:257.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:526px; top:257.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.4px; left:540.9px; top:257.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:646.1px; top:257.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:253.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.4px; left:660.9px; top:257.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:456.1px; height:1px; left:66.8px; top:252.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:20px; left:508.3px; top:252.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:1px; left:522.9px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:20px; left:628.3px; top:252.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:1px; left:642.9px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:426.8px; height:15.4px; left:78.9px; top:298.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:526px; top:298.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.4px; left:540.9px; top:298.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:646.1px; top:298.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:293.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.4px; left:660.9px; top:298.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:456.1px; height:21px; left:67.2px; top:292.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:456.1px; height:1px; left:66.8px; top:292.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:1px; left:522.9px; top:292.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:21px; left:628.3px; top:292.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:1px; left:642.9px; top:292.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:106px; height:1px; left:522.3px; top:315.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:106px; height:1px; left:522.3px; top:313.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:105.9px; height:1px; left:642.4px; top:315.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:105.9px; height:1px; left:642.4px; top:313.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.9px; left:67.2px; top:809.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.9px; left:67.2px; top:809.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:481.1px; height:1px; left:66.8px; top:807.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17.9px; left:538.3px; top:808.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:547.9px; top:807.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:642.9px; top:807.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:807.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:842.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:842.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:874.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:651.1px; height:15.2px; left:97.2px; top:875px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:906.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:906.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:547.9px; top:921.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:921.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:938.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:938.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:547.9px; top:953.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:653px; top:953.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:547.3px; top:974.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:96px; height:1px; left:547.3px; top:972.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.8px; height:1px; left:652.5px; top:974.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:95.8px; height:1px; left:652.5px; top:972.5px; background-color:#000000; ">&nbsp;</div>
<div id="a41787" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a41789" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a41791" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a41793" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a41796" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">94 </div><div id="div_815_XBRL_TS_12e063a2d71c40a28ee6c2d9169a919a" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_12e063a2d71c40a28ee6c2d9169a919a" name="us-gaap:DebtDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_73b97263e3434a6e9259948ee337a6bf" escape="true"><div id="TextBlockContainer816" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:102px;height:18px;"><div id="a41798" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 12 – Debt</div></div></ix:nonnumeric></div><div id="a41804" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:129px;">&nbsp;</div><div id="div_817_XBRL_TS_73b97263e3434a6e9259948ee337a6bf" style="position:absolute;left:62px;top:145px;float:left;"><ix:continuation id="XBRL_TS_73b97263e3434a6e9259948ee337a6bf" continuedat="XBRL_TS_11bb9d41c623437ea7d42ea26b231672"><div id="TextBlockContainer818" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:271px;height:51px;"><div id="a41805" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Bank Credit Lines </div><div id="a41808" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Bank credit lines consisted of the following:</div></div></ix:continuation></div><div id="div_819_XBRL_TS_2063c5d73bb647ba9d50c483d1af0f44" style="position:absolute;left:65px;top:218px;float:left;"><ix:nonnumeric id="ID_1210" name="us-gaap:ScheduleOfShortTermDebtTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer822" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:680px;height:97px;"><div id="div_820_XBRL_TS_11bb9d41c623437ea7d42ea26b231672" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_11bb9d41c623437ea7d42ea26b231672" continuedat="XBRL_TS_dd15c320d13c4ac1812b370f18a90c3b"><div id="TextBlockContainer821" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:680px;height:97px;"><div id="a41815" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:471px;top:0px;">December 31, </div><div id="a41818" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:591px;top:0px;">December 25, </div><div id="a41823" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:497px;top:20px;">2022 </div><div id="a41826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:617px;top:20px;">2021 </div><div id="a41828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">Revolving credit agreement </div><div id="a41831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:461px;top:40px;">$ </div><div id="a41833" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:552px;top:40px;"><ix:nonfraction id="ID_1737" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:40px;">$ </div><div id="a41838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:40px;"><ix:nonfraction id="ID_1738" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a41840" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Other short-term bank credit lines </div><div id="a41846" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:60px;"><ix:nonfraction id="ID_1211" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_CommittedLoanAssociatedWithAnimalHealthSpinOffMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a41850" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:60px;"><ix:nonfraction id="ID_1212" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_CommittedLoanAssociatedWithAnimalHealthSpinOffMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction></div><div id="a41852" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:81px;">Total </div><div id="a41855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:461px;top:81px;">$ </div><div id="a41857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:536px;top:81px;"><ix:nonfraction id="ID_517A" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a41860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:81px;">$ </div><div id="a41862" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:81px;"><ix:nonfraction id="ID_518A" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_823_XBRL_TS_dd15c320d13c4ac1812b370f18a90c3b" style="position:absolute;left:62px;top:334px;float:left;"><ix:continuation id="XBRL_TS_dd15c320d13c4ac1812b370f18a90c3b" continuedat="XBRL_TS_b6902a6cd7df4ed0a37b916e68e43a25"><div id="TextBlockContainer824" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:372px;"><div id="a41865" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Revolving Credit Agreement </div><div id="a41868" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">On </div><div id="a41868_3_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:27px;top:34px;"><ix:nonnumeric id="ID_1228" name="us-gaap:LineOfCreditFacilityInitiationDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen">August 20, 2021</ix:nonnumeric></div><div id="a41868_18_21" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:124px;top:34px;">, we entered into a $</div><div id="a41868_39_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:243px;top:34px;"><ix:nonfraction id="ID_1230" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="INF" format="ixt:numdotdecimal" scale="9">1.0</ix:nonfraction></div><div id="a41868_42_68" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:261px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>billion revolving credit agreement (the “Credit Agreement”).<div style="display:inline-block;width:6px">&nbsp;</div>This </div><div id="a41869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">facility which matures on </div><div id="a41869_26_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:158px;top:51px;"><ix:nonnumeric id="ID_1229" name="us-gaap:LineOfCreditFacilityExpirationDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" format="ixt:datemonthdayyearen">August 20, 2026</ix:nonnumeric></div><div id="a41869_41_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:255px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>replaced our $</div><div id="a41869_56_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:51px;"><ix:nonfraction id="ID_1231" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_RevolvingCreditFacilityApril2022Member" unitref="USD" decimals="INF" format="ixt:numdotdecimal" scale="6">750</ix:nonfraction></div><div id="a41869_59_55" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million revolving credit facility which was scheduled </div><div id="a41871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">to mature in April 2022.<div style="display:inline-block;width:7px">&nbsp;</div>The interest rate is based on the USD LIBOR plus a spread based<div style="display:inline-block;width:2px">&nbsp;</div>on our leverage ratio at </div><div id="a41873" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">the end of each financial reporting quarter.<div style="display:inline-block;width:7px">&nbsp;</div>Most LIBOR rates have been discontinued after December 31,<div style="display:inline-block;width:2px">&nbsp;</div>2021, </div><div id="a41878" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">while the remaining LIBOR rates will be discontinued immediately after<div style="display:inline-block;width:2px">&nbsp;</div>June 30, 2023.<div style="display:inline-block;width:7px">&nbsp;</div>We do not expect the </div><div id="a41886" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">discontinuation of LIBOR as a reference rate in our debt agreements<div style="display:inline-block;width:2px">&nbsp;</div>to have a material adverse effect on our </div><div id="a41887" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">financial position or to materially affect our interest expense.<div style="display:inline-block;width:7px">&nbsp;</div>The Credit Agreement requires, among other things, </div><div id="a41892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">that we maintain certain maximum leverage ratios.<div style="display:inline-block;width:6px">&nbsp;</div>Additionally, the Credit Agreement contains customary </div><div id="a41893" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">representations, warranties and affirmative covenants as well as customary negative<div style="display:inline-block;width:2px">&nbsp;</div>covenants, subject to </div><div id="a41894" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">negotiated exceptions, on liens, indebtedness, significant corporate changes<div style="display:inline-block;width:2px">&nbsp;</div>(including mergers), dispositions and </div><div id="a41896" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">certain restrictive agreements.<div style="display:inline-block;width:7px">&nbsp;</div>As of December 31, 2022 and December 25, 2021, we had </div><div id="a41896_87_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:202px;"><ix:nonfraction id="ID_1232" name="us-gaap:LineOfCredit" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonfraction id="ID_1233" name="us-gaap:LineOfCredit" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonfraction></ix:nonfraction></div><div id="a41896_89_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:202px;"><div style="display:inline-block;width:4px">&nbsp;</div>borrowings under this </div><div id="a41897" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">revolving credit facility.<div style="display:inline-block;width:8px">&nbsp;</div>As of December 31, 2022 and December 25, 2021, there<div style="display:inline-block;width:2px">&nbsp;</div>were $</div><div id="a41897_87_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:219px;"><ix:nonfraction id="ID_1234" name="us-gaap:LettersOfCreditOutstandingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a41897_88_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:219px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a41897_102_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:618px;top:219px;"><ix:nonfraction id="ID_1235" name="us-gaap:LettersOfCreditOutstandingAmount" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a41897_103_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:219px;"><div style="display:inline-block;width:4px">&nbsp;</div>million </div><div id="a41900" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">of letters of credit, respectively, provided to third parties under the credit facility. </div><div id="a41903" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:270px;">Other Short-Term Bank Credit<div style="display:inline-block;width:5px">&nbsp;</div>Lines </div><div id="a41908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">As of December 31, 2022 and December 25, 2021, we had various other short-term<div style="display:inline-block;width:2px">&nbsp;</div>bank credit lines available, with </div><div id="a41912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">a maximum borrowing capacity of $</div><div id="a41912_33_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:219px;top:321px;"><ix:nonfraction id="ID_1765" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember" unitref="USD" decimals="INF" format="ixt:numdotdecimal" scale="6">402</ix:nonfraction></div><div id="a41912_36_44" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:241px;top:321px;"><div style="display:inline-block;width:4px">&nbsp;</div>million as of December 31, 2022, of which $</div><div id="a41912_80_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:321px;"><ix:nonfraction id="ID_1191" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">103</ix:nonfraction></div><div id="a41912_83_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:530px;top:321px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a41912_97_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:321px;"><ix:nonfraction id="ID_1192" name="us-gaap:ShortTermBorrowings" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">51</ix:nonfraction></div><div id="a41912_99_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:321px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a41913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">respectively, were outstanding.<div style="display:inline-block;width:8px">&nbsp;</div>At December 31, 2022 and December 25, 2021, borrowings under<div style="display:inline-block;width:2px">&nbsp;</div>all of these </div><div id="a41915" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">credit lines had a weighted average interest rate of </div><div id="a41915_53_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:304px;top:354px;"><ix:nonfraction id="ID_1193" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">10.11</ix:nonfraction></div><div id="a41915_58_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:337px;top:354px;">% and </div><div id="a41915_64_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:377px;top:354px;"><ix:nonfraction id="ID_1194" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_CreditFacilityAxis_hsic_VariousBankCreditLinesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">10.44</ix:nonfraction></div><div id="a41915_69_16" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:354px;">%, respectively.</div></div></ix:continuation></div><div id="div_825_XBRL_TS_b6902a6cd7df4ed0a37b916e68e43a25" style="position:absolute;left:62px;top:722px;float:left;"><ix:continuation id="XBRL_TS_b6902a6cd7df4ed0a37b916e68e43a25" continuedat="XBRL_TS_0c4cc48f3a1b4807bd6b7edaa28413b7"><div id="TextBlockContainer826" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:263px;height:52px;"><div id="a41918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Long-term debt<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a41923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Long-term debt consisted of the following:</div></div></ix:continuation></div><div id="div_827_XBRL_TS_52efa25a272d48dc9837a6e84c15c496" style="position:absolute;left:63px;top:775px;float:left;"><ix:nonnumeric id="ID_1209" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer830" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:198px;"><div id="div_828_XBRL_TS_0c4cc48f3a1b4807bd6b7edaa28413b7" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_0c4cc48f3a1b4807bd6b7edaa28413b7" continuedat="XBRL_TS_59ff27ce429f4563bd7287037fca9cb2"><div id="TextBlockContainer829" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:198px;"><div id="a41930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:494px;top:0px;">December 31, </div><div id="a41933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:599px;top:0px;">December 25, </div><div id="a41938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:520px;top:18px;">2022 </div><div id="a41941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:625px;top:18px;">2021 </div><div id="a41943" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:36px;">Private placement facilities<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a41946" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:36px;">$ </div><div id="a41948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:36px;"><ix:nonfraction id="ID_1173" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">699</ix:nonfraction></div><div id="a41951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:36px;">$ </div><div id="a41953" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:36px;"><ix:nonfraction id="ID_1782" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">706</ix:nonfraction></div><div id="a41955" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:52px;">U.S. trade accounts receivable securitization </div><div id="a41959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:561px;top:52px;"><ix:nonfraction id="ID_1582" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">330</ix:nonfraction></div><div id="a41963" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:52px;"><ix:nonfraction id="ID_1583" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">105</ix:nonfraction></div><div id="a41965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Various<div style="display:inline-block;width:5px">&nbsp;</div>collateralized and uncollateralized loans payable with interest, </div><div id="a41974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:84px;">in varying installments through 2023 at interest rates </div><div id="a41985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:100px;">ranging from </div><div id="a41985_13_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:100px;"><ix:nonfraction id="ID_1177" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.00</ix:nonfraction></div><div id="a41985_17_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:131px;top:100px;">% to </div><div id="a41985_22_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:159px;top:100px;"><ix:nonfraction id="ID_1179" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.50</ix:nonfraction></div><div id="a41985_26_27" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:100px;">% at December 31, 2022 and </div><div id="a41994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:116px;">ranging from </div><div id="a41994_13_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:116px;"><ix:nonfraction id="ID_1178" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MinimumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">2.62</ix:nonfraction></div><div id="a41994_17_5" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:131px;top:116px;">% to </div><div id="a41994_22_4" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:159px;top:116px;"><ix:nonfraction id="ID_1180" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec25_2021_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">4.27</ix:nonfraction></div><div id="a41994_26_23" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:183px;top:116px;">% at December 25, 2021 </div><div id="a41998" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:116px;"><ix:nonfraction id="ID_1778" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a42002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:116px;"><ix:nonfraction id="ID_1779" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_us-gaap_LoansPayableMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a42004" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:132px;">Finance lease obligations </div><div id="a42008" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:567px;top:132px;"><ix:nonfraction id="ID_752AA" name="us-gaap:FinanceLeaseLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a42012" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:132px;"><ix:nonfraction id="ID_814A" name="us-gaap:FinanceLeaseLiability" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a42015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:148px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:148px;"><ix:nonfraction id="ID_40" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,046</ix:nonfraction></div><div id="a42023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:148px;"><ix:nonfraction id="ID_1174" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">822</ix:nonfraction></div><div id="a42025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:164px;">Less current maturities </div><div id="a42029" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:565px;top:164px;display:flex;">(<ix:nonfraction id="ID_271A" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a42033" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:164px;display:flex;">(<ix:nonfraction id="ID_372A" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction>)</div><div id="a42036" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:182px;">Total long-term debt<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a42041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:485px;top:182px;">$ </div><div id="a42043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:550px;top:182px;"><ix:nonfraction id="ID_1175A" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,040</ix:nonfraction></div><div id="a42046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:182px;">$ </div><div id="a42048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:182px;"><ix:nonfraction id="ID_1176A" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">811</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page95" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:120px; height:15.4px; left:290.3px; top:552.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:15.4px; left:420.2px; top:552.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:680.1px; height:16px; left:67.2px; top:551.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:213px; height:1px; left:66.8px; top:550.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:17px; left:280.2px; top:550.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:289.9px; top:550.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17px; left:410.3px; top:550.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105.1px; height:1px; left:419.8px; top:550.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:525px; top:550.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:212px; height:1px; left:534.9px; top:550.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:15.2px; left:290.3px; top:586.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:30.1px; height:16.8px; left:505.2px; top:584.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:680.1px; height:17px; left:67.2px; top:584.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:15.4px; left:290.3px; top:620.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:680.1px; height:17px; left:67.2px; top:618.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:15.2px; left:290.3px; top:654.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:30.1px; height:16.8px; left:505.2px; top:652.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:680.1px; height:17px; left:67.2px; top:652.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:15.4px; left:290.3px; top:688.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:680.1px; height:17px; left:67.2px; top:686.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:289.9px; top:703.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:290.3px; top:720.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:1px; left:290.3px; top:722.5px; background-color:#000000; ">&nbsp;</div>
<div id="a42051" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a42053" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a42055" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a42057" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a42060" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">95 </div><div id="div_831_XBRL_TS_59ff27ce429f4563bd7287037fca9cb2" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_59ff27ce429f4563bd7287037fca9cb2" continuedat="XBRL_TS_e8fb9ddfb11f4da5b540001f015f1fe3"><div id="TextBlockContainer832" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:685px;height:321px;"><div id="a42062" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Private Placement Facilities </div><div id="a42065" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Our private placement facilities were amended on </div><div id="a42065_49_16" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:301px;top:34px;"><ix:nonnumeric id="ID_1215" name="us-gaap:DebtInstrumentIssuanceDate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyearen">October 20, 2021</ix:nonnumeric></div><div id="a42065_65_46" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:403px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>to include four (previously three) insurance </div><div id="a42069" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">companies, have a total facility amount of $</div><div id="a42069_44_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:263px;top:51px;"><ix:nonfraction id="ID_1195" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-5" format="ixt:numdotdecimal" scale="6">1.5</ix:nonfraction></div><div id="a42069_47_22" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:281px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>billion (previously $</div><div id="a42069_69_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:404px;top:51px;"><ix:nonfraction id="ID_1236" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-8" format="ixt:numdotdecimal" scale="9">1.0</ix:nonfraction></div><div id="a42069_72_35" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:423px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>billion), and are available on an </div><div id="a42073" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">uncommitted basis at fixed rate economic terms to be agreed upon at the<div style="display:inline-block;width:2px">&nbsp;</div>time of issuance, from time to time </div><div id="a42078" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">through </div><div id="a42078_8_16" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:54px;top:84px;"><ix:nonnumeric id="ID_1196" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyearen">October 20, 2026</ix:nonnumeric></div><div id="a42078_24_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:157px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>(previously </div><div id="a42078_37_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:231px;top:84px;"><ix:nonnumeric id="ID_1199" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt:datemonthdayyearen">June 23, 2023</ix:nonnumeric></div><div id="a42078_50_64" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:313px;top:84px;">).<div style="display:inline-block;width:7px">&nbsp;</div>The facilities allow us to issue senior promissory notes to </div><div id="a42081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">the lenders at a fixed rate based on an agreed upon spread over applicable<div style="display:inline-block;width:2px">&nbsp;</div>treasury notes at the time of </div><div id="a42082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">issuance.<div style="display:inline-block;width:7px">&nbsp;</div>The term of each possible issuance will be selected by us and<div style="display:inline-block;width:2px">&nbsp;</div>can range from </div><div id="a42082_88_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:521px;top:118px;-sec-ix-hidden:ID_1380;">five</div><div id="a42082_92_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>to </div><div id="a42082_96_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:563px;top:118px;"><ix:nonnumeric id="ID_1197" name="us-gaap:DebtInstrumentTerm" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt-sec:durwordsen">15 years</ix:nonnumeric></div><div id="a42082_104_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>(with an </div><div id="a42088" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">average life no longer than </div><div id="a42088_28_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:166px;top:135px;"><ix:nonnumeric id="ID_1200" name="hsic:DebtInstrumentAverageTerm" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" format="ixt-sec:durwordsen">12 years</ix:nonnumeric></div><div id="a42088_36_80" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:215px;top:135px;">).<div style="display:inline-block;width:7px">&nbsp;</div>The proceeds of any issuances under the facilities will be used for<div style="display:inline-block;width:2px">&nbsp;</div>general </div><div id="a42089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">corporate purposes, including working capital and capital expenditures,<div style="display:inline-block;width:2px">&nbsp;</div>to refinance existing indebtedness, and/or </div><div id="a42091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">to fund potential acquisitions.<div style="display:inline-block;width:7px">&nbsp;</div>The agreements provide, among other things, that we maintain<div style="display:inline-block;width:2px">&nbsp;</div>certain maximum </div><div id="a42092" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">leverage ratios, and contain restrictions relating to subsidiary indebtedness,<div style="display:inline-block;width:2px">&nbsp;</div>liens, affiliate transactions, disposal of </div><div id="a42094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">assets and certain changes in ownership.<div style="display:inline-block;width:7px">&nbsp;</div>These facilities contain make-whole provisions in the event that we<div style="display:inline-block;width:2px">&nbsp;</div>pay </div><div id="a42099" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">off the facilities prior to the applicable due dates. </div><div id="a42102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">On March 5, 2021, we amended the private placement facilities to,<div style="display:inline-block;width:2px">&nbsp;</div>among other things, (a) modify the financial </div><div id="a42104" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">covenant from being based on a net leverage ratio to a total leverage<div style="display:inline-block;width:2px">&nbsp;</div>ratio and (b) restore the maximum </div><div id="a42105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">maintenance total leverage ratio to </div><div id="a42105_36_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:211px;top:287px;"><ix:nonfraction id="ID_1213" name="us-gaap:RatioOfIndebtednessToNetCapital1" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">3.25</ix:nonfraction></div><div id="a42105_40_17" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:237px;top:287px;">x and remove the </div><div id="a42105_57_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:287px;"><ix:nonfraction id="ID_1198" name="us-gaap:DebtInstrumentInterestRateIncreaseDecrease" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">1.00</ix:nonfraction></div><div id="a42105_61_55" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:368px;top:287px;">% interest rate increase triggered if the net leverage </div><div id="a42107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">ratio were to exceed </div><div id="a42107_21_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:127px;top:304px;"><ix:nonfraction id="ID_1214" name="us-gaap:RatioOfIndebtednessToNetCapital1" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">3.0</ix:nonfraction></div><div id="a42107_24_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:146px;top:304px;">x.</div></div></ix:continuation></div><div id="div_833_XBRL_TS_e8fb9ddfb11f4da5b540001f015f1fe3" style="position:absolute;left:62px;top:449px;float:left;"><ix:continuation id="XBRL_TS_e8fb9ddfb11f4da5b540001f015f1fe3" continuedat="XBRL_TS_f6cf758bd2134df09cc35cef8c248a20"><div id="TextBlockContainer834" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:655px;height:35px;"><div id="a42110" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The components of our private placement facility borrowings, which<div style="display:inline-block;width:2px">&nbsp;</div>have a weighted average interest rate of </div><div id="a42113" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;"><ix:nonfraction id="ID_1766" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">2.99</ix:nonfraction></div><div id="a42113_4_64" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:17px;">%, as of December 31, 2022 are presented in the following table:</div></div></ix:continuation></div><div id="div_835_XBRL_TS_f6cf758bd2134df09cc35cef8c248a20" style="position:absolute;left:63px;top:502px;float:left;"><ix:continuation id="XBRL_TS_f6cf758bd2134df09cc35cef8c248a20" continuedat="XBRL_TS_af89ec647f254eb684239625ce0ded2c"><div id="TextBlockContainer838" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:634px;height:220px;"><div id="div_836_XBRL_TS_4bac9fe510e64e94a2c918313369e13e" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1208" name="hsic:ScheduleOfPrivatePlacementFacilitiesDebtTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer837" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:634px;height:220px;"><div id="a42120" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:257px;top:0px;">Amount of </div><div id="a42127" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:90px;top:17px;">Date of<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42130" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:257px;top:17px;">Borrowing </div><div id="a42133" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:379px;top:17px;">Borrowing<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:80px;top:34px;">Borrowing </div><div id="a42140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:252px;top:34px;">Outstanding </div><div id="a42143" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:397px;top:34px;">Rate </div><div id="a42146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:552px;top:34px;">Due Date </div><div id="a42148" style="position:absolute;font-family:'Times New Roman';left:4px;top:51px;-sec-ix-hidden:ID_1680;">January 20, 2012</div><div id="a42151" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:228px;top:51px;">$ </div><div id="a42153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:51px;"><ix:nonfraction id="ID_1696" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">50</ix:nonfraction></div><div id="a42156" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:51px;"><ix:nonfraction id="ID_1705" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.45</ix:nonfraction></div><div id="a42158" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:51px;">% </div><div id="a42161" style="position:absolute;font-family:'Times New Roman';left:533px;top:51px;-sec-ix-hidden:ID_1688;">January 20, 2024</div><div id="a42163" style="position:absolute;font-family:'Times New Roman';left:4px;top:68px;-sec-ix-hidden:ID_1681;">December 24, 2012</div><div id="a42167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:334px;top:68px;"><ix:nonfraction id="ID_1697" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">50</ix:nonfraction></div><div id="a42170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:68px;"><ix:nonfraction id="ID_1706" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesDecember2024Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.00</ix:nonfraction></div><div id="a42174" style="position:absolute;font-family:'Times New Roman';left:526px;top:68px;-sec-ix-hidden:ID_1689;">December 24, 2024</div><div id="a42176" style="position:absolute;font-family:'Times New Roman';left:4px;top:85px;-sec-ix-hidden:ID_1682;">June 16, 2017</div><div id="a42180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:85px;"><ix:nonfraction id="ID_1698" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42183" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:85px;"><ix:nonfraction id="ID_1707" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJune2027Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.42</ix:nonfraction></div><div id="a42187" style="position:absolute;font-family:'Times New Roman';left:541px;top:85px;-sec-ix-hidden:ID_1690;">June 16, 2027</div><div id="a42189" style="position:absolute;font-family:'Times New Roman';left:4px;top:102px;-sec-ix-hidden:ID_1683;">September 15, 2017</div><div id="a42193" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:102px;"><ix:nonfraction id="ID_1699" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42196" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:102px;"><ix:nonfraction id="ID_1708" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesSeptember2029Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.52</ix:nonfraction></div><div id="a42200" style="position:absolute;font-family:'Times New Roman';left:525px;top:102px;-sec-ix-hidden:ID_1691;">September 15, 2029</div><div id="a42202" style="position:absolute;font-family:'Times New Roman';left:4px;top:119px;-sec-ix-hidden:ID_1684;">January 2, 2018</div><div id="a42206" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:119px;"><ix:nonfraction id="ID_1700" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:119px;"><ix:nonfraction id="ID_1709" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilitiesJanuary2028Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.32</ix:nonfraction></div><div id="a42213" style="position:absolute;font-family:'Times New Roman';left:536px;top:119px;-sec-ix-hidden:ID_1692;">January 2, 2028</div><div id="a42215" style="position:absolute;font-family:'Times New Roman';left:4px;top:136px;-sec-ix-hidden:ID_1685;">September 2, 2020</div><div id="a42219" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:136px;"><ix:nonfraction id="ID_1701" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42222" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:136px;"><ix:nonfraction id="ID_1710" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_Privateplacementfacilities2030memberMember_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">2.35</ix:nonfraction></div><div id="a42226" style="position:absolute;font-family:'Times New Roman';left:528px;top:136px;-sec-ix-hidden:ID_1693;">September 2, 2030</div><div id="a42228" style="position:absolute;font-family:'Times New Roman';left:4px;top:153px;-sec-ix-hidden:ID_1686;">June 2, 2021</div><div id="a42232" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:153px;"><ix:nonfraction id="ID_1702" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:153px;"><ix:nonfraction id="ID_1711" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2031Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">2.48</ix:nonfraction></div><div id="a42239" style="position:absolute;font-family:'Times New Roman';left:545px;top:153px;-sec-ix-hidden:ID_1694;">June 2, 2031</div><div id="a42241" style="position:absolute;font-family:'Times New Roman';left:4px;top:170px;-sec-ix-hidden:ID_1687;">June 2, 2021</div><div id="a42245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:170px;"><ix:nonfraction id="ID_1703" name="us-gaap:DebtInstrumentCarryingAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42248" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:419px;top:170px;"><ix:nonfraction id="ID_1712" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_DebtInstrumentAxis_hsic_PrivatePlacementFacilities2033Member_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">2.58</ix:nonfraction></div><div id="a42252" style="position:absolute;font-family:'Times New Roman';left:545px;top:170px;-sec-ix-hidden:ID_1695;">June 2, 2033</div><div id="a42254" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:187px;">Less: Deferred debt issuance costs </div><div id="a42258" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:187px;display:flex;">(<ix:nonfraction id="ID_1704" name="us-gaap:DeferredFinanceCostsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a42265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:204px;">Total </div><div id="a42268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:228px;top:204px;">$ </div><div id="a42270" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:204px;"><ix:nonfraction id="ID_1173A" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_PrivatePlacementFacilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">699</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_839_XBRL_TS_af89ec647f254eb684239625ce0ded2c" style="position:absolute;left:62px;top:745px;float:left;"><ix:continuation id="XBRL_TS_af89ec647f254eb684239625ce0ded2c" continuedat="XBRL_TS_af89ec647f254eb684239625ce0ded2c_1"><div id="TextBlockContainer840" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:684px;height:220px;"><div id="a42287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">U.S. Trade Accounts Receivable Securitization </div><div id="a42291" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We have a facility agreement based on the securitization of our U.S. trade accounts receivable that is structured as </div><div id="a42294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">an asset-backed securitization program with pricing committed for up<div style="display:inline-block;width:2px">&nbsp;</div>to </div><div id="a42294_72_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:433px;top:51px;"><ix:nonnumeric id="ID_1182" name="hsic:DebtPricingCommittmentPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" format="ixt-sec:durwordsen">three years</ix:nonnumeric></div><div id="a42294_83_28" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:51px;">.<div style="display:inline-block;width:7px">&nbsp;</div>On December 15, 2022, we </div><div id="a42300" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">extended the expiration date of this facility agreement to </div><div id="a42300_59_17" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:340px;top:68px;"><ix:nonnumeric id="ID_1579" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" format="ixt:datemonthdayyearen">December 15, 2025</ix:nonnumeric></div><div id="a42300_76_33" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>(the previous maturity date was </div><div id="a42302" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:5px;top:84px;"><ix:nonnumeric id="ID_1580" name="us-gaap:DebtInstrumentMaturityDate" contextref="FROM_Jun26_2022_TO_Sep24_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" format="ixt:datemonthdayyearen">October 18, 2024</ix:nonnumeric></div><div id="a42302_16_59" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:107px;top:84px;">) and maintained the purchase limit under the facility as<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a42302_75_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:84px;"><ix:nonfraction id="ID_1581" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">450</ix:nonfraction></div><div id="a42302_78_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>million with </div><div id="a42302_92_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:84px;"><ix:nonfraction id="ID_1783" name="hsic:NumberOfBanksAsAgentsForDebtInstrument" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="myNumber" decimals="0" format="ixt-sec:numwordsen">two</ix:nonfraction></div><div id="a42302_95_18" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>banks as agents. </div><div id="a42305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">As of December 31, 2022 and December 25, 2021, the borrowings outstanding<div style="display:inline-block;width:2px">&nbsp;</div>under this securitization facility </div><div id="a42307" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">were $</div><div id="a42307_6_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:45px;top:135px;"><ix:nonfraction id="ID_1582A" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">330</ix:nonfraction></div><div id="a42307_9_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:67px;top:135px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a42307_23_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:148px;top:135px;"><ix:nonfraction id="ID_1583A" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">105</ix:nonfraction></div><div id="a42307_26_85" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:170px;top:135px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>At December 31, 2022, the interest rate on borrowings under </div><div id="a42311" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">this facility was based on the asset-backed commercial paper rate of </div><div id="a42311_69_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:152px;"><ix:nonfraction id="ID_1183" name="hsic:DebtInstrumentVariableRateBasisAtPeriodEnd" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">4.58</ix:nonfraction></div><div id="a42311_73_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:152px;">% plus </div><div id="a42311_80_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:477px;top:152px;"><ix:nonfraction id="ID_1184" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.75</ix:nonfraction></div><div id="a42311_84_26" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:503px;top:152px;">%, for a combined rate of </div><div id="a42314" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;"><ix:nonfraction id="ID_1185" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">5.33</ix:nonfraction></div><div id="a42314_4_108" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:169px;">%.<div style="display:inline-block;width:7px">&nbsp;</div>At December 25, 2021, the interest rate on borrowings under<div style="display:inline-block;width:2px">&nbsp;</div>this facility was based on the asset-backed </div><div id="a42321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">commercial paper rate of </div><div id="a42321_25_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:156px;top:186px;"><ix:nonfraction id="ID_1186" name="hsic:DebtInstrumentVariableRateBasisAtPeriodEnd" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.19</ix:nonfraction></div><div id="a42321_29_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:181px;top:186px;">% plus </div><div id="a42321_36_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:225px;top:186px;"><ix:nonfraction id="ID_1187" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.75</ix:nonfraction></div><div id="a42321_40_26" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:251px;top:186px;">%, for a combined rate of </div><div id="a42321_66_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:405px;top:186px;"><ix:nonfraction id="ID_1188" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember_us-gaap_VariableRateAxis_hsic_AssetBackedCommercialPaperRateMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.94</ix:nonfraction></div><div id="a42321_70_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:186px;">%. </div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page96" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:385.1px; height:20px; left:215.2px; top:246.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:15.4px; left:215.2px; top:251.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:20px; left:215.2px; top:286.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:15.4px; left:215.2px; top:291.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:20px; left:215.2px; top:326.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:15.4px; left:215.2px; top:331.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:385.1px; height:20px; left:215.2px; top:367.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:359.1px; height:15.4px; left:241.1px; top:372.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:280.1px; height:1px; left:214.8px; top:366.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:105px; height:1px; left:494.9px; top:366.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:106px; height:1px; left:494.3px; top:389.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:106px; height:1px; left:494.3px; top:387.7px; background-color:#000000; ">&nbsp;</div>
<div id="a42324" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a42326" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a42328" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a42330" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a42333" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">96 </div><div id="div_841_XBRL_TS_af89ec647f254eb684239625ce0ded2c_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_af89ec647f254eb684239625ce0ded2c_1" continuedat="XBRL_TS_136296efa897427485a508b2dd1dee31"><div id="TextBlockContainer842" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:682px;height:68px;"><div id="a42335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">If our accounts receivable collection pattern changes due to customers<div style="display:inline-block;width:2px">&nbsp;</div>either paying late or not making payments, </div><div id="a42337" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">our ability to borrow under this facility may be reduced. </div><div id="a42340" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">We are required to pay a commitment fee of </div><div id="a42340_43_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:269px;top:51px;"><ix:nonfraction id="ID_1189" name="hsic:CommittmentFeeForUsageUpperFacilityLimit" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="pure" decimals="8" format="ixt:numdotdecimal" scale="-4">30</ix:nonfraction></div><div id="a42340_45_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:283px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>to </div><div id="a42340_49_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:302px;top:51px;"><ix:nonfraction id="ID_1190" name="hsic:CommittmentFeeForUsageLowerFacilityLimit" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_LongtermDebtTypeAxis_hsic_USTradeAccountsReceivableSecuritizationMember" unitref="pure" decimals="8" format="ixt:numdotdecimal" scale="-4">35</ix:nonfraction></div><div id="a42340_51_49" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:317px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>basis points depending upon program utilization.</div></div></ix:continuation></div><div id="a42341" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#212529;left:670px;top:162px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="div_843_XBRL_TS_136296efa897427485a508b2dd1dee31" style="position:absolute;left:62px;top:196px;float:left;"><ix:continuation id="XBRL_TS_136296efa897427485a508b2dd1dee31" continuedat="XBRL_TS_4a5446a63c44466d82f9f61a4fb0dbe5"><div id="TextBlockContainer844" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:686px;height:35px;"><div id="a42344" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">As of December 31, 2022,<div style="display:inline-block;width:3px">&nbsp;</div>the aggregate amounts of long-term debt, including finance lease obligations<div style="display:inline-block;width:2px">&nbsp;</div>and net of </div><div id="a42351" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">deferred debt issuance costs of $</div><div id="a42351_33_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:196px;top:17px;"><ix:nonfraction id="ID_1181" name="us-gaap:DeferredFinanceCostsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a42351_34_80" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:203px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, maturing in each of the next five years and thereafter<div style="display:inline-block;width:2px">&nbsp;</div>are as follows:</div></div></ix:continuation></div><div id="div_845_XBRL_TS_4a5446a63c44466d82f9f61a4fb0dbe5" style="position:absolute;left:211px;top:252px;float:left;"><ix:continuation id="XBRL_TS_4a5446a63c44466d82f9f61a4fb0dbe5"><div id="TextBlockContainer848" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:394px;height:137px;"><div id="div_846_XBRL_CS_8cf59126eb80496daf6fe01f67d186b8" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_200" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer847" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:394px;height:137px;"><div id="a42360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">2023<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42362" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:284px;top:0px;">$ </div><div id="a42364" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:383px;top:0px;"><ix:nonfraction id="ID_402" name="hsic:LongTermDebtAndFinanceLeaseLiabilityRepaymentsOfPrincipalInNextTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a42368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:20px;">2024<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42371" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:20px;"><ix:nonfraction id="ID_27" name="hsic:LongTermDebtAndFinanceLeaseLiabilityMaturitiesRepaymentsOfPrincipalInYearTwo" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">109</ix:nonfraction></div><div id="a42375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">2025<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:40px;"><ix:nonfraction id="ID_201" name="hsic:LongTermDebtAndFinanceLeaseLiabilityMaturitiesRepaymentsOfPrincipalInYearThree" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">331</ix:nonfraction></div><div id="a42382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">2026<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42385" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:385px;top:60px;"><ix:nonfraction id="ID_167" name="hsic:LongTermDebtAndFinanceLeaseLiabilityMaturitiesRepaymentsOfPrincipalInYearFour" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a42389" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">2027<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:80px;"><ix:nonfraction id="ID_92" name="hsic:LongTermDebtAndFinanceLeaseLiabilityMaturitiesRepaymentsOfPrincipalInYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonfraction></div><div id="a42396" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Thereafter<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42399" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:370px;top:100px;"><ix:nonfraction id="ID_464" name="hsic:LongTermDebtAndFinanceLeaseLiabilityMaturitiesRepaymentsOfPrincipalAfterYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">500</ix:nonfraction></div><div id="a42404" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:30px;top:121px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42406" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:284px;top:121px;">$ </div><div id="a42408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:121px;"><ix:nonfraction id="ID_40A" name="us-gaap:LongTermDebt" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,046</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page97" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:198.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:240.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:240.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:238.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:238.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:528.3px; top:239.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:238.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:638.4px; top:239.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:238.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:280.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.2px; left:87.2px; top:284.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:21px; left:67.2px; top:279.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:278.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:278.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21px; left:528.3px; top:279.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:278.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:21px; left:638.4px; top:279.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:278.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:302.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:300.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:302.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:300.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:302.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:300.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:372px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.8px; left:67.2px; top:411.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.8px; left:67.2px; top:411.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:410.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.8px; left:418.3px; top:410.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:410.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.8px; left:528.3px; top:410.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:410.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.8px; left:638.4px; top:410.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:410.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:449.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:453.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:16.8px; left:67.2px; top:490.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.2px; left:67.2px; top:489.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:646px; height:15.4px; left:102.3px; top:492.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:19.2px; left:67.2px; top:488.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:487.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:487.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:528.3px; top:488.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:487.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:638.4px; top:488.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:487.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:507px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:507px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:507px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:518.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:518.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:556.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:661.1px; height:15.4px; left:87.2px; top:560.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.1px; height:17px; left:67.2px; top:597.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.2px; left:67.2px; top:596.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:646px; height:15.4px; left:102.3px; top:599.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:19.2px; left:67.2px; top:595.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:594.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:594.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:528.3px; top:595.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:594.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:638.4px; top:595.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:594.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:614.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:614.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:614.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:636.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:634.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:636.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:634.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:636.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:634.7px; background-color:#000000; ">&nbsp;</div>
<div id="a42411" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a42413" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a42415" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a42417" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a42420" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">97 </div><div id="div_849_XBRL_TS_676ce46d054b4fac8308ec64c257ee32" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_676ce46d054b4fac8308ec64c257ee32" name="us-gaap:IncomeTaxDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_9b70d5a9136e4102baf52c4f366e9921" escape="true"><div id="TextBlockContainer850" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:428px;height:51px;"><div id="a42422" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 13 – Income Taxes </div><div id="a42428" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a42429" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Income before taxes and equity in earnings of affiliates was as follows:</div></div></ix:nonnumeric></div><div id="div_851_XBRL_CS_9b70d5a9136e4102baf52c4f366e9921" style="position:absolute;left:63px;top:184px;float:left;"><ix:continuation id="XBRL_CS_9b70d5a9136e4102baf52c4f366e9921" continuedat="XBRL_CS_ff2e8a99197b4bd68e086f67abcaeafa"><div id="TextBlockContainer854" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:117px;"><div id="div_852_XBRL_CS_6267ed1e163542ab9caaac091caa3779" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_196" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer853" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:117px;"><div id="a42456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:490px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>ended </div><div id="a42460" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:20px;">December 31, </div><div id="a42463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:20px;">December 25, </div><div id="a42466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:20px;">December 26, </div><div id="a42470" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:40px;">2022 </div><div id="a42473" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:40px;">2021 </div><div id="a42476" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:40px;">2020 </div><div id="a42478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Domestic<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:60px;">$ </div><div id="a42482" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:60px;"><ix:nonfraction id="ID_305" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">506</ix:nonfraction></div><div id="a42485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:60px;">$ </div><div id="a42487" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:60px;"><ix:nonfraction id="ID_18" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">593</ix:nonfraction></div><div id="a42490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:60px;">$ </div><div id="a42492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:60px;"><ix:nonfraction id="ID_213" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">431</ix:nonfraction></div><div id="a42494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Foreign<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:80px;"><ix:nonfraction id="ID_335" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">215</ix:nonfraction></div><div id="a42501" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:80px;"><ix:nonfraction id="ID_7" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">238</ix:nonfraction></div><div id="a42505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:80px;"><ix:nonfraction id="ID_422" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">69</ix:nonfraction></div><div id="a42508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:101px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:101px;">$ </div><div id="a42512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:101px;"><ix:nonfraction id="ID_251AA" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">721</ix:nonfraction></div><div id="a42515" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:101px;">$ </div><div id="a42517" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:101px;"><ix:nonfraction id="ID_239AA" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">831</ix:nonfraction></div><div id="a42520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:101px;">$ </div><div id="a42522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:101px;"><ix:nonfraction id="ID_2AA" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">500</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_855_XBRL_CS_ff2e8a99197b4bd68e086f67abcaeafa" style="position:absolute;left:62px;top:321px;float:left;"><ix:continuation id="XBRL_CS_ff2e8a99197b4bd68e086f67abcaeafa" continuedat="XBRL_CS_c52b0fc7dca2481886c2cc11e3f8ed05"><div id="TextBlockContainer858" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:314px;"><div id="div_856_XBRL_CS_c9cf425ee20141cf804ab448420b948c" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_407" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer857" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:314px;"><div id="a42525" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The provisions for income taxes were as follows: </div><div id="a42554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:491px;top:36px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>ended </div><div id="a42561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:55px;">December 31, </div><div id="a42564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:55px;">December 25, </div><div id="a42567" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:55px;">December 26, </div><div id="a42574" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:403px;top:74px;">2022 </div><div id="a42577" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:513px;top:74px;">2021 </div><div id="a42580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:623px;top:74px;">2020 </div><div id="a42582" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:94px;">Current income tax expense: </div><div id="a42594" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:113px;">U.S. Federal<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:113px;">$ </div><div id="a42599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:113px;"><ix:nonfraction id="ID_39" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">150</ix:nonfraction></div><div id="a42602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:113px;">$ </div><div id="a42604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:113px;"><ix:nonfraction id="ID_318" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">129</ix:nonfraction></div><div id="a42607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:113px;">$ </div><div id="a42609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:113px;"><ix:nonfraction id="ID_47" name="us-gaap:CurrentFederalTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">83</ix:nonfraction></div><div id="a42612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:133px;">State and local<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42616" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:133px;"><ix:nonfraction id="ID_46" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a42620" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:133px;"><ix:nonfraction id="ID_128" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">37</ix:nonfraction></div><div id="a42624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:133px;"><ix:nonfraction id="ID_221" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">24</ix:nonfraction></div><div id="a42627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:152px;">Foreign<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:453px;top:152px;"><ix:nonfraction id="ID_6" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a42635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:152px;"><ix:nonfraction id="ID_425" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">43</ix:nonfraction></div><div id="a42639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:152px;"><ix:nonfraction id="ID_338" name="us-gaap:CurrentForeignTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a42643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:40px;top:171px;">Total current<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a42647" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:171px;"><ix:nonfraction id="ID_453" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">243</ix:nonfraction></div><div id="a42651" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:171px;"><ix:nonfraction id="ID_141" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">209</ix:nonfraction></div><div id="a42655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:171px;"><ix:nonfraction id="ID_49" name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">148</ix:nonfraction></div><div id="a42670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:201px;">Deferred income tax expense (benefit): </div><div id="a42682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:221px;">U.S. Federal<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:221px;display:flex;">(<ix:nonfraction id="ID_21" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">48</ix:nonfraction>)</div><div id="a42690" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:221px;display:flex;">(<ix:nonfraction id="ID_261" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction>)</div><div id="a42694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:221px;display:flex;">(<ix:nonfraction id="ID_440" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">18</ix:nonfraction>)</div><div id="a42697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:240px;">State and local<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:240px;display:flex;">(<ix:nonfraction id="ID_160" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">13</ix:nonfraction>)</div><div id="a42705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:240px;display:flex;">(<ix:nonfraction id="ID_433" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction>)</div><div id="a42709" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:240px;display:flex;">(<ix:nonfraction id="ID_203" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">5</ix:nonfraction>)</div><div id="a42712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:259px;">Foreign<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:259px;display:flex;">(<ix:nonfraction id="ID_273" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction>)</div><div id="a42720" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:259px;"><ix:nonfraction id="ID_228" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a42724" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:259px;display:flex;">(<ix:nonfraction id="ID_71" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">30</ix:nonfraction>)</div><div id="a42728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:40px;top:278px;">Total deferred<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a42732" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:444px;top:278px;display:flex;">(<ix:nonfraction id="ID_10" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">73</ix:nonfraction>)</div><div id="a42736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:278px;display:flex;">(<ix:nonfraction id="ID_345" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a42740" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:278px;display:flex;">(<ix:nonfraction id="ID_154" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">53</ix:nonfraction>)</div><div id="a42745" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:55px;top:298px;">Total provision<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42748" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:298px;">$ </div><div id="a42750" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:446px;top:298px;"><ix:nonfraction id="ID_60AA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">170</ix:nonfraction></div><div id="a42753" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:298px;">$ </div><div id="a42755" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:298px;"><ix:nonfraction id="ID_437AA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">198</ix:nonfraction></div><div id="a42758" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:298px;">$ </div><div id="a42760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:298px;"><ix:nonfraction id="ID_198AA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">95</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page98" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:210px; height:1px; left:537.9px; top:166.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:202.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:202.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:213.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:213.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:249.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:249.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:285.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:285.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:321.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:653.1px; height:15.4px; left:95.2px; top:324.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:358.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:653.1px; height:15.4px; left:95.2px; top:360.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:18.1px; left:67.2px; top:357.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:357.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:357.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:357.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:357.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:394.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:653.1px; height:15.4px; left:95.2px; top:396.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:18.1px; left:67.2px; top:393.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:393.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:393.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:393.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:393.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:429.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:653.1px; height:15.4px; left:95.2px; top:432.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.1px; left:67.2px; top:465.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:653.1px; height:15.4px; left:95.2px; top:468.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:483.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:483.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:502.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:502.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:471.1px; height:1px; left:66.8px; top:501.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:18.1px; left:528.3px; top:501.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:501.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:18.1px; left:638.4px; top:501.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:501.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:519.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:538.3px; top:521.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:519.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:648.3px; top:521.8px; background-color:#000000; ">&nbsp;</div>
<div id="a42762" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a42764" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a42766" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a42768" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a42771" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">98 </div><div id="div_859_XBRL_CS_c52b0fc7dca2481886c2cc11e3f8ed05" style="position:absolute;left:62px;top:113px;float:left;"><ix:continuation id="XBRL_CS_c52b0fc7dca2481886c2cc11e3f8ed05" continuedat="XBRL_TS_e2ced9a246a84542b19d872b9691f576"><div id="TextBlockContainer862" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:446px;"><div id="div_860_XBRL_CS_a11abe490b4040fdbaf024b6f80dfd3d" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_390" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer861" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:446px;"><div id="a42773" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The tax effects of temporary differences that give rise to our deferred income tax asset (liability) were<div style="display:inline-block;width:2px">&nbsp;</div>as follows: </div><div id="a42788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:544px;top:39px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a42794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:57px;">December 31, </div><div id="a42797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:57px;">December 25, </div><div id="a42803" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:513px;top:75px;">2022 </div><div id="a42806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:623px;top:75px;">2021 </div><div id="a42817" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:104px;">Deferred income tax asset: </div><div id="a42826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:122px;">Net operating losses and other carryforwards </div><div id="a42829" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:122px;">$ </div><div id="a42831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:122px;"><ix:nonfraction id="ID_445" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">64</ix:nonfraction></div><div id="a42834" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:122px;">$ </div><div id="a42836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:122px;"><ix:nonfraction id="ID_217" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">55</ix:nonfraction></div><div id="a42839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:140px;">Inventory, premium<div style="display:inline-block;width:5px">&nbsp;</div>coupon redemptions and accounts receivable </div><div id="a42849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:61px;top:158px;">valuation allowances<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:158px;"><ix:nonfraction id="ID_20" name="hsic:DeferredTaxAssetsNoncurrentTaxDeferredExpenseReservesAndAccrualsReserves" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">57</ix:nonfraction></div><div id="a42857" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:158px;"><ix:nonfraction id="ID_396" name="hsic:DeferredTaxAssetsNoncurrentTaxDeferredExpenseReservesAndAccrualsReserves" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction></div><div id="a42860" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:176px;">Stock-based compensation<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a42866" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:176px;"><ix:nonfraction id="ID_878" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a42870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:176px;"><ix:nonfraction id="ID_879" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a42873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:194px;">Uniform capitalization adjustment to inventories </div><div id="a42877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:194px;"><ix:nonfraction id="ID_880" name="hsic:DeferredTaxAssetsNoncurrentInventory" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a42881" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:194px;"><ix:nonfraction id="ID_881" name="hsic:DeferredTaxAssetsNoncurrentInventory" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a42884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:212px;">Operating lease liability </div><div id="a42888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:212px;"><ix:nonfraction id="ID_837" name="hsic:DeferredTaxAssetsOperatingLeaseLiabliity" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">77</ix:nonfraction></div><div id="a42892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:212px;"><ix:nonfraction id="ID_838" name="hsic:DeferredTaxAssetsOperatingLeaseLiabliity" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">79</ix:nonfraction></div><div id="a42895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:230px;">Other asset<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42899" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:230px;"><ix:nonfraction id="ID_281" name="us-gaap:DeferredTaxAssetsOther" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">48</ix:nonfraction></div><div id="a42903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:230px;"><ix:nonfraction id="ID_151" name="us-gaap:DeferredTaxAssetsOther" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a42906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:248px;">Total deferred income<div style="display:inline-block;width:5px">&nbsp;</div>tax asset<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a42910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:248px;"><ix:nonfraction id="ID_157" name="us-gaap:DeferredTaxAssetsGross" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">268</ix:nonfraction></div><div id="a42914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:248px;"><ix:nonfraction id="ID_416" name="us-gaap:DeferredTaxAssetsGross" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">244</ix:nonfraction></div><div id="a42917" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:51px;top:266px;">Valuation<div style="display:inline-block;width:5px">&nbsp;</div>allowance for deferred tax assets </div><div id="a42918" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:285px;top:265px;">(1)</div><div id="a42922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:266px;display:flex;">(<ix:nonfraction id="ID_249" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction>)</div><div id="a42926" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:266px;display:flex;">(<ix:nonfraction id="ID_304" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction>)</div><div id="a42929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:284px;">Net deferred income tax asset </div><div id="a42933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:556px;top:284px;"><ix:nonfraction id="ID_219" name="us-gaap:DeferredTaxAssetsNet" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">232</ix:nonfraction></div><div id="a42937" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:284px;"><ix:nonfraction id="ID_207" name="us-gaap:DeferredTaxAssetsNet" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">208</ix:nonfraction></div><div id="a42939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:302px;">Deferred income tax liability </div><div id="a42948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:320px;">Intangibles amortization </div><div id="a42952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:320px;display:flex;">(<ix:nonfraction id="ID_208" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">112</ix:nonfraction>)</div><div id="a42956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:320px;display:flex;">(<ix:nonfraction id="ID_446" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">134</ix:nonfraction>)</div><div id="a42959" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:338px;">Operating lease right-of-use asset </div><div id="a42967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:338px;display:flex;">(<ix:nonfraction id="ID_839" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">61</ix:nonfraction>)</div><div id="a42971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:664px;top:338px;display:flex;">(<ix:nonfraction id="ID_840" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction>)</div><div id="a42974" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:356px;">Property and equipment </div><div id="a42979" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:356px;display:flex;">(<ix:nonfraction id="ID_158" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a42983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:356px;display:flex;">(<ix:nonfraction id="ID_250" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a42986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:374px;">Total deferred tax<div style="display:inline-block;width:5px">&nbsp;</div>liability </div><div id="a42990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:374px;display:flex;">(<ix:nonfraction id="ID_417" name="us-gaap:DeferredIncomeTaxLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">180</ix:nonfraction>)</div><div id="a42994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:374px;display:flex;">(<ix:nonfraction id="ID_294" name="us-gaap:DeferredIncomeTaxLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">215</ix:nonfraction>)</div><div id="a42996" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:392px;">Net deferred income tax asset (liability) </div><div id="a42999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:392px;">$ </div><div id="a43001" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:563px;top:392px;"><ix:nonfraction id="ID_891" name="hsic:DeferredTaxAssetsOrLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">52</ix:nonfraction></div><div id="a43004" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:392px;">$ </div><div id="a43006" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:392px;display:flex;">(<ix:nonfraction id="ID_892" name="hsic:DeferredTaxAssetsOrLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction>)</div><div id="a43026" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:418px;">(1) </div><div id="a43028" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:418px;">Primarily relates to operating losses, the benefits of which are uncertain.<div style="display:inline-block;width:6px">&nbsp;</div>Any future reductions of such valuation allowances will be </div><div id="a43030" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:33px;top:432px;">reflected as a reduction of income tax expense.</div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_863_XBRL_TS_e2ced9a246a84542b19d872b9691f576" style="position:absolute;left:62px;top:566px;float:left;"><ix:continuation id="XBRL_TS_e2ced9a246a84542b19d872b9691f576" continuedat="XBRL_CS_4014a45d85b24deab5e3270e33a40dd6"><div id="TextBlockContainer864" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:271px;"><div id="a43032" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The assessment of the amount of value assigned to our deferred tax assets under<div style="display:inline-block;width:2px">&nbsp;</div>the applicable accounting rules is </div><div id="a43070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">judgmental.<div style="display:inline-block;width:7px">&nbsp;</div>We are required to consider all available positive and negative evidence in evaluating the likelihood </div><div id="a43102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">that we will be able to realize the benefit of our deferred tax assets in the future.<div style="display:inline-block;width:6px">&nbsp;</div>Such evidence includes reversals </div><div id="a43145" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">of deferred tax liabilities and projected future taxable income.<div style="display:inline-block;width:6px">&nbsp;</div>Since this evaluation requires consideration of </div><div id="a43175" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">events that may occur some years into the future, there is an element of<div style="display:inline-block;width:2px">&nbsp;</div>judgment involved.<div style="display:inline-block;width:7px">&nbsp;</div>Realization of our </div><div id="a43214" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">deferred tax assets is dependent on generating sufficient taxable income in future periods.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a43240" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:538px;top:84px;">We </div><div id="a43242" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:84px;">believe that it is </div><div id="a43250" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">more likely than not that future taxable income will be sufficient to allow us to recover<div style="display:inline-block;width:2px">&nbsp;</div>substantially all of the value </div><div id="a43293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">assigned to our deferred tax assets.<div style="display:inline-block;width:7px">&nbsp;</div>However, if future events cause us to conclude that it is not more likely than </div><div id="a43335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">not that we will be able to recover the value assigned to our deferred tax assets, we<div style="display:inline-block;width:2px">&nbsp;</div>will be required to adjust our </div><div id="a43382" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">valuation allowance accordingly. </div><div id="a43389" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">As of December 31, 2022, we had federal, state and foreign net operating<div style="display:inline-block;width:2px">&nbsp;</div>loss carryforwards of approximately </div><div id="a43423" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">$</div><div id="a43423_1_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:202px;"><ix:nonfraction id="ID_1584" name="us-gaap:OperatingLossCarryforwards" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">30</ix:nonfraction></div><div id="a43423_3_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:27px;top:202px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a43423_14_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:88px;top:202px;"><ix:nonfraction id="ID_1585" name="us-gaap:OperatingLossCarryforwards" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a43423_16_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:103px;top:202px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a43423_30_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:184px;top:202px;"><ix:nonfraction id="ID_1586" name="us-gaap:OperatingLossCarryforwards" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">220</ix:nonfraction></div><div id="a43423_33_75" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:206px;top:202px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>The federal, state and foreign net operating loss </div><div id="a43456" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">carryforwards will begin to expire in various years from 2023 through<div style="display:inline-block;width:2px">&nbsp;</div>2041.<div style="display:inline-block;width:7px">&nbsp;</div>The amounts of federal, state and </div><div id="a43492" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">foreign net operating losses that can be carried forward indefinitely are $</div><div id="a43492_75_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:432px;top:236px;"><ix:nonfraction id="ID_1587" name="hsic:OperatingLossCarryforwardsNotSubjectToExpiration" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a43492_77_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a43492_88_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:508px;top:236px;"><ix:nonfraction id="ID_1588" name="hsic:OperatingLossCarryforwardsNotSubjectToExpiration" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a43492_89_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a43492_103_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:236px;"><ix:nonfraction id="ID_1589" name="hsic:OperatingLossCarryforwardsNotSubjectToExpiration" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">218</ix:nonfraction></div><div id="a43492_106_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a43528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">respectively.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page99" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:164.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:18.2px; left:67.2px; top:203.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:206.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:202.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:418.3px; top:202.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:202.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:19.2px; left:528.3px; top:202.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:202.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.2px; left:638.4px; top:202.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:202.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:241.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:245.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:279.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:283.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:318.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:321.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.2px; left:67.2px; top:356.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:360.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:375.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:375.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:375.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:397.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:395.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:397.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:395.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:397.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:395.9px; background-color:#000000; ">&nbsp;</div>
<div id="a43531" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a43533" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a43535" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a43537" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a43540" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:401px;top:997px;">99 </div><div id="a43542" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:112px;">The tax provisions differ from the amount computed using the federal statutory income<div style="display:inline-block;width:2px">&nbsp;</div>tax rate as follows: </div><div id="div_865_XBRL_CS_4014a45d85b24deab5e3270e33a40dd6" style="position:absolute;left:63px;top:150px;float:left;"><ix:continuation id="XBRL_CS_4014a45d85b24deab5e3270e33a40dd6" continuedat="XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7"><div id="TextBlockContainer868" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:247px;"><div id="div_866_XBRL_CS_36aec24989a8412d9068462696b0d250" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_388" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer867" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:247px;"><div id="a43580" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:490px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>ended </div><div id="a43585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:19px;">December 31, </div><div id="a43588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:19px;">December 25, </div><div id="a43591" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:19px;">December 26, </div><div id="a43596" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:38px;">2022 </div><div id="a43599" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:38px;">2021 </div><div id="a43602" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:38px;">2020 </div><div id="a43604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:58px;">Income tax provision at federal statutory rate<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a43607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:58px;">$ </div><div id="a43609" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:58px;"><ix:nonfraction id="ID_35" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">151</ix:nonfraction></div><div id="a43612" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:58px;">$ </div><div id="a43614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:58px;"><ix:nonfraction id="ID_171" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">175</ix:nonfraction></div><div id="a43617" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:58px;">$ </div><div id="a43619" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:58px;"><ix:nonfraction id="ID_131" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">105</ix:nonfraction></div><div id="a43621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">State income tax provision, net of federal income tax effect<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a43625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:77px;"><ix:nonfraction id="ID_91" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction></div><div id="a43629" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:77px;"><ix:nonfraction id="ID_293" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a43633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:77px;"><ix:nonfraction id="ID_225" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a43635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Foreign income tax provision </div><div id="a43639" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:96px;"><ix:nonfraction id="ID_274" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a43643" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:96px;"><ix:nonfraction id="ID_463" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a43647" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:96px;"><ix:nonfraction id="ID_195" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a43649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:115px;">Pass-through noncontrolling interest<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a43655" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:115px;display:flex;">(<ix:nonfraction id="ID_256" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction>)</div><div id="a43659" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:115px;display:flex;">(<ix:nonfraction id="ID_104" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction>)</div><div id="a43663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:115px;display:flex;">(<ix:nonfraction id="ID_454" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a43665" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:134px;">Valuation<div style="display:inline-block;width:5px">&nbsp;</div>allowance<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a43669" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:134px;display:flex;">(<ix:nonfraction id="ID_288" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a43673" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:134px;display:flex;">(<ix:nonfraction id="ID_229" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction>)</div><div id="a43677" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:134px;"><ix:nonfraction id="ID_227" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a43679" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:154px;">Unrecognized tax benefits and audit settlements </div><div id="a43683" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:154px;"><ix:nonfraction id="ID_3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a43687" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:154px;"><ix:nonfraction id="ID_398" name="us-gaap:IncomeTaxReconciliationTaxContingencies" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a43691" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:154px;display:flex;">(<ix:nonfraction id="ID_289" name="us-gaap:IncomeTaxReconciliationTaxContingencies" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">18</ix:nonfraction>)</div><div id="a43693" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:173px;">Interest expense related to loans<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a43697" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:173px;display:flex;">(<ix:nonfraction id="ID_42" name="hsic:IncomeTaxReconciliationInterestExpenseRelatedToLoans" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction>)</div><div id="a43701" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:173px;display:flex;">(<ix:nonfraction id="ID_177" name="hsic:IncomeTaxReconciliationInterestExpenseRelatedToLoans" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a43705" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:173px;display:flex;">(<ix:nonfraction id="ID_166" name="hsic:IncomeTaxReconciliationInterestExpenseRelatedToLoans" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a43707" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:192px;">Tax benefit related<div style="display:inline-block;width:5px">&nbsp;</div>to legal entity reorganization outside the U.S. </div><div id="a43711" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:461px;top:192px;"><ix:nonfraction id="ID_442" name="us-gaap:IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a43715" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:192px;"><ix:nonfraction id="ID_209" name="us-gaap:IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a43719" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:192px;display:flex;">(<ix:nonfraction id="ID_218" name="us-gaap:IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction>)</div><div id="a43721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:211px;">Other<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a43725" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:211px;"><ix:nonfraction id="ID_153" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a43729" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:211px;"><ix:nonfraction id="ID_59" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a43733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:211px;"><ix:nonfraction id="ID_15" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a43736" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:32px;top:231px;">Total income<div style="display:inline-block;width:5px">&nbsp;</div>tax provision<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a43739" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:231px;">$ </div><div id="a43741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:231px;"><ix:nonfraction id="ID_60AAA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">170</ix:nonfraction></div><div id="a43744" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:231px;">$ </div><div id="a43746" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:231px;"><ix:nonfraction id="ID_437AAA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">198</ix:nonfraction></div><div id="a43749" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:231px;">$ </div><div id="a43751" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:231px;"><ix:nonfraction id="ID_198AAA" name="us-gaap:IncomeTaxExpenseBenefit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">95</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_869_XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7" style="position:absolute;left:62px;top:416px;float:left;"><ix:continuation id="XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7" continuedat="XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7_1"><div id="TextBlockContainer870" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:689px;height:541px;"><div id="a43754" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">For the year ended December 31, 2022, our effective tax rate was </div><div id="a43754_65_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:0px;"><ix:nonfraction id="ID_1739" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">23.5</ix:nonfraction></div><div id="a43754_69_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:418px;top:0px;">%, compared to </div><div id="a43754_84_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:0px;"><ix:nonfraction id="ID_1201" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">23.8</ix:nonfraction></div><div id="a43754_88_21" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:540px;top:0px;">% for the prior year </div><div id="a43799" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">period.<div style="display:inline-block;width:7px">&nbsp;</div>In 2022, the difference between our effective tax rate and the federal statutory tax rate primarily<div style="display:inline-block;width:2px">&nbsp;</div>relates to </div><div id="a43835" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">state and foreign income taxes and interest expense.<div style="display:inline-block;width:6px">&nbsp;</div>In 2021, the difference between our effective tax rate and the </div><div id="a43859" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">federal statutory tax rate was primarily due to state and foreign income<div style="display:inline-block;width:2px">&nbsp;</div>taxes and interest expense.<div style="display:inline-block;width:7px">&nbsp;</div>In 2020, our </div><div id="a43878" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">effective tax rate was </div><div id="a43878_23_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:134px;top:68px;"><ix:nonfraction id="ID_1590" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">19.1</ix:nonfraction></div><div id="a43878_27_89" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:159px;top:68px;">%.<div style="display:inline-block;width:7px">&nbsp;</div>The difference between our effective tax rate and the federal statutory tax rate was </div><div id="a43916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">primarily due to an Advance Pricing Agreement with the U.S Internal Revenue<div style="display:inline-block;width:2px">&nbsp;</div>Service (the “IRS”) in the U.S., </div><div id="a43950" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">other audit resolutions, state and foreign income taxes and interest expense.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a43974" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">On August 16, 2022, the Inflation Reduction Act (H.R. 5376) (“IRA”) was<div style="display:inline-block;width:2px">&nbsp;</div>signed into law in the United States.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a43975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">Among other things, the IRA imposes a 15% corporate alternative minimum<div style="display:inline-block;width:2px">&nbsp;</div>tax for tax years beginning after </div><div id="a43977" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">December 31, 2022 and levies a 1% excise tax on net stock repurchases after<div style="display:inline-block;width:2px">&nbsp;</div>December 31, 2022.<div style="display:inline-block;width:7px">&nbsp;</div>We are still in </div><div id="a43978" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">the process of analyzing the provisions of the IRA. </div><div id="a43981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES<div style="display:inline-block;width:2px">&nbsp;</div>Act”) was enacted in </div><div id="a44016" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">response to the COVID-19 pandemic.<div style="display:inline-block;width:7px">&nbsp;</div>The CARES Act includes, but is not limited to, certain income tax </div><div id="a44052" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">provisions that modify the Section 163(j) limitation of business interest and<div style="display:inline-block;width:2px">&nbsp;</div>net operating loss carryover and </div><div id="a44084" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">carryback rules.<div style="display:inline-block;width:7px">&nbsp;</div>The modifications to Section 163(j) increase the allowable business<div style="display:inline-block;width:2px">&nbsp;</div>interest deduction from </div><div id="a44084_110_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:647px;top:270px;"><ix:nonfraction id="ID_857" name="hsic:EffectiveIncomeTaxRateReconciliationInterestDeductionFromAdjustableTaxableIncomeBeforeModificationPercent" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">30</ix:nonfraction></div><div id="a44084_112_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:662px;top:270px;">% </div><div id="a44114" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">of adjusted taxable income to </div><div id="a44114_30_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:181px;top:287px;"><ix:nonfraction id="ID_858" name="hsic:EffectiveIncomeTaxRateReconciliationInterestDeductionFromAdjustableTaxableIncomeAfterModificationPercent" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">50</ix:nonfraction></div><div id="a44114_32_78" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:196px;top:287px;">% of adjusted taxable income for years beginning in 2019 and 2020.<div style="display:inline-block;width:6px">&nbsp;</div>The CARES </div><div id="a44152" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">Act eliminated the NOL income limitation for years beginning before 2021<div style="display:inline-block;width:2px">&nbsp;</div>and it extended the carryback period to </div><div id="a44188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">five years for losses incurred in 2018, 2019 and 2020.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a44208" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:328px;top:321px;">We </div><div id="a44210" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:352px;top:321px;">have analyzed the income tax provisions of the CARES </div><div id="a44228" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">Act and have accounted for the impact in the year ended December 26, 2020,<div style="display:inline-block;width:2px">&nbsp;</div>which did not have a material impact </div><div id="a44270" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">on our consolidated financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>There are certain other non-income tax benefits available to us under<div style="display:inline-block;width:2px">&nbsp;</div>the </div><div id="a44306" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">CARES Act that require further clarification or interpretation that<div style="display:inline-block;width:2px">&nbsp;</div>may affect our consolidated financial statements </div><div id="a44337" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">in the future.<div style="display:inline-block;width:7px">&nbsp;</div>On December 27, 2020, the Consolidated Appropriations Act was<div style="display:inline-block;width:2px">&nbsp;</div>enacted into law and extended </div><div id="a44371" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">certain non-income tax benefits under the CARES Act. </div><div id="a44390" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">On July 20, 2020, the IRS issued final regulations related to the Tax Cuts and Jobs Act enacted in 2017 (the “Tax </div><div id="a44435" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">Act”).<div style="display:inline-block;width:7px">&nbsp;</div>The final regulations concern the global intangible low-taxed income<div style="display:inline-block;width:2px">&nbsp;</div>(“GILTI”) and subpart F income </div><div id="a44468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:472px;">provisions of the Tax Act.<div style="display:inline-block;width:8px">&nbsp;</div>To provide flexibility to taxpayers, the IRS is permitting the application of these final </div><div id="a44507" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">regulations to prior tax years, if the taxpayer elects to do so.<div style="display:inline-block;width:6px">&nbsp;</div>We have analyzed the final regulations, which do not </div><div id="a44550" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">have a material impact to our consolidated financial statements. </div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page100" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a44569" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a44571" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a44573" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a44575" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a44578" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">100 </div><div id="div_871_XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_09e5ff19cd344a139a7ba703d2d881f7_1" continuedat="XBRL_CS_e27b1d84861d41ddaef87c9295cc8681"><div id="TextBlockContainer874" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:693px;height:743px;"><div id="div_872_XBRL_TS_f7d4e6f6f9a745dd95815537504b6498" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_f7d4e6f6f9a745dd95815537504b6498"><div id="TextBlockContainer873" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:85px;"><div id="a44580" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">On December 22, 2017, the U.S. government passed the Tax Act, which requires U.S. companies to pay a </div><div id="a44616" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">mandatory one-time transition tax on historical offshore earnings that have not been<div style="display:inline-block;width:2px">&nbsp;</div>repatriated to the U.S.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a44652" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">transition tax is payable over eight years.<div style="display:inline-block;width:7px">&nbsp;</div>Within our consolidated balance sheets, transition tax of $</div><div id="a44652_104_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:34px;"><ix:nonfraction id="ID_1591" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_hsic_AccruedTaxesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction></div><div id="a44652_106_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:609px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and </div><div id="a44690" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">$</div><div id="a44690_1_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:51px;"><ix:nonfraction id="ID_1592" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_hsic_AccruedTaxesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a44690_3_80" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:27px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million were included in “accrued taxes” for 2022 and 2021, respectively, and $</div><div id="a44690_83_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:500px;top:51px;"><ix:nonfraction id="ID_1593" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a44690_85_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:515px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a44690_99_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:597px;top:51px;"><ix:nonfraction id="ID_1594" name="us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiabilityCurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">42</ix:nonfraction></div><div id="a44690_101_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>million </div><div id="a44732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">were included in “other liabilities” for 2022 and 2021, respectively.</div></div></ix:continuation></div><div id="a44756" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">Due to the one-time transition tax and the imposition of the GILTI provisions, all previously unremitted earnings </div><div id="a44792" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">will no longer be subject to U.S. federal income tax; however, there could be U.S., state and/or foreign withholding </div><div id="a44831" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">taxes upon distribution of such unremitted earnings.<div style="display:inline-block;width:7px">&nbsp;</div>Determination of the amount of unrecognized deferred tax </div><div id="a44862" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">liability with respect to such earnings is not practicable. </div><div id="a44881" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">ASC 740 prescribes the accounting for uncertainty in income taxes recognized<div style="display:inline-block;width:2px">&nbsp;</div>in the financial statements in </div><div id="a44913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">accordance with other provisions contained within this guidance.<div style="display:inline-block;width:6px">&nbsp;</div>This topic prescribes a recognition threshold and </div><div id="a44944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">a measurement attribute for the financial statement recognition and measurement<div style="display:inline-block;width:2px">&nbsp;</div>of tax positions taken or expected </div><div id="a44976" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">to be taken in a tax return.<div style="display:inline-block;width:7px">&nbsp;</div>For those benefits to be recognized, a tax position must be more likely<div style="display:inline-block;width:2px">&nbsp;</div>than not to be </div><div id="a45026" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">sustained upon examination by the taxing authorities.<div style="display:inline-block;width:6px">&nbsp;</div>The amount recognized is measured as the largest amount of </div><div id="a45061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">benefit that has a greater than 50% likely of being realized upon ultimate<div style="display:inline-block;width:2px">&nbsp;</div>audit settlement.<div style="display:inline-block;width:7px">&nbsp;</div>In the normal course of </div><div id="a45101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">business, our tax returns are subject to examination by various taxing<div style="display:inline-block;width:2px">&nbsp;</div>authorities.<div style="display:inline-block;width:7px">&nbsp;</div>Such examinations may result in </div><div id="a45135" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">future tax and interest assessments by these taxing authorities for uncertain<div style="display:inline-block;width:2px">&nbsp;</div>tax positions taken in respect of certain </div><div id="a45172" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">tax matters. </div><div id="a45177" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">The total amount of unrecognized tax benefits, which are included in “other<div style="display:inline-block;width:2px">&nbsp;</div>liabilities” within our consolidated </div><div id="a45209" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">balance sheets, as of December 31, 2022 and December 25, 2021 was approximately<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a45209_81_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:371px;"><ix:nonfraction id="ID_1595" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">94</ix:nonfraction></div><div id="a45209_83_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:528px;top:371px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a45209_97_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:610px;top:371px;"><ix:nonfraction id="ID_1596" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">84</ix:nonfraction></div><div id="a45209_99_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:625px;top:371px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a45246" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">respectively, of which $</div><div id="a45246_24_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:146px;top:388px;"><ix:nonfraction id="ID_1597" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">80</ix:nonfraction></div><div id="a45246_26_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:161px;top:388px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a45246_40_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:243px;top:388px;"><ix:nonfraction id="ID_1598" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">69</ix:nonfraction></div><div id="a45246_42_78" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:257px;top:388px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively would affect the effective tax rate if recognized.<div style="display:inline-block;width:7px">&nbsp;</div>It </div><div id="a45283" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">is possible that the amount of unrecognized tax benefits will change in<div style="display:inline-block;width:2px">&nbsp;</div>the next 12 months, which may result in a </div><div id="a45325" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">material impact on our consolidated statements of income. </div><div id="a45342" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">All tax returns audited by the IRS are officially closed through 2018.<div style="display:inline-block;width:6px">&nbsp;</div>The tax years subject to examination by the </div><div id="a45385" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:472px;">IRS include years 2019 and forward.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, limited positions reported in the 2017 tax year are subject<div style="display:inline-block;width:2px">&nbsp;</div>to IRS </div><div id="a45427" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">examination.<div style="display:inline-block;width:7px">&nbsp;</div>During the quarter ended December 25, 2021, we were notified by<div style="display:inline-block;width:2px">&nbsp;</div>the IRS that tax year 2019 was </div><div id="a45465" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">selected for examination.<div style="display:inline-block;width:7px">&nbsp;</div>During the quarter ended June 26, 2021 we reached a resolution with<div style="display:inline-block;width:2px">&nbsp;</div>the Appellate </div><div id="a45501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">Division for all remaining outstanding issues for 2012 and 2013.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a45524" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:557px;">During the quarter ended September 26, 2020 we reached an agreement with<div style="display:inline-block;width:2px">&nbsp;</div>the Advanced Pricing Division on an </div><div id="a45560" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:574px;">appropriate transfer pricing methodology for the years 2014-2025.<div style="display:inline-block;width:6px">&nbsp;</div>The objective of this resolution was to mitigate </div><div id="a45596" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:590px;">future transfer pricing audit adjustments.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a45609" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:624px;">In the fourth quarter of 2020, we reached a resolution with the IRS for the<div style="display:inline-block;width:2px">&nbsp;</div>2014-2016 audit cycle. </div><div id="a45649" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:658px;">The total amounts of interest and penalties are classified as a component of<div style="display:inline-block;width:2px">&nbsp;</div>the provision for income taxes.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a45688" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:675px;">amount of tax interest expense (credit) was approximately $</div><div id="a45688_59_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:675px;"><ix:nonfraction id="ID_1599" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a45688_60_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:675px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a45688_71_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:675px;"><ix:nonfraction id="ID_1600" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a45688_72_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:433px;top:675px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $(</div><div id="a45688_87_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:519px;top:675px;"><ix:nonfraction id="ID_1601" name="us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction></div><div id="a45688_88_24" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:675px;">) million in 2022, 2021 </div><div id="a45727" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:692px;">and 2020, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>The total amount of accrued interest is included in “other liabilities”,<div style="display:inline-block;width:2px">&nbsp;</div>and was </div><div id="a45762" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:709px;">approximately $</div><div id="a45762_15_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:101px;top:709px;"><ix:nonfraction id="ID_1602" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a45762_17_38" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:115px;top:709px;"><div style="display:inline-block;width:4px">&nbsp;</div>million as of December 31, 2022 and $</div><div id="a45762_55_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:709px;"><ix:nonfraction id="ID_1603" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherLiabilitiesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a45762_57_49" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:363px;top:709px;"><div style="display:inline-block;width:4px">&nbsp;</div>million as of December 25, 2021.<div style="display:inline-block;width:7px">&nbsp;</div>The amount of </div><div id="a45803" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:725px;">penalties accrued for during the periods presented were not material<div style="display:inline-block;width:2px">&nbsp;</div>to our consolidated financial statements.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page101" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:186.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:186.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:20px; left:67.2px; top:185.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:184.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:184.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20px; left:528.3px; top:185.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:184.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:638.4px; top:185.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:184.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:225.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:225.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:265.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:265.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20.1px; left:67.2px; top:306.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20.1px; left:67.2px; top:306.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:21.1px; left:67.2px; top:305.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:304.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:304.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:21.1px; left:528.3px; top:305.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:304.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:21.1px; left:638.4px; top:305.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:304.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:328.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:427.3px; top:326.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:328.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:537.4px; top:326.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:328.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:647.3px; top:326.4px; background-color:#000000; ">&nbsp;</div>
<div id="a45833" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a45835" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a45837" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a45839" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a45842" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">101 </div><div id="div_875_XBRL_CS_e27b1d84861d41ddaef87c9295cc8681" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_CS_e27b1d84861d41ddaef87c9295cc8681" continuedat="XBRL_CS_005f54ec419443099e0aafdac20cd3f5"><div id="TextBlockContainer876" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:450px;height:18px;"><div id="a45844" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table provides a reconciliation of unrecognized tax benefits:</div></div></ix:continuation></div><div id="div_877_XBRL_CS_fff678d058d94d5481c3e5b974702b49" style="position:absolute;left:63px;top:150px;float:left;"><ix:nonnumeric id="ID_216" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer880" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:176px;"><div id="div_878_XBRL_CS_005f54ec419443099e0aafdac20cd3f5" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_005f54ec419443099e0aafdac20cd3f5"><div id="TextBlockContainer879" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:690px;height:176px;"><div id="a45867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:0px;">December 31, </div><div id="a45870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:0px;">December 25, </div><div id="a45873" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:0px;">December 26, </div><div id="a45877" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:20px;">2022 </div><div id="a45880" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:20px;">2021 </div><div id="a45883" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:20px;">2020 </div><div id="a45885" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">Balance, beginning of period<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:40px;">$ </div><div id="a45890" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:40px;"><ix:nonfraction id="ID_1604" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">71</ix:nonfraction></div><div id="a45893" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:40px;">$ </div><div id="a45895" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:40px;"><ix:nonfraction id="ID_859" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">70</ix:nonfraction></div><div id="a45898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:40px;">$ </div><div id="a45900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:40px;"><ix:nonfraction id="ID_133" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec28_2019_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">91</ix:nonfraction></div><div id="a45902" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Additions based on current year tax positions<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:60px;"><ix:nonfraction id="ID_100" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a45910" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:569px;top:60px;"><ix:nonfraction id="ID_266" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a45914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:60px;"><ix:nonfraction id="ID_230" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a45916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Additions based on prior year tax positions<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45920" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:80px;"><ix:nonfraction id="ID_430" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a45924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:80px;"><ix:nonfraction id="ID_301" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">11</ix:nonfraction></div><div id="a45928" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:80px;"><ix:nonfraction id="ID_222" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a45930" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Reductions based on prior year tax positions<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45934" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:461px;top:100px;"><ix:nonfraction id="ID_54" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a45938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:100px;display:flex;">(<ix:nonfraction id="ID_57" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a45942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:100px;display:flex;">(<ix:nonfraction id="ID_277" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a45944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">Reductions resulting from settlements with taxing authorities<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a45948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:450px;top:120px;display:flex;">(<ix:nonfraction id="ID_389" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a45952" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:120px;display:flex;">(<ix:nonfraction id="ID_118" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction>)</div><div id="a45956" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:120px;display:flex;">(<ix:nonfraction id="ID_337" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">19</ix:nonfraction>)</div><div id="a45958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:140px;">Reductions resulting from lapse in statutes of limitations<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:140px;display:flex;">(<ix:nonfraction id="ID_142" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction>)</div><div id="a45966" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:140px;display:flex;">(<ix:nonfraction id="ID_122" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a45970" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:140px;display:flex;">(<ix:nonfraction id="ID_264" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction>)</div><div id="a45972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:161px;">Balance, end of period<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a45975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:161px;">$ </div><div id="a45977" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:161px;"><ix:nonfraction id="ID_4" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">82</ix:nonfraction></div><div id="a45980" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:161px;">$ </div><div id="a45982" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:161px;"><ix:nonfraction id="ID_1605" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">71</ix:nonfraction></div><div id="a45985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:161px;">$ </div><div id="a45987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:161px;"><ix:nonfraction id="ID_859A" name="us-gaap:UnrecognizedTaxBenefits" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">70</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_881_XBRL_TS_04d1856c69b44397a840a8b4fda4a3a6" style="position:absolute;left:62px;top:346px;float:left;"><ix:nonnumeric id="ID_04d1856c69b44397a840a8b4fda4a3a6" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_e59aeb7981d5484885d50faac54b8be9" escape="true"><div id="TextBlockContainer882" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:212px;height:17px;"><div id="a45990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 14 – Plans of Restructuring</div></div></ix:nonnumeric></div><div id="a45990_32_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:271px;top:346px;"><div style="display:inline-block;width:4px">&nbsp;</div>and Integration Costs </div><div id="a45998" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:363px;">&nbsp;</div><div id="div_883_XBRL_TS_e59aeb7981d5484885d50faac54b8be9" style="position:absolute;left:62px;top:380px;float:left;"><ix:continuation id="XBRL_TS_e59aeb7981d5484885d50faac54b8be9" continuedat="XBRL_TS_9d0f5d23e818427aa2a9ba2b27f602f0"><div id="TextBlockContainer884" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:474px;"><div id="a45999" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">On August 1, 2022, we committed to a restructuring plan focused on<div style="display:inline-block;width:2px">&nbsp;</div>funding the priorities of the strategic plan and </div><div id="a46000" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">streamlining operations and other initiatives to increase efficiency.<div style="display:inline-block;width:7px">&nbsp;</div>We expect this initiative to extend through </div><div id="a46001" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">2023.<div style="display:inline-block;width:7px">&nbsp;</div>We are currently unable in good faith to make a determination of an estimate of the amount or range of </div><div id="a46003" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">amounts expected to be incurred in connection with these activities, both with<div style="display:inline-block;width:2px">&nbsp;</div>respect to each major type of cost </div><div id="a46004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">associated therewith and with respect to the total cost, or an estimate of the<div style="display:inline-block;width:2px">&nbsp;</div>amount or range of amounts that will </div><div id="a46006" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">result in future cash expenditures. </div><div id="a46009" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">During the year ended December 31, 2022, we recorded restructuring charges of $</div><div id="a46009_79_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:488px;top:118px;"><ix:nonfraction id="ID_1608" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a46009_82_30" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>million primarily related to </div><div id="a46010" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">severance and employee-related costs, accelerated amortization of right-of-use<div style="display:inline-block;width:2px">&nbsp;</div>lease assets, impairment of other </div><div id="a46018" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">long-lived assets and lease exit costs.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a46023" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">During the three months ended December 31, 2022, in connection with our<div style="display:inline-block;width:2px">&nbsp;</div>restructuring plan, we vacated </div><div id="a46023_103_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:186px;"><ix:nonfraction id="ID_1609" name="hsic:NumberOfBuildingsVacated" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_BuildingVacatedMember" unitref="myNumber" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonfraction></div><div id="a46023_106_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:651px;top:186px;"><div style="display:inline-block;width:4px">&nbsp;</div>of </div><div id="a46024" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">the buildings at our corporate headquarters in Melville NY, which resulted in an accelerated amortization of right-</div><div id="a46027" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">of-use lease asset of $</div><div id="a46027_23_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:134px;top:219px;"><ix:nonfraction id="ID_1611" name="hsic:OperatingLeaseAcceleratedAmortizationOfRightOfUseAsset" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_BuildingVacatedMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">34</ix:nonfraction></div><div id="a46027_25_87" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:148px;top:219px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>We also initiated the disposal of a non-profitable US business and recorded </div><div id="a46032" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">related costs of $</div><div id="a46032_18_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:105px;top:236px;"><ix:nonfraction id="ID_1612" name="us-gaap:RestructuringCharges" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a46032_20_94" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million which primarily consisted of impairment of intangible assets<div style="display:inline-block;width:2px">&nbsp;</div>and goodwill, inventory </div><div id="a46034" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">impairment, and severance and employee-related costs.<div style="display:inline-block;width:6px">&nbsp;</div>These expenses are included in the $</div><div id="a46034_91_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:552px;top:253px;"><ix:nonfraction id="ID_1610" name="us-gaap:RestructuringCharges" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a46034_94_12" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:574px;top:253px;"><div style="display:inline-block;width:4px">&nbsp;</div>million of </div><div id="a46037" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">restructuring charges discussed above.<div style="display:inline-block;width:7px">&nbsp;</div>The disposal is expected to be completed in the first quarter of 2023.<div style="display:inline-block;width:2px">&nbsp;</div></div><div id="a46041" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">On August 26, 2022, we acquired Midway Dental Supply.<div style="display:inline-block;width:7px">&nbsp;</div>In connection with this acquisition, during the year </div><div id="a46042" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">ended December 31, 2022, we recorded integration costs of $</div><div id="a46042_59_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:366px;top:321px;"><ix:nonfraction id="ID_1613" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_hsic_MidwayDentalSupplyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46042_60_48" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:373px;top:321px;"><div style="display:inline-block;width:4px">&nbsp;</div>million related to one-time employee and other </div><div id="a46045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">costs, as well as restructuring charges of $</div><div id="a46045_44_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:253px;top:337px;"><ix:nonfraction id="ID_1614" name="us-gaap:RestructuringCharges" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228_us-gaap_BusinessAcquisitionAxis_hsic_MidwayDentalSupplyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a46045_45_37" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:260px;top:337px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, which are included in the $</div><div id="a46045_82_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:337px;"><ix:nonfraction id="ID_1610A" name="us-gaap:RestructuringCharges" contextref="FROM_Sep25_2022_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a46045_85_34" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:337px;"><div style="display:inline-block;width:4px">&nbsp;</div>million of restructuring charges </div><div id="a46047" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">discussed above. </div><div id="a46050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">On November 20, 2019, we committed to a contemplated restructuring<div style="display:inline-block;width:2px">&nbsp;</div>initiative intended to mitigate stranded costs </div><div id="a46053" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">associated with the spin-off of our animal health business and to rationalize operations<div style="display:inline-block;width:2px">&nbsp;</div>and provide expense </div><div id="a46058" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">efficiencies.<div style="display:inline-block;width:7px">&nbsp;</div>These activities were originally expected to be completed by<div style="display:inline-block;width:2px">&nbsp;</div>the end of 2020 but we extended them to </div><div id="a46059" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">the end of 2021 in light of the changes to the business environment brought<div style="display:inline-block;width:2px">&nbsp;</div>on by the COVID-19 pandemic.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a46063" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:456px;">restructuring activities under this prior initiative were completed<div style="display:inline-block;width:2px">&nbsp;</div>in 2021.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page102" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:452.1px; height:1px; left:311.8px; top:177.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:217.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:217.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:314.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:415.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:512.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:614.1px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:711px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:15.8px; left:67.2px; top:262.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:263.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:245px; height:1px; left:66.8px; top:260.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16.8px; left:307.3px; top:261.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:260.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:502.3px; top:261.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:260.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:700.3px; top:261.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:260.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:14.6px; left:307.3px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:14.6px; left:502.3px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23px; height:14.6px; left:700.3px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:16.8px; left:67.2px; top:327.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:330px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:14.6px; left:307.3px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:14.6px; left:502.3px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23px; height:14.6px; left:700.3px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:16.8px; left:67.2px; top:361.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:363.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:377.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:377.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:377.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:312.2px; top:395.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:312.2px; top:397.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:510.3px; top:395.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:510.3px; top:397.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:708.3px; top:395.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:708.3px; top:397.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:452.1px; height:1px; left:311.8px; top:428.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:457.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:457.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:314.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:415.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:512.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:614.1px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:711px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:15.8px; left:67.2px; top:493.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:494.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:245px; height:1px; left:66.8px; top:492.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16.8px; left:307.3px; top:492.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:492.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:502.3px; top:492.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:492.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:700.3px; top:492.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:492.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:509.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:509.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:509.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:312.2px; top:527.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:312.2px; top:529px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:510.3px; top:527.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:510.3px; top:529px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:708.3px; top:527.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:708.3px; top:529px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:452.1px; height:1px; left:311.8px; top:561.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:590.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:590.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:314.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:415.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.8px; height:14.6px; left:512.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:614.1px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:14.6px; left:711px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:15.8px; left:67.2px; top:626.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:627.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:245px; height:1px; left:66.8px; top:625.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16.8px; left:307.3px; top:625.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:625.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:502.3px; top:625.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:625.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:8px; height:16.8px; left:700.3px; top:625.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:625.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:234.6px; height:14.6px; left:69.9px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:14.6px; left:307.3px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:14.6px; left:330px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.6px; height:14.6px; left:431px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:14.6px; left:502.3px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:14.6px; left:527.9px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:68.8px; height:14.6px; left:628.9px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23px; height:14.6px; left:700.3px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:697.1px; height:16.8px; left:67.2px; top:694.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:35.7px; height:14.6px; left:726.1px; top:696.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:190.1px; height:1px; left:311.8px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190px; height:1px; left:509.9px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:56px; height:1px; left:707.9px; top:710.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:191.1px; height:1px; left:311.3px; top:730.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:191.1px; height:1px; left:311.3px; top:728.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.9px; height:1px; left:509.4px; top:730.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:190.9px; height:1px; left:509.4px; top:728.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:57px; height:1px; left:707.3px; top:730.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:57px; height:1px; left:707.3px; top:728.9px; background-color:#000000; ">&nbsp;</div>
<div id="a46066" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a46068" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a46070" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a46072" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a46075" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">102 </div><div id="div_885_XBRL_TS_9d0f5d23e818427aa2a9ba2b27f602f0" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_9d0f5d23e818427aa2a9ba2b27f602f0" continuedat="XBRL_TS_2e0c9f2dc7384702b6860373053e6277"><div id="TextBlockContainer886" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:633px;height:35px;"><div id="a46077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Restructuring and integration costs recorded during our 2022, 2021 and<div style="display:inline-block;width:2px">&nbsp;</div>2020 fiscal years consisted of the </div><div id="a46078" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">following:</div></div></ix:continuation></div><div id="div_887_XBRL_TS_c6c482b5f4694c84a3a6283c3f59aa32" style="position:absolute;left:66px;top:164px;float:left;"><ix:nonnumeric id="ID_1606" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer890" style="position:relative;font-family:'Times New Roman';font-size:12.64px;color:#000000;line-height:normal;width:701px;height:565px;"><div id="div_888_XBRL_TS_2e0c9f2dc7384702b6860373053e6277" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_2e0c9f2dc7384702b6860373053e6277" continuedat="XBRL_TS_2a20728491a0413aa505ea90daa2d6b7"><div id="TextBlockContainer889" style="position:relative;font-family:'Times New Roman';font-size:12.64px;color:#000000;line-height:normal;width:701px;height:565px;"><div id="a46086" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:0px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended December 31, 2022 </div><div id="a46096" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:281px;top:40px;">Health-Care Distribution </div><div id="a46102" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:466px;top:25px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and Value-Added </div><div id="a46105" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:525px;top:40px;">Services </div><div id="a46116" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:267px;top:68px;">Restructuring </div><div id="a46117" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:290px;top:83px;">Costs </div><div id="a46120" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:369px;top:68px;">Integration </div><div id="a46121" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:83px;">Costs </div><div id="a46125" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:68px;">Restructuring </div><div id="a46126" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:83px;">Costs </div><div id="a46129" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:567px;top:68px;">Integration </div><div id="a46130" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:83px;">Costs </div><div id="a46134" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:664px;top:83px;">Total </div><div id="a46136" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Severance and employee-related costs </div><div id="a46141" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:100px;">$ </div><div id="a46143" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:100px;"><ix:nonfraction id="ID_1637" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">25</ix:nonfraction></div><div id="a46145" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:100px;">$ </div><div id="a46147" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:100px;">- </div><div id="a46150" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:100px;">$ </div><div id="a46152" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:100px;"><ix:nonfraction id="ID_1644" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46154" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:100px;">$ </div><div id="a46156" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:100px;">- </div><div id="a46159" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:100px;">$ </div><div id="a46161" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:100px;"><ix:nonfraction id="ID_1615" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction></div><div id="a46163" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:120px;">Impairment and accelerated depreciation and </div><div id="a46164" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:135px;">amortization of right-of-use lease assets and </div><div id="a46169" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:149px;">other long-lived assets </div><div id="a46175" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:149px;"><ix:nonfraction id="ID_1638" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ImpairmentAndAcceleratedDepreciationAndAmortizationMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction></div><div id="a46178" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:149px;">- </div><div id="a46182" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:149px;">- </div><div id="a46185" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:149px;">- </div><div id="a46189" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:149px;"><ix:nonfraction id="ID_1635" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ImpairmentAndAcceleratedDepreciationAndAmortizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction></div><div id="a46191" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Exit and other related costs </div><div id="a46195" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:166px;"><ix:nonfraction id="ID_1639" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46198" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:166px;">- </div><div id="a46202" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:166px;">- </div><div id="a46205" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:166px;">- </div><div id="a46209" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:166px;"><ix:nonfraction id="ID_1616" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46211" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:183px;">Loss on disposal of a business </div><div id="a46215" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:183px;"><ix:nonfraction id="ID_1640" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a46218" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:183px;">- </div><div id="a46227" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:183px;"><ix:nonfraction id="ID_1636" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">49</ix:nonfraction></div><div id="a46229" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:200px;">Integration employee-related and other costs </div><div id="a46235" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:341px;top:200px;">- </div><div id="a46238" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:200px;"><ix:nonfraction id="ID_1642" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_IntegrationEmployeeRelatedAndOtherCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46242" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:200px;">- </div><div id="a46245" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:200px;">- </div><div id="a46249" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:200px;"><ix:nonfraction id="ID_1617" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_IntegrationEmployeeRelatedAndOtherCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46252" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:217px;">Total restructuring and integration costs </div><div id="a46256" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:217px;">$ </div><div id="a46258" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:217px;"><ix:nonfraction id="ID_1641" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">124</ix:nonfraction></div><div id="a46260" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:217px;">$ </div><div id="a46262" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:217px;"><ix:nonfraction id="ID_1643" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46265" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:217px;">$ </div><div id="a46267" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:217px;"><ix:nonfraction id="ID_1645" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46269" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:217px;">$ </div><div id="a46271" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:217px;">- </div><div id="a46274" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:217px;">$ </div><div id="a46276" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:217px;"><ix:nonfraction id="ID_1618" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">131</ix:nonfraction></div><div id="a46300" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:250px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended December 25, 2021 </div><div id="a46308" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:281px;top:280px;">Health-Care Distribution </div><div id="a46314" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:466px;top:265px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and Value-Added </div><div id="a46317" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:525px;top:280px;">Services </div><div id="a46328" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:267px;top:300px;">Restructuring </div><div id="a46329" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:290px;top:314px;">Costs </div><div id="a46332" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:369px;top:300px;">Integration </div><div id="a46333" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:314px;">Costs </div><div id="a46337" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:300px;">Restructuring </div><div id="a46338" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:314px;">Costs </div><div id="a46341" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:567px;top:300px;">Integration </div><div id="a46342" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:314px;">Costs </div><div id="a46346" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:664px;top:314px;">Total </div><div id="a46348" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:331px;">Severance and employee-related costs </div><div id="a46353" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:331px;">$ </div><div id="a46355" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:331px;"><ix:nonfraction id="ID_1631" name="us-gaap:RestructuringCharges" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a46357" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:331px;">$ </div><div id="a46359" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:331px;">- </div><div id="a46362" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:331px;">$ </div><div id="a46364" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:331px;"><ix:nonfraction id="ID_1633" name="us-gaap:RestructuringCharges" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a46366" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:331px;">$ </div><div id="a46368" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:331px;">- </div><div id="a46371" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:331px;">$ </div><div id="a46373" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:331px;"><ix:nonfraction id="ID_1619" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a46376" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:349px;">Total restructuring and integration costs </div><div id="a46379" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:349px;">$ </div><div id="a46381" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:349px;"><ix:nonfraction id="ID_1632" name="us-gaap:RestructuringCharges" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a46383" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:349px;">$ </div><div id="a46385" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:349px;">- </div><div id="a46388" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:349px;">$ </div><div id="a46390" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:349px;"><ix:nonfraction id="ID_1634" name="us-gaap:RestructuringCharges" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a46392" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:349px;">$ </div><div id="a46394" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:349px;">- </div><div id="a46397" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:349px;">$ </div><div id="a46399" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:349px;"><ix:nonfraction id="ID_1620" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a46423" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:387px;top:383px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended December 26, 2020 </div><div id="a46431" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:281px;top:413px;">Health-Care Distribution </div><div id="a46437" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:466px;top:398px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and Value-Added </div><div id="a46440" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:525px;top:413px;">Services </div><div id="a46451" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:267px;top:433px;">Restructuring </div><div id="a46452" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:290px;top:447px;">Costs </div><div id="a46455" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:369px;top:433px;">Integration </div><div id="a46456" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:385px;top:447px;">Costs </div><div id="a46460" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:433px;">Restructuring </div><div id="a46461" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:488px;top:447px;">Costs </div><div id="a46464" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:567px;top:433px;">Integration </div><div id="a46465" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:583px;top:447px;">Costs </div><div id="a46469" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:bold;font-style:normal;color:#000000;left:664px;top:447px;">Total </div><div id="a46471" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:464px;">Severance and employee-related costs </div><div id="a46476" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:464px;">$ </div><div id="a46478" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:464px;"><ix:nonfraction id="ID_1625" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">25</ix:nonfraction></div><div id="a46480" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:464px;">$ </div><div id="a46482" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:464px;">- </div><div id="a46485" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:464px;">$ </div><div id="a46487" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:464px;"><ix:nonfraction id="ID_1629" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a46489" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:464px;">$ </div><div id="a46491" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:464px;">- </div><div id="a46494" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:464px;">$ </div><div id="a46496" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:464px;"><ix:nonfraction id="ID_1621" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_SeveranceAndEmployeeRelatedCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">26</ix:nonfraction></div><div id="a46498" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:487px;">Impairment and accelerated depreciation and </div><div id="a46499" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:502px;">amortization of right-of-use lease assets and </div><div id="a46504" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:516px;">other long-lived assets </div><div id="a46510" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:516px;"><ix:nonfraction id="ID_1626" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_AcceleratedDepreciationAndAmortizationMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46513" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:516px;">- </div><div id="a46517" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:516px;">- </div><div id="a46520" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:516px;">- </div><div id="a46524" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:516px;"><ix:nonfraction id="ID_1622" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_AcceleratedDepreciationAndAmortizationMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46526" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:533px;">Exit and other related costs </div><div id="a46530" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:339px;top:533px;"><ix:nonfraction id="ID_1627" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a46533" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:533px;">- </div><div id="a46537" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:533px;">- </div><div id="a46540" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:533px;">- </div><div id="a46544" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:690px;top:533px;"><ix:nonfraction id="ID_1623" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RestructuringCostAndReserveAxis_hsic_ExitAndOtherRelatedCostsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a46547" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:24px;top:550px;">Total restructuring and integration costs </div><div id="a46550" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:249px;top:550px;">$ </div><div id="a46552" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:332px;top:550px;"><ix:nonfraction id="ID_1628" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a46554" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:550px;">$ </div><div id="a46556" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:430px;top:550px;">- </div><div id="a46559" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:447px;top:550px;">$ </div><div id="a46561" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:550px;"><ix:nonfraction id="ID_1630" name="us-gaap:RestructuringCharges" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyAndValueAddedServicesMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a46563" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:548px;top:550px;">$ </div><div id="a46565" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:550px;">- </div><div id="a46568" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:550px;">$ </div><div id="a46570" style="position:absolute;font-family:'Times New Roman';font-size:12.64px;font-weight:normal;font-style:normal;color:#000000;left:683px;top:550px;"><ix:nonfraction id="ID_1624" name="hsic:RestructuringAndIntegrationRelatedCosts1" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">32</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page103" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:663.2px; height:15px; left:67.2px; top:244.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:343.1px; height:1px; left:66.8px; top:243.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:409.9px; top:243.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:509.9px; top:243.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:519.9px; top:243.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:1px; left:619.9px; top:243.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:630px; top:243.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:663.2px; height:56.8px; left:67.2px; top:275.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:663.2px; height:15.2px; left:67.2px; top:317.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:663.2px; height:16px; left:67.2px; top:348.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:663.2px; height:15.2px; left:67.2px; top:349.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:409.9px; top:364.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:519.9px; top:364.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:630px; top:364.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:409.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:409.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:519.3px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:519.3px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:629.4px; top:382.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:101px; height:1px; left:629.4px; top:380.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:20px; left:67.2px; top:532.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:15.4px; left:67.2px; top:537.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:20px; left:67.2px; top:572.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:15.4px; left:67.2px; top:577.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:20px; left:67.2px; top:612.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:15.4px; left:67.2px; top:617.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:527.2px; height:15.4px; left:76.2px; top:658.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:677.1px; height:20px; left:67.2px; top:653.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:91px; height:15.4px; left:653.3px; top:658.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:536.1px; height:21px; left:67.2px; top:652.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:586.2px; height:1px; left:66.8px; top:652.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:653px; top:652.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:91.8px; height:1px; left:652.5px; top:675.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:91.8px; height:1px; left:652.5px; top:673.7px; background-color:#000000; ">&nbsp;</div>
<div id="a46572" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a46574" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a46576" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a46578" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a46581" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">103 </div><div id="div_891_XBRL_TS_2a20728491a0413aa505ea90daa2d6b7" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_2a20728491a0413aa505ea90daa2d6b7" continuedat="XBRL_TS_65318b4d136642828502f7200bf74570"><div id="TextBlockContainer892" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:678px;height:68px;"><div id="a46583" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes, by reportable segment, the activity related<div style="display:inline-block;width:2px">&nbsp;</div>to the liabilities associated with our </div><div id="a46585" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">restructuring initiatives for the year ended December 31, 2022.<div style="display:inline-block;width:6px">&nbsp;</div>The remaining accrued balance of restructuring </div><div id="a46591" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">costs as of December 31, 2022 is included in accrued expenses: other within<div style="display:inline-block;width:2px">&nbsp;</div>our condensed consolidated balance </div><div id="a46595" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">sheet.</div></div></ix:continuation></div><div id="div_893_XBRL_TS_65318b4d136642828502f7200bf74570" style="position:absolute;left:63px;top:197px;float:left;"><ix:continuation id="XBRL_TS_65318b4d136642828502f7200bf74570"><div id="TextBlockContainer896" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:672px;height:185px;"><div id="div_894_XBRL_TS_564746d15459482c8e268b91931d1a41" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1607" name="hsic:ScheduleOfRestructuringReserveBySegmentTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer895" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:672px;height:185px;"><div id="a46604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:462px;top:0px;">Technology<div style="display:inline-block;width:5px">&nbsp;</div>and </div><div id="a46611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:363px;top:16px;">Health Care </div><div id="a46614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:470px;top:16px;">Value-Added </div><div id="a46624" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:363px;top:32px;">Distribution </div><div id="a46627" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:484px;top:32px;">Services </div><div id="a46630" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:602px;top:32px;">Total </div><div id="a46632" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:48px;">Balance, December 25, 2021<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46635" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:48px;">$ </div><div id="a46637" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:441px;top:48px;"><ix:nonfraction id="ID_1646" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46640" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:48px;">$ </div><div id="a46642" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:48px;"><ix:nonfraction id="ID_1651" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a46645" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:48px;">$ </div><div id="a46647" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:661px;top:48px;"><ix:nonfraction id="ID_1655" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46649" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Restructuring charges </div><div id="a46653" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:64px;"><ix:nonfraction id="ID_1641A" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">124</ix:nonfraction></div><div id="a46657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:64px;"><ix:nonfraction id="ID_1652" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46661" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:648px;top:64px;"><ix:nonfraction id="ID_1608A" name="us-gaap:RestructuringCharges" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a46663" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:90px;">Non-cash asset impairment and accelerated depreciation and </div><div id="a46666" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">amortization of right-of-use lease assets and other long-lived </div><div id="a46674" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:121px;">assets </div><div id="a46678" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:121px;display:flex;">(<ix:nonfraction id="ID_1648" name="hsic:RestructuringReserveSettledWithoutCashAssetImpairrmentsAndAcceleratedDepreciationAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction>)</div><div id="a46682" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:121px;">- </div><div id="a46686" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:121px;display:flex;">(<ix:nonfraction id="ID_1656" name="hsic:RestructuringReserveSettledWithoutCashAssetImpairrmentsAndAcceleratedDepreciationAndAmortization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction>)</div><div id="a46688" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Non-cash impairment on disposal of a business </div><div id="a46694" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:137px;display:flex;">(<ix:nonfraction id="ID_1647" name="hsic:RestructuringReserveSettledWithoutCashLossOnDisposal" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction>)</div><div id="a46698" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:553px;top:137px;">- </div><div id="a46702" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:137px;display:flex;">(<ix:nonfraction id="ID_1657" name="hsic:RestructuringReserveSettledWithoutCashLossOnDisposal" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction>)</div><div id="a46704" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:153px;">Cash payments and other adjustments<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46708" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:153px;display:flex;">(<ix:nonfraction id="ID_1649" name="hsic:PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction>)</div><div id="a46712" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:153px;display:flex;">(<ix:nonfraction id="ID_1653" name="hsic:PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction>)</div><div id="a46716" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:153px;display:flex;">(<ix:nonfraction id="ID_1658" name="hsic:PaymentsForRestructuringAndRestructuringReserveAccrualAdjustment" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction>)</div><div id="a46718" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:169px;">Balance, December 31, 2022<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46721" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:348px;top:169px;">$ </div><div id="a46723" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:434px;top:169px;"><ix:nonfraction id="ID_1650" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_HealthcareDistributionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a46726" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:457px;top:169px;">$ </div><div id="a46728" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:169px;"><ix:nonfraction id="ID_1654" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_StatementBusinessSegmentsAxis_hsic_TechnologyMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a46731" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:169px;">$ </div><div id="a46733" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:654px;top:169px;"><ix:nonfraction id="ID_1659" name="us-gaap:RestructuringReserve" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">24</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_897_XBRL_CS_90be9126144f4159b89ad5cb122f02ea" style="position:absolute;left:62px;top:401px;float:left;"><ix:nonnumeric id="ID_90be9126144f4159b89ad5cb122f02ea" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_1a8b7668583d4c6c8f0694b20089a060" escape="true"><div id="TextBlockContainer898" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:692px;height:116px;"><div id="a46736" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 15 – Commitments and Contingencies </div><div id="a46741" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a46742" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:32px;">Purchase Commitments </div><div id="a46745" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:64px;">In our health care distribution business, we sometimes enter into long-term purchase<div style="display:inline-block;width:2px">&nbsp;</div>commitments to ensure the </div><div id="a46748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:81px;">availability of products for distribution.<div style="display:inline-block;width:7px">&nbsp;</div>Future minimum annual payments for inventory purchase commitments<div style="display:inline-block;width:2px">&nbsp;</div>as </div><div id="a46749" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:98px;">of December 31, 2022 were:</div></div></ix:nonnumeric></div><div id="div_899_XBRL_CS_887f30bcff494ac39a5b18db1fb6149d" style="position:absolute;left:63px;top:538px;float:left;"><ix:nonnumeric id="ID_178" name="us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer902" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:686px;height:137px;"><div id="div_900_XBRL_CS_1a8b7668583d4c6c8f0694b20089a060" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_1a8b7668583d4c6c8f0694b20089a060" continuedat="XBRL_CS_3860884bc883441180266ace3ba09394"><div id="TextBlockContainer901" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:686px;height:137px;"><div id="a46752" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:0px;">2023<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46756" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:0px;">$ </div><div id="a46758" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:0px;"><ix:nonfraction id="ID_460" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a46760" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:20px;">2024<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46764" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:20px;"><ix:nonfraction id="ID_356" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46766" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:40px;">2025<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46770" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:40px;"><ix:nonfraction id="ID_123" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46772" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">2026<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46776" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:60px;"><ix:nonfraction id="ID_384" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46778" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">2027<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46782" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:80px;"><ix:nonfraction id="ID_106" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFifthAnniversary" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a46784" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Thereafter<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a46788" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:677px;top:100px;"><ix:nonfraction id="ID_326" name="us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a46790" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:121px;">Total minimum<div style="display:inline-block;width:5px">&nbsp;</div>inventory purchase commitment payments </div><div id="a46793" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:590px;top:121px;">$ </div><div id="a46795" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:668px;top:121px;"><ix:nonfraction id="ID_87" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_903_XBRL_CS_3860884bc883441180266ace3ba09394" style="position:absolute;left:62px;top:694px;float:left;"><ix:continuation id="XBRL_CS_3860884bc883441180266ace3ba09394" continuedat="XBRL_TS_746da48b41f948c9933873fdbf190636"><div id="TextBlockContainer904" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:134px;"><div id="a46798" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Employment, Consulting and Non-Compete Agreements </div><div id="a46803" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">We have employment, consulting and non-compete agreements that have varying base aggregate annual payments </div><div id="a46808" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">for the years 2023 through 2027 and thereafter of approximately $</div><div id="a46808_65_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:394px;top:49px;"><ix:nonfraction id="ID_311" name="us-gaap:OtherCommitmentDueInNextTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a46808_67_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a46808_78_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:49px;"><ix:nonfraction id="ID_184" name="us-gaap:OtherCommitmentDueInSecondYear" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a46808_79_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a46808_90_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:49px;"><ix:nonfraction id="ID_334" name="us-gaap:OtherCommitmentDueInThirdYear" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a46808_91_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a46808_102_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:605px;top:49px;"><ix:nonfraction id="ID_329" name="us-gaap:OtherCommitmentDueInFourthYear" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a46808_103_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:613px;top:49px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a46808_114_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:49px;"><ix:nonfraction id="ID_72" name="us-gaap:OtherCommitmentDueInFifthYear" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a46813" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">million, and $</div><div id="a46813_14_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:87px;top:66px;"><ix:nonfraction id="ID_876" name="us-gaap:OtherCommitmentDueAfterFifthYear" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_OtherCommitmentsAxis_hsic_EmploymentConsultingAndNoncompeteAgreementsMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a46813_15_94" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:94px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>We also have lifetime consulting agreements that provide for current </div><div id="a46818" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">compensation of </div><div id="a46818_16_21" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:106px;top:83px;-sec-ix-hidden:ID_1748;">four-hundred thousand</div><div id="a46818_37_30" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:240px;top:83px;"><div style="display:inline-block;width:4px">&nbsp;</div>dollars per year, increasing </div><div id="a46818_67_20" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:406px;top:83px;-sec-ix-hidden:ID_1749;">twenty-five thousand</div><div id="a46818_87_26" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:83px;"><div style="display:inline-block;width:4px">&nbsp;</div>dollars every fifth year </div><div id="a46830" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">with the next increase in 2026.<div style="display:inline-block;width:7px">&nbsp;</div>In addition, some agreements have provisions for additional<div style="display:inline-block;width:2px">&nbsp;</div>incentives and </div><div id="a46833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">compensation.</div></div></ix:continuation></div><div id="a46833_13_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:152px;top:810px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="div_905_XBRL_TS_746da48b41f948c9933873fdbf190636" style="position:absolute;left:62px;top:844px;float:left;"><ix:continuation id="XBRL_TS_746da48b41f948c9933873fdbf190636" continuedat="XBRL_TS_746da48b41f948c9933873fdbf190636_1"><div id="TextBlockContainer906" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:689px;height:151px;"><div id="a46836" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Litigation</div><div id="a46838" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:63px;top:0px;"><div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a46841" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Henry Schein, Inc. has been named as a defendant in multiple opioid<div style="display:inline-block;width:2px">&nbsp;</div>related lawsuits (currently less than one-</div><div id="a46843" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">hundred and fifty (</div><div id="a46843_19_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:115px;top:49px;"><ix:nonfraction id="ID_1660" name="us-gaap:LossContingencyPendingClaimsNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_srt_RangeAxis_srt_MaximumMember" unitref="myNumber" decimals="INF" format="ixt:numdotdecimal">150</ix:nonfraction></div><div id="a46843_22_92" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:137px;top:49px;">); in approximately half of those cases one or more of Henry Schein, Inc.’s subsidiaries is </div><div id="a46846" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">also named as a defendant).<div style="display:inline-block;width:7px">&nbsp;</div>Generally, the lawsuits allege that the manufacturers of prescription opioid drugs </div><div id="a46847" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">engaged in a false advertising campaign to expand the market for such drugs and<div style="display:inline-block;width:2px">&nbsp;</div>their own market share and that </div><div id="a46849" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">the entities in the supply chain (including Henry Schein, Inc. and<div style="display:inline-block;width:2px">&nbsp;</div>its affiliated companies) reaped financial rewards </div><div id="a46850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">by refusing or otherwise failing to monitor appropriately and restrict<div style="display:inline-block;width:2px">&nbsp;</div>the improper distribution of those drugs.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a46852" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">These actions consist of some that have been consolidated within the<div style="display:inline-block;width:2px">&nbsp;</div>MultiDistrict Litigation (“MDL”) proceeding </div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page104" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a46853" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a46855" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a46857" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a46859" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a46862" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">104 </div><div id="div_907_XBRL_TS_746da48b41f948c9933873fdbf190636_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_746da48b41f948c9933873fdbf190636_1"><div id="TextBlockContainer908" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:574px;"><div id="a46864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">In Re National Prescription Opiate Litigation (MDL No. 2804; Case No.<div style="display:inline-block;width:2px">&nbsp;</div>17-md-2804) and are currently stayed, and </div><div id="a46869" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">others which remain pending in state courts and are proceeding independently<div style="display:inline-block;width:2px">&nbsp;</div>and outside of the MDL.<div style="display:inline-block;width:7px">&nbsp;</div>At this </div><div id="a46871" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">time, the following cases are set for trial: the action filed by DCH Health<div style="display:inline-block;width:2px">&nbsp;</div>Care Authority, et al. in Alabama state </div><div id="a46872" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">court, which has been designated a bellwether with </div><div id="a46872_51_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:51px;"><ix:nonfraction id="ID_1750" name="hsic:LossContingencyNumberOfPlaintiffsSetForJuryTrial" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_DchHealthCareAuthorityEtAlMember" unitref="pure" decimals="INF" format="ixt-sec:numwordsen">eight</ix:nonfraction></div><div id="a46872_56_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:338px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>of </div><div id="a46872_60_12" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:51px;"><ix:nonfraction id="ID_1751" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_DchHealthCareAuthorityEtAlMember" unitref="pure" decimals="0" format="ixt-sec:numwordsen">thirty-eight</ix:nonfraction></div><div id="a46872_72_45" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:424px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>plaintiffs set for a jury trial on July 24, </div><div id="a46876" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">2023; and the action filed by Florida Health Sciences Center, Inc. (and </div><div id="a46876_72_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:423px;top:68px;"><ix:nonfraction id="ID_1752" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_OtherHospitalsLocatedThroughoutFloridaMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal">38</ix:nonfraction></div><div id="a46876_74_40" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>other hospitals located throughout the </div><div id="a46877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">State of Florida) in Florida state court, which is currently scheduled for a jury<div style="display:inline-block;width:2px">&nbsp;</div>trial in October 2024.<div style="display:inline-block;width:7px">&nbsp;</div>In December </div><div id="a46879" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">2022, we settled </div><div id="a46879_17_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:104px;top:101px;"><ix:nonfraction id="ID_1753" name="us-gaap:LossContingencyClaimsSettledNumber" contextref="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_CasesInUtahMember" unitref="myClaims" decimals="INF" format="ixt-sec:numwordsen">seven</ix:nonfraction></div><div id="a46879_22_83" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:138px;top:101px;"><div style="display:inline-block;width:4px">&nbsp;</div>cases filed in Utah (plus one case in which we were not yet<div style="display:inline-block;width:2px">&nbsp;</div>named a defendant) by </div><div id="a46879_105_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:101px;"><ix:nonfraction id="ID_1757" name="us-gaap:LossContingencyNumberOfPlaintiffs" contextref="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_CasesInUtahMember" unitref="pure" decimals="INF" format="ixt-sec:numwordsen">nineteen</ix:nonfraction></div><div id="a46880" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">plaintiffs for a total amount of </div><div id="a46880_33_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:186px;top:118px;-sec-ix-hidden:ID_1756;">sixty thousand</div><div id="a46880_47_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:271px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>dollars.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a46880_62_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:352px;top:118px;"><ix:nonfraction id="ID_1758" name="us-gaap:LossContingencyClaimsDismissedNumber" contextref="FROM_Dec01_2022_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_CasesInUtahMember" unitref="pure" decimals="INF" format="ixt-sec:numwordsen">seven</ix:nonfraction></div><div id="a46880_67_47" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:386px;top:118px;"><div style="display:inline-block;width:4px">&nbsp;</div>cases have been dismissed.<div style="display:inline-block;width:7px">&nbsp;</div>Of Henry Schein’s </div><div id="a46882" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">2022 net sales of approximately $</div><div id="a46882_33_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:203px;top:135px;"><ix:nonfraction id="ID_1679" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_LitigationCaseAxis_hsic_ActionsConsolidatedInTheMultiDistrictLitigationMember_us-gaap_StatementOperatingActivitiesSegmentAxis_us-gaap_SegmentContinuingOperationsMember" unitref="USD" decimals="-8" format="ixt:numdotdecimal" scale="9">12.6</ix:nonfraction></div><div id="a46882_37_76" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:229px;top:135px;"><div style="display:inline-block;width:4px">&nbsp;</div>billion from continuing operations, sales of opioids represented<div style="display:inline-block;width:2px">&nbsp;</div>less than </div><div id="a46883" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:5px;top:152px;-sec-ix-hidden:ID_1759;">two-tenths of 1 percent</div><div id="a46883_23_87" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:141px;top:152px;">.<div style="display:inline-block;width:7px">&nbsp;</div>Opioids represent a negligible part of our business.<div style="display:inline-block;width:6px">&nbsp;</div>We intend to defend ourselves </div><div id="a46886" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">vigorously against these actions. </div><div id="a46890" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">In August 2022, Henry Schein received a Grand Jury Subpoena from the United<div style="display:inline-block;width:2px">&nbsp;</div>States Attorney’s Office for the </div><div id="a46891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">Western District of Virginia,<div style="display:inline-block;width:5px">&nbsp;</div>seeking documents in connection with an investigation of possible<div style="display:inline-block;width:2px">&nbsp;</div>violations of the </div><div id="a46892" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">Federal Food, Drug &amp; Cosmetic Act by Butler Animal Health Supply, LLC (“Butler”), a former subsidiary of </div><div id="a46894" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">Henry Schein.<div style="display:inline-block;width:7px">&nbsp;</div>The investigation relates to the sale of veterinary prescription drugs<div style="display:inline-block;width:2px">&nbsp;</div>to certain customers.<div style="display:inline-block;width:7px">&nbsp;</div>In </div><div id="a46895" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">October 2022, Henry Schein received a second Grand Jury Subpoena from<div style="display:inline-block;width:2px">&nbsp;</div>the United States Attorney’s Office for </div><div id="a46897" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">the Western District of Virginia.<div style="display:inline-block;width:9px">&nbsp;</div>The October Subpoena seeks documents relating to payments Henry<div style="display:inline-block;width:2px">&nbsp;</div>Schein </div><div id="a46898" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">received from Butler or Covetrus, Inc. (“Covetrus”).<div style="display:inline-block;width:6px">&nbsp;</div>Butler was spun off into a separate company and became a </div><div id="a46901" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">subsidiary of Covetrus in 2019 and is no longer owned by Henry Schein.<div style="display:inline-block;width:6px">&nbsp;</div>We are cooperating with the </div><div id="a46902" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">investigation. </div><div id="a46905" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">From time to time, we may become a party to other legal proceedings,<div style="display:inline-block;width:2px">&nbsp;</div>including, without limitation, product </div><div id="a46906" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">liability claims, employment matters, commercial disputes, governmental<div style="display:inline-block;width:2px">&nbsp;</div>inquiries and investigations (which may </div><div id="a46908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">in some cases involve our entering into settlement arrangements or consent<div style="display:inline-block;width:2px">&nbsp;</div>decrees), and other matters arising out </div><div id="a46909" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">of the ordinary course of our business.<div style="display:inline-block;width:7px">&nbsp;</div>While the results of any legal proceeding cannot be predicted with certainty, </div><div id="a46912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">in our opinion none of these other pending matters are currently<div style="display:inline-block;width:2px">&nbsp;</div>anticipated to have a material adverse effect on our </div><div id="a46913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">consolidated financial position, liquidity or results of operations. </div><div id="a46917" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">As of December 31, 2022, we had accrued our best estimate of potential<div style="display:inline-block;width:2px">&nbsp;</div>losses relating to claims that were probable </div><div id="a46918" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">to result in liability and for which we were able to reasonably estimate<div style="display:inline-block;width:2px">&nbsp;</div>a loss.<div style="display:inline-block;width:7px">&nbsp;</div>This accrued amount, as well as </div><div id="a46919" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">related expenses, was not material to our financial position, results of operations<div style="display:inline-block;width:2px">&nbsp;</div>or cash flows.<div style="display:inline-block;width:7px">&nbsp;</div>Our method for </div><div id="a46921" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:540px;">determining estimated losses considers currently available<div style="display:inline-block;width:2px">&nbsp;</div>facts, presently enacted laws and regulations and other </div><div id="a46922" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:557px;">factors, including probable recoveries from third parties.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page105" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a46925" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a46927" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a46929" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a46931" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a46934" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">105 </div><div id="div_909_XBRL_TS_7d3a68b201974cb3bffd3f9499682804" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_7d3a68b201974cb3bffd3f9499682804" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_7d3a68b201974cb3bffd3f9499682804_1" escape="true"><div id="TextBlockContainer910" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:844px;"><div id="a46936" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 16 – Stock-Based Compensation</div><div id="a46943" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a46944" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">Stock-based awards are provided to certain employees under the terms of our<div style="display:inline-block;width:2px">&nbsp;</div>2020 Stock Incentive Plan and to </div><div id="a46954" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">non-employee directors under the terms of our 2015 Non-Employee Director<div style="display:inline-block;width:2px">&nbsp;</div>Stock Incentive Plan (together, the </div><div id="a46959" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">“Plans”).<div style="display:inline-block;width:7px">&nbsp;</div>The Plans are administered by the Compensation Committee of the Board<div style="display:inline-block;width:2px">&nbsp;</div>of Directors (the </div><div id="a46962" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">“Compensation Committee”).<div style="display:inline-block;width:7px">&nbsp;</div>Historically, equity-based awards to our employees have been granted solely in the </div><div id="a46972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">form of time-based and performance-based restricted stock units<div style="display:inline-block;width:2px">&nbsp;</div>(“RSUs”).<div style="display:inline-block;width:7px">&nbsp;</div>However, for our 2021 fiscal year, in </div><div id="a46981" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">light of the COVID-19 pandemic, the Compensation Committee determined<div style="display:inline-block;width:2px">&nbsp;</div>it would be difficult for management </div><div id="a46985" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">to set a meaningful three-year cumulative earnings per share target as the goal applicable<div style="display:inline-block;width:2px">&nbsp;</div>to performance-based </div><div id="a46990" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">RSU awards as it had done in prior years.<div style="display:inline-block;width:7px">&nbsp;</div>Instead, the Compensation Committee set our equity-based awards<div style="display:inline-block;width:2px">&nbsp;</div>to </div><div id="a46993" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">employees for fiscal 2021 in the form of time-based RSUs and non-qualified<div style="display:inline-block;width:2px">&nbsp;</div>stock options which focus on stock </div><div id="a46999" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">value appreciation and retention instead of pre-established performance goals.<div style="display:inline-block;width:6px">&nbsp;</div>Our non-employee directors </div><div id="a47004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">continued to receive equity-based awards for fiscal 2021 solely in the form of time-based<div style="display:inline-block;width:2px">&nbsp;</div>RSUs.<div style="display:inline-block;width:7px">&nbsp;</div>In March 2022, </div><div id="a47010" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">the Compensation Committee reinstated performance-based RSUs<div style="display:inline-block;width:2px">&nbsp;</div>for equity-based awards to employees for fiscal </div><div id="a47015" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">2022 and awarded grants in the form of performance-based RSUs,<div style="display:inline-block;width:2px">&nbsp;</div>time-based RSUs and non-qualified stock </div><div id="a47023" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">options.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47027" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">As of December 31, 2022, there were </div><div id="a47027_36_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:229px;top:287px;"><ix:nonfraction id="ID_233" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">70,942,657</ix:nonfraction></div><div id="a47027_46_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:295px;top:287px;"><div style="display:inline-block;width:4px">&nbsp;</div>shares authorized and </div><div id="a47027_69_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:287px;"><ix:nonfraction id="ID_1719" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">8,034,696</ix:nonfraction></div><div id="a47027_78_32" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:488px;top:287px;"><div style="display:inline-block;width:4px">&nbsp;</div>shares available to be granted </div><div id="a47032" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">under the 2020 Stock Incentive Plan and </div><div id="a47032_40_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:247px;top:304px;"><ix:nonfraction id="ID_408" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_NonEmployeeDirectorStockIncentivePlanMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,892,657</ix:nonfraction></div><div id="a47032_49_23" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:305px;top:304px;"><div style="display:inline-block;width:4px">&nbsp;</div>shares authorized and </div><div id="a47032_72_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:304px;"><ix:nonfraction id="ID_1720" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_PlanNameAxis_hsic_NonEmployeeDirectorStockIncentivePlanMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">192,400</ix:nonfraction></div><div id="a47032_79_32" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:487px;top:304px;"><div style="display:inline-block;width:4px">&nbsp;</div>shares available to be granted </div><div id="a47037" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">under the 2015 Non-Employee Director Stock Incentive Plan.</div><div id="a47043" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">RSUs are stock-based awards granted to recipients with specified vesting provisions.<div style="display:inline-block;width:6px">&nbsp;</div>In the case of RSUs, common </div><div id="a47046" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">stock is delivered on or following satisfaction of vesting conditions.<div style="display:inline-block;width:6px">&nbsp;</div>We issue RSUs to employees that primarily </div><div id="a47050" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">vest (i) solely based on the recipient’s continued service over time, primarily with </div><div id="a47050_85_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:489px;top:388px;-sec-ix-hidden:ID_1721;">four</div><div id="a47050_89_32" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:513px;top:388px;">-year cliff vesting and/or (ii) </div><div id="a47053" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">based on achieving specified performance measurements and the recipient’s continued service over time, primarily </div><div id="a47055" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">with </div><div id="a47055_5_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:35px;top:422px;-sec-ix-hidden:ID_1722;">three</div><div id="a47055_10_103" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:64px;top:422px;">-year cliff vesting.<div style="display:inline-block;width:7px">&nbsp;</div>RSUs granted under the 2015 Non-Employee Director Stock Incentive<div style="display:inline-block;width:2px">&nbsp;</div>Plan primarily </div><div id="a47060" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">are granted with </div><div id="a47060_17_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:104px;top:439px;-sec-ix-hidden:ID_1723;">12</div><div id="a47060_19_90" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:439px;">-month cliff vesting.<div style="display:inline-block;width:7px">&nbsp;</div>For these RSUs, we recognize the cost as compensation expense on<div style="display:inline-block;width:2px">&nbsp;</div>a </div><div id="a47063" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">straight-line basis. </div><div id="a47068" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">With<div style="display:inline-block;width:4px">&nbsp;</div>respect to time-based RSUs, we estimate the fair value on the date<div style="display:inline-block;width:2px">&nbsp;</div>of grant based on our closing stock price at </div><div id="a47072" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:506px;">the time of grant.<div style="display:inline-block;width:7px">&nbsp;</div>With respect to performance-based RSUs, the number of shares that ultimately vest<div style="display:inline-block;width:2px">&nbsp;</div>and are </div><div id="a47077" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">received by the recipient is based upon our performance as measured against<div style="display:inline-block;width:2px">&nbsp;</div>specified targets over a specified </div><div id="a47079" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:540px;">period, as determined by the Compensation Committee.<div style="display:inline-block;width:6px">&nbsp;</div>Although there is no guarantee that performance targets </div><div id="a47082" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:557px;">will be achieved, we estimate the fair value of performance-based RSUs based<div style="display:inline-block;width:2px">&nbsp;</div>on our closing stock price at time of </div><div id="a47086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:574px;">grant. </div><div id="a47089" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:607px;">Each of the Plans provide for certain adjustments to the performance<div style="display:inline-block;width:2px">&nbsp;</div>measurement in connection with awards under </div><div id="a47090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:624px;">the Plans.<div style="display:inline-block;width:7px">&nbsp;</div>With respect to the performance-based RSUs granted under our 2020 Stock Incentive Plan, such </div><div id="a47095" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:641px;">performance measurement adjustments relate to significant events, including,<div style="display:inline-block;width:2px">&nbsp;</div>without limitation, acquisitions, </div><div id="a47096" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:658px;">divestitures, new business ventures, certain capital transactions (including share<div style="display:inline-block;width:2px">&nbsp;</div>repurchases), differences in </div><div id="a47098" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:675px;">budgeted average outstanding shares (other than those resulting from capital<div style="display:inline-block;width:2px">&nbsp;</div>transactions referred to above), </div><div id="a47099" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:692px;">restructuring costs, if any, certain litigation settlements or payments, if any, changes in accounting principles or in </div><div id="a47101" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:709px;">applicable laws or regulations, changes in income tax rates in certain<div style="display:inline-block;width:2px">&nbsp;</div>markets, foreign exchange fluctuations, the </div><div id="a47102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:725px;">financial impact of certain products and unforeseen events or circumstances affecting us.<div style="display:inline-block;width:6px">&nbsp;</div></div><div id="a47106" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:759px;">Over the performance period, the number of shares of common stock that will<div style="display:inline-block;width:2px">&nbsp;</div>ultimately vest and be issued and the </div><div id="a47108" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:776px;">related compensation expense is adjusted upward or downward based upon<div style="display:inline-block;width:2px">&nbsp;</div>our estimation of achieving such </div><div id="a47109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:793px;">performance targets.<div style="display:inline-block;width:7px">&nbsp;</div>The ultimate number of shares delivered to recipients and the<div style="display:inline-block;width:2px">&nbsp;</div>related compensation cost </div><div id="a47114" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:810px;">recognized as an expense will be based on our actual performance metrics<div style="display:inline-block;width:2px">&nbsp;</div>as defined under the Plans. </div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page106" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a47117" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a47119" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a47121" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a47123" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a47126" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">106 </div><div id="div_911_XBRL_TS_7d3a68b201974cb3bffd3f9499682804_1" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_7d3a68b201974cb3bffd3f9499682804_1" continuedat="XBRL_TS_007662c02f4649b88270417c532f89cd"><div id="TextBlockContainer912" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:794px;"><div id="a47128" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Stock options are awards that allow the recipient to purchase shares of our<div style="display:inline-block;width:2px">&nbsp;</div>common stock at a fixed price following </div><div id="a47130" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">vesting of the stock options.<div style="display:inline-block;width:7px">&nbsp;</div>Stock options are granted at an exercise price equal to our closing stock<div style="display:inline-block;width:2px">&nbsp;</div>price on the </div><div id="a47131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">date of grant.<div style="display:inline-block;width:7px">&nbsp;</div>Stock options issued beginning in 2021 vest </div><div id="a47131_60_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:352px;top:34px;-sec-ix-hidden:ID_1803;">one-third</div><div id="a47131_69_45" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:406px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>per year based on the recipient’s continued </div><div id="a47134" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">service, subject to the terms and conditions of the 2020 Stock Incentive Plan,<div style="display:inline-block;width:2px">&nbsp;</div>are fully vested </div><div id="a47134_96_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:555px;top:51px;"><ix:nonnumeric id="ID_1724" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">three years</ix:nonnumeric></div><div id="a47134_107_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:51px;"><div style="display:inline-block;width:4px">&nbsp;</div>from the </div><div id="a47137" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">grant date and have a contractual term of </div><div id="a47137_42_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:248px;top:68px;"><ix:nonnumeric id="ID_1725" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:durwordsen">ten years</ix:nonnumeric></div><div id="a47137_51_65" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:301px;top:68px;"><div style="display:inline-block;width:4px">&nbsp;</div>from the grant date, subject to earlier termination of the term </div><div id="a47138" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">upon certain events.<div style="display:inline-block;width:7px">&nbsp;</div>Compensation expense for these stock options is recognized<div style="display:inline-block;width:2px">&nbsp;</div>using a graded vesting method.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47140" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">We estimate the fair value of stock options using the Black-Scholes valuation model.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a47145" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">In addition to equity-based awards granted in fiscal 2021 under the long-term<div style="display:inline-block;width:2px">&nbsp;</div>incentive program, the Compensation </div><div id="a47151" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">Committee granted a Special Pandemic Recognition Award under the 2020 Stock Incentive Plan to recipients of </div><div id="a47152" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">performance-based RSUs under the 2018 long-term incentive program.<div style="display:inline-block;width:6px">&nbsp;</div>The payout under the performance-based </div><div id="a47159" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:186px;">restricted stock units granted under the fiscal 2018 long-term incentive program<div style="display:inline-block;width:2px">&nbsp;</div>(the “2018 LTIP”) was negatively </div><div id="a47163" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">impacted by the global COVID-19 pandemic.<div style="display:inline-block;width:7px">&nbsp;</div>Given the significance of the impact of the pandemic on our </div><div id="a47163_103_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:637px;top:202px;-sec-ix-hidden:ID_1726;">three</div><div id="a47163_108_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:202px;">-</div><div id="a47167" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">year EPS goal under such equity awards and the contributions made by our employees<div style="display:inline-block;width:2px">&nbsp;</div>(including those who </div><div id="a47169" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">received such awards), on March 3, 2021, the Compensation Committee granted<div style="display:inline-block;width:2px">&nbsp;</div>a Special Pandemic Recognition </div><div id="a47170" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">Award to recipients of performance-based restricted stock units under the 2018 LTIP who were employed by us on </div><div id="a47174" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:270px;">the grant date of the Special Pandemic Recognition Award.<div style="display:inline-block;width:8px">&nbsp;</div>These time-based RSU awards vest </div><div id="a47174_92_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:270px;"><ix:nonfraction id="ID_1727" name="hsic:StockBasedCompensationPercentageOfOptionsVestPerYearFirstAnniversary" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_SpecialPandemicRecognitionAwardMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">50</ix:nonfraction></div><div id="a47174_94_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:587px;top:270px;">% on the first </div><div id="a47177" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:287px;">anniversary of the grant date and </div><div id="a47177_34_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:201px;top:287px;"><ix:nonfraction id="ID_1728" name="hsic:StockBasedCompensationPercentageOfOptionsVestPerYearSecondAnniversary" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_SpecialPandemicRecognitionAwardMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">50</ix:nonfraction></div><div id="a47177_36_72" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:216px;top:287px;">% on the second anniversary of the grant date, based on the recipient’s </div><div id="a47178" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:304px;">continued service and subject to the terms and conditions of the 2020 Stock Incentive<div style="display:inline-block;width:2px">&nbsp;</div>Plan, and are recorded as </div><div id="a47180" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">compensation expense using a graded vesting method.<div style="display:inline-block;width:6px">&nbsp;</div>The combination of the </div><div id="a47180_76_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:321px;"><ix:nonfraction id="ID_1729" name="hsic:StockBasedCompensationPercentagePayoutBasedOnActualPerformance" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">20</ix:nonfraction></div><div id="a47180_78_25" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:487px;top:321px;">% payout based on actual </div><div id="a47181" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">performance of the 2018 LTIP and the one-time Special Pandemic Recognition Award granted in 2021 will </div><div id="a47185" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">generate a cumulative payout of </div><div id="a47185_32_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:197px;top:354px;"><ix:nonfraction id="ID_1730" name="hsic:StockBasedCompensationCumulativePercentagePayoutBasedOnActualPerformanceAndOneTimeSpecialAward" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_SpecialPandemicRecognitionAwardMember_us-gaap_PlanNameAxis_hsic_StockIncentivePlanMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">75</ix:nonfraction></div><div id="a47185_34_76" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:211px;top:354px;">% of each recipient’s original number of performance-based restricted stock </div><div id="a47188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">units awarded in 2018 if the recipient satisfies the </div><div id="a47188_53_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:300px;top:371px;-sec-ix-hidden:ID_1731;">two</div><div id="a47188_56_53" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:371px;">-year vesting schedule commencing on the grant date. </div><div id="a47193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">Our accompanying consolidated statements of income reflect pre-tax share-based<div style="display:inline-block;width:2px">&nbsp;</div>compensation expense of $</div><div id="a47193_104_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:645px;top:405px;"><ix:nonfraction id="ID_234" name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">54</ix:nonfraction></div><div id="a47199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">million ($</div><div id="a47199_10_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:63px;top:422px;"><ix:nonfraction id="ID_83" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">41</ix:nonfraction></div><div id="a47199_12_22" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:78px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million after-tax), $</div><div id="a47199_34_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:197px;top:422px;"><ix:nonfraction id="ID_85" name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">78</ix:nonfraction></div><div id="a47199_36_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:212px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million ($</div><div id="a47199_47_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:422px;"><ix:nonfraction id="ID_102" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">60</ix:nonfraction></div><div id="a47199_49_25" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:288px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million after-tax) and $</div><div id="a47199_74_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:428px;top:422px;"><ix:nonfraction id="ID_383" name="us-gaap:AllocatedShareBasedCompensationExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a47199_75_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:436px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million ($</div><div id="a47199_86_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:497px;top:422px;"><ix:nonfraction id="ID_357" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a47199_87_34" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:422px;"><div style="display:inline-block;width:4px">&nbsp;</div>million after-tax) for the years </div><div id="a47216" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">ended December 31, 2022, December 25, 2021 and December 26, 2020. </div><div id="a47220" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:472px;">Total unrecognized compensation cost related to non-vested awards as of December 31, 2022 was $</div><div id="a47220_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:472px;"><ix:nonfraction id="ID_874" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a47220_97_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:472px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a47223" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:489px;">which is expected to be recognized over a weighted-average period of<div style="display:inline-block;width:2px">&nbsp;</div>approximately </div><div id="a47223_83_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:508px;top:489px;"><ix:nonnumeric id="ID_875" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:duryear">2.1</ix:nonnumeric></div><div id="a47223_86_9" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:526px;top:489px;"><div style="display:inline-block;width:4px">&nbsp;</div>years.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47229" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:523px;">The weighted-average grant date fair value of stock-based awards granted<div style="display:inline-block;width:2px">&nbsp;</div>before forfeitures was $</div><div id="a47229_97_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:582px;top:523px;"><ix:nonfraction id="ID_1784" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">85.51</ix:nonfraction></div><div id="a47229_102_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:615px;top:523px;">, $</div><div id="a47229_105_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:630px;top:523px;"><ix:nonfraction id="ID_1785" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">62.72</ix:nonfraction></div><div id="a47235" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:540px;">and $</div><div id="a47235_5_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:37px;top:540px;"><ix:nonfraction id="ID_1786" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">60.23</ix:nonfraction></div><div id="a47235_10_96" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:70px;top:540px;"><div style="display:inline-block;width:4px">&nbsp;</div>per share during the years ended December 31, 2022, December 25,<div style="display:inline-block;width:2px">&nbsp;</div>2021 and December 26, 2020.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="a47238" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:574px;">Certain stock-based compensation granted may require us to settle in<div style="display:inline-block;width:2px">&nbsp;</div>the form of a cash payment.<div style="display:inline-block;width:7px">&nbsp;</div>During the year </div><div id="a47243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:590px;">ended December 31, 2022, we recorded a liability of $</div><div id="a47243_53_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:325px;top:590px;"><ix:nonfraction id="ID_1415" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-5" format="ixt:numdotdecimal" scale="6">0.4</ix:nonfraction></div><div id="a47243_56_62" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:343px;top:590px;"><div style="display:inline-block;width:4px">&nbsp;</div>million relating to the grant date fair value of stock-based </div><div id="a47246" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:607px;">compensation to be settled in cash. </div><div id="a47249" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:641px;">We </div><div id="a47251" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:641px;">record deferred income tax assets for awards that will result in<div style="display:inline-block;width:2px">&nbsp;</div>future deductions on our income tax returns </div><div id="a47288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:658px;">based on the amount of compensation cost recognized and our statutory tax<div style="display:inline-block;width:2px">&nbsp;</div>rate in the jurisdiction in which we will </div><div id="a47328" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:675px;">receive a deduction. </div><div id="a47335" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:709px;">Our accompanying consolidated statements of cash flows present our stock-based<div style="display:inline-block;width:2px">&nbsp;</div>compensation expense as an </div><div id="a47339" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:725px;">adjustment to reconcile net income to net cash provided by operating<div style="display:inline-block;width:2px">&nbsp;</div>activities for all periods presented.<div style="display:inline-block;width:7px">&nbsp;</div>In the </div><div id="a47340" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:742px;">accompanying consolidated statements of cash flows, there were no benefits<div style="display:inline-block;width:2px">&nbsp;</div>associated with tax deductions in </div><div id="a47342" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:759px;">excess of recognized compensation as a cash inflow from financing<div style="display:inline-block;width:2px">&nbsp;</div>activities for the years ended December 31, </div><div id="a47344" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:776px;">2022, December 25, 2021 and December 26, 2020.</div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page107" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:310px; height:13.7px; left:67.2px; top:171.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:199.1px; height:14.7px; left:67.2px; top:170.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:265.9px; top:170px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:21.1px; height:1px; left:355.8px; top:170px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:310px; height:14.7px; left:67.2px; top:200px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:391.1px; height:1px; left:357.9px; top:448.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:15px; left:67.2px; top:513.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:213px; height:12.3px; left:536.3px; top:516.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:16px; left:67.2px; top:512.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:1px; left:66.8px; top:512.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.9px; height:1px; left:357.9px; top:512.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:16px; left:428.3px; top:512.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:437.9px; top:512.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:531.3px; top:512.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:130.1px; height:1px; left:535.9px; top:512.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:16px; left:666.4px; top:512.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.1px; height:1px; left:670.9px; top:512.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:14.9px; left:67.2px; top:543.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:13.9px; left:67.2px; top:574.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:1px; left:66.8px; top:572.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.9px; height:1px; left:357.9px; top:572.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:321.2px; height:1px; left:427.9px; top:572.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.9px; height:1px; left:358.3px; top:587.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:69.9px; height:1px; left:358.3px; top:589.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:14.9px; left:67.2px; top:602.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.9px; height:1px; left:357.3px; top:619.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:70.9px; height:1px; left:357.3px; top:617.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:19.6px; left:67.2px; top:699.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:682.1px; height:19.6px; left:67.2px; top:699.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:20.6px; left:67.2px; top:698.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:1px; left:66.8px; top:698.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:69.9px; height:1px; left:357.9px; top:698.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:20.6px; left:428.3px; top:698.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:93px; height:1px; left:437.9px; top:698.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:20.6px; left:531.3px; top:698.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:130.1px; height:1px; left:535.9px; top:698.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:20.6px; left:666.4px; top:698.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:78.1px; height:1px; left:670.9px; top:698.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:260.1px; height:1px; left:241.9px; top:789.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:280.1px; height:1px; left:506.9px; top:789.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:17.6px; left:67.2px; top:836px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:17.6px; left:67.2px; top:836px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:175.1px; height:1px; left:66.8px; top:834.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70px; height:1px; left:241.9px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5.1px; height:1px; left:311.8px; top:834.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.9px; height:1px; left:316.9px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5.1px; height:1px; left:411.8px; top:834.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:416.9px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:18.6px; left:502.3px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:506.9px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:5px; height:18.6px; left:582.3px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:95.1px; height:1px; left:586.9px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:18.6px; left:682.4px; top:835px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:20px; height:1px; left:682px; top:834.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:702px; top:834.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:18.4px; left:67.2px; top:871.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:18.4px; left:67.2px; top:871.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:16.6px; left:67.2px; top:909.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:720.2px; height:16.6px; left:67.2px; top:909.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:175.1px; height:1px; left:66.8px; top:907.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70px; height:1px; left:241.9px; top:907.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:80px; height:17.6px; left:332.2px; top:908.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:17.6px; left:432.3px; top:908.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:195.1px; height:1px; left:311.8px; top:907.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:75px; height:1px; left:506.9px; top:907.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:120px; height:17.6px; left:582.3px; top:908.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:205px; height:1px; left:581.9px; top:907.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:70.9px; height:1px; left:241.3px; top:927.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:70.9px; height:1px; left:241.3px; top:925.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:76px; height:1px; left:506.3px; top:927.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:76px; height:1px; left:506.3px; top:925.9px; background-color:#000000; ">&nbsp;</div>
<div id="a47347" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a47349" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a47351" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a47353" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a47356" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">107 </div><div id="div_913_XBRL_TS_007662c02f4649b88270417c532f89cd" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_007662c02f4649b88270417c532f89cd" continuedat="XBRL_TS_a60a57f49c0443909edf1dac25a2223c"><div id="TextBlockContainer914" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:35px;"><div id="a47358" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following weighted-average assumptions were used in determining<div style="display:inline-block;width:2px">&nbsp;</div>the most recent fair values of stock options </div><div id="a47363" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">using the Black-Scholes valuation model:</div></div></ix:continuation></div><div id="a47363_40_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:312px;top:129px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="div_915_XBRL_TS_a60a57f49c0443909edf1dac25a2223c" style="position:absolute;left:63px;top:155px;float:left;"><ix:continuation id="XBRL_TS_a60a57f49c0443909edf1dac25a2223c" continuedat="XBRL_TS_836cf9fd7db348cea6262c9b60009690"><div id="TextBlockContainer918" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:293px;height:75px;"><div id="div_916_XBRL_TS_57af346b045f4535b689bccbf668c9a8" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1151" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer917" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:293px;height:75px;"><div id="a47368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:235px;top:0px;">2022 </div><div id="a47372" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:16px;">Expected dividend yield<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47374" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:250px;top:16px;"><ix:nonfraction id="ID_1152" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">0.00</ix:nonfraction></div><div id="a47376" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:16px;">% </div><div id="a47380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:30px;">Expected stock price volatility<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:244px;top:30px;"><ix:nonfraction id="ID_1153" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="5" format="ixt:numdotdecimal" scale="-2">27.80</ix:nonfraction></div><div id="a47384" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:30px;">% </div><div id="a47388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:45px;">Risk-free interest rate<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47392" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:250px;top:45px;"><ix:nonfraction id="ID_1154" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">3.62</ix:nonfraction></div><div id="a47394" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:273px;top:45px;">% </div><div id="a47398" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:60px;">Expected life of options (years)<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47400" style="position:absolute;font-family:'Times New Roman';left:250px;top:60px;"><ix:nonnumeric id="ID_1155" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" format="ixt-sec:duryear">6.00</ix:nonnumeric></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_919_XBRL_TS_836cf9fd7db348cea6262c9b60009690" style="position:absolute;left:62px;top:247px;float:left;"><ix:continuation id="XBRL_TS_836cf9fd7db348cea6262c9b60009690" continuedat="XBRL_CS_24802f7847214a4bb29a74f6f97489fc"><div id="TextBlockContainer920" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:136px;"><div id="a47406" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">We have not declared cash dividends on our stock in the past and we do not anticipate declaring cash dividends in </div><div id="a47407" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">the foreseeable future.<div style="display:inline-block;width:7px">&nbsp;</div>The expected stock price volatility is based on implied volatilities<div style="display:inline-block;width:2px">&nbsp;</div>from traded options on </div><div id="a47409" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">our stock, historical volatility of our stock, and other factors.<div style="display:inline-block;width:6px">&nbsp;</div>The risk-free interest rate is based on the U.S. </div><div id="a47412" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">Treasury yield curve in effect at the time of grant in conjunction with considering the expected life of options.<div style="display:inline-block;width:6px">&nbsp;</div>The </div><div id="a47414" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:5px;top:68px;-sec-ix-hidden:ID_1155A;">six</div><div id="a47414_3_111" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:68px;">-year expected life of the options was determined using the simplified<div style="display:inline-block;width:2px">&nbsp;</div>method for estimating the expected term </div><div id="a47417" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">as permitted under SAB Topic 14.<div style="display:inline-block;width:8px">&nbsp;</div>Estimates of fair value are not intended to predict actual future events or<div style="display:inline-block;width:2px">&nbsp;</div>the </div><div id="a47419" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">value ultimately realized by recipients of stock options, and subsequent<div style="display:inline-block;width:2px">&nbsp;</div>events are not indicative of the </div><div id="a47420" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">reasonableness of the original estimates of fair value made by us.</div></div></ix:continuation></div><div id="div_921_XBRL_CS_24802f7847214a4bb29a74f6f97489fc" style="position:absolute;left:62px;top:398px;float:left;"><ix:continuation id="XBRL_CS_24802f7847214a4bb29a74f6f97489fc" continuedat="XBRL_CS_94859ab64f0744148e1c298a2185d86b"><div id="TextBlockContainer922" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:578px;height:17px;"><div id="a47423" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes the stock option activity for the year<div style="display:inline-block;width:2px">&nbsp;</div>ended December 31, 2022:</div></div></ix:continuation></div><div id="div_923_XBRL_CS_e1ea1fffc42f487399eed667723ae74f" style="position:absolute;left:64px;top:437px;float:left;"><ix:nonnumeric id="ID_84" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer926" style="position:relative;font-family:'Times New Roman';font-size:10.72px;color:#000000;line-height:normal;width:686px;height:182px;"><div id="div_924_XBRL_CS_94859ab64f0744148e1c298a2185d86b" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_94859ab64f0744148e1c298a2185d86b" continuedat="XBRL_TS_05bdb110dfcc4034bb3982d6901e5a26"><div id="TextBlockContainer925" style="position:relative;font-family:'Times New Roman';font-size:10.72px;color:#000000;line-height:normal;width:686px;height:182px;"><div id="a47428" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:458px;top:0px;">Stock Options </div><div id="a47445" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:399px;top:19px;">Weighted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47448" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:513px;top:19px;">Remaining </div><div id="a47457" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:34px;">Average<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47460" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:495px;top:34px;">Weighted Average </div><div id="a47463" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:623px;top:34px;">Aggregate </div><div id="a47469" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:49px;">Exercise </div><div id="a47472" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:484px;top:49px;">Remaining Contractual </div><div id="a47475" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:627px;top:49px;">Intrinsic </div><div id="a47479" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:314px;top:64px;">Shares </div><div id="a47482" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:409px;top:64px;">Price </div><div id="a47485" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:508px;top:64px;">Life in Years </div><div id="a47488" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:633px;top:64px;">Value </div><div id="a47490" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:77px;">Outstanding at beginning of year<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47493" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:77px;"><ix:nonfraction id="ID_1787" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">767,717</ix:nonfraction></div><div id="a47496" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:77px;">$ </div><div id="a47498" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:77px;"><ix:nonfraction id="ID_1792" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">63.24</ix:nonfraction></div><div id="a47505" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:92px;">Granted<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47508" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:92px;"><ix:nonfraction id="ID_1788" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">420,075</ix:nonfraction></div><div id="a47512" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:92px;"><ix:nonfraction id="ID_1793" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">85.81</ix:nonfraction></div><div id="a47519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:107px;">Exercised<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47522" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:107px;display:flex;">(<ix:nonfraction id="ID_1789" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">36,150</ix:nonfraction>)</div><div id="a47526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:107px;"><ix:nonfraction id="ID_1794" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">62.92</ix:nonfraction></div><div id="a47533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:122px;">Forfeited<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47536" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:122px;display:flex;">(<ix:nonfraction id="ID_1790" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">34,068</ix:nonfraction>)</div><div id="a47540" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:122px;"><ix:nonfraction id="ID_1795" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">74.84</ix:nonfraction></div><div id="a47547" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:137px;">Outstanding at end of year<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:311px;top:137px;"><ix:nonfraction id="ID_1791" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,117,574</ix:nonfraction></div><div id="a47554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:137px;">$ </div><div id="a47556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:137px;"><ix:nonfraction id="ID_1796" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">71.38</ix:nonfraction></div><div id="a47559" style="position:absolute;font-family:'Times New Roman';left:586px;top:137px;"><ix:nonnumeric id="ID_1237" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear">8.5</ix:nonnumeric></div><div id="a47562" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:608px;top:137px;">$ </div><div id="a47564" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:673px;top:137px;"><ix:nonfraction id="ID_1799" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a47577" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:166px;">Options exercisable at end of year<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47581" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:166px;"><ix:nonfraction id="ID_1798" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">220,688</ix:nonfraction></div><div id="a47584" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:166px;">$ </div><div id="a47586" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:166px;"><ix:nonfraction id="ID_1797" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">63.35</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_927_XBRL_TS_a53e3fe5de4a4e9d8a0d35a866c9af7e" style="position:absolute;left:64px;top:641px;float:left;"><ix:nonnumeric id="ID_236" name="hsic:IntrinsicValuesOfStockOptionsTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer930" style="position:relative;font-family:'Times New Roman';font-size:10.72px;color:#000000;line-height:normal;width:686px;height:79px;"><div id="div_928_XBRL_TS_05bdb110dfcc4034bb3982d6901e5a26" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_05bdb110dfcc4034bb3982d6901e5a26" continuedat="XBRL_TS_0d0329f37f64486bac1b1ac7d4f906f5"><div id="TextBlockContainer929" style="position:relative;font-family:'Times New Roman';font-size:10.72px;color:#000000;line-height:normal;width:686px;height:79px;"><div id="a47608" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:399px;top:0px;">Weighted </div><div id="a47611" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:495px;top:0px;">Weighted Average </div><div id="a47620" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:15px;">Average </div><div id="a47623" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:513px;top:15px;">Remaining </div><div id="a47626" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:623px;top:15px;">Aggregate </div><div id="a47630" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:305px;top:31px;">Number of </div><div id="a47633" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:31px;">Exercise </div><div id="a47636" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:510px;top:31px;">Contractual </div><div id="a47639" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:627px;top:31px;">Intrinsic </div><div id="a47643" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:312px;top:46px;">Options </div><div id="a47646" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:409px;top:46px;">Price </div><div id="a47649" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:506px;top:46px;">Life (in years) </div><div id="a47652" style="position:absolute;font-family:'Times New Roman';font-size:10.72px;font-weight:bold;font-style:normal;color:#000000;left:633px;top:46px;">Value </div><div id="a47654" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:63px;">Vested<div style="display:inline-block;width:5px">&nbsp;</div>or expected to vest </div><div id="a47657" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:321px;top:63px;"><ix:nonfraction id="ID_1715" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">885,428</ix:nonfraction></div><div id="a47660" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:63px;">$ </div><div id="a47662" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:438px;top:63px;"><ix:nonfraction id="ID_1716" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">73.50</ix:nonfraction></div><div id="a47665" style="position:absolute;font-family:'Times New Roman';left:586px;top:63px;"><ix:nonnumeric id="ID_1717" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember" format="ixt-sec:duryear">8.7</ix:nonnumeric></div><div id="a47668" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:612px;top:63px;">$ </div><div id="a47670" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:63px;"><ix:nonfraction id="ID_1718" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_EmployeeAndDirectorsStockOptionsMember" unitref="USD" decimals="-4" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_931_XBRL_TS_0d0329f37f64486bac1b1ac7d4f906f5" style="position:absolute;left:62px;top:736px;float:left;"><ix:continuation id="XBRL_TS_0d0329f37f64486bac1b1ac7d4f906f5" continuedat="XBRL_CS_faf0ca401d644cb6a6bdbd7e9aee8b7f"><div id="TextBlockContainer932" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:635px;height:17px;"><div id="a47673" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following tables summarize the activity of our unvested RSUs for<div style="display:inline-block;width:2px">&nbsp;</div>the year ended December 31, 2022:</div></div></ix:continuation></div><div id="div_933_XBRL_CS_faf0ca401d644cb6a6bdbd7e9aee8b7f" style="position:absolute;left:63px;top:776px;float:left;"><ix:continuation id="XBRL_CS_faf0ca401d644cb6a6bdbd7e9aee8b7f" continuedat="XBRL_TS_2df7350738b64a78ba6b7efe7d2bb9ce"><div id="TextBlockContainer936" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:728px;height:150px;"><div id="div_934_XBRL_CS_24e3b4323f9d44f29faa70ca9187aa91" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_156" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer935" style="position:relative;font-family:'Times New Roman';font-size:12px;color:#000000;line-height:normal;width:728px;height:150px;"><div id="a47696" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:220px;top:0px;">Time-Based Restricted Stock Units </div><div id="a47701" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:474px;top:0px;">Performance-Based Restricted Stock Units </div><div id="a47709" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:254px;top:16px;">Weighted Average<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47716" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:524px;top:16px;">Weighted Average<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47725" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:260px;top:30px;">Grant Date Fair </div><div id="a47728" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:358px;top:30px;">Intrinsic Value </div><div id="a47733" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:530px;top:30px;">Grant Date Fair </div><div id="a47737" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:643px;top:30px;">Intrinsic Value </div><div id="a47741" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:181px;top:45px;">Shares/Units </div><div id="a47744" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:259px;top:45px;">Value Per Share </div><div id="a47747" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:371px;top:45px;">Per Share </div><div id="a47750" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:449px;top:45px;">Shares/Units </div><div id="a47753" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:530px;top:45px;">Value Per Share </div><div id="a47757" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:bold;font-style:normal;color:#000000;left:656px;top:45px;">Per Share </div><div id="a47759" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Outstanding at beginning of period<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47763" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:201px;top:64px;"><ix:nonfraction id="ID_343" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,945,862</ix:nonfraction></div><div id="a47766" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:64px;">$ </div><div id="a47768" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:64px;"><ix:nonfraction id="ID_284" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">58.79</ix:nonfraction></div><div id="a47774" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:64px;"><ix:nonfraction id="ID_370" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">674,753</ix:nonfraction></div><div id="a47777" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:64px;">$ </div><div id="a47779" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:64px;"><ix:nonfraction id="ID_138" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">59.63</ix:nonfraction></div><div id="a47785" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:81px;">Granted<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47788" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:210px;top:81px;"><ix:nonfraction id="ID_74" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">471,840</ix:nonfraction></div><div id="a47792" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:81px;"><ix:nonfraction id="ID_120" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">85.49</ix:nonfraction></div><div id="a47798" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:81px;"><ix:nonfraction id="ID_1767" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">267,865</ix:nonfraction></div><div id="a47802" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:81px;"><ix:nonfraction id="ID_53" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">82.35</ix:nonfraction></div><div id="a47808" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:100px;">Vested<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a47811" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:202px;top:100px;display:flex;">(<ix:nonfraction id="ID_210" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">566,887</ix:nonfraction>)</div><div id="a47815" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:100px;"><ix:nonfraction id="ID_55" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">55.46</ix:nonfraction></div><div id="a47821" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:100px;display:flex;">(<ix:nonfraction id="ID_67" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">396,220</ix:nonfraction>)</div><div id="a47825" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:100px;"><ix:nonfraction id="ID_69" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">59.21</ix:nonfraction></div><div id="a47831" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:118px;">Forfeited<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47834" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:208px;top:118px;display:flex;">(<ix:nonfraction id="ID_358" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">94,771</ix:nonfraction>)</div><div id="a47838" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:118px;"><ix:nonfraction id="ID_395" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">67.87</ix:nonfraction></div><div id="a47844" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:478px;top:118px;display:flex;">(<ix:nonfraction id="ID_147" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">25,482</ix:nonfraction>)</div><div id="a47848" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:118px;"><ix:nonfraction id="ID_88" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">67.65</ix:nonfraction></div><div id="a47854" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Outstanding at end of period<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47857" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:201px;top:136px;"><ix:nonfraction id="ID_410" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,756,044</ix:nonfraction></div><div id="a47860" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:254px;top:136px;">$ </div><div id="a47862" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:136px;"><ix:nonfraction id="ID_224" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">66.59</ix:nonfraction></div><div id="a47865" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:354px;top:136px;">$ </div><div id="a47867" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:412px;top:136px;"><ix:nonfraction id="ID_324" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_TimeBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">79.87</ix:nonfraction></div><div id="a47870" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:136px;"><ix:nonfraction id="ID_135" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="shares" decimals="0" format="ixt:numdotdecimal">520,916</ix:nonfraction></div><div id="a47873" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:136px;">$ </div><div id="a47875" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:592px;top:136px;"><ix:nonfraction id="ID_257" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">60.23</ix:nonfraction></div><div id="a47879" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:639px;top:136px;">$ </div><div id="a47881" style="position:absolute;font-family:'Times New Roman';font-size:12px;font-weight:normal;font-style:normal;color:#000000;left:697px;top:136px;"><ix:nonfraction id="ID_286" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_PerformanceBasedRestrictedStockRestrictedUnitsMember" unitref="myUSDperShare" decimals="2">79.87</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_937_XBRL_TS_2df7350738b64a78ba6b7efe7d2bb9ce" style="position:absolute;left:62px;top:946px;float:left;"><ix:continuation id="XBRL_TS_2df7350738b64a78ba6b7efe7d2bb9ce"><div id="TextBlockContainer938" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:656px;height:35px;"><div id="a47884" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The total intrinsic value per share of RSUs that vested was $</div><div id="a47884_61_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:360px;top:0px;"><ix:nonfraction id="ID_1156" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">78.74</ix:nonfraction></div><div id="a47884_66_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:393px;top:0px;">, $</div><div id="a47884_69_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:0px;"><ix:nonfraction id="ID_1157" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">73.99</ix:nonfraction></div><div id="a47884_74_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:440px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>and $</div><div id="a47884_80_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:0px;"><ix:nonfraction id="ID_1158" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_AwardTypeAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="myUSDperShare" decimals="2" format="ixt:numdotdecimal">61.49</ix:nonfraction></div><div id="a47884_85_24" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:509px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>during the years ended </div><div id="a47890" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">December 31, 2022, December 25, 2021 and December 26, 2020.</div></div></ix:continuation></div><div id="a47890_59_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:453px;top:963px;"><div style="display:inline-block;width:4px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page108" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:266.1px; height:1px; left:419.8px; top:296.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:347.7px; height:15.4px; left:69.9px; top:333px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:16.1px; left:67.2px; top:332.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:266.1px; height:15.4px; left:420.2px; top:333px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:353px; height:1px; left:66.8px; top:330.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:330.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:17.1px; left:548.3px; top:331.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:330.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:329.8px; height:15.4px; left:87.9px; top:366.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:6.7px; height:15.4px; left:422.9px; top:366.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:435px; top:366.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:6.7px; height:15.4px; left:560.9px; top:366.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:365.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:366.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:401px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:435px; top:401px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:401px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17.1px; left:67.2px; top:399.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:401px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:434.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:435px; top:434.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:434.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:433.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.8px; height:15.4px; left:572.9px; top:434.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:469px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:435px; top:469px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:469px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17.1px; left:67.2px; top:467.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:469px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:435px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:501.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.8px; height:15.4px; left:572.9px; top:502.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:517.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:517.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:534.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:534.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:338.8px; height:15.4px; left:78.9px; top:554px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:552.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:266.1px; height:15.4px; left:420.2px; top:554px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:587.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:435px; top:587.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:587.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:586.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:587.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:622px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:435px; top:622px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:622px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:620.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:622px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:655.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:435px; top:655.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:655.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:654.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.8px; height:15.4px; left:572.9px; top:655.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:320.8px; height:15.4px; left:96.8px; top:690px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:435px; top:690px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.1px; height:15.4px; left:548.3px; top:690px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:17px; left:67.2px; top:688.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.8px; height:15.4px; left:572.9px; top:690px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:705px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:705px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:16px; left:67.2px; top:723.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:619.2px; height:15.4px; left:67.2px; top:723.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:353px; height:1px; left:66.8px; top:721.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:721.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:17px; left:548.3px; top:722.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:721.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:419.8px; top:738.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:557.9px; top:738.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:420.2px; top:757.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:420.2px; top:759.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:558.3px; top:757.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:558.3px; top:759.3px; background-color:#000000; ">&nbsp;</div>
<div id="a47892" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a47894" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a47896" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a47898" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a47901" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">108 </div><div id="div_939_XBRL_TS_467715bc5d4a45818df2483b59ce2f94" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_467715bc5d4a45818df2483b59ce2f94" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_3f635b35ccc24a72a6d2c2bf79e143a6" escape="true"><div id="TextBlockContainer940" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:689px;height:153px;"><div id="a47903" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 17 – Employee Benefit Plans</div><div id="a47908" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a47909" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:34px;">Defined benefit plans </div><div id="a47912" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">Certain of our employees in our international markets participate<div style="display:inline-block;width:2px">&nbsp;</div>in various noncontributory defined benefit plans.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a47913" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">These plans are managed to provide pension benefits to covered employees<div style="display:inline-block;width:2px">&nbsp;</div>in accordance with local regulations </div><div id="a47914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">and practices.<div style="display:inline-block;width:7px">&nbsp;</div>Our net unfunded liability for these plans are recorded<div style="display:inline-block;width:2px">&nbsp;</div>in accrued expenses: other; and other </div><div id="a47916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">liabilities within our consolidated balance sheets.<div style="display:inline-block;width:7px">&nbsp;</div>The following table presents the changes in projected benefit </div><div id="a47917" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">obligations, plan assets, and the funded status of our defined benefit pension<div style="display:inline-block;width:2px">&nbsp;</div>plans:</div></div></ix:nonnumeric></div><div id="a47917_85_19" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:554px;top:247px;"><div style="display:inline-block;width:66px">&nbsp;</div></div><div id="div_941_XBRL_TS_3f635b35ccc24a72a6d2c2bf79e143a6" style="position:absolute;left:65px;top:282px;float:left;"><ix:continuation id="XBRL_TS_3f635b35ccc24a72a6d2c2bf79e143a6" continuedat="XBRL_TS_b3e03ecf484c407d9c8ad0f9d584d153"><div id="TextBlockContainer944" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:623px;height:475px;"><div id="div_942_XBRL_TS_2f37bb294f034d0ba056d243da049d17" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_2f37bb294f034d0ba056d243da049d17" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_d75a1b886f464890beb105dab0533b41" escape="true"><div id="TextBlockContainer943" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:623px;height:475px;"><div id="a47924" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:457px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a47929" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:386px;top:17px;">December 31, </div><div id="a47933" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:524px;top:17px;">December 25, </div><div id="a47938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:411px;top:34px;">2022 </div><div id="a47942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:549px;top:34px;">2021 </div><div id="a47944" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Obligation and funded status: </div><div id="a47951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:13px;top:68px;">Change in benefit obligation </div><div id="a47958" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:85px;">Projected benefit obligation, beginning of period </div><div id="a47960" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:85px;">$ </div><div id="a47962" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:85px;"><ix:nonfraction id="ID_1379" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a47965" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:85px;">$ </div><div id="a47967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:85px;"><ix:nonfraction id="ID_1331" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">130</ix:nonfraction></div><div id="a47969" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:102px;">Service costs </div><div id="a47972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:102px;"><ix:nonfraction id="ID_1322" name="us-gaap:DefinedBenefitPlanServiceCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a47976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:102px;"><ix:nonfraction id="ID_1332" name="us-gaap:DefinedBenefitPlanServiceCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a47978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:119px;">Interest cost </div><div id="a47981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:119px;"><ix:nonfraction id="ID_1323" name="us-gaap:DefinedBenefitPlanInterestCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a47985" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:610px;top:119px;"><ix:nonfraction id="ID_1333" name="us-gaap:DefinedBenefitPlanInterestCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a47987" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:136px;">Past service cost </div><div id="a47990" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:136px;"><ix:nonfraction id="ID_1324" name="hsic:DefinedBenefitPlanBenefitObligationPastServiceCostAndCredit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a47994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:136px;"><ix:nonfraction id="ID_1334" name="hsic:DefinedBenefitPlanBenefitObligationPastServiceCostAndCredit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a47996" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:153px;">Actuarial loss </div><div id="a47999" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:458px;top:153px;display:flex;">(<ix:nonfraction id="ID_1325" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">19</ix:nonfraction>)</div><div id="a48003" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:153px;display:flex;">(<ix:nonfraction id="ID_1335" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">5</ix:nonfraction>)</div><div id="a48005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:170px;">Benefits paid</div><div id="a48006" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:170px;"><div style="display:inline-block;width:2px">&nbsp;</div>(1)</div><div id="a48010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:170px;display:flex;">(<ix:nonfraction id="ID_1326" name="hsic:DefinedBenefitPlanBenefitObligationBenefitsPaidReceived" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a48014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:610px;top:170px;"><ix:nonfraction id="ID_1336" name="hsic:DefinedBenefitPlanBenefitObligationBenefitsPaidReceived" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a48016" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:187px;">Participant contributions </div><div id="a48019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:187px;"><ix:nonfraction id="ID_1327" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:187px;"><ix:nonfraction id="ID_1337" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:204px;">Settlements </div><div id="a48028" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:204px;display:flex;">(<ix:nonfraction id="ID_1328" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48032" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:204px;display:flex;">(<ix:nonfraction id="ID_1338" name="us-gaap:DefinedBenefitPlanSettlementsBenefitObligation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction>)</div><div id="a48034" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:221px;">Effect of foreign currency translation </div><div id="a48037" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:221px;display:flex;">(<ix:nonfraction id="ID_1329" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a48041" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:221px;display:flex;">(<ix:nonfraction id="ID_1339" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">5</ix:nonfraction>)</div><div id="a48043" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:238px;">Projected benefit obligation, end of period </div><div id="a48046" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:238px;">$ </div><div id="a48048" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:456px;top:238px;"><ix:nonfraction id="ID_1330" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">108</ix:nonfraction></div><div id="a48051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:238px;">$ </div><div id="a48053" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:594px;top:238px;"><ix:nonfraction id="ID_1379A" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">128</ix:nonfraction></div><div id="a48062" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:13px;top:272px;">Change in plan assets </div><div id="a48069" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:289px;">Fair value of plan assets at beginning of period </div><div id="a48071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:289px;">$ </div><div id="a48073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:463px;top:289px;"><ix:nonfraction id="ID_1356" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a48076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:289px;">$ </div><div id="a48078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:289px;"><ix:nonfraction id="ID_1348" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextref="AS_OF_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">65</ix:nonfraction></div><div id="a48080" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:306px;">Actual return on plan assets </div><div id="a48083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:306px;display:flex;">(<ix:nonfraction id="ID_1340" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction>)</div><div id="a48087" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:306px;"><ix:nonfraction id="ID_1349" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a48089" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:323px;">Employer contributions </div><div id="a48092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:323px;"><ix:nonfraction id="ID_1341" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a48096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:323px;"><ix:nonfraction id="ID_1350" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a48098" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:340px;">Plan participant contributions </div><div id="a48102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:340px;"><ix:nonfraction id="ID_1342" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48106" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:340px;"><ix:nonfraction id="ID_1351" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:357px;">Expected return on plan assets </div><div id="a48111" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:357px;"><ix:nonfraction id="ID_1343" name="hsic:DefinedBenefitPlanPlanAssetsExpectedReturnLossOnPlanAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:357px;"><ix:nonfraction id="ID_1352" name="hsic:DefinedBenefitPlanPlanAssetsExpectedReturnLossOnPlanAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48117" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:374px;">Benefit received</div><div id="a48118" style="position:absolute;font-family:'Times New Roman';font-size:8.64px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:374px;"><div style="display:inline-block;width:2px">&nbsp;</div>(1)</div><div id="a48122" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:374px;"><ix:nonfraction id="ID_1344" name="hsic:DefinedBenefitPlanPlanAssetsBenefitsPaidReceived" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a48126" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:607px;top:374px;"><ix:nonfraction id="ID_1353" name="hsic:DefinedBenefitPlanPlanAssetsBenefitsPaidReceived" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a48128" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:391px;">Settlements </div><div id="a48131" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:391px;display:flex;">(<ix:nonfraction id="ID_1345" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48135" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:391px;display:flex;">(<ix:nonfraction id="ID_1354" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a48137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:31px;top:408px;">Effect of foreign currency translation </div><div id="a48140" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:408px;display:flex;">(<ix:nonfraction id="ID_1346" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a48144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:408px;display:flex;">(<ix:nonfraction id="ID_1355" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a48146" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:22px;top:425px;">Fair value of plan assets at end of period </div><div id="a48148" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:425px;">$ </div><div id="a48150" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:463px;top:425px;"><ix:nonfraction id="ID_1347" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">73</ix:nonfraction></div><div id="a48153" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:425px;">$ </div><div id="a48155" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:425px;"><ix:nonfraction id="ID_1356A" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a48164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:460px;">Unfunded status at end of period </div><div id="a48167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:357px;top:460px;">$ </div><div id="a48169" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:463px;top:460px;"><ix:nonfraction id="ID_1357" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_UnfundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">35</ix:nonfraction></div><div id="a48172" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:460px;">$ </div><div id="a48174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:460px;"><ix:nonfraction id="ID_1358" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_UnfundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">53</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="a48183" style="position:absolute;font-family:'Times New Roman';font-size:12px;left:80px;top:778px;">(1)</div><div id="div_945_XBRL_TS_b3e03ecf484c407d9c8ad0f9d584d153" style="position:absolute;left:104px;top:776px;float:left;"><ix:continuation id="XBRL_TS_b3e03ecf484c407d9c8ad0f9d584d153" continuedat="XBRL_TS_e902815dab0a4913933e959d8be2a50f"><div id="TextBlockContainer948" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:493px;height:18px;"><div id="div_946_XBRL_TS_d75a1b886f464890beb105dab0533b41" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_d75a1b886f464890beb105dab0533b41"><div id="TextBlockContainer947" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:493px;height:18px;"><div id="a48185" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Includes regular benefit payments and amounts transferred in by new<div style="display:inline-block;width:2px">&nbsp;</div>participants.</div></div></ix:continuation></div></div></ix:continuation></div><div id="div_949_XBRL_TS_e902815dab0a4913933e959d8be2a50f" style="position:absolute;left:62px;top:809px;float:left;"><ix:continuation id="XBRL_TS_e902815dab0a4913933e959d8be2a50f" continuedat="XBRL_TS_b688962a471447cd9bb5e2efa98db49a"><div id="TextBlockContainer950" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:672px;height:51px;"><div id="a48188" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The majority of our defined benefit plans are unfunded, with the exception<div style="display:inline-block;width:2px">&nbsp;</div>of one plan in one country where the </div><div id="a48191" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">amount of assets exceeds the projected benefit obligation by approximately<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a48191_76_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:458px;top:17px;"><ix:nonfraction id="ID_1811" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_FundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a48191_77_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a48191_91_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:17px;"><ix:nonfraction id="ID_1812" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanFundingStatusAxis_us-gaap_FundedPlanMember_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a48191_92_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:554px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million as of </div><div id="a48192" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">December 31, 2022 and December 25, 2021, respectively.</div></div></ix:continuation></div><div id="a48192_54_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:408px;top:843px;"><div style="display:inline-block;width:26px">&nbsp;</div></div></div>
</div>
<div style="padding: 7px">
<div id="Page109" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:266px; height:1px; left:357.9px; top:178.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:415.1px; height:15.4px; left:67.2px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:557.1px; height:16.1px; left:67.2px; top:214.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:134px; height:15.4px; left:486.3px; top:214.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:291.1px; height:1px; left:66.8px; top:212.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:357.9px; top:212.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:485.9px; top:212.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:495.9px; top:212.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:557.1px; height:17px; left:67.2px; top:247.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:557.1px; height:15.4px; left:67.2px; top:248.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406px; height:1px; left:329.9px; top:349.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:257.7px; height:15.4px; left:69.9px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:6.7px; height:15.4px; left:332.9px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:344.9px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:6.7px; height:15.4px; left:471.9px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:483.9px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:6.7px; height:15.4px; left:611px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:669.1px; height:16.6px; left:67.2px; top:385.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:623px; top:386.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:263.1px; height:17.6px; left:67.2px; top:384.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:329.9px; top:384.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:11px; height:1px; left:457.9px; top:384.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:469px; top:384.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.9px; height:1px; left:597px; top:384.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:607.9px; top:384.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:257.7px; height:15.4px; left:69.9px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:344.9px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:15.4px; left:458.3px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:483.9px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23.1px; height:15.4px; left:597.2px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:669.1px; height:17.6px; left:67.2px; top:419.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:623px; top:422.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:257.7px; height:15.4px; left:69.9px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:344.9px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:15.4px; left:458.3px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:483.9px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23.1px; height:15.4px; left:597.2px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:669.1px; height:17.6px; left:67.2px; top:455.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:623px; top:457.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:257.7px; height:15.4px; left:69.9px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:106.7px; height:15.4px; left:344.9px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:22.9px; height:15.4px; left:458.3px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:483.9px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:23.1px; height:15.4px; left:597.2px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:669.1px; height:17.6px; left:67.2px; top:490.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:110.7px; height:15.4px; left:623px; top:492.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:329.9px; top:507.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:469px; top:507.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:128px; height:1px; left:607.9px; top:507.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:329.3px; top:528.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:329.3px; top:526.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:468.4px; top:528.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:468.4px; top:526.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:607.3px; top:528.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:129px; height:1px; left:607.3px; top:526.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:245px; height:1px; left:502.9px; top:613.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:418.7px; height:15.4px; left:69.9px; top:649.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:15.4px; left:506px; top:649.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.4px; left:595.9px; top:649.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:15.4px; left:636px; top:649.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:648.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.4px; left:726.1px; top:649.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:424.1px; height:1px; left:66.8px; top:647.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:12px; height:17px; left:491.3px; top:647.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:115.1px; height:1px; left:502.9px; top:647.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:15px; height:1px; left:618px; top:647.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:114.9px; height:1px; left:633px; top:647.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:369px; height:1px; left:378.9px; top:698.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:294.6px; height:15.2px; left:69.9px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:15.2px; left:382px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.2px; left:471.9px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.2px; left:508.9px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.2px; left:599px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:15.2px; left:636px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:733.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.2px; left:726.1px; top:734.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:300.1px; height:1px; left:66.8px; top:732.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:12px; height:17px; left:367.3px; top:732.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:115.1px; height:1px; left:378.9px; top:732.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:12px; height:17px; left:494.3px; top:732.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:115.1px; height:1px; left:505.9px; top:732.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:12px; height:1px; left:621px; top:732.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:114.9px; height:1px; left:633px; top:732.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:294.6px; height:15.4px; left:69.9px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.7px; height:15.4px; left:382px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.4px; left:471.9px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.8px; height:15.4px; left:508.9px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.4px; left:599px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:80.6px; height:15.4px; left:636px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:766.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:19.7px; height:15.4px; left:726.1px; top:768.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div id="a48194" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a48196" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a48198" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a48200" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a48203" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">109 </div><div id="div_951_XBRL_TS_b688962a471447cd9bb5e2efa98db49a" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_b688962a471447cd9bb5e2efa98db49a" continuedat="XBRL_TS_fffa36d3ca4f42f5b711315c416154c5"><div id="TextBlockContainer952" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:668px;height:35px;"><div id="a48205" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table provides the amounts recognized in our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>balance sheets for our defined benefit </div><div id="a48207" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">pension plans:</div></div></ix:continuation></div><div id="div_953_XBRL_TS_fffa36d3ca4f42f5b711315c416154c5" style="position:absolute;left:63px;top:164px;float:left;"><ix:continuation id="XBRL_TS_fffa36d3ca4f42f5b711315c416154c5" continuedat="XBRL_TS_4d72688ea6d740f8a1caf83d59a6b02d"><div id="TextBlockContainer956" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:566px;height:118px;"><div id="div_954_XBRL_TS_d5eb6978f442471b982ed5c31eaf0b87" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_1409" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer955" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:566px;height:118px;"><div id="a48212" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:398px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a48216" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:327px;top:17px;">December 31, </div><div id="a48220" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:465px;top:17px;">December 25, </div><div id="a48224" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:352px;top:34px;">2022 </div><div id="a48228" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:490px;top:34px;">2021 </div><div id="a48230" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Non-current assets </div><div id="a48234" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:301px;top:51px;">$ </div><div id="a48236" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:406px;top:51px;"><ix:nonfraction id="ID_1662" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">25</ix:nonfraction></div><div id="a48239" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:439px;top:51px;">$ </div><div id="a48241" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:51px;"><ix:nonfraction id="ID_1663" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">22</ix:nonfraction></div><div id="a48243" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Current liabilities </div><div id="a48246" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:408px;top:68px;display:flex;">(<ix:nonfraction id="ID_1664" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48250" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:68px;display:flex;">(<ix:nonfraction id="ID_1665" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48252" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Non-current liabilities </div><div id="a48257" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:401px;top:85px;display:flex;">(<ix:nonfraction id="ID_1359" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">59</ix:nonfraction>)</div><div id="a48261" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:85px;display:flex;">(<ix:nonfraction id="ID_1360" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">74</ix:nonfraction>)</div><div id="a48263" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Accumulated other comprehensive loss, pre-tax </div><div id="a48268" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:102px;"><ix:nonfraction id="ID_1418" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48272" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:102px;"><ix:nonfraction id="ID_1419" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_957_XBRL_TS_4d72688ea6d740f8a1caf83d59a6b02d" style="position:absolute;left:62px;top:298px;float:left;"><ix:continuation id="XBRL_TS_4d72688ea6d740f8a1caf83d59a6b02d" continuedat="XBRL_TS_1c1ee909a81e48dda23e24b78509d677"><div id="TextBlockContainer958" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:527px;height:17px;"><div id="a48275" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table provides the net periodic pension cost for our<div style="display:inline-block;width:2px">&nbsp;</div>defined benefit plans:</div></div></ix:continuation></div><div id="a48275_89_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:583px;top:298px;"><div style="display:inline-block;width:11px">&nbsp;</div></div><div id="div_959_XBRL_TS_269ed788b5bc4a43a1e893c379d4d290" style="position:absolute;left:65px;top:335px;float:left;"><ix:nonnumeric id="ID_1410" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer962" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:666px;height:192px;"><div id="div_960_XBRL_TS_1c1ee909a81e48dda23e24b78509d677" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_1c1ee909a81e48dda23e24b78509d677" continuedat="XBRL_TS_c9e1f0f48b3842d1aa2eaf4a572dd341"><div id="TextBlockContainer961" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:666px;height:192px;"><div id="a48280" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:437px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a48284" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:296px;top:18px;">December 31, </div><div id="a48288" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:435px;top:18px;">December 25, </div><div id="a48292" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:574px;top:18px;">December 26, </div><div id="a48296" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:321px;top:35px;">2022 </div><div id="a48300" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:460px;top:35px;">2021 </div><div id="a48304" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:599px;top:35px;">2020 </div><div id="a48306" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:53px;">Service cost </div><div id="a48308" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:267px;top:53px;">$ </div><div id="a48310" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:379px;top:53px;"><ix:nonfraction id="ID_1322A" name="us-gaap:DefinedBenefitPlanServiceCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a48313" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:406px;top:53px;">$ </div><div id="a48315" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:518px;top:53px;"><ix:nonfraction id="ID_1332A" name="us-gaap:DefinedBenefitPlanServiceCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48318" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:53px;">$ </div><div id="a48320" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:53px;"><ix:nonfraction id="ID_1288" name="us-gaap:DefinedBenefitPlanServiceCost" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a48322" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:70px;">Interest cost </div><div id="a48325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:379px;top:70px;"><ix:nonfraction id="ID_1323A" name="us-gaap:DefinedBenefitPlanInterestCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48329" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:70px;">- </div><div id="a48333" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:70px;">- </div><div id="a48335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Expected return on plan assets </div><div id="a48338" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:88px;display:flex;">(<ix:nonfraction id="ID_1289" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48342" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:514px;top:88px;display:flex;">(<ix:nonfraction id="ID_1290" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction>)</div><div id="a48346" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:88px;">- </div><div id="a48348" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:106px;">Employee contributions </div><div id="a48352" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:106px;">- </div><div id="a48356" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:521px;top:106px;">- </div><div id="a48360" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:106px;">- </div><div id="a48362" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:123px;">Amortization of prior service credit </div><div id="a48365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:379px;top:123px;"><ix:nonfraction id="ID_1291" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48369" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:518px;top:123px;"><ix:nonfraction id="ID_1292" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:123px;"><ix:nonfraction id="ID_1293" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a48375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:141px;">Recognized net actuarial loss </div><div id="a48378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:141px;">- </div><div id="a48382" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:141px;">- </div><div id="a48386" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:141px;">- </div><div id="a48388" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:158px;">Settlements </div><div id="a48391" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:158px;">- </div><div id="a48395" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:525px;top:158px;">- </div><div id="a48399" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:158px;">- </div><div id="a48401" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:177px;">Net periodic pension cost </div><div id="a48403" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:267px;top:177px;">$ </div><div id="a48405" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:379px;top:177px;"><ix:nonfraction id="ID_1294" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48408" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:406px;top:177px;">$ </div><div id="a48410" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:518px;top:177px;"><ix:nonfraction id="ID_1295" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48413" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:546px;top:177px;">$ </div><div id="a48415" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:658px;top:177px;"><ix:nonfraction id="ID_1296" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_963_XBRL_TS_c9e1f0f48b3842d1aa2eaf4a572dd341" style="position:absolute;left:62px;top:546px;float:left;"><ix:continuation id="XBRL_TS_c9e1f0f48b3842d1aa2eaf4a572dd341" continuedat="XBRL_TS_0232e3c6386a4a509ec5fc8911c4f73c"><div id="TextBlockContainer964" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:667px;height:34px;"><div id="a48418" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following tables present the weighted-average actuarial assumptions<div style="display:inline-block;width:2px">&nbsp;</div>used to determine our pension benefit </div><div id="a48421" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">obligation and our net periodic pension cost for the periods presented:</div></div></ix:continuation></div><div id="a48421_71_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:478px;top:563px;"><div style="display:inline-block;width:22px">&nbsp;</div></div><div id="div_965_XBRL_TS_498de16a89bc482fa359936846e7acad" style="position:absolute;left:65px;top:599px;float:left;"><ix:nonnumeric id="ID_498de16a89bc482fa359936846e7acad" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_ad49772eca984ee7be5301b996a750b3" escape="true"><div id="TextBlockContainer968" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:678px;height:67px;"><div id="div_966_XBRL_TS_0232e3c6386a4a509ec5fc8911c4f73c" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_0232e3c6386a4a509ec5fc8911c4f73c" continuedat="XBRL_TS_7123646f3d3e4045a2eb930a7823d9aa"><div id="TextBlockContainer967" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:678px;height:67px;"><div id="a48427" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:523px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a48431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:444px;top:17px;">December 31, </div><div id="a48435" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:574px;top:17px;">December 25, </div><div id="a48438" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Pension Benefit Obligation </div><div id="a48441" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:469px;top:34px;">2022 </div><div id="a48445" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:599px;top:34px;">2021 </div><div id="a48448" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Weighted average<div style="display:inline-block;width:5px">&nbsp;</div>discount rate </div><div id="a48451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:498px;top:51px;"><ix:nonfraction id="ID_1297" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">1.67</ix:nonfraction></div><div id="a48453" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:539px;top:51px;">% </div><div id="a48456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:51px;"><ix:nonfraction id="ID_1298" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.87</ix:nonfraction></div><div id="a48458" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:51px;">%</div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_969_XBRL_TS_ad49772eca984ee7be5301b996a750b3" style="position:absolute;left:65px;top:684px;float:left;"><ix:continuation id="XBRL_TS_ad49772eca984ee7be5301b996a750b3"><div id="TextBlockContainer972" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:689px;height:118px;"><div id="div_970_XBRL_TS_7123646f3d3e4045a2eb930a7823d9aa" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_7123646f3d3e4045a2eb930a7823d9aa" continuedat="XBRL_TS_19942a9242fd44b1bccd1b626b238390"><div id="TextBlockContainer971" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:689px;height:118px;"><div id="a48463" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:461px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a48467" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:320px;top:17px;">December 31, </div><div id="a48471" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:447px;top:17px;">December 25, </div><div id="a48475" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:574px;top:17px;">December 26, </div><div id="a48478" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:4px;top:34px;">Net Periodic Pension Cost </div><div id="a48481" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:345px;top:34px;">2022 </div><div id="a48485" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:472px;top:34px;">2021 </div><div id="a48489" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:599px;top:34px;">2020 </div><div id="a48492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">Discount rate-pension benefit </div><div id="a48497" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:51px;"><ix:nonfraction id="ID_1299" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">1.25</ix:nonfraction></div><div id="a48499" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:51px;">% </div><div id="a48502" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:51px;"><ix:nonfraction id="ID_1300" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.56</ix:nonfraction></div><div id="a48504" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:51px;">% </div><div id="a48507" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:51px;"><ix:nonfraction id="ID_1301" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.51</ix:nonfraction></div><div id="a48509" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:51px;">% </div><div id="a48511" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Expected return on plan assets </div><div id="a48514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:68px;"><ix:nonfraction id="ID_1302" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.81</ix:nonfraction></div><div id="a48516" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:68px;">% </div><div id="a48519" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:68px;"><ix:nonfraction id="ID_1303" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.71</ix:nonfraction></div><div id="a48521" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:68px;">% </div><div id="a48524" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:68px;"><ix:nonfraction id="ID_1304" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.87</ix:nonfraction></div><div id="a48526" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:68px;">% </div><div id="a48528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">Rate of compensation increase </div><div id="a48532" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:85px;"><ix:nonfraction id="ID_1305" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">1.68</ix:nonfraction></div><div id="a48534" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:85px;">% </div><div id="a48537" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:85px;"><ix:nonfraction id="ID_1306" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">1.95</ix:nonfraction></div><div id="a48539" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:85px;">% </div><div id="a48542" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:85px;"><ix:nonfraction id="ID_1307" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">1.97</ix:nonfraction></div><div id="a48544" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:85px;">% </div><div id="a48546" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">Pension increase rate </div><div id="a48549" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:374px;top:102px;"><ix:nonfraction id="ID_1308" name="hsic:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionRate" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.61</ix:nonfraction></div><div id="a48551" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:415px;top:102px;">% </div><div id="a48554" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:501px;top:102px;"><ix:nonfraction id="ID_1309" name="hsic:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionRate" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.72</ix:nonfraction></div><div id="a48556" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:542px;top:102px;">% </div><div id="a48559" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:628px;top:102px;"><ix:nonfraction id="ID_1310" name="hsic:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostPensionRate" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="pure" decimals="6" format="ixt:numdotdecimal" scale="-2">0.67</ix:nonfraction></div><div id="a48561" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:669px;top:102px;">%</div></div></ix:continuation></div></div></ix:continuation></div></div>
</div>
<div style="padding: 7px">
<div id="Page110" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:71.7px; height:15.4px; left:77.9px; top:169px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:169.9px; top:169px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:189px; height:16px; left:75.2px; top:168.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72.8px; height:15.4px; left:184.8px; top:169px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:77px; height:1px; left:74.8px; top:167px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:112px; height:17px; left:152.2px; top:167.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:112px; height:1px; left:151.8px; top:167px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:77.9px; top:203.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:30.1px; height:15.4px; left:152.2px; top:203.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:189px; height:17.1px; left:75.2px; top:201.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72.8px; height:15.4px; left:184.8px; top:203.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:71.7px; height:15.4px; left:77.9px; top:237px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:30.1px; height:15.4px; left:152.2px; top:237px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:189px; height:17px; left:75.2px; top:235.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72.8px; height:15.4px; left:184.8px; top:237px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:62.7px; height:15.4px; left:86.9px; top:272px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:9.6px; height:15.4px; left:169.9px; top:272px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:189px; height:17.1px; left:75.2px; top:270.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:72.8px; height:15.4px; left:184.8px; top:272px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:18.1px; left:75.2px; top:269.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:92px; height:1px; left:74.8px; top:268.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:97px; height:1px; left:166.8px; top:268.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98px; height:1px; left:166.3px; top:289.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:98px; height:1px; left:166.3px; top:287.5px; background-color:#000000; ">&nbsp;</div>
<div id="a48563" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a48565" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a48567" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a48569" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a48572" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">110 </div><div id="div_973_XBRL_TS_19942a9242fd44b1bccd1b626b238390" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_19942a9242fd44b1bccd1b626b238390" continuedat="XBRL_TS_8ba339063f904922ab7d39047044e79e"><div id="TextBlockContainer974" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:35px;"><div id="a48574" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table presents the estimated pension benefit payments that<div style="display:inline-block;width:2px">&nbsp;</div>are payable to the plan’s participants as of </div><div id="a48576" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">December 31, 2022:</div></div></ix:continuation></div><div id="a48576_18_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:187px;top:129px;"><div style="display:inline-block;width:22px">&nbsp;</div></div><div id="div_975_XBRL_TS_a376d934acd94d3193515c0b845544cb" style="position:absolute;left:73px;top:152px;float:left;"><ix:nonnumeric id="ID_1412" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer978" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:186px;height:135px;"><div id="div_976_XBRL_TS_8ba339063f904922ab7d39047044e79e" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_8ba339063f904922ab7d39047044e79e" continuedat="XBRL_TS_3ec38f457e1f4e7389ae7ee7af6f1fb8"><div id="TextBlockContainer977" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:186px;height:135px;"><div id="a48579" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:26px;top:0px;">Year </div><div id="a48585" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:17px;">2023 </div><div id="a48588" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:96px;top:17px;">$ </div><div id="a48590" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:17px;"><ix:nonfraction id="ID_1311" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a48593" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:34px;">2024 </div><div id="a48597" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:34px;"><ix:nonfraction id="ID_1312" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a48600" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:51px;">2025 </div><div id="a48604" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:51px;"><ix:nonfraction id="ID_1313" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a48607" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">2026 </div><div id="a48611" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:68px;"><ix:nonfraction id="ID_1314" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a48614" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:85px;">2027 </div><div id="a48618" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:177px;top:85px;"><ix:nonfraction id="ID_1315" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a48621" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:102px;">2028 to 2032 </div><div id="a48625" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:171px;top:102px;"><ix:nonfraction id="ID_1316" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction></div><div id="a48628" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:13px;top:120px;">Total </div><div id="a48631" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:96px;top:120px;">$ </div><div id="a48633" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:171px;top:120px;"><ix:nonfraction id="ID_1317" name="hsic:DefinedBenefitPlanExpectedFutureBenefitPayment" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_us-gaap_PensionPlansDefinedBenefitMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">67</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_979_XBRL_TS_3ec38f457e1f4e7389ae7ee7af6f1fb8" style="position:absolute;left:62px;top:307px;float:left;"><ix:continuation id="XBRL_TS_3ec38f457e1f4e7389ae7ee7af6f1fb8" continuedat="XBRL_TS_d58e75e91f3a4f85b8184daca382b789"><div id="TextBlockContainer980" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:473px;"><div id="a48636" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">401(k) Plans </div><div id="a48640" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">We offer<div style="display:inline-block;width:5px">&nbsp;</div>qualified 401(k) plans to substantially all our domestic full-time<div style="display:inline-block;width:2px">&nbsp;</div>employees.<div style="display:inline-block;width:7px">&nbsp;</div>As determined by our Board </div><div id="a48645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">of Directors, matching contributions to these plans generally do not<div style="display:inline-block;width:2px">&nbsp;</div>exceed </div><div id="a48645_76_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:51px;"><ix:nonfraction id="ID_1401" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">100</ix:nonfraction></div><div id="a48645_79_37" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:471px;top:51px;">% of the participants’ contributions </div><div id="a48646" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">up to </div><div id="a48646_6_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:39px;top:68px;"><ix:nonfraction id="ID_1402" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">7</ix:nonfraction></div><div id="a48646_7_110" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:46px;top:68px;">% of their base compensation, subject to applicable legal limits.<div style="display:inline-block;width:6px">&nbsp;</div>Matching contributions consist of cash and </div><div id="a48648" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">were allocated entirely to the participants’ investment elections on file,<div style="display:inline-block;width:2px">&nbsp;</div>subject to a </div><div id="a48648_88_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:495px;top:84px;"><ix:nonfraction id="ID_1403" name="hsic:DefinedContributionPlanMaximumPercentContributionsAllocatedCompanyStockFund" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="pure" decimals="INF" format="ixt:numdotdecimal" scale="-2">20</ix:nonfraction></div><div id="a48648_90_26" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:510px;top:84px;">% allocation limit to the </div><div id="a48649" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">Henry Schein Stock Fund.<div style="display:inline-block;width:7px">&nbsp;</div>Due to the impact of COVID-19, as part of our initiative to generate cash savings,<div style="display:inline-block;width:2px">&nbsp;</div>we </div><div id="a48653" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">suspended the matching contribution for the second half of 2020.<div style="display:inline-block;width:6px">&nbsp;</div>The matching contribution was reinstated in </div><div id="a48654" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:135px;">2021.<div style="display:inline-block;width:7px">&nbsp;</div>Forfeitures attributable to participants whose employment terminates prior<div style="display:inline-block;width:2px">&nbsp;</div>to becoming fully vested are used </div><div id="a48657" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:152px;">to reduce our matching contributions and offset administrative expenses of the 401(k)<div style="display:inline-block;width:2px">&nbsp;</div>plans. </div><div id="a48660" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:185px;">Assets of the 401(k) and other defined contribution plans are held<div style="display:inline-block;width:2px">&nbsp;</div>in self-directed accounts enabling participants to </div><div id="a48663" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:202px;">choose from various investment fund options.<div style="display:inline-block;width:6px">&nbsp;</div>Matching contributions related to these plans charged to operations </div><div id="a48665" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:219px;">during the years ended December 31, 2022, December 25, 2021 and December<div style="display:inline-block;width:2px">&nbsp;</div>26, 2020 amounted to $</div><div id="a48665_95_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:219px;"><ix:nonfraction id="ID_1398" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">45</ix:nonfraction></div><div id="a48665_97_10" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:626px;top:219px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, </div><div id="a48666" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:236px;">$</div><div id="a48666_1_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:236px;"><ix:nonfraction id="ID_1399" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction></div><div id="a48666_3_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:27px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a48666_17_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:109px;top:236px;"><ix:nonfraction id="ID_1400" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a48666_19_72" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:124px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>Within our consolidated statements of income, $</div><div id="a48666_91_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:544px;top:236px;"><ix:nonfraction id="ID_1804" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">37</ix:nonfraction></div><div id="a48666_93_21" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:558px;top:236px;"><div style="display:inline-block;width:4px">&nbsp;</div>million is included </div><div id="a48669" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:253px;">in selling, general and administrative expenses; and $</div><div id="a48669_54_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:319px;top:253px;"><ix:nonfraction id="ID_1805" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember_us-gaap_RetirementPlanTypeAxis_hsic_Qualified401kPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a48669_55_44" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:326px;top:253px;"><div style="display:inline-block;width:4px">&nbsp;</div>million is included in cost of goods sold. </div><div id="a48675" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:287px;">Supplemental Executive Retirement Plan (“SERP”) </div><div id="a48678" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:321px;">We offer<div style="display:inline-block;width:5px">&nbsp;</div>an unfunded, non-qualified SERP to eligible employees.<div style="display:inline-block;width:6px">&nbsp;</div>This plan generally covers officers and certain </div><div id="a48682" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">highly compensated employees after they have reached the maximum<div style="display:inline-block;width:2px">&nbsp;</div>IRS allowed pre-tax 401(k) contribution </div><div id="a48685" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:354px;">limit.<div style="display:inline-block;width:7px">&nbsp;</div>Our contributions to this plan are equal to the 401(k)<div style="display:inline-block;width:2px">&nbsp;</div>employee-elected contribution percentage applied to </div><div id="a48689" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:371px;">base compensation for the portion of the year in which such employees are<div style="display:inline-block;width:2px">&nbsp;</div>not eligible to make pre-tax </div><div id="a48692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:388px;">contributions to the 401(k) plan.<div style="display:inline-block;width:7px">&nbsp;</div>Due to the impact of COVID-19, as part of our initiative<div style="display:inline-block;width:2px">&nbsp;</div>to generate cash savings, </div><div id="a48696" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:405px;">we suspended contributions under the SERP for the second half of<div style="display:inline-block;width:2px">&nbsp;</div>2020.<div style="display:inline-block;width:7px">&nbsp;</div>Contributions to the SERP were restored </div><div id="a48697" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:422px;">in 2021.<div style="display:inline-block;width:7px">&nbsp;</div>The amounts charged to operations during the years ended December 31,<div style="display:inline-block;width:2px">&nbsp;</div>2022, December 25, 2021 and </div><div id="a48698" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:439px;">December 26, 2020 amounted to $</div><div id="a48698_31_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:208px;top:439px;display:flex;">(<ix:nonfraction id="ID_1388" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a48698_34_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:225px;top:439px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a48698_45_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:286px;top:439px;"><ix:nonfraction id="ID_1389" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a48698_46_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:293px;top:439px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a48698_60_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:375px;top:439px;"><ix:nonfraction id="ID_1390" name="us-gaap:PensionAndOtherPostretirementBenefitExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RetirementPlanTypeAxis_hsic_SupplementalExecutiveRetirementPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a48698_61_53" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:382px;top:439px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>The charges are included in </div><div id="a48700" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:455px;">selling, general and administrative expenses line item within our consolidated<div style="display:inline-block;width:2px">&nbsp;</div>statements of income.</div></div></ix:continuation></div><div id="a48700_100_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:656px;top:763px;"><div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a48701" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:780px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Note 11 – Derivatives and Hedging Activities</a></div><div id="a48706" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:336px;top:780px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional information.<div style="display:inline-block;width:7px">&nbsp;</div></div><div id="div_981_XBRL_TS_d58e75e91f3a4f85b8184daca382b789" style="position:absolute;left:62px;top:813px;float:left;"><ix:continuation id="XBRL_TS_d58e75e91f3a4f85b8184daca382b789"><div id="TextBlockContainer982" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:692px;height:136px;"><div id="a48710" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:0px;">Deferred Compensation Plan (“DCP”) </div><div id="a48713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">During 2011, we began to offer DCP to a select group of management or highly compensated employees of<div style="display:inline-block;width:2px">&nbsp;</div>the </div><div id="a48714" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">Company and certain subsidiaries.<div style="display:inline-block;width:7px">&nbsp;</div>This plan allows for the elective deferral of base salary, bonus and/or </div><div id="a48716" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:68px;">commission compensation by eligible employees.<div style="display:inline-block;width:6px">&nbsp;</div>The amounts charged to operations during the years ended </div><div id="a48717" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">December 31, 2022, December 25, 2021 and December 26, 2020 were approximately<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a48717_79_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:518px;top:84px;display:flex;">(<ix:nonfraction id="ID_1391" name="us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a48717_83_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:543px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a48717_94_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:603px;top:84px;"><ix:nonfraction id="ID_1392" name="us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a48717_95_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:611px;top:84px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and </div><div id="a48719" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">$</div><div id="a48719_1_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:101px;"><ix:nonfraction id="ID_1393" name="us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_srt_TitleOfIndividualAxis_srt_ManagementMember_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_hsic_DeferredCompensationBonusAndCommissionPlanMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">8</ix:nonfraction></div><div id="a48719_2_115" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:101px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively.<div style="display:inline-block;width:8px">&nbsp;</div>The charges are included in selling, general and administrative expenses line<div style="display:inline-block;width:2px">&nbsp;</div>item within </div><div id="a48720" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:118px;">our consolidated statements of income.</div></div></ix:continuation></div><div id="a48720_38_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:297px;top:932px;"><div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a48721" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:368px;top:932px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Note 11 – Derivatives and Hedging Activities</a></div><div id="a48725" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:636px;top:932px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional </div><div id="a48728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:948px;">information. </div></div>
</div>
<div style="padding: 7px">
<div id="Page111" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:290.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:289.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:289.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:558.3px; top:289.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:289.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:289.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:289.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:35px; left:67.2px; top:339.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:359.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.9px; left:67.2px; top:390px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:439.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:454.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:454.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:454.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:471.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:470px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:471.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:470px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:471.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:470px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:636.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:637.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:635.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:635.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17px; left:558.3px; top:635.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:635.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:635.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:635.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.6px; left:67.2px; top:670.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:671.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:17.6px; left:67.2px; top:669.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:669.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:669.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17.6px; left:558.3px; top:669.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:669.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:669.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:669.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:704.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:705.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:720.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:720.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:720.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:738.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:740.4px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.2px; left:67.2px; top:772.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:774.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16px; left:67.2px; top:807.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:808.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:15.1px; height:17px; left:67.2px; top:806.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:806.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:806.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17px; left:558.3px; top:806.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:806.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:806.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:806.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:823.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:823.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:823.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17.1px; left:67.2px; top:840.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:842.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:857.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:857.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:859.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:857.9px; background-color:#000000; ">&nbsp;</div>
<div id="a48730" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a48732" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a48734" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a48736" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a48739" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">111 </div><div id="div_983_XBRL_TS_01982e62040e455d91f3e833421dec55" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_01982e62040e455d91f3e833421dec55" name="hsic:RedeemableNoncontrollingInterestsTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_0033ca7903d943c3a4a6d3e3e1dd9989" escape="true"><div id="TextBlockContainer984" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:688px;height:134px;"><div id="a48741" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 18 – Redeemable Noncontrolling Interests </div><div id="a48747" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a48748" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Some minority stockholders in certain of our subsidiaries have the right,<div style="display:inline-block;width:2px">&nbsp;</div>at certain times, to require us to acquire </div><div id="a48752" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">their ownership interest in those entities at fair value.<div style="display:inline-block;width:6px">&nbsp;</div>ASC 480-10 is applicable for noncontrolling interests where </div><div id="a48758" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">we are or may be required to purchase all or a portion of the outstanding<div style="display:inline-block;width:2px">&nbsp;</div>interest in a consolidated subsidiary from </div><div id="a48759" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">the noncontrolling interest holder under the terms of a put option<div style="display:inline-block;width:2px">&nbsp;</div>contained in contractual agreements.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a48763" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">components of the change in the redeemable noncontrolling interests for the<div style="display:inline-block;width:2px">&nbsp;</div>years ended December 31, 2022, </div><div id="a48768" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">December 25, 2021 and December 26, 2020 are presented in the following table:</div></div></ix:nonnumeric></div><div id="div_985_XBRL_TS_a1d9ebf3fc7949a9aec129be8565594d" style="position:absolute;left:63px;top:262px;float:left;"><ix:nonnumeric id="ID_909" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer988" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:210px;"><div id="div_986_XBRL_TS_0033ca7903d943c3a4a6d3e3e1dd9989" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_0033ca7903d943c3a4a6d3e3e1dd9989"><div id="TextBlockContainer987" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:210px;"><div id="a48774" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:0px;">December 31, </div><div id="a48777" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:509px;top:0px;">December 25, </div><div id="a48780" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:0px;">December 26, </div><div id="a48786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:14px;">2022 </div><div id="a48789" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:14px;">2021 </div><div id="a48792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:14px;">2020 </div><div id="a48794" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:29px;">Balance, beginning of period<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a48797" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:29px;">$ </div><div id="a48799" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:29px;"><ix:nonfraction id="ID_908A" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">613</ix:nonfraction></div><div id="a48802" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:29px;">$ </div><div id="a48804" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:29px;"><ix:nonfraction id="ID_1666" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">328</ix:nonfraction></div><div id="a48807" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:29px;">$ </div><div id="a48809" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:29px;"><ix:nonfraction id="ID_1667" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec28_2019_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">287</ix:nonfraction></div><div id="a48811" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:47px;">Decrease in redeemable noncontrolling interests due to acquisitions of </div><div id="a48812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:63px;">noncontrolling interests in subsidiaries </div><div id="a48816" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:63px;display:flex;">(<ix:nonfraction id="ID_894" name="us-gaap:TemporaryEquityEliminationAsPartofReorganization" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction>)</div><div id="a48820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:63px;display:flex;">(<ix:nonfraction id="ID_895" name="us-gaap:TemporaryEquityEliminationAsPartofReorganization" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">60</ix:nonfraction>)</div><div id="a48824" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:63px;display:flex;">(<ix:nonfraction id="ID_896" name="us-gaap:TemporaryEquityEliminationAsPartofReorganization" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">17</ix:nonfraction>)</div><div id="a48826" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:82px;">Increase in redeemable noncontrolling interests due to business </div><div id="a48827" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:98px;">acquisitions </div><div id="a48831" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:98px;"><ix:nonfraction id="ID_897" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction></div><div id="a48835" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:98px;"><ix:nonfraction id="ID_898" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">189</ix:nonfraction></div><div id="a48839" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:98px;"><ix:nonfraction id="ID_899" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">28</ix:nonfraction></div><div id="a48841" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:113px;">Net income attributable to redeemable noncontrolling interests </div><div id="a48845" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:113px;"><ix:nonfraction id="ID_900" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction></div><div id="a48849" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:113px;"><ix:nonfraction id="ID_901" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">23</ix:nonfraction></div><div id="a48853" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:113px;"><ix:nonfraction id="ID_902" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction></div><div id="a48855" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:128px;">Dividends declared<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a48859" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:128px;display:flex;">(<ix:nonfraction id="ID_903" name="hsic:RedeemableNoncontrollingDecreaseFromDistributionsByRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction>)</div><div id="a48863" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:128px;display:flex;">(<ix:nonfraction id="ID_904" name="hsic:RedeemableNoncontrollingDecreaseFromDistributionsByRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">21</ix:nonfraction>)</div><div id="a48867" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:128px;display:flex;">(<ix:nonfraction id="ID_905" name="hsic:RedeemableNoncontrollingDecreaseFromDistributionsByRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction>)</div><div id="a48869" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:147px;">Effect of foreign currency translation loss attributable to redeemable </div><div id="a48870" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:163px;">noncontrolling interests </div><div id="a48874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:163px;display:flex;">(<ix:nonfraction id="ID_66A" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction>)</div><div id="a48878" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:163px;display:flex;">(<ix:nonfraction id="ID_906A" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction>)</div><div id="a48882" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:163px;display:flex;">(<ix:nonfraction id="ID_907A" name="us-gaap:TemporaryEquityForeignCurrencyTranslationAdjustments" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a48884" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:178px;">Change in fair value of redeemable securities<div style="display:inline-block;width:8px">&nbsp;</div></div><div id="a48888" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:178px;display:flex;">(<ix:nonfraction id="ID_1376" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">4</ix:nonfraction>)</div><div id="a48892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:178px;"><ix:nonfraction id="ID_1377" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">160</ix:nonfraction></div><div id="a48896" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:178px;"><ix:nonfraction id="ID_1378" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">33</ix:nonfraction></div><div id="a48898" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:194px;">Balance, end of period<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a48901" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:194px;">$ </div><div id="a48903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:194px;"><ix:nonfraction id="ID_1668" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">576</ix:nonfraction></div><div id="a48906" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:194px;">$ </div><div id="a48908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:194px;"><ix:nonfraction id="ID_908AA" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">613</ix:nonfraction></div><div id="a48911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:194px;">$ </div><div id="a48913" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:194px;"><ix:nonfraction id="ID_1669" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">328</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_989_XBRL_CS_297deb95ae944f83b78196ba5e2a983b" style="position:absolute;left:62px;top:490px;float:left;"><ix:nonnumeric id="ID_297deb95ae944f83b78196ba5e2a983b" name="us-gaap:ComprehensiveIncomeNoteTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_3dfeb87c70da44a9b6e360ae011b1038" escape="true"><div id="TextBlockContainer990" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:686px;height:99px;"><div id="a48916" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 19 – Comprehensive Income </div><div id="a48922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a48923" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Comprehensive income includes certain gains and losses that, under U.S.<div style="display:inline-block;width:2px">&nbsp;</div>GAAP,<div style="display:inline-block;width:5px">&nbsp;</div>are excluded from net income as </div><div id="a48924" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">such amounts are recorded directly as an adjustment to stockholders’<div style="display:inline-block;width:2px">&nbsp;</div>equity.<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a48927" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:81px;">The following table summarizes our Accumulated other comprehensive loss, net of<div style="display:inline-block;width:2px">&nbsp;</div>applicable taxes as of:</div></div></ix:nonnumeric></div><div id="div_991_XBRL_CS_f0f955f27c934ea3b28c0f29630ca11e" style="position:absolute;left:63px;top:605px;float:left;"><ix:nonnumeric id="ID_381" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer994" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:254px;"><div id="div_992_XBRL_CS_3dfeb87c70da44a9b6e360ae011b1038" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_3dfeb87c70da44a9b6e360ae011b1038" continuedat="XBRL_CS_02813915c0fb47ec8422c0669e4dba99"><div id="TextBlockContainer993" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:254px;"><div id="a48935" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:0px;">December 31, </div><div id="a48938" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:509px;top:0px;">December 25, </div><div id="a48941" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:0px;">December 26, </div><div id="a48947" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:15px;">2022 </div><div id="a48950" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:15px;">2021 </div><div id="a48953" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:15px;">2020 </div><div id="a48955" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:32px;">Attributable to Redeemable noncontrolling interests: </div><div id="a48968" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:49px;">Foreign currency translation adjustment<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a48971" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:49px;">$ </div><div id="a48973" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:49px;display:flex;">(<ix:nonfraction id="ID_168" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToRedeemableNoncontrollingInterestNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">37</ix:nonfraction>)</div><div id="a48976" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:49px;">$ </div><div id="a48978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:49px;display:flex;">(<ix:nonfraction id="ID_451" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToRedeemableNoncontrollingInterestNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">31</ix:nonfraction>)</div><div id="a48981" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:49px;">$ </div><div id="a48983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:49px;display:flex;">(<ix:nonfraction id="ID_240" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToRedeemableNoncontrollingInterestNetOfTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">25</ix:nonfraction>)</div><div id="a48997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:84px;">Attributable to noncontrolling interests: </div><div id="a49010" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:101px;">Foreign currency translation adjustment<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49013" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:101px;">$ </div><div id="a49015" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:101px;display:flex;">(<ix:nonfraction id="ID_146" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToNonredeemableNoncontrollingInterestsNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">1</ix:nonfraction>)</div><div id="a49018" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:101px;">$ </div><div id="a49020" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:101px;"><ix:nonfraction id="ID_95" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToNonredeemableNoncontrollingInterestsNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49023" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:101px;">$ </div><div id="a49025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:101px;"><ix:nonfraction id="ID_346" name="hsic:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentAttributableToNonredeemableNoncontrollingInterestsNetOfTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49039" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:136px;">Attributable to Henry Schein, Inc.: </div><div id="a49051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:153px;">Foreign currency translation adjustment </div><div id="a49054" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:153px;">$ </div><div id="a49056" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:153px;display:flex;">(<ix:nonfraction id="ID_331" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">236</ix:nonfraction>)</div><div id="a49059" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:153px;">$ </div><div id="a49061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:153px;display:flex;">(<ix:nonfraction id="ID_319" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">155</ix:nonfraction>)</div><div id="a49064" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:153px;">$ </div><div id="a49066" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:153px;display:flex;">(<ix:nonfraction id="ID_28" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">77</ix:nonfraction>)</div><div id="a49069" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:170px;">Unrealized gain (loss) from foreign currency hedging activities<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:170px;"><ix:nonfraction id="ID_56" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">5</ix:nonfraction></div><div id="a49077" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:170px;display:flex;">(<ix:nonfraction id="ID_193" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a49081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:170px;display:flex;">(<ix:nonfraction id="ID_290" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">11</ix:nonfraction>)</div><div id="a49084" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:187px;">Pension adjustment loss<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:187px;display:flex;">(<ix:nonfraction id="ID_411" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction>)</div><div id="a49092" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:187px;display:flex;">(<ix:nonfraction id="ID_197" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">14</ix:nonfraction>)</div><div id="a49096" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:187px;display:flex;">(<ix:nonfraction id="ID_108" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">20</ix:nonfraction>)</div><div id="a49100" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:34px;top:204px;">Accumulated other comprehensive loss<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49103" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:204px;">$ </div><div id="a49105" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:204px;display:flex;">(<ix:nonfraction id="ID_169A" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">233</ix:nonfraction>)</div><div id="a49108" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:204px;">$ </div><div id="a49110" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:204px;display:flex;">(<ix:nonfraction id="ID_438A" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">171</ix:nonfraction>)</div><div id="a49113" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:204px;">$ </div><div id="a49115" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:204px;display:flex;">(<ix:nonfraction id="ID_461" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">108</ix:nonfraction>)</div><div id="a49129" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:238px;">Total Accumulated<div style="display:inline-block;width:5px">&nbsp;</div>other comprehensive loss<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49132" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:238px;">$ </div><div id="a49134" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:467px;top:238px;display:flex;">(<ix:nonfraction id="ID_223" name="hsic:AccumulatedOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableAndNonredeemableNoncontrollingInterests" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">271</ix:nonfraction>)</div><div id="a49137" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:238px;">$ </div><div id="a49139" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:238px;display:flex;">(<ix:nonfraction id="ID_300" name="hsic:AccumulatedOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableAndNonredeemableNoncontrollingInterests" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">202</ix:nonfraction>)</div><div id="a49142" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:238px;">$ </div><div id="a49144" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:657px;top:238px;display:flex;">(<ix:nonfraction id="ID_325" name="hsic:AccumulatedOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableAndNonredeemableNoncontrollingInterests" contextref="AS_OF_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">133</ix:nonfraction>)</div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page112" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:177px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:401.1px; height:16px; left:67.2px; top:176px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:175.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:175.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:558.3px; top:176px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:175.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:175.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:175.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:191.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:191.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:191.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:209px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:213.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19px; left:67.2px; top:250px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:253.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:401.1px; height:20px; left:67.2px; top:249px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:248.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:248.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:20px; left:558.3px; top:249px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:248.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:248.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:248.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:268.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:268.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:268.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:20px; left:67.2px; top:289px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:293.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.2px; left:67.2px; top:326.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:327.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:325.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:325.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:557.9px; top:325.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:325.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:325.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:325.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:342.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:342.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:342.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:17px; left:67.2px; top:360.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:361.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.1px; left:67.2px; top:395px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.4px; left:67.2px; top:395.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:393.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:393.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:557.9px; top:393.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:393.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:393.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:393.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:410.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:410.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:410.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:16.9px; left:67.2px; top:429.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15.2px; left:67.2px; top:430.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:401.1px; height:17.9px; left:67.2px; top:428.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:427.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:427.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:17.9px; left:558.3px; top:428.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:427.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:427.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:427.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:448.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:446.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:448.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:446.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:448.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:446.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14px; left:67.2px; top:684.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:391.1px; height:1px; left:66.8px; top:683.2px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:457.9px; top:683.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15px; left:548.3px; top:683.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:557.9px; top:683.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15px; left:648.3px; top:683.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:683.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:713.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:743.6px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.1px; left:67.2px; top:774.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:391.1px; height:1px; left:66.8px; top:773.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:457.9px; top:773.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15.1px; left:548.3px; top:773.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:90px; height:1px; left:557.9px; top:773.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:15.1px; left:648.3px; top:773.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:89.9px; height:1px; left:658px; top:773.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:457.4px; top:790.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:457.4px; top:788.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:557.4px; top:790.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:557.4px; top:788.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:657.4px; top:790.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:90.9px; height:1px; left:657.4px; top:788.8px; background-color:#000000; ">&nbsp;</div>
<div id="a49147" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a49149" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a49151" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a49153" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a49156" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">112 </div><div id="div_995_XBRL_CS_02813915c0fb47ec8422c0669e4dba99" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_CS_02813915c0fb47ec8422c0669e4dba99" continuedat="XBRL_CS_2868aa4222f54a9b81c9783cd5dbce06"><div id="TextBlockContainer996" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:658px;height:18px;"><div id="a49158" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes the components of comprehensive income, net of<div style="display:inline-block;width:2px">&nbsp;</div>applicable taxes as follows:</div></div></ix:continuation></div><div id="div_997_XBRL_CS_c3f12d78da9143f392c13a813ff6fcb4" style="position:absolute;left:63px;top:146px;float:left;"><ix:nonnumeric id="ID_73" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1000" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:301px;"><div id="div_998_XBRL_CS_2868aa4222f54a9b81c9783cd5dbce06" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_2868aa4222f54a9b81c9783cd5dbce06" continuedat="XBRL_CS_b3e736a65de943f4bc3bc8e7353e9e29"><div id="TextBlockContainer999" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:301px;"><div id="a49164" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:0px;">December 31, </div><div id="a49167" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:509px;top:0px;">December 25, </div><div id="a49170" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:0px;">December 26, </div><div id="a49174" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:15px;">2022 </div><div id="a49177" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:15px;">2021 </div><div id="a49180" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:15px;">2020 </div><div id="a49182" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Net income<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49185" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:31px;">$ </div><div id="a49187" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:31px;"><ix:nonfraction id="ID_885AAA" name="us-gaap:ProfitLoss" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">566</ix:nonfraction></div><div id="a49190" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:31px;">$ </div><div id="a49192" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:31px;"><ix:nonfraction id="ID_886AAA" name="us-gaap:ProfitLoss" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">660</ix:nonfraction></div><div id="a49195" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:31px;">$ </div><div id="a49197" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:31px;"><ix:nonfraction id="ID_887AAA" name="us-gaap:ProfitLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">420</ix:nonfraction></div><div id="a49209" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:68px;">Foreign currency translation gain (loss) </div><div id="a49213" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:68px;display:flex;">(<ix:nonfraction id="ID_409" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">88</ix:nonfraction>)</div><div id="a49217" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:68px;display:flex;">(<ix:nonfraction id="ID_242" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">84</ix:nonfraction>)</div><div id="a49221" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:68px;"><ix:nonfraction id="ID_291" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">63</ix:nonfraction></div><div id="a49223" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:88px;">Tax effect<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a49227" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:491px;top:88px;"><ix:nonfraction id="ID_161" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49231" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:88px;"><ix:nonfraction id="ID_353" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49235" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:88px;"><ix:nonfraction id="ID_423" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49237" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:108px;">Foreign currency translation gain (loss) </div><div id="a49241" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:473px;top:108px;display:flex;">(<ix:nonfraction id="ID_317A" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">88</ix:nonfraction>)</div><div id="a49245" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:568px;top:108px;display:flex;">(<ix:nonfraction id="ID_275A" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">84</ix:nonfraction>)</div><div id="a49249" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:108px;"><ix:nonfraction id="ID_310A" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">63</ix:nonfraction></div><div id="a49261" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:148px;">Unrealized gain (loss) from foreign currency hedging activities<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a49265" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:148px;"><ix:nonfraction id="ID_362" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a49269" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:148px;"><ix:nonfraction id="ID_13" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a49273" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:663px;top:148px;display:flex;">(<ix:nonfraction id="ID_0" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">10</ix:nonfraction>)</div><div id="a49275" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:165px;">Tax effect<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a49279" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:165px;display:flex;">(<ix:nonfraction id="ID_418A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a49283" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:165px;display:flex;">(<ix:nonfraction id="ID_352A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction>)</div><div id="a49287" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:165px;"><ix:nonfraction id="ID_61A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction></div><div id="a49289" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:182px;">Unrealized gain (loss) from foreign currency hedging activities<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a49293" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:489px;top:182px;"><ix:nonfraction id="ID_112A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a49297" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:182px;"><ix:nonfraction id="ID_400AA" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a49301" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:670px;top:182px;display:flex;">(<ix:nonfraction id="ID_43AA" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">7</ix:nonfraction>)</div><div id="a49313" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:216px;">Pension adjustment gain </div><div id="a49317" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:216px;"><ix:nonfraction id="ID_452" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">16</ix:nonfraction></div><div id="a49321" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:216px;"><ix:nonfraction id="ID_204" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">8</ix:nonfraction></div><div id="a49325" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:216px;"><ix:nonfraction id="ID_391" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49327" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:233px;">Tax effect<div style="display:inline-block;width:5px">&nbsp;</div></div><div id="a49331" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:480px;top:233px;display:flex;">(<ix:nonfraction id="ID_202A" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">4</ix:nonfraction>)</div><div id="a49335" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:575px;top:233px;display:flex;">(<ix:nonfraction id="ID_387A" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a49339" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:233px;"><ix:nonfraction id="ID_214" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49341" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:250px;">Pension adjustment gain </div><div id="a49345" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:250px;"><ix:nonfraction id="ID_404A" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">12</ix:nonfraction></div><div id="a49349" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:584px;top:250px;"><ix:nonfraction id="ID_226AA" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">6</ix:nonfraction></div><div id="a49353" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:250px;"><ix:nonfraction id="ID_68A" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:zerodash" scale="6">-</ix:nonfraction></div><div id="a49365" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:285px;">Comprehensive income<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49368" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:410px;top:285px;">$ </div><div id="a49370" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:285px;"><ix:nonfraction id="ID_186A" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">497</ix:nonfraction></div><div id="a49373" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:505px;top:285px;">$ </div><div id="a49375" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:571px;top:285px;"><ix:nonfraction id="ID_255A" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">591</ix:nonfraction></div><div id="a49378" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:601px;top:285px;">$ </div><div id="a49380" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:285px;"><ix:nonfraction id="ID_78A" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">476</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_1001_XBRL_CS_b3e736a65de943f4bc3bc8e7353e9e29" style="position:absolute;left:62px;top:466px;float:left;"><ix:continuation id="XBRL_CS_b3e736a65de943f4bc3bc8e7353e9e29" continuedat="XBRL_CS_a5e09a137e55463984e3eafcf2a57b6b"><div id="TextBlockContainer1002" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:119px;"><div id="a49383" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Our financial statements are denominated in the U.S. Dollar currency.<div style="display:inline-block;width:7px">&nbsp;</div>Fluctuations in the value of foreign </div><div id="a49386" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">currencies as compared to the U.S. Dollar may have a significant impact on our<div style="display:inline-block;width:2px">&nbsp;</div>comprehensive income.<div style="display:inline-block;width:7px">&nbsp;</div>The </div><div id="a49391" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">foreign currency translation gain (loss) during the years ended December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022, December 25, 2021 and </div><div id="a49395" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">December 26, 2020 was primarily due to changes in foreign currency exchange<div style="display:inline-block;width:2px">&nbsp;</div>rates of the Euro, British Pound, </div><div id="a49399" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:67px;">Australian Dollar, Brazilian Real, New Zealand Dollar and Canadian Dollar.<div style="display:inline-block;width:7px">&nbsp;</div>The foreign currency translation gain </div><div id="a49400" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:84px;">(loss) during the years ended December 31, 2022, December 25, 2021<div style="display:inline-block;width:2px">&nbsp;</div>and December 26, 2020 was primarily </div><div id="a49404" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:101px;">attributable to a net investment hedge that was entered into during 2019.</div></div></ix:continuation></div><div id="a49404_73_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:492px;top:567px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a49405" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:524px;top:567px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Note 11-Derivatives and Hedging </a></div><div id="a49408" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:584px;"><a href="#a41650" style="color:#0000FF;text-decoration:underline;">Activities</a></div><div id="a49409" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:584px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information. </div><div id="div_1003_XBRL_CS_a5e09a137e55463984e3eafcf2a57b6b" style="position:absolute;left:62px;top:618px;float:left;"><ix:continuation id="XBRL_CS_a5e09a137e55463984e3eafcf2a57b6b" continuedat="XBRL_CS_145fd55826ca483cb9fe85bc02a0eaa2"><div id="TextBlockContainer1004" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:599px;height:18px;"><div id="a49413" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The following table summarizes our total comprehensive income, net of<div style="display:inline-block;width:2px">&nbsp;</div>applicable taxes as follows:</div></div></ix:continuation></div><div id="div_1005_XBRL_CS_dadf1ee6c0404817be93f9f143ab92aa" style="position:absolute;left:63px;top:653px;float:left;"><ix:nonnumeric id="ID_443" name="hsic:TotalComprehensiveIncomeNetOfTaxTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1008" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:138px;"><div id="div_1006_XBRL_CS_145fd55826ca483cb9fe85bc02a0eaa2" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_145fd55826ca483cb9fe85bc02a0eaa2"><div id="TextBlockContainer1007" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:138px;"><div id="a49420" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:0px;">December 31, </div><div id="a49423" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:502px;top:0px;">December 25, </div><div id="a49426" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:602px;top:0px;">December 26, </div><div id="a49431" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:427px;top:15px;">2022 </div><div id="a49434" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:527px;top:15px;">2021 </div><div id="a49437" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:627px;top:15px;">2020 </div><div id="a49439" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:31px;">Comprehensive income attributable to </div><div id="a49451" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:46px;">Henry Schein, Inc.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49454" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:46px;">$ </div><div id="a49456" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:46px;"><ix:nonfraction id="ID_421A" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">476</ix:nonfraction></div><div id="a49459" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:46px;">$ </div><div id="a49461" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:46px;"><ix:nonfraction id="ID_268A" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">568</ix:nonfraction></div><div id="a49464" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:46px;">$ </div><div id="a49466" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:46px;"><ix:nonfraction id="ID_170A" name="us-gaap:ComprehensiveIncomeNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">463</ix:nonfraction></div><div id="a49468" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:61px;">Comprehensive income attributable to </div><div id="a49480" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:76px;">noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49484" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:479px;top:76px;"><ix:nonfraction id="ID_5" name="hsic:ComprehensiveIncomeAttributableToNoncontrollingInterestsExcludingComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a49488" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:579px;top:76px;"><ix:nonfraction id="ID_113" name="hsic:ComprehensiveIncomeAttributableToNoncontrollingInterestsExcludingComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a49492" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:679px;top:76px;"><ix:nonfraction id="ID_215" name="hsic:ComprehensiveIncomeAttributableToNoncontrollingInterestsExcludingComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">3</ix:nonfraction></div><div id="a49494" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:91px;">Comprehensive income attributable to </div><div id="a49506" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:106px;">Redeemable noncontrolling interests<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49510" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:472px;top:106px;"><ix:nonfraction id="ID_316" name="hsic:ComprehensiveIncomeNetOfTaxAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a49514" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:572px;top:106px;"><ix:nonfraction id="ID_132" name="hsic:ComprehensiveIncomeNetOfTaxAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">17</ix:nonfraction></div><div id="a49518" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:106px;"><ix:nonfraction id="ID_1" name="hsic:ComprehensiveIncomeNetOfTaxAttributableToRedeemableNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a49520" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:121px;">Comprehensive income<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a49523" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:396px;top:121px;">$ </div><div id="a49525" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:465px;top:121px;"><ix:nonfraction id="ID_186AA" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">497</ix:nonfraction></div><div id="a49528" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:496px;top:121px;">$ </div><div id="a49530" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:121px;"><ix:nonfraction id="ID_255AA" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">591</ix:nonfraction></div><div id="a49533" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:596px;top:121px;">$ </div><div id="a49535" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:121px;"><ix:nonfraction id="ID_78AA" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">476</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page113" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a49537" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a49539" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a49541" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a49543" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a49546" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">113 </div><div id="div_1009_XBRL_TS_67ab3d08a62d47c5bb2481626b35b564" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_67ab3d08a62d47c5bb2481626b35b564" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_09e63d8458704c8cbbd2f952154f10e3" escape="true"><div id="TextBlockContainer1010" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:696px;height:754px;"><div id="a49548" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 20 – Discontinued Operations </div><div id="a49554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:italic;color:#000000;left:5px;top:32px;">Animal Health Spin-off </div><div id="a49559" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:64px;">On February 7, 2019 (the “Distribution Date”), we completed the separation<div style="display:inline-block;width:2px">&nbsp;</div>(the “Separation”) and subsequent </div><div id="a49592" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:81px;">merger (“Merger”) of our animal health business (the “Henry Schein Animal Health Business”) with Direct<div style="display:inline-block;width:2px">&nbsp;</div>Vet </div><div id="a49625" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:98px;">Marketing, Inc. (d/b/a Vets First Choice, “Vets<div style="display:inline-block;width:6px">&nbsp;</div>First Choice”).<div style="display:inline-block;width:7px">&nbsp;</div>This was accomplished by a series of transactions </div><div id="a49662" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:115px;">among us, Vets<div style="display:inline-block;width:5px">&nbsp;</div>First Choice, Covetrus, Inc. (f/k/a HS Spinco, Inc. “Covetrus”), a<div style="display:inline-block;width:2px">&nbsp;</div>wholly owned subsidiary of ours </div><div id="a49698" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:132px;">prior to the Distribution Date, and HS Merger Sub, Inc., a wholly owned subsidiary<div style="display:inline-block;width:2px">&nbsp;</div>of Covetrus (“Merger </div><div id="a49733" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:149px;">Sub”).<div style="display:inline-block;width:7px">&nbsp;</div>In connection with the Separation, we contributed, assigned<div style="display:inline-block;width:2px">&nbsp;</div>and transferred to Covetrus certain applicable </div><div id="a49764" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:166px;">assets, liabilities and capital stock or other ownership interests relating<div style="display:inline-block;width:2px">&nbsp;</div>to the Henry Schein Animal Health </div><div id="a49796" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:183px;">Business.<div style="display:inline-block;width:7px">&nbsp;</div>On the Distribution Date, we received a tax-free distribution of $</div><div id="a49796_77_5" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:449px;top:183px;"><ix:nonfraction id="ID_466" name="us-gaap:ProceedsFromSaleOfInterestInCorporateUnit" contextref="FROM_Feb07_2019_TO_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_VetsFirstCorpMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1,120</ix:nonfraction></div><div id="a49796_82_35" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:482px;top:183px;"><div style="display:inline-block;width:4px">&nbsp;</div>million from Covetrus pursuant to </div><div id="a49833" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">certain debt financing incurred by Covetrus.<div style="display:inline-block;width:7px">&nbsp;</div>On the Distribution Date and prior to the Animal Health Spin-off, </div><div id="a49870" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:216px;">Covetrus issued shares of Covetrus common stock to certain institutional<div style="display:inline-block;width:2px">&nbsp;</div>accredited investors (the “Share Sale </div><div id="a49901" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:233px;">Investors”) for $</div><div id="a49901_17_3" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:233px;"><ix:nonfraction id="ID_467" name="us-gaap:ProceedsFromContributionsFromAffiliates" contextref="FROM_Feb07_2019_TO_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_VetsFirstCorpMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">361</ix:nonfraction></div><div id="a49901_20_87" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:124px;top:233px;"><div style="display:inline-block;width:4px">&nbsp;</div>million (the “Share Sale”).<div style="display:inline-block;width:7px">&nbsp;</div>The proceeds of the Share Sale were paid to Covetrus and </div><div id="a49938" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:250px;">distributed to us.<div style="display:inline-block;width:7px">&nbsp;</div>Subsequent to the Share Sale, we distributed, on a pro rata basis,<div style="display:inline-block;width:2px">&nbsp;</div>all of the shares of the common </div><div id="a49984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:267px;">stock of Covetrus held by us to our stockholders of record as of the close of<div style="display:inline-block;width:2px">&nbsp;</div>business on January 17, 2019 (the </div><div id="a50028" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:284px;">“Animal Health Spin-off”).<div style="display:inline-block;width:7px">&nbsp;</div>After the Share Sale and Animal Health Spin-off, Merger Sub consummated the </div><div id="a50063" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:301px;">Merger whereby it merged with and into Vets<div style="display:inline-block;width:5px">&nbsp;</div>First Choice, with Vets First Choice surviving the Merger as a </div><div id="a50102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:317px;">wholly owned subsidiary of Covetrus.<div style="display:inline-block;width:7px">&nbsp;</div>Immediately following the consummation of the Merger, on a fully diluted </div><div id="a50134" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:334px;">basis, (i) approximately </div><div id="a50134_25_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:148px;top:334px;"><ix:nonfraction id="ID_471" name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextref="AS_OF_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_VetsFirstCorpMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">63</ix:nonfraction></div><div id="a50134_27_84" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:162px;top:334px;">% of the shares of Covetrus common stock were (a) owned by our stockholders<div style="display:inline-block;width:2px">&nbsp;</div>and the </div><div id="a50172" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:351px;">Share Sale Investors, and (b) held by certain employees of the Henry Schein<div style="display:inline-block;width:2px">&nbsp;</div>Animal Health Business (in the form </div><div id="a50210" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:368px;">of certain equity awards), and (ii) approximately </div><div id="a50210_50_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:293px;top:368px;"><ix:nonfraction id="ID_472" name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextref="AS_OF_Feb07_2019_Entity_0001000228_dei_LegalEntityAxis_hsic_HenryScheinStockholdersAndTheShareSaleInvestorsMember_srt_OwnershipAxis_hsic_CovetrusIncMember_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="pure" decimals="4" format="ixt:numdotdecimal" scale="-2">37</ix:nonfraction></div><div id="a50210_52_59" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:308px;top:368px;">% of the shares of Covetrus common stock were (a) owned by </div><div id="a50249" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:385px;">stockholders of Vets<div style="display:inline-block;width:5px">&nbsp;</div>First Choice immediately prior to the Merger, and (b) held by certain employees of Vets First </div><div id="a50287" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:402px;">Choice (in the form of certain equity awards).<div style="display:inline-block;width:7px">&nbsp;</div>After the Separation and the Merger, we no longer beneficially </div><div id="a50325" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:419px;">owned any shares of Covetrus common stock and, following the Distribution<div style="display:inline-block;width:2px">&nbsp;</div>Date, will not consolidate the </div><div id="a50357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:436px;">financial results of Covetrus for the purpose of our financial reporting.<div style="display:inline-block;width:6px">&nbsp;</div>Following the Separation and the Merger, </div><div id="a50392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:452px;">Covetrus was an independent, publicly traded company on the Nasdaq Global Select<div style="display:inline-block;width:2px">&nbsp;</div>Market. </div><div id="a50419" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:485px;">In connection with the completion of the Animal Health Spin-off, we entered into<div style="display:inline-block;width:2px">&nbsp;</div>a transition services agreement, </div><div id="a50458" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:502px;">which ended in December 2020, with Covetrus under which we agreed to provide<div style="display:inline-block;width:2px">&nbsp;</div>certain transition services for up </div><div id="a50498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:518px;">to </div><div id="a50498_3_18" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:20px;top:518px;-sec-ix-hidden:ID_1732;">twenty-four months</div><div id="a50498_21_90" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:136px;top:518px;"><div style="display:inline-block;width:4px">&nbsp;</div>in areas such as information technology, finance and accounting, human resources, supply </div><div id="a50532" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:535px;">chain, and real estate and facility services.</div><div id="a50547" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:567px;">As a result of the Separation, the financial position and results of operations<div style="display:inline-block;width:2px">&nbsp;</div>of the Henry Schein Animal Health </div><div id="a50585" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:584px;">Business are presented as discontinued operations and have been excluded<div style="display:inline-block;width:2px">&nbsp;</div>from continuing operations and segment </div><div id="a50615" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:601px;">results for all periods presented.<div style="display:inline-block;width:7px">&nbsp;</div>The accompanying notes to the consolidated financial<div style="display:inline-block;width:2px">&nbsp;</div>statements have been </div><div id="a50646" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:618px;">revised to reflect the effect of the Separation and all prior year balances have been<div style="display:inline-block;width:2px">&nbsp;</div>revised accordingly to reflect </div><div id="a50684" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:635px;">continuing operations only.<div style="display:inline-block;width:8px">&nbsp;</div>The historical statements of Comprehensive Income (Loss) and Shareholders'<div style="display:inline-block;width:2px">&nbsp;</div>Equity </div><div id="a50710" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:652px;">have not been revised to reflect the Separation and instead reflect the Separation<div style="display:inline-block;width:2px">&nbsp;</div>as an adjustment to the balances at </div><div id="a50751" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:669px;">December 26, 2020. </div><div id="a50758" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:702px;">In February 2019, we completed the Animal Health Spin-off.<div style="display:inline-block;width:6px">&nbsp;</div>During the year ended December 26, 2020, we </div><div id="a50761" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:719px;">incurred $</div><div id="a50761_10_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:65px;top:719px;"><ix:nonfraction id="ID_1238" name="hsic:TransactionCostsRelatedToBusinessSegmentSpinOff" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">0</ix:nonfraction></div><div id="a50761_11_109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:72px;top:719px;"><div style="display:inline-block;width:4px">&nbsp;</div>million in transaction costs associated with this transaction.<div style="display:inline-block;width:6px">&nbsp;</div>All transaction costs related to the Animal </div><div id="a50763" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:736px;">Health Spin-off have been included in results from discontinued operations.</div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page114" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:109px; height:1px; left:641px; top:160.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:109px; height:1px; left:641px; top:192.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:539.8px; height:15.4px; left:69.9px; top:209.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:38.1px; height:15.4px; left:612.3px; top:209.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:16px; left:67.2px; top:209.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.7px; height:15.4px; left:652.9px; top:209.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:539.8px; height:15.4px; left:69.9px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:38.1px; height:15.4px; left:612.3px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:16px; left:67.2px; top:241.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.7px; height:15.4px; left:652.9px; top:241.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:539.8px; height:15.4px; left:69.9px; top:273.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:38.1px; height:15.4px; left:612.3px; top:273.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:683.2px; height:16px; left:67.2px; top:273.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:94.7px; height:15.4px; left:652.9px; top:273.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:274.9px; height:1px; left:473px; top:604.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.7px; left:67.2px; top:635.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:633.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:633.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.7px; left:558.3px; top:634.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:633.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:633.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:633.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:14.7px; left:67.2px; top:663.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:678.3px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:695.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:693.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:695.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:693.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:695.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:693.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:274.9px; height:1px; left:473px; top:778.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.7px; left:67.2px; top:809.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:808.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:808.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.7px; left:558.3px; top:808.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:808.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:808.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:808.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:15px; left:67.2px; top:839.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:401.1px; height:16px; left:67.2px; top:838.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:406.2px; height:1px; left:66.8px; top:837.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:473px; top:837.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:16px; left:558.3px; top:838.1px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85.2px; height:1px; left:567.9px; top:837.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:1px; left:653px; top:837.7px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:85px; height:1px; left:662.9px; top:837.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:856.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:472.4px; top:854.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:856.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:86.1px; height:1px; left:567.3px; top:854.2px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:856.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:85.9px; height:1px; left:662.4px; top:854.2px; background-color:#000000; ">&nbsp;</div>
<div id="a50767" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a50769" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a50771" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a50773" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a50776" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">114 </div><div id="div_1011_XBRL_TS_09e63d8458704c8cbbd2f952154f10e3" style="position:absolute;left:62px;top:112px;float:left;"><ix:continuation id="XBRL_TS_09e63d8458704c8cbbd2f952154f10e3" continuedat="XBRL_TS_3617895780a7406b835b1fafb86accce"><div id="TextBlockContainer1012" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:481px;height:18px;"><div id="a50778" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">Summarized financial information for our discontinued operations<div style="display:inline-block;width:2px">&nbsp;</div>is as follows:</div></div></ix:continuation></div><div id="div_1013_XBRL_TS_cf4a7028cc3b4482807bde73525612e6" style="position:absolute;left:65px;top:146px;float:left;"><ix:nonnumeric id="ID_468" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1016" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:687px;height:143px;"><div id="div_1014_XBRL_TS_3617895780a7406b835b1fafb86accce" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_3617895780a7406b835b1fafb86accce" continuedat="XBRL_TS_6b4979dcd7ba4b60a3718263407238c5"><div id="TextBlockContainer1015" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:687px;height:143px;"><div id="a50786" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:596px;top:0px;">Year<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a50792" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:591px;top:16px;">December 26, </div><div id="a50798" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:617px;top:32px;">2020 </div><div id="a50806" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:64px;">Selling, general and administrative </div><div id="a50812" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:64px;"><ix:nonfraction id="ID_830" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">2</ix:nonfraction></div><div id="a50814" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:80px;">Operating loss<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a50820" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:80px;display:flex;">(<ix:nonfraction id="ID_469" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">2</ix:nonfraction>)</div><div id="a50822" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:96px;">Income tax benefit </div><div id="a50828" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:96px;display:flex;">(<ix:nonfraction id="ID_470" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">3</ix:nonfraction>)</div><div id="a50830" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:112px;">Income from discontinued operations<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a50836" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:112px;"><ix:nonfraction id="ID_1416" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div><div id="a50838" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:128px;">Net income from discontinued operations attributable to Henry Schein,<div style="display:inline-block;width:5px">&nbsp;</div>Inc.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a50844" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:675px;top:128px;"><ix:nonfraction id="ID_1417" name="us-gaap:NetIncomeLoss" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_DisposalGroupClassificationAxis_hsic_AnimalHealthMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">1</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_1017_XBRL_TS_6b4979dcd7ba4b60a3718263407238c5" style="position:absolute;left:62px;top:306px;float:left;"><ix:continuation id="XBRL_TS_6b4979dcd7ba4b60a3718263407238c5" continuedat="XBRL_TS_72a7c915e7b4449dab62212d37e37867"><div id="TextBlockContainer1018" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:683px;height:34px;"><div id="a50847" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The operating loss from discontinued operations for the year ended<div style="display:inline-block;width:2px">&nbsp;</div>December 26, 2020 was primarily attributable </div><div id="a50848" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">to costs directly related to the Animal Health Spin-off.</div></div></ix:continuation></div><div id="a50848_56_6" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:387px;top:323px;"><div style="display:inline-block;width:7px">&nbsp;</div>See </div><div id="a50852" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:419px;top:323px;"><a href="#a51119" style="color:#0000FF;text-decoration:underline;">Note 23 – Related Party Transactions</a></div><div id="a50856" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:639px;top:323px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional </div><div id="a50858" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:340px;">information. </div><div id="div_1019_XBRL_TS_72a7c915e7b4449dab62212d37e37867" style="position:absolute;left:62px;top:374px;float:left;"><ix:continuation id="XBRL_TS_72a7c915e7b4449dab62212d37e37867"><div id="TextBlockContainer1020" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:691px;height:52px;"><div id="a50861" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The net income from discontinued operations for the year ended December<div style="display:inline-block;width:2px">&nbsp;</div>26, 2020 was primarily attributable to a </div><div id="a50862" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">reduction in a liability for tax indemnification and a tax refund received<div style="display:inline-block;width:2px">&nbsp;</div>during 2020 by a holding company </div><div id="a50864" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">previously part of our Animal Health legal structure and other<div style="display:inline-block;width:2px">&nbsp;</div>favorable tax resolutions.</div></div></ix:continuation></div><div id="div_1021_XBRL_TS_442a17fa569f4c229634230f5cab2d04" style="position:absolute;left:62px;top:441px;float:left;"><ix:nonnumeric id="ID_442a17fa569f4c229634230f5cab2d04" name="us-gaap:EarningsPerShareTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_0159659ff34945359956f691bf23f480" escape="true"><div id="TextBlockContainer1022" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:695px;height:132px;"><div id="a50867" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 21 – Earnings Per Share<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a50874" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a50875" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Basic earnings per share is computed by dividing net income attributable<div style="display:inline-block;width:2px">&nbsp;</div>to Henry Schein, Inc. by the weighted-</div><div id="a50877" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">average number of common shares outstanding for the period.<div style="display:inline-block;width:6px">&nbsp;</div>Our diluted earnings per share is computed similarly </div><div id="a50880" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:66px;">to basic earnings per share, except that it reflects the effect of common shares issuable<div style="display:inline-block;width:2px">&nbsp;</div>for presently unvested RSUs </div><div id="a50882" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">and upon exercise of stock options using the treasury stock method<div style="display:inline-block;width:2px">&nbsp;</div>in periods in which they have a dilutive effect. </div><div id="a50885" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:115px;">A reconciliation of shares used in calculating earnings per basic and diluted<div style="display:inline-block;width:2px">&nbsp;</div>share follows:</div></div></ix:nonnumeric></div><div id="div_1023_XBRL_CS_c0a7e38e464e4b20a13212466c399045" style="position:absolute;left:63px;top:590px;float:left;"><ix:nonnumeric id="ID_363" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1026" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:106px;"><div id="div_1024_XBRL_CS_0159659ff34945359956f691bf23f480" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_CS_0159659ff34945359956f691bf23f480" continuedat="XBRL_TS_9dd3c2a2f77f4fb8a1705c080f4a7abd"><div id="TextBlockContainer1025" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:106px;"><div id="a50892" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:511px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a50897" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:16px;">December 31, </div><div id="a50900" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:509px;top:16px;">December 25, </div><div id="a50903" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:16px;">December 26, </div><div id="a50908" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:30px;">2022 </div><div id="a50911" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:30px;">2021 </div><div id="a50914" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:30px;">2020 </div><div id="a50916" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:45px;">Basic<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a50919" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:45px;"><ix:nonfraction id="ID_263A" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">136,064,221</ix:nonfraction></div><div id="a50922" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:45px;"><ix:nonfraction id="ID_96A" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">140,090,889</ix:nonfraction></div><div id="a50925" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:45px;"><ix:nonfraction id="ID_269A" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">142,504,193</ix:nonfraction></div><div id="a50927" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:59px;">Effect of dilutive securities: </div><div id="a50936" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:74px;">Stock options and restricted stock units<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a50939" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:442px;top:74px;"><ix:nonfraction id="ID_342" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,691,449</ix:nonfraction></div><div id="a50942" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:537px;top:74px;"><ix:nonfraction id="ID_412" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">1,681,892</ix:nonfraction></div><div id="a50945" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:642px;top:74px;"><ix:nonfraction id="ID_165" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">899,489</ix:nonfraction></div><div id="a50948" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:89px;">Diluted<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a50951" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:429px;top:89px;"><ix:nonfraction id="ID_368A" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">137,755,670</ix:nonfraction></div><div id="a50954" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:524px;top:89px;"><ix:nonfraction id="ID_426A" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">141,772,781</ix:nonfraction></div><div id="a50957" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:619px;top:89px;"><ix:nonfraction id="ID_155A" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="0" format="ixt:numdotdecimal">143,403,682</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div><div id="div_1027_XBRL_TS_9dd3c2a2f77f4fb8a1705c080f4a7abd" style="position:absolute;left:62px;top:714px;float:left;"><ix:continuation id="XBRL_TS_9dd3c2a2f77f4fb8a1705c080f4a7abd" continuedat="XBRL_TS_1c3af52fdbea4580a04148baf09de17a"><div id="TextBlockContainer1028" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:690px;height:35px;"><div id="a50960" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">The number of antidilutive securities that were excluded from the calculation<div style="display:inline-block;width:2px">&nbsp;</div>of diluted weighted average common </div><div id="a50961" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">shares outstanding are as follows:</div></div></ix:continuation></div><div id="div_1029_XBRL_TS_ffcde27f8cc14ac0911280e248a22d7d" style="position:absolute;left:63px;top:764px;float:left;"><ix:nonnumeric id="ID_1714" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1032" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:90px;"><div id="div_1030_XBRL_TS_1c3af52fdbea4580a04148baf09de17a" style="position:absolute;left:0px;top:0px;float:left;"><ix:continuation id="XBRL_TS_1c3af52fdbea4580a04148baf09de17a"><div id="TextBlockContainer1031" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:691px;height:90px;"><div id="a50967" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:511px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>Ended </div><div id="a50972" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:414px;top:16px;">December 31, </div><div id="a50975" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:509px;top:16px;">December 25, </div><div id="a50978" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:604px;top:16px;">December 26, </div><div id="a50983" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:440px;top:30px;">2022 </div><div id="a50986" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:535px;top:30px;">2021 </div><div id="a50989" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:630px;top:30px;">2020 </div><div id="a50991" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:45px;">Stock options </div><div id="a50994" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:45px;"><ix:nonfraction id="ID_1670" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">342,716</ix:nonfraction></div><div id="a50997" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:45px;"><ix:nonfraction id="ID_1671" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">611,869</ix:nonfraction></div><div id="a51000" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:681px;top:45px;"><ix:nonfraction id="ID_1672" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitref="shares" decimals="INF" format="ixt:zerodash">-</ix:nonfraction></div><div id="a51002" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:59px;">Restricted stock units </div><div id="a51005" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:459px;top:59px;"><ix:nonfraction id="ID_1673" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">19,466</ix:nonfraction></div><div id="a51008" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:560px;top:59px;"><ix:nonfraction id="ID_1674" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">1,048</ix:nonfraction></div><div id="a51011" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:59px;"><ix:nonfraction id="ID_1675" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_hsic_RestrictedStockAndRestrictedStockUnitAwardsMember" unitref="shares" decimals="INF" format="ixt:numdotdecimal">2,398</ix:nonfraction></div><div id="a51014" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:19px;top:75px;">Total anti-dilutive<div style="display:inline-block;width:5px">&nbsp;</div>securities excluded from EPS computation </div><div id="a51019" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:75px;"><ix:nonfraction id="ID_1676" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">362,182</ix:nonfraction></div><div id="a51022" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:547px;top:75px;"><ix:nonfraction id="ID_1677" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">612,917</ix:nonfraction></div><div id="a51025" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:655px;top:75px;"><ix:nonfraction id="ID_1678" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="shares" decimals="INF" format="ixt:numdotdecimal">2,398</ix:nonfraction></div></div></ix:continuation></div></div></ix:nonnumeric></div></div>
</div>
<div style="padding: 7px">
<div id="Page115" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:320px; height:1px; left:427.9px; top:191.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:13.9px; left:67.2px; top:222.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:14.9px; left:67.2px; top:221.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:361.1px; height:1px; left:66.8px; top:221.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:427.9px; top:221.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:10.1px; height:14.9px; left:528.3px; top:221.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:537.9px; top:221.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:14.9px; left:638.4px; top:221.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:100px; height:1px; left:647.9px; top:221.5px; background-color:#000000; ">&nbsp;</div>
<div id="a51027" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a51029" style="position:absolute;font-family:'Times New Roman';font-size:18.72px;font-weight:bold;left:312px;top:45px;">HENRY SCHEIN, INC.</div><div id="a51031" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:232px;top:66px;">NOTES TO CONSOLIDATED<div style="display:inline-block;width:5px">&nbsp;</div>FINANCIAL STATEMENTS </div><div id="a51033" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:280px;top:81px;">(in millions, except share and per share data) </div><div id="a51036" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">115 </div><div id="div_1033_XBRL_CS_12f4a1cb5f08451291cdf320d7fa9598" style="position:absolute;left:62px;top:112px;float:left;"><ix:nonnumeric id="ID_12f4a1cb5f08451291cdf320d7fa9598" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_CS_5da17abfaa754a14be654b7e5625474f" escape="true"><div id="TextBlockContainer1034" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:321px;height:50px;"><div id="a51038" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 22 – Supplemental Cash Flow Information<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a51044" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a51045" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">Cash paid for interest and income taxes was:</div></div></ix:nonnumeric></div><div id="a51045_44_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:329px;top:144px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="div_1035_XBRL_CS_5da17abfaa754a14be654b7e5625474f" style="position:absolute;left:63px;top:178px;float:left;"><ix:continuation id="XBRL_CS_5da17abfaa754a14be654b7e5625474f" continuedat="XBRL_TS_5b663773a3dd4da784e764d23e3aed5c"><div id="TextBlockContainer1038" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:75px;"><div id="div_1036_XBRL_CS_47ee48f7d91a424c94b70dc475ac0e0a" style="position:absolute;left:0px;top:0px;float:left;"><ix:nonnumeric id="ID_8" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" escape="true"><div id="TextBlockContainer1037" style="position:relative;font-family:'Times New Roman';font-size:13.28px;color:#000000;line-height:normal;width:688px;height:75px;"><div id="a51051" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:490px;top:0px;">Years<div style="display:inline-block;width:5px">&nbsp;</div>ended </div><div id="a51055" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:377px;top:16px;">December 31, </div><div id="a51058" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:487px;top:16px;">December 25, </div><div id="a51061" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:597px;top:16px;">December 26, </div><div id="a51065" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:402px;top:30px;">2022 </div><div id="a51068" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:512px;top:30px;">2021 </div><div id="a51071" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:622px;top:30px;">2020 </div><div id="a51073" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:45px;">Interest<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a51076" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:365px;top:45px;">$ </div><div id="a51078" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:452px;top:45px;"><ix:nonfraction id="ID_63" name="us-gaap:InterestPaidNet" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">47</ix:nonfraction></div><div id="a51081" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:476px;top:45px;">$ </div><div id="a51083" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:562px;top:45px;"><ix:nonfraction id="ID_824" name="us-gaap:InterestPaidNet" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">29</ix:nonfraction></div><div id="a51086" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:586px;top:45px;">$ </div><div id="a51088" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:672px;top:45px;"><ix:nonfraction id="ID_105" name="us-gaap:InterestPaidNet" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">43</ix:nonfraction></div><div id="a51090" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:4px;top:59px;">Income taxes<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a51094" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:445px;top:59px;"><ix:nonfraction id="ID_322" name="us-gaap:IncomeTaxesPaid" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">265</ix:nonfraction></div><div id="a51098" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:555px;top:59px;"><ix:nonfraction id="ID_825" name="us-gaap:IncomeTaxesPaid" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">242</ix:nonfraction></div><div id="a51102" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:666px;top:59px;"><ix:nonfraction id="ID_441" name="us-gaap:IncomeTaxesPaid" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">207</ix:nonfraction></div></div></ix:nonnumeric></div></div></ix:continuation></div><div id="div_1039_XBRL_TS_5b663773a3dd4da784e764d23e3aed5c" style="position:absolute;left:62px;top:269px;float:left;"><ix:continuation id="XBRL_TS_5b663773a3dd4da784e764d23e3aed5c"><div id="TextBlockContainer1040" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:677px;height:51px;"><div id="a51105" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">For the years ended December 31, 2022, December 25, 2021 and December<div style="display:inline-block;width:2px">&nbsp;</div>26, 2020, we had $</div><div id="a51105_88_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:566px;top:0px;"><ix:nonfraction id="ID_362A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">10</ix:nonfraction></div><div id="a51105_90_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:581px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a51105_101_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:0px;"><ix:nonfraction id="ID_13A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a51106" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">million and $</div><div id="a51106_13_4" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:83px;top:17px;display:flex;">(<ix:nonfraction id="ID_0A" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">10</ix:nonfraction>)</div><div id="a51106_17_99" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:108px;top:17px;"><div style="display:inline-block;width:4px">&nbsp;</div>million of non-cash net unrealized gains (losses) related to foreign<div style="display:inline-block;width:2px">&nbsp;</div>currency hedging activities, </div><div id="a51111" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">respectively.</div></div></ix:continuation></div><div id="div_1041_XBRL_TS_179c7bea034e4a859ae8b2d52c3aec05" style="position:absolute;left:62px;top:336px;float:left;"><ix:nonnumeric id="ID_179c7bea034e4a859ae8b2d52c3aec05" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228" continuedat="XBRL_TS_b9e1ba8ddafb4ef3a22756ec7e9f00ec" escape="true"><div id="TextBlockContainer1042" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:684px;height:100px;"><div id="a51114" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Note 23 – Related Party Transactions </div><div id="a51119" style="position:absolute;font-family:'Times New Roman';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:17px;">&nbsp;</div><div id="a51120" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:32px;">In connection with the completion of the Animal Health Spin-off during our 2019<div style="display:inline-block;width:2px">&nbsp;</div>fiscal year, we entered into a </div><div id="a51160" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:49px;">transition services agreement with Covetrus under which we agreed to provide<div style="display:inline-block;width:2px">&nbsp;</div>certain transition services for up to </div><div id="a51194" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:5px;top:66px;-sec-ix-hidden:ID_1732A;">twenty-four months</div><div id="a51194_18_90" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:121px;top:66px;"><div style="display:inline-block;width:4px">&nbsp;</div>in areas such as information technology, finance and accounting, human resources, supply </div><div id="a51225" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">chain, and real estate and facility services.</div></div></ix:nonnumeric></div><div id="a51225_45_7" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:315px;top:419px;"><div style="display:inline-block;width:7px">&nbsp;</div>(see </div><div id="a51241" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:350px;top:419px;"><a href="#a49559" style="color:#0000FF;text-decoration:underline;">Note 20 – Discontinued Operations</a></div><div id="a51250" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:557px;top:419px;"><div style="display:inline-block;width:4px">&nbsp;</div>for additional details).<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="div_1043_XBRL_TS_b9e1ba8ddafb4ef3a22756ec7e9f00ec" style="position:absolute;left:62px;top:453px;float:left;"><ix:continuation id="XBRL_TS_b9e1ba8ddafb4ef3a22756ec7e9f00ec"><div id="TextBlockContainer1044" style="position:relative;font-family:'Times New Roman';font-size:14.72px;color:#000000;line-height:normal;width:694px;height:387px;"><div id="a51260" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">For the year ended December 26, 2020, we recorded approximately $</div><div id="a51260_65_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:413px;top:0px;"><ix:nonfraction id="ID_831" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">13</ix:nonfraction></div><div id="a51260_67_47" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:427px;top:0px;"><div style="display:inline-block;width:4px">&nbsp;</div>million of fees for these services.<div style="display:inline-block;width:7px">&nbsp;</div>Pursuant </div><div id="a51301" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:17px;">to the transition services agreement, Covetrus purchased<div style="display:inline-block;width:3px">&nbsp;</div>certain products from us.<div style="display:inline-block;width:7px">&nbsp;</div>During the year December 26, </div><div id="a51334" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:34px;">2020, net sales to Covetrus under the transition services agreement were<div style="display:inline-block;width:2px">&nbsp;</div>approximately $</div><div id="a51334_88_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:529px;top:34px;"><ix:nonfraction id="ID_1661" name="us-gaap:RevenueFromRelatedParties" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_CovetrusIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">75</ix:nonfraction></div><div id="a51334_90_20" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:543px;top:34px;"><div style="display:inline-block;width:4px">&nbsp;</div>million.<div style="display:inline-block;width:7px">&nbsp;</div>Sales to </div><div id="a51369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:51px;">Covetrus under the transition services agreement ended in December 2020. </div><div id="a51392" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:83px;">In connection with the formation of Henry Schein One, LLC, our joint venture<div style="display:inline-block;width:2px">&nbsp;</div>with Internet Brands, which was </div><div id="a51428" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:100px;">formed on July 1, 2018, we entered into a </div><div id="a51428_42_8" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:253px;top:100px;-sec-ix-hidden:ID_1733;">ten-year</div><div id="a51428_50_60" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:301px;top:100px;"><div style="display:inline-block;width:4px">&nbsp;</div>royalty agreement with Internet Brands whereby we will pay </div><div id="a51468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:117px;">Internet Brands approximately $</div><div id="a51468_31_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:195px;top:117px;"><ix:nonfraction id="ID_1159" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_srt_StatementScenarioAxis_us-gaap_ScenarioPlanMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a51468_33_80" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:210px;top:117px;"><div style="display:inline-block;width:4px">&nbsp;</div>million annually for the use of their intellectual property.<div style="display:inline-block;width:7px">&nbsp;</div>During the years </div><div id="a51501" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:133px;">ended December 31, 2022, December 25, 2021 and December 26, 2020, we recorded<div style="display:inline-block;width:2px">&nbsp;</div>$</div><div id="a51501_79_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:516px;top:133px;"><ix:nonfraction id="ID_1160" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a51501_81_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:531px;top:133px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a51501_92_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:591px;top:133px;"><ix:nonfraction id="ID_1161" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a51501_94_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:606px;top:133px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and </div><div id="a51538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:150px;">$</div><div id="a51538_1_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:150px;"><ix:nonfraction id="ID_1162" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_RoyaltyAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">31</ix:nonfraction></div><div id="a51538_3_112" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:27px;top:150px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively in connection with costs related to this royalty<div style="display:inline-block;width:2px">&nbsp;</div>agreement.<div style="display:inline-block;width:7px">&nbsp;</div>As of December 31, 2022 and </div><div id="a51575" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:167px;">December 25, 2021, Henry Schein One, LLC had a net receivable (payable)<div style="display:inline-block;width:2px">&nbsp;</div>balance from (to) Internet Brands of </div><div id="a51611" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">($</div><div id="a51611_2_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:17px;top:184px;"><ix:nonfraction id="ID_1734" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextref="AS_OF_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6" sign="-">8</ix:nonfraction></div><div id="a51611_3_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:25px;top:184px;">) million and $</div><div id="a51611_18_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:111px;top:184px;"><ix:nonfraction id="ID_1735" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" contextref="AS_OF_Dec25_2021_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_hsic_InternetBrandsIncMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a51611_19_94" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:119px;top:184px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, respectively, comprised of amounts related to results of operations and the royalty </div><div id="a51645" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:201px;">agreement.<div style="display:inline-block;width:7px">&nbsp;</div>The components of this receivable and payable are recorded within<div style="display:inline-block;width:2px">&nbsp;</div>prepaid expenses and other; and </div><div id="a51677" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:218px;">accrued expenses: other, respectively, within our consolidated balance sheets. </div><div id="a51696" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:252px;">During our normal course of business, we have interests in entities that we<div style="display:inline-block;width:2px">&nbsp;</div>account for under the equity accounting </div><div id="a51734" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:268px;">method.<div style="display:inline-block;width:7px">&nbsp;</div>During the years ended December 31, 2022, December<div style="display:inline-block;width:2px">&nbsp;</div>25, 2021 and December 26, 2020, we recorded net </div><div id="a51770" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:285px;">sales of $</div><div id="a51770_10_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:60px;top:285px;"><ix:nonfraction id="ID_1163" name="us-gaap:RevenueFromRelatedParties" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">46</ix:nonfraction></div><div id="a51770_12_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:75px;top:285px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a51770_23_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:136px;top:285px;"><ix:nonfraction id="ID_1164" name="us-gaap:RevenueFromRelatedParties" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">48</ix:nonfraction></div><div id="a51770_25_15" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:151px;top:285px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, and $</div><div id="a51770_40_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:236px;top:285px;"><ix:nonfraction id="ID_1165" name="us-gaap:RevenueFromRelatedParties" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">38</ix:nonfraction></div><div id="a51770_42_75" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:251px;top:285px;"><div style="display:inline-block;width:4px">&nbsp;</div>respectively, to such entities.<div style="display:inline-block;width:8px">&nbsp;</div>During our fiscal years ended 2022, 2021 </div><div id="a51810" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:302px;">and 2020, we purchased $</div><div id="a51810_24_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:158px;top:302px;"><ix:nonfraction id="ID_1166" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextref="FROM_Dec26_2021_TO_Dec31_2022_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">9</ix:nonfraction></div><div id="a51810_25_11" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:165px;top:302px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, $</div><div id="a51810_36_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:226px;top:302px;"><ix:nonfraction id="ID_1167" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextref="FROM_Dec27_2020_TO_Dec25_2021_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">15</ix:nonfraction></div><div id="a51810_38_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:240px;top:302px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a51810_52_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:322px;top:302px;"><ix:nonfraction id="ID_1168" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" contextref="FROM_Dec29_2019_TO_Dec26_2020_Entity_0001000228_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_EquityMethodInvesteeMember" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">12</ix:nonfraction></div><div id="a51810_54_60" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:337px;top:302px;"><div style="display:inline-block;width:4px">&nbsp;</div>million respectively, from such entities.<div style="display:inline-block;width:8px">&nbsp;</div>At December 31, </div><div id="a51850" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:319px;">2022 and December 25, 2021, we had in aggregate $</div><div id="a51850_49_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:314px;top:319px;"><ix:nonfraction id="ID_1169" name="us-gaap:DueFromRelatedParties" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">36</ix:nonfraction></div><div id="a51850_51_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:329px;top:319px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a51850_65_2" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:411px;top:319px;"><ix:nonfraction id="ID_1170" name="us-gaap:DueFromRelatedParties" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">44</ix:nonfraction></div><div id="a51850_67_46" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:425px;top:319px;"><div style="display:inline-block;width:4px">&nbsp;</div>million, due from our equity affiliates, and </div><div id="a51891" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:336px;">$</div><div id="a51891_1_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:12px;top:336px;"><ix:nonfraction id="ID_1171" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextref="AS_OF_Dec31_2022_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">6</ix:nonfraction></div><div id="a51891_2_14" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:20px;top:336px;"><div style="display:inline-block;width:4px">&nbsp;</div>million and $</div><div id="a51891_16_1" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:102px;top:336px;"><ix:nonfraction id="ID_1172" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" contextref="AS_OF_Dec25_2021_Entity_0001000228" unitref="USD" decimals="-6" format="ixt:numdotdecimal" scale="6">7</ix:nonfraction></div><div id="a51891_17_53" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:109px;top:336px;"><div style="display:inline-block;width:4px">&nbsp;</div>million due to our equity affiliates, respectively. </div><div id="a51914" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:370px;">Certain of our facilities related to our acquisitions are leased from employees<div style="display:inline-block;width:2px">&nbsp;</div>and minority shareholders.</div></div></ix:continuation></div><div id="a51914_106_13" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:680px;top:822px;"><div style="display:inline-block;width:7px">&nbsp;</div>Please see </div><div id="a51949" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;color:#0000FF;left:67px;top:839px;"><a href="#a39241" style="color:#0000FF;text-decoration:underline;">Note 6 – Leases</a></div><div id="a51953" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:161px;top:839px;"><div style="display:inline-block;width:4px">&nbsp;</div>for further information.</div></div>
</div>
<div style="padding: 7px">
<div id="Page116" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a51955" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a51958" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">116 </div><div id="a51960" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 9.<div style="display:inline-block;width:7px">&nbsp;</div>Changes in and Disagreements with Accountants on Accounting and<div style="display:inline-block;width:2px">&nbsp;</div>Financial Disclosure </div><div id="a51966" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:92px;">None. </div><div id="a51969" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:126px;">ITEM 9A.<div style="display:inline-block;width:7px">&nbsp;</div>Controls and Procedures </div><div id="a51972" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:159px;">Evaluation of Disclosure Controls and Procedures </div><div id="a51975" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:193px;">Under the supervision and with the participation of management, including<div style="display:inline-block;width:2px">&nbsp;</div>our principal executive officer and </div><div id="a51976" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:210px;">principal financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and </div><div id="a51977" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:227px;">procedures as of the end of the period covered by this annual report as<div style="display:inline-block;width:2px">&nbsp;</div>such term is defined in Rules 13a-15(e) and </div><div id="a51984" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:244px;">15d-15(e) promulgated under the Securities Exchange Act of 1934,<div style="display:inline-block;width:2px">&nbsp;</div>as amended (the “Exchange Act”).<div style="display:inline-block;width:7px">&nbsp;</div>Based on </div><div id="a51987" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:261px;">this evaluation, our management, including our principal executive officer and principal<div style="display:inline-block;width:2px">&nbsp;</div>financial officer, </div><div id="a51989" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:277px;">concluded that our disclosure controls and procedures were effective as of December 31,<div style="display:inline-block;width:2px">&nbsp;</div>2022, to ensure that all </div><div id="a51992" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:294px;">material information required to be disclosed by us in reports that we file<div style="display:inline-block;width:2px">&nbsp;</div>or submit under the Exchange Act is </div><div id="a51994" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:311px;">accumulated and communicated to them as appropriate to allow timely<div style="display:inline-block;width:2px">&nbsp;</div>decisions regarding required disclosure and </div><div id="a51995" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:328px;">that all such information is recorded, processed, summarized and reported<div style="display:inline-block;width:2px">&nbsp;</div>within the time periods specified in the </div><div id="a51996" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:345px;">SEC’s rules and forms.<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a52001" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:379px;">Changes in Internal Control over Financial Reporting</div><div id="a52004" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:412px;">The combination of acquisitions, continued acquisition integrations and systems<div style="display:inline-block;width:2px">&nbsp;</div>implementation activity </div><div id="a52005" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:429px;">undertaken during the quarter ended December 31, 2022 and carried over from<div style="display:inline-block;width:2px">&nbsp;</div>prior quarters when considered in </div><div id="a52029" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:446px;">the aggregate, does not represent a material change in our internal control over<div style="display:inline-block;width:2px">&nbsp;</div>financial reporting. </div><div id="a52061" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:480px;">Management’s<div style="display:inline-block;width:5px">&nbsp;</div>Report on Internal Control over Financial Reporting </div><div id="a52064" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:514px;">Our management is responsible for establishing and maintaining adequate<div style="display:inline-block;width:2px">&nbsp;</div>internal control over financial reporting, </div><div id="a52065" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:530px;">as such term is defined in Exchange Act Rule 13a-15(f).<div style="display:inline-block;width:6px">&nbsp;</div>Our internal control system is designed to provide </div><div id="a52070" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:547px;">reasonable assurance to our management and Board of Directors regarding the preparation<div style="display:inline-block;width:2px">&nbsp;</div>and fair presentation of </div><div id="a52072" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:564px;">published financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>Under the supervision and with the participation of our<div style="display:inline-block;width:2px">&nbsp;</div>management, including our </div><div id="a52073" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:581px;">principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our </div><div id="a52075" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:598px;">internal control over financial reporting based on the framework<div style="display:inline-block;width:2px">&nbsp;</div>in Internal Control-Integrated Framework (2013), </div><div id="a52078" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:615px;">updated and reissued by the Committee of Sponsoring Organizations, or the COSO<div style="display:inline-block;width:2px">&nbsp;</div>Framework.<div style="display:inline-block;width:7px">&nbsp;</div>Based on our </div><div id="a52080" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:632px;">evaluation under the COSO Framework, our management concluded that our<div style="display:inline-block;width:2px">&nbsp;</div>internal control over financial </div><div id="a52081" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:648px;">reporting was effective at a reasonable assurance level as of December 31, 2022. </div><div id="a52086" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:682px;">The effectiveness of our internal control over financial reporting as of December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022, has been independently </div><div id="a52090" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:699px;">audited by BDO USA, LLP, an independent registered public accounting firm, and their attestation is included </div><div id="a52091" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:716px;">herein. </div><div id="a52094" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-style:italic;left:67px;top:750px;">Limitations of the Effectiveness of Internal Control<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52097" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:784px;">A control system, no matter how well conceived and operated, can provide<div style="display:inline-block;width:2px">&nbsp;</div>only reasonable, not absolute, assurance </div><div id="a52099" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:800px;">that the objectives of the internal control system are met.<div style="display:inline-block;width:6px">&nbsp;</div>Because of the inherent limitations of any internal control </div><div id="a52100" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:817px;">system, no evaluation of controls can provide absolute assurance that all control<div style="display:inline-block;width:2px">&nbsp;</div>issues, if any, within a company </div><div id="a52102" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:834px;">have been detected. </div></div>
</div>
<div style="padding: 7px">
<div id="Page117" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a52104" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a52107" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">117 </div><div id="a52109" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">Report Of Independent Registered Public Accounting Firm </div><div id="a52131" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:84px;">Shareholders and Board of Directors </div><div id="a52135" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:101px;">Henry Schein, Inc.</div><div id="a52137" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:118px;">Melville, NY </div><div id="a52140" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:142px;">Opinion on Internal Control over Financial Reporting</div><div id="a52144" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:167px;">We<div style="display:inline-block;width:6px">&nbsp;</div>have audited Henry<div style="display:inline-block;width:6px">&nbsp;</div>Schein, Inc.’s<div style="display:inline-block;width:6px">&nbsp;</div>(the “Company’s”)<div style="display:inline-block;width:6px">&nbsp;</div>internal control over<div style="display:inline-block;width:6px">&nbsp;</div>financial reporting as<div style="display:inline-block;width:5px">&nbsp;</div>of December </div><div id="a52145" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:184px;">31, 2022, based on criteria established in Internal Control<div style="display:inline-block;width:5px">&nbsp;</div>– Integrated Framework (2013) (the “COSO criteria”). In </div><div id="a52154" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:201px;">our opinion, the<div style="display:inline-block;width:5px">&nbsp;</div>Company maintained, in all<div style="display:inline-block;width:5px">&nbsp;</div>material respects, effective<div style="display:inline-block;width:5px">&nbsp;</div>internal control over<div style="display:inline-block;width:5px">&nbsp;</div>financial reporting as </div><div id="a52156" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:218px;">of December 31, 2022, based on the COSO criteria.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52162" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:250px;">We<div style="display:inline-block;width:8px">&nbsp;</div>have<div style="display:inline-block;width:6px">&nbsp;</div>also<div style="display:inline-block;width:7px">&nbsp;</div>audited,<div style="display:inline-block;width:6px">&nbsp;</div>in<div style="display:inline-block;width:7px">&nbsp;</div>accordance<div style="display:inline-block;width:7px">&nbsp;</div>with<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>standards<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>Public<div style="display:inline-block;width:6px">&nbsp;</div>Company<div style="display:inline-block;width:7px">&nbsp;</div>Accounting<div style="display:inline-block;width:6px">&nbsp;</div>Oversight<div style="display:inline-block;width:6px">&nbsp;</div>Board </div><div id="a52166" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:267px;">(United<div style="display:inline-block;width:7px">&nbsp;</div>States)<div style="display:inline-block;width:7px">&nbsp;</div>(“PCAOB”),<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>consolidated<div style="display:inline-block;width:7px">&nbsp;</div>balance<div style="display:inline-block;width:7px">&nbsp;</div>sheets<div style="display:inline-block;width:7px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>the<div style="display:inline-block;width:7px">&nbsp;</div>Company<div style="display:inline-block;width:7px">&nbsp;</div>as<div style="display:inline-block;width:7px">&nbsp;</div>of<div style="display:inline-block;width:7px">&nbsp;</div>December<div style="display:inline-block;width:7px">&nbsp;</div>31,<div style="display:inline-block;width:7px">&nbsp;</div>2022<div style="display:inline-block;width:7px">&nbsp;</div>and </div><div id="a52172" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:284px;">December<div style="display:inline-block;width:5px">&nbsp;</div>25,<div style="display:inline-block;width:5px">&nbsp;</div>2021, the<div style="display:inline-block;width:6px">&nbsp;</div>related<div style="display:inline-block;width:5px">&nbsp;</div>consolidated statements<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>income, comprehensive<div style="display:inline-block;width:6px">&nbsp;</div>income, stockholders’<div style="display:inline-block;width:6px">&nbsp;</div>equity, </div><div id="a52177" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:301px;">and cash<div style="display:inline-block;width:6px">&nbsp;</div>flows for<div style="display:inline-block;width:6px">&nbsp;</div>each of<div style="display:inline-block;width:6px">&nbsp;</div>the three<div style="display:inline-block;width:6px">&nbsp;</div>years in<div style="display:inline-block;width:6px">&nbsp;</div>the period<div style="display:inline-block;width:6px">&nbsp;</div>ended December<div style="display:inline-block;width:6px">&nbsp;</div>31, 2022,<div style="display:inline-block;width:6px">&nbsp;</div>and the<div style="display:inline-block;width:6px">&nbsp;</div>related notes<div style="display:inline-block;width:6px">&nbsp;</div>and our </div><div id="a52183" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:318px;">report dated February 21, 2023<div style="display:inline-block;width:3px">&nbsp;</div>expressed as an unqualified opinion thereon. </div><div id="a52193" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:342px;">Basis for Opinion</div><div id="a52196" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:367px;">The Company’s<div style="display:inline-block;width:7px">&nbsp;</div>management is<div style="display:inline-block;width:6px">&nbsp;</div>responsible for<div style="display:inline-block;width:6px">&nbsp;</div>maintaining effective<div style="display:inline-block;width:6px">&nbsp;</div>internal control<div style="display:inline-block;width:6px">&nbsp;</div>over financial<div style="display:inline-block;width:6px">&nbsp;</div>reporting and </div><div id="a52199" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:384px;">for<div style="display:inline-block;width:5px">&nbsp;</div>its<div style="display:inline-block;width:5px">&nbsp;</div>assessment<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>effectiveness<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>internal<div style="display:inline-block;width:5px">&nbsp;</div>control<div style="display:inline-block;width:5px">&nbsp;</div>over<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>reporting,<div style="display:inline-block;width:5px">&nbsp;</div>included<div style="display:inline-block;width:5px">&nbsp;</div>in<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>accompanying </div><div id="a52200" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:401px;">“Item 9A, Management’s<div style="display:inline-block;width:6px">&nbsp;</div>Report on Internal<div style="display:inline-block;width:5px">&nbsp;</div>Control over Financial Reporting”. Our<div style="display:inline-block;width:5px">&nbsp;</div>responsibility is to<div style="display:inline-block;width:5px">&nbsp;</div>express an </div><div id="a52202" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:418px;">opinion on the<div style="display:inline-block;width:5px">&nbsp;</div>Company’s internal<div style="display:inline-block;width:5px">&nbsp;</div>control over financial<div style="display:inline-block;width:5px">&nbsp;</div>reporting based on<div style="display:inline-block;width:5px">&nbsp;</div>our audit. We<div style="display:inline-block;width:7px">&nbsp;</div>are a public<div style="display:inline-block;width:5px">&nbsp;</div>accounting </div><div id="a52205" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:434px;">firm<div style="display:inline-block;width:5px">&nbsp;</div>registered<div style="display:inline-block;width:5px">&nbsp;</div>with<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>PCAOB and<div style="display:inline-block;width:6px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>required<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>be<div style="display:inline-block;width:5px">&nbsp;</div>independent<div style="display:inline-block;width:5px">&nbsp;</div>with<div style="display:inline-block;width:5px">&nbsp;</div>respect<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>Company in<div style="display:inline-block;width:7px">&nbsp;</div>accordance </div><div id="a52206" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:451px;">with<div style="display:inline-block;width:8px">&nbsp;</div>U.S.<div style="display:inline-block;width:8px">&nbsp;</div>federal<div style="display:inline-block;width:8px">&nbsp;</div>securities<div style="display:inline-block;width:8px">&nbsp;</div>laws<div style="display:inline-block;width:8px">&nbsp;</div>and<div style="display:inline-block;width:8px">&nbsp;</div>the<div style="display:inline-block;width:8px">&nbsp;</div>applicable<div style="display:inline-block;width:8px">&nbsp;</div>rules<div style="display:inline-block;width:8px">&nbsp;</div>and<div style="display:inline-block;width:8px">&nbsp;</div>regulations<div style="display:inline-block;width:8px">&nbsp;</div>of<div style="display:inline-block;width:8px">&nbsp;</div>the<div style="display:inline-block;width:8px">&nbsp;</div>Securities<div style="display:inline-block;width:8px">&nbsp;</div>and<div style="display:inline-block;width:8px">&nbsp;</div>Exchange </div><div id="a52208" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:468px;">Commission and the PCAOB. </div><div id="a52211" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:502px;">We conducted our audit of internal control over financial reporting in accordance with the standards of the PCAOB. </div><div id="a52212" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:519px;">Those standards require<div style="display:inline-block;width:5px">&nbsp;</div>that we plan<div style="display:inline-block;width:6px">&nbsp;</div>and perform the<div style="display:inline-block;width:5px">&nbsp;</div>audit to<div style="display:inline-block;width:5px">&nbsp;</div>obtain reasonable assurance<div style="display:inline-block;width:5px">&nbsp;</div>about whether effective </div><div id="a52214" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:536px;">internal<div style="display:inline-block;width:5px">&nbsp;</div>control<div style="display:inline-block;width:5px">&nbsp;</div>over<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>reporting<div style="display:inline-block;width:5px">&nbsp;</div>was<div style="display:inline-block;width:5px">&nbsp;</div>maintained<div style="display:inline-block;width:5px">&nbsp;</div>in<div style="display:inline-block;width:5px">&nbsp;</div>all<div style="display:inline-block;width:5px">&nbsp;</div>material<div style="display:inline-block;width:5px">&nbsp;</div>respects.<div style="display:inline-block;width:5px">&nbsp;</div>Our<div style="display:inline-block;width:5px">&nbsp;</div>audit<div style="display:inline-block;width:5px">&nbsp;</div>included<div style="display:inline-block;width:5px">&nbsp;</div>obtaining<div style="display:inline-block;width:5px">&nbsp;</div>an </div><div id="a52215" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:553px;">understanding<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>internal<div style="display:inline-block;width:5px">&nbsp;</div>control<div style="display:inline-block;width:5px">&nbsp;</div>over<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>reporting,<div style="display:inline-block;width:5px">&nbsp;</div>assessing<div style="display:inline-block;width:5px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>risk<div style="display:inline-block;width:5px">&nbsp;</div>that<div style="display:inline-block;width:5px">&nbsp;</div>a<div style="display:inline-block;width:5px">&nbsp;</div>material<div style="display:inline-block;width:5px">&nbsp;</div>weakness<div style="display:inline-block;width:5px">&nbsp;</div>exists,<div style="display:inline-block;width:5px">&nbsp;</div>and </div><div id="a52218" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:569px;">testing and<div style="display:inline-block;width:6px">&nbsp;</div>evaluating the<div style="display:inline-block;width:6px">&nbsp;</div>design and<div style="display:inline-block;width:6px">&nbsp;</div>operating effectiveness<div style="display:inline-block;width:6px">&nbsp;</div>of internal<div style="display:inline-block;width:6px">&nbsp;</div>control based<div style="display:inline-block;width:6px">&nbsp;</div>on assessed<div style="display:inline-block;width:6px">&nbsp;</div>risk. Our<div style="display:inline-block;width:6px">&nbsp;</div>audit </div><div id="a52219" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:586px;">also included<div style="display:inline-block;width:5px">&nbsp;</div>performing such<div style="display:inline-block;width:5px">&nbsp;</div>other procedures<div style="display:inline-block;width:5px">&nbsp;</div>as we<div style="display:inline-block;width:5px">&nbsp;</div>considered necessary<div style="display:inline-block;width:5px">&nbsp;</div>in the<div style="display:inline-block;width:5px">&nbsp;</div>circumstances. We<div style="display:inline-block;width:6px">&nbsp;</div>believe that </div><div id="a52221" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:603px;">our audit provides a reasonable basis for our opinion. </div><div id="a52224" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:628px;">Definition and Limitations of Internal Control over Financial Reporting</div><div id="a52227" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:652px;">A<div style="display:inline-block;width:7px">&nbsp;</div>company’s<div style="display:inline-block;width:8px">&nbsp;</div>internal<div style="display:inline-block;width:7px">&nbsp;</div>control<div style="display:inline-block;width:7px">&nbsp;</div>over<div style="display:inline-block;width:7px">&nbsp;</div>financial<div style="display:inline-block;width:7px">&nbsp;</div>reporting<div style="display:inline-block;width:7px">&nbsp;</div>is<div style="display:inline-block;width:7px">&nbsp;</div>a<div style="display:inline-block;width:7px">&nbsp;</div>process<div style="display:inline-block;width:7px">&nbsp;</div>designed<div style="display:inline-block;width:7px">&nbsp;</div>to<div style="display:inline-block;width:7px">&nbsp;</div>provide<div style="display:inline-block;width:7px">&nbsp;</div>reasonable<div style="display:inline-block;width:7px">&nbsp;</div>assurance </div><div id="a52229" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:669px;">regarding the<div style="display:inline-block;width:6px">&nbsp;</div>reliability of<div style="display:inline-block;width:6px">&nbsp;</div>financial reporting<div style="display:inline-block;width:6px">&nbsp;</div>and the<div style="display:inline-block;width:6px">&nbsp;</div>preparation of<div style="display:inline-block;width:6px">&nbsp;</div>financial statements<div style="display:inline-block;width:6px">&nbsp;</div>for external<div style="display:inline-block;width:6px">&nbsp;</div>purposes in </div><div id="a52230" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:686px;">accordance<div style="display:inline-block;width:5px">&nbsp;</div>with<div style="display:inline-block;width:5px">&nbsp;</div>generally<div style="display:inline-block;width:5px">&nbsp;</div>accepted<div style="display:inline-block;width:5px">&nbsp;</div>accounting<div style="display:inline-block;width:5px">&nbsp;</div>principles.<div style="display:inline-block;width:5px">&nbsp;</div>A<div style="display:inline-block;width:5px">&nbsp;</div>company’s<div style="display:inline-block;width:6px">&nbsp;</div>internal<div style="display:inline-block;width:5px">&nbsp;</div>control<div style="display:inline-block;width:6px">&nbsp;</div>over<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>reporting </div><div id="a52232" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:703px;">includes<div style="display:inline-block;width:6px">&nbsp;</div>those<div style="display:inline-block;width:6px">&nbsp;</div>policies<div style="display:inline-block;width:6px">&nbsp;</div>and<div style="display:inline-block;width:6px">&nbsp;</div>procedures<div style="display:inline-block;width:6px">&nbsp;</div>that<div style="display:inline-block;width:6px">&nbsp;</div>(1)<div style="display:inline-block;width:6px">&nbsp;</div>pertain<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>maintenance<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>records<div style="display:inline-block;width:6px">&nbsp;</div>that,<div style="display:inline-block;width:6px">&nbsp;</div>in<div style="display:inline-block;width:6px">&nbsp;</div>reasonable<div style="display:inline-block;width:6px">&nbsp;</div>detail, </div><div id="a52233" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:720px;">accurately and<div style="display:inline-block;width:5px">&nbsp;</div>fairly reflect<div style="display:inline-block;width:5px">&nbsp;</div>the transactions<div style="display:inline-block;width:5px">&nbsp;</div>and dispositions<div style="display:inline-block;width:5px">&nbsp;</div>of the<div style="display:inline-block;width:6px">&nbsp;</div>assets of<div style="display:inline-block;width:6px">&nbsp;</div>the company;<div style="display:inline-block;width:5px">&nbsp;</div>(2) provide<div style="display:inline-block;width:6px">&nbsp;</div>reasonable </div><div id="a52234" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:737px;">assurance<div style="display:inline-block;width:5px">&nbsp;</div>that<div style="display:inline-block;width:5px">&nbsp;</div>transactions<div style="display:inline-block;width:5px">&nbsp;</div>are<div style="display:inline-block;width:5px">&nbsp;</div>recorded<div style="display:inline-block;width:5px">&nbsp;</div>as<div style="display:inline-block;width:5px">&nbsp;</div>necessary<div style="display:inline-block;width:5px">&nbsp;</div>to<div style="display:inline-block;width:5px">&nbsp;</div>permit<div style="display:inline-block;width:5px">&nbsp;</div>preparation<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:5px">&nbsp;</div>financial<div style="display:inline-block;width:5px">&nbsp;</div>statements<div style="display:inline-block;width:5px">&nbsp;</div>in<div style="display:inline-block;width:5px">&nbsp;</div>accordance </div><div id="a52236" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:753px;">with generally<div style="display:inline-block;width:6px">&nbsp;</div>accepted accounting<div style="display:inline-block;width:6px">&nbsp;</div>principles, and<div style="display:inline-block;width:6px">&nbsp;</div>that receipts<div style="display:inline-block;width:6px">&nbsp;</div>and expenditures<div style="display:inline-block;width:5px">&nbsp;</div>of the<div style="display:inline-block;width:6px">&nbsp;</div>company are<div style="display:inline-block;width:6px">&nbsp;</div>being made </div><div id="a52237" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:770px;">only<div style="display:inline-block;width:5px">&nbsp;</div>in<div style="display:inline-block;width:5px">&nbsp;</div>accordance with<div style="display:inline-block;width:6px">&nbsp;</div>authorizations of<div style="display:inline-block;width:6px">&nbsp;</div>management and<div style="display:inline-block;width:6px">&nbsp;</div>directors of<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:5px">&nbsp;</div>company; and<div style="display:inline-block;width:6px">&nbsp;</div>(3) provide<div style="display:inline-block;width:6px">&nbsp;</div>reasonable </div><div id="a52239" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:787px;">assurance<div style="display:inline-block;width:9px">&nbsp;</div>regarding<div style="display:inline-block;width:9px">&nbsp;</div>prevention<div style="display:inline-block;width:9px">&nbsp;</div>or<div style="display:inline-block;width:9px">&nbsp;</div>timely<div style="display:inline-block;width:9px">&nbsp;</div>detection<div style="display:inline-block;width:9px">&nbsp;</div>of<div style="display:inline-block;width:9px">&nbsp;</div>unauthorized<div style="display:inline-block;width:9px">&nbsp;</div>acquisition,<div style="display:inline-block;width:9px">&nbsp;</div>use,<div style="display:inline-block;width:9px">&nbsp;</div>or<div style="display:inline-block;width:9px">&nbsp;</div>disposition<div style="display:inline-block;width:9px">&nbsp;</div>of<div style="display:inline-block;width:9px">&nbsp;</div>the </div><div id="a52240" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:804px;">company’s assets that could have a material effect on the financial statements. </div><div id="a52243" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:829px;">Because<div style="display:inline-block;width:10px">&nbsp;</div>of<div style="display:inline-block;width:10px">&nbsp;</div>its<div style="display:inline-block;width:10px">&nbsp;</div>inherent<div style="display:inline-block;width:10px">&nbsp;</div>limitations,<div style="display:inline-block;width:10px">&nbsp;</div>internal<div style="display:inline-block;width:10px">&nbsp;</div>control<div style="display:inline-block;width:10px">&nbsp;</div>over<div style="display:inline-block;width:10px">&nbsp;</div>financial<div style="display:inline-block;width:10px">&nbsp;</div>reporting<div style="display:inline-block;width:10px">&nbsp;</div>may<div style="display:inline-block;width:10px">&nbsp;</div>not<div style="display:inline-block;width:10px">&nbsp;</div>prevent<div style="display:inline-block;width:10px">&nbsp;</div>or<div style="display:inline-block;width:10px">&nbsp;</div>detect </div><div id="a52245" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:845px;">misstatements.<div style="display:inline-block;width:6px">&nbsp;</div>Also,<div style="display:inline-block;width:6px">&nbsp;</div>projections<div style="display:inline-block;width:5px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>any<div style="display:inline-block;width:6px">&nbsp;</div>evaluation<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>effectiveness<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>future<div style="display:inline-block;width:6px">&nbsp;</div>periods<div style="display:inline-block;width:6px">&nbsp;</div>are<div style="display:inline-block;width:6px">&nbsp;</div>subject<div style="display:inline-block;width:6px">&nbsp;</div>to<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>risk<div style="display:inline-block;width:6px">&nbsp;</div>that </div><div id="a52246" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:862px;">controls<div style="display:inline-block;width:6px">&nbsp;</div>may<div style="display:inline-block;width:6px">&nbsp;</div>become<div style="display:inline-block;width:6px">&nbsp;</div>inadequate<div style="display:inline-block;width:6px">&nbsp;</div>because<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>changes<div style="display:inline-block;width:6px">&nbsp;</div>in<div style="display:inline-block;width:6px">&nbsp;</div>conditions,<div style="display:inline-block;width:6px">&nbsp;</div>or<div style="display:inline-block;width:6px">&nbsp;</div>that<div style="display:inline-block;width:6px">&nbsp;</div>the<div style="display:inline-block;width:6px">&nbsp;</div>degree<div style="display:inline-block;width:6px">&nbsp;</div>of<div style="display:inline-block;width:6px">&nbsp;</div>compliance<div style="display:inline-block;width:6px">&nbsp;</div>with<div style="display:inline-block;width:6px">&nbsp;</div>the </div><div id="a52248" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:879px;">policies or procedures may deteriorate.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52252" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:904px;">/s/ BDO USA, LLP</div><div id="a52254" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:921px;">New York<div style="display:inline-block;width:1px">&nbsp;</div>,<div style="display:inline-block;width:4px">&nbsp;</div>NY<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a52258" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:937px;">February 21, 2023</div></div>
</div>
<div style="padding: 7px">
<div id="Page118" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a52260" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a52263" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">118 </div><div id="a52265" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 9B.<div style="display:inline-block;width:7px">&nbsp;</div>Other Information </div><div id="a52268" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:92px;">Not applicable. </div><div id="a52273" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:126px;">ITEM 9C.<div style="display:inline-block;width:7px">&nbsp;</div>Disclosure Regarding Foreign Jurisdictions that Prevent Inspections </div><div id="a52280" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:158px;">Not applicable. </div><div id="a52285" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:378px;top:192px;">PART<div style="display:inline-block;width:5px">&nbsp;</div>III </div><div id="a52288" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:225px;">ITEM 10.<div style="display:inline-block;width:7px">&nbsp;</div>Directors, Executive Officers and Corporate Governance </div><div id="a52293" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:257px;">Information required by this item regarding our directors and executive<div style="display:inline-block;width:2px">&nbsp;</div>officers and our corporate governance is </div><div id="a52294" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:274px;">hereby incorporated by reference to the Section entitled “Election of Directors,”<div style="display:inline-block;width:2px">&nbsp;</div>with respect to directors, and the </div><div id="a52295" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:291px;">first paragraph of the Section entitled “Corporate Governance - Board<div style="display:inline-block;width:2px">&nbsp;</div>of Directors Meetings and Committees - </div><div id="a52302" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:308px;">Audit Committee,” with respect to corporate governance, in each case<div style="display:inline-block;width:2px">&nbsp;</div>in our definitive 2023 Proxy Statement to be </div><div id="a52303" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:325px;">filed pursuant to Regulation 14A and to the Section entitled “Information<div style="display:inline-block;width:2px">&nbsp;</div>about our Executive Officers” in Part I of </div><div id="a52305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:342px;">this report, with respect to executive officers.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52308" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:374px;">There have been no changes to the procedures by which stockholders<div style="display:inline-block;width:2px">&nbsp;</div>may recommend nominees to our Board of </div><div id="a52309" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:391px;">Directors since our last disclosure of such procedures, which appeared<div style="display:inline-block;width:2px">&nbsp;</div>in our definitive 2022 Proxy Statement filed </div><div id="a52311" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:408px;">pursuant to Regulation 14A on April 6, 2022. </div><div id="a52314" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:440px;">Information required by this item concerning compliance with Section<div style="display:inline-block;width:2px">&nbsp;</div>16(a) of the Securities Exchange Act of </div><div id="a52315" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:457px;">1934 is hereby incorporated by reference to the Section entitled “Delinquent<div style="display:inline-block;width:2px">&nbsp;</div>Section 16(a) Reports” in our </div><div id="a52317" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:474px;">definitive 2023 Proxy Statement to be filed pursuant to Regulation 14A,<div style="display:inline-block;width:2px">&nbsp;</div>to the extent responsive disclosure is </div><div id="a52318" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:490px;">required. </div><div id="a52321" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:523px;">We have adopted a Code of Ethics that applies to our Chief Executive Officer, Chief Financial Officer, Chief </div><div id="a52323" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:540px;">Accounting Officer and Controller.<div style="display:inline-block;width:8px">&nbsp;</div>We make available free of charge through our Internet website, </div><div id="a52324" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:556px;">www.henryschein.com,<div style="display:inline-block;width:4px">&nbsp;</div>under the “About Henry Schein--Corporate Governance<div style="display:inline-block;width:2px">&nbsp;</div>Highlights” caption, our Code of </div><div id="a52330" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:573px;">Ethics.<div style="display:inline-block;width:7px">&nbsp;</div>We intend to disclose on our Web<div style="display:inline-block;width:5px">&nbsp;</div>site any amendment to, or waiver of, a provision of the Code<div style="display:inline-block;width:2px">&nbsp;</div>of Ethics. </div><div id="a52333" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:607px;">ITEM 11.<div style="display:inline-block;width:8px">&nbsp;</div>Executive Compensation </div><div id="a52338" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:639px;">The information required by this item is hereby incorporated by reference<div style="display:inline-block;width:2px">&nbsp;</div>to the Sections<div style="display:inline-block;width:3px">&nbsp;</div>entitled “Compensation </div><div id="a52342" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:656px;">Discussion and Analysis,” “Compensation Committee Report” (which<div style="display:inline-block;width:2px">&nbsp;</div>information shall be deemed furnished in </div><div id="a52345" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:673px;">this Annual Report on Form 10-K), “Executive and Director Compensation” and<div style="display:inline-block;width:2px">&nbsp;</div>“Compensation Committee </div><div id="a52348" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:690px;">Interlocks and Insider Participation” in our definitive 2023 Proxy<div style="display:inline-block;width:2px">&nbsp;</div>Statement to be filed pursuant to Regulation 14A. </div></div>
</div>
<div style="padding: 7px">
<div id="Page119" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:681.1px; height:18.8px; left:67.2px; top:253.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:424.1px; height:15.4px; left:324.2px; top:257.3px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:247.1px; height:1px; left:66.8px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.8px; left:314.3px; top:252.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:150.1px; height:1px; left:323.8px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.8px; left:474.3px; top:252.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:130.1px; height:1px; left:483.9px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:9.9px; height:19.8px; left:614.4px; top:252.8px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:124px; height:1px; left:623.9px; top:252.4px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.6px; left:67.2px; top:292.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:681.1px; height:19.6px; left:67.2px; top:292.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:257px; height:20.6px; left:67.2px; top:291.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:257px; height:1px; left:66.8px; top:291.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:150.1px; height:1px; left:323.8px; top:291.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:150px; height:20.6px; left:474.3px; top:291.9px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:150px; height:1px; left:473.9px; top:291.5px; background-color:#B5F9F9; ">&nbsp;</div>
<div style="position:absolute; width:124px; height:1px; left:623.9px; top:291.5px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:151.1px; height:1px; left:323.3px; top:314.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:151.1px; height:1px; left:323.3px; top:312.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:125px; height:1px; left:623.3px; top:314.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:125px; height:1px; left:623.3px; top:312.7px; background-color:#000000; ">&nbsp;</div>
<div id="a52354" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a52357" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">119 </div><div id="a52359" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">ITEM 12.<div style="display:inline-block;width:7px">&nbsp;</div>Security Ownership of Certain Beneficial Owners and Management<div style="display:inline-block;width:2px">&nbsp;</div>and Related Stockholder </div><div id="a52362" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:76px;">Matters </div><div id="a52365" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:109px;">We maintain several stock incentive plans for the benefit of certain officers, directors and employees.<div style="display:inline-block;width:7px">&nbsp;</div>All active </div><div id="a52369" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:126px;">plans have been approved by our stockholders.<div style="display:inline-block;width:7px">&nbsp;</div>Descriptions of these plans appear in the notes to our consolidated </div><div id="a52374" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:142px;">financial statements.<div style="display:inline-block;width:7px">&nbsp;</div>The following table summarizes information relating to these plans as of December<div style="display:inline-block;width:2px">&nbsp;</div>31, 2022: </div><div id="a52383" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:340px;top:180px;">Number of Common </div><div id="a52393" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:327px;top:199px;">Shares to be Issued Upon </div><div id="a52396" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:494px;top:199px;">Weighted-<div style="display:inline-block;width:4px">&nbsp;</div>Average </div><div id="a52402" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:627px;top:199px;">Number of Common </div><div id="a52407" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:331px;top:219px;">Exercise of Outstanding </div><div id="a52410" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:502px;top:219px;">Exercise Price of </div><div id="a52413" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:628px;top:219px;">Shares Available<div style="display:inline-block;width:5px">&nbsp;</div>for </div><div id="a52415" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:150px;top:238px;">Plan Category </div><div id="a52418" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:344px;top:238px;">Options and Rights </div><div id="a52421" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:489px;top:238px;">Outstanding Options </div><div id="a52425" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:638px;top:238px;">Future Issuances </div><div id="a52427" style="position:absolute;font-family:'Times New Roman';left:67px;top:258px;">Plans Approved by Stockholders<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a52430" style="position:absolute;font-family:'Times New Roman';left:470px;top:258px;">- </div><div id="a52433" style="position:absolute;font-family:'Times New Roman';left:484px;top:258px;">$ </div><div id="a52435" style="position:absolute;font-family:'Times New Roman';left:610px;top:258px;">- </div><div id="a52438" style="position:absolute;font-family:'Times New Roman';left:695px;top:258px;">8,227,096 </div><div id="a52440" style="position:absolute;font-family:'Times New Roman';left:67px;top:277px;">Plans Not Approved by Stockholders<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a52443" style="position:absolute;font-family:'Times New Roman';left:470px;top:277px;">- </div><div id="a52447" style="position:absolute;font-family:'Times New Roman';left:610px;top:277px;">- </div><div id="a52450" style="position:absolute;font-family:'Times New Roman';left:744px;top:277px;">- </div><div id="a52453" style="position:absolute;font-family:'Times New Roman';left:87px;top:298px;">Total<div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a52456" style="position:absolute;font-family:'Times New Roman';left:470px;top:298px;">- </div><div id="a52459" style="position:absolute;font-family:'Times New Roman';left:484px;top:298px;">$ </div><div id="a52461" style="position:absolute;font-family:'Times New Roman';left:610px;top:298px;">- </div><div id="a52464" style="position:absolute;font-family:'Times New Roman';left:695px;top:298px;">8,227,096 </div><div id="a52467" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:333px;">The other information required by this item is hereby incorporated by<div style="display:inline-block;width:2px">&nbsp;</div>reference to the Section entitled “Security </div><div id="a52468" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:350px;">Ownership of Certain Beneficial Owners and Management” in our definitive<div style="display:inline-block;width:2px">&nbsp;</div>2023 Proxy Statement to be filed </div><div id="a52473" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:366px;">pursuant to Regulation 14A. </div><div id="a52476" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:400px;">ITEM 13.<div style="display:inline-block;width:7px">&nbsp;</div>Certain Relationships and Related Transactions, and Director Independence </div><div id="a52482" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:432px;">The information required by this item is hereby incorporated by reference<div style="display:inline-block;width:2px">&nbsp;</div>to the Section entitled “Certain </div><div id="a52483" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:449px;">Relationships and Related Transactions” and “Corporate Governance – Board of Directors Meetings and </div><div id="a52488" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:466px;">Committees – Independent Directors” in our definitive 2023 Proxy Statement<div style="display:inline-block;width:2px">&nbsp;</div>to be filed pursuant to Regulation </div><div id="a52495" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:483px;">14A.</div><div id="a52498" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:517px;">ITEM 14.<div style="display:inline-block;width:7px">&nbsp;</div>Principal Accounting Fees and Services </div><div id="a52505" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:549px;">The information required by this item is hereby incorporated by reference<div style="display:inline-block;width:2px">&nbsp;</div>to the Section entitled “Independent </div><div id="a52506" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:566px;">Registered Public Accounting Firm Fees and Pre-Approval Policies and<div style="display:inline-block;width:2px">&nbsp;</div>Procedures” in our definitive 2023 Proxy </div><div id="a52512" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:583px;">Statement to be filed pursuant to Regulation 14A.</div><div id="a52516" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:378px;top:616px;">PART<div style="display:inline-block;width:5px">&nbsp;</div>IV </div><div id="a52519" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:648px;">ITEM 15.<div style="display:inline-block;width:7px">&nbsp;</div>Exhibits, Financial Statement Schedules<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52521" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:666px;">(a)</div><div id="a52523" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:115px;top:666px;">List of Documents Filed as a Part of This Report: </div><div id="a52526" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:98px;top:709px;">1. </div><div id="a52528" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:709px;">Financial Statements: </div><div id="a52531" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:726px;">Our Consolidated Financial Statements filed as a part of this report<div style="display:inline-block;width:2px">&nbsp;</div>are listed on the index on<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a52534" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:743px;">Page 60. </div><div id="a52538" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:98px;top:777px;">2. </div><div id="a52541" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:777px;">Index to Exhibits: </div><div id="a52545" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:124px;top:794px;">See exhibits listed under Item 15(b) below. </div></div>
</div>
<div style="padding: 7px">
<div id="Page120" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a52549" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a52552" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">120 </div><div id="a52554" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:60px;">(b) Exhibits</div><div id="a52558" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:77px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex21.htm" style="color:#0000FF;text-decoration:underline;">2.1</a></div><div id="a52560" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:77px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex21.htm" style="color:#0000FF;text-decoration:underline;">Contribution and Distribution Agreement, dated as of April 20, 2018, by and </a></div><div id="a52564" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:95px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex21.htm" style="color:#0000FF;text-decoration:underline;">among us, HS Spinco, Inc., Direct Vet<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Marketing, Inc. and Shareholder </a></div><div id="a52565" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:113px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex21.htm" style="color:#0000FF;text-decoration:underline;">Representative Services LLC. (Incorporated by reference to Exhibit 2.1 to our </a></div><div id="a52566" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:132px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex21.htm" style="color:#0000FF;text-decoration:underline;">Current Report on Form 8-K filed on April 23, 2018 (film no. 18767875).)*</a></div><div id="a52572" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:170px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex22.htm" style="color:#0000FF;text-decoration:underline;">2.2</a></div><div id="a52574" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:170px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex22.htm" style="color:#0000FF;text-decoration:underline;">Agreement and Plan of Merger, dated as of April 20, 2018, by and among us, HS </a></div><div id="a52579" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:188px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex22.htm" style="color:#0000FF;text-decoration:underline;">Spinco, Inc, HS Merger Sub, Inc., Direct Vet<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Marketing, Inc. and Shareholder </a></div><div id="a52580" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:207px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex22.htm" style="color:#0000FF;text-decoration:underline;">Representative Services LLC. (Incorporated by reference to Exhibit 2.2 to our </a></div><div id="a52581" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:225px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518125791/d567106dex22.htm" style="color:#0000FF;text-decoration:underline;">Current Report on Form 8-K filed on April 23, 2018 (film no. 18767875).)*</a></div><div id="a52587" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:263px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">2.3</a></div><div id="a52588" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:263px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52590" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:263px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">Letter Agreement,<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Amendment<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>No. 1<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>to Contribution<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>and Distribution<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Agreement </a></div><div id="a52593" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:281px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">and<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Amendment<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>No.<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>1<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>to<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Agreement<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>and<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Plan<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>of<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Merger,<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>dated<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>as<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>of<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>September </a></div><div id="a52594" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:300px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">14,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>2018,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>by<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>and<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>among<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>us,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>HS<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Spinco,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Inc.,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>HS<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Merger<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Sub,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Inc.,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Direct<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Vet </a></div><div id="a52595" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:318px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">Marketing,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Inc.<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>and<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Shareholder<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Representative<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Services<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>LLC.(<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Incorporated<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>by</a></div><div id="a52597" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:337px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">reference<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>to<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Exhibit<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>2.3<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>to<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>our<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Annual<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Report<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>on<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Form<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>10-K<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>for<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>the<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>fiscal<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>year </a></div><div id="a52600" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:355px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_3.htm" style="color:#0000FF;text-decoration:underline;">ended December 29, 2018 filed on February 20, 2019.)</a></div><div id="a52601" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:492px;top:355px;"><div style="display:inline-block;width:8px">&nbsp;</div></div><div id="a52605" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:395px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">2.4</a></div><div id="a52606" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:395px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52608" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:395px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">Letter Agreement and Amendment No. 2 to Contribution and Distribution </a></div><div id="a52610" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:414px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of November 30, 2018, by and among us, HS Spinco, Inc., </a></div><div id="a52611" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:432px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">Direct Vet<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Marketing, Inc. and Shareholder Representative Services LLC.<span style="display:inline-block;width:4px;text-decoration:underline">&nbsp;</span></a></div><div id="a52612" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:450px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 2.4 to our Annual Report on Form 10-K for </a></div><div id="a52615" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:469px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_4.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 29, 2018 filed on February 20, 2019.)</a></div><div id="a52620" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:507px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">2.5</a></div><div id="a52621" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:507px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52623" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:507px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">Letter Agreement and Amendment No. 3 to Contribution and Distribution </a></div><div id="a52625" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:525px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">Agreement and Amendment No. 2 to Agreement and Plan of Merger, dated as of </a></div><div id="a52626" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:544px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">December 25, 2018, by and among us, HS Spinco, Inc., HS Merger Sub, Inc., </a></div><div id="a52627" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:562px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">Direct Vet<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Marketing, Inc. and Shareholder Representative Services </a></div><div id="a52628" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:580px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">LLC.(Incorporated by reference to Exhibit 2.5 to our Annual Report on Form 10-K </a></div><div id="a52632" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:599px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_5.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal year ended December 29, 2018 filed on February 20, 2019.)</a></div><div id="a52636" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:637px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">2.6</a></div><div id="a52637" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:637px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52639" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:637px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">Letter Agreement and Amendment No. 4 to Contribution and Distribution </a></div><div id="a52640" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:655px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of January 15, 2019, by and among us, HS Spinco, Inc., Direct </a></div><div id="a52641" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:673px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">Vet<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Marketing, Inc. and Shareholder Representative Services LLC.(Incorporated </a></div><div id="a52643" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:692px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">by reference to Exhibit 2.6 to our Annual Report on Form 10-K for the fiscal year </a></div><div id="a52646" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:710px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000015/exhibit2_6.htm" style="color:#0000FF;text-decoration:underline;">ended December 29, 2018 filed on February 20, 2019.)</a></div><div id="a52650" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:748px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518181713/d586703dex31.htm" style="color:#0000FF;text-decoration:underline;">3.1</a></div><div id="a52651" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:748px;"><div style="display:inline-block;width:36px">&nbsp;</div></div><div id="a52653" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:748px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518181713/d586703dex31.htm" style="color:#0000FF;text-decoration:underline;">Second Amended and Restated Certificate of Incorporation of Henry Schein, Inc. </a></div><div id="a52654" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:767px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518181713/d586703dex31.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed </a></div><div id="a52657" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:785px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312518181713/d586703dex31.htm" style="color:#0000FF;text-decoration:underline;">on June 1, 2018.)</a></div><div id="a52661" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:823px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521162809/d171651dex31.htm" style="color:#0000FF;text-decoration:underline;">3.2</a></div><div id="a52662" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:823px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52664" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:823px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521162809/d171651dex31.htm" style="color:#0000FF;text-decoration:underline;">Third Amended and Restated By-Laws of the Company, effective May 13, 2021. </a></div><div id="a52667" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:841px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521162809/d171651dex31.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed </a></div><div id="a52670" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:860px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521162809/d171651dex31.htm" style="color:#0000FF;text-decoration:underline;">on May 17, 2021.)</a></div><div id="a52676" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:898px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">4.1</a></div><div id="a52677" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:87px;top:898px;"><div style="display:inline-block;width:40px">&nbsp;</div></div><div id="a52679" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:898px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">Third Amended and Restated Multicurrency Master Note Purchase Agreement, </a></div><div id="a52681" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:916px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">dated as of October 20, 2021, by and among us, Metropolitan Life Insurance </a></div><div id="a52682" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:934px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">Company, MetLife Investment Management, LLC and each MetLife affiliate </a></div><div id="a52683" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:953px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">which becomes party thereto. (Incorporated by reference to Exhibit 4.4 to our </a></div><div id="a52685" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:971px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex44.htm" style="color:#0000FF;text-decoration:underline;">Current Report on Form 8-K filed on October 21, 2021.)</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page121" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a52689" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a52692" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">121 </div><div id="a52696" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:79px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex43.htm" style="color:#0000FF;text-decoration:underline;">4.2</a></div><div id="a52698" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:79px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex43.htm" style="color:#0000FF;text-decoration:underline;">Third Amended and Restated Master Note Facility, dated as of October 20, 2021, </a></div><div id="a52699" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:98px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex43.htm" style="color:#0000FF;text-decoration:underline;">by and among us, NYL Investors LLC and each New York<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Life affiliate which </a></div><div id="a52700" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:116px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex43.htm" style="color:#0000FF;text-decoration:underline;">becomes party thereto. (Incorporated by reference to Exhibit 4.3 to our Current </a></div><div id="a52702" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:135px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex43.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 8-K filed on October 21, 2021.)</a></div><div id="a52708" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:172px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex42.htm" style="color:#0000FF;text-decoration:underline;">4.3</a></div><div id="a52710" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:172px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex42.htm" style="color:#0000FF;text-decoration:underline;">Third Amended and Restated Multicurrency Private Shelf Agreement, dated as of </a></div><div id="a52711" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:191px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex42.htm" style="color:#0000FF;text-decoration:underline;">October 20, 2021, by and among us, PGIM, Inc. and each Prudential affiliate which</a></div><div id="a52713" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:209px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex42.htm" style="color:#0000FF;text-decoration:underline;">becomes party thereto. (Incorporated by reference to Exhibit 4.2 to our Current </a></div><div id="a52714" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:228px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex42.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 8-K filed on October 21, 2021.)</a></div><div id="a52720" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:266px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex41.htm" style="color:#0000FF;text-decoration:underline;">4.4</a></div><div id="a52722" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:266px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex41.htm" style="color:#0000FF;text-decoration:underline;">Multicurrency Private Shelf Agreement, dated as of October 20, 2021, by and </a></div><div id="a52723" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:284px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex41.htm" style="color:#0000FF;text-decoration:underline;">among us, AIG Asset Management (U.S.), LLC and each AIG affiliate which </a></div><div id="a52724" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:302px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex41.htm" style="color:#0000FF;text-decoration:underline;">becomes party thereto. (Incorporated by reference to Exhibit 4.1 to our Current </a></div><div id="a52726" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:321px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex41.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 8-K filed on October 21, 2021.)</a></div><div id="a52732" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:359px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000016/exhibit45.htm" style="color:#0000FF;text-decoration:underline;">4.5</a></div><div id="a52734" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:359px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000016/exhibit45.htm" style="color:#0000FF;text-decoration:underline;">Description of Securities. (Incorporated by reference to Exhibit 4.5 to our Annual </a></div><div id="a52736" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:377px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000016/exhibit45.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 10-K for the fiscal year ended December 25, 2021 filed on </a></div><div id="a52739" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:396px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000016/exhibit45.htm" style="color:#0000FF;text-decoration:underline;">February 15, 2022.)</a></div><div id="a52745" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:433px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513224319/d542871dex102.htm" style="color:#0000FF;text-decoration:underline;">10.1</a></div><div id="a52747" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:433px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513224319/d542871dex102.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. 2013 Stock Incentive Plan, as amended and restated effective as </a></div><div id="a52749" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:452px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513224319/d542871dex102.htm" style="color:#0000FF;text-decoration:underline;">of May 14, 2013. (Incorporated by reference to Exhibit 10.2 to our Current Report </a></div><div id="a52750" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:470px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513224319/d542871dex102.htm" style="color:#0000FF;text-decoration:underline;">on Form 8-K filed on May 16, 2013.)**</a></div><div id="a52756" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:508px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">10.2</a></div><div id="a52759" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:508px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Form of 2019 Restricted Stock Unit Agreement for performance-based restricted</a></div><div id="a52782" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:527px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">stock unit awards pursuant to the Henry Schein, Inc. 2013 Stock Incentive Plan (as</a></div><div id="a52810" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:545px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">amended and restated effective as of May 14, 2013). (Incorporated by reference to</a></div><div id="a52836" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:563px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended</a></div><div id="a52866" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:582px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">March 30, 2019 filed on May 7, 2019.)**</a></div><div id="a52884" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:620px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">10.3</a></div><div id="a52886" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:620px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Form of 2019 Restricted Stock Unit Agreement for time-based restricted stock unit</a></div><div id="a52912" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:638px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">awards pursuant to the Henry Schein, Inc. 2013 Stock Incentive Plan (as amended</a></div><div id="a52938" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:657px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">and restated effective as of May 14, 2013). (Incorporated by reference to Exhibit</a></div><div id="a52964" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:675px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended March 30,</a></div><div id="a52996" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:693px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">2019 filed on May 7, 2019.)**</a></div><div id="a53010" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:731px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520151575/d933896dex101.htm" style="color:#0000FF;text-decoration:underline;">10.4</a></div><div id="a53013" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:731px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520151575/d933896dex101.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. 2020 Stock Incentive Plan, as amended and restated effective as </a></div><div id="a53014" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:750px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520151575/d933896dex101.htm" style="color:#0000FF;text-decoration:underline;">of May 21, 2020. (Incorporated by reference to Exhibit 10.1 to our Current Report </a></div><div id="a53016" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:768px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520151575/d933896dex101.htm" style="color:#0000FF;text-decoration:underline;">on Form 8-K filed on May 26, 2020.)**</a></div><div id="a53022" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:806px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521072310/d131793dex101.htm" style="color:#0000FF;text-decoration:underline;">10.5</a></div><div id="a53025" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:806px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521072310/d131793dex101.htm" style="color:#0000FF;text-decoration:underline;">Form of 2021 Stock Option Agreement pursuant to the Henry Schein, Inc. 2020 </a></div><div id="a53026" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:824px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521072310/d131793dex101.htm" style="color:#0000FF;text-decoration:underline;">Stock Incentive Plan (as amended and restated effective as of May 21, 2020). </a></div><div id="a53027" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:843px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521072310/d131793dex101.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed </a></div><div id="a53031" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:861px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521072310/d131793dex101.htm" style="color:#0000FF;text-decoration:underline;">on March 8, 2021.)**</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page122" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a53035" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a53038" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">122 </div><div id="a53040" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">10.6</a></div><div id="a53043" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Form of 2021 Special Pandemic Recognition Award<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Restricted Stock Unit </a></div><div id="a53044" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Agreement for time-based restricted stock unit awards pursuant to the Henry </a></div><div id="a53047" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:97px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Schein, Inc. 2020 Stock Incentive Plan (as amended and restated effective as of </a></div><div id="a53049" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:115px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">May 21, 2020). (Incorporated by reference to Exhibit 10.2 to our Quarterly Report </a></div><div id="a53050" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:133px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">on Form 10-Q for the fiscal quarter ended March 27, 2021 filed on May 4, </a></div><div id="a53053" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:152px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022821000036/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">2021.)**</a></div><div id="a53057" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:190px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">10.7</a></div><div id="a53060" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:190px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">Form of 2022 Restricted Stock Unit Agreement for time-based restricted stock unit </a></div><div id="a53063" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:208px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">awards pursuant to the Henry Schein, Inc. 2020 Stock Incentive Plan (as amended </a></div><div id="a53064" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:227px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">and restated effective as of May 21, 2020). (Incorporated by reference to Exhibit</a></div><div id="a53076" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:245px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended March 26,</a></div><div id="a53108" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:263px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex101.htm" style="color:#0000FF;text-decoration:underline;">2022 filed on May 3, 2022.)**</a></div><div id="a53123" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:301px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">10.8</a></div><div id="a53126" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:301px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">Form of 2022 Restricted Stock Unit Agreement for performance-based restricted</a></div><div id="a53149" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:320px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">stock unit awards pursuant to the Henry Schein, Inc. 2020 Stock Incentive Plan (as</a></div><div id="a53177" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:338px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">amended and restated effective as of May 21, 2020). (Incorporated by reference to</a></div><div id="a53203" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:357px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended</a></div><div id="a53233" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:375px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex102.htm" style="color:#0000FF;text-decoration:underline;">March 26, 2022 filed on May 3, 2022.)**</a></div><div id="a53253" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:413px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000029/exhibit101_2q15.htm" style="color:#0000FF;text-decoration:underline;">10.9</a></div><div id="a53256" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:413px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000029/exhibit101_2q15.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. 2015 Non-Employee Director Stock Incentive Plan. </a></div><div id="a53261" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:431px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000029/exhibit101_2q15.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q </a></div><div id="a53266" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:450px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000029/exhibit101_2q15.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal quarter ended June 27, 2015 filed on July 29, 2015.)**</a></div><div id="a53271" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:488px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">10.10</a></div><div id="a53274" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:488px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">Form of 2018 Restricted Stock Unit Agreement for time-based restricted stock unit </a></div><div id="a53278" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:506px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">awards pursuant to the Henry Schein, Inc. 2015 Non-Employee Director Stock </a></div><div id="a53281" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:524px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">Incentive Plan (as amended and restated effective as of June 22, 2015). </a></div><div id="a53282" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:543px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.6 to our Quarterly Report on Form 10-Q </a></div><div id="a53285" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:561px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022818000022/exhibit106.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal quarter ended March 31, 2018 filed on May 8, 2018.)**</a></div><div id="a53290" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:599px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000036/exhibit10_13q13.htm" style="color:#0000FF;text-decoration:underline;">10.11</a></div><div id="a53293" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:599px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000036/exhibit10_13q13.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and restated </a></div><div id="a53294" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:617px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000036/exhibit10_13q13.htm" style="color:#0000FF;text-decoration:underline;">effective as of January 1, 2014. (Incorporated by reference to Exhibit 10.1 to our </a></div><div id="a53295" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:636px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000036/exhibit10_13q13.htm" style="color:#0000FF;text-decoration:underline;">Quarterly Report on Form 10-Q for the fiscal quarter ended September 28, 2013 </a></div><div id="a53301" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:654px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000036/exhibit10_13q13.htm" style="color:#0000FF;text-decoration:underline;">filed on November 5, 2013.)**</a></div><div id="a53305" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:692px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1018.htm" style="color:#0000FF;text-decoration:underline;">10.12</a></div><div id="a53308" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:692px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1018.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number One to the Henry Schein, Inc. Supplemental Executive</a></div><div id="a53328" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:711px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1018.htm" style="color:#0000FF;text-decoration:underline;">Retirement Plan, amended and restated effective as of January 1, 2014.</a></div><div id="a53349" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:594px;top:711px;"><div style="display:inline-block;width:4px">&nbsp;</div></div><div id="a53350" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:729px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1018.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.18 to our Annual Report on Form 10-K for</a></div><div id="a53381" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:747px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1018.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 28, 2020 filed on February 20, 2020.)**</a></div><div id="a53407" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:785px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex103.htm" style="color:#0000FF;text-decoration:underline;">10.13</a></div><div id="a53410" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:785px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex103.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Two to the Henry Schein, Inc. Supplemental Executive</a></div><div id="a53430" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:804px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex103.htm" style="color:#0000FF;text-decoration:underline;">Retirement Plan, amended and restated effective as of January 1, 2014.</a></div><div id="a53452" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:822px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex103.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.3 to our Quarterly Report on Form 10-Q</a></div><div id="a53481" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:841px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex103.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal quarter ended March 28, 2020 filed on May 5, 2020.)**</a></div><div id="a53509" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:878px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000066/d30258d8k102.htm" style="color:#0000FF;text-decoration:underline;">10.14</a></div><div id="a53512" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:878px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000066/d30258d8k102.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Three to the Henry Schein, Inc. Supplemental Executive</a></div><div id="a53532" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:897px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000066/d30258d8k102.htm" style="color:#0000FF;text-decoration:underline;">Retirement Plan, amended and restated effective as of January 1, 2014.</a></div><div id="a53554" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:915px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000066/d30258d8k102.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q</a></div><div id="a53582" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:934px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000066/d30258d8k102.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal quarter ended September 26, 2020 filed on November 2, 2020.)**</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page123" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a53610" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a53613" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">123 </div><div id="a53615" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000104746904013813/a2134452zdef14a.htm" style="color:#0000FF;text-decoration:underline;">10.15</a></div><div id="a53618" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000104746904013813/a2134452zdef14a.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. 2004 Employee Stock Purchase Plan, effective as of May 25, </a></div><div id="a53622" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000104746904013813/a2134452zdef14a.htm" style="color:#0000FF;text-decoration:underline;">2004. (Incorporated by reference to Exhibit D to our definitive 2004 Proxy </a></div><div id="a53623" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:97px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000104746904013813/a2134452zdef14a.htm" style="color:#0000FF;text-decoration:underline;">Statement on Schedule 14A, filed on April 27, 2004.)**</a></div><div id="a53631" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:135px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_112008.htm" style="color:#0000FF;text-decoration:underline;">10.16</a></div><div id="a53634" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:135px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_112008.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. Non-Employee Director Deferred Compensation Plan, amended </a></div><div id="a53637" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:153px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_112008.htm" style="color:#0000FF;text-decoration:underline;">and restated effective as of January 1, 2005. (Incorporated by reference to Exhibit </a></div><div id="a53640" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:171px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_112008.htm" style="color:#0000FF;text-decoration:underline;">10.11 to our Annual Report on Form 10-K for the fiscal year ended December 27, </a></div><div id="a53645" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:190px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_112008.htm" style="color:#0000FF;text-decoration:underline;">2008 filed on February 24, 2009.)**</a></div><div id="a53649" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:228px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022811000014/ex10_23.htm" style="color:#0000FF;text-decoration:underline;">10.17</a></div><div id="a53652" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:228px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022811000014/ex10_23.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. Deferred Compensation Plan. (Incorporated by reference to </a></div><div id="a53654" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:246px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022811000014/ex10_23.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.23 to our Annual Report on Form 10-K for the fiscal year ended </a></div><div id="a53657" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:264px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022811000014/ex10_23.htm" style="color:#0000FF;text-decoration:underline;">December 25, 2010 filed on February 22, 2011.)**</a></div><div id="a53661" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:302px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022812000009/exhibit10_26.htm" style="color:#0000FF;text-decoration:underline;">10.18</a></div><div id="a53664" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:302px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022812000009/exhibit10_26.htm" style="color:#0000FF;text-decoration:underline;">Amendment to the Henry Schein, Inc. Deferred Compensation Plan. (Incorporated </a></div><div id="a53665" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:321px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022812000009/exhibit10_26.htm" style="color:#0000FF;text-decoration:underline;">by reference to Exhibit 10.26 to our Annual Report on Form 10-K for the fiscal </a></div><div id="a53668" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:339px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022812000009/exhibit10_26.htm" style="color:#0000FF;text-decoration:underline;">year ended December 31, 2011 filed on February 15, 2012.)**</a></div><div id="a53673" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:377px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_204q13.htm" style="color:#0000FF;text-decoration:underline;">10.19</a></div><div id="a53676" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:377px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_204q13.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Two to the Henry Schein, Inc. Deferred Compensation </a></div><div id="a53677" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:396px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_204q13.htm" style="color:#0000FF;text-decoration:underline;">Plan.<span style="display:inline-block;width:8px;text-decoration:underline">&nbsp;</span>(Incorporated by reference to Exhibit 10.20 to our Annual Report on Form </a></div><div id="a53681" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:414px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_204q13.htm" style="color:#0000FF;text-decoration:underline;">10-K for the fiscal year ended December 28, 2013 filed on February 11, 2014.)**</a></div><div id="a53688" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:452px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_214q13.htm" style="color:#0000FF;text-decoration:underline;">10.20</a></div><div id="a53691" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:452px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_214q13.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Three to the Henry Schein, Inc. Deferred Compensation Plan. </a></div><div id="a53692" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:470px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_214q13.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.21 to our Annual Report on Form 10-K for </a></div><div id="a53695" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:489px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000010/exhibit10_214q13.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 28, 2013 filed on February 11, 2014.)**</a></div><div id="a53700" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:527px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000011/exhibit1046_2016.htm" style="color:#0000FF;text-decoration:underline;">10.21</a></div><div id="a53703" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:527px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000011/exhibit1046_2016.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Four to the Henry Schein, Inc. Deferred Compensation Plan. </a></div><div id="a53704" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:545px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000011/exhibit1046_2016.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.46 to our Annual Report on Form 10-K for </a></div><div id="a53708" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:563px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000011/exhibit1046_2016.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 31, 2016 filed on February 21, 2017.)**</a></div><div id="a53712" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:601px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1032.htm" style="color:#0000FF;text-decoration:underline;">10.22</a></div><div id="a53715" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:601px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1032.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Five to the Henry Schein, Inc. Deferred Compensation Plan. </a></div><div id="a53716" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:620px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1032.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.32 to our Annual Report on Form 10-K for</a></div><div id="a53722" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:638px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000018/d848607dex1032.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 28, 2020 filed on February 20, 2020.)**</a></div><div id="a53726" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:676px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex104.htm" style="color:#0000FF;text-decoration:underline;">10.23</a></div><div id="a53729" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:676px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex104.htm" style="color:#0000FF;text-decoration:underline;">Amendment Number Six to the Henry Schein, Inc. Deferred Compensation Plan. </a></div><div id="a53730" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:694px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex104.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.4 to our Quarterly Report on Form 10-Q </a></div><div id="a53733" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:713px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000034/d889896dex104.htm" style="color:#0000FF;text-decoration:underline;">for the fiscal quarter ended March 28, 2020 filed on May 5, 2020.)**</a></div><div id="a53737" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:751px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit107_1q14.htm" style="color:#0000FF;text-decoration:underline;">10.24</a></div><div id="a53740" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:751px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit107_1q14.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein Management Team Performance Incentive Plan and Plan Summary, </a></div><div id="a53742" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:769px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit107_1q14.htm" style="color:#0000FF;text-decoration:underline;">effective as of January 1, 2014. (Incorporated by reference to Exhibit 10.7 to our </a></div><div id="a53743" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:788px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit107_1q14.htm" style="color:#0000FF;text-decoration:underline;">Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, 2014 filed </a></div><div id="a53748" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:806px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit107_1q14.htm" style="color:#0000FF;text-decoration:underline;">on May 6, 2014.)**</a></div><div id="a53752" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:844px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312519217405/d770264dex102.htm" style="color:#0000FF;text-decoration:underline;">10.25</a></div><div id="a53755" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:844px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312519217405/d770264dex102.htm" style="color:#0000FF;text-decoration:underline;">Form of Performance-Based RSU Award Agreement<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>for Stanley M. Bergman </a></div><div id="a53758" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:862px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312519217405/d770264dex102.htm" style="color:#0000FF;text-decoration:underline;">Pursuant to the Henry Schein, Inc. 2013 Stock Incentive Plan (as Amended and </a></div><div id="a53760" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:881px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312519217405/d770264dex102.htm" style="color:#0000FF;text-decoration:underline;">Restated as of May 14, 2013). (Incorporated by reference to Exhibit 10.2 to our </a></div><div id="a53763" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:899px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312519217405/d770264dex102.htm" style="color:#0000FF;text-decoration:underline;">Current Report on Form 8-K filed on August 9, 2019.)**</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page124" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a53771" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a53774" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">124 </div><div id="a53776" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312522293869/d420796dex101.htm" style="color:#0000FF;text-decoration:underline;">10.26</a></div><div id="a53779" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312522293869/d420796dex101.htm" style="color:#0000FF;text-decoration:underline;">Amended and Restated Employment Agreement dated as of November 28, 2022, </a></div><div id="a53780" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312522293869/d420796dex101.htm" style="color:#0000FF;text-decoration:underline;">by and between Henry Schein, Inc. and Stanley M. Bergman. (Incorporated by </a></div><div id="a53781" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:97px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312522293869/d420796dex101.htm" style="color:#0000FF;text-decoration:underline;">reference to Exhibit 10.1 to our Current Report on Form 8-K filed on November </a></div><div id="a53787" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:115px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312522293869/d420796dex101.htm" style="color:#0000FF;text-decoration:underline;">29, 2022.)**</a></div><div id="a53791" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:153px;"><a href="exhibit1027.htm" style="color:#0000FF;text-decoration:underline;">10.27</a></div><div id="a53793" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:153px;"><a href="exhibit1027.htm" style="color:#0000FF;text-decoration:underline;">Letter Agreement dated November 11, 2021 between Henry Schein, Inc. and Brad </a></div><div id="a53794" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:171px;"><a href="exhibit1027.htm" style="color:#0000FF;text-decoration:underline;">Connett.**+</a></div><div id="a53798" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:209px;"><a href="exhibit1028.htm" style="color:#0000FF;text-decoration:underline;">10.28</a></div><div id="a53800" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:209px;"><a href="exhibit1028.htm" style="color:#0000FF;text-decoration:underline;">Agreement dated November 11, 2021 between Henry Schein, Inc. and Brad </a></div><div id="a53801" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:228px;"><a href="exhibit1028.htm" style="color:#0000FF;text-decoration:underline;">Connett.**+</a></div><div id="a53805" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:270px;"><a href="exhibit1029.htm" style="color:#0000FF;text-decoration:underline;">10.29</a></div><div id="a53807" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:270px;"><a href="exhibit1029.htm" style="color:#0000FF;text-decoration:underline;">Special Incentive Plan dated May 24, 2021 between Henry Schein, Inc. and Brad </a></div><div id="a53809" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:289px;"><a href="exhibit1029.htm" style="color:#0000FF;text-decoration:underline;">Connett.**#+</a></div><div id="a53813" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:327px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">10.30</a></div><div id="a53816" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:327px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">Form of Amended and Restated Change in Control Agreement dated December 12, </a></div><div id="a53817" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:345px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">2008 between us and certain executive officers who are a party thereto (James </a></div><div id="a53818" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:363px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">Breslawski, Michael S. Ettinger, Mark Mlotek and Steven Paladino, respectively). </a></div><div id="a53820" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:382px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">(Incorporated by reference to Exhibit 10.15 to our Annual Report on Form 10-K for </a></div><div id="a53823" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:400px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022809000011/exhibit10_152008.htm" style="color:#0000FF;text-decoration:underline;">the fiscal year ended December 27, 2008 filed on February 24, 2009.)**</a></div><div id="a53827" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:438px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">10.31</a></div><div id="a53830" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:438px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">Form of Amendment to Amended and Restated Change in Control Agreement</a></div><div id="a53832" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:457px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">effective January 1, 2012 between us and certain executive officers who are a party </a></div><div id="a53833" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:475px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">thereto (James Breslawski, Michael S. Ettinger, Mark Mlotek and Steven Paladino, </a></div><div id="a53834" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:493px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">respectively). (Incorporated by reference to Exhibit 10.1 to our Current Report on </a></div><div id="a53835" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:512px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312512018752/d285204dex101.htm" style="color:#0000FF;text-decoration:underline;">Form 8-K filed on January 20, 2012.)**</a></div><div id="a53841" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:550px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit103.htm" style="color:#0000FF;text-decoration:underline;">10.32</a></div><div id="a53844" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:550px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit103.htm" style="color:#0000FF;text-decoration:underline;">Form of Change in Control Agreement between us and certain executive officers</a></div><div id="a53868" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:568px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit103.htm" style="color:#0000FF;text-decoration:underline;">who are a party thereto (Walter Siegel).<span style="display:inline-block;width:9px;text-decoration:underline">&nbsp;</span>(Incorporated by reference to Exhibit 10.3</a></div><div id="a53895" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:586px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit103.htm" style="color:#0000FF;text-decoration:underline;">to our Quarterly Report on Form 10-Q for the fiscal quarter ended March 30, 2019</a></div><div id="a53927" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:605px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000030/exhibit103.htm" style="color:#0000FF;text-decoration:underline;">filed on May 7, 2019.)</a></div><div id="a53936" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:283px;top:605px;">**</div><div id="a53940" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:643px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">10.33</a></div><div id="a53943" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:643px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">Henry Schein, Inc. Executive Change in Control Plan, effective as of May 2, 2022</a></div><div id="a53957" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:661px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">between us and certain executive officers who are a party thereto (Ronald N. South, </a></div><div id="a53958" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:680px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">Brad Connett, David Brous, and Lorelei McGlynn). (Incorporated by reference to</a></div><div id="a53967" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:698px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.3 to our Quarterly Report on Form 10-Q for the fiscal quarter ended</a></div><div id="a53997" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:716px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022822000033/ex103.htm" style="color:#0000FF;text-decoration:underline;">March 26, 2022 filed on May 3, 2022.)**</a></div><div id="a54017" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:754px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">10.34</a></div><div id="a54020" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:754px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">Form of Indemnification Agreement between us and certain directors and executive </a></div><div id="a54021" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:773px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">officers who are a party thereto (Mohamed Ali, Deborah Derby, Joseph L. Herring, </a></div><div id="a54023" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:791px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">Kurt P.<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Kuehn, Philip A. Laskawy, Anne H. Margulies, Steven Paladino, Carol </a></div><div id="a54024" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:810px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">Raphael, Scott P.<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Serota, Bradley T. Sheares, Ph.D., Reed V.<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Tuckson, M.D., </a></div><div id="a54025" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:828px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">FACP,<span style="display:inline-block;width:7px;text-decoration:underline">&nbsp;</span>Stanley M. Bergman, James P.<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Breslawski, David Brous, Brad Connett, </a></div><div id="a54028" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:846px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">Michael S. Ettinger, Lorelei McGlynn, Mark E. Mlotek, Walter<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Siegel and Ronald </a></div><div id="a54030" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:865px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">N. South, respectively). (Incorporated by reference to Exhibit 10.1 to our Quarterly </a></div><div id="a54031" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:883px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 10-Q for the fiscal quarter ended September 26, 2015 filed on </a></div><div id="a54034" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:902px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022815000035/exhibit101_3q15.htm" style="color:#0000FF;text-decoration:underline;">November 4, 2015.)**</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page125" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a54038" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a54041" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">125 </div><div id="a54043" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521253351/d169457dex101.htm" style="color:#0000FF;text-decoration:underline;">10.35</a></div><div id="a54046" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521253351/d169457dex101.htm" style="color:#0000FF;text-decoration:underline;">Amended and Restated Revolving Credit Agreement, dated as of August 20, 2021,</a></div><div id="a54071" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521253351/d169457dex101.htm" style="color:#0000FF;text-decoration:underline;">among us, the several lenders parties thereto, and JPMorgan Chase Bank, N.A., as</a></div><div id="a54097" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:97px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521253351/d169457dex101.htm" style="color:#0000FF;text-decoration:underline;">administrative agent. (Incorporated by reference to Exhibit 10.1 to our Current</a></div><div id="a54119" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:115px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521253351/d169457dex101.htm" style="color:#0000FF;text-decoration:underline;">Report on Form 8-K filed on August 23, 2021.)</a></div><div id="a54141" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:153px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">10.36</a></div><div id="a54144" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:153px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">Receivables Purchase Agreement, dated as of April 17, 2013, by and among us, as </a></div><div id="a54145" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:171px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">servicer, HSFR, Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., as agent </a></div><div id="a54149" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:190px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">and the various purchaser groups from time to time party thereto.<span style="display:inline-block;width:8px;text-decoration:underline">&nbsp;</span>(Incorporated by </a></div><div id="a54153" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:208px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 19, </a></div><div id="a54156" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:227px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex101.htm" style="color:#0000FF;text-decoration:underline;">2013.)</a></div><div id="a54159" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:264px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">10.37</a></div><div id="a54162" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:264px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 1 dated as of September 22, 2014 to the Receivables Purchase </a></div><div id="a54164" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:283px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., </a></div><div id="a54165" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:301px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, LTD.,<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>New York<span style="display:inline-block;width:6px;text-decoration:underline">&nbsp;</span>Branch, as agent </a></div><div id="a54168" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:320px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">and the various purchaser groups from time to time party thereto. (Incorporated by </a></div><div id="a54170" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:338px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">reference to Exhibit 10.2 to our Current Report on Form 8-K filed on September </a></div><div id="a54173" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:357px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312514353796/d794216dex102.htm" style="color:#0000FF;text-decoration:underline;">26, 2014.)</a></div><div id="a54177" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:394px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">10.38</a></div><div id="a54180" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:394px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 2 dated as of April 17, 2015 to Receivables Purchase Agreement, </a></div><div id="a54181" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:413px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, as performance guarantor, HSFR, </a></div><div id="a54182" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:431px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., New York<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Branch, as </a></div><div id="a54186" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:450px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">agent and the various purchaser groups party thereto. (Incorporated by reference to </a></div><div id="a54187" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:468px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended </a></div><div id="a54190" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:486px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">June 25, 2016 filed on August 4, 2016.)</a></div><div id="a54194" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:524px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">10.39</a></div><div id="a54197" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:524px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 3 dated as of June 1, 2016 to Receivables Purchase Agreement, </a></div><div id="a54198" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:543px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, as performance guarantor, HSFR, </a></div><div id="a54200" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:561px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., New York<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Branch, as </a></div><div id="a54203" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:580px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">agent and the various purchaser groups party thereto. (Incorporated by reference to </a></div><div id="a54204" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:598px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.2 to our Quarterly Report on Form 10-Q for the fiscal quarter ended </a></div><div id="a54208" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:616px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022816000090/exhibit102.htm" style="color:#0000FF;text-decoration:underline;">June 25, 2016 filed on August 4, 2016.)</a></div><div id="a54212" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:654px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">10.40</a></div><div id="a54215" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:654px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 4 dated as of July 6, 2017 to Receivables Purchase Agreement, </a></div><div id="a54216" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:673px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, as performance guarantor, HSFR, </a></div><div id="a54217" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:691px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., New York<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Branch, as </a></div><div id="a54222" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:709px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">agent and the various purchaser groups party thereto.<span style="display:inline-block;width:8px;text-decoration:underline">&nbsp;</span>(Incorporated by reference to </a></div><div id="a54226" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:728px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended </a></div><div id="a54229" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:746px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022817000058/exhibit101.htm" style="color:#0000FF;text-decoration:underline;">September 30, 2017 filed on November 6, 2017.)</a></div><div id="a54234" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:784px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">10.41</a></div><div id="a54237" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:784px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 5 dated as of May 13, 2019 to Receivables Purchase Agreement, </a></div><div id="a54239" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:803px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, as performance guarantor, HSFR, </a></div><div id="a54240" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:821px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., New York<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>Branch, as </a></div><div id="a54243" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:839px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">agent and the various purchaser groups party thereto. (Incorporated by reference to</a></div><div id="a54254" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:858px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">Exhibit 10.1 to our Quarterly Report on Form 10-Q for the fiscal quarter ended</a></div><div id="a54284" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:876px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022819000048/d778189dex101.htm" style="color:#0000FF;text-decoration:underline;">June 29, 2019 filed on August 6, 2019.)</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page126" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a54302" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a54305" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">126 </div><div id="a54307" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">10.42</a></div><div id="a54310" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">Limited Waiver dated as of May 22, 2020 to Receivables Purchase Agreement, </a></div><div id="a54313" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as seller, </a></div><div id="a54314" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:97px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">lender, as agent and the various purchaser groups from time to time party thereto, </a></div><div id="a54315" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:115px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">as amended. (Incorporated by reference to Exhibit 10.7 to our Quarterly Report on </a></div><div id="a54318" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:133px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022820000055/d26627dex107.htm" style="color:#0000FF;text-decoration:underline;">Form 10-Q for the fiscal quarter ended June 27, 2020 filed on August 4, 2020.)</a></div><div id="a54324" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:171px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">10.43</a></div><div id="a54327" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:171px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 6 dated as of June 22, 2020 to the Receivables Purchase </a></div><div id="a54329" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:190px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., </a></div><div id="a54330" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:208px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">as seller, lender, as agent<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>and the various purchaser groups from time to time party </a></div><div id="a54331" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:227px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">thereto. (Incorporated by reference to Exhibit 10.1 to our Current Report on Form </a></div><div id="a54333" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:245px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312520178254/d948426dex101.htm" style="color:#0000FF;text-decoration:underline;">8-K filed on June 25, 2020.)</a></div><div id="a54339" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:283px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">10.44</a></div><div id="a54342" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:283px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 7 dated as of October 20, 2021 to Receivables Purchase </a></div><div id="a54343" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:301px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., </a></div><div id="a54344" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:320px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">as seller, lender, as agent<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>and the various purchaser groups from time to time party </a></div><div id="a54346" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:338px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">thereto. (Incorporated by reference to Exhibit 10.1 to our Current Report on Form </a></div><div id="a54347" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:357px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312521303524/d245093dex101.htm" style="color:#0000FF;text-decoration:underline;">8-K filed on October 21, 2021.)</a></div><div id="a54353" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:394px;"><a href="exhibit1045.htm" style="color:#0000FF;text-decoration:underline;">10.45</a></div><div id="a54355" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:394px;"><a href="exhibit1045.htm" style="color:#0000FF;text-decoration:underline;">Amendment No. 8 dated as of December 15, 2022 to Receivables Purchase </a></div><div id="a54356" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:413px;"><a href="exhibit1045.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., </a></div><div id="a54357" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:431px;"><a href="exhibit1045.htm" style="color:#0000FF;text-decoration:underline;">as seller, lender, as agent<span style="display:inline-block;width:5px;text-decoration:underline">&nbsp;</span>and the various purchaser groups from time to time party </a></div><div id="a54359" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:450px;"><a href="exhibit1045.htm" style="color:#0000FF;text-decoration:underline;">thereto.*+</a></div><div id="a54363" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:488px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">10.46</a></div><div id="a54366" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:488px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">Omnibus Amendment No. 1, dated July 22, 2013, to Receivables Purchase </a></div><div id="a54369" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:506px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">Agreement dated as of April 17, 2013, by and among us, as servicer, HSFR, Inc., as </a></div><div id="a54370" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:524px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., as agent, and the various </a></div><div id="a54373" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:543px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">purchaser groups from time to time party thereto and Receivables Sales Agreement, </a></div><div id="a54375" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:561px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">dated as of April 17, 2013, by and among us, certain of our wholly-owned </a></div><div id="a54378" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:580px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">subsidiaries and HSFR, Inc., as buyer.<span style="display:inline-block;width:9px;text-decoration:underline">&nbsp;</span>(Incorporated by reference to Exhibit 10.5 </a></div><div id="a54382" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:598px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">to our Quarterly Report on Form 10-Q for the fiscal quarter ended June 29, 2013 </a></div><div id="a54386" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:616px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022813000030/exhibit10_52q13.htm" style="color:#0000FF;text-decoration:underline;">filed on August 6, 2013.)</a></div><div id="a54390" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:654px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">10.47</a></div><div id="a54393" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:654px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">Omnibus Amendment No. 2, dated April 21, 2014, to Receivables Purchase </a></div><div id="a54394" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:673px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">Agreement dated as of April 17, 2013, as amended, by and among us, as servicer, </a></div><div id="a54395" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:691px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">HSFR, Inc., as seller, The Bank of Tokyo<span style="display:inline-block;width:2px;text-decoration:underline">&nbsp;</span>-Mitsubishi UFJ, Ltd., as agent, and the </a></div><div id="a54400" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:709px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">various purchaser groups from time to time party thereto and Receivables Sales </a></div><div id="a54401" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:728px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">Agreement, dated as of April 17, 2013, by and among us, certain of our wholly-</a></div><div id="a54403" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:746px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">owned subsidiaries and HSFR, Inc., as buyer. (Incorporated by reference to Exhibit </a></div><div id="a54405" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:765px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">10.8 to our Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, </a></div><div id="a54410" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:783px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000100022814000017/exhibit108_1q14.htm" style="color:#0000FF;text-decoration:underline;">2014 filed on May 6, 2014.)</a></div><div id="a54414" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:821px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex102.htm" style="color:#0000FF;text-decoration:underline;">10.48</a></div><div id="a54417" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:821px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex102.htm" style="color:#0000FF;text-decoration:underline;">Receivables Sale Agreement, dated as of April 17, 2013, by and among us, certain </a></div><div id="a54419" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:839px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex102.htm" style="color:#0000FF;text-decoration:underline;">of our wholly-owned subsidiaries and HSFR, Inc., as buyer.<span style="display:inline-block;width:9px;text-decoration:underline">&nbsp;</span>(Incorporated by </a></div><div id="a54425" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:858px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex102.htm" style="color:#0000FF;text-decoration:underline;">reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 19, </a></div><div id="a54428" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:876px;"><a href="http://www.sec.gov/Archives/edgar/data/1000228/000119312513161803/d523250dex102.htm" style="color:#0000FF;text-decoration:underline;">2013.)</a></div><div id="a54432" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:914px;"><a href="exhibit211.htm" style="color:#0000FF;text-decoration:underline;">21.1</a></div><div id="a54434" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:914px;"><a href="exhibit211.htm" style="color:#0000FF;text-decoration:underline;">List of our Subsidiaries.+</a></div><div id="a54438" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:952px;"><a href="exhibit231.htm" style="color:#0000FF;text-decoration:underline;">23.1</a></div><div id="a54440" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:952px;"><a href="exhibit231.htm" style="color:#0000FF;text-decoration:underline;">Consent of BDO USA, LLP.+</a></div></div>
</div>
<div style="padding: 7px">
<div id="Page127" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div id="a54444" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a54447" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">127 </div><div id="a54449" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:60px;"><a href="exhibit311.htm" style="color:#0000FF;text-decoration:underline;">31.1</a></div><div id="a54451" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:60px;"><a href="exhibit311.htm" style="color:#0000FF;text-decoration:underline;">Certification of our Chief Executive Officer pursuant to Section 302 of the </a></div><div id="a54453" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:78px;"><a href="exhibit311.htm" style="color:#0000FF;text-decoration:underline;">Sarbanes-Oxley Act of 2002.+</a></div><div id="a54459" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:116px;"><a href="exhibit312.htm" style="color:#0000FF;text-decoration:underline;">31.2</a></div><div id="a54461" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:116px;"><a href="exhibit312.htm" style="color:#0000FF;text-decoration:underline;">Certification of our Chief Financial Officer pursuant to Section 302 of the </a></div><div id="a54462" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:135px;"><a href="exhibit312.htm" style="color:#0000FF;text-decoration:underline;">Sarbanes-Oxley Act of 2002.+</a></div><div id="a54468" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:67px;top:172px;"><a href="exhibit321.htm" style="color:#0000FF;text-decoration:underline;">32.1</a></div><div id="a54470" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:172px;"><a href="exhibit321.htm" style="color:#0000FF;text-decoration:underline;">Certification of our Chief Executive Officer and Chief Financial Officer pursuant </a></div><div id="a54471" style="position:absolute;font-family:'Times New Roman';font-size:16px;color:#0000FF;left:139px;top:191px;"><a href="exhibit321.htm" style="color:#0000FF;text-decoration:underline;">to Section 906 of the Sarbanes-Oxley Act of 2002.+</a></div><div id="a54477" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:228px;">101.INS </div><div id="a54479" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:228px;">Inline XBRL Instance Document - the instance document does not </div><div id="a54500" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:247px;">appear in the Interactive Data File because its XBRL tags are embedded </div><div id="a54524" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:266px;">within the Inline XBRL document.+ </div><div id="a54534" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:287px;">101.SCH </div><div id="a54536" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:287px;">Inline XBRL Taxonomy Extension Schema Document+ </div><div id="a54548" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:308px;">101.CAL </div><div id="a54550" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:308px;">Inline XBRL Taxonomy Extension Calculation Linkbase Document+ </div><div id="a54564" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:328px;">101.DEF </div><div id="a54566" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:328px;">Inline XBRL Taxonomy Extension Definition Linkbase Document+ </div><div id="a54580" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:349px;">101.LAB </div><div id="a54582" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:349px;">Inline XBRL Taxonomy Extension Label Linkbase Document+ </div><div id="a54596" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:370px;">101.PRE </div><div id="a54598" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:370px;">Inline XBRL Taxonomy Extension Presentation Linkbase Document+ </div><div id="a54612" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:390px;">104 </div><div id="a54614" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:390px;">The cover page of Henry Schein, Inc.’s Annual Report on Form 10-K </div><div id="a54640" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:410px;">for the year ended December 31, 2022, formatted in Inline XBRL </div><div id="a54662" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:142px;top:429px;">(included within Exhibit 101 attachments).+ </div><div id="a54672" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:449px;">_________ </div><div id="a54675" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:477px;">+<div style="display:inline-block;width:20px">&nbsp;</div>Filed or furnished herewith. </div><div id="a54683" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:504px;">* Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company </div><div id="a54687" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:523px;">hereby agrees to furnish supplementally a copy of any of the omitted schedules and exhibits upon request </div><div id="a54688" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:541px;">by the U.S. Securities and Exchange Commission. </div><div id="a54691" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:578px;">**<div style="display:inline-block;width:12px">&nbsp;</div>Indicates management contract or compensatory plan or agreement. </div><div id="a54698" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:615px;"># Certain identified information has been excluded from the exhibit because it is both not material and is </div><div id="a54699" style="position:absolute;font-family:'Times New Roman';font-size:16px;left:67px;top:633px;">the type that the registrant treats as private or confidential. </div><div id="a54703" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:67px;top:685px;">ITEM 16.<div style="display:inline-block;width:7px">&nbsp;</div>Form 10-K Summary </div><div id="a54708" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:717px;">None. </div></div>
</div>
<div style="padding: 7px">
<div id="Page128" style="background-color:RGB(255, 255, 255);position:relative;margin-left:auto;margin-right:auto;overflow:hidden;border-style:solid;border-width:thin;border-color:RGB(198, 198, 198);page-break-after:always;width:816px;height:1056px;">
<div style="position:absolute; width:319.3px; height:1px; left:378.9px; top:178.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:282.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:307.1px; height:1px; left:294.9px; top:282.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:117px; height:1px; left:610px; top:282.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:305.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:348px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:388.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:429.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:469.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:510.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:550.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:591.7px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:632.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:673.1px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:712.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:752.8px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:792.9px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:831.6px; background-color:#000000; ">&nbsp;</div>
<div style="position:absolute; width:220.1px; height:1px; left:66.8px; top:875.3px; background-color:#000000; ">&nbsp;</div>
<div id="a54710" style="position:absolute;font-family:'Times New Roman';color:#0000FF;left:67px;top:29px;"><a href="#a280" style="color:#0000FF;text-decoration:underline;">Table of Contents</a></div><div id="a54713" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:397px;top:997px;">128 </div><div id="a54715" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;font-weight:bold;left:360px;top:60px;">SIGNATURES </div><div id="a54718" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:86px;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange<div style="display:inline-block;width:2px">&nbsp;</div>Act of 1934, the Registrant has duly </div><div id="a54719" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:103px;">caused this report to be signed on its behalf by the undersigned,<div style="display:inline-block;width:2px">&nbsp;</div>thereunto duly authorized.<div style="display:inline-block;width:3px">&nbsp;</div></div><div id="a54723" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:129px;">Henry Schein, Inc. </div><div id="a54728" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:162px;">By: /s/ STANLEY M. BERGMAN </div><div id="a54732" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:180px;">Stanley M. Bergman </div><div id="a54735" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:197px;">Chairman and Chief Executive Officer </div><div id="a54738" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:386px;top:214px;">February 21, 2023 </div><div id="a54740" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:230px;">Pursuant to the requirements of the Securities Exchange Act of 1934, this<div style="display:inline-block;width:2px">&nbsp;</div>report has been signed below by the </div><div id="a54741" style="position:absolute;font-family:'Times New Roman';font-size:14.72px;left:67px;top:247px;">following persons on behalf of the Registrant and in the capacities and on<div style="display:inline-block;width:2px">&nbsp;</div>the dates indicated. </div><div id="a54743" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:149px;top:268px;">Signature </div><div id="a54746" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:423px;top:268px;">Capacity </div><div id="a54749" style="position:absolute;font-family:'Times New Roman';font-weight:bold;left:655px;top:268px;">Date </div><div id="a54756" style="position:absolute;font-family:'Times New Roman';left:67px;top:291px;">/s/ STANLEY M. BERGMAN </div><div id="a54760" style="position:absolute;font-family:'Times New Roman';left:295px;top:291px;">Chairman, Chief Executive Officer </div><div id="a54763" style="position:absolute;font-family:'Times New Roman';left:620px;top:291px;">February 21, 2023 </div><div id="a54765" style="position:absolute;font-family:'Times New Roman';left:67px;top:310px;">Stanley M. Bergman </div><div id="a54768" style="position:absolute;font-family:'Times New Roman';left:295px;top:310px;">and Director (principal executive officer) </div><div id="a54777" style="position:absolute;font-family:'Times New Roman';left:67px;top:333px;">/s/ RONALD N. SOUTH </div><div id="a54780" style="position:absolute;font-family:'Times New Roman';left:295px;top:333px;">Senior Vice President, Chief<div style="display:inline-block;width:5px">&nbsp;</div>Financial Officer </div><div id="a54783" style="position:absolute;font-family:'Times New Roman';left:620px;top:333px;">February 21, 2023 </div><div id="a54785" style="position:absolute;font-family:'Times New Roman';left:67px;top:351px;">Ronald N. South </div><div id="a54788" style="position:absolute;font-family:'Times New Roman';left:295px;top:351px;"><div style="display:inline-block;width:3px">&nbsp;</div>(principal financial and accounting officer) </div><div id="a54798" style="position:absolute;font-family:'Times New Roman';left:67px;top:374px;">/s/ JAMES P.<div style="display:inline-block;width:5px">&nbsp;</div>BRESLAWSKI </div><div id="a54801" style="position:absolute;font-family:'Times New Roman';left:295px;top:374px;">Vice Chairman, President<div style="display:inline-block;width:5px">&nbsp;</div>and Director </div><div id="a54804" style="position:absolute;font-family:'Times New Roman';left:620px;top:374px;">February 21, 2023 </div><div id="a54806" style="position:absolute;font-family:'Times New Roman';left:67px;top:392px;">James P.<div style="display:inline-block;width:5px">&nbsp;</div>Breslawski </div><div id="a54817" style="position:absolute;font-family:'Times New Roman';left:67px;top:415px;">/s/ MARK E. MLOTEK </div><div id="a54820" style="position:absolute;font-family:'Times New Roman';left:295px;top:415px;">Director </div><div id="a54823" style="position:absolute;font-family:'Times New Roman';left:620px;top:415px;">February 21, 2023 </div><div id="a54825" style="position:absolute;font-family:'Times New Roman';left:67px;top:433px;">Mark E. Mlotek </div><div id="a54836" style="position:absolute;font-family:'Times New Roman';left:67px;top:455px;">/s/ MOHAMAD ALI </div><div id="a54840" style="position:absolute;font-family:'Times New Roman';left:295px;top:455px;">Director </div><div id="a54843" style="position:absolute;font-family:'Times New Roman';left:620px;top:455px;">February 21, 2023 </div><div id="a54845" style="position:absolute;font-family:'Times New Roman';left:67px;top:473px;">Mohamad Ali </div><div id="a54856" style="position:absolute;font-family:'Times New Roman';left:67px;top:495px;">/s/ DEBORAH DERBY </div><div id="a54859" style="position:absolute;font-family:'Times New Roman';left:295px;top:495px;">Director </div><div id="a54862" style="position:absolute;font-family:'Times New Roman';left:620px;top:495px;">February 21, 2023 </div><div id="a54864" style="position:absolute;font-family:'Times New Roman';left:67px;top:513px;">Deborah Derby </div><div id="a54875" style="position:absolute;font-family:'Times New Roman';left:67px;top:536px;">/s/ JOSEPH L. HERRING </div><div id="a54878" style="position:absolute;font-family:'Times New Roman';left:295px;top:536px;">Director </div><div id="a54881" style="position:absolute;font-family:'Times New Roman';left:620px;top:536px;">February 21, 2023 </div><div id="a54883" style="position:absolute;font-family:'Times New Roman';left:67px;top:554px;">Joseph L. Herring </div><div id="a54894" style="position:absolute;font-family:'Times New Roman';left:67px;top:577px;">/s/ KURT P.<div style="display:inline-block;width:6px">&nbsp;</div>KUEHN </div><div id="a54897" style="position:absolute;font-family:'Times New Roman';left:295px;top:577px;">Director </div><div id="a54900" style="position:absolute;font-family:'Times New Roman';left:620px;top:577px;">February 21, 2023 </div><div id="a54902" style="position:absolute;font-family:'Times New Roman';left:67px;top:595px;">Kurt P.<div style="display:inline-block;width:5px">&nbsp;</div>Kuehn </div><div id="a54913" style="position:absolute;font-family:'Times New Roman';left:67px;top:618px;">/s/ PHILIP A. LASKAWY </div><div id="a54916" style="position:absolute;font-family:'Times New Roman';left:295px;top:618px;">Director </div><div id="a54919" style="position:absolute;font-family:'Times New Roman';left:620px;top:618px;">February 21, 2023 </div><div id="a54921" style="position:absolute;font-family:'Times New Roman';left:67px;top:636px;">Philip A. Laskawy </div><div id="a54932" style="position:absolute;font-family:'Times New Roman';left:67px;top:659px;">/s/ ANNE H. MARGULIES </div><div id="a54935" style="position:absolute;font-family:'Times New Roman';left:295px;top:659px;">Director </div><div id="a54938" style="position:absolute;font-family:'Times New Roman';left:620px;top:659px;">February 21, 2023 </div><div id="a54940" style="position:absolute;font-family:'Times New Roman';left:67px;top:675px;">Anne H. Margulies </div><div id="a54951" style="position:absolute;font-family:'Times New Roman';left:67px;top:698px;">/s/ STEVEN PALADINO </div><div id="a54954" style="position:absolute;font-family:'Times New Roman';left:295px;top:698px;">Director </div><div id="a54957" style="position:absolute;font-family:'Times New Roman';left:620px;top:698px;">February 21, 2023 </div><div id="a54960" style="position:absolute;font-family:'Times New Roman';left:67px;top:715px;">Steven Paladino </div><div id="a54971" style="position:absolute;font-family:'Times New Roman';left:67px;top:738px;">/s/ CAROL RAPHAEL </div><div id="a54974" style="position:absolute;font-family:'Times New Roman';left:295px;top:738px;">Director </div><div id="a54977" style="position:absolute;font-family:'Times New Roman';left:620px;top:738px;">February 21, 2023 </div><div id="a54979" style="position:absolute;font-family:'Times New Roman';left:67px;top:757px;">Carol Raphael </div><div id="a54990" style="position:absolute;font-family:'Times New Roman';left:67px;top:778px;">/s/ SCOTT SEROTA </div><div id="a54993" style="position:absolute;font-family:'Times New Roman';left:295px;top:778px;">Director </div><div id="a54996" style="position:absolute;font-family:'Times New Roman';left:620px;top:778px;">February 21, 2023 </div><div id="a54998" style="position:absolute;font-family:'Times New Roman';left:67px;top:794px;">Scott Serota </div><div id="a55009" style="position:absolute;font-family:'Times New Roman';left:67px;top:817px;">/s/ BRADLEY T. SHEARES,<div style="display:inline-block;width:5px">&nbsp;</div>PH. D. </div><div id="a55012" style="position:absolute;font-family:'Times New Roman';left:295px;top:817px;">Director </div><div id="a55015" style="position:absolute;font-family:'Times New Roman';left:620px;top:817px;">February 21, 2023 </div><div id="a55017" style="position:absolute;font-family:'Times New Roman';left:67px;top:836px;">Bradley T.<div style="display:inline-block;width:5px">&nbsp;</div>Sheares, Ph. D. </div><div id="a55029" style="position:absolute;font-family:'Times New Roman';left:67px;top:861px;">/s/ REED V.<div style="display:inline-block;width:5px">&nbsp;</div>TUCKSON, M.D., FACP </div><div id="a55032" style="position:absolute;font-family:'Times New Roman';left:295px;top:861px;">Director </div><div id="a55035" style="position:absolute;font-family:'Times New Roman';left:620px;top:861px;">February 21, 2023 </div><div id="a55037" style="position:absolute;font-family:'Times New Roman';left:67px;top:880px;">Reed V.<div style="display:inline-block;width:5px">&nbsp;</div>Tuckson, M.D., FACP </div></div>
</div>
</div>


</body></html>
